VAERS Reports #EW0183

VAERS 2723148

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EW0183

kritisch

Staat: TX
Alter: 73,0
Geschlecht: F
Eingang: 12.12.2023
Impfdatum: 31.08.2021
Beginn: 14.01.2022
Tage bis Beginn: 136,0
Dosis: 2
Route/Site: IM / UN

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: nein

Acute respiratory failure COVID-19 pneumonia

Symptomtext

Acute hypoxic respiratory failure due to Covid 19 pneumonia: Was on HFNC. Now on NC 3L liters/minute. Wean off as tolerated, received Remdesivir, on IV steroids, will change to oral prednisone taper. VQ with no PE. Better, she is off of precautions today. OK for home today, home O2 arragned, f/u noted , ER precautions d/w pt, med reconciled, eliquis with card for one month

Weitere VAERSDATA-Felder

Praegender Schweregrund: Acute respiratory failure
Hospital-Tage: 12,0
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2719967

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EW0183

kritisch

Staat: TX
Alter: 48,0
Geschlecht: M
Eingang: 01.12.2023
Impfdatum: 12.05.2021
Beginn: 29.01.2022
Tage bis Beginn: 262,0
Dosis: 2
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: ja

Acute myocardial infarction COVID-19 Chest pain Electrocardiogram ST segment elevation Pain Pain in extremity Percutaneous coronary intervention SARS-CoV-2 test positive Sinus tachycardia

Symptomtext

Patient presents emergency department with complaints of chest pain that started 1 hour prior to arrival. Patient reported pain as being constant and severe radiating to the right arm and right side of the chest. On arrival to the ED showed sinus tachycardia with ST elevation in leads V2 to be 5. STEMI was activated. Patient was also found to be covid positive. Patient was admitted for a STEMI with clinical course complicated by Covid-19. Patient had a PCI done of LCX. Patient was discharged home.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Acute myocardial infarction
Hospital-Tage: 2,0
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2650499

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EW0183

kritisch

Staat: -
Alter: 28,0
Geschlecht: M
Eingang: 28.06.2023
Impfdatum: 06.05.2021
Beginn: 17.04.2023
Tage bis Beginn: 711,0
Dosis: 2
Route/Site: UN / UN

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: nein

Acute respiratory failure Respiratory failure Sleep apnoea syndrome

Symptomtext

G47.30 SLEEP APNEA 4/20/2023 ACUTE ON CHRONIC HYPOXEMIC RESPIRATORY FAILURE J96.21 ACUTE ON CHRONIC HYPOXEMIC RESPIRATORY FAILURE 4/17/2023 ACUTE ON CHRONIC HYPOXEMIC RESPIRATORY FAILURE J96.90 RESPIRATORY FAILURE, UNSPECIFIED ACUITY 5/1/2023 ACUTE ON CHRONIC HYPOXEMIC RESPIRATORY FAILURE

Weitere VAERSDATA-Felder

Praegender Schweregrund: Acute respiratory failure
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2640996

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EW0183

kritisch

Staat: MI
Alter: 14,0
Geschlecht: F
Eingang: 05.06.2023
Impfdatum: 24.06.2021
Beginn: 02.05.2023
Tage bis Beginn: 677,0
Dosis: 2
Route/Site: - / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: ja

Acute respiratory failure Adenovirus infection Adenovirus test positive Bladder catheterisation Blood culture negative COVID-19 Chest X-ray abnormal Clostridium test negative Condition aggravated Cough Diarrhoea Electroencephalogram Hypoxia Intensive care Laboratory test Leukocytosis Lung opacity Metabolic function test normal

Symptomtext

Discharge Provider: MD Primary Care Physician at Discharge: DO Admission Date: 5/2/2023 Discharge Date: 5/13/2023 DETAILS OF HOSPITAL STAY: Pneumonia due to organism Acute respiratory failure with hypoxia (HCC) Acute hypoxemic respiratory failure due to COVID-19 (HCC) HOSPITAL COURSE: Patient is a 16 y.o. female with past medical history including agenesis of the corpus callosum, cerebral palsy, global developmental delay, epilepsy with VNS device, and G-tube dependence who presented on 5/2/23 with four day history of cough and one day history of increased congestion, secretions, fever, and hypoxia requiring increased oxygen at home. Mother also noted increased seizure frequency, and she held home feeds due to poor tolerance with respiratory infection. She was admitted for hypoxia and increased seizures frequency secondary to COVID-19 and Adenovirus viral pneumonia. In the emergency department, pt was febrile, hypoxic to 86% on room air, and mildly tachypneic. She was placed on 2 L nasal cannula. Chest x-ray was obtained and concerning for retrocardiac opacities. She received a dose of ampicillin for community-acquired pneumonia. She had leukocytosis WBC 13.7K. CMP was unremarkable. Procalcitonin 0.15. Viral panel was positive for adenovirus and COVID-19. Blood culture was collected, which was ultimately negative. Upon admission, pt was continued on her respiratory Yellow Zone with albuterol 2 puffs, hypertonic saline, cough assist, and vest chest physiotherapy every 4 hours. She was started on Remdesivir and completed a 5 day course in the setting of COVID-19 infection. Antibiotics were not initially continued for CAP due to improved aeration of the left lower lobe on 5/2 CXR compared to previous imaging. Neurology was consulted, and pt was placed on EEG overnight 5/2-5/3. She was continued on her home seizure regimen with Briviact, Onfi, Vimpat, Trileptal, and phenobarbital. Neurology increased valium to 10 mg three times daily for bridge. She remained on daily sodium chloride. No seizure activity was captured on imaging. Patient had worsening respiratory status on 5/4 requiring escalation of care to PICU where she was initiated on BiPAP. Ceftriaxone 50 mg/kg was started for CAP coverage. She transitioned back to the floors 5/7 where she completed her 7 day course of antibiotics. She also completed a 10 day course of steroids with dexamethasone. The patient did struggle with antibiotic-associated diarrhea through her stay. Enteric panel and C diff testing were negative. On 5/9 she began to develop urinary retention with need for straight catheterization but continued to produce appropriate amounts of urine and was euvolemic in appearence. UA and BMP were unremarkable. Increased free water flushes were added for a few days to make up for increased GI losses. The patient's urinary retention resolved prior to discharge. Nutrition was consulted throughout the hospitalization and formula was changed to Jevity 1.5 cal with the same mixing regimen as her prior home feeds to increase total calories. A new prescription was sent for this formula. Patient tolerated de-escalation to her home respiratory regimen. Family was provided with discharge instructions and return precautions. She was discharged home in stable condition on 5/13/2023.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Acute respiratory failure
Hospital-Tage: 11,0
Labordaten: -
Aktuelle Erkrankungen: 5/25/2021 1. Facial rash - appears to be allergic type rash, may use OTC cortisone cream in thin layer, blot off excess to avoid contact with eye, report back if not improving in 1 wk as anticipated. 2. Cough - symptomatic care, and monitor and report back if fever or sign of pneumonia. 3. Keratosis pilaris - rash on arms consistent with keratosis pilaris, likely different etiology from facial rash which appears to be allergic.
Vorgeschichte: Localization-related symptomatic epilepsy and epileptic syndromes with simple partial seizures, intractable, with status epilepticus (HCC) Unbalanced chromosomal translocation Global developmental delay History of recurrent UTI (urinary tract infection) Mild OSA (obstructive sleep apnea) GERD (gastroesophageal reflux disease) Ineffective airway clearance Chronic lung disease S/P placement of VNS (vagus nerve stimulation) device Chronic lung disease of prematurity Seizures (HCC) Spastic quadriplegic cerebral palsy (HCC) Medically complex patient Refractory epilepsy (HCC) Static encephalopathy Dysgenesis of corpus callosum (HCC) Oropharyngeal dysphagia Feeding by G-tube (HCC) Hypotonia History of neurological testing - DO NOT EDIT Kidney stone Generalized pain LLL pneumonia Normocytic anemia Passive smoke exposure At low risk for venous thromboembolism (VTE) Menstrual symptom or sign Pressure injury of skin of foot Acquired bronchomalacia Constipation Macrocytic anemia Adenovirus infection Breakthrough bleeding on Nexplanon Pneumonia, viral COVID-19 Pneumonia, bacterial
Andere Medikamente: acetaminophen (TYLENOL) 500 mg tablet albuterol (PROVENTIL) (2.5 MG/3ML) 0.083% nebulization albuterol HFA (PROVENTIL HFA, VENTOLIN HFA, PROAIR HFA) 108 (90 Base) MCG/ACT inhaler atropine 1 % ophthalmic solution brivaracetam (BRIVIACT) 10
Allergien: Augmentin [Penicillins]Diarrhea Desitin [Diaper Rash Products]Rash Flu Virus VaccineNausea and Vomiting Other Zinc OxideOther
Vorherige Impfungen: Influenza Vaccine-Nausea and Vomiting (Noted 4/3/2019)

VAERS 2624756

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EW0183

kritisch

Staat: -
Alter: 42,0
Geschlecht: F
Eingang: 02.05.2023
Impfdatum: 26.03.2022
Beginn: 01.09.2022
Tage bis Beginn: 159,0
Dosis: 3
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: unbekannt

Acute respiratory failure

Symptomtext

PATIENT RECEIVED VACCINE FROM OUTSIDE SOURCE ACUTE RESPIRATORY FAILURE

Weitere VAERSDATA-Felder

Praegender Schweregrund: Acute respiratory failure
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2613775

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EW0183

kritisch

Staat: -
Alter: 52,0
Geschlecht: F
Eingang: 12.04.2023
Impfdatum: 16.06.2021
Beginn: 24.07.2021
Tage bis Beginn: 38,0
Dosis: 2
Route/Site: IM / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: nein

Acute left ventricular failure Acute myocardial infarction

Symptomtext

ACUTE NON ST ELEVATION MI 7/24/2021 DIASTOLIC HEART FAILURE, ACUTE

Weitere VAERSDATA-Felder

Praegender Schweregrund: Acute myocardial infarction
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2612462

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EW0183

kritisch

Staat: -
Alter: 58,0
Geschlecht: F
Eingang: 10.04.2023
Impfdatum: 08.06.2021
Beginn: 02.11.2021
Tage bis Beginn: 147,0
Dosis: 2
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: nein

Hypotension Septic shock

Symptomtext

I95.9 HYPOTENSION 11/20/2021 SEPTIC SHOCK I95.9 HYPOTENSION 11/20/2021 HX OF INVASIVE BREAST CANCER

Weitere VAERSDATA-Felder

Praegender Schweregrund: Septic shock
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2586942

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EW0183

kritisch

Staat: MI
Alter: 75,0
Geschlecht: M
Eingang: 24.02.2023
Impfdatum: 21.09.2021
Beginn: 07.02.2023
Tage bis Beginn: 504,0
Dosis: 3
Route/Site: - / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: ja

Acute respiratory failure Asthenia COVID-19 Chest X-ray abnormal Failure to thrive Fall Hypoxia Insulin therapy Laboratory test Loss of personal independence in daily activities Lung infiltration Malaise Memory impairment Mental status changes Respiratory disorder Respiratory tract infection Swallow study abnormal

Symptomtext

Discharge Provider: MD Primary Care Provider: DO Admission Date: 2/7/2023 Discharge Date: 2/20/2023 PRESENTING PROBLEM: Weakness [R53.1] Generalized weakness [R53.1] Fall, initial encounter [W19.XXXA] Respiratory tract infection due to COVID-19 virus [U07.1, J98.8] Acute respiratory failure with hypoxia (HCC) [J96.01] HOSPITAL COURSE: Patient is a 77-year-old man with past medical history significant for obesity, non-insulin-dependent diabetes mellitus who presented to ED for generalized weakness and failure to thrive 2/2 to COVID 19. In the emergency department patient's vitals and labs hemodynamically stable. He was not hypoxic and had normal chest x-ray. He was severely weak so was admitted to internal medicine service for PT/OT and likely placement. During hospitalization he did develop hypoxia at one point briefly requiring high-flow nasal cannula. He was placed on remdesivir and Decadron. He was quickly weaned back to room air. However again had worsening respiratory status on 2/15. CXR at that time showed worsening RLL infiltrate. He was seen by SLP w/ concern for aspiration. He had VFSS which did showed low risk for aspiration. Pt was noted to have waxing and waning mental status. Per wife he has had worsening memory otpt, no longer handles medication or finances. Pt was advised to follow up with neuropsych as an outpatient. Of note while on steroids he did have uncontrolled hyperglycemia and was placed on basal bolus insulin. Was consulted and they managed insulin therapy while inpatient. Advised that patient patient should increase metformin to 1000mg twice daily at discharge as well as corrective Humalog insulin. COVID-19 symptoms did improve however remains severely weak. PT/OT did recommend SAR. Patient discharged to SAR in stable condition on 2/20/2023

Weitere VAERSDATA-Felder

Praegender Schweregrund: Acute respiratory failure
Hospital-Tage: 13,0
Labordaten: -
Aktuelle Erkrankungen: None
Vorgeschichte: OSA on CPAP Tobacco dependence Dilation of thoracic aorta (HCC) Essential hypertension Spinal stenosis of lumbar region without neurogenic claudication Numbness and tingling of both feet Balance problems Cholecystitis, acute (HFpEF) heart failure with preserved ejection fraction (HCC) Class 2 severe obesity due to excess calories with serious comorbidity and body mass index (BMI) of 35.0 to 35.9 in adult (HCC) Generalized weakness Type 2 diabetes mellitus with hyperglycemia, without long-term current use of insulin (HCC)
Andere Medikamente: acetaminophen (TYLENOL) 500 MG tablet albuterol HFA (PROVENTIL HFA, VENTOLIN HFA, PROAIR HFA) 108 (90 Base) MCG/ACT inhaler amlodipine-benazepril (LOTREL) 10-40 MG per capsule aspirin 81 MG tablet furosemide (LASIX) 20 MG tablet insulin li
Allergien: Shellfish-derived ProductsShortness of Breath, Itching, Swelling IodineShortness of Breath, Itching, Swelling
Vorherige Impfungen: -

VAERS 2579603

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EW0183

kritisch

Staat: MI
Alter: 67,0
Geschlecht: F
Eingang: 10.02.2023
Impfdatum: 14.12.2021
Beginn: 15.01.2023
Tage bis Beginn: 397,0
Dosis: 2
Route/Site: - / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: unbekannt

Anticoagulant therapy COVID-19 Chronic respiratory failure Dyspnoea Hypoxia Pneumonia staphylococcal Pulmonary embolism Respiratory syncytial virus infection SARS-CoV-2 test positive Superinfection

Symptomtext

01/15/23 presents to ED for "SOB". PMHx of "CKD stage III, PE on Eliquis (December 2022), chronic hypoxic respiratory failure status post RSV with superimposed MRSA pneumonia (November 2022), asthma, bronchiectasis, IgA deficiency, CVA with PFO, HFpEF, COVID-19 pneumonia"

Weitere VAERSDATA-Felder

Praegender Schweregrund: Pulmonary embolism
Hospital-Tage: -
Labordaten: 01/15/23 SARS-CoV-2 (COVID-19) by NAA detected
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2554594

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EW0183

kritisch

Staat: MI
Alter: 77,0
Geschlecht: M
Eingang: 09.01.2023
Impfdatum: 24.04.2021
Beginn: 06.01.2023
Tage bis Beginn: 622,0
Dosis: 2
Route/Site: - / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: unbekannt

Acute myocardial infarction COVID-19 pneumonia Chest pain Cough Dyspnoea exertional Respiratory failure

Symptomtext

Pt has a PMH of chronic systolic CHF with CKD stage III. He presented to the ED for chest pain, a nonproductive cough and exertional dyspnea. He was admitted due to an NSTEMI and acute hypoxic respiratory failure secondary to COVID pneumonia.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Acute myocardial infarction
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2543534

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EW0183

kritisch

Staat: MI
Alter: 79,0
Geschlecht: M
Eingang: 27.12.2022
Impfdatum: 25.05.2021
Beginn: 24.12.2022
Tage bis Beginn: 578,0
Dosis: 1
Route/Site: - / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: unbekannt

Acute respiratory failure COVID-19 pneumonia Confusional state

Symptomtext

Pt arrived due to confusion. Pt admitted due to acute hypoxic respiratory failure secondary to COVID-19 pneumonia.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Acute respiratory failure
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2519909

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EW0183

kritisch

Staat: MI
Alter: 77,0
Geschlecht: M
Eingang: 30.11.2022
Impfdatum: 29.09.2021
Beginn: 24.11.2022
Tage bis Beginn: 421,0
Dosis: 4
Route/Site: IM / -

Tod: ja Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: nein

Acute kidney injury Acute respiratory failure Ascites Aspiration pleural cavity Asthenia Atelectasis Blood creatinine increased Blood gases Blood lactic acid increased COVID-19 Cardiomegaly Chest X-ray abnormal Coagulopathy Computerised tomogram head normal Computerised tomogram thorax abnormal Death Electrocardiogram QT prolonged Exposure to SARS-CoV-2

Symptomtext

COVID+ 11/24/22. Vaccination status - pfizer x4 BRIEF OVERVIEW: Discharge Provider: MD Primary Care Physician at Discharge: MD Admission Date: 11/24/2022 Active Hospital Problems Diagnosis Date Noted POA ? Chronic bilateral pleural effusions 11/25/2022 Yes ? Open wound of dorsum of foot 11/25/2022 Unknown ? Counseling regarding advance care planning and goals of care 11/25/2022 Unknown ? Septic shock 11/24/2022 Yes ? COVID-19 virus infection 11/24/2022 Yes ? Anasarca 11/24/2022 Yes ? Open wound of left foot 11/24/2022 Yes ? Acute respiratory failure with hypoxia and hypercapnia 11/24/2022 Yes ? Medication induced coagulopathy 11/24/2022 Yes ? AKI (acute kidney injury) DETAILS OF HOSPITAL STAY: PRESENTING PROBLEM: Septic shock HOSPITAL COURSE: 78 y/o male with past medical history significant for HTN, Afib for which he is on Coumadin s/p pacemaker placement, PVD. He presented to ED 11/24 with one week history of weakness and recent falls. Family was unable to get him out of bed and called EMS. In the ED, patient denied any focal complaints but it was noted that 2 of his family members with whom he lives recently tested positive for COVID. Of note, patient has been recently treated with antibiotics for a foot infection. Upon arrival to ED, patient was noted to be hypothermic/hypotensive/hypoxic. His oxygen requirements quickly escalated to requiring HFNC. Initial gas noted to be 7.27/66.5/145.2. Labs were notable for AKI with a Cr of 1.92 (baseline around 1-1.2), pro-bnp of 4663, initial troponin of 69, LA-2.7 which subsequently normalized to 1.9, normal PCT, and WBC-3.56. INR was elevated at >8 with stable Hg of 15 and no reported bleeding. COVID (+). UA unremarkable. EKG demonstrated ventricular paced rhythm with prolonged Qtc. CTH was negative for any acute abnormalities. CXR showed cardiomegaly with pulmonary vascular congestion as well as bilateral pleural effusions and patchy midlung opacities. Right basilar atelectasis or PNA was also reported. Patient was ultimately transitioned to Bipap with improvement in his respiratory status. Patient was given 250 ml of IVFs and then transitioned to NE gtt due to concerns of fluid overload. He additionally received Rocephin, Doxycycline, 10 mg of IV decadron, 40 mg IV lasix, and 2.5 mg PO of Vitamin K. He was then transferred to ICU for further care. CT thorax 11/24 with bilateral pleural effusions, partially loculated. INR reversed and patient received left sided thoracentesis with right pleural drain. IR also performed diagnostic paracentesis for noted ascites on CT. Pleural fluid noted to be transudative, no signs of SBP in ascitic fluid. Renal function worsening with poor urine output. Following discussions with family patient transitioned to DNR/DNI. He was transitioned to comfort care 11/26 and pronounced deceased at 2110 11/26/23

Weitere VAERSDATA-Felder

Praegender Schweregrund: Acute respiratory failure
Hospital-Tage: 2,0
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: Atrial fibrillation, unspecified type 11/22/2022 Unknown ? CAD (coronary artery disease) 11/22/2022 Unknown ? Other forms of systemic lupus erythematosus 11/22/2022 Unknown ? Anxiety and depression 11/22/2022 Unknown ? Mixed hyperlipidemia 11/22/2022 Unknown ? Essential hypertension 11/22/2022 Unknown ? Recurrent falls 11/22/2022 Unknown ? Dyspnea on exertion
Andere Medikamente: furosemide (LASIX) 20 MG tablet lisinopril (PRINIVIL,ZESTRIL) 40 MG tablet metoprolol succinate-XL (TOPROL-XL) 100 MG 24 hr tablet traZODone (DESYREL) 50 MG tablet warfarin (COUMADIN) 2.5 MG tablet warfarin (COUMADIN) 5 MG tablet
Allergien: No known allergies
Vorherige Impfungen: -

VAERS 2496450

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EW0183

kritisch

Staat: MI
Alter: 65,0
Geschlecht: F
Eingang: 02.11.2022
Impfdatum: 16.11.2021
Beginn: 21.10.2022
Tage bis Beginn: 339,0
Dosis: 3
Route/Site: IM / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: ja

Acute respiratory failure Angiogram pulmonary abnormal Blood sodium decreased COVID-19 Catheter placement Chest X-ray abnormal Chest pain Chest tube insertion Full blood count Haemophilus test positive Hyponatraemia Hypophagia Hypovolaemia Leukocytosis Metabolic function test Neutrophilia Pneumonia pneumococcal Pneumothorax

Symptomtext

Vaccination status - Pfizer x3 Inpt -10/21/2022 - discharge 11/1/2021 CHIEF COMPLAINT: COVID-19 ASSESSMENT / PLAN: #Acute hypoxemic respiratory insufficiency #Acute COVID-19 infection with superimposed strep pneumonia pneumonia #COPD, no exacerbation - Symptom onset 10/14/22, and tested positive on 10/21/22. - The patient was on room air at home, has been requiring 3 L nasal cannula - Hypoxia worsened on 10/25/22, and was placed on non-rebreather - Repeat stat chest xray showed right basilar catheter remains in position. Minimal residual pneumothorax in the right apex - CTA-thorax was negative for PE; there is a progression of mild to moderate right and mild left lung base airspace disease - Patient was hypoxic and required 2L initially now is on high flow - sputum culture growing has strep pneumoniae and H influenzae - Completed a total of 5 doses of Remdesivir Plan - currently on 4 L of nasal cannula, will attempt to wean down as tolerated - Continue with dexamethasone 6 mg Daily (Day 10) - Consult to pulmonary medicine, signed off - Continue Ceftriaxone 1gm Daily (Day 6) tomorrow is last day - Continue daily creatinine, complete blood count with differential, and liver function lab monitoring while on IV antibiotic therapy to monitor for renal, myelo-, and hepatoxicity. - Continue inhalers as needed - Continue Robitussin - Tessalon prn - DVT prophylaxis with Lovenox - Home oxygen was completed and patient qualified, she currently lives in Mobile trailer he because her house is being built. Husband is at doing to arrange staying with his sister in order to deliver the concentrator Spontaneous right pneumothorax, improving Chest tube associated chest pain CTA thorax: moderate size right pneumothorax. CTS consulted and recommended IR for chest tube. Chest tube placed 10/22. Attempted water seal on 10/24, with worsening PTX and returned to suction. - Appreciate IR assistance with chest tube management - chest tube was removed today and repeat chest x-ray showed no pneumothorax - Continue Oxy PRN for pain control, if uncontrolled can increase dose. Mild hypovolemic hyponatremia - resolved - Na 132 on admission, now resolved - suspect secondary to decreased oral intake - monitor with daily CMP Neutrophilic Leukocytosis - resolved - WBC 17.85 on admission -- > 13 -- > 20 -- > 16 -- > 12.8 - suspect secondary to acute COVID-19 infection and steroids, and pneumonia - Continue treatment as above - Continue to monitor with daily CBC and antibiotics HLD - Continue statin Hx CVA - No residual deficits - Continue plavix Carotid stenosis s/p right endarterectomy - Continue Plavix Essential Hypertension - Restarted Lozol Tobacco use disorder - 1/2 pack ppd x 55 years - nicotine replacement order prn Diet: General DVT ppx: Lovenox Code: Full Dispo: Patient will transition home once chest tube is removed; Attempt water seal today. Will need home oxygen evaluation prior to discharge.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Acute respiratory failure
Hospital-Tage: 11,0
Labordaten: -
Aktuelle Erkrankungen: 10/27/21 - Hospital walk in clinic visit for psoriasis - new meds methylprednisolone injection & deltasone 10 mg taper 11/16/21- ER for exacerbation of COPD - new meds albuterol sulfate, dexamethasone x1 & ipratropium-albuterol
Vorgeschichte: Psoriasis COPD (chronic obstructive pulmonary disease) Hyperlipidemia Tobacco use disorder Stenosis of right carotid artery Dyslipidemia, goal LDL below 70 Transient neurological symptoms CVA (cerebral vascular accident) Carotid stenosis, right Unspecified severe protein-calorie malnutrition Hip fracture Pneumonia Supraventricular tachycardia Panlobular emphysema Tobacco abuse Dyspnea on exertion
Andere Medikamente: Albuterol Sulfate 108 (90 Base) MCG/ACT Aers, 2 puffs Inhalation Every 6 hours PRN 2.5 mg Nebulization Every 4 hours PRN Atorvastatin Calcium 80 MG TAKE 1 TABLET BY MOUTH EVERY DAY Betamethasone Valerate 0.1 % Topical 2 times daily, Apply t
Allergien: Chantix [Varenicline]GI Upset SpirivaOther Vicodin [Hydrocodone-acetaminophen]GI Upset
Vorherige Impfungen: -

VAERS 2467206

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EW0183

kritisch

Staat: TX
Alter: 85,0
Geschlecht: F
Eingang: 03.10.2022
Impfdatum: 27.05.2021
Beginn: 19.09.2022
Tage bis Beginn: 480,0
Dosis: 2
Route/Site: IM / LA

Tod: ja Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: nein

Anuria COVID-19 Chest X-ray abnormal Death Endotracheal intubation Leukocytosis Mechanical ventilation Metabolic acidosis Oxygen saturation decreased Pneumonia SARS-CoV-2 test positive Septic shock Shock Urinary tract infection

Symptomtext

Pfizer BioNTech COVID-19 Vaccine EUA: COVID-19 case resulting in Hospitalization/Death. Rec'd Pfizer BioNTech vaccine on 4/29/21 and 5/27/21. Presented to ED after O2 level checked dropped to 70% at home. Admitted w/septic shock, Covid, PNA, anion gap acidosis, UTI, leukocytosis. She was intubated, IV abx's, fluid resuscitation, steroids, refractory shock on 3 pressors, anuria, and max vent settings. CXR revealed PNA. Transitioned to comfort care; expired 9/19/22. Tx'd with decadron, azithromycin, zosyn, and vancomycin.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Death
Hospital-Tage: 1,0
Labordaten: covid + 9/18/22 - This sample was analyzed using the Roche LIAT SARS assay platform using PCR or equivalent Nucleic Acid Amplification(NAA)technology.
Aktuelle Erkrankungen: -
Vorgeschichte: atrial fibrillation, hypothyroidism, diastolic congestive heart failure, chronic anemia, CML, rheumatoid arthritis, hx of DVT, Sjogren syndrome, oropharyngeal dysphagia with PEG tube
Andere Medikamente: calcium carbonate, vitamin d3, clopidogrel, epoetin alfa escitalopram, esomeprazole, ferrous sulfate, folic acid, furosemide, ipratropium/albuterol, levothyroxine, meclizine, metoclopramide, metoprolol tartrate, multivitamin w/ folic acid,
Allergien: cephalexin, ciprofloxacin,epinephrine,opioid analogues, scopolamine, tramadol,
Vorherige Impfungen: -

VAERS 2430117

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EW0183

kritisch

Staat: CA
Alter: 22,0
Geschlecht: F
Eingang: 07.09.2022
Impfdatum: 27.04.2021
Beginn: 08.06.2021
Tage bis Beginn: 42,0
Dosis: 2
Route/Site: SYR / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: ja ER: ja Erholt: nein

Anxiety Arthralgia Asthenia Blood test Chest X-ray normal Computerised tomogram Crying Decreased appetite Dizziness Electrocardiogram normal Fear Fear of death Generalised anxiety disorder Heart rate increased Nausea Neuralgia Pain Panic attack

Symptomtext

Onset of panic disorder less than two months after second dose. No past phycological disorders. Went to ER multiple times thinking I was having heart problems. Chest x ray and EKG normal. Symptoms: radiating nerve pain down wrists, increased heart rate, feeling of impending doom, dizziness, nausea, loss of appetite, being woken by panic attacks, shaking, uncontrollably crying, fear of death, constant and uncontrollable worry. I was close to admitting myself out of fear that I may snap and do something unlike me. I saw a psychiatrist and was diagnosed with general anxiety and panic disorder. I was put on Zoloft 25-50mg it did work but after stopping medication all the symptoms are back. It?s debilitating.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Fear of death
Hospital-Tage: -
Labordaten: EKG, Chest X-Ray, CT scan, blood test, psychiatric evaluation.
Aktuelle Erkrankungen: None
Vorgeschichte: Chiari Malformation
Andere Medikamente: None
Allergien: Penicillin
Vorherige Impfungen: -

VAERS 2402977

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EW0183

kritisch

Staat: MI
Alter: 76,0
Geschlecht: F
Eingang: 07.09.2022
Impfdatum: 06.05.2021
Beginn: 02.08.2022
Tage bis Beginn: 453,0
Dosis: 1
Route/Site: - / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: unbekannt

Acute myocardial infarction Angiogram pulmonary abnormal Arthralgia Back pain Blood creatinine normal Blood electrolytes normal Brain natriuretic peptide normal COVID-19 Chest pain Echocardiogram abnormal Cardiac stress test normal Coronary artery disease Ejection fraction Haemoglobin normal Pain Pericardial effusion Ejection fraction normal Platelet count normal

Symptomtext

78 yo female w/ hx of recent COVID, HTN, HLP, PVD, Carotid artery dz, GERD, H pylori, asthma,hypothyroidism who presented to ED secondary to CP. Recent hospitalization for COVID and NSTEMI. 2D echo w/ EF 60%, no WMA, small pericardial effusion w/o compromise. Completed hep gtt x 48h. Recommended OP ischemic work up. Pt overall did well and was discharged home. Pt w/ intermittent L sided burning chest pain w/ radiation to her back and shoulder over the past 1.5 weeks. Chest pain did get worse therefore she came to ED for further evaluation. Upon arrival to ED, 159/95, HR 93, afebrile, no hypoxia. No leukocytosis, Hgb 12.4, plts 157k. Lytes/renal function WNL. Cr 0.95. Trops WNL, BNP 43.COVID remains positive. CTA PE w/o thrombus , 3-vessel dz noted. Noted Extensive vascular calcifications and complete occlusion of the proximal left subclavian artery with a patent shunt through left carotid artery. Pt admitted for further care with cardio consult. Stress MPI done - no ischemia. Pt feeling well and agreeable for DC on 8/4. Pt notes she cannot tolerate statin. Pt was feeling well on day of discharge and medically stable for discharge. Pt was present during discharge planning and agreeable to plan.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Acute myocardial infarction
Hospital-Tage: 2,0
Labordaten: 8/2 SARS-CoV-2 (COVID-19) by Nucleic Acid Amplification, POC --detected
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2357627

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EW0183

kritisch

Staat: MI
Alter: 83,0
Geschlecht: F
Eingang: 05.07.2022
Impfdatum: 27.10.2021
Beginn: 23.06.2022
Tage bis Beginn: 239,0
Dosis: 3
Route/Site: - / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: ja

Acute respiratory failure Atelectasis Blood lactic acid decreased COVID-19 COVID-19 pneumonia Chest X-ray abnormal Cough Cystitis Hypoxia Laboratory test Lung infiltration Pain Pleural effusion Pyrexia SARS-CoV-2 test positive Tachycardia Tachypnoea Viral infection

Symptomtext

Discharge Physician: MD Primary Care Clinician at Discharge: MD Admission Date: 6/23/2022 Discharge Date: 6/26/2022 PRESENTING PROBLEM: Hypoxia [R09.02] Acute cystitis without hematuria [N30.00] COVID-19 [U07.1] Acute respiratory failure with hypoxia [J96.01] HOSPITAL COURSE: Patient is a 84 y.o. female with a past medical history of autoimmune hepatitis, type 2 diabetes, hyperlipidemia, and hypothyroidism who presents today with sore and cough. In the emergency department patient was febrile with temperature of 101.1? F, she was tachycardic and tachypneic. Patient also was hypoxic and required 6 L by nasal cannula supplemental oxygen. Pertinent lab findings include a white blood cell count within normal limits at 7.28. Lactic acid within normal limits at 1.8. COVID testing was positive. Chest x-ray showed mild bibasilar infiltrates and/or atelectasis. Suspect small right pleural effusion. She was admitted to the medical service for treatment of COVID-19 pneumonia. She was started on dexamethasone. Azathioprine for autoimmune hepatitis was held due to viral infection. Oxygen support was titrated down to room air. She was afebrile and hemodynamically stable. On 06/26/2022 she was discharged home to continue immunosuppressive medications and with follow-up with her primary care physician.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Acute respiratory failure
Hospital-Tage: 3,0
Labordaten: -
Aktuelle Erkrankungen: None
Vorgeschichte: Type 2 diabetes mellitus Autoimmune hepatitis Arthritis, multiple joint involvement Generalized edema Hypothyroidism, unspecified type Polyp of sigmoid colon Skin tags, multiple acquired Acute respiratory failure due to COVID-19 COVID-19 Bilateral lower extremity edema
Andere Medikamente: azaTHIOprine (IMURAN) 50 MG tablet CALCIUM CITRATE-VITAMIN D PO furosemide (LASIX) 40 MG tablet glipiZIDE CR (GLUCOTROL) 5 MG 24 hr tablet insulin glargine (LANTUS SOLOSTAR) 100 UNIT/ML pen-injector levothyroxine (SYNTHROID) 100 MCG ta
Allergien: PenicillinsRash
Vorherige Impfungen: -

VAERS 2305074

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EW0183

kritisch

Staat: MI
Alter: 87,0
Geschlecht: M
Eingang: 01.06.2022
Impfdatum: 10.09.2021
Beginn: 22.05.2022
Tage bis Beginn: 254,0
Dosis: 3
Route/Site: - / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: ja

Acute respiratory failure Adrenal insufficiency Angiogram pulmonary normal COVID-19 COVID-19 pneumonia Diarrhoea Dysphagia Dyspnoea Intensive care Medical diet Nausea Nothing by mouth order Pneumonia bacterial Pyrexia SARS-CoV-2 test positive Sepsis Staphylococcus test negative Superinfection

Symptomtext

Discharge Provider: MD Primary Care Provider at Discharge: DO Admission Date: 5/22/2022 Discharge Date: 05/27/2022 PRESENTING PROBLEM: Patient resides at Facility, brought over to ED because of nausea, vomiting and diarrhea, fever and shortness of breath. Positive for Covid. See H&P from 5/22/22 for full details HOSPITAL COURSE: Patient was admitted to the hospitalist service with severe sepsis secondary to Covid 19 pneumonia with superimposed bacterial pneumonia and acute hypoxic respiratory failure secondary to the viral and bacterial pneumonia requiring 75% FiO2 on high flow nasal cannula. PE was ruled on by CTA. He was started on stress dose steroids for his adrenal insufficiency and IV Zosyn and Vancomycin to cover for possible bacterial pneumonia. He did require vasopressors, norepinephrine, for about 24 hours. He was initially made NPO for an SLP consult given his history of dysphagia, after eval he was placed on nectar thick liquids and dysphagia advanced diet . His oxygen demands decreased and he was off high flow nasal cannula and maintaining his blood pressures, he was transferred out of the ICU. He was on Remdesivir for which he completed a 5 day course. Antibiotic coverage was deescalated after MRSA swab resulted negative and he was on Rocephin 2g daily and completed 5 days of antibiotics. He worked with physical and occupational therapy who recommended discharge back to long term care. On day of discharge he was doing well on room air, eating and drinking okay, he will be discharged back to Facility on his dysphagia diet.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Acute respiratory failure
Hospital-Tage: 4,0
Labordaten: -
Aktuelle Erkrankungen: None
Vorgeschichte: Hospital History of pituitary tumor Adrenal insufficiency Mixed hyperlipidemia Essential hypertension Central hypothyroidism History of CVA (cerebrovascular accident) Hypopituitarism DVT (deep venous thrombosis) Generalized muscle weakness Vascular dementia without behavioral disturbance Dysphagia, oropharyngeal phase Long term (current) use of anticoagulants Long term current use of antithrombotics/antiplatelets Current moderate episode of major depressive disorder without prior episode Benign prostatic hyperplasia with urinary retention Neurogenic bladder UTI (urinary tract infection) Transient neurological symptoms Other hydronephrosis Suprapubic abdominal pain Vaccine counseling Right ureteral calculus Left ear pain Fatigue Fall Groin pain COVID-19 virus infection Non-Hospital Abnormal MRI of head Abnormality of gait
Andere Medikamente: acetaminophen (TYLENOL) capsule 1,000 mg aspirin chewable tablet 81 mg atorvastatin (LIPITOR) tablet 40 mg benzonatate (TESSALON) capsule 200 mg guaiFENesin (MUCINEX) 12 hr tablet 1,200 mg hydrocortisone (CORTEF) tablet 10 mg levothyr
Allergien: Sulfamethoxazole W-trimethoprimShortness of Breath AzithromycinDiarrhea
Vorherige Impfungen: -

VAERS 2278443

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EW0183

kritisch

Staat: MA
Alter: 57,0
Geschlecht: M
Eingang: 16.05.2022
Impfdatum: 28.04.2021
Beginn: 21.06.2021
Tage bis Beginn: 54,0
Dosis: 2
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: ja ER: ja Erholt: nein

Angiogram Anticoagulant therapy Atrial fibrillation Blindness Cerebral haemorrhage Computerised tomogram head Diplopia Electrocardiogram Impaired work ability

Symptomtext

Atrial Fibrillation. Heart Rate was 160bpm for 4 hours. Treated at Hospital, Emergency Department. Several months later suffered Capillary Brain Bleeding which caused severe Diplopia in the Left Eye. Unable to see or woek for 3 months. Treated at Hospital. Ongoing Atrial Fibrilation now being treated with Eloquis blood thinners.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Cerebral haemorrhage
Hospital-Tage: 3,0
Labordaten: EKG, CT angiogram, Brain CT
Aktuelle Erkrankungen: Diabetes II, Well controlled hypertension for 20 years
Vorgeschichte: Diabetees II and Hypertension
Andere Medikamente: Metformin, Lantus Insulin, Lisinopril, Metoprolol, Amlodipine
Allergien: Lidocaine
Vorherige Impfungen: -

VAERS 2278214

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EW0183

kritisch

Staat: MI
Alter: 76,0
Geschlecht: M
Eingang: 16.05.2022
Impfdatum: 06.10.2021
Beginn: 05.05.2022
Tage bis Beginn: 211,0
Dosis: 3
Route/Site: IM / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: unbekannt

Acute kidney injury Acute respiratory failure Anion gap Anticoagulant therapy Appetite disorder Asthenia Blood creatinine increased COVID-19 Back pain Blood chloride normal Blood electrolytes Blood glucose normal Blood lactic acid normal Blood magnesium Blood potassium normal Blood sodium normal Blood urea increased Cardiac telemetry abnormal

Symptomtext

Hospitalized (5.5.22 - 5.8.22); COVID-19 positive (5.5.22); fully vaccinated PLUS Booster - pfizer x3 Hospitalist Discharge Summary BRIEF OVERVIEW: Discharge Provider: PA-C Attending Physician: MD Primary Care Provider at Discharge: DO Admission Date: 5/5/2022 Discharge Date: 05/08/2022 DISCHARGE DISPOSITION: Home without services Active Hospital Problems Diagnosis Date Noted POA ? COVID-19 05/06/2022 Yes ? Acute respiratory insufficiency 05/06/2022 Yes ? Generalized weakness 05/06/2022 Yes ? AKI (acute kidney injury) 05/06/2022 Yes ? Leukocytosis 05/06/2022 Yes ? History of ischemic stroke without residual deficits Yes ? Essential hypertension 12/19/2016 Yes ? Dyslipidemia Yes ? Major depression, recurrent, chronic DETAILS OF HOSPITAL STAY: PRESENTING PROBLEM: Acute respiratory insufficiency [R06.89] COVID [U07.1] HOSPITAL COURSE: Patient is a 77-year-old male with a history of remote ischemic stroke without residual deficits, hyperlipidemia, GERD, depression, and anxiety who presented secondary to severe worsening generalized weakness. About 5 days prior to admission, he began to notice worsening weakness, along with a mild cough, sore throat, shortness of breath on exertion, diarrhea, nausea, and vomiting. He had received his COVID vaccination x2 and 1st booster in 10/2021. On arrival, he was febrile and tachycardic. He desatted on room air and was placed on 2 L nasal cannula. Labs notable for leukocytosis, acute kidney injury, and COVID positive. Chest x-ray clear. He was given 1 L of normal saline, started on Decadron and admitted for further care. Procalcitonin elevated at 13 for which he was started on a ceftriaxone and azithromycin. Supplemental oxygen weaned to room air. Additional fluids held on admission given COVID positive status, but creatinine down trended to baseline with encouragement of oral intake. OT evaluated and recommended discharge home. He was discharged home in stable condition on 5/8/22. He will complete a 5 day total course of antibiotics with remaining 2 days of Ceftin and azithromycin. He was advised to arrange hospital follow-up with his primary care physician. CONSULTS: none INPATIENT PROCEDURES: none PHYSICAL EXAM: BP 129/95 | Pulse 69 | Temp 36.7 ?C (Oral) | Resp 22 | Ht 1.626 m | Wt 80.7 kg | SpO2 96% | BMI 30.54 kg/m? Physical ExamVitals and nursing note reviewed. Constitutional: General: He is not in acute distress. Appearance: He is well-developed and well-nourished. HENT: Head: Normocephalic and atraumatic. Mouth/Throat: Mouth: Oropharynx is clear and moist. Mucous membranes are moist. Pharynx: Oropharynx is clear. Neck: Vascular: No JVD. Cardiovascular: Rate and Rhythm: Normal rate and regular rhythm. Heart sounds: Normal heart sounds. Pulmonary: Effort: Pulmonary effort is normal. No respiratory distress. Breath sounds: Normal breath sounds. Abdominal: General: Bowel sounds are normal. There is no distension. Palpations: Abdomen is soft. Tenderness: There is no abdominal tenderness. Musculoskeletal: Cervical back: Normal range of motion and neck supple. Right lower leg: No edema. Left lower leg: No edema. Skin: General: Skin is warm and dry. Neurological: Mental Status: He is alert and oriented to person, place, and time. Psychiatric: Mood and Affect: Mood and affect and mood normal. Behavior: Behavior normal. H&P:CHIEF COMPLAINT "I have never felt so weak" ASSESSMENT Principal Problem: Acute respiratory insufficiency Active Problems: Dyslipidemia Major depression, recurrent, chronic Essential hypertension History of ischemic stroke without residual deficits COVID-19 Generalized weakness AKI (acute kidney injury) Leukocytosis PLAN Acute respiratory insufficiency 2nd COVID-19 infection COVID-19 positive SIRS, second to above Desatted to high 80s on room air, currently on 2 L nasal cannula He is vaccinated with Pfizer x2 plus booster in 10/2021 Hemodynamically stable at this time but will need close inpatient monitoring as he is at high risk for deterioration given his increased supplemental oxygen requirements Continuous pulse oximetry Wean oxygen as able, aim for O2 sats > 90% Given supplemental O2 requirements, we will start orally Decadron 6 mg daily Inhalers p.r.n. If patient desaturates further and renal function improves, would start remdesivir Leukocytosis Likely 2nd to COVID-19 infection Doubt bacterial coinfection so will hold off on antibiotics at this time Procalcitonin pending, if positive would start CAP coverage with IV ceftriaxone and azithromycin Mild AKI Likely 2nd to infection and poor oral intake Baseline creatinine 1.0-1.1, now 1.49 Given 1 L IVF bolus in ER, will hold off on additional fluids with goal to keep COVID-19 positive patient is on the dry side Daily basic panel to assess renal function and determine need for additional IV fluids Hypophosphatemia Given sodium phosphate 40 millimoles in ER Recheck phosphorus in a.m. Frequent PACs on telemetry Daily monitoring of electrolytes including magnesium, replace p.r.n. Generalized weakness Likely 2nd to COVID-19 infection PT/OT evaluations Remote ischemic stroke without residual deficits Dyslipidemia Continue home aspirin, atorvastatin GERD Continue home pantoprazole, especially while on steroids Depressive disorder Generalized anxiety disorder Continue home Lexapro and BuSpar Diet: General VTE ppx: Padua score is 6, will start subcutaneous Lovenox 40 mg daily Code status: Full code. Did discuss and confirm with patient. Disposition: admitted as inpatient for acute respiratory insufficiency 2nd to COVID-19. Anticipated LOS > 2 midnights. HISTORY OF PRESENT ILLNESS Patient is a 77 y.o. male with medical history significant for dyslipidemia, remote ischemic stroke with no residual deficits, GERD, osteoporosis, generalized anxiety disorder. Presents to ER for severe weakness for past few days. Reports he was feeling at baseline health until about 5 days ago, developed progressive worsening of weakness, felt so weak that he was unable to walk on his own today and was unable to get out of a chair on his own. Denies fall, head injury. Says weakness is generalized, not one-sided. No numbness or tingling in extremities. No vision or speech changes noted. He reports cough intermittently productive of clear phlegm, sore throat, mild dyspnea with exertion, loose stools. Having chills but does not know about fever. No chest pain or pressure. No pain or swelling in his legs. Denies sick contacts, his wife with whom he lives is not ill. Notes he received initial COVID vaccine x2 and 1st booster in 10/2021. Denies lung issues, cardiac issues. Never smoker. Takes aspirin 325 mg daily, no other blood thinners. No history of blood clots. In ER, afebrile at 101.5? F, mildly tachycardic. Low normal blood pressures (patient states this is baseline for him). Desatted to 89% on room air, 2 L nasal cannula applied. EKG image independently reviewed showing a sinus tachycardia, frequent PACs, no acute ST changes when compared to prior EKG from 08/2021. Lab significant for mild AKI with creatinine 1.49, baseline 1.0-1.1. WBC 12.76. LA x2 normal. ProBNP normal. Found to be COVID-19 positive. CXR image independently reviewed with no clear acute process noted though does have coarsened lung markings in right lower lobe, ?developing infiltrate. Will admit to medicine for further management. REVIEW OF SYSTEMS Review of Systems Constitutional: Positive for activity change, appetite change, chills and fatigue. Negative for diaphoresis and fever. HENT: Positive for rhinorrhea and sore throat. Negative for congestion, sinus pressure, sneezing and trouble swallowing. Eyes: Negative for visual disturbance. Respiratory: Positive for cough and shortness of breath. Cardiovascular: Negative for chest pain, palpitations and leg swelling. Gastrointestinal: Positive for diarrhea. Negative for abdominal distention, abdominal pain, blood in stool, constipation, nausea and vomiting. Endocrine: Negative for polyuria. Genitourinary: Negative for difficulty urinating, dysuria, frequency, hematuria and urgency. Musculoskeletal: Positive for back pain (Chronic low back pain) and myalgias. Negative for neck pain. Skin: Negative for pallor and rash. Allergic/Immunologic: Negative for immunocompromised state. Neurological: Positive for weakness. Negative for dizziness, speech difficulty, light-headedness, numbness and headaches. Hematological: Does not bruise/bleed easily. Psychiatric/Behavioral: Negative for confusion and sleep disturbance. The patient is not nervous/anxious. OBJECTIVE BP 94/62 | Pulse 100 | Temp (!) 101.5 ?F (38.6 ?C) (Oral) | Resp 27 | Ht 1.626 m (5' 4") | Wt 85.2 kg (187 lb 13.3 oz) | SpO2 92% | BMI 32.24 kg/m? Physical ExamVitals and nursing note reviewed. Constitutional: General: He is not in acute distress. Appearance: Normal appearance. He is not ill-appearing, toxic-appearing or diaphoretic. HENT: Head: Normocephalic and atraumatic. Right Ear: External ear normal. Left Ear: External ear normal. Nose: Nose normal. Mouth/Throat: Mouth: Mucous membranes are moist. Pharynx: Oropharynx is clear. Eyes: General: No scleral icterus. Right eye: No discharge. Left eye: No discharge. Extraocular Movements: Extraocular movements intact. Conjunctiva/sclera: Conjunctivae normal. Cardiovascular: Rate and Rhythm: Normal rate and regular rhythm. Pulses: Normal pulses. Heart sounds: Normal heart sounds. Pulmonary: Effort: Pulmonary effort is normal. No respiratory distress. Breath sounds: Normal breath sounds. Comments: On 2 L supplemental oxygen, O2 saturations in mid 90s, no accessory muscle use or increased work of breathing noted Chest: Chest wall: No tenderness. Abdominal: General: Abdomen is flat. Bowel sounds are normal. There is no distension. Palpations: Abdomen is soft. There is no mass. Tenderness: There is no abdominal tenderness. Musculoskeletal: General: No tenderness. Normal range of motion. Cervical back: Normal range of motion. No tenderness. Right lower leg: No edema. Left lower leg: No edema. Skin: General: Skin is warm and dry. Coloration: Skin is not pale. Findings: No erythema. Neurological: General: No focal deficit present. Mental Status: He is alert and oriented to person, place, and time. Mental status is at baseline. Sensory: No sensory deficit. Motor: No weakness. Psychiatric: Mood and Affect: Mood normal. Behavior: Behavior normal. Thought Content: Thought content Thought content normal. Judgment: Judgment normal

Weitere VAERSDATA-Felder

Praegender Schweregrund: Acute respiratory failure
Hospital-Tage: 3,0
Labordaten: PERTINENT LABS AND STUDIES: Lab Results Component Value Date WBC 14.98 (H) 05/08/2022 WBC 10.54 12/04/2015 RBC 4.86 05/08/2022 RBC 5.28 12/04/2015 HGB 13.2 (L) 05/08/2022 HGB 15.0 12/04/2015 HCT 41.4 (L) 05/08/2022 HCT 44.7 12/04/2015 MCV 85.2 05/08/2022 MCV 84.7 12/04/2015 PLATELET 203 05/08/2022 PLATELET 230 12/04/2015 Lab Results Component Value Date GLUCOSE 104 (H) 05/08/2022 GLUCOSE 109 (H) 09/21/2017 SODIUM 137 05/08/2022 SODIUM 143 09/21/2017 POTASSIUM 4.5 05/08/2022 POTASSIUM 4.1 09/21/2017 CHLORIDE 104 05/08/2022 CHLORIDE 105 09/21/2017 ANIONGAP 14 05/08/2022 ANIONGAP 15 09/21/2017 BUN 33 (H) 05/08/2022 BUN 23 (H) 09/21/2017 CREATININE 1.17 05/08/2022 CREATININE 1.12 09/21/2017 EGFR 60 05/08/2022 EGFR >60 09/21/2017 DR CHEST 2 VIEWS FRONTAL AND LATERAL Final Result No acute cardiopulmonary process.
Aktuelle Erkrankungen: -
Vorgeschichte: Pre-Existing Active Problems Diagnosis Date Noted POA ? OSA (obstructive sleep apnea) 11/14/2016 Unknown ? RLS (restless legs syndrome)/Periodic Limb Movments of Sleep 01/16/2017 Unknown ? History of vertebral compression fracture 10/02/2019 Unknown ? Diastasis recti 04/02/2019 Unknown ? AK (actinic keratosis) 04/02/2019 Unknown ? Elevated PSA Unknown ? BPH with obstruction/lower urinary tract symptoms Unknown ? Dizziness Unknown ? Abnormal echocardiogram Unknown ? PLMD (periodic limb movement disorder) 05/15/2017 Unknown ? Age-related osteoporosis without current pathological fracture Unknown ? Snoring 08/24/2016 Unknown ? Rotator cuff tear 03/20/2014 Unknown ? OA (osteoarthritis) Unknown ? Gastroesophageal reflux disease without esophagitis Unknown ? Colon polyps
Andere Medikamente: Acetaminophen 500 mg Oral Every 6 hours PRN Alendronate Sodium 70 MG TAKE 1 TABLET BY MOUTH ONE TIME A WEEK 30 minutes before breakfast with water for bones Aspirin 325 mg Oral Nightly Atorvastatin Calcium 40 mg Oral Daily busPIRone HCl 10
Allergien: No Known Allergies
Vorherige Impfungen: -

VAERS 2278214

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EW0183

kritisch

Staat: MI
Alter: 76,0
Geschlecht: M
Eingang: 16.05.2022
Impfdatum: 06.10.2021
Beginn: 05.05.2022
Tage bis Beginn: 211,0
Dosis: 3
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: unbekannt

Acute kidney injury Acute respiratory failure Anion gap Anticoagulant therapy Appetite disorder Asthenia Blood creatinine increased COVID-19 Back pain Blood chloride normal Blood electrolytes Blood glucose normal Blood lactic acid normal Blood magnesium Blood potassium normal Blood sodium normal Blood urea increased Cardiac telemetry abnormal

Symptomtext

Hospitalized (5.5.22 - 5.8.22); COVID-19 positive (5.5.22); fully vaccinated PLUS Booster - pfizer x3 Hospitalist Discharge Summary BRIEF OVERVIEW: Discharge Provider: PA-C Attending Physician: MD Primary Care Provider at Discharge: DO Admission Date: 5/5/2022 Discharge Date: 05/08/2022 DISCHARGE DISPOSITION: Home without services Active Hospital Problems Diagnosis Date Noted POA ? COVID-19 05/06/2022 Yes ? Acute respiratory insufficiency 05/06/2022 Yes ? Generalized weakness 05/06/2022 Yes ? AKI (acute kidney injury) 05/06/2022 Yes ? Leukocytosis 05/06/2022 Yes ? History of ischemic stroke without residual deficits Yes ? Essential hypertension 12/19/2016 Yes ? Dyslipidemia Yes ? Major depression, recurrent, chronic DETAILS OF HOSPITAL STAY: PRESENTING PROBLEM: Acute respiratory insufficiency [R06.89] COVID [U07.1] HOSPITAL COURSE: Patient is a 77-year-old male with a history of remote ischemic stroke without residual deficits, hyperlipidemia, GERD, depression, and anxiety who presented secondary to severe worsening generalized weakness. About 5 days prior to admission, he began to notice worsening weakness, along with a mild cough, sore throat, shortness of breath on exertion, diarrhea, nausea, and vomiting. He had received his COVID vaccination x2 and 1st booster in 10/2021. On arrival, he was febrile and tachycardic. He desatted on room air and was placed on 2 L nasal cannula. Labs notable for leukocytosis, acute kidney injury, and COVID positive. Chest x-ray clear. He was given 1 L of normal saline, started on Decadron and admitted for further care. Procalcitonin elevated at 13 for which he was started on a ceftriaxone and azithromycin. Supplemental oxygen weaned to room air. Additional fluids held on admission given COVID positive status, but creatinine down trended to baseline with encouragement of oral intake. OT evaluated and recommended discharge home. He was discharged home in stable condition on 5/8/22. He will complete a 5 day total course of antibiotics with remaining 2 days of Ceftin and azithromycin. He was advised to arrange hospital follow-up with his primary care physician. CONSULTS: none INPATIENT PROCEDURES: none PHYSICAL EXAM: BP 129/95 | Pulse 69 | Temp 36.7 ?C (Oral) | Resp 22 | Ht 1.626 m | Wt 80.7 kg | SpO2 96% | BMI 30.54 kg/m? Physical ExamVitals and nursing note reviewed. Constitutional: General: He is not in acute distress. Appearance: He is well-developed and well-nourished. HENT: Head: Normocephalic and atraumatic. Mouth/Throat: Mouth: Oropharynx is clear and moist. Mucous membranes are moist. Pharynx: Oropharynx is clear. Neck: Vascular: No JVD. Cardiovascular: Rate and Rhythm: Normal rate and regular rhythm. Heart sounds: Normal heart sounds. Pulmonary: Effort: Pulmonary effort is normal. No respiratory distress. Breath sounds: Normal breath sounds. Abdominal: General: Bowel sounds are normal. There is no distension. Palpations: Abdomen is soft. Tenderness: There is no abdominal tenderness. Musculoskeletal: Cervical back: Normal range of motion and neck supple. Right lower leg: No edema. Left lower leg: No edema. Skin: General: Skin is warm and dry. Neurological: Mental Status: He is alert and oriented to person, place, and time. Psychiatric: Mood and Affect: Mood and affect and mood normal. Behavior: Behavior normal. H&P:CHIEF COMPLAINT "I have never felt so weak" ASSESSMENT Principal Problem: Acute respiratory insufficiency Active Problems: Dyslipidemia Major depression, recurrent, chronic Essential hypertension History of ischemic stroke without residual deficits COVID-19 Generalized weakness AKI (acute kidney injury) Leukocytosis PLAN Acute respiratory insufficiency 2nd COVID-19 infection COVID-19 positive SIRS, second to above Desatted to high 80s on room air, currently on 2 L nasal cannula He is vaccinated with Pfizer x2 plus booster in 10/2021 Hemodynamically stable at this time but will need close inpatient monitoring as he is at high risk for deterioration given his increased supplemental oxygen requirements Continuous pulse oximetry Wean oxygen as able, aim for O2 sats > 90% Given supplemental O2 requirements, we will start orally Decadron 6 mg daily Inhalers p.r.n. If patient desaturates further and renal function improves, would start remdesivir Leukocytosis Likely 2nd to COVID-19 infection Doubt bacterial coinfection so will hold off on antibiotics at this time Procalcitonin pending, if positive would start CAP coverage with IV ceftriaxone and azithromycin Mild AKI Likely 2nd to infection and poor oral intake Baseline creatinine 1.0-1.1, now 1.49 Given 1 L IVF bolus in ER, will hold off on additional fluids with goal to keep COVID-19 positive patient is on the dry side Daily basic panel to assess renal function and determine need for additional IV fluids Hypophosphatemia Given sodium phosphate 40 millimoles in ER Recheck phosphorus in a.m. Frequent PACs on telemetry Daily monitoring of electrolytes including magnesium, replace p.r.n. Generalized weakness Likely 2nd to COVID-19 infection PT/OT evaluations Remote ischemic stroke without residual deficits Dyslipidemia Continue home aspirin, atorvastatin GERD Continue home pantoprazole, especially while on steroids Depressive disorder Generalized anxiety disorder Continue home Lexapro and BuSpar Diet: General VTE ppx: Padua score is 6, will start subcutaneous Lovenox 40 mg daily Code status: Full code. Did discuss and confirm with patient. Disposition: admitted as inpatient for acute respiratory insufficiency 2nd to COVID-19. Anticipated LOS > 2 midnights. HISTORY OF PRESENT ILLNESS Patient is a 77 y.o. male with medical history significant for dyslipidemia, remote ischemic stroke with no residual deficits, GERD, osteoporosis, generalized anxiety disorder. Presents to ER for severe weakness for past few days. Reports he was feeling at baseline health until about 5 days ago, developed progressive worsening of weakness, felt so weak that he was unable to walk on his own today and was unable to get out of a chair on his own. Denies fall, head injury. Says weakness is generalized, not one-sided. No numbness or tingling in extremities. No vision or speech changes noted. He reports cough intermittently productive of clear phlegm, sore throat, mild dyspnea with exertion, loose stools. Having chills but does not know about fever. No chest pain or pressure. No pain or swelling in his legs. Denies sick contacts, his wife with whom he lives is not ill. Notes he received initial COVID vaccine x2 and 1st booster in 10/2021. Denies lung issues, cardiac issues. Never smoker. Takes aspirin 325 mg daily, no other blood thinners. No history of blood clots. In ER, afebrile at 101.5? F, mildly tachycardic. Low normal blood pressures (patient states this is baseline for him). Desatted to 89% on room air, 2 L nasal cannula applied. EKG image independently reviewed showing a sinus tachycardia, frequent PACs, no acute ST changes when compared to prior EKG from 08/2021. Lab significant for mild AKI with creatinine 1.49, baseline 1.0-1.1. WBC 12.76. LA x2 normal. ProBNP normal. Found to be COVID-19 positive. CXR image independently reviewed with no clear acute process noted though does have coarsened lung markings in right lower lobe, ?developing infiltrate. Will admit to medicine for further management. REVIEW OF SYSTEMS Review of Systems Constitutional: Positive for activity change, appetite change, chills and fatigue. Negative for diaphoresis and fever. HENT: Positive for rhinorrhea and sore throat. Negative for congestion, sinus pressure, sneezing and trouble swallowing. Eyes: Negative for visual disturbance. Respiratory: Positive for cough and shortness of breath. Cardiovascular: Negative for chest pain, palpitations and leg swelling. Gastrointestinal: Positive for diarrhea. Negative for abdominal distention, abdominal pain, blood in stool, constipation, nausea and vomiting. Endocrine: Negative for polyuria. Genitourinary: Negative for difficulty urinating, dysuria, frequency, hematuria and urgency. Musculoskeletal: Positive for back pain (Chronic low back pain) and myalgias. Negative for neck pain. Skin: Negative for pallor and rash. Allergic/Immunologic: Negative for immunocompromised state. Neurological: Positive for weakness. Negative for dizziness, speech difficulty, light-headedness, numbness and headaches. Hematological: Does not bruise/bleed easily. Psychiatric/Behavioral: Negative for confusion and sleep disturbance. The patient is not nervous/anxious. OBJECTIVE BP 94/62 | Pulse 100 | Temp (!) 101.5 ?F (38.6 ?C) (Oral) | Resp 27 | Ht 1.626 m (5' 4") | Wt 85.2 kg (187 lb 13.3 oz) | SpO2 92% | BMI 32.24 kg/m? Physical ExamVitals and nursing note reviewed. Constitutional: General: He is not in acute distress. Appearance: Normal appearance. He is not ill-appearing, toxic-appearing or diaphoretic. HENT: Head: Normocephalic and atraumatic. Right Ear: External ear normal. Left Ear: External ear normal. Nose: Nose normal. Mouth/Throat: Mouth: Mucous membranes are moist. Pharynx: Oropharynx is clear. Eyes: General: No scleral icterus. Right eye: No discharge. Left eye: No discharge. Extraocular Movements: Extraocular movements intact. Conjunctiva/sclera: Conjunctivae normal. Cardiovascular: Rate and Rhythm: Normal rate and regular rhythm. Pulses: Normal pulses. Heart sounds: Normal heart sounds. Pulmonary: Effort: Pulmonary effort is normal. No respiratory distress. Breath sounds: Normal breath sounds. Comments: On 2 L supplemental oxygen, O2 saturations in mid 90s, no accessory muscle use or increased work of breathing noted Chest: Chest wall: No tenderness. Abdominal: General: Abdomen is flat. Bowel sounds are normal. There is no distension. Palpations: Abdomen is soft. There is no mass. Tenderness: There is no abdominal tenderness. Musculoskeletal: General: No tenderness. Normal range of motion. Cervical back: Normal range of motion. No tenderness. Right lower leg: No edema. Left lower leg: No edema. Skin: General: Skin is warm and dry. Coloration: Skin is not pale. Findings: No erythema. Neurological: General: No focal deficit present. Mental Status: He is alert and oriented to person, place, and time. Mental status is at baseline. Sensory: No sensory deficit. Motor: No weakness. Psychiatric: Mood and Affect: Mood normal. Behavior: Behavior normal. Thought Content: Thought content Thought content normal. Judgment: Judgment normal

Weitere VAERSDATA-Felder

Praegender Schweregrund: Acute respiratory failure
Hospital-Tage: 3,0
Labordaten: PERTINENT LABS AND STUDIES: Lab Results Component Value Date WBC 14.98 (H) 05/08/2022 WBC 10.54 12/04/2015 RBC 4.86 05/08/2022 RBC 5.28 12/04/2015 HGB 13.2 (L) 05/08/2022 HGB 15.0 12/04/2015 HCT 41.4 (L) 05/08/2022 HCT 44.7 12/04/2015 MCV 85.2 05/08/2022 MCV 84.7 12/04/2015 PLATELET 203 05/08/2022 PLATELET 230 12/04/2015 Lab Results Component Value Date GLUCOSE 104 (H) 05/08/2022 GLUCOSE 109 (H) 09/21/2017 SODIUM 137 05/08/2022 SODIUM 143 09/21/2017 POTASSIUM 4.5 05/08/2022 POTASSIUM 4.1 09/21/2017 CHLORIDE 104 05/08/2022 CHLORIDE 105 09/21/2017 ANIONGAP 14 05/08/2022 ANIONGAP 15 09/21/2017 BUN 33 (H) 05/08/2022 BUN 23 (H) 09/21/2017 CREATININE 1.17 05/08/2022 CREATININE 1.12 09/21/2017 EGFR 60 05/08/2022 EGFR >60 09/21/2017 DR CHEST 2 VIEWS FRONTAL AND LATERAL Final Result No acute cardiopulmonary process.
Aktuelle Erkrankungen: -
Vorgeschichte: Pre-Existing Active Problems Diagnosis Date Noted POA ? OSA (obstructive sleep apnea) 11/14/2016 Unknown ? RLS (restless legs syndrome)/Periodic Limb Movments of Sleep 01/16/2017 Unknown ? History of vertebral compression fracture 10/02/2019 Unknown ? Diastasis recti 04/02/2019 Unknown ? AK (actinic keratosis) 04/02/2019 Unknown ? Elevated PSA Unknown ? BPH with obstruction/lower urinary tract symptoms Unknown ? Dizziness Unknown ? Abnormal echocardiogram Unknown ? PLMD (periodic limb movement disorder) 05/15/2017 Unknown ? Age-related osteoporosis without current pathological fracture Unknown ? Snoring 08/24/2016 Unknown ? Rotator cuff tear 03/20/2014 Unknown ? OA (osteoarthritis) Unknown ? Gastroesophageal reflux disease without esophagitis Unknown ? Colon polyps
Andere Medikamente: Acetaminophen 500 mg Oral Every 6 hours PRN Alendronate Sodium 70 MG TAKE 1 TABLET BY MOUTH ONE TIME A WEEK 30 minutes before breakfast with water for bones Aspirin 325 mg Oral Nightly Atorvastatin Calcium 40 mg Oral Daily busPIRone HCl 10
Allergien: No Known Allergies
Vorherige Impfungen: -

VAERS 2228337

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EW0183

kritisch

Staat: CO
Alter: 38,0
Geschlecht: F
Eingang: 12.04.2022
Impfdatum: 13.05.2021
Beginn: 03.01.2022
Tage bis Beginn: 235,0
Dosis: 2
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: ja

Acute respiratory failure Anticoagulant therapy COVID-19 Chest X-ray abnormal Influenza virus test positive Lung opacity Parainfluenzae virus infection SARS-CoV-2 test positive

Symptomtext

Pfizer-BioNTech COVID-19 Vaccine EUA: hospitalized with acute hypoxemic respiratory failure due to COVID-19 and parainfluenza. Patient received remdesivir, steroids, supplemental oxygen, and anticoagulation. Discharged to home medically stable.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Acute respiratory failure
Hospital-Tage: 3,0
Labordaten: On admission: SARS-CoV-2: positive. Parainfluenza positive. Chest x-ray shows opacities in the right lung base.
Aktuelle Erkrankungen: none
Vorgeschichte: autism, cerebral palsy, seizures, asthma
Andere Medikamente: albuterol, fluticasone, lacosamide, lamotrigine, Keppra, olanz
Allergien: sulfaonamides, lactose, latex, zinc
Vorherige Impfungen: -

VAERS 2177674

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EW0183

kritisch

Staat: MI
Alter: 66,0
Geschlecht: F
Eingang: 14.03.2022
Impfdatum: 29.12.2021
Beginn: 04.03.2022
Tage bis Beginn: 65,0
Dosis: 1
Route/Site: IM / AR

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: ja

Acute respiratory failure Angiogram pulmonary normal Anticoagulant therapy Blood gases COVID-19 Chronic respiratory failure Condition aggravated Cough Dyspnoea Endotracheal intubation COVID-19 pneumonia Cardiac failure Chest X-ray abnormal Chest pain Chronic obstructive pulmonary disease Headache Hypercapnia Hypoxia

Symptomtext

Hospitalized 3.4.22 - 3.12.22; COVID-19 positive (3.4.22); Fully vaccinated PLUS booster Admission Date: 3/4/2022 Details of Hospital Stay PRESENTING PROBLEM: Chronic respiratory failure with hypoxia and hypercapnia (HCC) HOSPITAL COURSE: History of Present Illness History obtained from patient, ED physician/records, and personally reviewed past medical records. The patient is a 66 y.o. female who presents today with worsening hypoxia. Patient has a history of chronic respiratory failure on 2 L nasal cannula at baseline, chronic diastolic heart failure, obstructive sleep apnea, hypothyroid, anxiety/depression, morbid obesity. She recently had a hospitalization for heart failure and hypoxia. She currently has been at a facility for rehab. She had been coughing and feeling sick for past 3-4 days. The staff found that she was hypoxic down to 77% and was placed on 5 L nasal cannula. When EMS arrived placed on non-rebreather and she was satting 98%. She recently had an x-ray which showed concern for possible pneumonia in the right lower lung. Patient denies any fevers/chills, abdominal pain, nausea/vomiting. She had a headache earlier which has resolved. Patient also states that she did have COVID a few months ago. She is vaccinated. The patient was brought to the emergency department, she was able to be weaned down to 3-4 L nasal cannula. Chest x-ray shows bilateral airspace disease. Procalcitonin is unremarkable. Patient was started on Decadron. The patient is a 66 y.o. female who presented with worsening hypoxia. Admitted for COVID-19 pneumonia and acute/chronic hypoxic respiratory failure. She is normally on 2L NC but was requiring 5L at her assisted living facility before she was sent to ED. She was started on dexamethasone and lovenox subQ for DVT prophylaxis. O2 was weaned back to 2L and discharged back assisted living facility.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Acute respiratory failure
Hospital-Tage: 8,0
Labordaten: DR CHEST SINGLE VIEW Exam End: 3/4/2022 5:48 AM (Final result) Narrative: EXAMINATION: Single View Chest EXAM DATE: 3/4/2022 5:47 AM FINDINGS: Heart size is stable. Right mid and lower lung airspace disease and mild left lower lobe airspace disease have improved since the prior study. No pneumothorax is seen. Bony thorax is stable. Impression: Bilateral airspace disease, more pronounced on the right, has mildly improved in the interval. PE ON DISCHARGE: BP 140/73 | Pulse 66 | Temp 36.6 ?C (Oral) | Resp 18 | Ht 1.676 m | Wt 126.4 kg | SpO2 96% | BMI 44.98 kg/m?
Aktuelle Erkrankungen: 2.21.22 - Hospital admission - Acute respiratory failure with hypoxia: The patient is a 66 y.o. female that presented to the ED with acute worsening of subacute dyspnea. States that shortness of breath and orthopnea worsened the last few weeks but reports acute chest pain with associated shortness of breath evening at 7pm on 2/21 and lasted for a few hours. Currently she states that her shortness of breath has improved after receiving IV Lasix emergency room. She also states that her chest pain also improving rated 3/10. Described as chest pain as left lateral sharp and associated with deep inspiration. Denies substernal chest pain. She does report a dry cough that is worth while lying flat. She denies fevers, chills, productive cough, hemoptysis abdominal pain. She also states that lower extremity edema has worsened in the last few weeks with associated soreness in both lower extremitiesShe follows in the outpatient pulmonary clinic with Dr. (Privacy). Her course has been characterized by frequent decompensations requiring hospitalization, occasional intubation/mechanical ventilation, frequent BiPAP use.Carries a label of chronic obstructive pulmonary disease treated with Advair 500, although pulmonary function testing suggests restrictive physiology due to morbid obesity. She has a chronic diffusion impairment. She was admitted to inpatient service, lung CTA negative for PE. AbGs showed high Pco2 which improved dramatically by BIPAP. Pulmonary rehab was consulted for the new setting of BIPAP. She will discharge back to assisted living facility in (Privacy). And she will follow with her PCP in one week To start her on iron supplement 2.4.22 - Pulmonary office visit - Chronic dyspnea, chronic respiratory failure (hypoxia, hypercapnia) 2ndary to COPD, OSA COVID-19 positive 1.7.22 (She tested positive for COVID-19 infection on 1/7/22. She was admitted from 1/7-1/10/22 and treated with remdesivir and dexamethasone (for only 2 days as symptomatically noted to improve). She was also treated for potential superimposed bacterial pneumonia with IV ABx initially and then transitioned to Augmentin.)
Vorgeschichte: Hyperlipidemia Cigarette nicotine dependence in remission OSA (obstructive sleep apnea) Hypertension Depression Hypothyroid Morbid obesity (HCC) Chronic dyspnea Pulmonary nodule Acute on chronic hypercapnic and chronic hypoxemic respiratory failure (HCC) Other chest pain At risk for falls Diverticulosis of colon History of malignant neoplasm of cervix MVC (motor vehicle collision), sequela Anxiety disorder Community acquired pneumonia Right medial tibial plateau fracture, open type I or II, with routine healing, subsequent encounter Closed fracture of proximal end of right fibula with routine healing Closed fracture of tenth thoracic vertebra with routine healing Closed fracture of metacarpal bone Cirrhosis of liver (HCC) Chronic ulcer of left calf with fat layer exposed (HCC) Delirium Mild cognitive impairment Chronic diastolic congestive heart failure (HCC) Gastroesophageal reflux disease without esophagitis Murmur, cardiac Pleural effusion, bilateral Acute embolism and thrombosis of superficial vein of right upper extremity Acute on chronic diastolic heart failure (HCC) Nausea and vomiting Paresthesia of left arm Vitamin D deficiency Thyroid nodule Neoplasm of uncertain behavior of colon Cerebral atrophy (HCC) Chronic maxillary sinusitis Herniated lumbar intervertebral disc Migraine Chest pain Chronic respiratory failure with hypoxia and hypercapnia (HCC) Pneumonia due to COVID-19 virus Acute respiratory failure with hypoxia (HCC) Acute respiratory failure due to COVID-19 (HCC)
Andere Medikamente: acetaminophen (TYLENOL) 500 MG tablet albuterol HFA (PROVENTIL HFA, VENTOLIN HFA, PROAIR HFA) 108 (90 Base) MCG/ACT inhaler ALPRAZolam (XANAX) 0.25 MG tablet ARIPiprazole (ABILIFY) 15 MG tablet ARIPiprazole (ABILIFY) 2 MG tablet benzocaine-
Allergien: NKDA
Vorherige Impfungen: -

VAERS 2177674

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EW0183

kritisch

Staat: MI
Alter: 66,0
Geschlecht: F
Eingang: 14.03.2022
Impfdatum: 29.12.2021
Beginn: 04.03.2022
Tage bis Beginn: 65,0
Dosis: 2
Route/Site: IM / AR

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: ja

Acute respiratory failure Angiogram pulmonary normal Anticoagulant therapy Blood gases COVID-19 Chronic respiratory failure Condition aggravated Cough Dyspnoea Endotracheal intubation COVID-19 pneumonia Cardiac failure Chest X-ray abnormal Chest pain Chronic obstructive pulmonary disease Headache Hypercapnia Hypoxia

Symptomtext

Hospitalized 3.4.22 - 3.12.22; COVID-19 positive (3.4.22); Fully vaccinated PLUS booster Admission Date: 3/4/2022 Details of Hospital Stay PRESENTING PROBLEM: Chronic respiratory failure with hypoxia and hypercapnia (HCC) HOSPITAL COURSE: History of Present Illness History obtained from patient, ED physician/records, and personally reviewed past medical records. The patient is a 66 y.o. female who presents today with worsening hypoxia. Patient has a history of chronic respiratory failure on 2 L nasal cannula at baseline, chronic diastolic heart failure, obstructive sleep apnea, hypothyroid, anxiety/depression, morbid obesity. She recently had a hospitalization for heart failure and hypoxia. She currently has been at a facility for rehab. She had been coughing and feeling sick for past 3-4 days. The staff found that she was hypoxic down to 77% and was placed on 5 L nasal cannula. When EMS arrived placed on non-rebreather and she was satting 98%. She recently had an x-ray which showed concern for possible pneumonia in the right lower lung. Patient denies any fevers/chills, abdominal pain, nausea/vomiting. She had a headache earlier which has resolved. Patient also states that she did have COVID a few months ago. She is vaccinated. The patient was brought to the emergency department, she was able to be weaned down to 3-4 L nasal cannula. Chest x-ray shows bilateral airspace disease. Procalcitonin is unremarkable. Patient was started on Decadron. The patient is a 66 y.o. female who presented with worsening hypoxia. Admitted for COVID-19 pneumonia and acute/chronic hypoxic respiratory failure. She is normally on 2L NC but was requiring 5L at her assisted living facility before she was sent to ED. She was started on dexamethasone and lovenox subQ for DVT prophylaxis. O2 was weaned back to 2L and discharged back assisted living facility.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Acute respiratory failure
Hospital-Tage: 8,0
Labordaten: DR CHEST SINGLE VIEW Exam End: 3/4/2022 5:48 AM (Final result) Narrative: EXAMINATION: Single View Chest EXAM DATE: 3/4/2022 5:47 AM FINDINGS: Heart size is stable. Right mid and lower lung airspace disease and mild left lower lobe airspace disease have improved since the prior study. No pneumothorax is seen. Bony thorax is stable. Impression: Bilateral airspace disease, more pronounced on the right, has mildly improved in the interval. PE ON DISCHARGE: BP 140/73 | Pulse 66 | Temp 36.6 ?C (Oral) | Resp 18 | Ht 1.676 m | Wt 126.4 kg | SpO2 96% | BMI 44.98 kg/m?
Aktuelle Erkrankungen: 2.21.22 - Hospital admission - Acute respiratory failure with hypoxia: The patient is a 66 y.o. female that presented to the ED with acute worsening of subacute dyspnea. States that shortness of breath and orthopnea worsened the last few weeks but reports acute chest pain with associated shortness of breath evening at 7pm on 2/21 and lasted for a few hours. Currently she states that her shortness of breath has improved after receiving IV Lasix emergency room. She also states that her chest pain also improving rated 3/10. Described as chest pain as left lateral sharp and associated with deep inspiration. Denies substernal chest pain. She does report a dry cough that is worth while lying flat. She denies fevers, chills, productive cough, hemoptysis abdominal pain. She also states that lower extremity edema has worsened in the last few weeks with associated soreness in both lower extremitiesShe follows in the outpatient pulmonary clinic with Dr. (Privacy). Her course has been characterized by frequent decompensations requiring hospitalization, occasional intubation/mechanical ventilation, frequent BiPAP use.Carries a label of chronic obstructive pulmonary disease treated with Advair 500, although pulmonary function testing suggests restrictive physiology due to morbid obesity. She has a chronic diffusion impairment. She was admitted to inpatient service, lung CTA negative for PE. AbGs showed high Pco2 which improved dramatically by BIPAP. Pulmonary rehab was consulted for the new setting of BIPAP. She will discharge back to assisted living facility in (Privacy). And she will follow with her PCP in one week To start her on iron supplement 2.4.22 - Pulmonary office visit - Chronic dyspnea, chronic respiratory failure (hypoxia, hypercapnia) 2ndary to COPD, OSA COVID-19 positive 1.7.22 (She tested positive for COVID-19 infection on 1/7/22. She was admitted from 1/7-1/10/22 and treated with remdesivir and dexamethasone (for only 2 days as symptomatically noted to improve). She was also treated for potential superimposed bacterial pneumonia with IV ABx initially and then transitioned to Augmentin.)
Vorgeschichte: Hyperlipidemia Cigarette nicotine dependence in remission OSA (obstructive sleep apnea) Hypertension Depression Hypothyroid Morbid obesity (HCC) Chronic dyspnea Pulmonary nodule Acute on chronic hypercapnic and chronic hypoxemic respiratory failure (HCC) Other chest pain At risk for falls Diverticulosis of colon History of malignant neoplasm of cervix MVC (motor vehicle collision), sequela Anxiety disorder Community acquired pneumonia Right medial tibial plateau fracture, open type I or II, with routine healing, subsequent encounter Closed fracture of proximal end of right fibula with routine healing Closed fracture of tenth thoracic vertebra with routine healing Closed fracture of metacarpal bone Cirrhosis of liver (HCC) Chronic ulcer of left calf with fat layer exposed (HCC) Delirium Mild cognitive impairment Chronic diastolic congestive heart failure (HCC) Gastroesophageal reflux disease without esophagitis Murmur, cardiac Pleural effusion, bilateral Acute embolism and thrombosis of superficial vein of right upper extremity Acute on chronic diastolic heart failure (HCC) Nausea and vomiting Paresthesia of left arm Vitamin D deficiency Thyroid nodule Neoplasm of uncertain behavior of colon Cerebral atrophy (HCC) Chronic maxillary sinusitis Herniated lumbar intervertebral disc Migraine Chest pain Chronic respiratory failure with hypoxia and hypercapnia (HCC) Pneumonia due to COVID-19 virus Acute respiratory failure with hypoxia (HCC) Acute respiratory failure due to COVID-19 (HCC)
Andere Medikamente: acetaminophen (TYLENOL) 500 MG tablet albuterol HFA (PROVENTIL HFA, VENTOLIN HFA, PROAIR HFA) 108 (90 Base) MCG/ACT inhaler ALPRAZolam (XANAX) 0.25 MG tablet ARIPiprazole (ABILIFY) 15 MG tablet ARIPiprazole (ABILIFY) 2 MG tablet benzocaine-
Allergien: NKDA
Vorherige Impfungen: -

VAERS 2123145

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EW0183

kritisch

Staat: MI
Alter: 51,0
Geschlecht: M
Eingang: 14.03.2022
Impfdatum: 11.05.2021
Beginn: 06.06.2021
Tage bis Beginn: 26,0
Dosis: 1
Route/Site: SYR / -

Tod: unbekannt Lebensbedrohlich: ja Hospital: unbekannt Disable: ja ER: unbekannt Erholt: nein

Allergy test Antinuclear antibody Arrhythmia Blood test Blood thyroid stimulating hormone Borrelia test C-reactive protein Cardiac stress test Chest X-ray Computerised tomogram Cardiac imaging procedure abnormal Dyspnoea exertional Exercise tolerance decreased Pulmonary embolism Pulmonary hypertension Dyspnoea Electrocardiogram Liver function test

Symptomtext

Roughly 1-2 weeks after receiving his 2nd dose of the vaccination, the patient notice increasing dyspnea on exertion and exercise intolerance. After several months of evaluation, it appears the patient has chronic thromboembolic pulmonary hypertension. By clinical history, this appears to have happened roughly 2 weeks after receiving the 2nd dose of the vaccine.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Pulmonary embolism
Hospital-Tage: -
Labordaten: 03/04/2022 cardiac MRI showing severe right ventricular dilation and moderately reduced right ventricular systolic function. 03/10/2022 VQ scan showing multiple age indeterminate pulmonary emboli.
Aktuelle Erkrankungen: None
Vorgeschichte: None
Andere Medikamente: None
Allergien: Ibuprofen
Vorherige Impfungen: -

VAERS 2163498

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EW0183

kritisch

Staat: MI
Alter: 57,0
Geschlecht: F
Eingang: 07.03.2022
Impfdatum: 13.10.2021
Beginn: 27.02.2022
Tage bis Beginn: 137,0
Dosis: 3
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: ja

Abdominal pain Acute respiratory failure Anticoagulant therapy Back pain Blood gases abnormal Computerised tomogram spine Culture negative Dehydration Depressed level of consciousness Electrocardiogram normal COVID-19 Cardiac telemetry Chest X-ray normal Computerised tomogram abdomen normal Computerised tomogram head normal Fall Feeling abnormal Fibrin D dimer normal

Symptomtext

Hospitalized (2.27.22 - 3.3.22); COVID-19 positive (2.27.22); Fully Vaccinated PLUS booster Discharge Provider: MD Primary Care Provider: MD Admission Date: 2/27/2022 Discharge Date: Mar 3, 2022 DETAILS OF HOSPITAL STAY: PRESENTING PROBLEM: Vasovagal syncope [R55] Somnolence [R40.0] Hypoxia, sleep related [G47.34] Acute respiratory failure with hypoxia and hypercapnia (HCC) [J96.01, J96.02] DC summary edit pending HOSPITAL COURSE: A 57 y.o. female with h/o COPD, T2DM, HTN, HLD, GERD/DUD, IBS, migraines, bipolar disorder and chronic pain with opioid dependence, presenting to the Butterworth ER on 2/27 following a syncopal episode. She was laying in bed today nursing chronic back pain, when she became nauseous and felt the need to vomit and have a BM. She then suffered a syncopal episode, whereafter she rapidly regained consciousness and immediately returned to baseline mentation. She did endorse some left-sided neck pain after her fall. Family noted to the ED provider that she has been feeling poorly in recent days and, as such, is not eating/drinking normally per her baseline. In the ER, she was afebrile, hypotensive, with normal HR, tachypnic and hypoxic to 85% on baseline RA. Initial labs were notable for AGMA, leukocytosis, hypoalbuminemia. Serial VBG showed mild respiratory acidosis with pCO2 in 50s. COVID screen was positive and she is vaccinated. EKG shows NSR. CTH and CTCS negative for acute processes. CXR was clear. She was treated with Zofran, Decadron and IV fluids, and admission to IM was requested for management of acute hypoxic and hypercapnic respiratory failure. BiPAP trial in setting of persistent lethargy and persistently elevated pCO2 with respiratory acidosis was started. CT of the abdomen and pelvis was performed which showed no obvious source of her leukocytosis and abdominal pain. She was transferred to Hospital to the hospitalist service. Hypotension, asx HTN by hx HOLD lisinopril 10 and prazosin 1 HS at DC given presenting and persistent hypotension with resumption only after verifying BPs high enough to support DASH diet at discharge Acute hypoxic and hypercapnic respiratory failure Attributed to polypharmacy w/ sedating meds including opioid, COVID infection, poor oral intake, and continued anti-HTNs COVID + COPD Hypoxic to 85% on baseline RA VBG w/ hypercapnia and mild respiratory acidosis CXR clear BiPAP trial in ER given persistent lethargy and hypercapnia w/ repeat VBG w/ improvement in both; was still very sleepy. Dexamethasone 6 d with plan to stop at DC given no support for this indication INH inhalers Sx mngt, supportive care, encourage IS use D-dimer not elevated Syncope w/ collapse Presumed vasovagal v orthostatic hypotension due to decreased oral intake, continued anti-HTN med use, illness w/ Covid infection Neck pain possible muscle strain from fall CT head and CT cervical spine with no acute processes Encephalopathy, acute toxic metabolic: Resolved Likely secondary to polypharmacy esp w/ opioid, hypercapnic respiratory failure, and infection Avoid sedating meds/doses Telemetry and continuous pulse ox AGMA: Resolved IVFs now off so verify taking oral to avoid return of si/sx that led to admission Bipolar disorder Chronic pain with opioid dependence Abdominal pain CT AP w/o clear source of pain; chronic opioid not likely helpful Tylenol w/ Suboxone in lieu of buprenorphine 8 PO q8 for past year when home Med effect noted despite pt more alert 3/2/22 - Monitor for S/Sx of opioid withdrawal, consider Addiction Med consult for re-dosing if needed. SIRS, no clear source for sepsis Likely reactive and due to acute viral illness Pyuria w/ mod leuks and few bacteria, no growth from ctx sent from ER. CXR and CT AP without e/o acute processes Hold on abx for now, but monitor for infectious si/sx DMII, A1c 6.8 Hold metformin No indication for insulin so canceled HLD Aspirin and statin continued GERD/PUD PPI continued VTE ppx: High risk so Lovenox SQ; note low wt so may need dose adjust over time Diet: Consistent carb Partial code, desires intubation and ventilation if needed but no CPR DC home 3/3/22 given consistently awake, alert and not intermittently somnolent w/ hypoxia or respiratory insufficiency to suggest hypercapnia The following was provided in writing at discharge: Opioid pain medicine, buprenorphine and other sedating medicine Do not take more than scribed given risk of death by doing so Work with your doctor on pain management strategies that do not involve opioid given this risk Taking opioid medications during time of illness (Covid infection), not consuming enough food/fluids (dehydrated), and continuing meds such as anti-hypertensives leading to low blood pressures can come together leading to decreased levels of consciousness and hospitalization. Work with your doctor on safe medicine use, especially when ill or not eating/drinking enough. Your dose of Lyrica was reduced while here, from 200 mg twice daily to 150 mg twice daily in the setting of excess sedation You did very well with this dose reduction. Consider lowering your dose so you take the lowest effective dose of medicines like these No adjustment to this medicine and its dose was made at discharge Hypotension HOLD lisinopril and prazosin These medicines lower blood pressure. Your pressures were too soft during your stay to support safe use at discharge Keep them near, however as you and your doctor may decide they need to be restarted in the future We recommend your blood pressures are at least 130/80

Weitere VAERSDATA-Felder

Praegender Schweregrund: Acute respiratory failure
Hospital-Tage: 4,0
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: Fibromyalgia;GERD (gastroesophageal reflux disease);COPD (chronic obstructive pulmonary disease) (HCC);Tremor, essential; Bipolar 1 disorder, mixed (HCC);Diabetes mellitus type 2 without retinopathy (HCC); Hyperopia, bilateral; Abnormal MRA, brain;S/P cervical spinal fusion;H/O: hysterectomy Tobacco use; Dysphagia;Basilar artery aneurysm (HCC);Fibromuscular; Dysplasia (HCC);Cervical radiculopathy.
Andere Medikamente: albuterol HFA (PROVENTIL HFA, VENTOLIN HFA, PROAIR HFA) 108 (90 Base) MCG/ACT inhaler;Amitriptyline (ELAVIL);Aspirin;Atorvastatin (LIPITOR); Budesonide/formoterol (SYMBICORT); ACT inhaler;Buprenorphine HCl Duloxetine (CYMBALTA); Ergocalcif
Allergien: Chocolate Rash; Codeine; Environmental; Sulfa Drugs-Hives; Tylenol With Codeine #3 [Acetaminophen-codeine]Hives.
Vorherige Impfungen: -

VAERS 2163495

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EW0183

kritisch

Staat: IL
Alter: 14,0
Geschlecht: F
Eingang: 07.03.2022
Impfdatum: 17.05.2021
Beginn: 19.02.2022
Tage bis Beginn: 278,0
Dosis: 2
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: nein

Blister Blood urine present Computerised tomogram Cytomegalovirus test negative Depressed mood Educational problem Emotional distress Epstein-Barr virus test negative Eye pain Fatigue Fear Fear of death Full blood count Gait disturbance Genital ulcer syndrome Headache Hepatic enzyme increased Herpes simplex test

Symptomtext

15 year old child presented very sick with high fever and red painful eyes. Fever was 103 for three days. No lowering. Condition worsened with headache, fever of 103.8, fatigue, and rash in vagina, thought to be from maxi pads. Saw urgent care after virtual dr. appointment. Urgent care said it was viral or covid. I asked for urine test for UTI. Came back blood in urine, but not UTI. Refused Covid test as I had done three already that were negative. Sent home and said was viral. SHe got much worse so I called and asked for antibiotics. They called in and said if not improve call. I called after 2 days of no improvement and getting worse. The on call dr. suggested we go to hospital. After day6 of fever of 1 103.8 the er was very concerned. They suggested herpes or another STI. we were nortified. CHild was not sexually active and they said it did not matter. They tested for EBV, CMV and many others. so they called specialist OB GYN. She came and said it was Lipschutz Disease. They needed to wait for tests. She was in extreme pain and could not move. We were admitted and continued for 5 days. SHe was in extreme pain. They took pictures to document her recovery. She was sad and embarrassed. SHe mentally was struggling. COuldn't drink or eat out of fear of using the restroom. She was very ill and feared dying. She had blisters covering the inside and out. She had many doctors looking daily at her progress. She tested negative for all viruses that could have caused this including COVID-19. No antibodies. No EBV, CMV or Mono, or many others they tested. No flu. Her liver enzymes were high and her blood showed her body had inflamation. My child is still in extreme pain and suffering and can barely walk. Is afraid to use the bathroom and is struggling in school now.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Fear of death
Hospital-Tage: 6,0
Labordaten: CBC, Covid Antibodies, Covid, Flu, CMV, pneumonia, Complete panel, EBV, Herpes, HSV, CT Scan, STI
Aktuelle Erkrankungen: None
Vorgeschichte: None
Andere Medikamente: SIngulair
Allergien: Seasonal
Vorherige Impfungen: -

VAERS 2148310

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EW0183

kritisch

Staat: MI
Alter: 63,0
Geschlecht: M
Eingang: 28.02.2022
Impfdatum: 22.09.2021
Beginn: 07.02.2022
Tage bis Beginn: 138,0
Dosis: 3
Route/Site: IM / RA

Tod: ja Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: nein

Abdominal pain Acute respiratory failure Angiogram abnormal Arteriosclerosis Atelectasis Bladder catheterisation Bronchial secretion retention Bronchiectasis COVID-19 Central venous catheterisation Chest X-ray abnormal Colectomy total Colitis ulcerative Computerised tomogram abdomen abnormal Computerised tomogram thorax abnormal Condition aggravated Death Emphysema

Symptomtext

Patient expired. 63 year old male with history of Ulcerative colitis (on Xeljanz and Sulfasalazine) with prior history of DVT (on Eliquis) with recent admission 1/20-2/4 due to UC flare complicated by colonic perforation who underwent total abdominal colectomy with end-ileostomy 1/28. He was discharged home but was re-admitted 2/7 due small bowel obstruction. He was also found to have portal vein thrombosis and was incidentally found to be COVID 19 positive. He was treated non-operatively with NGT and foley catheter placed in stoma. He was treated with Unasyn for possible aspiration given bibasilar infiltrates noted on CT. For COVID 19, he was started on Decadron course. Given persistent ileus/SBO, the patient was started on TPN 2/13 after RIJ CVC was placed. On 2/14 AM, the patient developed severe abdominal pain associated with decreased ostomy output, hypotension and tachycardia. He was brought to CT and was found to have increased intra-abdominal free air and increased small bowel wall thickening. On arrival to ICU he only required low dose vasopressors but quickly decompensated and was taken to OR which noted possible perforation located at the GE junction, feculent peritonitis. He returned to the ICU requiring high dose quad pressor support. Family updated and transitioned patient to comfort care. He was pronounced dead at 2050. Medical Examiner Case Assessment Select Applicable Patient Criteria: Does not meet any of the listed criteria

Weitere VAERSDATA-Felder

Praegender Schweregrund: Acute respiratory failure
Hospital-Tage: 7,0
Labordaten: Procedure Component Value Ref Range Date/Time DR CHEST SINGLE VIEW Collected: 02/14/22 1642 Order Status: Completed Updated: 02/14/22 1653 Narrative: EXAMINATION: Single View Chest EXAM DATE: 2/14/2022 4:07 PM TECHNIQUE: Single view chest INDICATION: Intubation, shock COMPARISON: Chest radiograph 2/10/2022 ENCOUNTER: Not applicable _________________________ FINDINGS: Endotracheal tube tip is approximately 4.5 cm above the carina. Enteric tube courses below the diaphragm. Additional drain/tubing overlies the upper abdomen. Right IJ approach catheter tip is seen near at the mid/lower SVC. The cardiomediastinal silhouette is unchanged in appearance. Bilateral infrahilar opacities persist with streaky appearance to a pronounced on the left. Trace left pleural effusion is suspected. No pneumothorax is visualized. ______________________________________ Impression: ET tube tip 4.5 cm above the carina. Ongoing mild bibasilar atelectasis versus airspace disease. CT ABDOMEN AND PELVIS WITH IV CONTRAST Collected: 02/14/22 0702 Order Status: Completed Updated: 02/14/22 0731 Narrative: EXAMINATION: CT Abdomen and Pelvis with IV Contrast EXAM DATE: 2/14/2022 7:00 AM TECHNIQUE: CT imaging of the abdomen and pelvis was performed with intravenous contrast. Coronal and sagittal images were reconstructed. CONTRAST: The amount and type of contrast are recorded in the medical record. QPP DOCUMENTATION: At least one of the following dose reduction techniques was utilized: Iterative reconstruction, and/or Automatic Exposure Control, and/or mA/kV adjustment based on body size. INDICATION: abdominal pain. Hypotension COMPARISON: 2/10/2022 ENCOUNTER: Not applicable ____________________ FINDINGS: Lung Bases: Again seen is bibasilar airspace disease with air bronchograms. This is likely atelectasis and consolidation. The appearance has improved at the right base. There may have been minimal improvement in the left base. Emphysematous changes are again seen in the lungs. Hepatobiliary: There is a cyst in segment 4, unchanged. There is periportal edema. No new and suspicious liver lesions are seen. There is mildly dense material along the dependent aspect the gallbladder, possibly sludge or previous excreted contrast (vicarious excretion). Pancreas: The pancreas is normal. Spleen: The spleen has a normal size and there are no splenic lesions. Adrenals: The adrenal glands are normal. Kidneys, Ureters, & Bladder: Both kidneys have a normal size and there is no hydronephrosis. Again seen is an exophytic cyst from the upper pole the left kidney. Parapelvic cysts are also present. Both ureters have a normal caliber. The urinary bladder is unremarkable. Gastrointestinal: The small bowel is diffusely abnormal with dilatation and diffuse bowel wall thickening. Postoperative changes seen from a colectomy and Hartmann pouch. There is an ileostomy in the right lower quadrant with an ileostomy tube. The Hartmann pouch is unremarkable. Reproductive Organs: Unremarkable. Lymphatic System: There is no lymph node enlargement within the abdomen or pelvis. Vasculature: Abdominal aorta has a normal caliber with moderate atherosclerotic plaque. The main abdominal aortic branch vessels including the celiac, mesenteric, and renal arteries appear patent with no evidence of a stenosis. There is no evidence for mesenteric venous thrombosis. Peritoneum: There is a moderate to large volume of free air and fluid. The volume of pneumoperitoneum has clearly increased from the prior study. Peritoneal surfaces appear mildly enhancing, suggesting peritonitis. Abdominal Wall & Musculoskeletal: There is a right mid abdominal ileostomy. Postoperative changes are seen with the midline incision from the recent colectomy. There is marked degenerative disc disease in the lumbar spine. _________________________ Impression: 1. Significant increase in the volume of ascites and free air consistent with interval perforation. There are findings suggesting. Tinnitus. 2. Diffusely abnormal small bowel dilatation and diffuse bowel wall thickening. 3. Postoperative changes from a colectomy and Hartmann pouch. 4. Bibasilar airspace disease, mildly improved on the right and probably slightly improved on the left. 5. Periportal edema. A Red Critical Result was communicated. IR TUNNELED CENTRAL INSERT CATHETER Resulted: 02/13/22 1233 Order Status: Completed Updated: 02/13/22 1235 Narrative: EXAMINATION: Internal Jugular Vein Tunneled Central Venous Catheter Placement With Ultrasound and Fluoroscopic Guidance TECHNIQUE: Ultrasound-guided right central venous catheter placement with ultrasound evaluation of potential access site, documentation of selected vessel patency, concurrent real-time ultrasound visualization of vascular needle entry, permanent ultrasound image recording and fluoroscopy spot image documenting tip location. INDICATION: 2 lumen CVC for TPN COMPARISON: None PQRS RADIATION EXPOSURE: Peak skin dose: 1 mGy PQRS MAXIMUM STERILE BARRIER: The patient was prepped and draped with the maximum sterile barrier technique. This included cap, mask, sterile gloves, sterile gown, sterile large sheet, hand hygiene, sterile ultrasound techniques, and 2% chlorhexidine for cutaneous antisepsis. ________________________ PROCEDURE: Risks, benefits, and alternatives were discussed with the patient who agreed to proceed. The right neck and chest wall were prepped and draped with the maximal sterile barrier technique. Digital ultrasound image was obtained and stored in the system confirming right internal jugular vein patency. The puncture site and tunnel in the anterior chest wall were anesthetized with 1% lidocaine. The right internal jugular vein was punctured with a micropuncture needle using ultrasound guidance and a size 5 dilator was placed. A small skin incision was made for the catheter exit site that was also bluntly dissected. A size 5 double-lumen, CT injectable PICC line was then pulled through subcutaneous tunnel and cut to position the catheter tip at the cavoatrial junction. Catheter was advanced through a peel-away sheath and sheath were removed. Spot film documents final placement. Both lumens freely aspirated and both were flushed with sterile saline. The catheter was secured in place with 2-0 Ethilon and small incision at the base the neck sealed with Dermabond. A sterile dressing was applied to the site. No procedural complications were encountered. Estimated blood loss: Less than 2 mL. ____________________ Impression: Right internal jugular vein double-lumen PICC line venous catheter placement. Tip is at the cavoatrial junction and catheter is ready for use. CT ABDOMEN AND PELVIS WITH IV CONTRAST Collected: 02/10/22 2156 Order Status: Completed Updated: 02/10/22 2221 Narrative: EXAMINATION: CT Angiography of the Thorax EXAM DATE: 2/10/2022 9:21 PM TECHNIQUE: Standard protocol CT angiogram images were obtained through the chest following the administration of intravenous contrast. Coronal and sagittal MIP 3-D reformations were performed. CONTRAST: The amount and type of contrast are recorded in the medical record. QPP DOCUMENTATION: At least one of the following dose reduction techniques was utilized: Iterative reconstruction, and/or Automatic Exposure Control, and/or mA/kV adjustment based on body size. INDICATION: Covid 19. Possible PE. Bowel obstruction. COMPARISON: 2/10/2022 chest x-ray, 2/7/2022 ENCOUNTER: Not applicable ____________________ FINDINGS: Base of Neck & Axillae: There is no lymph node enlargement. Mediastinum & Hila: Mild bilateral hilar adenopathy . No mediastinal adenopathy. Cardiovascular: Moderate coronary artery calcification indicating coronary artery disease. The heart has a normal size. There is no pericardial effusion. The thoracic aorta is not aneurysmal and there is no dissection. There is no evidence for right heart strain. Pulmonary Arteries: No pulmonary embolism is present. Lungs & Airways: Consolidation of posterior lower lobes with air bronchograms. COPD. No suspicious nodule identified Moderate central bronchial wall thickening. Mild bronchiectasis suspected in right lower lobe. Mucous plugging is suspected in bilateral lower lobes peripherally Pleural Space: There are no pleural effusions. There is no pneumothorax. Chest Wall & Musculoskeletal: Mild to moderate spondylosis and disc disease. Posterior disc spur complex at T7-8 is associated with mild spinal stenosis ____________________ Impression: 1. Posterior lower lobe infiltrates as described consistent with massive aspiration or bilateral pneumonia, new since 2/7/2022. 2. No acute pulmonary embolic disease -- EXAMINATION: CT Abdomen and Pelvis with IV Contrast EXAM DATE: 2/10/2022 9:21 PM TECHNIQUE: CT imaging of the abdomen and pelvis was performed with intravenous contrast. Coronal and sagittal images were reconstructed. CONTRAST: The amount and type of contrast are recorded in the medical record. QPP DOCUMENTATION: At least one of the following dose reduction techniques was utilized: Iterative reconstruction, and/or Automatic Exposure Control, and/or mA/kV adjustment based on body size. INDICATION: Bowel obstruction. Covid 19 COMPARISON: 2/7/2022 ENCOUNTER: Not applicable ____________________ FINDINGS: Hepatobiliary: The liver has a normal size with a smooth surface. Resolution of partially occlusive thrombus in right portal vein. 11 mm left hepatic lobe cyst unchanged.. No calcified gallstones or biliary dilation Pancreas: Marked atrophy Spleen: The spleen has a normal size and there are no splenic lesions. Adrenals: The adrenal glands are normal. Kidneys, Ureters, & Bladder: Both kidneys have a normal size and there is no hydronephrosis. 5.3 cm cyst upper pole left kidney. Scattered peripelvic cysts bilaterally. Nephrograms are symmetric. Both ureters have a normal caliber. The urinary bladder is unremarkable. Gastrointestinal: Moderately dilated small bowel in the abdomen and pelvis to just proximal to level of the ostomy. Defunctionalized rectosigmoid. Right lower quadrant ostomy. Ostomy tube is present with proximal tip in bowel in left lower quadrant. Stomach decompressed; transesophageal tube tip in stomach Reproductive Organs: Unremarkable. Lymphatic System: There is no lymph node enlargement within the abdomen or pelvis. Vasculature: Normal caliber abdominal aorta. See above. Peritoneum: Small amount of free intraperitoneal air. Small amount of pelvic free fluid. Abdominal Wall & Musculoskeletal: Mild anasarca. Small amount of air in the right abdominal wall, decreased. Mild presacral edema. Moderate to marked disc disease and spondylosis, L2-3 through L5-S1; associated spinal stenosis at these levels. ____________________ IMPRESSION: 1. New decompression tube traversing the right lower quadrant ostomy including transition zone described below. 2. Moderate grade mechanical small bowel obstruction with transition zone immediately proximal to the right lower quadrant ostomy. No significant change. 3. Small amount of pelvic free fluid, slightly increased 4. Small amount of free air, not significantly changed CT ANGIO THORAX WITH IV CONTRAST Collected: 02/10/22 2156 Order Status: Completed Updated: 02/10/22 2221 Narrative: EXAMINATION: CT Angiography of the Thorax EXAM DATE: 2/10/2022 9:21 PM TECHNIQUE: Standard protocol CT angiogram images were obtained through the chest following the administration of intravenous contrast. Coronal and sagittal MIP 3-D reformations were performed. CONTRAST: The amount and type of contrast are recorded in the medical record. QPP DOCUMENTATION: At least one of the following dose reduction techniques was utilized: Iterative reconstruction, and/or Automatic Exposure Control, and/or mA/kV adjustment based on body size. INDICATION: Covid 19. Possible PE. Bowel obstruction. . COMPARISON: 2/10/2022 chest x-ray, 2/7/2022 ENCOUNTER: Not applicable ____________________ FINDINGS: Base of Neck & Axillae: There is no lymph node enlargement. Mediastinum & Hila: Mild bilateral hilar adenopathy . No mediastinal adenopathy. Cardiovascular: Moderate coronary artery calcification indicating coronary artery disease. The heart has a normal size. There is no pericardial effusion. The thoracic aorta is not aneurysmal and there is no dissection. There is no evidence for right heart strain. Pulmonary Arteries: No pulmonary embolism is present. Lungs & Airways: Consolidation of posterior lower lobes with air bronchograms. COPD. No suspicious nodule identified Moderate central bronchial wall thickening. Mild bronchiectasis suspected in right lower lobe. Mucous plugging is suspected in bilateral lower lobes peripherally Pleural Space: There are no pleural effusions. There is no pneumothorax. Chest Wall & Musculoskeletal: Mild to moderate spondylosis and disc disease. Posterior disc spur complex at T7-8 is associated with mild spinal stenosis ____________________ Impression: 1. Posterior lower lobe infiltrates as described consistent with massive aspiration or bilateral pneumonia, new since 2/7/2022. 2. No acute pulmonary embolic disease -- EXAMINATION: CT Abdomen and Pelvis with IV Contrast EXAM DATE: 2/10/2022 9:21 PM TECHNIQUE: CT imaging of the abdomen and pelvis was performed with intravenous contrast. Coronal and sagittal images were reconstructed. CONTRAST: The amount and type of contrast are recorded in the medical record. QPP DOCUMENTATION: At least one of the following dose reduction techniques was utilized: Iterative reconstruction, and/or Automatic Exposure Control, and/or mA/kV adjustment based on body size. INDICATION: Bowel obstruction. Covid 19 COMPARISON: 2/7/2022 ENCOUNTER: Not applicable ____________________ FINDINGS: Hepatobiliary: The liver has a normal size with a smooth surface. Resolution of partially occlusive thrombus in right portal vein. 11 mm left hepatic lobe cyst unchanged. No calcified gallstones or biliary dilation Pancreas: Marked atrophy Spleen: The spleen has a normal size and there are no splenic lesions. Adrenals: The adrenal glands are normal. Kidneys, Ureters, & Bladder: Both kidneys have a normal size and there is no hydronephrosis. 5.3 cm cyst upper pole left kidney. Scattered peripelvic cysts bilaterally. Nephrograms are symmetric. Both ureters have a normal caliber. The urinary bladder is unremarkable. Gastrointestinal: Moderately dilated small bowel in the abdomen and pelvis to just proximal to level of the ostomy. Defunctionalized rectosigmoid. Right lower quadrant ostomy. Ostomy tube is present with proximal tip in bowel in left lower quadrant. Stomach decompressed; transesophageal tube tip in stomach Reproductive Organs: Unremarkable. Lymphatic System: There is no lymph node enlargement within the abdomen or pelvis. Vasculature: Normal caliber abdominal aorta. See above. Peritoneum: Small amount of free intraperitoneal air. Small amount of pelvic free fluid. Abdominal Wall & Musculoskeletal: Mild anasarca. Small amount of air in the right abdominal wall, decreased. Mild presacral edema. Moderate to marked disc disease and spondylosis, L2-3 through L5-S1; associated spinal stenosis at these levels. ____________________ IMPRESSION: 1. New decompression tube traversing the right lower quadrant ostomy including transition zone described below. 2. Moderate grade mechanical small bowel obstruction with transition zone immediately proximal to the right lower quadrant ostomy. No significant change. 3. Small amount of pelvic free fluid, slightly increased 4. Small amount of free air, not significantly changed DR CHEST SINGLE VIEW Resulted: 02/10/22 1346 Order Status: Completed Updated: 02/10/22 1349 Narrative: EXAMINATION: Single View Chest EXAM DATE: 2/10/2022 1:19 PM TECHNIQUE: Single portable AP upright view chest INDICATION: hypoxia COMPARISON: 2/8/2022 ENCOUNTER: Not applicable _________________________ FINDINGS: An NG tube remains in place extending into the stomach. The heart is stable in size. The pulmonary vessels are not congested. Increasing opacities at both lung bases right greater than left are noted compared to the prior study consistent with worsening atelectasis and/or pneumonitis. No pleural effusions are identified. There is no pneumothorax. _________________________ Impression: Worsening bibasilar atelectasis and/or pneumonitis since 2/8/2022, right greater than left. DR CHEST SINGLE VIEW Resulted: 02/08/22 1324 Order Status: Completed Updated: 02/08/22 1326 Narrative: EXAMINATION: Single View Chest EXAM DATE: 2/8/2022 1:09 PM TECHNIQUE: Single view chest INDICATION: hemoptysis - COVID-19 COMPARISON: June 5, 2019 ENCOUNTER: Not applicable _________________________ FINDINGS: An NG tube transverses the chest with its tip projecting over the gastric fundus directed towards the left. The heart and mediastinal structures have a normal appearance. There are a few mild streaky opacities at the left base with slight blunting of the left CP angle. Right lung is essentially clear. The right CP angle is sharp. Moderate dorsal spondylosis. _________________________ Impression: Mild streaky atelectasis/infiltrate at the left base and slight blunting of the left CP angle. DR ABDOMEN FLAT PLATE - AP Collected: 02/07/22 0303 Order Status: Completed Updated: 02/07/22 0306 Narrative: EXAMINATION: DR ABDOMEN FLAT PLATE - AP EXAM DATE: 2/7/2022 2:45 AM TECHNIQUE: Supine views of the abdomen INDICATION: NG Tube placement COMPARISON: CT 2/7/2022 _________________________ FINDINGS: The enteric tube terminates in the stomach. Small bowel dilation is redemonstrated. No visualized renal stones or gallstones. The bones are unremarkable. _________________________ Impression: 1. The enteric tube terminates in the stomach. 2. Small bowel obstruction. CT ABDOMEN AND PELVIS WITH IV CONTRAST Resulted: 02/07/22 0234 Order Status: Completed Updated: 02/07/22 0236 Addenda: Addendum: Addendum is being issued to address an anatomic correction. The thrombus within the mesentery is within the region of the right colic vein and extends a short ways into the superior mesenteric vein not the IVC. The IVC while somewhat flattened is without thrombus. Narrative: EXAMINATION: CT Abdomen and Pelvis with IV Contrast EXAM DATE: 2/7/2022 1:26 AM TECHNIQUE: CT imaging of the abdomen and pelvis was performed with intravenous contrast. Coronal and sagittal images were reconstructed. CONTRAST: The amount and type of contrast are recorded in the medical record. QPP DOCUMENTATION: At least one of the following dose reduction techniques was utilized: Iterative reconstruction, and/or Automatic Exposure Control, and/or mA/kV adjustment based on body size. INDICATION: Abdominal abscess/infection suspected, Recent total colectomy, abdominal pain COMPARISON: 1/28/2022 ENCOUNTER: Not applicable ____________________ FINDINGS: Lung Bases: Mild dependent atelectasis is present. Similar emphysematous findings. Heart size and pericardium are within normal limits. Hepatobiliary: No interval suspicious hepatic parenchymal findings. Similar appearance to small cyst within the central liver. Mild periportal edema likely on the basis of IV hydration effects. There is no biliary dilatation and the gallbladder is unremarkable with no calcified stones. Pancreas: The pancreas is normal. Spleen: The spleen has a normal size and there are no splenic lesions. Adrenals: The adrenal glands are normal. Kidneys, Ureters, & Bladder: Both kidneys have a normal size and there is no hydronephrosis. No interval suspicious renal findings. Moderate to large left upper pole renal cyst is stable. Both ureters have a normal caliber. The urinary bladder is unremarkable. Gastrointestinal: There are now findings of a distal small bowel obstruction. While there is a paucity of intra-abdominal fat, the transition point is suspected to be at the level of the ileostomy (2:100). The stomach and small bowel are significantly diffusely distended. No radiographic findings suspicious for ischemia. The appendix is surgically absent. Status post interval colectomy without complicating feature otherwise. Specifically there is no evidence of abscess at the sigmoid colon stump resection site. Reproductive Organs: Vasectomy clips are visualized. Lymphatic System: There is no lymph node enlargement within the abdomen or pelvis. Vasculature: Abdominal aorta has a normal caliber with moderate atherosclerotic plaque. There are findings of nonocclusive thrombus within the peripheral portions of the right portal vein extending into the region of segment 7 and segment 8. Main portal vein is patent. There is a miniscule nonocclusive thrombus within the proximal right colonic mesenteric region likely right colic vein. This vein is truncated more distal to this and suspect postsurgical thrombus. A portion of this protrudes into the IVC. The major mesenteric venous trunks are otherwise patent. Aortic branch vessels are patent. Peritoneum: Scattered very small amounts of residual free intraperitoneal gas from recent colectomy noted, felt to be within tolerance for postoperative status. There are scattered small areas of interloop free fluid and mesenteric edema present from the bowel obstruction. No findings suspicious for abscess. Abdominal Wall & Musculoskeletal: Interval right lower quadrant ileostomy site. Associated adjacent abdominal wall soft tissue gas is seen compatible with recent surgery. No findings of soft tissue abscess. Bone windows demonstrate no interval suspicious findings. Similar significant multilevel degenerative findings of the lumbar spine again noted. ____________________ Impression: 1. Findings of distal small bowel obstruction at the level of the recently created ileostomy with significant distention of the small bowel and stomach. Patient would likely benefit from gastric decompression. No radiographic findings suspicious for ischemia. No evidence of abscess. 2. Nonocclusive right portal venous distribution thrombus. Main portal vein is patent. 3. Additional tiny thrombus within a suspected ligated right mesenteric vein perhaps the right colic vein. While this does extend a short ways into the IVC, its extension here is minimal. Would however recommend close follow-up given the additional portal vein thrombosis.
Aktuelle Erkrankungen: -
Vorgeschichte: Respiratory Snoring COPD (chronic obstructive pulmonary disease) Acute respiratory failure with hypoxia Circulatory Portal vein thrombosis, with hx of RLE DVT Digestive Ulcerative colitis Perforated ulcerative colitis now s/p TAC with end ileostomy (JWO; 1/28), return with ileus/SBO Severe protein-calorie malnutrition Small bowel obstruction Postoperative intestinal obstruction Infectious/Inflammatory Herpes simplex type 2 infection Septic shock Genitourinary Benign prostatic hyperplasia Other Osteoarthritis of lumbar spine Hypersomnia Alopecia areata universalis Depression Insomnia History of ulcerative colitis History of COPD
Andere Medikamente: buPROPion (WELLBUTRIN XL) 300 MG 24 hr tablet cetirizine (ZYRTEC) 10 MG tablet Ciclopirox 8 % KIT finasteride (PROSCAR) 5 MG tablet fluticasone (FLONASE) 50 MCG/ACT nasal spray fluticasone-salmeterol (ADVAIR DISKUS) 250-50 MCG/DOSE diskus i
Allergien: Humira [Adalimumab]Other Ileostomy Restricted Foods
Vorherige Impfungen: -

VAERS 2137192

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EW0183

kritisch

Staat: CO
Alter: 79,0
Geschlecht: M
Eingang: 24.02.2022
Impfdatum: 24.10.2021
Beginn: 15.11.2021
Tage bis Beginn: 22,0
Dosis: 3
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Angiogram Pulmonary embolism

Symptomtext

Developed a PE

Weitere VAERSDATA-Felder

Praegender Schweregrund: Pulmonary embolism
Hospital-Tage: -
Labordaten: CTA chest confirmed PE. Has seen hem-onc that feels the pt's PE is related to the COVID19 vaccine
Aktuelle Erkrankungen: None
Vorgeschichte: BPH, HTN, peripheral neuropathy
Andere Medikamente: metoprolol and gabapentin
Allergien: NKDA
Vorherige Impfungen: -

VAERS 2080315

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EW0183

kritisch

Staat: WA
Alter: 67,0
Geschlecht: F
Eingang: 01.02.2022
Impfdatum: 31.05.2021
Beginn: 29.01.2022
Tage bis Beginn: 243,0
Dosis: 2
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: unbekannt

Acute respiratory failure COVID-19 COVID-19 pneumonia Inappropriate schedule of product administration SARS-CoV-2 test positive

Symptomtext

Patient received Pfizer COVID vaccine on 5/4/21 and 5/31/21. On 1/29/22, patient admitted to our inpatient facility with acute toxic respiratory failure and COVID19 pneumonia. Patient is chronic immunosuppressed due to treatment for myasthenia gravis. As of today (2/1/22), patient is still admitted in the med/surg unit.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Acute respiratory failure
Hospital-Tage: 3,0
Labordaten: COVID status positive 1/29/22.
Aktuelle Erkrankungen: -
Vorgeschichte: myasthenia gravis (on pyridostigmine, mycophenolate, and prednisone), HTN, HLD, OSA on CPAP, IDDM type II, MDD, hypothyroidism, and HCV with spontaneous clearance and negative HCVRNA
Andere Medikamente: albuterol neb, allopurinol, vitamin c, atorvastatin, baclofen, calcium, fluoxetine, fluticasone nasal sp, furosemide, gabapentin, glipizide, insulin 70/30, levothyroxine, losartan, magnesium, metformin xr, montelukast, mycophenolate, naprox
Allergien: jardiance, levofloxacin, lisinopril, penicillin g, cephalexin
Vorherige Impfungen: -

VAERS 2079467

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EW0183

kritisch

Staat: MI
Alter: 43,0
Geschlecht: F
Eingang: 01.02.2022
Impfdatum: 07.06.2021
Beginn: 18.01.2022
Tage bis Beginn: 225,0
Dosis: 1
Route/Site: IM / AR

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: nein

Acute kidney injury Acute respiratory failure Alkalosis Angiogram pulmonary normal Anticoagulant therapy Bladder catheterisation Blood pH decreased COVID-19 COVID-19 pneumonia Cough Culture urine Dyspnoea Endotracheal intubation Feeding tube user Headache Hypoxia Intensive care Lung disorder

Symptomtext

Hospitalized (1.24.22 - PRESENT; in ICU); COVID-19 positive (1.18.22); Fully vaccinated (no booster) 1.24.22 - Intubated in ED of outside hospital - HPI: 44 y.o. with Down Syndrome, per father fairly high functioning. She has a history of OSA not treated (noct O2), and respiratory failure in the past that led to prolonged trach and eventual decannulation in 2012. She was COVID-19 positive on 1/18 and presented to the ed with worsening hypoxemia, and was intubated in the ed. A 6.5 ETT was placed due to her prior tracheal stenosis. She was given 2 L of ivf in the ED, and CT angio showed no PE but did show small bilateral effusions and extensive bilateral airspace disease, more posterior. She was transferred to hospital for continued care. Labs were also notable for AKI. ASSESSMENT / PLAN: 44 y.o. female with Down Syndrome, remote resp failure/trach with history of tracheal stenosis, untreated OSA, admitted on 1/24/2022 with acute respiratory failure with hypoxemia. Assessment and Plan Acute respiratory failure with hypoxemia Assessment & Plan Due to covid-19 Intubation date: 1/24/22 Current respiratory support: Device (Oxygen Therapy): ventilator Vent Settings: Lung mechanics: Plateau Pressure: 34 cmH2O Peak Pressure: 39 cmH2O Patient-ventilator interaction: o synchrony ? Neuromuscular blockade: Yes ? Proning:Yes ? Body Position: prone, head left facing Sedation: o RASS goal: -5 o propofol o fentanyl VAP prophylaxis: Chlorhexidine GI prophylaxis: PPI DVT prophylaxis: subcutaneous heparin Plan: Goal TV 4-6 ml/kg with pPlat <30, ph 7.24 - 7.4 Goal SpO2 88-92%, PaO2 55-65 Initiate proning PEEP 16 * COVID-19 Assessment & Plan Vaccinated x 2, not boosted Positive test: 1/18 Severe respiratory isolation until 2/8/22 and fever-free Secondary infection workup: MRSA swab pending Sputum culture pending Treatment: Remdesivir: none due to AKI Tocilizumab: none due to shortage Steroids: Methylprednisolone 40 mg iv q8h 1/24 - (1mg/kg) Antibiotics: Ampicillin-sulbactam 1/24 - Shock Assessment & Plan Hypotensive Suspect largely due to sedation, possible pulmonary hypertension Check echo Empiric antibiotics (ampicillin-sulbactam) Follow up cultures AKI (acute kidney injury) Assessment & Plan UA Foley Follow I/O Progress Note from 2.1.22: Plan: Intubated and sedated in the ICU N: Continue RASS-5 while paralyzed and proned. CV: Contd. Diuresis Pulm: Stop prone, keep paralyzed, optimize PEEP GI: Continue goal feeds, having stool Renal: Lasix to keep even to net negative Heme: NAI, baseline anemia, on prophy lovenox due to BMI ID: On unasyn, last day today for 7 day course Endo: Continue current basal bolus schedule, reduce Lantus PLAN 2/1/2022 - Optimize PEEP back to 16 - Keep Pplat < 30 and DP < 15 - Monitor ABG - Control alkalemia as able - Continue on deep sedation and paralytics - Wean steroids by 10mg q5 day given relative improvement - Completed course of abx for MSSA - Sedation related hypotension, low requirement of norepi, stable - Continue diuresis with Lasix 20mg daily to keep even to net negative - Tube feeds are at goal - Bowel regimen acceptable - BS acceptable on BBI - GI / VTE ppx

Weitere VAERSDATA-Felder

Praegender Schweregrund: Acute respiratory failure
Hospital-Tage: 8,0
Labordaten: -
Aktuelle Erkrankungen: 1.17.22: Called nurse triage - patient has Down Syndrome. Staff states patient has been having nasal congestion, stuffy nose, runny nose, coughing, and sore throat x 4 days. Patient has not been running a fever. She has been eating and drinking normally. Patient has not been having any shortness of breath 1.22.22: called nurse triage - Intermittent Mild and Moderate cough, shortness of breath in the morning gave treatment which helped a lot, and headache when coughs. Nebulizer medication was not sent to Facility but does have the Combivent inhaler to use. Oxygen Sat usually runs 90-94. Now after treatment is at 89 and breathing very well. Usually worse when first wakes up 1.24.22: ED - SOB, COVID-19 - intubated in ED - She was intubated for COVID pneumonia respiratory failure. Intubation was without complication. She has been placed on the ventilator with the FiO2 of 100% and a PEEP at 18. She is on a low dose of propofol but seems to be tolerating it fine with good sedation and ventilating well. I did speak with the intensivist who did accept the admission and transfer. Patient will go by EMS ground crew and approximately 30 minutes. Mother is at the bedside and understands plan. CT angiogram report came back just prior to departure of EMS and patient with no PE noted. COVID changes as previously discussed. Urinalysis was obtained from the Foley catheter that was placed. Looks to be a contaminated specimen but is nitrate positive. I have added on a urine culture but the EMS have arrive so no antibiotics were given for that. I did given order for p.r.n. rocuronium to be given in route if they find patient to be agitated or difficult to ventilate. She has been doing well here. On a low propofol drip at 10mcg.
Vorgeschichte: Obstructive Sleep apnea (OSA) Downs Syndrome Hypothyroidism Obesity, Class III, BMI 40-49.9 (morbid obesity) mild intermittent asthma without complication Attention to tracheostomy Hypoxemia GERD (gastroesophageal reflux disease) Macrocytosis without anemia Environmental allergies
Andere Medikamente: albuterol (PROVENTIL) (2.5 MG/3ML) 0.083% nebulization cetirizine (ZYRTEC) 10 MG tablet fluticasone (FLONASE) 50 MCG/ACT nasal spray guaifenesin (MUCINEX) 600 MG 12 hr tablet ipratropium-albuterol (COMBIVENT RESPIMAT) 20-100 MCG/ACT inhalat
Allergien: Ceclor [Cefaclor]Hives
Vorherige Impfungen: -

VAERS 2075988

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EW0183

kritisch

Staat: MI
Alter: 52,0
Geschlecht: F
Eingang: 31.01.2022
Impfdatum: 12.10.2021
Beginn: 21.01.2022
Tage bis Beginn: 101,0
Dosis: 3
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: ja

Acne Alanine aminotransferase increased Angiogram pulmonary abnormal Anticoagulant therapy Anxiety Aspartate aminotransferase increased Asthenia Asymptomatic bacteriuria Bacterial test positive Blood albumin decreased Blood calcium decreased Blood chloride increased Blood creatinine normal Blood glucose normal Blood potassium normal Blood sodium normal Blood urea normal Blood viscosity increased

Symptomtext

Hospitalized (1.21.22 - 1.26.22); COVID-19 positive (1.21.22); fully vaccinated PLUS Booster - pfizer x3. Subsequent ED visit 1/27/22-1/28/22 (11 hrs) d/c summary from 1/26 d/c:Discharge Summary (Physician) General Medicine Hospitalist Discharge Summary Patient is a 52 y.o. female CHIEF COMPLAINT Chief Complaint Patient presents with ? WEAKNESS lymphoma with brain mets. no current chemo/radiation. yesterday started new medication. increased confusion for months but today more weak. family says pt almost collapsed today. reports intermittent R facial droop throught cancer tx. present today but unknown for how long. family states baseline HR for pt is about 120 1. SARs pneumonia Continue treatment with dexamethasone, not on supplemental Oxygen 2. Pulmonary embolus secondary to increased viscosity due to lymphoma and SARs 2 Lovenox for 90 days plan for discharge in the next 24h. Patient is not on supplemental oxygen. Plan for continue treatment as outpatient. Patient has plan for bone marrow transplant. 3. Asymptomatic bacteriuria No treatment, repeat UA was nehative 4. Diffuse large B-cell lymphoma Patient is undergoing outpatient taper with steroids. Patient has bone and brain Mets. Patient is getting external beam radiation. Patient is scheduled for bone marrow transplant February of of this year. 5. Cognitive decline Secondary to brain metastasis and brain external beam radiation due to metastatic B-cell lymphoma. Patient is currently not undergoing chemotherapy. 6. Pancytopenia Secondary to past chemotherapy. Bone marrow toxicity. Summary of Hospitalization: The patient is a 54-year-old female who presented to the emergency room with increasing dyspnea on exertion fevers and shortness of breath. The patient was worked up in emergency room found have a positive test for COVID and a pulmonary embolus. Given the patient also has a concomitant hypercoagulable state due to COVID and lymphoma she was admitted and put on a heparin drip. She was not requiring supplemental oxygen and did not meet criteria for treatment with remdesivir. She had outpatient dexamethasone that was continued. Patient was transition to Lovenox for discharge home after discussion with the oncology team. I did partner with the patient's husband at bedside for discharge planning. Patient has a bone marrow transplant that is planned in February of 2022 and patient will follow up per primary team. Patient is a full code. PRIMARY DIAGNOSIS Pulmonary embolism on left [I26.99] Pulmonary embolism associated with COVID-19 [U07.1, I26.99] PROBLEM LIST Patient Active Problem List Diagnosis ? Dense breast tissue level 3 ? Enlarged cervical lymph nodes ? Anxiety about the development of breast ca ? 1/13/21 Abnormal ultrasound of breast B-5 Dr App ? Lymphoma ? 1/23/21 BHWC Invitae ( 84 gene panel:): MUTYH One pathogenic variant ? Diffuse large B cell lymphoma ? DLBCL (diffuse large B cell lymphoma) ? Gastrostomy status ? Abnormal positron emission tomography (PET) scan ? Mass of lower outer quadrant of right breast ? 7/22/2021: Abnormal pelvic ultrasound: rec FU in 6 months ( 1/22/2022 ) ? Diffuse large B-cell lymphoma of extranodal site excluding spleen and other solid organs ? Abnormal MRI ? Admission for chemotherapy ? Secondary malignant neoplasm of brain ? Altered mental status ? Follicular acne ? apical HCM ? Pneumonia due to COVID-19 virus ? Pulmonary embolism without acute cor pulmonale secondary to Covid ? acute encephalopathy ? UTI (urinary tract infection) ? Pulmonary embolism on left ? Pancytopenia ? Facial twitching ? Cognitive impairment ? Debilitated ? Bacteriuria ? Abnormal chest x-ray BMI Body mass index is 22.13 kg/m?. CONSTITUTIONAL: Appears well, no pain HEENT: MMM, PERRLA LUNGS: CTAB HEART: RRR, S2 is greater than S1, ABDOMEN: Obese soft NP/ND, + BS all 4 quadrants, MUSK: Decreased bulk and tone, difficulty with ambulation due to falls possibly due to progression of metastatic brain disease. NEUROLOGICAL: Alert and oriented to person not time place or situation. Husband answers most questions PSYCH: Pleasant but confused DERM: No rashes, lesions, petechia, purpura, or ecchymosis. No jaundice. Patient has thin atrophic defatted geriatric skin I personally examined patient of privacy on discharge. All questions were answered to the best of my ability regarding new medications, use and side effects. The reason for admission, treatment, and disease were discussed with the patient. Our discussion also centered on medications, side effects, need for medications and the effects that they will have on his general health, teach back was performed and confirmed. The patient acknowledged their understanding and accepts all responsibility for obtaining prescriptions, following prescribed diet and fluid recommendations, out patient tests and follow-up with primary care provider or specialists H&P:CHIEF COMPLAINT Pulmonary embolism without acute cor pulmonale ASSESSMENT AND PLAN Principal Problem: Pulmonary embolism without acute cor pulmonale secondary to Covid Active Problems: Diffuse large B cell lymphoma Pneumonia due to COVID-19 virus acute encephalopathy UTI (urinary tract infection) Pulmonary embolism on left Pancytopenia Facial twitching Cognitive impairment Debilitated _________________________________________________________ sepsis -HR>90, RR>20, WBC<4, covid 19 PNA, possible UTI -check lactic and BC x 2 -s/p 1L IVF bolus -start NSS IVF 100 covid 19 infection -immunocompromised, vaccinated and boosted, SxS began 1/20/21, husband with covid -CTA thorax showed ground glass opacities suggestive of covid 19 PNA -CXR showed RIJ port with tip in proximal right atrium, and mild to moderate airspace disease in the mid and lower lungs -ID consult, await recomendations -start decadron -check sputum culture Acute Pulmonary embolism -CTA thorax showed acute LUL and LLL pulmonary embolism without evidence of heart strain -continue heparin ggt -continuous pulse ox ST depression and Twave inversion, hypertrophic cardiomyopathy -cardiac MRI 1/14/21 showed possibe variant of hypertrophic cardiomyopathy -cardiac soft tissue 1/14/21 showed moderate amount of b/l lower lobe consolidation compatable with PNA, mild wall thickening of the distal esophagus suggestove of esophagitis -EKG showed SR with inferior and anterolateral ST depression and twave inversions and Qtc 457 -HsTnT 30--- >repeat HsTnT 30 -cardiology consult, await recomendations -telemetry acute encphalopathy, cognitive decline and facial twitch -no focal deficits on exam -husband states pt has had progressive cognitive impairment since starting chemotherapy and radiation to her brain but is more confused today than her baseline -MRI brain with and without IVC 12/30/21 showed persistent ill-defined enhancement at the left frontoparietal junction corresponding to an area of treated brain mass -CT head negative for acute changes, positive for an area of remote hemorrhage -start neurochecks -continue home diffuse B cell lymphoma with mets to brain -unclear if last chemo was 12/17/21 or 1/7/22, but chemo is currently on hold so pt can begin bone marrow transplant at the U of M on 2/4/22, if BMT is delayed, plan is to resume chemotherapy -continue prophylactic home acyclovir and bactrim suspected UTI -UA with positive nitrites, moderate leukocytes, 9 WBC and bacteria -check urine Cx -continue rocephin _________________________________________________________ DVT prophylaxis -heparin ggt Lines, Drains, Tubes, Braces -right chest port Antibiotics, Antivirals, Antifungals -chronic acyclovir -chronic bactrim -rocephin 1/21-present Code Status -Full Code per discussion with pt's husband at bedside Disposition: inpatient admission for immunocompromised pt with covid 19 PNA, acute PE, pancytopenia, EKG changes, encephalopathy, and possible UTI. check lactic and ECHO. Continue heparin ggt. Head CT showed an area of remote hemorrhage. Discussed with on call neurosurgeon Dr who recommended checking a repeat head CT once heparin is therapeutic and did not feel a neurosurgery consult was needed unless there are acute findings on repeat Head CT. ID consult and Cardiology consults. Monitor BP. Likely to stay greater than 2 midnights SUBJECTIVE This is a 52 y/o WF with a PMH of diffuse B cell lymphoma with brain mets s/p radiation and chemotherapy who presents with a CC of weakness x 1 day. On interview, pt does not know where she is, cannot provide history, and is pleasantly confused. she can cooperate with exam and does recognized her husband who is at bedside and provides history. Husband states the couple were running errands today when the pt became disoriented and nearly fell at curbside. he states he thinks he gave her covid because he has covid. he states they are both vaccinated and boosted. he states the pt has had a poor appetite and PO intake x 24-36 hours. he states the pt stopped chemotherapy 2 weeks ago and is scheduled to start bone marrow transplant on Februray 4th. He states the pt has had progressive cognitive impairment since starting chemotherapy and radiation to her brain but is more confused today than her baseline. He states the pt was started on Keppra for facial twitching 1 month ago. he state the pt has also had foul smelling urine x 1 month but no other urinary symptoms. he states the pt is likely constipated. In the ER the pt was found to be afebrile with HR 130, BP 91/64, RR 22, stable on RA. limited viral PCR positive for covid 19. CBC showed WBC 3.0, Hgb 9.7, and platelets 92. CMP with Ca 8.4, albumin 2.8 otherwise WNL. BNP and procal WNL. HsTnT 30-- >repeat HstnT 30. EKG showed SR with inferior and anterolateral ST depression and twave inversions and Qtc 457. UA with positive nitrites, moderate leukocytes, 9 WBC and bacteria. CTA thorax showed acute LUL and LLL pulmonary embolism without evidence of heart strain, and ground glass opacities suggestive of covid 19 PNA. CXR showed RIJ port with tip in proximal right atrium, and mild to moderate airspace disease in the mid and lower lungs. The pt was given rocephin, 1L IVF bolus, started on heparin ggt and admitted for workup. Review of Systems Unable to perform ROS: mental status change Vitals: 01/21/22 2100 01/21/22 2115 01/21/22 2130 01/21/22 2140 BP: 91/50 90/50 (!) 84/52 99/59 Pulse: 79 77 77 76 Resp: 18 17 16 17 Temp: TempSrc: SpO2: 98% 99% 97% 96% Weight: Data Unavailable Physical Exam Constitutional: General: She is not in acute distress. HENT: Head: Normocephalic and atraumatic. Eyes: Pupils: Pupils are equal, round, and reactive to light. Neck: Vascular: No JVD. Cardiovascular: Rate and Rhythm: Normal rate and regular rhythm. Heart sounds: Normal heart sounds. No murmur heard. Comments: No peripheral edema Pulmonary: Effort: Pulmonary effort is normal. Breath sounds: Normal breath sounds. No wheezing or rales. Comments: Stable on RA Abdominal: General: Bowel sounds are normal. There is no distension. Palpations: Abdomen is soft. Tenderness: There is no abdominal tenderness. Musculoskeletal: General: No deformity. Normal range of motion. Cervical back: Neck supple. Skin: General: Skin is warm and dry. Findings: No rash. Neurological: General: No focal deficit present. Mental Status: She is alert. She is disoriented. Cranial Nerves: No cranial nerve deficit. Comments: Recognizes husband Unable to provide history Psychiatric: Behavior: Behavior normal. Comments: Cooperative, friendly

Weitere VAERSDATA-Felder

Praegender Schweregrund: Cerebral haemorrhage
Hospital-Tage: 5,0
Labordaten: Results from last 7 days Lab Units 01/27/22 2354 01/27/22 2132 01/26/22 0732 WBC x10*3/uL 1.89* 2.59* 1.54* HGB g/dL 8.1* 10.6* 9.3* HCT % 24.6* 31.8* 28.2* Recent Labs 01/21/22 1348 WBC 3.00* HGB 9.7* MCV 93.7 HCT 29.5* PLATELET 92* SODIUM 138 POTASSIUM 3.9 CHLORIDE 108 HCO3 19* BUN 17 CREATININE 0.66 GLUCOSE 117* AST 46* ALT 44* Serum creatinine: 0.66 mg/dL 01/21/22 1348 Estimated creatinine clearance: 92.9 mL/min DR CHEST SINGLE VIEW Narrative: EXAMINATION: Single View Chest EXAM DATE: 1/27/2022 10:37 PM TECHNIQUE: Single view chest INDICATION: SOB COMPARISON: Chest x-ray of 1/25/2022 ENCOUNTER: Not applicable _________________________ FINDINGS: Right chest Mediport is again noted. There is a very slightly increased bilateral pulmonary airspace consolidation. Cardiac size is stable. There is a small right pleural effusion. No pneumothorax or acute osseous abnormalities. _________________________ Impression: Slightly increased bilateral pulmonary airspace consolidation, concerning for worsening pneumonia.
Aktuelle Erkrankungen: ongoing treatments including radiation for diffuse large B cell lymphoma. Treatment/therapy for progression of disease/side effects - i.e. PT for weakness
Vorgeschichte: Past Medical History: Diagnosis Date Diffuse large B cell lymphoma Gastrostomy status Diffuse large B-cell lymphoma of extranodal site excluding spleen and other solid organs Secondary malignant neoplasm of brain
Andere Medikamente: acyclovir (ZOVIRAX) 400 MG tablet Take 400 mg by mouth twice daily. allopurinol (ZYLOPRIM) 300 MG tablet Take 300 mg by mouth daily. dexamethasone (DECADRON) 4 MG tablet Take 4 mg by mouth DAILY. fluconazole (DIFLUCAN) 100 MG tablet
Allergien: No known allergies
Vorherige Impfungen: -

VAERS 2075760

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EW0183

kritisch

Staat: MI
Alter: 65,0
Geschlecht: F
Eingang: 31.01.2022
Impfdatum: 18.05.2021
Beginn: 20.01.2022
Tage bis Beginn: 247,0
Dosis: 2
Route/Site: IM / AR

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: ja

Ataxia COVID-19 Cardiac telemetry Cerebral haemorrhage Cerebral infarction Cerebrovascular accident Computerised tomogram head abnormal Condition aggravated Dizziness Ischaemic stroke Magnetic resonance imaging head abnormal Nausea Neurological examination SARS-CoV-2 test positive

Symptomtext

Hospitalized 01/20/22; COVID-19 positive 01/20/2022; fully vaccinated. Discharge Provider: PRIVATE MD. Primary Care Provider: PRIVATE MD. Admission Date: 1/20/2022. Discharge Date: 1/22/2022. DETAILS OF HOSPITAL STAY: PRESENTING PROBLEM: Ischemic stroke (HCC) [I63.9], Ischemic cerebrovascular accident (CVA) (HCC) [I63.9], COVID-19 virus infection [U07.1]. HOSPITAL COURSE: 66 yo female presented to the ER with the complaint of dizziness, nausea, and ataxia that started the day prior. Her head CT noted an acute infarct in the superior right MCA distribution. She additionally tested positive for Covid. She was admitted for further evaluation and management. She was monitored on telemetry and had serial neurologic exams. A MRI was done noting a stroke with small petechial hemorrhages. Given this, Lovenox was held and neurology advised repeating a CT the following day. Over the course of her hospital stay her dizziness and ataxia resolved. Physical and occupational therapy has no concerns and feels she does not need outpatient therapy. Her repeat CT showed no worsening of her infarct or petechial hemorrhage. She will discharge home today in improved and stable condition.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Cerebral haemorrhage
Hospital-Tage: 2,0
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: Unspecified essential hypertension, Acute right MCA stroke (HCC), Obesity (BMI 35.0-39.9 without comorbidity), Class 2 obesity due to excess calories with body mass index, (BMI) of 36.0 to 36.9 in adult, unspecified whether serious comorbidity present, Type 2 diabetes mellitus without complication, without long-term current use of insulin (HCC), Hyperlipidemia, unspecified hyperlipidemia type, Osteopenia, unspecified location.
Andere Medikamente: acetaminophen (TYLENOL) 500 MG tablet, aspirin 81 MG chewable tablet, atorvastatin (LIPITOR) 20 MG tablet, calcium-vitamin D (CALCIUM 600+D) 600-200 MG-UNIT TABS per tablet, celecoxib (CELEBREX) 200 MG capsule, Cholecalciferol (VITAMIN D3)
Allergien: NKA
Vorherige Impfungen: -

VAERS 2068828

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EW0183

kritisch

Staat: WI
Alter: 87,0
Geschlecht: F
Eingang: 27.01.2022
Impfdatum: 15.06.2021
Beginn: 27.01.2022
Tage bis Beginn: 226,0
Dosis: 1
Route/Site: IM / LA

Tod: ja Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

COVID-19 Death

Symptomtext

Death related to complications of COVID-19 infection

Weitere VAERSDATA-Felder

Praegender Schweregrund: Death
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: OSC: COPD; CKD Stage 3; CHF; HTN
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2068828

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EW0183

kritisch

Staat: WI
Alter: 87,0
Geschlecht: F
Eingang: 27.01.2022
Impfdatum: 15.06.2021
Beginn: 27.01.2022
Tage bis Beginn: 226,0
Dosis: 2
Route/Site: IM / LA

Tod: ja Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

COVID-19 Death

Symptomtext

Death related to complications of COVID-19 infection

Weitere VAERSDATA-Felder

Praegender Schweregrund: Death
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: OSC: COPD; CKD Stage 3; CHF; HTN
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2039832

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EW0183

kritisch

Staat: MN
Alter: 50,0
Geschlecht: M
Eingang: 27.01.2022
Impfdatum: 14.05.2021
Beginn: 26.01.2022
Tage bis Beginn: 257,0
Dosis: 2
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: nein

COVID-19 Hydrocephalus Pulmonary embolism SARS-CoV-2 test positive Vaccine breakthrough infection

Symptomtext

Hospitalized with breakthrough COVID infection

Weitere VAERSDATA-Felder

Praegender Schweregrund: Pulmonary embolism
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2039832

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EW0183

kritisch

Staat: MN
Alter: 50,0
Geschlecht: M
Eingang: 27.01.2022
Impfdatum: 14.05.2021
Beginn: 26.01.2022
Tage bis Beginn: 257,0
Dosis: 2
Route/Site: SYR / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: nein

COVID-19 Hydrocephalus Pulmonary embolism SARS-CoV-2 test positive Vaccine breakthrough infection

Symptomtext

Hospitalized with breakthrough COVID infection

Weitere VAERSDATA-Felder

Praegender Schweregrund: Pulmonary embolism
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2014425

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EW0183

kritisch

Staat: MI
Alter: 57,0
Geschlecht: M
Eingang: 07.01.2022
Impfdatum: 07.07.2021
Beginn: 29.12.2021
Tage bis Beginn: 175,0
Dosis: 2
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: nein

Blood albumin decreased Blood bilirubin increased Blood glucose normal COVID-19 Cerebrovascular accident Chest X-ray abnormal Chronic obstructive pulmonary disease Computerised tomogram thorax abnormal Condition aggravated Differential white blood cell count abnormal Dyspnoea Dyspnoea exertional Fibrin D dimer increased Full blood count abnormal Granulocyte percentage Haematocrit decreased Haemoglobin decreased Hypoxia

Symptomtext

This is a 58-year-old male with a past medical history of chronic obstructive pulmonary disease and recent CVA this past November, that presents to the emergency room by way of EMS with complaints of cough and shortness of breath. The patient states that symptoms started yesterday. He describes his cough as being productive. The patient is legally blind and cannot describe to sputum. He states that shortness of breath usually occurs with exertional activity including wall walking around. The patient denies any chest pain, abdominal discomfort, nausea, vomiting, diarrhea or urinary symptoms such as dysuria, hematuria or increased/decreased urinary frequency. He denies any dizziness or lightheadedness. Again the patient is legally blind and has visual disturbance including blurry vision secondary to this. He states that this does not feel like his normal chronic obstructive pulmonary disease exacerbation. The patient's family has tested positive for COVID within the last 90 days, but he himself has had no known exposure as family members did self isolate during the normal quarantine time. He is vaccinated against COVID-19. Ultimately, the patient comes to the emergency department for evaluation and care. Patient is a 58 year old male with a history of left sided multifocal ischemic stroke at the end of November and returned home on December 10, COPD, legally blind, congenital glaucoma, hypothyroid, hypertension, and a lung mass suspected to be cancer who presented to the ER with complaints of worsening shortness of breath and cough over the last 24 hours. He denied fever, chills, loss of taste or smell, nausea, vomiting, diarrhea, headaches, body aches, or falls. While in the ER he was put on 2 liters of oxygen and he maintained oxygen saturations in the mid 90s. Lab work showed an elevated WBC at 18.72, elevated blood glucose at 129, and the patient tested Covid positive. His chest xray confirmed COPD, a nodular opacity near the right costophrenic angle as per previous CT, and parenchymal scarring, though no acute disease. The patient was transferred and admitted observation in hospital with COPD exacerbation, hypoxia and Covid for further monitoring and treatment. He was weaned to room air on arrival to the inpatient; the monoclonal antibody team was contacted as he is a potential candidate for therapy. The patient received one dose of remdesivir and then qualified for monoclonal antibodies which was given on 12/30. He did not require supplemental oxygen while inpatient though he did have episodes of shortness of breath that resolved with time or inhalers. The patient states he has a nebulizer and duoneb solution at home that he normally uses 4 times per day. He also has a walker. He understands that he is to be following up with oncology regarding the CT results from his previous admission. A walking oxygen saturation test was completed and he did not need supplemental oxygen. The patient is being discharged in stable condition on room air to complete a course of azithromycin and steroid taper for COPD exacerbation. Active Issues Requiring Follow-up 12/10/21 CT that identified new lung mass

Weitere VAERSDATA-Felder

Praegender Schweregrund: Cerebrovascular accident
Hospital-Tage: 1,0
Labordaten: COMPLETE BLOOD COUNT (CBC) W/DIFFERENTIAL - Abnormal; Notable for the following components: White Blood Cell 18.72 (*) 4.00 - 10.80 x10*3/uL Final Red Blood Cell 4.00 (*) 4.60 - 6.00 x10*6/uL Final Hemoglobin 13.2 (*) 14.0 - 18.0 g/dL Final Hematocrit 39.7 (*) 42.0 - 52.0 % Final Neutrophil Automated 89.9 (*) 35.0 - 80.0 % Final Immature Granulocyte Automated 0.9 (*) 0.0 - 0.6 % Final Lymphocyte Automated 6.0 (*) 20.0 - 50.0 % Final Neutrophil Absolute Count 16.83 (*) 1.80 - 7.80 x10*3/uL Final Immature Granulocyte Absolute Count 0.16 (*) 0.00 - 0.05 x10*3/uL Final All other components within normal limits COMPREHENSIVE METABOLIC PANEL - Abnormal; Notable for the following components: Glucose Level 129 (*) 70 - 99 mg/dL Final Albumin Level 3.2 (*) 3.5 - 5.0 g/dL Final Bilirubin Total 1.1 (*) 0.2 - 1.0 mg/dL Final All other components within normal limits D-DIMER,QUANTITATIVE - Abnormal; Notable for the following components: D-Dimer Quant 540 (*) 0 - 500 ng/mL FEU Final All other components within normal limits PRO B NATRIURETIC PEPTIDE BLOOD LVL - Normal PROCALCITONIN Imaging: DR CHEST 2 VIEWS FRONTAL AND LATERAL Final Result 1. COPD. 2. Nodular opacity near the right costophrenic angle likely corresponds to findings seen on chest CT of 11/28/2021. 3. Parenchymal scarring most prominent in the medial right upper lobe. 4. No definite evidence of acute cardiopulmonary disease.
Aktuelle Erkrankungen: -
Vorgeschichte: Respiratory Other emphysema Lung nodules/masses RUL, noted June 2017 COPD with acute exacerbation Circulatory HTN (hypertension) History of ischemic left MCA stroke History of ischemic multifocal multiple vascular territories stroke Nervous Glaucoma Rib pain Thoracic back pain Intractable chronic post-traumatic headache Genitourinary Enlarged prostate Prostatism Benign prostatic hyperplasia without lower urinary tract symptoms Endocrine/Metabolic Other specified hypothyroidism Impaired fasting glucose Immune Psoriasis Other Pes planus (flat feet) Tobacco abuse, approximately 50 pack years Depression Anxiety Amputation of toe of right foot Amputation of toe of left foot Other osteoporosis without current pathological fracture Abnormal CT scan, lung
Andere Medikamente: acetaminophen (TYLENOL 8 HOUR) 650 MG extended release tablet albuterol HFA (PROVENTIL HFA, VENTOLIN HFA, PROAIR HFA) 108 (90 Base) MCG/ACT inhaler alendronate (FOSAMAX) 70 MG tablet ALPHAGAN P 0.1 % SOLN Artificial Tear Solution (TEARS AGA
Allergien: No known allergies
Vorherige Impfungen: -

VAERS 1410229

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EW0183

kritisch

Staat: -
Alter: -
Geschlecht: M
Eingang: 01.01.2022
Impfdatum: -
Beginn: -
Tage bis Beginn: -
Dosis: 2
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Acquired factor V deficiency Pulmonary thrombosis Thrombosis Angiogram Anticoagulant therapy Blood electrolytes Brain natriuretic peptide Chest X-ray Deep vein thrombosis Differential white blood cell count Dyspnoea Echocardiogram Full blood count Pulmonary embolism Rheumatoid arthritis SARS-CoV-2 test negative Troponin Ultrasound scan

Symptomtext

had a blood clot in the leg and in both his lungs; had a blood clot in the leg and in both his lungs; genetic disorder called Factor 5; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from medical information team. The reporter is the patient. A male patient received bnt162b2 (COMIRNATY) (Batch/Lot number: unknown) as dose 2, single and (Batch/Lot number: unknown) as dose 1, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: PULMONARY THROMBOSIS (medically significant), THROMBOSIS (medically significant), outcome "unknown" and all described as "had a blood clot in the leg and in both his lungs"; ACQUIRED FACTOR V DEFICIENCY (non-serious), outcome "unknown", described as "genetic disorder called Factor 5". Therapeutic measures were taken as a result of pulmonary thrombosis, thrombosis. The patient was now on blood thinners, takes Xarelto 20 mg once a day. The patient did not have a history of blood clots so his hematologist stated it was possible the vaccine can contribute to the blood clots. The patient was scheduled tomorrow evening for the booster dose and he was nervous about it. The patient's hematologist and family doctor stated there was a potential risk of blood clots if he gets Covid-19 and there was potential risk if he takes the vaccine. The patient wanted to know if there has been any reports of blood clots or if there were any issues with blood clots after receiving the vaccine. The lot number for bnt162b2 was not provided and will be requested during follow up.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Pulmonary embolism
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1988911

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EW0183

kritisch

Staat: MI
Alter: 74,0
Geschlecht: F
Eingang: 29.12.2021
Impfdatum: 07.07.2021
Beginn: 18.12.2021
Tage bis Beginn: 164,0
Dosis: 2
Route/Site: IM / LA

Tod: ja Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: nein

Acute kidney injury Acute respiratory failure Anaemia of chronic disease Anion gap Anticoagulant therapy Asthenia Atrioventricular block second degree Back pain Basophil percentage decreased Blood bicarbonate decreased Blood calcium decreased Blood chloride decreased Blood creatine increased Blood creatinine increased Blood culture Blood glucose normal Blood lactic acid Blood potassium increased

Symptomtext

Deceased (12.27.21); Hospitalized (12.18.21); COVID-19 positive (12.18.21); Fully vaccinated - pfizer x2 d/c summary: Discharge Summary BRIEF OVERVIEW: Active Hospital Problems Diagnosis Date Noted POA ? Mobitz type 1 second degree atrioventricular block 12/27/2021 Unknown ? Oral candidiasis 12/19/2021 Yes ? Acute respiratory failure with hypoxia (HCC) 12/18/2021 Yes ? E. coli UTI 12/18/2021 Yes ? COVID-19 viral pneumonia 12/18/2021 Yes ? Hyperphosphatemia 12/18/2021 Yes ? Acute kidney injury superimposed on chronic kidney disease (HCC) 04/13/2021 Yes ? Anemia of chronic disease 04/13/2021 Yes ? Tobacco dependence 02/09/2017 Yes ? History of CVA (cerebrovascular accident) 08/12/2015 Yes ? Hypertension Yes ? Hyperlipidemia Yes ? Class 1 obesity in adult Yes Resolved Hospital Problems Diagnosis Date Noted Date Resolved POA ? D-dimer, elevated 12/23/2021 12/25/2021 Unknown ? Community acquired pneumonia of left upper lobe of lung 12/18/2021 12/25/2021 Yes ? Severe sepsis (HCC) 12/18/2021 12/25/2021 Yes ? Type 2 diabetes mellitus with stage 4 chronic kidney disease, with long-term current use of insulin (HCC) 12/22/2020 12/25/2021 Yes Pre-Existing Active Problems Diagnosis Date Noted POA ? Hyperparathyroidism (HCC) 04/15/2021 Unknown ? Left homonymous hemianopsia 06/20/2018 Unknown ? PAD (peripheral artery disease) (HCC) 06/12/2017 Unknown ? Microalbuminuria 02/09/2017 Unknown ? Lumbago Unknown Date of Death: 12/27/21 Time of Death: 9:09 PM Preliminary Cause of Death: Respiratory failure Discharge Disposition: Deceased DETAILS OF HOSPITAL STAY: PRESENTING PROBLEM: CAP (community acquired pneumonia) due to Chlamydia species Respiratory failure (HCC) Acute respiratory failure with hypoxia (HCC) HOSPITAL COURSE: Patient was admitted on 12/18/21 for COVID 19 viral pneumonia and acute hypoxic respiratory failure. She was intubated on 12/23/21. Patient was diagnosed with superimpsoed bacterial pneumonia and fluid overload in the setting of COVID 19 pneumonia. Patient was treated with IV antibiotics from 12/18- through 12/27. Unfortunately in the setting of respiratory failure patient also developed an AKI on her stage 5 kidney disease. Patient was placed on a lasix drip in attempt to creat a fluid negative balance however it became clear to previous IM team that patient would likely need HD or CRRT in order to optimize fluid state. Doctor discussed with family goals of care on 12/27 and it was known that patient would not want a tracheostomy or HD. At that time it was decided to proceed with comfort care measures and hospice was consulted. Paralytic drip was discontinued at that time. We were unable to terminally extubate patient the afternoon of 12/27 due to paralytics still being active in patient system. However, later that evening on 12/27 patient became severely bradycardic and went into asystole. Grand daughter was contacted, and it was recommended to remove mechanical ventilator at that point. TOD 21:09 Chief complaint Shortness of breath Problem List Principal Problem: Community acquired pneumonia of left upper lobe of lung Active Problems: Hypertension Hyperlipidemia Class 1 obesity in adult History of CVA (cerebrovascular accident) Tobacco dependence Type 2 diabetes mellitus with stage 4 chronic kidney disease, with long-term current use of insulin (HCC) Anemia of chronic disease Chronic kidney disease, stage V (HCC) Severe sepsis (HCC) Acute respiratory failure with hypoxia (HCC) Acute cystitis without hematuria COVID-19 viral pneumonia Hyperphosphatemia Assessment and Plan Medical Decision Making Hyperphosphatemia Assessment & Plan - Place on low phos diet COVID-19 viral pneumonia Assessment & Plan - Decadron 6mg daily for 10 day course - Onset of symptoms: 7 days ago. - Mucinex - Encourage prone positioning and IS - Supportive medication with PRN cough medication - Vaccination status: vaccinated Acute cystitis without hematuria Assessment & Plan - Continue ceftriaxone - Urine culture pending Acute respiratory failure with hypoxia (HCC) Assessment & Plan - Due to COVID-19 pneumonia with superimposed bacterial infection - Currently requiring 4L NC - Wean oxygen to maintain sats >90% - Does not wear oxygen at baseline Severe sepsis (HCC) Assessment & Plan - Due to COVID-19 pneumonia with superimposed bacterial pneumonia and UTI - Received IV fluid resuscitation in Ed, will hold off additional IV fluids in the setting of COVID-19 - Blood cultures pending - Urine culture pending - Repeat lactic pending Chronic kidney disease, stage V (HCC) Assessment & Plan - Acute on CKD V - Mild worsening of renal function - Baseline GFR 11-14, Baseline Cr: 3.2 Anemia of chronic disease Assessment & Plan - Hgb stable - Trend with AM labs Type 2 diabetes mellitus with stage 4 chronic kidney disease, with long-term current use of insulin (HCC) Assessment & Plan - A1C 7.6 - Continue lantus 64 units - MDSS - BG monitoring AC/HS - Hold oral sitaglitin Tobacco dependence Assessment & Plan - Encourage nicotine cessation - Nicotine patches History of CVA (cerebrovascular accident) Assessment & Plan - Continue plavix and aspirin Class 1 obesity in adult Assessment & Plan - Increased risk factor for complications in the setting of COVID-19 - Encourage gradual weight loss in the outpatient setting Hyperlipidemia Assessment & Plan - Continue statin Hypertension Assessment & Plan - Continue home hydralazine, catapres, norvasc and atenolol - Hold bumex overnight given severe sepsis and lactic acidosis Monitor fluid status closely * Community acquired pneumonia of left upper lobe of lung Assessment & Plan - Continue ceftriaxone and azithromycin - Urine strep/pneumo pending Full code ICU admission Lovenox Qday History of Present Illness History and physical obtained using telehealth technology with the assistance of the bedside nurse. a 75 y.o. female who presents to Hospital. The Patient presents for weakness, shortness of breath, cough for about 1 week. She states that she came in today because symptoms became progressively worse specifically her shortness of breath. She also complains of dysuria for about 3 days. No fevers or chills. + nausea but no vomiting. No diarrhea. No flank pain. She has been vaccinated for COVID back in July. At the time of the interview she is feeling significantly better than when she first presented to the ER. She actually came from another ED. Review of Systems Review of Systems Constitutional: Positive for activity change, appetite change and fatigue. Negative for chills and fever. HENT: Positive for rhinorrhea. Negative for congestion. Eyes: Negative for eye discharge and pain. Respiratory: Positive for cough and shortness of breath. Negative for sputum production. Cardiovascular: Negative for chest pain and palpitations. Gastrointestinal: Positive for nausea. Negative for vomiting, diarrhea and rectal bleeding. Genitourinary: Positive for dysuria. Negative for flank pain. Musculoskeletal: Negative for joint pain and joint swelling. Neurological: Negative for headaches, tremors and numbness/tingling. Psychiatric/Behavioral: Negative for depression and anxiety. Skin: Negative for itching and rash. Objective BP (!) 193/37 | Pulse 64 | Temp 36.9 ?C (Oral) | Resp 22 | Ht 1.626 m | Wt 86.1 kg | SpO2 94% | BMI 32.58 kg/m? Physical Exam Constitutional: Appearance: She is well-developed. HENT: Head: Normocephalic and atraumatic. Eyes: General: Left eye: No discharge. Conjunctiva/sclera: Conjunctivae normal. Cardiovascular: Rate and Rhythm: Normal rate and regular rhythm. Heart sounds: Normal heart sounds. Pulmonary: Effort: No respiratory distress. Breath sounds: No stridor. No wheezing or rales. Comments: Diminished breath sounds throughout entire lung fields. Abdominal: General: There is no distension. Tenderness: There is no abdominal tenderness. There is no guarding or rebound. Musculoskeletal: General: No tenderness. Right lower leg: No edema. Left lower leg: No edema. Lymphadenopathy: Cervical: No cervical adenopathy. Skin: General: Skin is warm and dry. Findings: No erythema or rash. Neurological: Mental Status: She is alert and oriented to person, place, and time. Cranial Nerves: No cranial nerve deficit. Psychiatric: Behavior: Behavior normal.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Acute respiratory failure
Hospital-Tage: 9,0
Labordaten: Complete Blood Count w/Differential [360663096] (Abnormal) Collected: 12/27/21 1318 Order Status: Completed Specimen: Blood, Venous Updated: 12/27/21 1416 White Blood Cell 34.79 High 4.00 - 10.80 x10*3/uL Red Blood Cell 2.81 Low 4.20 - 5.40 x10*6/uL Hemoglobin 7.5 Low 12.0 - 16.0 g/dL Hematocrit 24.2 Low 37.0 - 47.0 % Mean Cell Volume 86.1 80.0 - 100.0 fL Mean Cell Hemoglobin 26.7 Low 27.0 - 33.0 pg Mean Cell Hemoglobin Concentration 31.0 Low 32.0 - 37.0 g/dL Red Cell Diameter Width 18.6 High 11.0 - 16.0 % NRBC Absolute Count 0.23 High 0.00 - 0.01 x10*3/uL NRBC Automated 0.7 High 0.0 - 0.1 %WBC Platelet 222 140 - 400 x10*3/uL Mean Platelet Volume -- Comment: NOT MEASURED. Neutrophil Absolute Count 29.19 High 1.80 - 7.80 x10*3/uL Manual Differential ADD ON [360663104] (Abnormal) Collected: 12/27/21 1318 Order Status: Completed Specimen: Blood, Venous Updated: 12/27/21 1416 Segmented Neutrophils Manual 81 High 35 - 80 % Bands Manual 5 0 - 10 % Lymphocytes Manual 4 Low 20 - 50 % Monocytes Manual 3 2 - 12 % Eosinophil Manual 0 0 - 6 % Basophils Manual 0 0 - 2 % Metamyelocyte Manual 4 High <=0 % Myelocyte Manual 3 High <=0 % RBC Morphology Normal Platelet Estimate Normal Basic Metabolic Panel (BMP) [360550574] (Abnormal) Collected: 12/27/21 1238 Order Status: Completed Specimen: Blood, Venous Updated: 12/27/21 1326 Sodium Level 119 Low Panic 134 - 146 mmol/L Potassium Level 6.6 High Panic 3.4 - 5.0 mmol/L Chloride 84 Low 98 - 112 mmol/L HCO3 18 Low 21 - 29 mmol/L Anion Gap 17 9 - 18 mmol/L Glucose Level 113 High 70 - 99 mg/dL Blood Urea Nitrogen 138 High Panic 8 - 20 mg/dL Creatinine 3.68 High 0.50 - 1.10 mg/dL MDRD eGFR 12 Low >=60 mL/min/1.73 m2 CG eCrCl 11 mL/min/1.73 m2 Comment: Creatinine clearance calculated by the Cockroft-Gault equation using age, calculated ideal body weight, gender, and serum creatinine. This equation is typically used for drug dosing determinations, but can also be used to assess for renal impairment. Calcium Level Total 7.3 Low 8.6 - 10.4 mg/dL DR CHEST SINGLE VIEW [360550541] Resulted: 12/27/21 0707 Order Status: Completed Updated: 12/27/21 0709 Narrative: EXAMINATION: Single View Chest EXAM DATE: 12/27/2021 5:19 AM TECHNIQUE: Single view chest INDICATION: Wrist breath COMPARISON: Most recent December 26, 2021 ENCOUNTER: Subsequent _________________________ FINDINGS: Tubes and lines not significantly changed. Left greater than right bilateral airspace opacities persist slightly improved on the right. No interval pneumothoraces _________________________ Impression: Persistent bilateral airspace opacities, slightly improved on the right
Aktuelle Erkrankungen: -
Vorgeschichte: Past Medical History: Diagnosis Date ? CKD (chronic kidney disease), stage III (HCC) ? Diabetes mellitus (HCC) ? Hyperlipidemia ? Hypertension ? Lumbago ? Lumbosacral spondylosis without myelopathy ? Obesity ? Obesity, unspecified ? Tobacco dependence 2/9/2017 ? Type II or unspecified type diabetes mellitus without mention of complication, uncontrolled ? Unspecified essential hypertension
Andere Medikamente: amLODIPine Besylate 10 mg Oral Daily Atenolol 50 MG TAKE TWO TABLETS ONCE DAILY Bumetanide 1 mg Oral Every other day, Alternates with 1 mg and 2 mg every other day Cholecalciferol 2,000 Units Oral Daily cloNIDine HCl 0.1 MG TAKE TWO TABLET
Allergien: ace inhibitors - swelling crab/shellfish penicillins - hives/rash
Vorherige Impfungen: -

VAERS 1988876

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EW0183

kritisch

Staat: MI
Alter: 72,0
Geschlecht: F
Eingang: 29.12.2021
Impfdatum: 01.10.2021
Beginn: 21.12.2021
Tage bis Beginn: 81,0
Dosis: 3
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: nein

Acute respiratory failure Alanine aminotransferase increased Angiogram Anion gap Anticoagulant therapy Aspartate aminotransferase normal Basophil percentage decreased Blood albumin decreased Blood alkaline phosphatase normal Blood bicarbonate normal Blood bilirubin normal Blood calcium decreased Blood chloride decreased Blood creatinine normal Blood glucose increased Blood potassium normal Blood sodium decreased Blood urea increased

Symptomtext

Hospitalized (12.21.21 - still admitted currently); COVID-19 positive (12.14.21); fully vaccinated PLUS Booster - pfizer x3 H&P: History and Physical Chief complaint Cough shortness of breath Problem List Principal Problem: Pneumonia due to COVID-19 virus Active Problems: Acute respiratory failure with hypoxia Diabetes mellitus HTN (hypertension) Assessment and Plan Medical Decision Making Patient seen evaluated in room 306 with nursing staff present. Patient currently is resting comfortably with nasal cannula O2 at 4 L she has no respiratory distress whatsoever at this time. Patient states that she has been vaccinated 3 times with a booster. Patient was hypoxic at home but came to the ER for evaluation. Patient be started on steroids from the severe albuterol MDI. Patient is not normally on oxygen. * Pneumonia due to COVID-19 virus Assessment & Plan Continue COVID-19 protocol steroids and remdesivir albuterol MDI. Acute respiratory failure with hypoxia Assessment & Plan Continue 4 L supplemental oxygen titrate as needed. Continue steroids remdesivir Diabetes mellitus Assessment & Plan Glucose monitoring a.c. and bedtime with moderate sliding scale. HTN (hypertension) Assessment & Plan Will maintain on cardiac monitoring and oral antihypertensives as previously prescribed. Review of Systems Review of Systems See HPI for pertinent positives and negatives, all other systems reviewed and are negative. Objective BP 131/56 | Pulse 81 | Temp 37.4 ?C (Oral) | Resp 17 | Ht 1.676 m | Wt 102.8 kg | SpO2 92% | BMI 36.58 kg/m? Physical Exam Vitals and nursing note reviewed. Exam conducted with a chaperone present. Constitutional: General: She is not in acute distress. Appearance: Normal appearance. She is obese. She is not ill-appearing, toxic-appearing or diaphoretic. Comments: Patient was examined in room 306 with nursing staff present. HENT: Head: Normocephalic and atraumatic. Right Ear: External ear normal. Left Ear: External ear normal. Mouth/Throat: Mouth: Mucous membranes are moist. Eyes: General: No scleral icterus. Extraocular Movements: Extraocular movements intact. Conjunctiva/sclera: Conjunctivae normal. Cardiovascular: Rate and Rhythm: Normal rate and regular rhythm. Pulses: Normal pulses. Heart sounds: Normal heart sounds. No murmur heard. No gallop. Pulmonary: Effort: No respiratory distress. Breath sounds: Rhonchi present. No wheezing or rales. Comments: Patient has rhonchi bilaterally very mild right greater than left., slightly diminished bibasilar breath sounds. Abdominal: Comments: Obese but nontender no rebound or guarding is appreciated to palpation. Musculoskeletal: General: No swelling. Normal range of motion. Cervical back: Normal range of motion and neck supple. Right lower leg: No edema. Left lower leg: No edema. Skin: General: Skin is warm and dry. Capillary Refill: Capillary refill takes less than 2 seconds. Neurological: General: No focal deficit present. Mental Status: She is alert and oriented to person, place, and time. Mental status is at baseline. Psychiatric: Mood and Affect: Mood normal. Behavior: Behavior normal. Thought Content: Thought content normal. Judgment: Judgment normal 12/28/21 progress note: CHIEF COMPLAINT: Pneumonia due to COVID-19 virus Length of Stay: 7 days Assessment/Plan ASSESSMENT / PLAN: 72 y.o. female admitted on 12/21/2021 with acute hypoxic respiratory due to severe COVID-19 viral pneumonia. MICU consulted on 12/28/2021 for the same. Assessment and Plan Acute respiratory failure with hypoxia Assessment & Plan Progressive, severe hypoxia since admission due to severe COVID-19 viral pneumonia CXR and CT imaging with severe/progressive bilateral lung infiltrates, L>R, with no obvious PE having been identified on 12/21 CTA chest FiO2 needs escalated from low flow to high flow nasal oxygen, maximal support - with pt intubated 12/27 evening Current vent settings: FIO2 (%): 90 % Mechanical Rate: 24 breaths/min Set/Target Tidal Volume: 360 PEEP (cm H2O): 12 cm H2O Current Pplat and DP are acceptable Sedation: Fentanyl, propofol NMB: Yes, vecuronium (12/27-present) Proning: Yes (12/27-present) Continue with current lung protective ventilatory strategy - Goal Pplat <30, DP <15, pH >7.25 with permissive hypercapnia if needed Continue with deep sedation, NMB, and proning 16-20 hrs on/4-8 hrs off Trend ABG and oxygen saturations, and wean FiO2 depending on clinical progress - Goal PaO2 55-80, SpO2 88-95% Current PEEP is at 12 - would trial increasing to 14 to see if this helps lung compliance or not Continue tx's for COVID pneumonitis, as below Continue current empiric abx - infectious studies have been sent and are pending; please ensure tracheal aspirate has been sent for cx now that pt is intubated - If work-up negative, would complete abx x 5 days and then observe off of abx Continue diuresis, as needed, for goal even to negative fluid balance * Pneumonia due to COVID-19 virus Assessment & Plan Date of positive PCR test 12/14. Concomitant flu testing was negative. Presented on 12/21 with >1 week hx of cough, sputum production, and SOB symptoms Hx full vaccination (two initial doses 3/2021, plus booster 10/2021), but likely chronically immunosuppressed due to hx of CLL Intubated 12/27 Steroids: Dexamethasone 6 mg daily (12/21-12/27) Solumedrol 60 mg BID (12/27-present) Antimicrobials: Remdesivir (12/22-12/12/26) Ceftriaxone/azithromycin (12/26-present) CRP 38 -> 22 -> 17 D-dimer 1400 (12/21) -> 700 (12/25) -> 1300 (12/28) No convincing evidence of PE on CTA chest 12/21 Pro-calcitonin 0.08 (12/26) - Continue weight based steroid regimen with solumedrol 60 mg BID - Diuresis as needed, with goal even to negative fluid balance - No evidence of PE thus far, with stable D-dimer. Would continue Lovenox 40 mg once daily for DVT ppx. Trend D-dimer. If increasing, would obtain U/S x 4 to exclude DVT. Shock Assessment & Plan Mild shock state post intubation Currently requiring low dose NE infusion, 0.02 mcg/kg/min Suspect this is secondary to sedation needs, but cannot R/O concomitant bacterial sepsis definitively Would wean NE as able, goal MAP >65, and just monitor for now Already getting abx in the event of superimposed bacterial sepsis CLL (chronic lymphocytic leukemia) Assessment & Plan Hx of CLL that has not yet required treatment - observation previously recommended Acute on chronic lymphadenopathy seen on CT imaging of the chest, reactive component due to acute illness on top of chronic component Suspect that her hx of CLL does lend to some degree of chronic immunocompromise which would explain her severe COVID illness despite hx of complete vaccination Diabetes mellitus Assessment & Plan BG intermittently elevated between 300-400 in the setting of steroid administration and critical illness Continue basal bolus insulin for now, but if no achieving effective control would start insulin gtt Target BG 100-180 in the setting of critical illness Class 2 obesity in adult Assessment & Plan Body mass index is 36.22 kg/m?. HTN (hypertension) Assessment & Plan BP has been somewhat borderline low over the past couple days BP medications (lisinopril-HCTZ) have been on hold Would continue to hold in the setting of post intubation shock Discussion Intubated overnight. Deeply sedated, paralyzed, and proned for refractory hypoxemia. Getting high dose steroids and empiric abx. Would continue these therapies. Wean FiO2 as able. Please send tracheal aspirate for cx. Otherwise, plan as above. Prognosis is guarded.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Acute respiratory failure
Hospital-Tage: 8,0
Labordaten: Complete Blood Count w/Differential (Abnormal) Collected: 12/29/21 0509 Order Status: Completed Specimen: Blood, Venous Updated: 12/29/21 0602 White Blood Cell 52.74 High Panic 4.00 - 10.80 x10*3/uL Red Blood Cell 4.64 4.20 - 5.40 x10*6/uL Hemoglobin 13.0 12.0 - 16.0 g/dL Hematocrit 41.5 37.0 - 47.0 % Mean Cell Volume 89.4 80.0 - 100.0 fL Mean Cell Hemoglobin 28.0 27.0 - 33.0 pg Mean Cell Hemoglobin Concentration 31.3 Low 32.0 - 37.0 g/dL Red Cell Diameter Width 14.6 11.0 - 16.0 % NRBC Absolute Count 0.00 0.00 - 0.01 x10*3/uL NRBC Automated 0.0 0.0 - 0.1 %WBC Platelet 187 140 - 400 x10*3/uL Mean Platelet Volume 10.2 7.4 - 11 fL Neutrophil Absolute Count 11.27 High 1.80 - 7.80 x10*3/uL Manual Differential ADD ON (Abnormal) Collected: 12/29/21 0509 Order Status: Completed Specimen: Blood, Venous Updated: 12/29/21 0601 Segmented Neutrophils Manual 19 Low 35 - 80 % Lymphocytes Manual 80 High 20 - 50 % Monocytes Manual 1 Low 2 - 12 % Eosinophil Manual 0 0 - 6 % Basophils Manual 0 0 - 2 % RBC Morphology See Below Platelet Estimate Normal Comprehensive Metabolic Panel (CMP) (Abnormal) Collected: 12/29/21 0509 Order Status: Completed Specimen: Blood, Venous Updated: 12/29/21 0547 Sodium Level 133 Low 134 - 146 mmol/L Potassium Level 4.7 3.4 - 5.0 mmol/L Chloride 96 Low 98 - 112 mmol/L HCO3 27 21 - 29 mmol/L Anion Gap 10 9 - 18 mmol/L Glucose Level 476 High Panic 70 - 99 mg/dL Blood Urea Nitrogen 53 High 8 - 20 mg/dL Creatinine 0.81 0.50 - 1.10 mg/dL MDRD eGFR >60 >=60 mL/min/1.73 m2 CG eCrCl 59 mL/min/1.73 m2 Calcium Level Total 8.5 Low 8.6 - 10.4 mg/dL Protein Total 5.3 Low 6.0 - 8.0 g/dL Albumin Level 2.7 Low 3.5 - 5.0 g/dL Bilirubin Total 0.6 0.2 - 1.0 mg/dL Alkaline Phosphatase 69 35 - 104 IU/L Alanine Aminotransferase 38 10 - 40 IU/L Aspartate Aminotransferase 11 10 - 40 IU/L C Reactive Protein (CRP), Blood Level (Abnormal) Collected: 12/29/21 0509 Order Status: Completed Specimen: Blood, Venous Updated: 12/29/21 0540 C-Reactive Protein 9.4 High <=5.0 mg/L D-Dimer (Abnormal) Collected: 12/29/21 0509 Order Status: Completed Specimen: Blood, Venous Updated: 12/29/21 0531 D-Dimer Quant 1,020 High 0 - 500 ng/mL FEU
Aktuelle Erkrankungen: -
Vorgeschichte: Past Medical History: Diagnosis Date ? Arthritis ? CVA (cerebral vascular accident) 2010 - generalized weakness since then ? Diabetes mellitus ? Diverticulosis ? DJD (degenerative joint disease) of knee right ? Goiter ? Hyperlipidemia ? Hypertension ? Other and unspecified hyperlipidemia ? Other malignant neoplasm of skin, site unspecified ? Other malignant neoplasm without specification of site Skin Cancer (arms, back and face) ?squamous ? Skin lesion 12/18/2014 Upper right back/neck basal cell completely removed ? Squamous cell carcinoma 1/10/2018 On her neck ? Type II or unspecified type diabetes mellitus without mention of complication, not stated as uncontrolled ? Unspecified cerebral artery occlusion ? Unspecified disorder of thyroid
Andere Medikamente: Amoxicillin 500 MG take 4 capsules by mouth 1 hour prior to dental appointment Aspirin 81 mg Daily Calcium Citrate-Vitamin D 315-250 MG-UNIT Oral Cetirizine HCl 10 mg Oral Daily Dulaglutide 0.75 mg Subcutaneous Weekly Fluorouracil 2 % APPLY
Allergien: No known Allergies
Vorherige Impfungen: -

VAERS 1962234

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EW0183

kritisch

Staat: WA
Alter: 48,0
Geschlecht: M
Eingang: 19.12.2021
Impfdatum: 08.05.2021
Beginn: 11.05.2021
Tage bis Beginn: 3,0
Dosis: 1
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: ja Hospital: ja Disable: unbekannt ER: ja Erholt: ja

Alanine aminotransferase Aspartate aminotransferase Asthenia Blood albumin Blood bilirubin Blood calcium normal Blood gases Blood lactic acid Blood magnesium Blood phosphorus Brain natriuretic peptide Chest discomfort Computerised tomogram thorax abnormal Deep vein thrombosis Dizziness Dyspnoea Dyspnoea exertional Echocardiogram abnormal

Symptomtext

Patient states 3 days after receiving the 1st dose of the PFIZER COVID- 19 Vaccination, he began to feel SOB. States he was at the gym doing his normal cardio routine and in doing so felt SOB which is unusual for him. States 3 days later began having right calf pain and swelling with a blue/green discoloration. He continued to have SOB for the following 2 weeks to the point he was winded with walking to the car or to get the mail and finally went to the ER when the SOB was getting worse, he began having some chest discomfort, pain with taking a deep breath, feeling like he had fever, lightheadness, weakness and feeling like he was going to pass out.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Pulmonary embolism
Hospital-Tage: 4,0
Labordaten: 5/24/21- CT Scan- "Acute pulmonary embolism involving the bilateral main pulmonary arteries extending to the upper and lower segmental and subsegmental pulmonary arteries. There is evidence of right heart strain with an RV to LV ratio of 1.6 and intraventricular septal bowing. RV to LV ratio: 1.6.". 5/24/21 ECHO- "Small left ventricular cavity with normal systolic function (estimated EF 60-65%). Interventricular septum flattening in systole consistent with right ventricular pressure overload. No LV thrombus. Severely dilated right ventricle with moderate systolic dysfunction (FAC 25%) and hypokinesis of the mid segment. No RV thrombus. Severely elevated pulmonary artery pressure (PASP 56-61 mmHg)". 5/24/21 EKG- sinus tachy, rate 115, R axis deviation, inferior lead & V3-V6 T wave inversions 5/24/21 Labs- Chemistries CBC LFT Gases, other 136 102 14 114 14.3 AST: - ALT: - -/-/-/- | -/-/-/- 3.9 25 0.91 7.67 >< 184 AP: - T bili: - Lact (a): - Lact (v): 2.7 eGFR: >60 Ca: 9.1 40 Prot: - Alb: - Trop I: 0.08 D-dimer: - Mg: - PO4: - ANC: 3.79 BNP: - Anti-Xa: 0.98 ALC: 3.06 INR: - 5/24/21 LE US- 1. RIGHT LOWER EXTREMITY VENOUS - Acute deep vein thrombosis (non-occlusive) is identified in the right popliteal and posterior tibial veins. - Acute deep vein thrombosis (occlusive) is identified in the right peroneal and two soleal veins. No deep vein thrombosis in the right common femoral, deep femoral, femoral, and gastrocnemius veins - No superficial vein thrombosis in the right great saphenous vein at the confluence.
Aktuelle Erkrankungen: None
Vorgeschichte: None
Andere Medikamente: None
Allergien: NKDA
Vorherige Impfungen: -

VAERS 1932777

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EW0183

kritisch

Staat: KY
Alter: 88,0
Geschlecht: M
Eingang: 08.12.2021
Impfdatum: 07.07.2021
Beginn: 07.12.2021
Tage bis Beginn: 153,0
Dosis: 2
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: nein

Acute myocardial infarction Anaemia Asthenia COVID-19 pneumonia Chest X-ray abnormal Chronic kidney disease Disorientation Lung infiltration Oxygen saturation decreased SARS-CoV-2 test positive Troponin increased

Symptomtext

presented to ED complaining on weakness, pt also disoriented, O2 sats dropped to 88% in ED so placed on 4L O2 also with elevated troponin - per cardio consult "Type II myocardial infarction in the setting of chronic kidney disease, anemia, Covid pneumonia" pt started on decadron 6mg PO qday and remdesivir

Weitere VAERSDATA-Felder

Praegender Schweregrund: Acute myocardial infarction
Hospital-Tage: -
Labordaten: covid positive 12/7 CXR - consistent with Covid-19 infiltrates
Aktuelle Erkrankungen: -
Vorgeschichte: MDS (myelodysplastic syndrome) CKD stage 4 type 2 diabetes diastolic CHF
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1901857

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EW0183

kritisch

Staat: MI
Alter: 56,0
Geschlecht: M
Eingang: 26.11.2021
Impfdatum: 04.05.2021
Beginn: 23.11.2021
Tage bis Beginn: 203,0
Dosis: 2
Route/Site: UN / UN

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: nein

Acute respiratory failure Blood culture negative Blood gases COVID-19 COVID-19 pneumonia Chest X-ray abnormal Chronic obstructive pulmonary disease Condition aggravated Cough Dyspnoea Fatigue Fibrin D dimer normal Hypoxia Lung infiltration Lung opacity Respiratory distress SARS-CoV-2 test positive Spirometry

Symptomtext

Patient currently admitted at (3) days inpatient stay starting at 11/23/2021. PT 56 y.o. male who presents to hospital with shortness of breath. Patient is presently vaccinated against COVID in May of this year. He states approximately 2-3 days ago he began having worsening cough shortness of breath and fatigue. Denies any GI complaints. He has been using his oxygen around the clock; normally only uses 3 L at night. Because of worsening shortness of breath he presented to the emergency department for evaluation. Oxygen saturations on room air were in the 70s. He is currently saturating 94% with 4 L of oxygen. Chest x-ray showed bilateral infiltrates and COVID testing was positive. He had significant wheezing; he did get steroids but did not get bronchodilators. D-dimer was negative. Because of his worsening hypoxemia and respiratory distress he was referred to the hospital for further evaluation and care. Acute respiratory failure with hypoxia Assessment & Plan Patient uses 3 L of oxygen at nighttime only Concurrently saturating 94% on 4 L Plan incentive spirometry, flutter, proning as tolerated Check blood gases to rule out hypercapnia COPD with acute exacerbation Assessment & Plan Patient with history of severe disease based on PFTs Uses trilogy at home Suspect exacerbation worsened due to underlying COVID Aggressive respiratory hygiene steroids and bronchodilators Strongly encouraged smoking cessation * Pneumonia due to COVID-19 virus Assessment & Plan Patient with symptom onset 11/21 Worsening shortness of breath cough and hypoxia Chest x-ray showing bilateral infiltrates Vaccinated in April and May of 2021 COVID positive 11/23 Plan admission, steroids, remdesivir, and aggressive supportive respiratory care Hypertension Assessment & Plan Blood pressure is currently stable Obesity Assessment & Plan Body mass index 47.6

Weitere VAERSDATA-Felder

Praegender Schweregrund: Acute respiratory failure
Hospital-Tage: 3,0
Labordaten: Procedure Component Value Ref Range Date/Time DR CHEST SINGLE VIEW Resulted: 11/23/21 1235 Order Status: Completed Updated: 11/23/21 1237 Narrative: EXAMINATION: Single View Chest EXAM DATE: 11/23/2021 12:31 PM TECHNIQUE: Single view chest INDICATION: dyspnea COMPARISON: 9/3/2021 ENCOUNTER: Not applicable _________________________ FINDINGS: Heart size is normal. No mediastinal pathology. The lateral aspect of the left lower lung is not included on this study. Within the visualized lungs, there has been increase in moderately prominent streaky opacification in both lungs. No pneumothorax or definite pleural effusion. _________________________ Impression: Increase in moderate streaky opacification of both lungs. This could represent either vascular congestion or pneumonia. Recommend clinical correlation. Procedure Component Value Ref Range Date/Time Peripheral Blood Culture Collected: 11/23/21 1148 Order Status: Completed Specimen: Blood, Venous Updated: 11/25/21 1401 Cult Blood Peripheral No Growth 48 hours Peripheral Blood Culture Collected: 11/23/21 1156 Order Status: Completed Specimen: Blood, Venous Updated: 11/25/21 1401 Cult Blood Peripheral No Growth 48 hours Narrative: Draw from a different site than draw one. COVID-19 PCR - Rapid (Abnormal) Collected: 11/23/21 1155 Order Status: Completed Specimen: Swabbed Collection from Nasopharynx Updated: 11/23/21 1211 COVID-19 PCR Detected Abnormal
Aktuelle Erkrankungen: 4/27/2021- COPD with exacerbation; Acute suppurative otitis media of right ear without spontaneous rupture of tympanic membrane, recurrence not specified; Acute pansinusitis, recurrence not specified; Benign paroxymal positional vertigo, unspecific laterality; Trapezius muscle spasm
Vorgeschichte: Hospital Pneumonia due to COVID-19 virus Acute respiratory failure with hypoxia COPD with acute exacerbation Hypertension Obesity Non-Hospital Benign prostatic hyperplasia, unspecified whether lower urinary tract symptoms present Seasonal allergic rhinitis due to pollen Low testosterone in male Tobacco abuse Heart failure, unspecified HF chronicity, unspecified heart failure type Lung nodule < 6cm on CT
Andere Medikamente: ADVAIR HFA 230-21 MCG/ACT inhaler albuterol HFA (PROVENTIL HFA, VENTOLIN HFA, PROAIR HFA) 108 (90 Base) MCG/ACT inhaler aspirin 81 MG EC tablet fluticasone-umeclidin-vilant (TRELEGY ELLIPTA) 100-62.5-25 MCG/INH inhaler ipratropium-albut
Allergien: No Known Allergies
Vorherige Impfungen: -

VAERS 1877266

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EW0183

kritisch

Staat: TX
Alter: 67,0
Geschlecht: M
Eingang: 17.11.2021
Impfdatum: 23.09.2021
Beginn: 19.10.2021
Tage bis Beginn: 26,0
Dosis: 3
Route/Site: IM / LA

Tod: ja Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: nein

Acute kidney injury Anticoagulant therapy Asthenia COVID-19 Chest X-ray abnormal Chest pain Chest tube insertion Cough Death Diarrhoea Endotracheal intubation Hypotension Hypoxia Intensive care Lung opacity Mechanical ventilation Nausea Pneumonia

Symptomtext

Pfizer BioNTech COVID-19 Vaccine EUA: COVID-19 case resulting in Hospitalization / Death. Patient received Pfizer Vaccines on 3/8/2021, 3/29/2021, and 9/23/2021. Patient tested for COVID at clinic on 10/19/2021 which resulted positive. Presented to ED on 10/20/2021 with complaints of cough, nausea, vomiting, diarrhea and weakness for 10 days. Admitted for acute kidney injury and requiring oxygen supplementation 3-4 L nasal cannula. Received: dexamethasone, full anticoagulation, remdesivir, broad spectrum antibiotics, paralytics, pressors, and nitric oxide. Transferred to ICU for chest pain and hypoxia. Developed pneumothorax, chest tube placed and intubated.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Death
Hospital-Tage: 8,0
Labordaten: COVID positive 10/19/2021 and 10/20/2021; CXR: Patchy bibasilar opacities compatible with edema or pneumonia on 10/20/2021.
Aktuelle Erkrankungen: -
Vorgeschichte: Kidney transplant, allergic rhinitis, anemia, Autonomic nervous system disorder, thrombocytopenia, benign prostatic
Andere Medikamente: atorvastatin Take 1 tablet (20 mg total)by mouth daily,
Allergien: Flomax
Vorherige Impfungen: -

VAERS 1872692

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EW0183

kritisch

Staat: MI
Alter: 79,0
Geschlecht: M
Eingang: 16.11.2021
Impfdatum: 17.06.2021
Beginn: 03.11.2021
Tage bis Beginn: 139,0
Dosis: 2
Route/Site: SYR / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: nein

Alanine aminotransferase normal Angiogram pulmonary abnormal Anion gap normal Aspartate aminotransferase normal Atelectasis Atrial fibrillation Bacterial test negative Basophil count normal Basophil percentage Bilirubin urine Blood albumin decreased Blood alkaline phosphatase normal Blood bicarbonate increased Blood bilirubin normal Blood calcium decreased Blood chloride decreased Blood creatinine normal Blood culture negative

Symptomtext

Patient is a 79 y.o. male who presents today with worsening shortness of breath and cough. The patient has a pertinent medical history of chronic obstructive pulmonary disease on 3 L nasal cannula baseline per patient, systolic and diastolic heart failure with EF 54% in Dec 2020, coronary artery disease, PAD, hypertension, and hyperlipidemia. The patient states his symptoms started roughly 3-4 days ago that included shortness of breath on exertion and cough. The symptoms progressively have gotten worse over these previous days so he presented to the ER. He was febrile in the ER and a code sepsis was started and he was given a 1000 mL fluid bolus. He was requiring BiPAP support 12/6 100%. He subsequently tested positive for COVID so code sepsis was stopped. Chest x-ray shows interstitial opacities at the lung bases. Procalcitonin was 0.24. He was vaccinated for COVID with Pfizer on 05/27/2021 and 06/17/2021. The patient was admitted to the hospitalist team for further medical management. He endorses fever, shortness of breath, cough. He denies sputum production, nausea, vomiting, diarrhea, dizziness, lightheadedness, headaches, chest pain. The plan will be to start dexamethasone and remdesivir for COVID pneumonia. Will obtain a D-dimer at this time and can consider CTA of the chest if elevated. Given her normal WBC and procalcitonin I have low suspicion for concurrent bacterial pneumonia. He he is currently on BiPAP 12/6 at 35% with plan to wean to high-flow nasal cannula with assistance from respiratory therapy. Given heart failure history and large fluid bolus in the ER, patient may need intravenous Lasix for hypervolemia and significant bilateral lower extremity edema. I updated the patient on the plan of care and all questions and concerns were addressed

Weitere VAERSDATA-Felder

Praegender Schweregrund: Gynaecomastia
Hospital-Tage: 13,0
Labordaten: Procedure Component Value Ref Range Date/Time Comprehensive Metabolic Panel (CMP) (Abnormal) Collected: 11/16/21 0421 Order Status: Completed Specimen: Blood, Venous Updated: 11/16/21 0514 Sodium Level 134 134 - 146 mmol/L Potassium Level 4.3 3.4 - 5.0 mmol/L Chloride 91 Low 98 - 112 mmol/L HCO3 33 High 21 - 29 mmol/L Anion Gap 10 9 - 18 mmol/L Glucose Level 146 High 70 - 99 mg/dL Blood Urea Nitrogen 51 High 8 - 20 mg/dL Creatinine 0.82 0.60 - 1.30 mg/dL MDRD eGFR >60 >=60 mL/min/1.73 m2 Comment: MDRD GFR calculation is based on the 4 value MDRD equation. Clinical Practice Guidelines for chronic kidney disease. Part 5 Guideline 5. MDRD estimated GFR (eGFR) is best used for detection of chronic kidney disease in clinically stable patients. DO NOT USE VALUES FROM THIS EQUATION FOR DRUG DOSING. It has not yet been validated for drug dosing or for patients with rapidly changing clinical situations (inpatient care). The calculated GFR is gender, age, and race specific. Values for patients identified are calculated using the equation. Values for patients of all other races and for patients who do not report their race are calculated using the equation for patients. CG eCrCl 73 mL/min/1.73 m2 Calcium Level Total 8.5 Low 8.6 - 10.4 mg/dL Protein Total 6.3 6.0 - 8.0 g/dL Albumin Level 2.3 Low 3.5 - 5.0 g/dL Bilirubin Total 0.6 0.2 - 1.0 mg/dL Alkaline Phosphatase 99 40 - 129 IU/L Alanine Aminotransferase 30 10 - 40 IU/L Aspartate Aminotransferase 26 10 - 40 IU/L Magnesium, Blood Level (Abnormal) Collected: 11/16/21 0421 Order Status: Completed Specimen: Blood, Venous Updated: 11/16/21 0514 Magnesium Level 2.8 High 1.6 - 2.5 mg/dL Complete Blood Count w/Differential (Abnormal) Collected: 11/16/21 0421 Order Status: Completed Specimen: Blood, Venous Updated: 11/16/21 0452 White Blood Cell 16.81 High 4.00 - 10.80 x10*3/uL Red Blood Cell 3.98 Low 4.60 - 6.00 x10*6/uL Hemoglobin 11.8 Low 14.0 - 18.0 g/dL Hematocrit 37.1 Low 42.0 - 52.0 % Mean Cell Volume 93.2 80.0 - 100.0 fL Mean Cell Hemoglobin 29.6 27.0 - 33.0 pg Mean Cell Hemoglobin Concentration 31.8 Low 32.0 - 37.0 g/dL Red Cell Diameter Width 15.9 11.0 - 16.0 % NRBC Absolute Count 0.00 0.00 - 0.01 x10*3/uL NRBC Automated 0.0 0.0 - 0.1 %WBC Platelet 248 140 - 400 x10*3/uL Mean Platelet Volume 12.4 High 7.4 - 11 fL Neutrophil Automated 85.0 High 35.0 - 80.0 % Immature Granulocyte Automated 2.0 High 0.0 - 0.6 % Lymphocyte Automated 6.1 Low 20.0 - 50.0 % Monocytes Automated 6.7 2.0 - 12.0 % Eosinophil Automated 0.0 0.0 - 6.0 % Basophil Automated 0.2 0.0 - 2.0 % Neutrophil Absolute Count 14.30 High 1.80 - 7.80 x10*3/uL Immature Granulocyte Absolute Count 0.34 High 0.00 - 0.05 x10*3/uL Lymphocyte Absolute Count 1.02 1.00 - 4.00 x10*3/uL Monocyte Absolute Count 1.12 High 0.00 - 0.90 x10*3/uL Eosinophil Absolute Count 0.00 0.00 - 0.50 x10*3/uL Basophil Absolute Count 0.03 0.00 - 0.20 x10*3/uL Peripheral Blood Culture Collected: 11/12/21 1702 Order Status: Completed Specimen: Blood, Venous Updated: 11/15/21 1801 Cult Blood Peripheral No Growth 3 Days Comprehensive Metabolic Panel (CMP) (Abnormal) Collected: 11/15/21 0512 Order Status: Completed Specimen: Blood, Venous Updated: 11/15/21 0609 Sodium Level 135 134 - 146 mmol/L Potassium Level 4.4 3.4 - 5.0 mmol/L Chloride 92 Low 98 - 112 mmol/L HCO3 34 High 21 - 29 mmol/L Anion Gap 9 9 - 18 mmol/L Glucose Level 130 High 70 - 99 mg/dL Blood Urea Nitrogen 56 High 8 - 20 mg/dL Creatinine 0.83 0.60 - 1.30 mg/dL MDRD eGFR >60 >=60 mL/min/1.73 m2 Comment: MDRD GFR calculation is based on the 4 value MDRD equation. Clinical Practice Guidelines for chronic kidney disease. Part 5 Guideline 5. MDRD estimated GFR (eGFR) is best used for detection of chronic kidney disease in clinically stable patients. DO NOT USE VALUES FROM THIS EQUATION FOR DRUG DOSING. It has not yet been validated for drug dosing or for patients with rapidly changing clinical situations (inpatient care). The calculated GFR is gender, age, and race specific. Values for patients identified are calculated using the equation. Values for patients of all other races and for patients who do not report their race are calculated using the equation for patients. CG eCrCl 72 mL/min/1.73 m2 Calcium Level Total 8.6 8.6 - 10.4 mg/dL Protein Total 6.2 6.0 - 8.0 g/dL Albumin Level 2.3 Low 3.5 - 5.0 g/dL Bilirubin Total 0.7 0.2 - 1.0 mg/dL Alkaline Phosphatase 102 40 - 129 IU/L Alanine Aminotransferase 23 10 - 40 IU/L Aspartate Aminotransferase 22 10 - 40 IU/L Magnesium, Blood Level (Abnormal) Collected: 11/15/21 0512 Order Status: Completed Specimen: Blood, Venous Updated: 11/15/21 0609 Magnesium Level 2.9 High 1.6 - 2.5 mg/dL Complete Blood Count w/Differential (Abnormal) Collected: 11/15/21 0512 Order Status: Completed Specimen: Blood, Venous Updated: 11/15/21 0545 White Blood Cell 16.08 High 4.00 - 10.80 x10*3/uL Red Blood Cell 4.13 Low 4.60 - 6.00 x10*6/uL Hemoglobin 11.9 Low 14.0 - 18.0 g/dL Hematocrit 38.4 Low 42.0 - 52.0 % Mean Cell Volume 93.0 80.0 - 100.0 fL Mean Cell Hemoglobin 28.8 27.0 - 33.0 pg Mean Cell Hemoglobin Concentration 31.0 Low 32.0 - 37.0 g/dL Red Cell Diameter Width 15.8 11.0 - 16.0 % NRBC Absolute Count 0.00 0.00 - 0.01 x10*3/uL NRBC Automated 0.0 0.0 - 0.1 %WBC Platelet 266 140 - 400 x10*3/uL Mean Platelet Volume 11.9 High 7.4 - 11 fL Neutrophil Automated 84.1 High 35.0 - 80.0 % Immature Granulocyte Automated 1.4 High 0.0 - 0.6 % Lymphocyte Automated 7.7 Low 20.0 - 50.0 % Monocytes Automated 6.6 2.0 - 12.0 % Eosinophil Automated 0.0 0.0 - 6.0 % Basophil Automated 0.2 0.0 - 2.0 % Neutrophil Absolute Count 13.52 High 1.80 - 7.80 x10*3/uL Immature Granulocyte Absolute Count 0.23 High 0.00 - 0.05 x10*3/uL Lymphocyte Absolute Count 1.24 1.00 - 4.00 x10*3/uL Monocyte Absolute Count 1.06 High 0.00 - 0.90 x10*3/uL Eosinophil Absolute Count 0.00 0.00 - 0.50 x10*3/uL Basophil Absolute Count 0.03 0.00 - 0.20 x10*3/uL Peripheral Blood Culture (Abnormal) Collected: 11/12/21 1840 Order Status: Completed Specimen: Blood, Venous Updated: 11/14/21 1216 Cult Blood Peripheral Staphylococcus epidermidis Abnormal Comment: (Coagulase-negative Staphylococcus) This is an edited result. Previous organism was Gram positive cocci in clusters on 11/13/2021 at 1448. TELEMETRY STRIP Collected: 11/14/21 0725 Order Status: Completed Updated: 11/14/21 0806 Magnesium, Blood Level (Abnormal) Collected: 11/14/21 0426 Order Status: Completed Specimen: Blood, Venous Updated: 11/14/21 0601 Magnesium Level 2.9 High 1.6 - 2.5 mg/dL Comprehensive Metabolic Panel (CMP) (Abnormal) Collected: 11/14/21 0426 Order Status: Completed Specimen: Blood, Venous Updated: 11/14/21 0601 Sodium Level 136 134 - 146 mmol/L Potassium Level 4.6 3.4 - 5.0 mmol/L Chloride 92 Low 98 - 112 mmol/L HCO3 32 High 21 - 29 mmol/L Anion Gap 12 9 - 18 mmol/L Glucose Level 140 High 70 - 99 mg/dL Blood Urea Nitrogen 60 High 8 - 20 mg/dL Creatinine 0.90 0.60 - 1.30 mg/dL MDRD eGFR >60 >=60 mL/min/1.73 m2 Comment: MDRD GFR calculation is based on the 4 value MDRD equation. Clinical Practice Guidelines for chronic kidney disease. Part 5 Guideline 5. MDRD estimated GFR (eGFR) is best used for detection of chronic kidney disease in clinically stable patients. DO NOT USE VALUES FROM THIS EQUATION FOR DRUG DOSING. It has not yet been validated for drug dosing or for patients with rapidly changing clinical situations (inpatient care). The calculated GFR is gender, age, and race specific. Values for patients identified are calculated using the equation. Values for patients of all other races and for patients who do not report their race are calculated using the equation for patients. CG eCrCl 67 mL/min/1.73 m2 Calcium Level Total 8.6 8.6 - 10.4 mg/dL Protein Total 6.4 6.0 - 8.0 g/dL Albumin Level 2.2 Low 3.5 - 5.0 g/dL Bilirubin Total 0.7 0.2 - 1.0 mg/dL Alkaline Phosphatase 100 40 - 129 IU/L Alanine Aminotransferase 23 10 - 40 IU/L Aspartate Aminotransferase 23 10 - 40 IU/L Hemolysis -- Comment: Interpret results with caution. Slight specimen hemolysis. Hemolysis can affect laboratory results for the listed analytes; however, the degree of hemolysis in this specimen may not be high enough to cause significant change. Analytes that may be affected are: Ammonia, AST, Bilirubin Direct, Folate, Haptoglobin, Insulin, LDH, Osteocalcin, and Potassium. Complete Blood Count w/Differential (Abnormal) Collected: 11/14/21 0426 Order Status: Completed Specimen: Blood, Venous Updated: 11/14/21 0541 White Blood Cell 15.83 High 4.00 - 10.80 x10*3/uL Red Blood Cell 4.36 Low 4.60 - 6.00 x10*6/uL Hemoglobin 12.5 Low 14.0 - 18.0 g/dL Hematocrit 40.9 Low 42.0 - 52.0 % Mean Cell Volume 93.8 80.0 - 100.0 fL Mean Cell Hemoglobin 28.7 27.0 - 33.0 pg Mean Cell Hemoglobin Concentration 30.6 Low 32.0 - 37.0 g/dL Red Cell Diameter Width 15.8 11.0 - 16.0 % NRBC Absolute Count 0.00 0.00 - 0.01 x10*3/uL NRBC Automated 0.0 0.0 - 0.1 %WBC Platelet 265 140 - 400 x10*3/uL Mean Platelet Volume 11.9 High 7.4 - 11 fL Neutrophil Automated 86.2 High 35.0 - 80.0 % Immature Granulocyte Automated 1.0 High 0.0 - 0.6 % Lymphocyte Automated 7.2 Low 20.0 - 50.0 % Monocytes Automated 5.5 2.0 - 12.0 % Eosinophil Automated 0.0 0.0 - 6.0 % Basophil Automated 0.1 0.0 - 2.0 % Neutrophil Absolute Count 13.64 High 1.80 - 7.80 x10*3/uL Immature Granulocyte Absolute Count 0.16 High 0.00 - 0.05 x10*3/uL Lymphocyte Absolute Count 1.14 1.00 - 4.00 x10*3/uL Monocyte Absolute Count 0.87 0.00 - 0.90 x10*3/uL Eosinophil Absolute Count 0.00 0.00 - 0.50 x10*3/uL Basophil Absolute Count 0.02 0.00 - 0.20 x10*3/uL Blood Culture ID Panel (Lab Use Only) Collected: 11/12/21 1840 Order Status: Completed Specimen: Blood, Venous Updated: 11/13/21 1850 USV Venous Lower Extremity Duplex Bilateral Resulted: 11/13/21 1449 Order Status: Completed Updated: 11/13/21 1451 Narrative: EXAMINATION: Complete Right and Left Lower Extremity Venous Duplex Doppler Ultrasound EXAM DATE: 11/13/2021 2:04 PM TECHNIQUE: Real-time B-mode imaging with and without compression was used to evaluate the right and left lower extremity for deep venous thrombosis (DVT). Duplex Doppler with color and spectral Doppler was used. INDICATION: COVID-19, elevated D-dimer, PE negative. Abdominal aortic aneurysm on the prior ultrasound of November 25, 2019 COMPARISON: None _____________________ Right Lower Extremity Findings: Right Common Femoral Vein: No DVT. Right Femoral Vein: No DVT. Right Popliteal Vein: No DVT. Right Posterior Tibial Veins: No DVT. Right Peroneal Veins: Suboptimally visualized. Right proximal Greater Saphenous Vein: No thrombus. Left Lower Extremity Findings: Left Common Femoral Vein: No DVT. Left Femoral Vein: No DVT. Left Popliteal Vein: No DVT. Left Posterior Tibial Veins: No DVT. Left Peroneal Veins: Suboptimally visualized. Left proximal Greater Saphenous Vein: No thrombus. Duplex Doppler: Spectral Doppler demonstrates bilateral normal respirophasic waveforms in the common femoral veins. Additional Findings: A fusiform aneurysm of the popliteal arteries present measuring 1.5 cm in AP dimension. There appears to be a large amount of isoechoic thrombus within the aneurysm. The aneurysm is incompletely assessed on this venous examination. _____________________ Impression: There is no deep venous thrombosis in the visualized deep veins of the right or left lower extremity. Calf veins image poorly. There is a fusiform aneurysm of the right popliteal artery. Popliteal arteries are commonly bilateral. Consider complete assessment of the left and right popliteal arteries with an arterial examination. The patient has a known abdominal aortic aneurysm which has not been assessed at this institution since November 25, 2019. Consider ultrasound assessment. * USV Venous Upper Extremity Duplex Bilateral Resulted: 11/13/21 1440 Order Status: Completed Updated: 11/13/21 1442 Narrative: EXAMINATION: Complete Bilateral Upper Extremity Venous Duplex Doppler Ultrasound EXAM DATE: 11/13/2021 2:04 PM TECHNIQUE: Real-time B-mode imaging with and without compression was used to evaluate the right and left upper extremity for deep venous thrombosis (DVT). Duplex Doppler with color and spectral Doppler was used. INDICATION: COVID-19, elevated D-dimer, PE negative COMPARISON: None _____________________ Right Upper Extremity Findings: Right Internal Jugular Vein: No thrombus. Right Subclavian Vein: No thrombus. Right Axillary Vein: No thrombus. Right Brachial Vein: No thrombus. Right Radial Vein: No thrombus. Right Ulnar Vein: No thrombus. Superficial Veins: Right Basilic Vein: No thrombus. Right Cephalic Vein: No thrombus. Left Upper Extremity Findings: Left Internal Jugular Vein: No thrombus. Left Subclavian Vein: No thrombus. Left Axillary Vein: No thrombus. Left Brachial Vein: No thrombus. Left Radial Vein: No thrombus. Left Ulnar Vein: No thrombus. Superficial Veins: Left Basilic Vein: No thrombus. Left Cephalic Vein: No thrombus. ADDITIONAL FINDINGS: Normal cardiac pulsatility is present in the subclavian veins. _____________________ Impression: There is no deep venous thrombosis in the visualized deep veins of the right or left upper extremity. D-Dimer (Abnormal) Collected: 11/13/21 1100 Order Status: Completed Specimen: Blood, Venous Updated: 11/13/21 1130 D-Dimer Quant 3,330 High 0 - 500 ng/mL FEU Comment: It should be noted that the published studies evaluating this assay have included only Emergency Room or other outpatients presenting with new symptoms suggestive of thromboembolic disease. This assay has not been evaluated for this purpose in hospital inpatients, postoperative patients, or other patient types than those indicated. Elevated D-Dimers may be seen in activation states of coagulation. Elevated states of D-Dimer levels may be associated with the following: DVT, DIC, hemorrhages, fibrinolysis, post-operative periods, cancer, and severe infections. D-Dimer levels may be falsely elevated in underlying, non-thrombotic conditions common in hospitalized patients. Cut-off value for D-dimer use in evaluation of VTE is 500 ng/mL FEU. The measurement of D-Dimer should not be used as an aid in the diagnosis of VTE in patients with: - Therapeutic dose anticoagulant therapy for >24 hours - Fibrinolytic therapy within previous 7 days - Trauma or surgery within previous 4 weeks - Aortic aneurysm - Sepsis, severe infections, pneumonia, severe skin infections - Liver cirrhosis - Renal Failure - Pregnancy The Agencies recommend that in patients older than 50 years with low-to-intermediate pretest probability for acute pulmonary embolism, an age-adjusted D-dimer cutoff of age x 10 (FEU units) can be used to exclude a diagnosis of PE without need for further imaging. C Reactive Protein (CRP), Blood Level (Abnormal) Collected: 11/13/21 1100 Order Status: Completed Specimen: Blood, Venous Updated: 11/13/21 1127 C-Reactive Protein 36.2 High <=5.0 mg/L DR CHEST SINGLE VIEW Resulted: 11/13/21 0710 Order Status: Completed Updated: 11/13/21 0712 Narrative: EXAMINATION: Single View Chest EXAM DATE: 11/12/2021 4:43 PM TECHNIQUE: Single view chest INDICATION: pna COMPARISON: 11/6/2021 ENCOUNTER: Not applicable _________________________ FINDINGS: No significant change in bilateral mid to lower lung airspace opacities. Probable small bilateral pleural effusions. No pneumothorax. Stable cardiomediastinal silhouette. _________________________ Impression: Stable appearance of the chest. Magnesium, Blood Level (Abnormal) Collected: 11/13/21 0459 Order Status: Completed Specimen: Blood, Venous Updated: 11/13/21 0547 Magnesium Level 2.7 High 1.6 - 2.5 mg/dL Comprehensive Metabolic Panel (CMP) (Abnormal) Collected: 11/13/21 0459 Order Status: Completed Specimen: Blood, Venous Updated: 11/13/21 0546 Sodium Level 134 134 - 146 mmol/L Potassium Level 4.1 3.4 - 5.0 mmol/L Chloride 89 Low 98 - 112 mmol/L HCO3 34 High 21 - 29 mmol/L Anion Gap 11 9 - 18 mmol/L Glucose Level 164 High 70 - 99 mg/dL Blood Urea Nitrogen 71 High 8 - 20 mg/dL Creatinine 1.07 0.60 - 1.30 mg/dL MDRD eGFR >60 >=60 mL/min/1.73 m2 Comment: MDRD GFR calculation is based on the 4 value MDRD equation. Clinical Practice Guidelines for chronic kidney disease. Part 5 Guideline 5. MDRD estimated GFR (eGFR) is best used for detection of chronic kidney disease in clinically stable patients. DO NOT USE VALUES FROM THIS EQUATION FOR DRUG DOSING. It has not yet been validated for drug dosing or for patients with rapidly changing clinical situations (inpatient care). The calculated GFR is gender, age, and race specific. Values for patients identified are calculated using the equation. Values for patients of all other races and for patients who do not report their race are calculated using the equation for patients. CG eCrCl 56 mL/min/1.73 m2 Calcium Level Total 8.9 8.6 - 10.4 mg/dL Protein Total 7.3 6.0 - 8.0 g/dL Albumin Level 2.4 Low 3.5 - 5.0 g/dL Bilirubin Total 0.9 0.2 - 1.0 mg/dL Alkaline Phosphatase 113 40 - 129 IU/L Alanine Aminotransferase 26 10 - 40 IU/L Aspartate Aminotransferase 23 10 - 40 IU/L Complete Blood Count w/Differential (Abnormal) Collected: 11/13/21 0459 Order Status: Completed Specimen: Blood, Venous Updated: 11/13/21 0530 White Blood Cell 16.52 High 4.00 - 10.80 x10*3/uL Red Blood Cell 4.51 Low 4.60 - 6.00 x10*6/uL Hemoglobin 13.0 Low 14.0 - 18.0 g/dL Hematocrit 42.5 42.0 - 52.0 % Mean Cell Volume 94.2 80.0 - 100.0 fL Mean Cell Hemoglobin 28.8 27.0 - 33.0 pg Mean Cell Hemoglobin Concentration 30.6 Low 32.0 - 37.0 g/dL Red Cell Diameter Width 15.7 11.0 - 16.0 % NRBC Absolute Count 0.00 0.00 - 0.01 x10*3/uL NRBC Automated 0.0 0.0 - 0.1 %WBC Platelet 328 140 - 400 x10*3/uL Mean Platelet Volume 11.9 High 7.4 - 11 fL Neutrophil Automated 87.6 High 35.0 - 80.0 % Immature Granulocyte Automated 1.3 High 0.0 - 0.6 % Lymphocyte Automated 6.5 Low 20.0 - 50.0 % Monocytes Automated 4.4 2.0 - 12.0 % Eosinophil Automated 0.0 0.0 - 6.0 % Basophil Automated 0.2 0.0 - 2.0 % Neutrophil Absolute Count 14.48 High 1.80 - 7.80 x10*3/uL Immature Granulocyte Absolute Count 0.21 High 0.00 - 0.05 x10*3/uL Lymphocyte Absolute Count 1.07 1.00 - 4.00 x10*3/uL Monocyte Absolute Count 0.72 0.00 - 0.90 x10*3/uL Eosinophil Absolute Count 0.00 0.00 - 0.50 x10*3/uL Basophil Absolute Count 0.04 0.00 - 0.20 x10*3/uL Urinalysis (UA) (Abnormal) Collected: 11/12/21 2013 Order Status: Completed Specimen: Urine, catheter Updated: 11/12/21 2054 Urine Color Yellow Urine Appearance Cloudy Urine Specific Gravity 1.022 1.010 - 1.030 U pH 5.0 5.0 - 9.0 Urine Glucose Negative Negative mg/dL Urine Ketones Negative Negative mg/dL Urine Protein 30 Abnormal Negative mg/dL Urine Blood Trace Abnormal Negative Urine Bilirubin Negative Negative Urine Urobilinogen 1.0 0.2 - 1.0 mg/dL Urine Nitrite Negative Negative Urine Leukocyte Esterase Negative Negative Urine WBC 1.0 0 - 5 HPF /HPF Urine RBC 3.0 0 - 3 /HPF Urine Bacteria Negative Negative Urine Squamous Epithelial Cells 6.2 0 - 9 /HPF Urine Hyaline Casts 14.52 High <3 /LPF Procalcitonin (Normal) Collected: 11/12/21 1702 Order Status: Completed Specimen: Blood, Venous Updated: 11/12/21 1741 Procalcitonin 0.20 <=0.25 ng/mL Comment: <0.05 ng/mL = Negative Between 0.05 - 0.25 ng/mL = Low, bacterial infection is possible but unlikely. Between 0.25 and 0.50 ng/mL = Intermediate; bacterial infection is likely. >0.50 ng/mL = High; bacterial infection is very likely. Procalcitonin (Normal) Collected: 11/11/21 0455 Order Status: Completed Specimen: Blood, Venous Updated: 11/12/21 1059 Procalcitonin 0.18 <=0.25 ng/mL Comment: <0.05 ng/mL = Negative Between 0.05 - 0.25 ng/mL = Low, bacterial infection is possible but unlikely. Between 0.25 and 0.50 ng/mL = Intermediate; bacterial infection is likely. >0.50 ng/mL = High; bacterial infection is very likely. Comprehensive Metabolic Panel (CMP) (Abnormal) Collected: 11/12/21 0613 Order Status: Completed Specimen: Blood, Venous Updated: 11/12/21 0638 Sodium Level 137 134 - 146 mmol/L Potassium Level 4.3 3.4 - 5.0 mmol/L Chloride 91 Low 98 - 112 mmol/L HCO3 37 High 21 - 29 mmol/L Anion Gap 9 9 - 18 mmol/L Glucose Level 148 High 70 - 99 mg/dL Blood Urea Nitrogen 65 High 8 - 20 mg/dL Creatinine 0.98 0.60 - 1.30 mg/dL MDRD eGFR >60 >=60 mL/min/1.73 m2 Comment: MDRD GFR calculation is based on the 4 value MDRD equation. Clinical Practice Guidelines for chronic kidney disease. Part 5 Guideline 5. MDRD estimated GFR (eGFR) is best used for detection of chronic kidney disease in clinically stable patients. DO NOT USE VALUES FROM THIS EQUATION FOR DRUG DOSING. It has not yet been validated for drug dosing or for patients with rapidly changing clinical situations (inpatient care). The calculated GFR is gender, age, and race specific. Values for patients identified are calculated using the equation. Values for patients of all other races and for patients who do not report their race are calculated using the equation for patients. CG eCrCl 61 mL/min/1.73 m2 Calcium Level Total 9.0 8.6 - 10.4 mg/dL Protein Total 7.2 6.0 - 8.0 g/dL Albumin Level 2.4 Low 3.5 - 5.0 g/dL Bilirubin Total 0.8 0.2 - 1.0 mg/dL Alkaline Phosphatase 107 40 - 129 IU/L Alanine Aminotransferase 28 10 - 40 IU/L Aspartate Aminotransferase 28 10 - 40 IU/L Hemolysis -- Comment: Interpret results with caution. Slight specimen hemolysis. Hemolysis can affect laboratory results for the listed analytes; however, the degree of hemolysis in this specimen may not be high enough to cause significant change. Analytes that may be affected are: Ammonia, AST, Bilirubin Direct, Folate, Haptoglobin, Insulin, LDH, Osteocalcin, and Potassium. Magnesium, Blood Level (Abnormal) Collected: 11/12/21 0613 Order Status: Completed Specimen: Blood, Venous Updated: 11/12/21 0638 Magnesium Level 2.6 High 1.6 - 2.5 mg/dL Complete Blood Count w/Differential (Abnormal) Collected: 11/12/21 0613 Order Status: Completed Specimen: Blood, Venous Updated: 11/12/21 0619 White Blood Cell 17.22 High 4.00 - 10.80 x10*3/uL Red Blood Cell 4.58 Low 4.60 - 6.00 x10*6/uL Hemoglobin 13.3 Low 14.0 - 18.0 g/dL Hematocrit 43.6 42.0 - 52.0 % Mean Cell Volume 95.2 80.0 - 100.0 fL Mean Cell Hemoglobin 29.0 27.0 - 33.0 pg Mean Cell Hemoglobin Concentration 30.5 Low 32.0 - 37.0 g/dL Red Cell Diameter Width 15.6 11.0 - 16.0 % NRBC Absolute Count 0.03 High 0.00 - 0.01 x10*3/uL NRBC Automated 0.2 High 0.0 - 0.1 %WBC Platelet 299 140 - 400 x10*3/uL Mean Platelet Volume 11.3 High 7.4 - 11 fL Neutrophil Automated 86.9 High 35.0 - 80.0 % Immature Granulocyte Automated 1.0 High 0.0 - 0.6 % Lymphocyte Automated 6.4 Low 20.0 - 50.0 % Monocytes Automated 5.6 2.0 - 12.0 % Eosinophil Automated 0.0 0.0 - 6.0 % Basophil Automated 0.1 0.0 - 2.0 % Neutrophil Absolute Count 14.96 High 1.80 - 7.80 x10*3/uL Immature Granulocyte Absolute Count 0.17 High 0.00 - 0.05 x10*3/uL Lymphocyte Absolute Count 1.11 1.00 - 4.00 x10*3/uL Monocyte Absolute Count 0.96 High 0.00 - 0.90 x10*3/uL Eosinophil Absolute Count 0.00 0.00 - 0.50 x10*3/uL Basophil Absolute Count 0.02 0.00 - 0.20 x10*3/uL Magnesium, Blood Level (Normal) Collected: 11/11/21 0455 Order Status: Completed Specimen: Blood, Venous Updated: 11/11/21 0524 Magnesium Level 2.5 1.6 - 2.5 mg/dL Comprehensive Metabolic Panel (CMP) (Abnormal) Collected: 11/11/21 0455 Order Status: Completed Specimen: Blood, Venous Updated: 11/11/21 0524 Sodium Level 138 134 - 146 mmol/L Potassium Level 4.2 3.4 - 5.0 mmol/L Chloride 93 Low 98 - 112 mmol/L HCO3 34 High 21 - 29 mmol/L Anion Gap 11 9 - 18 mmol/L Glucose Level 244 High 70 - 99 mg/dL Blood Urea Nitrogen 69 High 8 - 20 mg/dL Creatinine 0.96 0.60 - 1.30 mg/dL MDRD eGFR >60 >=60 mL/min/1.73 m2 Comment: MDRD GFR calculation is based on the 4 value MDRD equation. Clinical Practice Guidelines for chronic kidney disease. Part 5 Guideline 5. MDRD estimated GFR (eGFR) is best used for detection of chronic kidney disease in clinically stable patients. DO NOT USE VALUES FROM THIS EQUATION FOR DRUG DOSING. It has not yet been validated for drug dosing or for patients with rapidly changing clinical situations (inpatient care). The calculated GFR is gender, age, and race specific. Values for patients identified are calculated using the equation. Values for patients of all other races and for patients who do not report their race are calculated using the equation for patients. CG eCrCl 62 mL/min/1.73 m2 Calcium Level Total 8.8 8.6 - 10.4 mg/dL Protein Total 7.1 6.0 - 8.0 g/dL Albumin Level 2.4 Low 3.5 - 5.0 g/dL Bilirubin Total 0.8 0.2 - 1.0 mg/dL Alkaline Phosphatase 98 40 - 129 IU/L Alanine Aminotransferase 31 10 - 40 IU/L Aspartate Aminotransferase 28 10 - 40 IU/L Complete Blood Count w/Differential (Abnormal) Collected: 11/11/21 0455 Order Status: Completed Specimen: Blood, Venous Updated: 11/11/21 0508 White Blood Cell 11.89 High 4.00 - 10.80 x10*3/uL Red Blood Cell 4.61 4.60 - 6.00 x10*6/uL Hemoglobin 13.4 Low 14.0 - 18.0 g/dL Hematocrit 42.8 42.0 - 52.0 % Mean Cell Volume 92.8 80.0 - 100.0 fL Mean Cell Hemoglobin 29.1 27.0 - 33.0 pg Mean Cell Hemoglobin Concentration 31.3 Low 32.0 - 37.0 g/dL Red Cell Diameter Width 15.4 11.0 - 16.0 % NRBC Absolute Count 0.00 0.00 - 0.01 x10*3/uL NRBC Automated 0.0 0.0 - 0.1 %WBC Platelet 323 140 - 400 x10*3/uL Mean Platelet Volume 11.6 High 7.4 - 11 fL Neutrophil Automated 85.3 High 35.0 - 80.0 % Immature Granulocyte Automated 0.8 High 0.0 - 0.6 % Lymphocyte Automated 6.2 Low 20.0 - 50.0 % Monocytes Automated 7.2 2.0 - 12.0 % Eosinophil Automated 0.2 0.0 - 6.0 % Basophil Automated 0.3 0.0 - 2.0 % Neutrophil Absolute Count 10.14 High 1.80 - 7.80 x10*3/uL Immature Granulocyte Absolute Count 0.10 High 0.00 - 0.05 x10*3/uL Lymphocyte Absolute Count 0.74 Low 1.00 - 4.00 x10*3/uL Monocyte Absolute Count 0.86 0.00 - 0.90 x10*3/uL Eosinophil Absolute Count 0.02 0.00 - 0.50 x10*3/uL Basophil Absolute Count 0.03 0.00 - 0.20 x10*3/uL Comprehensive Metabolic Panel (CMP) (Abnormal) Collected: 11/10/21 0504 Order Status: Completed Specimen: Blood, Venous Updated: 11/10/21 0606 Sodium Level 138 134 - 146 mmol/L Potassium Level 4.3 3.4 - 5.0 mmol/L Chloride 94 Low 98 - 112 mmol/L HCO3 30 High 21 - 29 mmol/L Anion Gap 14 9 - 18 mmol/L Glucose Level 243 High 70 - 99 mg/dL Blood Urea Nitrogen 64 High 8 - 20 mg/dL Creatinine 0.87 0.60 - 1.30 mg/dL MDRD eGFR >60 >=60 mL/min/1.73 m2 Comment: MDRD GFR calculation is based on the 4 value MDRD equation. Clinical Practice Guidelines for chronic kidney disease. Part 5 Guideline 5. MDRD estimated GFR (eGFR) is best used for detection of chronic kidney disease in clinically stable patients. DO NOT USE VALUES FROM THIS EQUATION FOR DRUG DOSING. It has not yet been validated for drug dosing or for patients with rapidly changing clinical situations (inpatient care). The calculated GFR is gender, age, and race specific. Values for patients identified are calculated using the equation. Values for patients of all other races and for patients who do not report their race are calculated using the equation for patients. CG eCrCl 69 mL/min/1.73 m2 Calcium Level Total 8.7 8.6 - 10.4 mg/dL Protein Total 6.8 6.0 - 8.0 g/dL Albumin Level 2.2 Low 3.5 - 5.0 g/dL Bilirubin Total 0.8 0.2 - 1.0 mg/dL Alkaline Phosphatase 92 40 - 129 IU/L Alanine Aminotransferase 33 10 - 40 IU/L Aspartate Aminotransferase 38 10 - 40 IU/L Complete Blood Count w/Differential (Abnormal) Collected: 11/10/21 0504 Order Status: Completed Specimen: Blood, Venous Updated: 11/10/21 0525 White Blood Cell 9.41 4.00 - 10.80 x10*3/uL Red Blood Cell 4.45 Low 4.60 - 6.00 x10*6/uL Hemoglobin 12.9 Low 14.0 - 18.0 g/dL Hematocrit 41.9 Low 42.0 - 52.0 % Mean Cell Volume 94.2 80.0 - 100.0 fL Mean Cell Hemoglobin 29.0 27.0 - 33.0 pg Mean Cell Hemoglobin Concentration 30.8 Low 32.0 - 37.0 g/dL Red Cell Diameter Width 15.4 11.0 - 16.0 % NRBC Absolute Count 0.02 High 0.00 - 0.01 x10*3/uL NRBC Automated 0.2 High 0.0 - 0.1 %WBC Platelet 291 140 - 400 x10*3/uL Mean Platelet Volume 11.2 High 7.4 - 11 fL Neutrophil Automated 82.1 High 35.0 - 80.0 % Immature Granulocyte Automated 1.1 High 0.0 - 0.6 % Lymphocyte Automated 6.6 Low 20.0 - 50.0 % Monocytes Automated 10.1 2.0 - 12.0 % Eosinophil Automated 0.0 0.0 - 6.0 % Basophil Automated 0.1 0.0 - 2.0 % Neutrophil Absolute Count 7.73 1.80 - 7.80 x10*3/uL Immature Granulocyte Absolute Count 0.10 High 0.00 - 0.05 x10*3/uL Lymphocyte Absolute Count 0.62 Low 1.00 - 4.00 x10*3/uL Monocyte Absolute Count 0.95 High 0.00 - 0.90 x10*3/uL Eosinophil Absolute Count 0.00 0.00 - 0.50 x10*3/uL Basophil Absolute Count 0.01 0.00 - 0.20 x10*3/uL Procalcitonin (Normal) Collected: 11/09/21 0536 Order Status: Completed Specimen: Blood, Venous Updated: 11/09/21 1427 Procalcitonin 0.12 <=0.25 ng/mL Comment: <0.05 ng/mL = Negative Between 0.05 - 0.25 ng/mL = Low, bacterial infection is possible but unlikely. Between 0.25 and 0.50 ng/mL = Intermediate; bacterial infection is likely. >0.50 ng/mL = High; bacterial infection is very likely. Comprehensive Metabolic Panel (CMP) (Abnormal) Collected: 11/09/21 0536 Order Status: Completed Specimen: Blood, Venous Updated: 11/09/21 0607 Sodium Level 140 134 - 146 mmol/L Potassium Level 4.6 3.4 - 5.0 mmol/L Chloride 97 Low 98 - 112 mmol/L HCO3 32 High 21 - 29 mmol/L Anion Gap 11 9 - 18 mmol/L Glucose Level 142 High 70 - 99 mg/dL Blood Urea Nitrogen 58 High 8 - 20 mg/dL Creatinine 0.82 0.60 - 1.30 mg/dL MDRD eGFR >60 >=60 mL/min/1.73 m2 Comment: MDRD GFR calculation is based on the 4 value MDRD equation. Clinical Practice Guidelines for chronic kidney disease. Part 5 Guideline 5. MDRD estimated GFR (eGFR) is best used for detection of chronic kidney disease in clinically stable patients. DO NOT USE VALUES FROM THIS EQUATION FOR DRUG DOSING. It has not yet been validated for drug dosing or for patients with rapidly changing clinical situations (inpatient care). The calculated GFR is gender, age, and race specific. Values for patients identified are calculated using the equation. Values for patients of all other races and for patients who do not report their race are calculated using the equation for patients. CG eCrCl 73 mL/min/1.73 m2 Calcium Level Total 8.9 8.6 - 10.4 mg/dL Protein Total 6.8 6.0 - 8.0 g/dL Albumin Level 2.4 Low 3.5 - 5.0 g/dL Bilirubin Total 0.7 0.2 - 1.0 mg/dL Alkaline Phosphatase 101 40 - 129 IU/L Alanine Aminotransferase 42 High 10 - 40 IU/L Aspartate Aminotransferase 47 High 10 - 40 IU/L Complete Blood Count w/Differential (Abnormal) Collected: 11/09/21 0536 Order Status: Completed Specimen: Blood, Venous Updated: 11/09/21 0547 White Blood Cell 11.97 High 4.00 - 10.80 x10*3/uL Red Blood Cell 4.53 Low 4.60 - 6.00 x10*6/uL Hemoglobin 13.1 Low 14.0 - 18.0 g/dL Hematocrit 43.8 42.0 - 52.0 % Mean Cell Volume 96.7 80.0 - 100.0 fL Mean Cell Hemoglobin 28.9 27.0 - 33.0 pg Mean Cell Hemoglobin Concentration 29.9 Low 32.0 - 37.0 g/dL Red Cell Diameter Width 15.4 11.0 - 16.0 % NRBC Absolute Count 0.00 0.00 - 0.01 x10*3/uL NRBC Automated 0.0 0.0 - 0.1 %WBC Platelet 291 140 - 400 x10*3/uL Mean Platelet Volume 10.9 7.4 - 11 fL Neutrophil Automated 83.
Aktuelle Erkrankungen: 6/9/21 Venous stasis ulcers of both extremities; Edema of both legs, Venous stasis ulcer of right lower extremity
Vorgeschichte: Hospital Pure hypercholesterolemia COPD (chronic obstructive pulmonary disease) Chronic combined systolic and diastolic heart failure Essential hypertension, benign Acute hypoxemic respiratory failure due to COVID-19 Paroxysmal atrial fibrillation Non-Hospital Normocytic anemia Ventricular tachycardia Venous stasis ulcer of left calf Coronary artery disease of native artery of native heart with stable angina pectoris Aortic stenosis Abdominal aortic aneurysm Peripheral neuropathy Bilateral hand numbness Tobacco dependency PAD (peripheral artery disease) Dependent edema Colon polyps Midline low back pain without sciatica Lumbar degenerative disc disease Dupuytren's contracture Ischemic cardiomyopathy Venous stasis dermatitis of both lower extremities Coronary artery disease involving native coronary artery without angina pectoris Chest pain, unspecified type Nonrheumatic mitral valve regurgitation Acute respiratory failure with hypoxia
Andere Medikamente: Outpatient Medications aspirin 81 MG chewable tablet Homeopathic Products (LEG CRAMPS PAIN RELIEF) TABS ipratropium-albuterol (COMBIVENT RESPIMAT) 20-100 MCG/ACT inhalation solution isosorbide mononitrate CR (IMDUR) 30 MG 24 hr tablet
Allergien: No Known Allergies
Vorherige Impfungen: -

VAERS 1869871

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EW0183

kritisch

Staat: MN
Alter: 68,0
Geschlecht: M
Eingang: 15.11.2021
Impfdatum: 27.04.2021
Beginn: 13.11.2021
Tage bis Beginn: 200,0
Dosis: 2
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: unbekannt

Acute respiratory failure COVID-19 COVID-19 pneumonia Diarrhoea Dizziness Dyspnoea Haemoptysis

Symptomtext

Hospitalized dyspnea and dizziness, COVID pneumonia, acute hypoxic respiratory failure, hemoptysis and diarrhea,

Weitere VAERSDATA-Felder

Praegender Schweregrund: Acute respiratory failure
Hospital-Tage: 2,0
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1847147

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EW0183

kritisch

Staat: WA
Alter: 69,0
Geschlecht: F
Eingang: 05.11.2021
Impfdatum: 09.06.2021
Beginn: 03.11.2021
Tage bis Beginn: 147,0
Dosis: 2
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: unbekannt

Acute respiratory failure COVID-19 COVID-19 pneumonia Exposure to SARS-CoV-2 SARS-CoV-2 test positive

Symptomtext

Patient received Pfizer COVID vaccine on 4/30/21 and 6/9/21. On 11/3/21, patient admitted to our facility's med/surg unit for acute respiratory failure with hypoxia due to COVID19 pneumonia (COVID positive on 11/3/21, symptoms started 2 weeks prior, patient lives with sister who is also COVID positive 2 weeks ago). On 11/5/21, patient discharged home in stable condition.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Acute respiratory failure
Hospital-Tage: 2,0
Labordaten: COVID status positive 11/3/21.
Aktuelle Erkrankungen: -
Vorgeschichte: type 2 diabetes, hypertension, and hyperlipidemia
Andere Medikamente: losartan, metformin, metoprolol succinate ER, naproxen, simvastatin
Allergien: NKDA
Vorherige Impfungen: -

VAERS 1833038

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EW0183

kritisch

Staat: MI
Alter: 67,0
Geschlecht: M
Eingang: 01.11.2021
Impfdatum: 07.05.2021
Beginn: 31.10.2021
Tage bis Beginn: 177,0
Dosis: 2
Route/Site: UN / UN

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: nein

Acute respiratory failure COVID-19 COVID-19 pneumonia

Symptomtext

Acute Hypoxemic Respiratory Failure due to COVID-19; pneumonia due to COVID-19

Weitere VAERSDATA-Felder

Praegender Schweregrund: Acute respiratory failure
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1815180

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EW0183

kritisch

Staat: MI
Alter: 70,0
Geschlecht: F
Eingang: 25.10.2021
Impfdatum: 11.10.2021
Beginn: 18.10.2021
Tage bis Beginn: 7,0
Dosis: 3
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: nein

Acute respiratory failure Anticoagulant therapy Aspartate aminotransferase increased Asthenia Blood creatinine increased Blood glucose increased C-reactive protein increased COVID-19 COVID-19 pneumonia Chest X-ray abnormal Chills Depression Diarrhoea Dyspnoea Exposure to SARS-CoV-2 Fall Fibrin D dimer Glomerular filtration rate decreased

Symptomtext

Hospitalized 10/18/2021; COVID-19 positive 10/18/2021; fully vaccinated Chief Complaint: Dyspnea Reason for Admission: Pneumonia due to covid-19 Admission Date: 10/18/2021 Length of Stay: 0 day(s) History of Present Illness: Patient is a 70 y.o. female with a past medical history of Type II diabetes on basal bolus insulin c/b retinopathy, CKD4 s/p renal txp in 2010 at hospital, hypertension, presenting with shortness of breath. Today she states that she has been feeling very weak and and short of breath. Approximately 8-10 days ago ago she noticed she was becoming weak and having vomiting, difficulty keeping food down. She developed chills and shaking, as well. She has received all 3 doses of the pfizer vaccine. Today, she developed shortness of breath and was unable to further care for herself at home and thus she called EMS. No chest pain, mild intermittent diarrhea which she states is infrequent. She does report mild cough with clear mucous. Her son recently had covid and she suspects she may have contracted it from him. She did fall one month ago but is unsure if she hit her head. In the emergency department she was febrile to 39.2, HR 89, BP 145/50, hypoxic and requiring 5L NC. Labs were significant for Cr 1.72, glucose 307, AST 47, hgb 10.4. CXR showed patchy bilateral reticular airspace disease most confluent in the mid left lung zone c/w covid-19. She was given vancomycin and zosyn and subsequently admitted to the internal medicine service for further care. 10/21/2021 note: ASSESSMENT / PLAN: Principal Problem: Pneumonia due to COVID-19 virus 70 yo woman with hx of renal transplant here w/ SOB, dx w/ Covid PNA and acute hypoxic respiratory failure. Sepsis criteria not met. Covid-19 PNA Acute hypoxic respiratory failure Fever last 10/18 PM HA N/V/D Vaccinated x3 (Pfizer) but immune suppressed with renal transplant Sx start 10/8 - 10/21 weakness, vomiting, chills and rigors Covid + 10/18/21 CRP 160 -> 93 D-dimer 3160 -> 2450 Unable to give remdesivir due to renal dysfunction, GFR consistently <30 MAb not given due to O2 use but ID questioned if it could be given under compassionate use protocol; have not heard back as yet? Decadron 6 mg d x10 days; holding daily prednisone 5 while on Decadron Lovenox for DVT ppx Prone as able Goal O2 sat >92% High flow at 100% FiO2 and 60 L/min with 97 - 100% saturations; decreasing support is indicated 10/25/2021 note: ASSESSMENT / PLAN: Principal Problem: Pneumonia due to COVID-19 virus 70 yo woman with hx of renal transplant here w/ SOB, dx w/ Covid PNA and acute hypoxic respiratory failure. Sepsis criteria not met. Orthostatic hypotension, increased creatinine and subdued with dry mm, suspect Lasix effective, in use for edema, currently on hold per Nephrology; strongly agree IVFs, 1 L, given back slowly 10/22/21 but appreciate we want a "dry lung"; she improved with this Depression, acute She declines to discuss what is bothering her or that she is willing to talk with someone about it Covid-19 PNA Acute hypoxic respiratory failure Fever last 10/18 PM HA N/V/D Vaccinated x3 (Pfizer) but immune suppressed with renal transplant Sx start 10/8 - 10/21 weakness, vomiting, chills and rigors Covid + 10/18/21 CRP 160 -> 93 -> 40 D-dimer 3160 -> 2450 -> 1620 Unable to give remdesivir due to renal dysfunction, GFR consistently <30 MAb given despite O2 use under compassionate use protocol, pursued; labor appreciated Decadron 6 mg d x10 days; holding daily prednisone 5 while on Decadron Lovenox for DVT ppx Prone as able Goal O2 sat >92% High flow support decreasing, 50% FiO2 and 40 L/min with 98% saturations; decreasing support is indicated Dispo: 7-10 day stay anticipated but will be based on progress and has potential for prolonged stay. Multiple recent surgeries and now Covid infection with progressive weakness and debility demand rehab.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Acute respiratory failure
Hospital-Tage: 7,0
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: Type II or unspecified type diabetes mellitus with ophthalmic Moderate nonproliferative diabetic retinopathy(362.05) Posterior synechiae of iris Cortical senile cataract Myopia CKD (chronic kidney disease) stage 4, GFR 15-29 ml/min Atherosclerosis of renal artery Controlled type 2 diabetes mellitus with complication, with long-term current use of insulin Essential hypertension, malignant GERD (gastroesophageal reflux disease) History of kidney transplant Immunosuppression Renovascular hypertension Type 2 diabetes mellitus with both eyes affected by mild nonproliferative retinopathy without macular edema, with long-term current use of insulin Senile nuclear cataract, bilateral Epiretinal membrane (ERM) of left eye Regular astigmatism of both eyes Chronic pain of right knee Arthralgia of right hand Environmental allergies Peripheral artery disease Arthritis of right knee S/P total knee arthroplasty, right Hyperkalemia Platelets decreased AKI (acute kidney injury) Intractable nausea and vomiting Hypercalcemia
Andere Medikamente: acetaminophen (TYLENOL) 500 MG tablet ALPRAZolam (XANAX) 0.25 MG tablet aspirin 81 MG enteric coated tablet Bacillus Coagulans-Inulin (PROBIOTIC FORMULA PO) cyclobenzaprine (FLEXERIL) 5 MG tablet diphenhydrAMINE (BENADRYL) 25 MG tablet ferr
Allergien: CT dye Seasonal allergies
Vorherige Impfungen: -

VAERS 1767471

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EW0183

kritisch

Staat: CA
Alter: 50,0
Geschlecht: U
Eingang: 07.10.2021
Impfdatum: 11.06.2021
Beginn: 01.06.2021
Tage bis Beginn: -
Dosis: 2
Route/Site: OT / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: ja ER: ja Erholt: nein

Adnexa uteri pain Angioscopy Back pain Blindness Cerebrovascular accident Computerised tomogram Computerised tomogram head Dyschromatopsia Intraocular pressure increased Limb discomfort Loss of personal independence in daily activities Magnetic resonance imaging Ophthalmological examination Retinal vascular disorder Rheumatoid factor Spinal osteoarthritis X-ray limb X-ray of pelvis and hip

Symptomtext

bulges spondylosis; retinal revascularization; eye pressure: increased 24; feels like ovaries pain; loss of central L eye vision; diminished colors. loss of central L eye vision.; stroke; diminished colors. loss of central L eye vision. Couldn't drive as usual; severe back pain; leg heavyness; This is a spontaneous report from a contactable consumer (patient). A 50-year-old patient of an unspecified gender received BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE; Lot Number: EW0183), intramuscular, administered in left deltoid on 11Jun2021 10:31 (at the age of 50-years-old) as dose 2, single for COVD-19 immunization. The patient's medical history was not reported. Concomitant medications included paracetamol (TYLENOL) and ibuprofen (MOTRIN) taken for back, leg pain and limping from 25May2021 and ongoing. The patient previously received FLUARIX vaccine (Batch/Lot number: 59HN3), intramuscular, administered in right deltoid on 04Jan2021 for an unspecified indication; and BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE), intramuscular, administered in left deltoid on 21May2021 11:52 (Lot number: EW0183) as dose 1, single for COVID-19 immunization and on 21May2021 experienced left eye central vision loss treated with Avastin eye injections, back pain/hip/knee pain, blurred vision thought needed new glasses, limping right leg. On 12Jun2021, the patient felt like she had ovaries pain. In Jun2021, the patient experienced diminished colors, loss of central left eye vision, couldn't drive as usual, severe back pain, leg heaviness, and she ended up in the ER after having a stroke. The patient had CT, X-rays, MRIs and saw Neurology, Ophthalmology. The patient was referred to "Ortho Phys med- Pain" had eye injection and will need more on a monthly basis. The event ovaries pain was reported as serious due to persistent/significant disability/incapacity. The patient underwent lab tests and procedures on 28Jun2021 which included CT scan head brain lumbar: normal, there was no mass and no stroke; and hip and knees x-rays were normal. Rheumatoid lab tests in Jul2021 was normal. On 27Aug2021, fluorescent angioscopy: left sub retinal revascularization and eye pressure: increased 24, comments: normal was 10-14. On 12Sep2021, MRI spine: bulges spondylosis, sub centimeter CSF cyst, comments: face and degeneration disc bulge, foramen narrowing. The patient did not report to physician yet and was more worried about vision and on and off limping, and constant back pain, will seek this week. The patient received treatment for the vision loss with Avastin 1.25 mg eye injection, intravitreal from 27Aug2021 and ongoing. Outcome of the events was unknown. Follow-up attempts are completed. No further information is expected.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Cerebrovascular accident
Hospital-Tage: -
Labordaten: Test Date: 20210827; Test Name: Fluorescent Angioscopy; Result Unstructured Data: Test Result:Left subretinal revascularization; Test Date: 20210628; Test Name: CT scan Lumbar; Result Unstructured Data: Test Result:Normal; Comments: No mass. No stroke; Test Date: 20210628; Test Name: CT scan Head Brain; Result Unstructured Data: Test Result:Normal; Comments: No mass. No stroke; Test Date: 20210912; Test Name: MRI spine; Result Unstructured Data: Test Result:Bulges spondylosis, subcentimeter CSF cyst; Comments: Face and degeneration disc bulge. foramen narrowing.; Test Date: 20210827; Test Name: Eye pressure; Result Unstructured Data: Test Result:increased 24; Comments: my normal is 10-14; Test Date: 202107; Test Name: Rheumatoid lab tests; Result Unstructured Data: Test Result:Normal; Test Date: 20210628; Test Name: Knees X-rays; Result Unstructured Data: Test Result:Normal; Test Date: 20210628; Test Name: Hip X-rays; Result Unstructured Data: Test Result:Normal
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: TYLENOL; MOTRIN [IBUPROFEN]
Allergien: -
Vorherige Impfungen: -

VAERS 1761982

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EW0183

kritisch

Staat: MI
Alter: 61,0
Geschlecht: M
Eingang: 05.10.2021
Impfdatum: 08.09.2021
Beginn: 17.09.2021
Tage bis Beginn: 9,0
Dosis: 1
Route/Site: IM / AR

Tod: ja Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: nein

Abdominal distension Abdominal wall oedema Acidosis Acute kidney injury Ammonia increased Antibody test negative Anticoagulant therapy Blood creatinine decreased Brain injury Bronchial secretion retention Bronchoscopy abnormal Cardiac arrest Cardiac disorder Chest discomfort Chest tube insertion Cognitive disorder Computerised tomogram abdomen abnormal Computerised tomogram head normal

Symptomtext

Deceased (10.1.21); Hospitalized (9.17.21 - Acute massive, bilateral PE; cardiac arrest); Fully Vaccinated (8.18 & 9.8.21) Discharge Provider: Doctor Primary Care Physician at Discharge: Doctor Admission Date: 9/17/2021 Date of Death: 10/1/21 Time of Death: 7:10 AM Preliminary Cause of Death: Acidosis Discharge Disposition: Deceased PRESENTING PROBLEM: Cardiac arrest Shock Acute pulmonary embolism with acute cor pulmonale, unspecified pulmonary embolism type HOSPITAL COURSE: Patient is a 61-year-old male with past medical history significant for glaucoma, hypertension, hyperlipidemia who presented to the emergency department with syncope on 9/17. Had PEA cardiac arrest x4 secondary to bilateral massive PE with right heart strain. Received systemic thrombolysis 9/17. Initially in shock, likely obstcutive, and requiring pressors, though this did improve after a few days and patient came off pressors. Also initially with metabolic/lactic acidosis, likely secondary to PEA arrest hypoperfusion. Labs monitored with resolution. Post arrest echo with mildly reduced EF and dilated RV. No DVT on lower extremity Dopplers. PE possibly provoked secondary to recent COVID-19 vaccination, though hematology felt to be unprovoked. There was initially some concern for vaccine induced immune thrombotic thrombocytopenia secondary to patient's recent receipt of the COVID vaccine as well as thrombocytopenia. Pf4 antibodies and serotonin release assay sent per hematology recommendation, and patient was started on argatroban for anticoagulation. Pf4 and SRA negative with improved platelet count, so patient was transitioned to heparin infusion and remained on this throughout the course of his hospitalization. Patient also initially with DIC, received cryoprecipitate, and labs were monitored with resolution. He was not cooled given concerns for increased risk of bleeding secondary to DIC, thrombocytopenia, receipt of tPA. The patient continued to require intubation and mechanical ventilation. Initially secondary to massive PE/PEA arrest. Continued predominantly secondary poor mental status secondary to anoxic brain injury and extremely high doses of sedating medication to control seizures. The patient developed severely refractory seizures secondary to anoxic brain injury. Initial EEG demonstrated status epilepticus. He eventually required multiple antiepileptic medications as well as very deep sedation to achieve suppression. Critical Care were consulted and followed patient's course, providing recommendation. Patient was also kept continuous EEG. Patient was taken for MRI on 09/20 after he was sufficiently stabilized, notable for anoxic brain injury. CT head obtained 9/27 stable, no acute abnormalities. Ammonia level mildly elevated, not enough to explain cognitive deficit. Per neuro recommendation, LP was not felt to be necessary given the predominantly etiology of anoxic brain injury. Patient also developed primary lung findings of hemopneumothorax, bilateral lower lobe consolidations and pleural effusions. Bronchoscopy performed 9/22 with removal of large amount of thick mucus, cultures negative. Bronchoscopy again performed 9/26 with thin secretions, cultures negative. Patient covered with Zosyn. Chest tube placed 9/24 for hemothorax, with decrease in the amount of hemothorax confirmed on imaging. Chest tube remained in place throughout remainder of admission. The patient was additionally found to have bilateral renal infarctions on CT as well as AKI. Initial AKI most likely secondary to ATN in the setting of cardiac arrest. He did not require dialysis. Creatinine plateaued, then improved, though eventually did again worsen, unclear etiology. Continued to make urine, though was very challenging to fully diurese, particularly given large intake from IV drips as well as hypernatremia. Patient eventually did again develope a metabolic acidosis, likely secondary to worsened renal function. Fluid overload caused a large amount of anasarca, particularly abdominal distension/abdominal wall edema. Abdominal distension was initially thought to be secondary to obstruction, though imaging demonstrated no signs of obstruction and patient had bowel movements. Patient additionally with a normocytic anemia, predominantly secondary to hemothorax. Down trended slowly during admission. Did require transfusion with one unit with appropriate response. Further issues addressed during patient's hospitalization include hemoperitoneum and lower abdominal mesentery hemorrhage demonstrated on CT 9/17, improved on repeat imaging. Chest wall fractures additionally noted on CT 9/17, though these did not require management. The patient also had shock liver with transaminitis, though LFTs trended downward appropriately. Family was kept appraised of patient's condition and poor prognosis, particularly given severe brain injury. Caregiving assisted, and patient's family made the decision to refrain from escalating care on 9/30. Planned to withdraw care likely the following day once further family had had time to come and see the patient. Patient had a worsening acidosis as well as FiO2 requirement overnight 9/30 to 10/1. Bicarb drip was held as decision had been made for no escalation of care. Patient expired on 10/1 at 0700.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Cardiac arrest
Hospital-Tage: 15,0
Labordaten: Brief History and Medical Decision-Making: This is a 61 year old male patient with past medical hx significant for glaucoma, HTN, hyperlipemia, recently received the second dose of COVID-19 pfizer vaccine ( first dose on 8//18 and second dose on 9/8/2021) presented to ED with syncope, had PEA cardiac arrest on PEA 4 times ( s/p 7 rounds of CPR, then 2 rounds, then 1 round and then 2 rounds per nursing report) achieved ROSC, was found to have bilateral PE ( massive PE) s/p TPA started in ED ( after discussion with IR), at time of transfer to Intensive Care, he was noted to be in shock ( most likely obstructive due to PE versus cardiogenic ) requiring epinephrine, initial labs remarkable for lactic acidosis, worsening kidney function and thrombocytopenia and slight drop in hemoglobin from 11.9 to 9.2. Shock and lactic acidosis seems to be improving post TPA, echocardiogram showed moderate to severe decreased RV function. Given the drop in platelets and recent receipt of vaccine, there is concern for vaccine induced immune thrombotic thrombocytopenia (VITT), we will obtain PF-4 Abs and serotonin release assay, we also consult hematology and use argatroban until results of PF-4 Abs is back. We will follow serial Hemoglobin to make sure no bleeding post TPA and post CPR. In addition to PE, he he was noted to have renal infarctions on CT abdomen for which we are using AC. EKG showed ST segment depressions in lateral and inferior leads and cardiac enzymes are elevated, we will consult cardiology for that (concern for ACS) and follow serial cardiac enzymes. Acute kidney injury is most likely due to ATN in the setting of cardiac arrest, no immediate indications for dialysis. We will continue to follow serial electrolytes and assess need for dialysis. We will not cool the patient given the increased risk of bleeding with thrombocytopenia and being on TPA.
Aktuelle Erkrankungen: NA
Vorgeschichte: glaucoma, HTN, hyperlipemia
Andere Medikamente: brimonidine (ALPHAGAN) 0.2 % ophthalmic solution gabapentin (NEURONTIN) 300 MG capsule hydroCHLOROthiazide (MICROZIDE) 12.5 MG capsule latanoprost (XALATAN) 0.005 % ophthalmic solution timolol (TIMOPTIC) 0.5 % ophthalmic solution
Allergien: NKDA
Vorherige Impfungen: -

VAERS 1759252

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EW0183

kritisch

Staat: CA
Alter: 68,0
Geschlecht: F
Eingang: 04.10.2021
Impfdatum: 13.05.2021
Beginn: 23.09.2021
Tage bis Beginn: 133,0
Dosis: 2
Route/Site: IM / LA

Tod: ja Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Abdominal pain upper Acute respiratory failure Adrenal mass Agitation Anxiety Biopsy Biopsy adrenal gland abnormal C-reactive protein increased COVID-19 COVID-19 pneumonia Chest pain Computerised tomogram head abnormal Computerised tomogram thorax Computerised tomogram thorax abnormal Condition aggravated Decreased appetite Dementia Dysphonia

Symptomtext

66 yo female with PMH of HTN, HLD, DM2, CKD (baseline creatinine 1.0-1.2), dementia (AOx 2-3), recently diagnosed metastatic lung adenocarcinoma (not yet formally seen by onc), hx of smoking (0.5pd x 30 years, quit 2013), COVID+ on 9/21/21 who presents 9/23/2021 with shortness of breath. Transferred to ICU on 9/25 for AHRF with likely in the setting of worsening COVID PNA and anxiety. From July-Sept, patient reported increasing fatigue, weight loss, and SOB. Patient was diagnosed with metastatic lung adenocarcinoma, following confirmatory biopsy on 9/17. Furthermore, patient tested positive for COVID on 9/21. Patient is vaccinated with pfizer (4/22/21 and 5/13/21). She was admitted on 9/23 with CRP of 13.2. While on the wards, patient was on 2-6 LPM O2. On 9/25, patient with desaturations and a rapid was called. Patient found to have accessory breathing and continual self-removement of HFNC/ NRB from anxiety. She was admitted to the ICU for escalation of O2 therapy in the setting of respiratory failure and precedex drip for agitation. CRP increased from to 25.9 (9/25). Empiric PE treatment with lovenox was started but CT PA was negative for PE. Despite treatment with remdesivir, decadron, and tocilizumab, patient's condition worsened and eventually required maximum settings on HFNC, NRB, and iNO. Per palliative meeting on 9/28, family would like patient to be intubated if necessary if no family member can be by her side. Their main goal is to get the patient home and they are open to home hospice if the patient can be transported home while alive. Patient is scheduled to be transported via ambulance with HFNC and NRB on 9/30. Grandson, who is vaccinated, is approved to be present throughout the transition from hospital to home hospice.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Acute respiratory failure
Hospital-Tage: -
Labordaten: /292021: Pt presented to PCP for complaint of hoarseness x2 weeks without odynophagia or dysphagia. Started on protonix. 8/3/21: Pt complaining of worsening hoarseness, stomach pain, and loss of appetite. Referral sent to ENT. 8/15/21: Pt presented to the ED for epigastric pain and shortness of breath. Also complaining of poor appetite and weight loss. CTA chest done showing 8cm left suprahilar mass with adjacent GGO and architectural distortion concerning for malignancy, enlarged medistinal lymph nodes, hypoattenuating area within the spleen which may represent malignancy. E-con sent to onc and recommended referral to pulm for bronch. 8/23/21: Pt had PET scan showing dominant hypermetabolic left perihilar/upper lobe lung mass (encasing left upper lobe bronchus, endoluminal component not excluded), extensive hypermetabolic left hilar, bilateral mediastinal, and upper abdominal/retreopertioneal lymphadenopathy, large hypermetabolic splenic mass, hypermetabolic bilateral adrenal masses. 8/25/21: Pt seen by ENT. Found to have true vocal cords without lesion but immobile L vocal fold with bowing and mild arytenoid prolapse noted, R VF mobile, compensatory supraglottic squeeze on phonation via endopscopy. 8/30/21: Seen by thoracic. Pt still complaining of shortness of breath. Referred to IR (for adrenal biopsy) and pulm (for consideration of bronch/EBUS). 8/31/21: Seen by pulm. Additional history reveals that pt with increasing left sided pleuritic chest pain x2 months, only able to walk several hundred feet before having to stop and catch her breath. Pt expressed that she did not want any treatment of biopsies at that time and expresed importance of quality of life vs quantity of life. Per daughter, pt's dementia seems to be worsening. Considered brain mets but pt claustrophobic so CT head ordered instead of MRI brain. 9/1/21: CT head suspicious for mets to right parietal lobe. Pulm contacted pt with results. Family agreeable for biopsy. 9/7: Given CT findings, prescribed decadron by pulm 9/17/21: Pt underwent IR guided biopsy of R adrenal mass. 9/21: Path results came back as metastatic adenocarcinoma consistent with lung. Pt also had COVID test which came back POSITIVE. Pt vaccine with Pfizer 4/22/21 and 5/13/21
Aktuelle Erkrankungen: Alzheimers, Diabetes
Vorgeschichte: 7/292021: Pt presented to PCP for complaint of hoarseness x2 weeks without odynophagia or dysphagia. Started on protonix. 8/3/21: Pt complaining of worsening hoarseness, stomach pain, and loss of appetite. Referral sent to ENT. 8/15/21: Pt presented to the ED for epigastric pain and shortness of breath. Also complaining of poor appetite and weight loss. CTA chest done showing 8cm left suprahilar mass with adjacent GGO and architectural distortion concerning for malignancy, enlarged medistinal lymph nodes, hypoattenuating area within the spleen which may represent malignancy. E-con sent to onc and recommended referral to pulm for bronch. 8/23/21: Pt had PET scan showing dominant hypermetabolic left perihilar/upper lobe lung mass (encasing left upper lobe bronchus, endoluminal component not excluded), extensive hypermetabolic left hilar, bilateral mediastinal, and upper abdominal/retreopertioneal lymphadenopathy, large hypermetabolic splenic mass, hypermetabolic bilateral adrenal masses. 8/25/21: Pt seen by ENT. Found to have true vocal cords without lesion but immobile L vocal fold with bowing and mild arytenoid prolapse noted, R VF mobile, compensatory supraglottic squeeze on phonation via endopscopy. 8/30/21: Seen by thoracic. Pt still complaining of shortness of breath. Referred (for adrenal biopsy) and pulm (for consideration of bronch/EBUS). 8/31/21: Seen by pulm. Additional history reveals that pt with increasing left sided pleuritic chest pain x2 months, only able to walk several hundred feet before having to stop and catch her breath. Pt expressed that she did not want any treatment of biopsies at that time and expresed importance of quality of life vs quantity of life. Per daughter, pt's dementia seems to be worsening. Considered brain mets but pt claustrophobic so CT head ordered instead of MRI brain. 9/1/21: CT head suspicious for mets to right parietal lobe. Pulm contacted pt with results. Family agreeable for biopsy. 9/7: Given CT findings, prescribed decadron by pulm 9/17/21: Pt underwent IR guided biopsy of R adrenal mass. 9/21: Path results came back as metastatic adenocarcinoma consistent with lung. Pt also had COVID test which came back POSITIVE. Pt vaccine with Pfizer 4/22/21 and 5/13/21.
Andere Medikamente: Atorvastatin (LIPITOR) 10 mg Oral Tab Sig: Take 1 tablet by mouth daily for cholesterol CYANOCOBALAMIN, VITAMIN B-12, (VITAMIN B-12 ORAL) Sig: None Entered Note (6/28/2016): LAST DOSE TAKEN @ 6/27/16 0700 ERGOCALCIFEROL, VITAMIN D2, (V
Allergien: nka
Vorherige Impfungen: -

VAERS 1723566

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EW0183

kritisch

Staat: -
Alter: 69,0
Geschlecht: M
Eingang: 22.09.2021
Impfdatum: 13.07.2021
Beginn: 10.08.2021
Tage bis Beginn: 28,0
Dosis: UNK
Route/Site: - / -

Tod: ja Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: unbekannt

Acute kidney injury Acute respiratory failure Cerebrovascular accident Death Thrombocytopenia

Symptomtext

death AKI (acute kidney injury) Cerebrovascular accident (CVA), unspecified mechanism Acute respiratory failure with hypoxia Acute kidney failure, unspecified Thrombocytopenia, unspecified

Weitere VAERSDATA-Felder

Praegender Schweregrund: Acute respiratory failure
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1718920

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EW0183

kritisch

Staat: MI
Alter: 38,0
Geschlecht: F
Eingang: 21.09.2021
Impfdatum: 26.04.2021
Beginn: 27.04.2021
Tage bis Beginn: 1,0
Dosis: 2
Route/Site: SYR / RA

Tod: unbekannt Lebensbedrohlich: ja Hospital: ja Disable: unbekannt ER: ja Erholt: nein

Blood test Chest X-ray Computerised tomogram thorax Fibrin D dimer increased Painful respiration Pulmonary embolism Pulmonary infarction Pulmonary pain Ultrasound Doppler

Symptomtext

The next day I started having pain in my right lung. On Wednesday 4/27/2021 I started having pain with breathing, and severe pain in my lung. I went to see my PCP. I was told it was just my fibromyalgia, and to take my medicine. On Thursday 4/29/2021 I was in so much pain, I went to the ER. I had a pulmonary embolism and infarction.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Pulmonary embolism
Hospital-Tage: 3,0
Labordaten: Blood Tests 4/29 D- Dimer 6243.00 Chest X-ray 4/29 and 5/1 CTA -Chest 4/30 US Doppler LE Veins 5/1
Aktuelle Erkrankungen: no
Vorgeschichte: Fibromyalgia
Andere Medikamente: Wellbutrin 150 mg, Gabapentin 100mg, pepcid, trazodone 50mg
Allergien: no
Vorherige Impfungen: -

VAERS 1692203

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EW0183

kritisch

Staat: NC
Alter: -
Geschlecht: F
Eingang: 11.09.2021
Impfdatum: -
Beginn: 27.08.2021
Tage bis Beginn: -
Dosis: UNK
Route/Site: - / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein

Cough Headache Hypersensitivity Nausea Near death experience Pruritus Rhinorrhoea Throat irritation Throat tightness

Symptomtext

nearly died yesterday; itching all over my body especially in my throat, around my throat; itching all over my body especially in my throat, around my throat; Coughing; Runny nose; Headache; Nausea; throat closed up; Allergic reaction; This is a spontaneous report from a contactable consumer. A 41-years-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for Injection, Batch/Lot number: EW0183) via an unspecified route of administration, administered in Arm Left on 2021 as Dose Number Unknown, Single for covid-19 immunisation; hydrochlorothiazid (HYDROCHLOROTHIAZID), route of administration, start and stop date, batch/lot number and dose were not reported for blood pressure abnormal. Medical history included blood pressure abnormal and stress. The patient's concomitant medication included vitamin. It was reported that, patient had a reaction to the vaccine on an unspecified date. It was reported that patient had to go to the urgent care yesterday and also spoke with his doctor patient had throat closed up and had itching all over body especially in the throat and around the throat. There was some coughing, runny nose, headache, nausea that was the most severe reaction patient had. The patient received treatment of Steroids Benadryl. Steroids and Benadryl were given by IM. Reporter further stated, that he nearly died yesterday (27Aug2021). Therapeutic measures were taken as a result of events. The outcome of the events was unknown. Follow-up attempts are completed. No further information is expected.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Near death experience
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: Medical History/Concurrent Conditions: Blood pressure abnormal (Verbatim: Blood pressure); Stress (Verbatim: Stress)
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1689598

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EW0183

kritisch

Staat: MN
Alter: 80,0
Geschlecht: M
Eingang: 10.09.2021
Impfdatum: 24.05.2021
Beginn: 03.09.2021
Tage bis Beginn: 102,0
Dosis: 2
Route/Site: - / -

Tod: ja Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Death

Symptomtext

Patient passed away on 09/03/2021

Weitere VAERSDATA-Felder

Praegender Schweregrund: Death
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: Depakote Sprinkles, tylenol, aspirin, namenda, neurontin, risperdal, lipitor, trandate, eliquis, albuterol, milk of mag.
Allergien: lisinopril
Vorherige Impfungen: -

VAERS 1326264

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EW0183

kritisch

Staat: MN
Alter: 48,0
Geschlecht: F
Eingang: 04.09.2021
Impfdatum: 05.05.2021
Beginn: -
Tage bis Beginn: -
Dosis: 2
Route/Site: - / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: nein

Angiocardiogram Chest pain Coronary artery thrombosis Dyspnoea Fatigue Angiogram Blood cholesterol Computerised tomogram Myocardial infarction Thrombosis Headache

Symptomtext

It give me a massive blood clot in my right coronary artery in my heart that leads to a massive heart attack; I developed blood clot in my heart; It give me a massive blood clot in my right coronary artery in my heart that leads to a massive heart attack; I developed blood clot in my heart; I was poor in cholesterol; This is a spontaneous report from a contactable Other HCP. A 48-years-old female patient received second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Batch/Lot Number: EW0183), via an unspecified route of administration, administered in Arm Right on 05May2021 as a single dose for COVID-19 immunization (at the age of 48-years-old). The patient medical history was not reported. The patient's concomitant medications were not reported. The patient historical vaccine included first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Batch/Lot Number: EW0169), via an unspecified route of administration, administered in Arm Right on 14Apr2021 as a single dose for COVID-19 immunization (at the age of 48-years-old). On an unspecified date, consumer stated that, "It give me a massive blood clot in my right coronary artery in my heart that leads to a massive heart attack and I have 3 strands now in my heart, I have lipocide 'not clear' and none of my labs were done for my heart attack, like I was poor in cholesterol and crap you know and when they did the CT and Angio whatever test they did, they did the dial of the heart and not prompt. I have a perfectly healthy heart and none of my laboratories made sense they lead to throwing or having a heart attack and when they went in to place the strands it was all blood clotted in there so it wasn't like attack. So I developed blood clot in my heart." Consumer stated, "I was really admit to the hospital for 5 days and I got 3 strands in my heart, now like treatment and now I am on medicine for the rest of my life because of this." The patient underwent lab tests and procedures which included angiogram: unknown result, blood cholesterol: poor (I was poor in cholesterol), and computerised tomogram: unknown result on an unspecified date. Therapeutic measures were taken as a result of it give me a massive blood clot in my right coronary artery in my heart that leads to a massive heart attack; i developed blood clot in my heart (myocardial infarction), it give me a massive blood clot in my right coronary artery in my heart that leads to a massive heart attack; i developed blood clot in my heart (thrombosis). The outcome of all the events was unknown.; Sender's Comments: Based on temporal relationship there is reasonable possibility of causal association between the reported events myocardial infarction, poor cholesterol, thrombosis and the suspect drug BNT162B2. The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to regulatory authorities, Ethics Committees, and Investigators, as appropriate.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Myocardial infarction
Hospital-Tage: 5,0
Labordaten: Test Name: Angio; Result Unstructured Data: Test Result:Unknown result; Test Name: cholesterol; Result Unstructured Data: Test Result:Poor; Comments: I was poor in cholesterol; Test Name: CT; Result Unstructured Data: Test Result:Unknown result
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1628746

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EW0183

kritisch

Staat: MN
Alter: 81,0
Geschlecht: F
Eingang: 24.08.2021
Impfdatum: 12.05.2021
Beginn: 17.06.2021
Tage bis Beginn: 36,0
Dosis: 2
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: unbekannt

Cerebrovascular accident

Symptomtext

Patient presented to the ED and subsequently hospitalized for CVA within 6 weeks of receiving COVID vaccination.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Cerebrovascular accident
Hospital-Tage: 2,0
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1592989

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EW0183

kritisch

Staat: WA
Alter: 71,0
Geschlecht: F
Eingang: 20.08.2021
Impfdatum: 19.06.2021
Beginn: 18.08.2021
Tage bis Beginn: 60,0
Dosis: 2
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: nein

Acute respiratory failure COVID-19 COVID-19 pneumonia Condition aggravated Malignant pleural effusion SARS-CoV-2 test positive

Symptomtext

Patient received Pfizer COVID vaccine on 5/29/21 and 6/19/21. On 8/18/21, patient admitted to our facility with acute hypoxemic respiratory failure due to recurrent malignant pleural effusion on the right and COVID pneumonia. As of 8/21/21, patient is still admitted in the med/surg unit.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Acute respiratory failure
Hospital-Tage: 2,0
Labordaten: COVID status positive on 8/18/21.
Aktuelle Erkrankungen: -
Vorgeschichte: History of prior SAH and left internal carotid aneurysm rupture s/p coiling complicated by hydrocephalus requiring VP shunt and seizure disorder (2011) and chronic left abdominal mass (biopsy on 2013 suggestive of angiomyolipoma), recent diagnosed of malignant pleural effusion.
Andere Medikamente: Albuterol inh PRN, vitamin D, gabapentin, levetiracetam, melatonin PRN, MVI, Percocet PRN, quetiapine PRN
Allergien: NKDA
Vorherige Impfungen: -

VAERS 1433509

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EW0183

kritisch

Staat: IN
Alter: 69,0
Geschlecht: M
Eingang: 29.06.2021
Impfdatum: 03.06.2021
Beginn: 06.06.2021
Tage bis Beginn: 3,0
Dosis: 2
Route/Site: IM / AR

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: ja

Cerebrovascular accident Computerised tomogram abnormal Computerised tomogram head Hemianaesthesia Hemiparesis

Symptomtext

Note: following first vaccine patient had complaints on insomnia, and confusion for 1 and 1/2 days following the vaccination. Patient call today 6/29 to inform clinic that he had has a stroke three days following the 2nd dose of the Pfizer vaccine. Patient received vaccine 6/3 and on 6/6 patient noted numbness and weakness in right side and went to hospital, Patient was diagnosed as having a stroke. Patient was admitted to a hospital. Currently patient feeling better with some small limitations.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Cerebrovascular accident
Hospital-Tage: 2,0
Labordaten: CT scan
Aktuelle Erkrankungen: None
Vorgeschichte: CABG x3 (2000), CAD, CHF, DM, GERD, Depression
Andere Medikamente: Carvedilol, Entresto, Furosemide, Spironolactone, Simvastatin, Vascepa, Folic Acid, Lexapro, Aspirin, Plavix
Allergien: None
Vorherige Impfungen: -

VAERS 1413050

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EW 0183

kritisch

Staat: UT
Alter: 58,0
Geschlecht: F
Eingang: 19.06.2021
Impfdatum: 11.06.2021
Beginn: 17.06.2021
Tage bis Beginn: 6,0
Dosis: UNK
Route/Site: IM / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: nein

Pulmonary embolism

Symptomtext

PE

Weitere VAERSDATA-Felder

Praegender Schweregrund: Pulmonary embolism
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: Anxiety Bilateral hip pain Bilateral knee pain Cataract Chondromalacia of both patellae Depression History of pneumonia Hyperlipidemia Hypothyroidism Osteoarthritis Osteoarthritis of carpometacarpal (CMC) joint of left thumb Osteoarthritis of patellofemoral joints, bilateral Osteoporosis screening Post-menopause Thyroid disease
Andere Medikamente: Armour Thyroid 60 mg oral tablet, 60 mg= 1 tabs, Oral, Daily aspirin 81 mg oral delayed release tablet, 81 mg= 1 tabs, Oral, BID ibuprofen 800 mg oral tablet, 800 mg= 1 tabs, Oral, TID, PRN oxyCODONE, 5 mg, Oral, every 4 hr, PRN
Allergien: No Know Allergies
Vorherige Impfungen: -

VAERS 1401471

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EW0183

kritisch

Staat: CA
Alter: 40,0
Geschlecht: F
Eingang: 16.06.2021
Impfdatum: 06.05.2021
Beginn: 20.05.2021
Tage bis Beginn: 14,0
Dosis: 2
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: ja

Antiphospholipid antibodies negative Blood thyroid stimulating hormone normal Cardiolipin antibody Cytomegalovirus test negative Cytomegalovirus test positive Exposure during pregnancy Foetal death Gestational diabetes Glycosylated haemoglobin normal Kleihauer-Betke test negative Labour induction Parvovirus B19 test Pregnancy Pregnancy with advanced maternal age Prenatal screening test Russell's viper venom time SARS-CoV-2 test negative Stillbirth

Symptomtext

40yo G7P3215 pregnant with EDD 7/28/21. Patient had h/o preterm delivery x2 and was receiving Makena (hydroxyprogesterone caproate) weekly IM injections, last dose 5/13/21. Pregnancy was complicated by AMA, had low risk NIPT, 2nd tri state screen, and normal level 2 anatomy ultrasound. She was diagnosed with GDM A1 5/14/21. Patient seen 4/29/21 at 27w with normal pregnancy. Next visit 5/20/21 was diagnosed with IUFD as no heart tones noted. She was not clear on last time fetal movement felt, but thought that demise occurred in the week prior to visit. Received Pfizer COVID vaccinations 4/8/21 and 5/6/21. She had induction of labor and delivered stillborn infant on 5/21/21 with birth weight 1305g. Gross examination was unremarkable as was work up - will include below in item 19.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Foetal death
Hospital-Tage: 2,0
Labordaten: Lab work up for IUFD 5/21/21: anticardiolipin IgG < 14, dRVVT screen 38, lupus anticoag screen neg, A1c 5.5, TSH 2.20 Kleihauer betke negative CMV IgG positive, IgM negative Parvovirus B19 IgG positive, IgM negative Toxoplasma IgG positive, IgM negative COVID RT PCR negative Urine tox negative Placental path: Specimen is received in formalin labeled with patient name and medical record Number, placenta. Specimen consists of a 404 g single disc placenta measuring 18 by 14 x 3.5 cm. Three-vessel umbilical cord inserts into placenta eccentrically(fragmented) measuring 42 long and 1.4 cm in diameter. Fetal membranes attach to placenta along the edge and are thin and transparent. Fetal surface shows normal vascular distribution. Maternal surface shows intact cotyledons. Sectioning of placenta shows red-purple spongy parenchyma. No hematoma identified. Representative sections submitted in 3 blocks. PATHOLOGIC DIAGNOSIS: PLACENTA, REMOVAL: - THIRD TRIMESTER PLACENTA WITH EDEMA(404G). - THREE-VESSELED UMBILICAL CORD. - FOCAL ACUTE CHORIONITIS.
Aktuelle Erkrankungen: Pregnancy
Vorgeschichte: none known
Andere Medikamente: Prenatal vitamins, miralax, loratadine, anusol rectal cream, flonase, hydroxyprogesterone caproate weekly IM injections
Allergien: none
Vorherige Impfungen: -

VAERS 1347101

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EW0183

kritisch

Staat: CO
Alter: 35,0
Geschlecht: F
Eingang: 26.05.2021
Impfdatum: 13.05.2021
Beginn: 16.05.2021
Tage bis Beginn: 3,0
Dosis: 2
Route/Site: - / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein

Blood test Chest pain Computerised tomogram Dyspnoea Electrocardiogram Blood thyroid stimulating hormone normal Chest X-ray normal Chills Computerised tomogram abnormal Electrocardiogram normal Fibrin D dimer Full blood count normal Hypoaesthesia Pulmonary embolism Limb discomfort Throat tightness

Symptomtext

Pfizer-BioNTech COVID-19 Vaccine EUA: patient presents to emergency department (ED) nauseated with intermittent chest pain and shortness of breath starting three days after vaccination. Initially experienced arms discomfort, throat tightness, chills, and numbness in face and chest that resolved. Seen at another ED three days after vaccination for chest pain and discharged. Followed-up by primary care the next day where vitals were stable and exam was not concerning. In current ED patient's vital signs within normal ranges and physical exam unremarkable. Patient diagnosed with pulmonary embolism, prescribed anticoagulants, and on follow-up with primary care provider patient reports no new symptoms and vital signs with within normal ranges.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Pulmonary embolism
Hospital-Tage: -
Labordaten: At outside ED: d-dimer 523, TSH within normal range, ECG normal At current ED: ECG: sinus rhythm HS troponin, electrolytes: within normal range CBC within normal range including platelets D-dimer: 720 FEU Chest x-ray: no acute radiographic abnormality in the chest CT PE: left lower lobe pulmonary arterial embolism
Aktuelle Erkrankungen: none reported
Vorgeschichte: anemia of pregnancy, COVID-19 infection, hypothyroidism, kidney stone
Andere Medikamente: levothyroxine
Allergien: None reported
Vorherige Impfungen: -

VAERS 2577924

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EW0183

schwer

Staat: VA
Alter: 34,0
Geschlecht: M
Eingang: 08.02.2023
Impfdatum: 30.08.2021
Beginn: 28.11.2022
Tage bis Beginn: 455,0
Dosis: 1
Route/Site: SYR / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: nein

Blood test abnormal Chest discomfort Chest pain Electrocardiogram ambulatory Electrocardiogram normal Myopericarditis Sensory disturbance Troponin increased

Symptomtext

On 28 November 2023 at 3:00 AM I was experiencing chest pain, sensation of chest sucking into spine and chest tightness. I arrived at the ER at 3:40

Weitere VAERSDATA-Felder

Praegender Schweregrund: Myopericarditis
Hospital-Tage: 2,0
Labordaten: I went to the ER and was given an EKG, the results were normal, they began my blood work and the ER saw my Troponin levels were elevated to 210. On 28 November 2022, I was admitted to Medical Center. I was attached to an EKG for continual monitoring and blood work was drawn every three hours. I was diagnosed with Myopericarditis.
Aktuelle Erkrankungen: None
Vorgeschichte: None
Andere Medikamente: Adderall XR 10mg Valcyclovir 500mg as needed
Allergien: Amoxicillin Penicillin Latex
Vorherige Impfungen: -

VAERS 2531201

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EW0183

schwer

Staat: MI
Alter: 84,0
Geschlecht: M
Eingang: 14.12.2022
Impfdatum: 05.03.2021
Beginn: 02.11.2022
Tage bis Beginn: 607,0
Dosis: 3
Route/Site: - / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: unbekannt

COVID-19 Mental status changes SARS-CoV-2 test positive Syncope

Symptomtext

11/02/22 presents with "altered mental status" "syncopal episode". PMHx of "PAF on warfarin, cardiomyopathy, DMII, CAD, PVD, asthma, colon cancer, and BPH".

Weitere VAERSDATA-Felder

Praegender Schweregrund: Syncope
Hospital-Tage: -
Labordaten: 11/02/22 SARS-CoV-2 (COVID-19) detected
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2528580

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EW0183

schwer

Staat: NC
Alter: 30,0
Geschlecht: F
Eingang: 11.12.2022
Impfdatum: 08.09.2021
Beginn: 01.10.2021
Tage bis Beginn: 23,0
Dosis: 1
Route/Site: SYR / AR

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Allergy test positive Anaphylactic reaction Seasonal allergy

Symptomtext

Develop allergies to grass. Went into anaphylaxis for the first time, twice in less than 24hours in march 2022.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Anaphylactic reaction
Hospital-Tage: -
Labordaten: Allergy test
Aktuelle Erkrankungen: None
Vorgeschichte: None
Andere Medikamente: None
Allergien: None
Vorherige Impfungen: -

VAERS 2452244

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EW0183

schwer

Staat: MI
Alter: 17,0
Geschlecht: M
Eingang: 20.09.2022
Impfdatum: 19.08.2021
Beginn: 09.09.2022
Tage bis Beginn: 386,0
Dosis: 3
Route/Site: - / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: ja

COVID-19 Condition aggravated Enterovirus infection Pyrexia Rhinovirus infection Seizure Tachypnoea

Symptomtext

Discharge Provider: Dr. Primary Care Physician at Discharge: MD Admission Date: 9/9/2022 Discharge Date: 9/10/2022 Seizure disorder (HCC) [G40.909] COVID-19 [U07.1] HOSPITAL COURSE: The patient is a 18 y.o. male with PMH glutaric aciduria type 1 and focal epilepsy who is admitted for breakthrough seizure in the setting of covid and rhino/enterovirus infection. Patient was brought to ED with a left sided seizure. He was found to be febrile and tachypnic upon arrival. He was placed on a valium 10 mg TID bridge while awaiting approval for Onfi per neurology recommendations. Pediatric metabolism was also consulted and did not have any further recommendations about the patients glutaric aciduria. He continued to improve while inpatient. Patient was discharged to home in stable condition on 9/10/2022.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Seizure
Hospital-Tage: 1,0
Labordaten: -
Aktuelle Erkrankungen: None
Vorgeschichte: Glutaric aciduria, type 1 (HCC) Global developmental delay Ptyalism Episodic Dystonia Neuromuscular scoliosis of thoracolumbar region Chronic constipation Feeding by G-tube (HCC) Feeding intolerance History of urinary retention Focal epilepsy with impairment of consciousness, intractable (HCC) Acquired coxa vara of left hip Spastic hip dislocation, unspecified laterality Coxa vara of left hip Metabolic and nutritional disorder History of deep venous thrombosis Dental caries Spastic quadriparesis (HCC) Fluency disorder associated with underlying disease Anemia due to blood loss Dysphagia Epilepsy with partial complex seizures (HCC) Lack of expected normal physiological development Muscle spasticity Myoclonus Visual disturbance Acute thrombosis of internal jugular vein (HCC) Feeding by G-tube (HCC) Seizure disorder (HCC) Seizures (HCC) Quadriplegic cerebral palsy (HCC) Loss of weight COVID-19 Seborrheic dermatitis
Andere Medikamente: adapalene (DIFFERIN) 0.1 % cream Amino Acids (GLUTARADE ESSENTIAL GA-1) POWD baclofen (LIORESAL) 10 MG tablet baclofen intrathecal (PATIENT SUPPLIED) pump cetirizine (ZYRTEC) 1 MG/ML oral solution cloBAZam (ONFI) 2.5 MG/ML SUSP suspension c
Allergien: AlcoholHives AmoxicillinRash Chlorhexidine LatexAnaphylaxis, Hives Magnesium HydroxideNausea and Vomiting MetoclopramideHives Milk Of Magnesia-Nausea and Vomiting Morphine PenicillinsRash, Nausea and Vomiting Reglan [Metoclopramide Hcl] Seasonal
Vorherige Impfungen: -

VAERS 2433454

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EW0183

schwer

Staat: MI
Alter: 67,0
Geschlecht: M
Eingang: 08.09.2022
Impfdatum: 01.04.2021
Beginn: 18.08.2022
Tage bis Beginn: 504,0
Dosis: 2
Route/Site: - / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: ja

Abdominal pain COVID-19 Laboratory test normal SARS-CoV-2 test positive Seizure Syncope

Symptomtext

69y.o. male who presents after syncopal episode. Patient was recently in another country when he had an episode of syncope. Per family, he was hospitalized overseas and workup was unremarkable. Family brought him to the hospital yesterday for further evaluation. While in the ED waiting area, patient complained of sudden abdominal pain and immediately after had a witnessed seizure. No falls, trauma or injury. He does not have history of seizures. Patient deemed medically stable for discharge by physician. Patient discharged to home with outpatient follow-up

Weitere VAERSDATA-Felder

Praegender Schweregrund: Seizure
Hospital-Tage: 4,0
Labordaten: 8/18 SARS-CoV-2 (COVID-19) by Nucleic Acid Amplification, POC --detected
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2398096

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EW0183

schwer

Staat: MI
Alter: 58,0
Geschlecht: M
Eingang: 01.08.2022
Impfdatum: 21.10.2021
Beginn: 22.07.2022
Tage bis Beginn: 274,0
Dosis: 3
Route/Site: - / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: ja

Abdominal discomfort Abdominal pain Anticoagulant therapy Blood bilirubin increased COVID-19 Chronic kidney disease Computerised tomogram abdomen normal Dehydration Diarrhoea Hepatic steatosis Hypokalaemia Malaise Nausea Occult blood positive Orthostatic hypotension SARS-CoV-2 test positive Syncope Ultrasound abdomen abnormal

Symptomtext

Discharge Provider: MD Primary Care Provider: MD Admission Date: 7/22/2022 Discharge Date: Jul 26, 2022 PRESENTING PROBLEM: Syncope and collapse [R55] Hypokalemia [E87.6] Total bilirubin, elevated [R17] Stage 3 chronic kidney disease, unspecified whether stage 3a or 3b CKD [N18.30] COVID-19 [U07.1] HOSPITAL COURSE: 59-year-old man with a past medical history significant for atrial fibrillation on Eliquis, Hawkins status post ICD placement, AAA status post repair, type 2 diabetes, hypertension who presented to the emergency department chief concern of worsening abdominal pain along with nausea and vomiting. In the emergency department patient was positive for COVID. His GI symptoms were thought to be secondary to COVID infection. Patient also experienced a syncopal episode prior to his presentation which is most likely secondary to orthostatic hypotension and dehydration in the setting of GI losses. Cardiology was consulted to interrogate patient's ICD, which showed no significant abnormalities. At the time of admission CT abdomen was done which did not show acute abnormalities. However due to concern for AAA and repair history vascular surgery was consulted in the emergency department who reviewed the images of the CT abdomen and were concerned for infrarenal thrombus although this is not seen in the official CT abdomen read. Patient was started on IV heparin drip and Eliquis was placed on hold in case of procedure. CT abdomen pelvis repeated on 07/25 improved vascular surgery no intervention planned okay to transition back to Eliquis. Patient did well with COVID symptoms having no respiratory symptoms and improved diarrhea by the day of discharge. Patient was able to maintain hydration with po. In the emergency department patient was also found to have guaiac-positive stool test. GI was consulted and plan is to pursue outpatient colonoscopy and EGD. Plan is to continue Protonix 40 mg 2 times a day. Right upper quadrant ultrasound was consistent with hepatic steatosis. Patient was monitored for alcohol withdrawal and remained symptom-free. Patient with noted elevated bilirubin transaminases during hospital course that were improving by discharge. Discussion was had patient regarding need to have complete alcohol cessation. Recommend repeat CMP to follow within 1 week.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Syncope
Hospital-Tage: 4,0
Labordaten: -
Aktuelle Erkrankungen: None
Vorgeschichte: Aortic dissection Hyperlipidemia Hypertension Nonspecific abnormal electrocardiogram (ECG) (EKG) Status post aortic valve replacement Alcohol abuse Stage I (pT1, N0, M0) cecal cancer, S/p Hemicolectomy Acute gastroenteritis Hypovolemia AKI (acute kidney injury) Hypokalemia OSA (obstructive sleep apnea), mild to moderate Tobacco abuse Hypertrophic cardiomyopathy Genetic testing for HCM, inherited aortopathy, inherited cardiac arrhythmia (DO NOT EDIT) Prostate cancer Abdominal aortic aneurysm (AAA) Acute cystitis without hematuria Diet-controlled diabetes mellitus Stage 2 chronic kidney disease Vitamin D deficiency Permanent atrial fibrillation Senile nuclear cataract, bilateral Dry eyes, bilateral Presbyopia of both eyes Acute pharyngitis ICD (implantable cardioverter-defibrillator) in place Chronic kidney disease, stage 3a Syncope and collapse
Andere Medikamente: albuterol HFA (PROVENTIL HFA, VENTOLIN HFA, PROAIR HFA) 108 (90 Base) MCG/ACT inhaler apixaban (ELIQUIS) 5 MG tablet atorvastatin (LIPITOR) 80 MG tablet fluticasone (FLONASE) 50 MCG/ACT nasal spray folic acid (FOLVITE) 400 MCG tablet K
Allergien: CodeineShortness of Breath, Nausea and Vomiting, Unknown PenicillinsHives Sulfa DrugsUnknown
Vorherige Impfungen: -

VAERS 2305015

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EW0183

schwer

Staat: MI
Alter: 65,0
Geschlecht: M
Eingang: 01.06.2022
Impfdatum: 17.10.2021
Beginn: 22.05.2022
Tage bis Beginn: 217,0
Dosis: 3
Route/Site: - / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: ja

Atrial fibrillation Brain natriuretic peptide increased COVID-19 COVID-19 pneumonia Cardioversion Chest X-ray abnormal Condition aggravated Dyspnoea Echocardiogram abnormal Ejection fraction abnormal Fatigue Heart rate decreased Polyuria Pulmonary oedema SARS-CoV-2 test positive

Symptomtext

Admission Date: 5/22/2022 Discharge Date: May 27, 2022 PRESENTING PROBLEM: Atrial fibrillation with rapid ventricular response Pneumonia due to COVID-19 virus HOSPITAL COURSE: Patient is a 66 year old man with a history of HTN, HLD, Afib with RVR who presented to the ER due to worsening dyspnea and fatigue .Found to be in Afib with RVR requiring 4 l of oxygen . CXR was consistent with pulmonary edema with BNP 3600. He was started on IV lasix and cardiology was consulted. He underwent Cardioversion which helped with his AFib with RVR , ECHO showed preserved ejection fraction. He was started on short acting cardizem 60 q6 hours along with toprol XL . But due to significant drop in HRs to 40s , metoprolol was held and cardizem dose was changed to long acting cardizem 120 mg daily. Patient was able to go on room air with diuresis and his symptoms significantly improved. Plan is he will follow with cardiology as outpatient for titration of cardizem dose . He also was treated with decadron at the hospital as he was found to have positive COVID this hospitalization. Remdisivir was not given as he was outside the window.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Pulmonary oedema
Hospital-Tage: 5,0
Labordaten: -
Aktuelle Erkrankungen: None
Vorgeschichte: Essential hypertension Neuromuscular disease Hypothyroidism Dyslipidemia History of CVA (cerebrovascular accident) Coronary artery disease involving native coronary artery of native heart without angina pectoris Pre-diabetes Urinary frequency Persistent atrial fibrillation Acute right-sided low back pain without sciatica Atrial fibrillation with rapid ventricular response Pulmonary edema
Andere Medikamente: amLODIPine (NORVASC) 10 MG tablet apixaban (ELIQUIS) 5 MG tablet ascorbic acid (VITAMIN C) 500 MG tablet atorvastatin (LIPITOR) 20 MG tablet beclomethasone Diprop HFA (QVAR REDIHALER) 80 MCG/ACT inhaler benzonatate (TESSALON) 200 MG ca
Allergien: Sulfa Drugs- Hives
Vorherige Impfungen: -

VAERS 2289080

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EW0183

schwer

Staat: MD
Alter: -
Geschlecht: U
Eingang: 21.05.2022
Impfdatum: 03.09.2021
Beginn: 11.09.2021
Tage bis Beginn: 8,0
Dosis: 3
Route/Site: - / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Angina pectoris Pericarditis Computerised tomogram thorax Echovirus test Electrocardiogram

Symptomtext

pericarditis; pericarditis pain; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from Regulatory Authority. The reporter is the patient. A patient (no qualifiers provided) received BNT162b2 (BNT162B2), on 03Sep2021 as dose 3 (booster), single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Covid-19 vaccine (Dose: 1, Unknown manufacturer), for COVID-19 immunization; Covid-19 vaccine (Dose: 2, Unknown manufacturer), for COVID-19 immunization. The following information was reported: PERICARDITIS (medically significant) with onset 11Sep2021, outcome "unknown"; ANGINA PECTORIS (medically significant) with onset 11Sep2021, outcome "recovered" (12Sep2021), described as "pericarditis pain". Therapeutic measures were taken as a result of pericarditis, angina pectoris. Clinical course- The patient received Pfizer COVID-19 booster on 03Sep and was then diagnosed with pericarditis on 11Sep for 90 days. The patient have rheumatoid arthritis being treated with Humira and methotrexate and tramadol daily for avoiding pain. The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Pericarditis
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2271121

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EW0183

schwer

Staat: -
Alter: 46,0
Geschlecht: F
Eingang: 11.05.2022
Impfdatum: 01.06.2021
Beginn: 18.01.2022
Tage bis Beginn: 231,0
Dosis: UNK
Route/Site: - / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: unbekannt

Dysarthria Facial paralysis Immobile Muscular weakness

Symptomtext

01/18/22 presents to ED as transfer from a HCF for "Extremity Weakness, LKW 2145; +slurred speech, facial droop, L sided immobility". No significant PMH.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Facial paralysis
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2271081

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EW0183

schwer

Staat: -
Alter: 17,0
Geschlecht: F
Eingang: 11.05.2022
Impfdatum: 28.05.2021
Beginn: 04.02.2022
Tage bis Beginn: 252,0
Dosis: UNK
Route/Site: - / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: unbekannt

COVID-19 SARS-CoV-2 test positive Syncope

Symptomtext

02/04/22 presented to ED for "syncope ". PMHx of "ADHD, depression, anxiety, and asthma"

Weitere VAERSDATA-Felder

Praegender Schweregrund: Syncope
Hospital-Tage: -
Labordaten: 02/04/22 SARS-CoV-2 (COVID-19) by NAA detected
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2267359

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EW0183

schwer

Staat: MI
Alter: 84,0
Geschlecht: M
Eingang: 09.05.2022
Impfdatum: 05.10.2021
Beginn: 31.01.2022
Tage bis Beginn: 118,0
Dosis: 3
Route/Site: - / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: ja

Anticoagulant therapy Arteriogram coronary abnormal COVID-19 Chest X-ray normal Chest pain Condition aggravated Confusional state Coronary angioplasty Coronary artery stenosis Cough Delirium Dysphagia Dyspnoea Hypotension Insomnia Lactic acidosis Pneumonia Polyuria

Symptomtext

Patient up to date on Pfizer COVID vaccination who admitted to hospital with positive COVID test. Provider discharge summary below: "84 year old widow with past medical history significant for chronic heart failure with reduced ejection fraction with AICD in setting of ischemic cardiomyopathy with history of coronary artery disease status post CABG and multiple cardiac stents, bioprosthetic aortic valve replacement, peripheral vascular disease, paroxysmal atrial fibrillation on apixaban, ventricular tachycardia, chronic kidney disease, stage 3b and type 2 diabetes mellitus presented with two week history of shortness of breath and cough as well as a near syncopal episode at home. Patient was found to have lactic acidosis, soft blood pressures and was COVID 19 positive. Brief Summary of Hospital Stay: (Include Significant Findings and Invasive Procedures) With lactic acidosis and tachycardia and some question of COVID 19 pneumonia patient was started on Decadron after given a one liter normal saline fluid bolus. Admitting team also stated Ceftriaxone and Doxycycline for possibility of pneumonia although CXR was relatively unremarkable and procalcitonin was within normal limits. Patient developed wide complex tachycardia. Cardiology was consulted. Patient was stated on Amiodarone bolus and drip and IV Lidocarine as well as low dose IV Lasix. His home beta blocker dose was increased. Patient developed substernal chest pain. Apixaban was held and he was scheduled for a coronary angiogram to assess for ischemic etiology. He was found to have two tandem left circumflex lesions (70-80% ostial and 90-90% proximal segment stenosis) as well an open stent further down from November 2020. He had successful PTCA and stenting of the two tandem lesions. His IV drips were discontinued. He was started on Plavix and continued on low dose Aspirin and Apixaban. He was continued on oral Amiodarone at 200 mg daily (higher dose than at home) and Metoprolol XL 50 mg daily (higher dos than at home). He had no further chest pain or tachyaryythmia. He had some worsening of his renal function with soft blood pressures so diuretics were held as was his low dose ARB. He received two small fluid boluses with normal saline and his renal function returned back towards baseline. Patient completed a five day course of Doxycycline and Ceftriaxone for a soft call community acquired pneumonia. He was also continued on Decadron for COVID 19 and completed 8 days by time of discharge. He had no signs of hypoxia and was taken out of isolation by time of discharge. Patient had some sensation of solid foods getting stuck in his throat. He was seen by speech therapy who recommended a soft diet with liquids when eating solid foods. No evidence of dysphagia. Patient was referred to GI as an outpatient to address his possible esophageal dysphagia. Patient also had insomnia with some sundowning at night. He had significant confusion when taking his home Ambien. He was trialed on Trazodone to replace Ambien which helped with sleep and seemed to have less side effects. This was continued on discharge. Issues Requiring Follow Up: (Who, what, when, and how communicated?) Follow-up chronic heart failure with cardiology (patient's home Losartan and Bumex were discontinued with patient to weigh himself daily at home and if gains more than 2 pounds to call his cardiologist - likely will be restarting these medications in the future); follow-up ventricular tachycardia and coronary artery disease with new LCX DES with cardiology, plan to continue DAPT with Eliquis for one month and then discontinue low dose Aspirin; follow-up resolution of COVID 19, Type 2 diabetes and other issues with PCP; follow-up esophageal dysphagia with GI"

Weitere VAERSDATA-Felder

Praegender Schweregrund: Presyncope
Hospital-Tage: 8,0
Labordaten: COVID detected PCR on 01/31/22.
Aktuelle Erkrankungen: -
Vorgeschichte: CAD (coronary artery disease) Ischemic cardiomyopathy Aortic valve disease HTN (hypertension) Dyslipidemia Type 2 diabetes mellitus without complication (*) PAF (paroxysmal atrial fibrillation) (*) Stage 3b chronic kidney disease (*) Dilated aortic root (*) PVD (peripheral vascular disease) (*) Cardiac defibrillator in place FH: CAD (coronary artery disease) Squamous cell carcinoma of skin of scalp
Andere Medikamente: Record empty.
Allergien: NKDA
Vorherige Impfungen: -

VAERS 2266001

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EW0183

schwer

Staat: MI
Alter: 86,0
Geschlecht: M
Eingang: 06.05.2022
Impfdatum: 18.10.2021
Beginn: 28.04.2022
Tage bis Beginn: 192,0
Dosis: 3
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: ja

Anticoagulant therapy Aortic dissection Aortic intramural haematoma COVID-19 COVID-19 pneumonia Chest X-ray abnormal Deep vein thrombosis Dyspnoea exertional Hypertension Positive airway pressure therapy Productive cough Pulmonary oedema Respiratory distress SARS-CoV-2 test positive

Symptomtext

Admission Date: 4/28/2022 Discharge Date: 5/4/2022 Condition on discharge: Stable Patient is a 87 y.o. male with PMH of HTN, Paroxysmal afib on Eliquis, complete heart block s/p AICD placement, recent admission on 3/20 for (type B aortic dissection with intramural hematoma and subsequently admitted to cardiothoracic surgery for continued management. Over course of hospital stay patient developed DVT and was started on Eliquis. Patient was subseqntly treated and realeased on 3/29. He presented to the ED on 4/28 with worsening exertional dyspnea and productive cough. Patient arrived to the ED in respirtaroy distress satting to the 80s in nonrebreather. Patient was started on BIPAP and improved. A chest xray showed pulmonary edema. Patient was subsequently admitted to the hospitalist medicine team for further medical management. Patient also found to be positive for COVID-19 pneumonia. Patient treated with 5 days of IV remdesivir and 7 days of Decadron. He should finish 4 more days of po Decadron 6 mg daily. He was weaned to RA, and did not require any home O2 at discharge. He was evaluated by PT/OT and was discharged home with HHC. Patient was also found to be hypertensive to systolic blood pressure to the 200s and placed on a nitroglycerin drip. Patient weaned off nitroglycerin drip as blood pressure improved with BiPAP and IV Lasix. Cardiology consulted increased hydralazine for improved blood pressure control. Of note spoke with outpatient vascular surgery team no need for inpatient CT angiogram thorax they have arranged outpatient follow-up for repeat imaging and follow-up visit with vascular surgery has been scheduled.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Deep vein thrombosis
Hospital-Tage: 6,0
Labordaten: -
Aktuelle Erkrankungen: None
Vorgeschichte: Personal history of colonic polyps PVC (premature ventricular contraction) Cardiac pacemaker in situ Obstructive sleep apnea on CPAP Permanent atrial fibrillation (HCC) Essential hypertension Closed comminuted intertrochanteric fracture of proximal end of right femur (HCC) Closed comminuted intertrochanteric fracture of right femur, initial encounter (HCC) Hip fracture (HCC) Mitral regurgitation Primary osteoarthritis of right hip Complete heart block (HCC) Non-sustained ventricular tachycardia (HCC) Intramural aortic hematoma (HCC) Deep vein thrombosis (DVT) of left upper extremity (HCC) Counseling regarding advance care planning and goals of care Hyponatremia Dissecting aneurysm of thoracic aorta, Stanford type B (HCC) Acute hypoxemic respiratory failure (HCC) Pneumonia due to COVID-19 virus Acute pulmonary edema (HCC)
Andere Medikamente: acetaminophen (TYLENOL) 500 MG tablet amLODIPine (NORVASC) 10 MG tablet amoxicillin (AMOXIL) 500 MG tablet apixaban (ELIQUIS) 5 MG TABS ascorbic acid (VITAMIN C) 500 MG tablet Carboxymethylcellulose Sodium (REFRESH TEARS OPTH) choleca
Allergien: Lisinopril Swelling, Edema
Vorherige Impfungen: -

VAERS 2165673

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EW0183

schwer

Staat: WI
Alter: 14,0
Geschlecht: F
Eingang: 11.03.2022
Impfdatum: 13.01.2022
Beginn: 18.02.2022
Tage bis Beginn: 36,0
Dosis: 2
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: unbekannt

Abnormal loss of weight Accident Anxiety Dysstasia Fall Asthenia CSF test abnormal Guillain-Barre syndrome Immunoglobulin therapy Ligament sprain Gait disturbance Intervertebral disc degeneration Loss of personal independence in daily activities Magnetic resonance imaging spinal abnormal Magnetic resonance imaging Pain Paraesthesia Muscular weakness

Symptomtext

"Patient is a 14 y.o. female with ADHD who presents with leg weakness, gait disturbance resulting in multiple falls, and right foot paresthesias. Of note, patient recently had right foot sprain after kickboxing on 1/25. This was thoroughly worked up with both X-rays and MRI and was normal. She had briefly used a post-op shoe but that made the pain worse. The pain had been in the arch of her right foot and that has improved but now she is having pain over the ball of the foot and with associated intermittent paresthesias of ball and toes. Over the last 2 weeks she has had leg weakness and difficulty walking. Her symptoms seem to be worst in the morning and she is now unable to get herself dressed. It's difficult for her to get from sitting to standing by herself. She was provided with crutches but has fallen with those so now is using a scooter. She pushes the scooter with her left leg. In general, she has been having progressively more falls over the past 2 weeks with 2 falls yesterday. She has not hit her head or lost consciousness with any of her falls. Otherwise she denies any other change in her symptoms over this time period. She has not had any change in bladder or bowel function and denies saddle paresthesia. No ataxia or true numbness. No difficulty breathing or swallowing. She has not had any confusion or altered behavior. She denies headaches or vision changes and she has not experienced any back or neck pain. No recent fevers or sick symptoms over the past 2 months. She did receive her COVID-19 booster (Pfizer) on 1/13. Of note, she has had 10 lbs of unintentional weight loss over past 6 weeks and she feels she is eating just as well as she was prior to this. She has been trying to supplement with protein shakes but has continued to lose weight. Denies any night sweats or cough. She also reports some anxiety revolving around her current symptoms, especially related to falling or being alone. She had some sleep disturbance related to her initial foot injury in January but has been sleeping well over the past few weeks."

Weitere VAERSDATA-Felder

Praegender Schweregrund: Guillain-Barre syndrome
Hospital-Tage: 6,0
Labordaten: 3/4/22 MRI spine Diffuse smooth thickening and enhancement of the cauda equina nerve roots, concerning for Guillain-Barre syndrome. Mild degenerative disc disease at the L3-L4 and L4-L5 levels. 3/5/22 ACUTE NEUROPATHY PANEL FROM FACILITY Pending
Aktuelle Erkrankungen: None
Vorgeschichte: ADHD
Andere Medikamente: -
Allergien: Amoxicillin
Vorherige Impfungen: -

VAERS 2155374

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge ew0183

schwer

Staat: MA
Alter: 55,0
Geschlecht: F
Eingang: 03.03.2022
Impfdatum: 09.05.2021
Beginn: 31.01.2022
Tage bis Beginn: 267,0
Dosis: 2
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: unbekannt

Anti-cyclic citrullinated peptide antibody negative Antibody test normal Antineutrophil cytoplasmic antibody negative Antinuclear antibody negative Blood thyroid stimulating hormone normal C-reactive protein increased Cardiac imaging procedure abnormal Chest pain Computerised tomogram thorax normal Cortisol normal Dyspnoea exertional Echocardiogram Electrocardiogram normal Inflammation Magnetic resonance imaging heart Myocardial oedema Myocarditis N-terminal prohormone brain natriuretic peptide normal

Symptomtext

#Myopericarditis Patient with significant hx of SOB, presenting with progressive worsening of DOE and new pleuritic chest pain. Low c/f ACS given pt with atypical prolonged chest pain, pt without significant vascular risk factor, and EKG without ischemic changes. Low c/f tamponade given pt without clinical features, pulsus of 8, and bedside u/s with collapsible IVC. Low c/f HF given normal NTproBNP, no LE swelling, and no c/f volume overload on CT PE. Overall highest suspicion for myopericarditis given pleuritic chest pain, and pericardial effusion. Unclear what precipitated pericarditis but consider viral process vs underlying autoimmune etiology. Ischemic workup unremarkable. CRP elevated to 251.6, ESR 98. Respiratory viral panel was negative. Consulted rheumatology to consider autoimmune physiology, workup was unremarkable. ANA negative, ANCA negative, TSH wnl. SS-A/SS-B, CCP, Syphilis, TspotTB, Cortisol AM wnl. TTE on 2/1/22 showed normal biventricular size and function. Small pericardial effusion with echocardiographic signs suggestive of effusive constrictive physiology. Cardiac MRI showed findings consistent with pericardial inflammation, without evidence of constrictive physiology. - continue colchicine 0.6mg TID for three months - continue indomethacin 50mg TID for 2 weeks followed by indomethacin 25mg TID for 2 weeks - continue famotidine 20mg BID

Weitere VAERSDATA-Felder

Praegender Schweregrund: Myocarditis
Hospital-Tage: 5,0
Labordaten: Troponin t-hs gen5 2/2/22=53, 3/3/33=47, 1/31/22=45, 1/31/22=69 (reference range 0-9) CRP 1/31/22=251.6 (ref range 0-3) cMRI 2/3/22 = IMPRESSIONS: 1. The left ventricular size is normal. The left ventricular ejection fraction is 57 % by Simpson's method. Global left ventricular function is normal. The left ventricular mass is normal. 2. There is no myocardial late gadolinium enhancement suggesting prior infarct, inflammation or infiltration. Native T1 times is in the upper limit of normal, measuring approximately 1300 ms. Extracellular volume is normal, measuring 31%. 3. The right ventricular size is normal. The right ventricular ejection fraction is 55 % by Simpson's method. Global right ventricular function is normal. There are no regional wall motion abnormalities of the right ventricular wall. 4. Left atrial size is mildly enlarged. Right atrial size is mildly enlarged. 5. There is thickening of the pericardium, which measures 4.0 mm. There is pericardial edema on T2-weighted images. The pericardium is enhanced post-contrast indicating pericardial fibrosis/inflammation. There is no ventricular interdependence, tubular shaped RV, or restricted motion of the right ventricular free wall. Collectively, these findings indicate no evidence of constrictive physiology. There is a small pericardial effusion. 6. Small bilateral pleural effusions. CONCLUSIONS: Overall, these findings are consistent with pericardial inflammation, without evidence of constrictive physiology.
Aktuelle Erkrankungen: unknown.
Vorgeschichte: menopause, RBB, obesitty, gerd,
Andere Medikamente: albuterol, cyclobenzaprine, docusate, famotidine, fluoxetine (off at time of admission) Flonase, ativan, miralax
Allergien: penicillin, sulfa
Vorherige Impfungen: -

VAERS 1519683

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge ew0183

schwer

Staat: -
Alter: -
Geschlecht: U
Eingang: 12.02.2022
Impfdatum: -
Beginn: -
Tage bis Beginn: -
Dosis: 2
Route/Site: IM / AR

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Diarrhoea Diplegia Dysstasia Guillain-Barre syndrome Immunoglobulin therapy Laboratory test Lumbar puncture Movement disorder Muscle spasms

Symptomtext

Guillain-Barre Syndrome; This is a spontaneous report received from a contactable reporter(s) (Pharmacist) from medical information team for a Pfizer sponsored program. A patient (no qualifiers provided) received bnt162b2 (BNT162B2) (Batch/Lot number: unknown) as dose number unknown, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: GUILLAIN-BARRE SYNDROME (medically significant), outcome "unknown", described as "Guillain-Barre Syndrome". Additional information: The pharmacist wanted to know if there's any information on the relationship between the Pfizer-BioNTech COVID-19 Vaccine and Guillain-Barre Syndrome. The pharmacist knew of a person (close relationship; the patient) who got diagnosed with this syndrome. The lot number for bnt162b2 was not provided and will be requested during follow up.; Sender's Comments: Based on the available information, the causal relationship between the reported Guillain-Barre Syndrome and the use of BNT162B2 cannot be fully excluded. The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to Regulatory Authorities, Ethics committees and Investigators, as appropriate.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Guillain-Barre syndrome
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2075894

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EW0183

schwer

Staat: GA
Alter: 48,0
Geschlecht: M
Eingang: 31.01.2022
Impfdatum: 02.08.2021
Beginn: 03.09.2021
Tage bis Beginn: 32,0
Dosis: 1
Route/Site: - / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: nein

Arthralgia COVID-19 Pulmonary thrombosis Thrombosis

Symptomtext

08/29 Was diagnosed with COVID. Received Infusion. Blood clots appeared in lungs and legs, severe joint pain. Was referred to a rehab facility.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Pulmonary thrombosis
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: None.
Vorgeschichte: High blood pressure, MS.
Andere Medikamente: None.
Allergien: None.
Vorherige Impfungen: -

VAERS 2054149

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EW0183

schwer

Staat: MI
Alter: 80,0
Geschlecht: F
Eingang: 21.01.2022
Impfdatum: 09.07.2021
Beginn: 17.01.2022
Tage bis Beginn: 192,0
Dosis: 2
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: nein

Alanine aminotransferase normal Anion gap Aspartate aminotransferase normal Basophil count Basophil percentage decreased Blood albumin normal Blood alkaline phosphatase normal Blood bicarbonate normal Blood bilirubin normal Blood calcium normal Blood chloride normal Blood creatinine normal Blood culture Blood glucose normal Blood lactic acid Blood magnesium normal Blood osmolarity decreased Blood phosphorus

Symptomtext

Patient discharged. The patient is an 80-year-old lady who presented to the hospital with chief complaint of diarrhea and dry heaving with hyponatremia. She initially presented in early january and required admission to the intensive care unit with initiation of 3% normal saline. She was discharged on 13th of January however since that time she had continued to have nausea and diarrhea and new onset shortness of breath. She presented back to ER with concerns about recurrence of hyponatremia. She was found to be COVID positive and was noted to desaturate to 87% room air and started on 1 L per nasal cannula. X-ray chest showed the possible overlying pneumonia and hilar lymphadenopathy.She had an elevated procalcitonin and was started on antibiotics for community-acquired pneumonia and dexamethasone. She refused Remdisvir. She was subsequently transferred to hospital. The patient was then noted to be hypoxic and was started on supplemental oxygen. She was also continued on dexamethasone however she once again declined remdesivir. The patient continued to improve and was subsequently off oxygen on day 3. The patient's imaging studies were reviewed x-ray showed evidence of hilar lymphadenopathy. On going back on her CT scan from August of 2021 she had multiple nodules up to the size of 1.5 cm in the right lower zone. I asked the patient if she had any follow-up down on that apparently she had gone to a pulmonologist and never followed up again. I therefore spoke with the patient's primary care physician and updated him about the findings and the necessary follow-up. The patient was also informed about these findings and the need to follow-up. The patient was also found to have hyponatremia that is chronic and could be related to these findings. She has been on sodium chloride tablets which were continued. Workup confirmed the diagnosis of SIADH with an elevated urine sodium elevated urine osmolality and low serum osmolality. The patient otherwise did well and was off oxygen and did well with room air and was subsequently discharged home.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Intensive care
Hospital-Tage: 3,0
Labordaten: Labs Reviewed COVID19 PCR, RAPID - Abnormal Result Value COVID-19 PCR Detected (*) Covid 19 Result Comment See Comment COMPLETE BLOOD COUNT (CBC) W/DIFFERENTIAL - Abnormal White Blood Cell 6.78 Red Blood Cell 3.00 (*) Hemoglobin 10.5 (*) Hematocrit 31.2 (*) Mean Cell Volume 104.0 (*) Mean Cell Hemoglobin 35.0 (*) Mean Cell Hemoglobin Concentration 33.7 Red Cell Diameter Width 15.9 NRBC Absolute Count 0.00 NRBC Automated 0.0 Platelet 239 Mean Platelet Volume 9.6 Neutrophil Automated 73.6 Immature Granulocyte Automated 0.3 Lymphocyte Automated 10.9 (*) Monocytes Automated 13.3 (*) Eosinophil Automated 1.5 Basophil Automated 0.4 Neutrophil Absolute Count 4.99 Immature Granulocyte Absolute Count 0.02 Lymphocyte Absolute Count 0.74 (*) Monocyte Absolute Count 0.90 Eosinophil Absolute Count 0.10 Basophil Absolute Count 0.03 COMPREHENSIVE METABOLIC PANEL - Abnormal Sodium Level 135 Potassium Level 4.1 Chloride 101 HCO3 21 Anion Gap 13 Glucose Level 114 (*) Blood Urea Nitrogen 7 (*) Creatinine 0.54 MDRD eGFR >60 CG eCrCl Calcium Level Total 9.2 Protein Total 7.1 Albumin Level 3.8 Bilirubin Total 0.3 Alkaline Phosphatase 71 Alanine Aminotransferase 18 Aspartate Aminotransferase 26 PROCALCITONIN - Abnormal Procalcitonin 0.30 (*) MAGNESIUM - Normal Magnesium Level 1.7 LACTIC ACID 2 HOUR, BLOOD LEVEL - Normal Lactic Acid 2 Hour, Blood Level 1.3 PHOSPHORUS - Normal Phosphorus Level 3.1 PRO B NATRIURETIC PEPTIDE BLOOD LVL - Normal Pro B Natriuretic Peptide 288 PERIPHERAL BLOOD CULTURE PERIPHERAL BLOOD CULTURE EXTRA TUBE/BLUE URINALYSIS DR CHEST SINGLE VIEW Final Result Low lung volumes. Redemonstration of the right hilar prominence which may be accentuated by the low lung volumes. However, differential considerations include overlapping pneumonia or lymphadenopathy. As previously suggested this can be further assessed with CT. Slight interstitial prominence which may be accentuated by the low lung volumes but can be seen with pulmonary edema. No evidence of pneumothorax or large pleural effusion. The cardiac silhouette appears mildly enlarged. Dictated by: DO on 1/16/2022 9:02 PM. Electronically signed by: DO on 1/16/2022 9:07 PM.
Aktuelle Erkrankungen: -
Vorgeschichte: Respiratory Emphysema/COPD Pulmonary nodule 1 cm or greater in diameter Pneumonia due to COVID-19 virus Hypoxic Circulatory Atherosclerotic heart disease of native coronary artery without angina pectoris Hematologic Lymphopenia Nervous SIADH (syndrome of inappropriate ADH production) Chronic back pain Chronic midline low back pain without sciatica Tooth pain Endocrine/Metabolic Acute hyponatremia Other Osteoporosis, senile Tobacco abuse Loose total hip arthroplasty, sequela Osteoarthritis, unspecified osteoarthritis type, unspecified site Lower extremity edema Moderate episode of recurrent major depressive disorder
Andere Medikamente: acetaminophen (TYLENOL) 500 MG tablet albuterol HFA (PROVENTIL HFA, VENTOLIN HFA, PROAIR HFA) 108 (90 Base) MCG/ACT inhaler benzocaine (HURRICAINE) 20 % SOLN benzonatate (TESSALON) 100 MG capsule Calcium Carbonate-Vitamin D (CALCIUM-VITAMIN
Allergien: Codeine: Other Sulfa Drugs: Hives Sulfadiazine: Other Celexa [Citalopram]: Diarrhea Hydrocodone: Nausea and Vomiting Propoxyphene: Nausea and Vomiting Tramadol:: Other
Vorherige Impfungen: -

VAERS 2054124

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EW0183

schwer

Staat: CO
Alter: 49,0
Geschlecht: F
Eingang: 21.01.2022
Impfdatum: 31.08.2021
Beginn: 03.12.2021
Tage bis Beginn: 94,0
Dosis: 2
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Dysmenorrhoea Fatigue Heavy menstrual bleeding Intermenstrual bleeding Menopause Menstruation irregular Restlessness Thrombosis

Symptomtext

I was in full menopause. After the vaccines I started my period. It was very painful and produced black sludgy clots. My period lasted about 10 days which is very unusual. My past typical cycle lasted 2 days and very lite. Now I'm having breakthrough bleeding and feel very tired and restless.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Thrombosis
Hospital-Tage: -
Labordaten: None
Aktuelle Erkrankungen: None
Vorgeschichte: Vestibular migraine disease/vertigo, Recently diagnosed, Chronic for around 3 years
Andere Medikamente: Zoloft 100 mg, Trazodone nightly for sleep, Mirapex nightly for restless leg
Allergien: Latex
Vorherige Impfungen: -

VAERS 2005579

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EW0183

schwer

Staat: MI
Alter: 85,0
Geschlecht: F
Eingang: 05.01.2022
Impfdatum: 25.07.2021
Beginn: 25.12.2021
Tage bis Beginn: 153,0
Dosis: 2
Route/Site: IM / AR

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: ja

Blood creatinine increased Blood sodium decreased Brain natriuretic peptide increased COVID-19 COVID-19 pneumonia Cardiac failure acute Cardiac failure congestive Chest X-ray abnormal Condition aggravated Dyspnoea Echocardiogram abnormal Haemoglobin decreased Left ventricular hypertrophy Leukopenia Mitral valve stenosis Pulmonary congestion Pulmonary oedema SARS-CoV-2 test positive

Symptomtext

Hospitalized 12/25/2021; COVID-19 positive 12/25/2021; fully vaccinated Discharge Provider: MD Primary Care Provider: DO Admission Date: 12/25/2021 Discharge Date: Dec 29, 2021 DETAILS OF HOSPITAL STAY: PRESENTING PROBLEM: Pulmonary edema cardiac cause Acute on chronic congestive heart failure, unspecified heart failure type Pneumonia due to COVID-19 virus HOSPITAL COURSE: 85 year female with a history of chronic diastolic heart failure, aortic valve replacement, hypertension, who presented gradually increasing shortness of breath for a few days prior to admission. In the emergency department, Sodium was 130, hemoglobin was 9.5 and BNP was 1821. Chest x-ray shows finding concerning for pulmonary vascular congestion. COVID-19 PCR was positive. Patient was not found to be hypoxic She was given a dose of 40 mg IV Lasix in the emergency department. Echocardiogram was obtained and showed any was seen%, mild LVH, LV normal in size, no WMA, status post TAVR, mild-to-moderate mitral stenosis. She was seen by cardiology and they felt that patient had mild CHF exacerbation and also felt that COVID 19 pneumonia could also be playing a role in her symptoms. She was placed on Remdesivir and continued on IV lasix. She had improvement in her shortness of breath. Cardiology recommended that IV diuretics were discontinued and she be placed back on her home dose of torsemide especially as she was found to have increasing creatinine. She was also found to have leukopenia of unclear etiology but was afebrile. Patient continued improvement that she has been weaned off oxygen. Pulmonary rehab assess for home oxygen need and patient found to be not needing any. PTOT evaluation completed and recommended home health with assist. Patient then discharged to home stable.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Pulmonary oedema
Hospital-Tage: 4,0
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: Pleural effusion on right Renovascular hypertension Chronic diastolic heart failure Mitral regurgitation Aortic stenosis CAD, multiple vessel Bilateral carotid artery stenosis Renal artery stenosis CHF exacerbation Acute on chronic diastolic (congestive) heart failure Coronary artery disease with stable angina pectoris Status post transcatheter aortic valve replacement (TAVR) using bioprosthesis Essential hypertension Heartburn Gastroesophageal reflux disease without esophagitis Iron deficiency anemia due to chronic blood loss Claudication of both lower extremities Other chest pain Type 2 diabetes mellitus with stage 3b chronic kidney disease Stage 3 chronic kidney disease Mixed hyperlipidemia associated with type 2 diabetes mellitus
Andere Medikamente: amLODIPine (NORVASC) 5 MG tablet atorvastatin (LIPITOR) 40 MG tablet azelastine (ASTELIN) 0.1 % nasal spray Blood Glucose Monitoring Suppl MISC carvedilol (COREG) 25 MG tablet cholecalciferol (VITAMIN D3) 25 MCG (1000 UT) tablet clopidogrel
Allergien: NKA
Vorherige Impfungen: -

VAERS 1972812

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EW0183

schwer

Staat: CA
Alter: 46,0
Geschlecht: M
Eingang: 22.12.2021
Impfdatum: 26.05.2021
Beginn: 06.06.2021
Tage bis Beginn: 11,0
Dosis: 1
Route/Site: IM / AR

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: ja ER: ja Erholt: nein

Arthralgia Blister Blood thyroid stimulating hormone Electric shock sensation Erythema Eye irritation Full blood count Glycosylated haemoglobin Headache Herpes zoster Hypertensive urgency Lipids Loss of personal independence in daily activities Metabolic function test Muscle twitching Ocular discomfort Ocular hyperaemia Pain in extremity

Symptomtext

June 6 - developed a painful rash on the left side of my head, my left eye became very red and irritated, and I had a severe headache. June 7 - a red bump developed on my left forehead above my eyebrow which was blistering and growing bigger. June 8 - I started experiencing continuous electrical shocks in my head causing me to twitch every few minutes. Affecting my face, ear and eye which interfered with daily activities and sleep. June 9 - I went to urgent care and was diagnosed with Hypertensive urgency and shingles (Herpes Zoster) complication and postherpetic Neuralgia. According to the physician, I had a shingles flare-up after the COVID vaccination. The vaccine was a trigger in producing an episode of shingles. I was prescribed the following medications ? clonidine (Catapres), amlodipine and valacyclovir. I was referred to an Ophthalmologist (same day) for eye examination and was started on a treatment of Prednisolone steroid drops for infection and Alfagan drops for increased eye pressure. June 11 - follow up urgent care visit, I was advised to proceed with the second Pfizer vaccine after the attending physician consulted with my primary care dr. June 19 ? Ophthalmologist visit. Continue use of eye drops 4 times per day. Following the second Pfizer vaccine, I started to experience pain in my left shoulder and a pain running from my left hip all the way down my leg. I mostly treated it by using a heating pad, ibuprofen and rest. July 7 - follow up visit with primary care physician, he indicated that the vaccine was a likely cause of the Shingles and the other health issues I was experiencing. Advised to monitor arm pain and consider physical therapy if it doesn?t improve. July 9 - Ophthalmologist visit. Continue use of eye drops 4 times per day. Aug 18 - Ophthalmologist visit. Continue use of eye drops 4 times per day. Sep 8 - Ophthalmologist visit. Reduce use of eye drops to 2 times per day. Oct 6 - Ophthalmologist visit. Continue use of eye drops 2 times per day. Oct 13 ? follow up visit with primary care physician. Advised to continue on Amlodopine for blood pressure, and referred to Physical Therapy for arm pain Nov 11 ? started physical Therapy. Treatment ongoing with 2-3 sessions per week Nov 17 - Ophthalmologist visit. Advised to discontinue use of eyedrops and monitor redness.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Electric shock sensation
Hospital-Tage: -
Labordaten: July 7 - CVC without differential. Comprehensive metabolic panel. Hemoglobin A1C. Lipid Panel PSA Total. TSH with reflex to FT4
Aktuelle Erkrankungen: None
Vorgeschichte: None
Andere Medikamente: None
Allergien: None
Vorherige Impfungen: -

VAERS 1967527

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EW0183

schwer

Staat: WI
Alter: 40,0
Geschlecht: M
Eingang: 21.12.2021
Impfdatum: 24.05.2021
Beginn: 16.12.2021
Tage bis Beginn: 206,0
Dosis: 2
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: unbekannt

Agitation Alcohol poisoning COVID-19 Craniocerebral injury Endotracheal intubation Facial bones fracture Intensive care Intraventricular haemorrhage Laboratory test abnormal Mental status changes Multiple injuries Road traffic accident SARS-CoV-2 test positive Subarachnoid haemorrhage Subdural haematoma Toxicity to various agents Unresponsive to stimuli

Symptomtext

Pt. is a 41 y.o. male who presented on 12/16/21 for injuries sustained in a pedestrian injured in a traffic accident involving a motor vehicle. Labs showed alcohol and methamphetamine intoxication. Per report, patient was crossing the street and the mirror of a motor vehicle hit his head while traveling at 45mph. He had altered mental status and was unresponsive. on scene was E1, V1, M4 (6). upon arrival in ED, required intubation and extubated on 12/18/21. Patient tested positive for COVID-19. Patient sustained TBI/SAH/SDH/IVH and multiple facial fractures. Patient was transferred back to CCU on 12/19/21 due to increased agitation and need for a Precedex. Tested positive for COVID-19 upon admission on 12/16/21. Patient is homeless.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Intensive care
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1909852

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EW0183

schwer

Staat: MI
Alter: 62,0
Geschlecht: F
Eingang: 30.11.2021
Impfdatum: 07.05.2021
Beginn: 19.11.2021
Tage bis Beginn: 196,0
Dosis: 2
Route/Site: IM / AR

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: ja

Acute respiratory distress syndrome COVID-19 Chest X-ray normal Chronic obstructive pulmonary disease Condition aggravated Dyspnoea Hypoxia Illness Polyuria Wheezing

Symptomtext

Hospitalized 11/21/2021; COVID-19 positive 11/19/2021; fully vaccinated DATE OF ADMISSION: 11/21/2021 DATE OF DISCHARGE: 11/25/2021 HOSPITAL COURSE A 63-year-old patient presented to the ER with shortness of breath and increasing oxygen requirements. See H and P for full details. She was diagnosed with COVID infection and hypoxia with COPD exacerbation. Her chest x-ray was clear. She was started on Solu-Medrol and Remdesivir. Completed 5 days Remdesivir. Solu-Medrol slowly weaned during the hospitalization, and she received a total of 5 days of steroids. At discharge, she was given prednisone 40 mg daily x5 additional days. She has minimal wheezing on the day of discharge. She does require 2 L of oxygen to maintain saturations above 90%. The patient did receive 2 doses of Lasix with good diuresis.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Acute respiratory distress syndrome
Hospital-Tage: 4,0
Labordaten: -
Aktuelle Erkrankungen: Office visit 11/19/2021 notes: Assessment 1. Viral illness COVID-19 PCR methylPREDNISolone sodium succinate (SOLU-Medrol) injection 125 mg 2. Acute respiratory distress predniSONE (DELTASONE) 10 MG tablet 3. COPD with acute exacerbation (HCC) predniSONE (DELTASONE) 10 MG tablet azithromycin (ZITHROMAX Z-PAK) 250 MG tablet This case is difficult. The patient is sick. I have high suspicion for covid but she is a smoker with COPD. This is also a COPD exacerbation. With the tools I have today and limited resources currently available for hospital access, I think it is in the best interest of the patient to start azithromycin and a steroid. I did explain that if this is covid the antibiotic will not help. But I am doing it anyway.
Vorgeschichte: COPD (chronic obstructive pulmonary disease) (HCC) Chronic respiratory failure with hypoxia (HCC) Acute hypoxemic respiratory failure due to COVID-19 (HCC) Peripheral vascular disease, unspecified (HCC) Essential (primary) hypertension Atherosclerotic heart disease of native coronary artery with other forms of angina pectoris (HCC) Cerebral microvascular disease Type 2 diabetes mellitus with diabetic peripheral angiopathy without gangrene (HCC) Class 1 obesity due to excess calories with serious comorbidity and body mass index (BMI) of 34.0 to 34.9 in adult Gastro-esophageal reflux disease without esophagitis Ankle pain, chronic Lumbago Dyslipidemia Type 2 diabetes mellitus without complications (HCC) Tobacco use disorder Status post total left knee replacement Major depressive disorder, single episode, unspecified
Andere Medikamente: albuterol (PROVENTIL) (2.5 MG/3ML) 0.083% nebulization albuterol HFA (PROVENTIL HFA, VENTOLIN HFA, PROAIR HFA) 108 (90 Base) MCG/ACT inhaler ascorbic acid (VITAMIN C) 500 MG tablet aspirin 81 MG tablet atorvastatin (LIPITOR) 80 MG table
Allergien: Tramadol
Vorherige Impfungen: -

VAERS 1897787

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EW0183

schwer

Staat: LA
Alter: 34,0
Geschlecht: F
Eingang: 24.11.2021
Impfdatum: 04.05.2021
Beginn: 06.08.2021
Tage bis Beginn: 94,0
Dosis: 2
Route/Site: SYR / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein

Abortion spontaneous Deep vein thrombosis Gait disturbance Maternal exposure before pregnancy Pain in extremity Ultrasound scan

Symptomtext

Pregnancy was discovered shortly rafter first vaccine. Was advised to safely continue, so I did. My date date was January 16, 2022. Late June I started feeling stabbing pain in my leg occasionally. At 16 weeks pregnant, I suffered a miscarriage and had to deliver the fetus on August 6, 2021. After delivery the pain in my leg was so bad I couldn?t walk. There was no swelling, nor color or temperature change- just stabbing and burning pain. An ultrasound found a DVT, and I have been on blood thinners ever since. I have had two perfectly healthy pregnancy prior to this. And have no history of blood clots; and no family history of blood clots.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Deep vein thrombosis
Hospital-Tage: -
Labordaten: Ultrasound done at 16 weeks checkup showed no heartbeat, August 4, 2021. Confirmation of fetal demise, August 4, 2021. Ultrasound on leg done August 17, 2021- results, DVT.
Aktuelle Erkrankungen: N/a
Vorgeschichte: N/a
Andere Medikamente: Prenatal vitamins
Allergien: None
Vorherige Impfungen: -

VAERS 1888363

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EW0183

schwer

Staat: WA
Alter: 58,0
Geschlecht: M
Eingang: 20.11.2021
Impfdatum: 14.05.2021
Beginn: 06.07.2021
Tage bis Beginn: 53,0
Dosis: 2
Route/Site: SYR / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: ja

Deep vein thrombosis Full blood count Haematocrit Haemoglobin Metabolic function test Metabolic function test abnormal Ultrasound Doppler abnormal

Symptomtext

Acute deep vein thrombosis (DVT) of popliteal vein of right lower extremity. Likely started 7/6/2021. Diagnosed via ultrasound in hospital ER on 7/12/2021. Treatment is to take apixaban. Note that patient had a PE in November 2017, but any source DVT was not diagnosed at that time.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Deep vein thrombosis
Hospital-Tage: -
Labordaten: VAS lower extremity venous bilateral ultrasound. CBC with Differential POC Group Chem 8 + (HGB, HCT, BMP-ICA)
Aktuelle Erkrankungen: none
Vorgeschichte: hyper tension
Andere Medikamente: Amlodipine Besylate
Allergien: none
Vorherige Impfungen: Prior PE (11/2017) likely started 1-2 weeks after receiving yearly Flu shot in 9/2017 at age 55

VAERS 1880687

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EW0183

schwer

Staat: PA
Alter: 33,0
Geschlecht: M
Eingang: 18.11.2021
Impfdatum: 03.09.2021
Beginn: 04.09.2021
Tage bis Beginn: 1,0
Dosis: 1
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Asthenia Cold sweat Contusion Dizziness Ear discomfort Face injury Feeling abnormal Headache Hyperhidrosis Injection site pain Lethargy Loss of consciousness Myalgia Pain Pyrexia Skin abrasion

Symptomtext

I recently (9/3) received my first dose of the Pfizer vaccination. The next day I had the normal symptoms of a vaccine. Lethargy, achy, clammy and sweating intermittently, headaches, both ears filled with fluid, muscle pain, pain at the injection site, generalized weakness and a fever of 101 with both Tylenol and ibuprofen together. I increased my fluids and rested all day. Two naps and early to bed, with my wife taking care of the kids for me. However, the next morning when I woke up, I felt lightheaded and sweaty and didn?t feel right. While walking into the bathroom, I lost consciousness and passed out. Falling face first into the floor with my nose breaking my fall first unfortunetly. I arose to my wife shaking my body, laying in a pile of clotty blood from my nose. No other injuries other then facial bruises and rub burns on my face and knees. Felt horrible (remaining symptoms from the day before continued) on top of the new body injury pains.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Loss of consciousness
Hospital-Tage: -
Labordaten: Na
Aktuelle Erkrankungen: None. Healthy
Vorgeschichte: None
Andere Medikamente: None
Allergien: None
Vorherige Impfungen: -

VAERS 1526767

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EW0183

schwer

Staat: MI
Alter: 14,0
Geschlecht: M
Eingang: 15.11.2021
Impfdatum: 28.07.2021
Beginn: 29.07.2021
Tage bis Beginn: 1,0
Dosis: 1
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: ja

Body temperature increased Chest pain Coxsackie virus test Cytomegalovirus test Echocardiogram Cardiac stress test Electrocardiogram Laboratory test Electrocardiogram ST segment elevation Fatigue Myalgia Myocarditis Electrocardiogram ST-T change Epstein-Barr virus antibody negative HIV antibody negative HIV antigen negative Hepatitis C antibody negative Movement disorder

Symptomtext

Day after vaccine he had a fever and couldn't move. 3 days after vaccine, chest pain and was see at the ER but then admitted to the hospital for Myocarditis with high levels of triponin. He had an overnight stay in the hospital, sent home with meds and asked to do labs twice that week before coming in to see Infectious diseases Specialist . Saw Cardio for a follow up on 8/24. Was cleared for sports with an echo and stress test on 10/28.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Myocarditis
Hospital-Tage: 2,0
Labordaten: 7/31 hospitalization: EKG, Cardiology, Labs (47 tests run) 8/3 Labs 8/24 EKG 10/28 EKG, Cardiac Stress Test
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: Concerta, Welbutrin
Allergien: -
Vorherige Impfungen: -

VAERS 1526767

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EW0183

schwer

Staat: MI
Alter: 14,0
Geschlecht: M
Eingang: 15.11.2021
Impfdatum: 28.07.2021
Beginn: 29.07.2021
Tage bis Beginn: 1,0
Dosis: 2
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: ja

Body temperature increased Chest pain Coxsackie virus test Cytomegalovirus test Echocardiogram Cardiac stress test Electrocardiogram Laboratory test Electrocardiogram ST segment elevation Fatigue Myalgia Myocarditis Electrocardiogram ST-T change Epstein-Barr virus antibody negative HIV antibody negative HIV antigen negative Hepatitis C antibody negative Movement disorder

Symptomtext

Day after vaccine he had a fever and couldn't move. 3 days after vaccine, chest pain and was see at the ER but then admitted to the hospital for Myocarditis with high levels of triponin. He had an overnight stay in the hospital, sent home with meds and asked to do labs twice that week before coming in to see Infectious diseases Specialist . Saw Cardio for a follow up on 8/24. Was cleared for sports with an echo and stress test on 10/28.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Myocarditis
Hospital-Tage: 2,0
Labordaten: 7/31 hospitalization: EKG, Cardiology, Labs (47 tests run) 8/3 Labs 8/24 EKG 10/28 EKG, Cardiac Stress Test
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: Concerta, Welbutrin
Allergien: -
Vorherige Impfungen: -

VAERS 1526767

UNKNOWN MANUFACTURER · COVID19 (COVID19 (UNKNOWN)) · Charge EW0183

schwer

Staat: MI
Alter: 14,0
Geschlecht: M
Eingang: 15.11.2021
Impfdatum: 28.07.2021
Beginn: 29.07.2021
Tage bis Beginn: 1,0
Dosis: 2
Route/Site: SYR / AR

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: ja

Body temperature increased Chest pain Coxsackie virus test Cytomegalovirus test Echocardiogram Cardiac stress test Electrocardiogram Laboratory test Electrocardiogram ST segment elevation Fatigue Myalgia Myocarditis Electrocardiogram ST-T change Epstein-Barr virus antibody negative HIV antibody negative HIV antigen negative Hepatitis C antibody negative Movement disorder

Symptomtext

Day after vaccine he had a fever and couldn't move. 3 days after vaccine, chest pain and was see at the ER but then admitted to the hospital for Myocarditis with high levels of triponin. He had an overnight stay in the hospital, sent home with meds and asked to do labs twice that week before coming in to see Infectious diseases Specialist . Saw Cardio for a follow up on 8/24. Was cleared for sports with an echo and stress test on 10/28.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Myocarditis
Hospital-Tage: 2,0
Labordaten: 7/31 hospitalization: EKG, Cardiology, Labs (47 tests run) 8/3 Labs 8/24 EKG 10/28 EKG, Cardiac Stress Test
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: Concerta, Welbutrin
Allergien: -
Vorherige Impfungen: -

VAERS 1865004

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EW0183

schwer

Staat: MI
Alter: 38,0
Geschlecht: M
Eingang: 12.11.2021
Impfdatum: 14.04.2021
Beginn: 12.09.2021
Tage bis Beginn: 151,0
Dosis: 2
Route/Site: SYR / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: unbekannt

Arthralgia Back pain Chest X-ray Chest pain Musculoskeletal pain Myocarditis Pain in extremity

Symptomtext

Starting around the 12 of Spetember I would say, I started to have chest pain in my right side and down my right arm. It would come on strong and last 5-10 mins or so. The only thins that would help is to drink water, put my arms up and over my head and walk around. This was happening at least once or twice a day all week. I then went to the ER on 9/17/21 after talking with a nurse at my doctor's office. Since I had chest pains, wish I did not after receiving the hospital bill. When as the ER they did not ask me if has covid, or if had been vaccinated. They checked my vitals and blood pressure, they were going to do an EKG but decided not to. I had chest x-ray of the front and side. They said that I had a muscle virus, but this was not written on the paper work for diagnosis. I thought it seemed like myocarditis possibly becasue i heard this from the doctor on TV and looked it up and it seemed like most of the sympstoms I had. I'm sure my symptoms could fall into many things. I was subscribed flexaral and something else for any infection and to take it easy for that day and the next. I did not take all the flexaral as it was use as needed. Since then I have not had the chest pain as I did before, but for the last week or two I have had some pain in my back shoulder blade, it also runs down to my left elbow. At times I feel as i get winded easier then i used to.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Myocarditis
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1860941

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EW0183

schwer

Staat: KY
Alter: 39,0
Geschlecht: M
Eingang: 11.11.2021
Impfdatum: 03.03.2021
Beginn: 08.11.2021
Tage bis Beginn: 250,0
Dosis: 2
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt

Hospitalisation

Symptomtext

hospitilization

Weitere VAERSDATA-Felder

Praegender Schweregrund: Hospitalisation
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: obesity, short gut syndrome, ILJV thrombosis
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1493157

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EW0183

schwer

Staat: CA
Alter: 54,0
Geschlecht: U
Eingang: 29.10.2021
Impfdatum: 11.06.2021
Beginn: 21.09.2021
Tage bis Beginn: 102,0
Dosis: 2
Route/Site: - / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein

Abdominal pain Alopecia Blood glucose increased Blood pressure increased Blood pressure measurement Condition aggravated Dizziness Headache Nausea Body temperature Cluster headache Insomnia Investigation Pain Pyrexia Rash Thrombosis

Symptomtext

start falling my head hair, which is causing baldness; bloot clot on my right leg; immence headaches; dizzyness; left right abdomenal left abdonemal pains; rashes scars on my right lef; pains all over body; insomnia; feaver; My Sugar And Blood Preasure Wehn Hi; My Sugar And Blood Preasure Wehn Hi; This is a spontaneous report from a contactable consumer (patient). A 55-year-old patient of unspecified gender received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Lot Number: EW0183), via an unspecified route of administration, administered in arm left on 11Jun2021 (at the age of 54-years-old) as dose 2, single for covid-19 immunisation. The patient's medical history and concomitant medications were not reported. The vaccine was administered at the clinic. The patient got his/her first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Lot Number was not reported), on 21May2021 (at the age of 54-years-old) for covid-19 immunisation, and experienced the following symptoms: immense headaches, dizzyness left right abdominal and left abdominal pains, blood clot on his/her right leg, rashes, scars on his/her right leg, left permanent pains all over body, insomnia, feverish, and went to urgent care. His/her sugar and blood pressure went high. Then again, he/she went back for second dose of Pfizer Covid-19 Vaccine on 11Jun2021. After that second dose, he/she got even worst same symptoms, and this was vaccinated on his/her left arm. He/She got rashes to permanent marks on his/her left leg with the same above mentioned, worst symptoms. The patient was in extreme pain sufferings. His/her rashes marks caused by Covid-19 vaccine were permanent on both legs. After Covid-19 Vaccine shots, his/her life was in immensely pains and sufferings. After the second dose of Pfizer Covid 19 Vaccine, start falling his/her head hair, which was causing baldness on 21Sep2021. The outcome of the events was unknown. Follow-up attempts are completed. No further information is expected.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Thrombosis
Hospital-Tage: -
Labordaten: Test Date: 2021; Test Name: My Sugar And Blood Preasure Wehn Hi; Result Unstructured Data: Test Result:High; Test Date: 2021; Test Name: fever; Result Unstructured Data: Test Result:Fever; Test Date: 2021; Test Name: My Sugar And Blood Preasure Wehn Hi; Result Unstructured Data: Test Result:High
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1825141

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EW0183

schwer

Staat: TX
Alter: 15,0
Geschlecht: F
Eingang: 28.10.2021
Impfdatum: 13.08.2021
Beginn: 12.10.2021
Tage bis Beginn: 60,0
Dosis: 1
Route/Site: SYR / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: nein

Acute motor axonal neuropathy Central venous catheterisation Diplegia Flavivirus test negative Gait disturbance Guillain-Barre syndrome Immunoglobulin therapy Inflammation Laboratory test normal Loss of personal independence in daily activities Lumbar puncture Magnetic resonance imaging abnormal Mobility decreased Muscular weakness Pain Plasmapheresis Syncope Walking aid user

Symptomtext

Patient was diagnosed with Acute Guillain-Barre Syndrome. She had a weak ankle on Tuesday, 10/12/2021 and saw a physical therapist who referred her to another PT the next day. On 10/13/2021, she collapsed getting out of bed with weakness in her legs. She saw PT, who referred her to a neurologist, who then sent her to the ER for an MRI, who then sent her to Hospital for that MRI. The MRI happened early morning of 10/14/2021. It showed inflammation consistent with GBS so they put her under to install a central line and do a spinal tap. By hen, she was only able to move her head a couple inches. No movement in her arms and legs, but there was pain everywhere. The tests came back verifying GBS and the Neurologist said it was Acute Motor Axonal Neuropathy. Plasmapheresis began the evening of 10/14/2021 (7 bottles) and IVIG right after. Patient had a total of 5 treatments of plasmapheresis over 10 days, every other day (Thursday, Saturday, Monday, Wednesday and Friday). IVIG then followed on Saturday and another Sunday. Patient worked with PT and OT every day after movement started again. She worked on standing the Friday of the last plasmapheresis, worked on walking with a walker on Saturday and Sunday and could walk on her own a little Monday. She will be working on walking more each day and start outpatient PT at hospital TIRR on November 8, 2021. Please note, patient is 15 and the youngest Studio Company This is really effecting her and her future job opportunities that she has been training for since she was 2 years old!

Weitere VAERSDATA-Felder

Praegender Schweregrund: Guillain-Barre syndrome
Hospital-Tage: 14,0
Labordaten: I was told she was tested for Wast Nile, Zika and other pathogens that have been shown to set off the GBS. She was negative to all. The MRI showed no structural issues, only the inflammation consistent with GBS.
Aktuelle Erkrankungen: None
Vorgeschichte: None
Andere Medikamente: Vitamin D, Calcium & Cranberry Concentrate
Allergien: None
Vorherige Impfungen: -

VAERS 1813792

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EW0183

schwer

Staat: AZ
Alter: 47,0
Geschlecht: F
Eingang: 24.10.2021
Impfdatum: 23.10.2021
Beginn: 24.10.2021
Tage bis Beginn: 1,0
Dosis: 1
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Asthenia Headache Injection site pain Loss of consciousness Nausea Vomiting

Symptomtext

I passed out for a few minutes (unsure of amount of time) on the toilet 8 hours after receiving the dose, then proceeded to become nauseous and vomit, unable to hold down water for a few hours. Next day, low energy, pain in injection site and slight headache.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Loss of consciousness
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: Shingles
Vorgeschichte: n/a
Andere Medikamente: valcyclovir, protandim, vit D, energy blend
Allergien: n/a
Vorherige Impfungen: -

VAERS 1810513

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EW0183

schwer

Staat: CO
Alter: 32,0
Geschlecht: F
Eingang: 23.10.2021
Impfdatum: 08.10.2021
Beginn: 08.10.2021
Tage bis Beginn: 0,0
Dosis: 3
Route/Site: OT / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Chills Hypotension Immunisation Loss of consciousness Off label use Vomiting

Symptomtext

loss of consciousness; severe hypotension; two episodes of emesis and LOC; severe chills; received the third dose of BNT162B2; received the third dose of BNT162B2; This is a spontaneous report from a contactable nurse (patient). A 32-year-old female patient (not pregnant) received the third dose of BNT162B2 (PFIZER BIONTECH COVID 19) via intramuscular on the left arm on 08Oct2021 at 09:00 AM (Lot Number: EW0183) at the age of 32-year-old as single dose for COVID-19 immunization. Medical history was none. The patient didn't received other vaccines within 4 weeks prior to the COVID vaccine. Known allergy was none. Prior to vaccination, the patient wasn't diagnosed with COVID-19. Since the vaccination, the patient hadn't been tested for COVID-19. Concomitant medication was none. The patient previously received the first dose and the second dose of BNT162B2, the second dose on 15Jan2021 at 12:00 PM (Lot Number: EL1283) on the left arm, the first dose on 24Dec2020 at 01:15 PM (Lot Number: EK5730) on the right arm, both via intramuscular at the age of 31-year-old as single dose for COVID-19 immunization. On 09Oct2021 at 12:15 PM, the patient experienced severe hypotension and loss of consciousness. Hypotension lasting about 60 min with two episodes of emesis and LOC. followed by severe chills. No treatment was received. The outcome of booster and off label use was unknown. The outcome of other events was recovered with sequel in 2021.; Sender's Comments: Based on the current available information, a possible contributory role of the suspect product BNT162B2 to the development loss of consciousness cannot be totally excluded.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Loss of consciousness
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: Comments: List of non-encoded Patient Relevant History: Patient Other Relevant History 1: none
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1808612

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EW0183

schwer

Staat: MI
Alter: 18,0
Geschlecht: F
Eingang: 22.10.2021
Impfdatum: 22.10.2021
Beginn: 22.10.2021
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Fall Nervousness Syncope

Symptomtext

Patient received first dose of Pfizer vaccine and fainted after walking out of consultation room. Another customer was close by and was able to catch her and prevent her from hitting her head. Patient came to right away and felt fine. Her mother was also present. We provided juice and offered ambulance ride but patient declined. After sitting for a few minutes, she had no other concerns or questions. Stated she was probably just nervous and doesn't like needles.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Syncope
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1794742

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EW0183

schwer

Staat: NC
Alter: 51,0
Geschlecht: M
Eingang: 18.10.2021
Impfdatum: 30.06.2021
Beginn: 11.07.2021
Tage bis Beginn: 11,0
Dosis: 2
Route/Site: SYR / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein

Arthralgia Burning sensation Chest pain Computerised tomogram normal Echocardiogram normal Electric shock sensation Electromyogram Heart rate increased Muscle spasms Palpitations Restless legs syndrome

Symptomtext

- Restless legs, Feeling like an electrical current was moving through my body , Heart pounding, Heart aching, Heart beating very very fast, Muscle spasm all over my body, Burning sensation in lower legs, and sometime all over my body, pain in ankle area,.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Electric shock sensation
Hospital-Tage: -
Labordaten: - CT SCAN of the chest. on October 14 2021 NO ABNORMALITIES - ECHO CARDIOGRAM On August 17 2021 NORMAL - EMG TEST OF LEFT RIGHT LEG AND RIGHT ARM on Friday 7/30 NORMAL. Since this test my left arm and leg I have been having extreme muscle pain, tingling, arm and leg are very weak, very sensitive, muscle soreness.
Aktuelle Erkrankungen: None
Vorgeschichte: None
Andere Medikamente: Vitamin D
Allergien: None
Vorherige Impfungen: -

VAERS 1790791

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EW0183

schwer

Staat: GA
Alter: 36,0
Geschlecht: F
Eingang: 16.10.2021
Impfdatum: 07.08.2021
Beginn: 07.08.2021
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: - / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Confusional state Dizziness Dysarthria Electric shock sensation Electromyogram Head discomfort Heart rate Heart rate increased Hypoaesthesia Hypopnoea Magnetic resonance imaging Menstruation irregular Muscle spasms Nerve injury Palpitations SARS-CoV-2 test Tinnitus Tremor

Symptomtext

EMG revealed nerve damage/sensation of nervous system experiencing electricity/vibrations throughout body; Confusion; slurred speech; severe muscle spasms; tremors; sudden episodes of numbness in arms and legs; severe pressure in head; dizziness; tinnitus; heart palpitations; increased heart rate; shallow breathing; disturbance in menstrual cycle; sensation of nervous system experiencing electricity/vibrations throughtout body; This is a spontaneous report from a contactable consumer (patient). A 36-years-old female (not pregnant) patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE), dose 1 via an unspecified route of administration at age of 36 years, administered in arm left on 07Aug2021 12:30 (Lot Number: EW0183) as single dose for covid-19 immunisation. Medical history included allergies to Almonds. No covid prior vaccination. The patient's concomitant medications were none. No other vaccine in four weeks, no other medications in two weeks. The patient experienced Confusion/slurred speech, severe muscle spasms, tremors, sudden episodes of numbness in arms and legs, severe pressure in head, dizziness, tinnitus, heart palpitations, increased heart rate, shallow breathing, disturbance in menstrual cycle, and sensation of nervous system experiencing electricity/vibrations throughout body post vaccination. EMG (20Aug2021) revealed nerve damage of questionable clinical significance thirteen days post vaccination. MRI (2021) revealed no underlying condition. Covid test via nasal swab on 13Aug2021 and negative. The pharmacy does not recommend that patient receive the 2nd shot after her adverse reaction to the Pfizer Covid-19 vaccine. The pharmacy also guided she to the Pfizer website to report adverse reaction event. Adverse events start date was 07Aug2021 13:30 and resulted in Doctor or other healthcare professional office/clinic visit, no treatment was received. The outcome of the events was Recovered/Resolved with Sequel in 2021. No follow-up attempts are possible. No further information is expected.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Electric shock sensation
Hospital-Tage: -
Labordaten: Test Date: 20210820; Test Name: EMG; Result Unstructured Data: Test Result:nerve damage; Comments: EMG revealed nerve damage of questionable clinical significance thirteen days post vaccination; Test Date: 20210807; Test Name: Heart rate; Result Unstructured Data: Test Result:increased; Comments: increased heart rate; Test Date: 2021; Test Name: MRI; Result Unstructured Data: Test Result:No underlying condition; Comments: MRI revealed no underlying condition; Test Date: 20210813; Test Name: Covid test; Test Result: Negative ; Comments: nasal swab
Aktuelle Erkrankungen: -
Vorgeschichte: Medical History/Concurrent Conditions: Allergy to nuts
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1779622

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EW0183

schwer

Staat: TX
Alter: 46,0
Geschlecht: F
Eingang: 12.10.2021
Impfdatum: 12.10.2021
Beginn: 12.10.2021
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein

Blood glucose normal Chest discomfort Dizziness Dyspnoea Electrocardiogram normal Feeling hot Flushing Hypoaesthesia Hypoaesthesia oral Injection site hypoaesthesia Injection site paraesthesia Muscular weakness Nausea Paraesthesia Paraesthesia oral Presyncope Productive cough Throat irritation

Symptomtext

Vaccination administered to L deltoid at 1250pm with no issues or complaints until 10 minutes later. Patient reported numbness and tingling to L arm, where injection was given, at 1255pm and then reported feeling slight SOB and mild chest tightness around 1305 pm. Requested assistance by LVN,, to monitor patient while NP was being retrieved for medical evaluation. NP presented where a presyncopal episode occurred with patient already reclined in chair; vitals were taken with O2 Sats ranging from 97% to 100% with pulse rate ranging between 67 to 71, RR at 14 - 18 breaths per minute. Breathing was noted to be non-labored. BP was attempted multiple times on LA by RN and LVN before obtaining 139/88 with larger cuff. NP offered to give patient epinephrine, but patient declined as she did not want to go to the hospital. Patient then ? lightheadedness, nausea and scratchy throat as well as facial flushing and feeling hot. Noted productive cough with clear and foamy sputum. Provided water; tolerated well with no emesis. OHN recommended that she contact her closest relative for pick up from TAO to rest. LVN remained with patient for direct observation while patient was allowed time to recover from her reported symptoms. LVN reported to OHN patient ? numbness and tingling around her lips and cheeks as well as weakness in her arms and legs when NP and OHN returned to check in on patient. Noted that patient was on phone with relative discussing pick up from work. Patient was offered epinephrine again by NP, but again declined. Provided stand-by assistance while patient stood up and ambulated slowly to the restroom and was allowed to proceed without direct observation. Patient was noted to be already standing upright when restroom door was opened for escort to sink. Patient reported feeling faint again and was then placed into a chair while EMS was contacted. Patient remained awake and responsive following commands appropriately during entire monitoring period.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Presyncope
Hospital-Tage: -
Labordaten: EMS reported BG = 78; BP = 140/90; P = 71; and O2 sats = 99%. EMT also reported normal EKG results.
Aktuelle Erkrankungen: Patient did not disclose, but reports history of COVID-19 Illness x 2, pleurisy, gastroparesis, anxiety, syncopal episodes, and hypoglycemia
Vorgeschichte: Anxiety
Andere Medikamente: Patient did not disclose
Allergien: Flagyl, Codeine, NSAID's
Vorherige Impfungen: -

VAERS 1779362

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EW0183

schwer

Staat: NJ
Alter: 46,0
Geschlecht: M
Eingang: 12.10.2021
Impfdatum: 28.09.2021
Beginn: 01.10.2021
Tage bis Beginn: 3,0
Dosis: 3
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Bell's palsy Eye irritation Eyelid function disorder Hypoaesthesia Impaired work ability

Symptomtext

Pfizer-BioNTech COVID-19 Vaccine EUA: Vaccine recipient was vaccinated on 9/28/2021. Around bedtime on 10/1/2021, he noticed symptoms of numbness on the right side of his face. On 10/2/2021., he woke up and was unable brush his teeth. he noticed that his right face was numb and he could not close his right eye. He then went to urgent care and they diagnosed him with Bell's Palsy. He is currently going to physical therapy. He currently cannot close is right eye completely at all. He has to sleep with an eye patch at night, sometimes he eye burns from keeping it open all the time. He was out of work for 1 week and returned to work on 10/12/2021.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Bell's palsy
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: diabetes, hypertension
Andere Medikamente: metformin, glipizide, amlodipine, omeprazole
Allergien: nkda
Vorherige Impfungen: -

VAERS 1772596

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EW0183

schwer

Staat: MI
Alter: 19,0
Geschlecht: M
Eingang: 08.10.2021
Impfdatum: 08.10.2021
Beginn: 08.10.2021
Tage bis Beginn: 0,0
Dosis: 2
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein

Dizziness Incontinence Loss of consciousness Tremor Unresponsive to stimuli

Symptomtext

Right after the injection, the patient felt dizzy and lost consciousness. He became unresponsive and his head was shaking. The patient also had an incontinence episode. After regaining consciousness, he was laid on the floor and started to become more alert as time went on. Paramedic services were called and they assessed the patient after arrival on the scene, He was then taken to hospital.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Loss of consciousness
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1735445

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EW0183

schwer

Staat: NY
Alter: 32,0
Geschlecht: F
Eingang: 26.09.2021
Impfdatum: 22.05.2021
Beginn: 23.05.2021
Tage bis Beginn: 1,0
Dosis: 1
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Fall Pain in extremity Presyncope Syncope Visual impairment

Symptomtext

Vasovagal syncope. I awoke at around 2:00 AM to use the bathroom and to get some Tylenol for left arm pain. As I was walking back to my bed I was seeing dark spots in my vision. I was able to reach my couch to lay down before falling to the ground. I have just read the reportable events table and see now that I am able to report this event; I would have reported it sooner if I was aware; also reporting it as my job; as a registered nurse, is in jeopardy. My doctor will not write me an exempt form for the second dose because I am well at this time. I do not feel safe getting the second dose and hope you may help me come to a conclusion or some documentation where I can be exempt from the second dose and keep caring for patients in the hospital. I was caring for patients throughout the COVID-19 pandemic and was safe enough to never get it prior to getting vaccinated as I did not have any antibodies for Covid-19. You may reach me. I look forward to speaking to someone about this if possible. Thank you.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Presyncope
Hospital-Tage: -
Labordaten: I did not see a doctor for this event.
Aktuelle Erkrankungen: None
Vorgeschichte: None
Andere Medikamente: Multivitamin
Allergien: None
Vorherige Impfungen: -

VAERS 1734495

UNKNOWN MANUFACTURER · VACCINE NOT SPECIFIED (NO BRAND NAME) · Charge ew0183

schwer

Staat: PA
Alter: 61,0
Geschlecht: F
Eingang: 25.09.2021
Impfdatum: 20.09.2021
Beginn: 22.09.2021
Tage bis Beginn: 2,0
Dosis: 1
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Bradykinesia Dizziness Feeling abnormal Hypoaesthesia Loss of consciousness

Symptomtext

48 hours following injection, i experienced dizziness, left arm numbness. left facial numbness. 72 hours after vaccine , i had heart rate 160's, dizziness, and short period of backing out. recovery was slow, felt everything was 'off' felt slow moving .

Weitere VAERSDATA-Felder

Praegender Schweregrund: Loss of consciousness
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: history of SVT HX OF PULMONRY EMBOLISM 2014
Vorgeschichte: HBP
Andere Medikamente: verapamil 180 daily progesterone100 mg
Allergien: -
Vorherige Impfungen: -

VAERS 1708324

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EW0183

schwer

Staat: MI
Alter: 13,0
Geschlecht: F
Eingang: 17.09.2021
Impfdatum: 10.08.2021
Beginn: 12.09.2021
Tage bis Beginn: 33,0
Dosis: 1
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein

Bell's palsy Facial paralysis Hypoaesthesia

Symptomtext

Unilateral Bell?s palsy. Onset was 9.12.21. 2nd dose of Pfizer vaccine was August 10th so she is about 4 weeks out CHIEF COMPLAINT: NUMBNESS and FACIAL DROOP Assessment/Plan - DIAGNOSIS at time of disposition: 1. Bell's palsy MEDICAL DECISION MAKING Supervising Physician: Dr. This is a 13-year-old previously healthy female presenting with 5 hours of complete left-sided facial droop without any other associated symptoms. Patient is very well-appearing in no acute distress upon arrival with normal vital signs. Patient has a GCS of 15, A&O x4. Patient does have complete left-sided facial droop including the forehead making this most consistent with Bell's palsy and not a central neurologic process such as stroke. Patient has no other neuro deficits on exam. I did speak with Neurology who agreed with the diagnosis and advised on 1000 mg of Valtrex 3 times daily for a week and prednisone burst with taper over total of 10 days. Patient was given 1st dose of both these medications here in the emergency department. Patient will follow up with Neurology in 4-6 weeks. Patient is also unable to fully close her left eye and therefore was given eye drops, eye gel for night and a eye patch which she was advised to wear while sleeping. Dad was agreeable with this plan patient was discharged home in stable condition. Medications valACYclovir (VALTREX) tablet 1,000 mg (has no administration in time range) glycerin-hypromellose-PEG 400 (ARTIFICIAL TEARS) ophthalmic solution 1 drop (has no administration in time range) predniSONE (DELTASONE) tablet 50 mg (50 mg Oral Given 9/12/21 1536)

Weitere VAERSDATA-Felder

Praegender Schweregrund: Bell's palsy
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: NA
Vorgeschichte: None
Andere Medikamente: cholecalciferol (VITAMIN D3 GUMMIES) 25 MCG (1000 UT) chewable tablet Multiple Vitamins-Minerals (EMERGEN-C IMMUNE PLUS/VIT D PO) Pediatric Vitamins (MULTIVITAMIN GUMMIES CHILDRENS PO)
Allergien: NA
Vorherige Impfungen: -

VAERS 1708324

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EW0183

schwer

Staat: MI
Alter: 13,0
Geschlecht: F
Eingang: 17.09.2021
Impfdatum: 10.08.2021
Beginn: 12.09.2021
Tage bis Beginn: 33,0
Dosis: 2
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein

Bell's palsy Facial paralysis Hypoaesthesia

Symptomtext

Unilateral Bell?s palsy. Onset was 9.12.21. 2nd dose of Pfizer vaccine was August 10th so she is about 4 weeks out CHIEF COMPLAINT: NUMBNESS and FACIAL DROOP Assessment/Plan - DIAGNOSIS at time of disposition: 1. Bell's palsy MEDICAL DECISION MAKING Supervising Physician: Dr. This is a 13-year-old previously healthy female presenting with 5 hours of complete left-sided facial droop without any other associated symptoms. Patient is very well-appearing in no acute distress upon arrival with normal vital signs. Patient has a GCS of 15, A&O x4. Patient does have complete left-sided facial droop including the forehead making this most consistent with Bell's palsy and not a central neurologic process such as stroke. Patient has no other neuro deficits on exam. I did speak with Neurology who agreed with the diagnosis and advised on 1000 mg of Valtrex 3 times daily for a week and prednisone burst with taper over total of 10 days. Patient was given 1st dose of both these medications here in the emergency department. Patient will follow up with Neurology in 4-6 weeks. Patient is also unable to fully close her left eye and therefore was given eye drops, eye gel for night and a eye patch which she was advised to wear while sleeping. Dad was agreeable with this plan patient was discharged home in stable condition. Medications valACYclovir (VALTREX) tablet 1,000 mg (has no administration in time range) glycerin-hypromellose-PEG 400 (ARTIFICIAL TEARS) ophthalmic solution 1 drop (has no administration in time range) predniSONE (DELTASONE) tablet 50 mg (50 mg Oral Given 9/12/21 1536)

Weitere VAERSDATA-Felder

Praegender Schweregrund: Bell's palsy
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: NA
Vorgeschichte: None
Andere Medikamente: cholecalciferol (VITAMIN D3 GUMMIES) 25 MCG (1000 UT) chewable tablet Multiple Vitamins-Minerals (EMERGEN-C IMMUNE PLUS/VIT D PO) Pediatric Vitamins (MULTIVITAMIN GUMMIES CHILDRENS PO)
Allergien: NA
Vorherige Impfungen: -

VAERS 1704728

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge ew0183

schwer

Staat: PA
Alter: 22,0
Geschlecht: M
Eingang: 16.09.2021
Impfdatum: 23.08.2021
Beginn: 04.09.2021
Tage bis Beginn: 12,0
Dosis: 1
Route/Site: IM / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein

Bell's palsy Facial paralysis

Symptomtext

Received vaccine on 08/23/21, felt symptomatic (facial paralysis) on 09/04/21, and went to Emergency Room on 09/10/21. Was diagnosed with Bell's Palsy and was treated with Prednisone.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Bell's palsy
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: unknown
Vorgeschichte: unknown
Andere Medikamente: unknown
Allergien: unknown
Vorherige Impfungen: -

VAERS 1683231

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EW0183

schwer

Staat: IL
Alter: 42,0
Geschlecht: F
Eingang: 08.09.2021
Impfdatum: 09.06.2021
Beginn: 30.07.2021
Tage bis Beginn: 51,0
Dosis: 1
Route/Site: SYR / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein

Ageusia Bell's palsy Computerised tomogram Corneal reflex decreased Ear pain Facial paralysis Headache Hemiplegia

Symptomtext

Complete paralysis of left side of face, severe left side head and ear pain, loss of taste and control of mouth, unable to close eye. First symptom was loss of taste and inability to blink with left eye on the evening of 7/30/2021 and within hours overnight I had full paralysis and drooping on the left side of my face.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Bell's palsy
Hospital-Tage: -
Labordaten: CT scan to rule out stroke on 7/31/2021 at Hospital. Diagnosed with Bell?s Palsy and prescribed prednisone and valtrex. Follow up with PCP on 8/3/2021.
Aktuelle Erkrankungen: None
Vorgeschichte: None
Andere Medikamente: None
Allergien: Sulfa drugs
Vorherige Impfungen: -

VAERS 1662554

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EW0183

schwer

Staat: CA
Alter: 59,0
Geschlecht: F
Eingang: 01.09.2021
Impfdatum: 28.05.2021
Beginn: 09.06.2021
Tage bis Beginn: 12,0
Dosis: 2
Route/Site: SYR / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein

Arthralgia Blood test Hyperhidrosis Impaired work ability Loss of consciousness Loss of personal independence in daily activities Magnetic resonance imaging Metabolic function test Mobility decreased Pain Pain in extremity Pallor Sleep disorder

Symptomtext

On June 9, 2021 my arms started hurting from my shoulders to my wrist and fingers. It would get worst at night and then it kept getting worse that I was having trouble sleeping and when I would get up in the morning I could hardly brush my teeth or hair....it progressive got worse that I was having extreme pain trying pull up my pj bottoms and get dressed. Then on June 23rd I woke up at 1:00am and in extreme pain, I could not move my arms and the pain in my fingers felt as though they would explode. When i stood up a felt as though I would pass out and was sweating and very pale. My daughter took my to the ER (I have not gone to a ER in 30 yrs) The ER ruled out bool clot, heart attack and stroke. They told me it was an inflammatory response possible to the Covid vaccine and to go see my Rheumatologist. As of today 9/1/2021 I am still in chronic pain in my shoulders, wrist and hands. I haven't slept well, have difficulty dressing, driving and doing everyday activities without being in pain. I have had to be on steroids, have steroid injections, 3 MRI's and numerous blood tests. I was never told this could happen, I was never given any information at all on the vaccine. I have become very depressed and can hardly get though the day. It has caused me to not be able to do my job as efficiently as once need and cry throughout my day just trying to complete tasks.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Loss of consciousness
Hospital-Tage: -
Labordaten: MRI 8/18/21 and I have 2 9/2/21 Bloodwork at the hospital 6/23/2021 and full panel on 8/24/2021
Aktuelle Erkrankungen: none
Vorgeschichte: Auto-immune mixed connective tissue, sjogren's, positive ANA, possitive HLA-B27, chronic polyarthralgias
Andere Medikamente: none
Allergien: none
Vorherige Impfungen: -

VAERS 1646697

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EW0183

schwer

Staat: TX
Alter: 15,0
Geschlecht: M
Eingang: 28.08.2021
Impfdatum: 06.08.2021
Beginn: 07.08.2021
Tage bis Beginn: 1,0
Dosis: 1
Route/Site: - / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Asthenia Dizziness Feeling abnormal Head injury Loss of consciousness Nasopharyngitis Vaccination site pain

Symptomtext

I must have blacked out for a second; Woke up cold the following morning; I then felt light headed. I couldn't hold my head up; I couldn't hold my head up; feeling weak; I hit my head when I fell.; arm was sore where I got the shot.; This is a spontaneous report from a contactable consumer (reported himself). A 15-year-old male patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation: solution for injection, lot number: EW0183), via an unspecified route of administration, administered in arm right on 06Aug2021 17:30 (age at vaccination 15-year-old) as dose 1, single for COVID-19 immunisation and school or student health clinic. The patient medical history was not reported. The patient concomitant medication was vitamin C (unspecified) received within two weeks of vaccination. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. The patient stated that on 07Aug2021 09:00, he woke up cold the following morning. Patient sat down to eat breakfast at the kitchen table. Patient stated that "I then felt lightheaded. I couldn't hold my head up". Patient stated that his body just went limp. Patient was feeling weak, then patient went sideways. Patient stated that "I must have blacked out for a second" because the next thing patient know, her mother was picking me up from the floor. Patient stated that "I hit my head when I fell". The rest of the day patient felt weak, his head hurt, and patient stated that "arm was sore where I got the shot". The patient received acetaminophen as the treatment for the events. The patient was not hospitalization. Since the vaccination, the patient had not tested for COVID-19. The outcome of the events was resolving. Follow-up attempts are completed. No further information is expected.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Loss of consciousness
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1591530

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge ew0183

schwer

Staat: MA
Alter: 38,0
Geschlecht: F
Eingang: 20.08.2021
Impfdatum: 20.08.2021
Beginn: 20.08.2021
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Dizziness Feeling hot Loss of consciousness Nervousness Tremor

Symptomtext

Patient received the vaccine at 9:30am. Approximately 10 minutes after receiving the vaccine she notified us that she was feeling hot and dizzy, and she may pass out. I gave her a cool pack to put on her back, she was sitting down, and breathing heavy. She stated that she was feeling very nervous and has a history of panic attacks. She slumped into her chair and started shaking, her head fell backwards. I held her head up , kept her head to the side, and removed her mask for air. Her entire body shook, including her legs. She came to about a minute later, and was very calm. She knew she had passed out, and that EMT's were en route. The EMT suggested that she may have had a vasovagal reaction, and was not convinced it was a seizure. She did not go to the hospital , but she did have a friend pick her up and drive her to her primary care.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Loss of consciousness
Hospital-Tage: -
Labordaten: none
Aktuelle Erkrankungen: none
Vorgeschichte: none
Andere Medikamente: None
Allergien: none listed
Vorherige Impfungen: -

VAERS 1314029

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EW0183

schwer

Staat: VT
Alter: 37,0
Geschlecht: M
Eingang: 17.08.2021
Impfdatum: 12.05.2021
Beginn: 12.05.2021
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: ja Hospital: ja Disable: ja ER: ja Erholt: nein

Back pain Computerised tomogram Electroencephalogram Impaired work ability Magnetic resonance imaging Dyskinesia Foaming at mouth Lip haemorrhage Loss of consciousness Seizure like phenomena Mobility decreased Seizure Spinal fracture Upper limb fracture X-ray

Symptomtext

Vaccine was administered around 12:30PM Wednesday 5/12/21. At approximately 12:34PM seizure occurred. Seizure caused fractured spine. Fractured spine resulted in loss of work/mobility. Second seizure occurred 1 month later, resulting in more back pain/fracture and broken shoulder. Had no prior neurology issues or family history with seizures. Saw a Neurologist and was prescribed Lamotrigine.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Loss of consciousness
Hospital-Tage: 1,0
Labordaten: After Seizure: EEG MRI CT Scan Multiple X-Rays
Aktuelle Erkrankungen: -
Vorgeschichte: Diabetes - 2 years
Andere Medikamente: Lantus- 16mg/day
Allergien: -
Vorherige Impfungen: -

VAERS 1314029

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EW0183

schwer

Staat: VT
Alter: 37,0
Geschlecht: M
Eingang: 17.08.2021
Impfdatum: 12.05.2021
Beginn: 12.05.2021
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: SYR / LA

Tod: unbekannt Lebensbedrohlich: ja Hospital: ja Disable: ja ER: ja Erholt: nein

Back pain Computerised tomogram Electroencephalogram Impaired work ability Magnetic resonance imaging Dyskinesia Foaming at mouth Lip haemorrhage Loss of consciousness Seizure like phenomena Mobility decreased Seizure Spinal fracture Upper limb fracture X-ray

Symptomtext

Vaccine was administered around 12:30PM Wednesday 5/12/21. At approximately 12:34PM seizure occurred. Seizure caused fractured spine. Fractured spine resulted in loss of work/mobility. Second seizure occurred 1 month later, resulting in more back pain/fracture and broken shoulder. Had no prior neurology issues or family history with seizures. Saw a Neurologist and was prescribed Lamotrigine.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Loss of consciousness
Hospital-Tage: 1,0
Labordaten: After Seizure: EEG MRI CT Scan Multiple X-Rays
Aktuelle Erkrankungen: -
Vorgeschichte: Diabetes - 2 years
Andere Medikamente: Lantus- 16mg/day
Allergien: -
Vorherige Impfungen: -

VAERS 1569131

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EW0183

schwer

Staat: WA
Alter: 24,0
Geschlecht: M
Eingang: 15.08.2021
Impfdatum: 15.08.2021
Beginn: 15.08.2021
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Asthenia Dizziness Hyperhidrosis Loss of consciousness

Symptomtext

Approx 3 mins after vaccine admin, patient felt weak, sweaty and light headed. Patient states he "passed out" for about a minute but quickly regained full alertness. Patient reports feeling 100% better after drinking juice and resting. Patient reports not having any food today prior to vaccine. After 15mins obvs time done, patient reports feeling well enough to leave clinic with partner and go home.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Loss of consciousness
Hospital-Tage: -
Labordaten: n/a
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1545268

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EW0183

schwer

Staat: IL
Alter: 36,0
Geschlecht: M
Eingang: 11.08.2021
Impfdatum: 11.08.2021
Beginn: 11.08.2021
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Fall Loss of consciousness Syncope

Symptomtext

Shortly after receiving the vaccine, patient fainted while sitting in a chair during the 15 minute observation period. He slowly slid off of the chair and landed beneath the chair. EMS was immediately alerted and I went to his aid. He quickly came to and was responsive. EMS arrived and evaluated him and he was released with family members about one-half hour after the event.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Loss of consciousness
Hospital-Tage: -
Labordaten: None
Aktuelle Erkrankungen: None
Vorgeschichte: None
Andere Medikamente: Unknown
Allergien: None
Vorherige Impfungen: -

VAERS 1536877

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EW0183

schwer

Staat: WA
Alter: 30,0
Geschlecht: M
Eingang: 09.08.2021
Impfdatum: 21.04.2021
Beginn: 17.07.2021
Tage bis Beginn: 87,0
Dosis: 2
Route/Site: - / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: ja

Bell's palsy Eyelid function disorder Facial paralysis Fine motor skill dysfunction Movement disorder Neurological examination

Symptomtext

Diagnosed with Bell's Palsy. Complete loss of motor skills and movement on left side of face. Unable to close left eye, unable to raise left eye brow, zero lip movement. Overall, total loss of control over lower cranial facial nerve. Prescribed with anti-viral and steroid. Recovery at about 95% of movement on August 9th, 2021.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Bell's palsy
Hospital-Tage: -
Labordaten: Multiple physical and neurological tests on 7/23
Aktuelle Erkrankungen: None
Vorgeschichte: Psoriasis, slightly elevated high blood pressure (pre-hypertension 130-140)
Andere Medikamente: Vitamin D3, Tumeric Curcumin, Fish Oil, Daily Probiotic, Ativan (prescribed)
Allergien: None
Vorherige Impfungen: -

VAERS 1536672

UNKNOWN MANUFACTURER · VACCINE NOT SPECIFIED (NO BRAND NAME) · Charge EW0183

schwer

Staat: CO
Alter: 61,0
Geschlecht: M
Eingang: 09.08.2021
Impfdatum: 22.05.2021
Beginn: 20.07.2021
Tage bis Beginn: 59,0
Dosis: 2
Route/Site: SYR / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein

Angiogram Bell's palsy Blood glucose Computerised tomogram head Electrocardiogram Facial paralysis Full blood count International normalised ratio Metabolic function test Prothrombin time Troponin Troponin I

Symptomtext

First vaccine given on 5/22/2021 no adverse reaction at that time. Second Vaccine given on 6/12/2021 no adverse reaction at the time of injection. On 7/20/2021 came home from work around 10:30 PM when wife noticed the drooping in face like a stroke. Was taken to Hospital emergency room by private vehicle. Bloodwork and CT scan was preformed. Diagnosed with Krames Bell's Palsy Prescribed Acyclovir and Prednisone. Released from emergency room

Weitere VAERSDATA-Felder

Praegender Schweregrund: Bell's palsy
Hospital-Tage: -
Labordaten: Basic Metabolic panel CBC with Auto Differential POCT Glucose (bedside) Preformed 2 times POCT Troponin PT/INR Troponin I Type and Screen CT Head Stroke Alert CTA Brain and Perfusion CTA head/neck WWO Contrast ECG (Electrocardiogram) 12 lead
Aktuelle Erkrankungen: Pfizer lot #EW0183 5/22/2021 1st dose Pfizer lot #EW0183 6/12/2021 2nd dose
Vorgeschichte: Diabetic High blood pressure High Cholesterol
Andere Medikamente: Cyanocobalamin b12 1000 mg once daily Glipizide 10 mg 1 @ am 1 @ noon and 2 @ bedtime Amlodipine 10 mg once daily Losartan 100 mg once daily Atenolol 50 mg once daily am Aspirin 81 mg once daily Metformin 1
Allergien: codine
Vorherige Impfungen: -

VAERS 1336040

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EW0183

schwer

Staat: WI
Alter: 17,0
Geschlecht: M
Eingang: 06.08.2021
Impfdatum: 13.05.2021
Beginn: 16.05.2021
Tage bis Beginn: 3,0
Dosis: 2
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: unbekannt

C-reactive protein increased Chest pain Echocardiogram normal Electrocardiogram ST segment depression Electrocardiogram ST segment elevation Condition aggravated Dyspnoea Hyperhidrosis Myocarditis Troponin increased Nausea Pain in extremity

Symptomtext

17 year old male with no significant past medical history who presents with chest pain. Over a few days prior to admission, his chest pain started to worsen, 8/10 and started to radiate down his left arm. It was also associated with shortness of breath, nausea, and sweating. He was brought to an outside ED for further evaluation. He otherwise has not had any recent fevers, chills, cough, runny nose, headache, vomiting, or diarrhea. He has not had any recent illnesses. He has no known COVID-19 infections. He received the second COVID-19 shot (pfizer) three days prior to admission. Of note, he does have a history of chest pain starting October of 2020. He was prescribed Prilosec 20 mg one time daily at that time and has been taking that since then. Primary Discharge Diagnosis Myopericarditis

Weitere VAERSDATA-Felder

Praegender Schweregrund: Myocarditis
Hospital-Tage: 3,0
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1523314

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge ew0183

schwer

Staat: MT
Alter: 15,0
Geschlecht: F
Eingang: 03.08.2021
Impfdatum: 03.08.2021
Beginn: 03.08.2021
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: ja

Generalised tonic-clonic seizure

Symptomtext

After receiving Pfizer vaccination, pt had a seizure 8 minutes later. Seizure, Grand Mal, lasting 10-15 seconds. Pt was triaged and stabilized. An ambulance transported pt to local hospital.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Generalised tonic-clonic seizure
Hospital-Tage: -
Labordaten: None in this clinic
Aktuelle Erkrankungen: none
Vorgeschichte: none
Andere Medikamente: none
Allergien: none
Vorherige Impfungen: -

VAERS 1522682

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EW0183

schwer

Staat: NJ
Alter: 35,0
Geschlecht: F
Eingang: 03.08.2021
Impfdatum: 02.08.2021
Beginn: 02.08.2021
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: ja

Dysmenorrhoea Electrocardiogram normal Syncope Tachycardia

Symptomtext

35-year-old female with past medical history of uterine fibroids, hypertension, syncopal episodes. She presents the emergency department after a witnessed syncopal episode at a vaccine clinic. She states she has had a syncopal episodes in the past which involved her being on her menstrual cycle and experiencing very painful menstrual cramps. She states this was no different in the past and she states she is currently on her cycle and was having extreme pain which she describes menstrual cramps before her syncopal episode. Her mother witnessed the syncopal episode and states she did not fall there is no signs of trauma on the patient. Patient states she would not come to emergency room other than staff at the vaccine site urging her to come. After using the Wells criteria on the patient it exhibits a very low risk approximately 2% that the patient has a pulmonary embolism. She had tachycardia upon arrival with a rate of 105, But she is currently having multiple pulse checks that have all been under 100 bpm.Patient was given fluids and lab work was ordered. Patient to be discharged, on physical exam and evaluation of lab work there is no concern for pulmonary embolism or any emergent condition.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Syncope
Hospital-Tage: -
Labordaten: Patient's EKG shows a rate of 99, normal sinus rhythm, no evidence prolonged QRS or PR intervals. There are no ST segment elevations..
Aktuelle Erkrankungen: -
Vorgeschichte: HYPERTENSION/UTERINE FIBROIDS/MORBID OBESITY
Andere Medikamente: -
Allergien: NONE
Vorherige Impfungen: -

VAERS 1355345

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EW0183

schwer

Staat: QM
Alter: 56,0
Geschlecht: M
Eingang: 03.08.2021
Impfdatum: 13.05.2021
Beginn: 13.05.2021
Tage bis Beginn: 0,0
Dosis: 2
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: nein

C-reactive protein increased Chest pain Echocardiogram abnormal Malaise Pericardial effusion Pericarditis Troponin normal

Symptomtext

Post covid vaccine pericarditis with persistent chest pain

Weitere VAERSDATA-Felder

Praegender Schweregrund: Pericarditis
Hospital-Tage: 3,0
Labordaten: EE was admitted to hospital on 5/26/21
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1512013

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EW0183

schwer

Staat: FL
Alter: 62,0
Geschlecht: F
Eingang: 29.07.2021
Impfdatum: 19.05.2021
Beginn: 08.06.2021
Tage bis Beginn: 20,0
Dosis: 2
Route/Site: - / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Anaphylactic reaction Drug ineffective Ear discomfort Headache Influenza Lymphadenopathy Neck pain Ocular discomfort Rash Suspected COVID-19 Swelling

Symptomtext

could have had COVID that's why I had severe allergic reaction; could have had COVID that's why I had severe allergic reaction; neck was swollen; felt like the back of her eyeballs were poking/feeling of the eyeball outward/like to the front, like they would pop out of her eye; severe headache; lymphadenopathy/appeared neck was swollen, probably lymph nodes, swollen to the back and side; neck pain feeling of the eye ball outward lasted 1-4 days/severe neck pain; ear burning in ear drums/burning in eardrums, both ears; I thought a severe allergic reaction was like anaphylaxis; little reaction on her left forearm, of a rash; bad flu; This is a spontaneous report from a contactable nurse (patient). This nurse reported different events for different vaccine doses for the same patient. This is one of the two reports. A 62-years-old female patient received dose 2 of BNT162B2 (Pfizer-BIONTECH COVID-19 Vaccine), via an unspecified route of administration on 08Jun2021 at 15:00 (Batch/Lot Number: EW1071) single; and dose 1 via an unspecified route of administration on 19May2021 (Batch/Lot Number: EW0183) single, for COVID-19 immunization. The patient's medical history was not reported. Concomitant medication included diphenhydramine hydrochloride (BENADRYL) taken for an unspecified indication from Jun2021 to 09Jun2021. It was reported that with the first Pfizer vaccine dose on 19May2021, she developed chills, had severe headache, feeling of ants crawling in her throat, and shooting pain in the calves and left calf shot down to the big toe, it was shooting pain, but both calves were involved. The patient experienced rash on 08Jun2021; anaphylactic reaction on 09Jun2021; severe headache, 'lymphadenopathy', 'neck pain', 'ear discomfort', 'swelling', 'ocular discomfort' on 09Jun2021 at 15:00; and bad flu in 2021. After what the patient experienced with the first vaccine dose, she was indicated to take Benadryl thirty minutes before the second vaccine. She was however told that it could mask potential side effects. Due to the masking potential, she stopped taking it and reported adverse events. The patient reported lymphadenopathy, headache, neck pain, feeling of the eye ball outward which lasted 1-4 days, and ear burning in ear drums. The patient stated that these (unspecified) stopped on Sunday. Stated that the headache was most severe. Also stated that "I thought a severe allergic reaction was like anaphylaxis". The patient was at another doctor's office and was indicated that she could also have had COVID that's why she had a severe allergic reaction. According to her, she had never been mask less, and was double masking. She works from home. Second vaccination was two weeks post. She could have possibly gotten it, bad flu, that would be the only time she could have. The patient had called on 09Jun2021 as she got her second dose of the Pfizer vaccine on 08Jun2021 and someone was supposed to call her back from the department, whoever handled Adverse Events, but no one ever returned the call or sent an email. She took the first Pfizer vaccine on 19May2021 and had severe headache, feeling of ants crawling in her throat, shooting pain in calves and left calf shot down to the big toe, it was shooting pain, but both calves were involved, and she had spoken to an employee health nurse, who suggested she take a Benadryl 30 minutes before the second vaccine. As they were concerned about the crawling in her throat, they feared anaphylactic reaction to the second, as people said the second was worse, and she called her doctor to confirm, who was also in agreement for her to take it. Her doctor said to take it and take it every 4-6 hours for the first 24 hours, and she had the vaccine on the 8th at around 3PM, and had a little reaction on her left forearm, of a rash. It lasted about 10 minutes and went away. At the vaccine site, they let her go, and she took the Benadryl twice more, her last dose was at 0130. On 09Jun2021, she called Pfizer, who said they don't recommend to take Benadryl, that it could be masking potential side effects that can lead to anaphylaxis, so she stopped taking her last dose at 0130, and at 3PM on the 9th, she had severe headache, neck pain, it appeared her neck was swollen, stated it was probably lymph nodes that were swollen to the back and side, she had burning in her eardrums, both ears, and she felt like the back of her eyeballs were poking, like to the front, like they would pop out of her eye (she thought that was the most predominant symptoms she had). It lasted for 3 days. She spoke to someone on 09Jun2021 in the morning. and stopped taking Benadryl, and they said she would get a call from Pfizer and she thought she would report those side effects after the second dose because they happened in the afternoon, and now she has a day off from work, so she thought to call and say what happened with the second dose. The patient stated that she works from home, but she was not clinical. Confirmed it was the COVID 19 Pfizer vaccine that she received. The severe headache started after 3PM on 09Jun 2021, it was not ongoing and it went away on Sunday, which the reporter provided as "12Jun2021" The patient stated that she has had intermittent headaches ever since, so has recovered with lasting effects, they are not as severe as the original, but she had some lasting effects. The patient was inquiring if she should receive a booster. According to the patient, they were talking about the potential of having to give boosters, and with everything she had been through with the first two (the second was worse than the first), she was ambivalent about getting the booster. Outcome of the event 'rash' was recovered on 08Jun2021; for 'lymphadenopathy', 'swelling', and 'ocular discomfort' was recovered on 10Jun2021; for 'neck pain' and 'ear discomfort' was recovered on 11Jun2021; for 'headache' was recovered with sequela on 12Jun2021; while for the other events was unknown. Seriousness criteria for the severe neck pain was reported as disabling; for the "burning in eardrums, both ears" was not serious; while for the initial headache, to the 12th was severely debilitating, she couldn't do anything, it was horrible, but the lasting effects were tolerable, she took Tylenol and it resolved. For the severe neck pain that ended in the morning and was no longer present (appeared neck was swollen: ended in the evening) seriousness was reported as just mild discomfort, not disabling. For the burning in eardrums that started in the evening, at hour of sleep, at night, was bilateral, burning, inner ear pain, and it was intermittent, and lasted until 11Jun2021, and she went to the ear doctor today, who said her eardrums were ok, but she was concerned, so this was reported as not serious. For the eyeballs poking that happened at the same time as burning eardrums, only at hour of sleep at night, and woke up on the 10th and it was gone, seriousness was reported that since it was intermittent, not disabling, but was annoying. Also stated that it was frightening, but she was worried if it continued, she would go to the eye doctor, but it went away. Causality for the events was reported as follows: severe headache: Yes (Related), severe neck pain: Yes (Related), "appeared neck was swollen, probably lymph nodes, swollen to the back and side": Yes (Related), burning in eardrums, both ears: Yes (Related), and "felt like the back of her eyeballs were poking, like to the front, like they would pop out of her eye": Yes (Related).; Sender's Comments: Linked Report(s) : US-PFIZER INC-2021677809 Same patient, same product, different events/vaccine dose

Weitere VAERSDATA-Felder

Praegender Schweregrund: Anaphylactic reaction
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: BENADRYL
Allergien: -
Vorherige Impfungen: -

VAERS 1508746

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EW0183

schwer

Staat: MN
Alter: 47,0
Geschlecht: M
Eingang: 28.07.2021
Impfdatum: 20.05.2021
Beginn: 20.05.2021
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: OT / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Bell's palsy Ear pain Eyelid function disorder Headache Hypoaesthesia Ocular discomfort Tongue movement disturbance

Symptomtext

Half of head became very numb; Drooping eye lid; Earache; Sharp pain in head on right side; Pressure behind eye; Tongue weakness in back of tongue on right side; bell's palsy; This is a spontaneous report from two contactable other health care professionals one of the (patient). A 47-year-old male patient received first dose of bnt162b2 (BNT162B2, Solution for injection, Lot number: EW0183), via intramuscular, administered in Deltoid Left on 20May2021 10:20 (age at the vaccination 47-year-old) as DOSE 1, SINGLE for covid-19 immunisation. Medical history included been dealing with tinnitus for over a year and hypertension from 12Jul2017 and ongoing. There were no concomitant medications. The patient previously took flush from alcohol and experienced known allergies. Patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Patient did not receive any other medications within 2 weeks of vaccination. Prior to vaccination the patient was not diagnosed with COVID-19. Since the vaccination, the patient has not been tested for COVID-19. Patient experienced bell's palsy on 20May2021 13:00, half of head became very numb, drooping eye lid, earache, sharp pain in head on right side, pressure behind eye, tongue weakness in back of tongue on right side on 20May2021 03:30 PM. Patient received treatment of Prednisone for the event Bell's palsy. Patient visit physician office for this event. Patient did not receive treatment for other events. The outcome of the event bell's palsy was recovering and not recovered for another events. Follow up attempts are needed; further information has been requested.; Sender's Comments: Based on available information, a possible contributory role of the suspect product, BNT162B2 vaccine, cannot be excluded for the reported event Bell's palsy due to close temporal relationship. The case will be reassessed once additional information is available. The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to Regulatory Authorities, Ethics Committees and Investigators, as appropriate.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Bell's palsy
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: Hypertension
Vorgeschichte: Medical History/Concurrent Conditions: Tinnitus (Other medical history: Been dealing with tinnitus for over a year)
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1501836

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EW0183

schwer

Staat: NY
Alter: 53,0
Geschlecht: F
Eingang: 26.07.2021
Impfdatum: 19.05.2021
Beginn: 23.05.2021
Tage bis Beginn: 4,0
Dosis: 1
Route/Site: SYR / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: nein

Blood test normal Computerised tomogram normal Disturbance in attention Dizziness Echocardiogram normal Electrocardiogram normal Fatigue Feeling abnormal Head discomfort Insomnia Magnetic resonance imaging head normal Pain Syncope

Symptomtext

Fainted twice 4 days following the first dose of the vaccine, then hospitalized for 6 days. At the hospital they conducted an EKG, blood tests, electrocardiogram, an MRI of the brain, and a CAT scan. All came back normal. Was released from hospital after 6 days with no diagnosis and experiencing, both light headed and heavy headedness, brain fog, fatigue, difficulty concentrating, and difficulty sleeping. Vertigo was ruled out after two weeks. Heart condition was ruled out. Currently on Clonazepam, Gabapentin, and Amitryptiline for pain and sleep with not much improvement (also on famotidine for stomach). Fainting has not reoccurred.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Syncope
Hospital-Tage: 6,0
Labordaten: EKG, MRI, CAT scan, electrocardiogram, bloodwork (week of 5/23)- all came back normal Blood tests (May, June, July)- all normal
Aktuelle Erkrankungen: Fractured Ankle
Vorgeschichte: Discoid Lupus, Gastro-intestinal problems
Andere Medikamente: Clonazepam, Famotidine, Gabapentin
Allergien: none
Vorherige Impfungen: -

VAERS 1500989

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EW0183

schwer

Staat: CA
Alter: 18,0
Geschlecht: F
Eingang: 24.07.2021
Impfdatum: 24.07.2021
Beginn: 24.07.2021
Tage bis Beginn: 0,0
Dosis: UNK
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Cold sweat Loss of consciousness Malaise Pallor

Symptomtext

At approximately 1132, following a 2nd dose Pfizer COVID (LOT# EW0183, exp: 08/31/2021) Co-Lead RN, noted client 18 y/o female sitting in observation area stating to her father " I am not feeling well". Co-Lead RN, Lead RN, and EMT responded. A few seconds later, client turned pale and lost consciousness while seated. Client assisted to a supine position on the floor by Lead RN , EMT and Co-Lead RN. Client regained consciousness within 10 seconds of being placed supine on the floor. Client's skins were pale, clammy and cool. At 1134 vital signs were taken in supine position: BP: 108/81, HR: 70, RR26, Spo2 98% RA. Client's father reports there is a family history of syncope with injections. Furthermore, the client's father states that the last time the client ate was last night. Client denies hydrating this morning prior to vaccination. Client's father denies allergies foods/medications/environment, medical history, or use of medications. At 1141, client was assisted to a seated positions on floor and monitored for about 1 minute before transferring client to wheelchair at 11:43. Vital signs were taken at 11:43 in seated position: BP 116/75, HR: 100, RR:16, Spo2: 99% RA, and skins were pink, warm and dry. At 1214 another set of vital signs were taken: BP 101/74, HR: 94, and RR 14. Pt states "I am feeling better" and symptoms have completely resolved at 1156. Client's father provided with ER precautions and advised to follow up with PCP. At 1215 client left observation site with her father and with a steady gait.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Loss of consciousness
Hospital-Tage: -
Labordaten: none provided at public health clinic.
Aktuelle Erkrankungen: None reported by client.
Vorgeschichte: None reported by client.
Andere Medikamente: Non reported by client.
Allergien: None reported by client.
Vorherige Impfungen: -

VAERS 1495675

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EW0183

schwer

Staat: WA
Alter: 28,0
Geschlecht: M
Eingang: 22.07.2021
Impfdatum: 17.05.2021
Beginn: 20.05.2021
Tage bis Beginn: 3,0
Dosis: 2
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: nein

C-reactive protein normal Chest X-ray normal Chest discomfort Chest pain Dyspnoea Electrocardiogram ST-T segment abnormal Fibrin D dimer normal Myocarditis Orthopnoea Palpitations Pericarditis Respiratory viral panel SARS-CoV-2 test negative Sinus arrhythmia Troponin normal

Symptomtext

Dx:Pericarditis Combination of sharp and dull pain similar to episode in 04/2018 s/s: Dyspnea with lying down or orthopnea, palpitations, acute chest pain or pressure Alternative diagnosis ofr the patietn's s/s other than myocarditis are MI, PE. Alternatice etiology for cause for the patient's myocarditis: History of pericarditis in 04/2018 similar symptoms to this time. Due to the past history, I feel this is not a pertinent case to include in our overall data, but if so we will need to review the hospitalization records from 05/20/2021. 06/11/2021: Further review of records from ED visit 5/20, follow up and labs, I feel this patient should not be included due to past medical history of pericarditis.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Myocarditis
Hospital-Tage: 2,0
Labordaten: Vitals: HR: 70 BP: 110/76 O2: 98 CXR: WNL EKG: NSR with sinus arrhythmia. St & T wave abnormality, consider inferior ischemia. Resp viral Panel: neg 05/20/2021 D-Dimer: WNL CRP: WNL Troponin: WNL COVID-19: Negative 05/20/2021
Aktuelle Erkrankungen: NA: Data received from ESSENCE pull at State level. Details are limited.
Vorgeschichte: NA: Data received from ESSENCE pull at State level. Details are limited. Report indicates history of substance abuse but no specifics.
Andere Medikamente: NA: Data received from ESSENCE pull at State level. Details are limited.
Allergien: NA: Data received from ESSENCE pull at State level. Details are limited.
Vorherige Impfungen: -

VAERS 1488203

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EW0183

schwer

Staat: CA
Alter: 16,0
Geschlecht: M
Eingang: 20.07.2021
Impfdatum: 20.07.2021
Beginn: 20.07.2021
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Cold sweat Dizziness Immediate post-injection reaction Nausea Pallor Paraesthesia Syncope

Symptomtext

Immediately following 1st dose Pfizer COVID vaccine client turned pale and had a syncopal episode. Client was assisted to a supine position on the floor. Client regained consciousness within 20 seconds of syncopal episode. Client skins were pale for ethnicity, clammy and cool. Vital signs were taken in supine position: BP 121/71, HR: 69, RR 12. Client's mother denied any medication use, stated client was positive for Asperger's syndrome, denied any NKDA or allergies to foods/ environment. Client was assisted to seated position in wheelchair vitals: BP 105/46, HR 60, RR 10, skins returning to normal color for ethnicity, dry and warm. Client was assisted to zero gravity chair without incidence. Client complained of nausea, dizziness and tingling of Left arm and hand. Denied SOB, CP or HA. EMS called. Client care transferred to EMS. EMS BP: 98/50, 12 lead EKG revealed NSR. Client's mother signed client AMA from EMS care. Client stayed at observation site an additional 30 minutes. Last set of vitals BP 117/69, HR 76 RR: 10. Client stated he felt much better and all symptoms were resolved. Client's mother instructed on ED protocols and advised to follow up with PCP. Client left observation site with his mother on his own accord and with a steady gait.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Syncope
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: None
Vorgeschichte: Aspergers Syndrome
Andere Medikamente: None
Allergien: None
Vorherige Impfungen: -

VAERS 1482997

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EW0183

schwer

Staat: CA
Alter: 37,0
Geschlecht: M
Eingang: 18.07.2021
Impfdatum: 11.06.2021
Beginn: 12.06.2021
Tage bis Beginn: 1,0
Dosis: 2
Route/Site: - / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Atrial flutter Chest pain Heart rate increased Myocarditis SARS-CoV-2 test

Symptomtext

Suspected heart inflammation; high heart rate; chest pain; palpation; This is a spontaneous report from a contactable consumer (patient). A 37-year-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, Batch/Lot Number: EW0183) via an unspecified route of administration in Arm Right on 11Jun2021 12:45(at the age of 37 years old) as dose 2, single for COVID-19 immunisation. The patient medical history was not reported. Concomitant medication the patient received within 2 weeks of vaccination included metoprolol tartrate (METOPROLOL TARTRATE) taken for an unspecified indication. The patient's historical vaccine included first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Lot no: EW0183) via unspecified route of administration on 24May2021 as dose 1, single for COVID-19 immunisation. The patient did not receive any other vaccines within 4 weeks prior to the COVID. Prior to vaccination the patient was diagnosed with COVID-19. The patient experienced suspected heart inflammation, high heart rate, chest pain, and palpation on 12Jun2021 10:00. Adverse event resulted in doctor or other healthcare professional office/clinic visit. Treatment received for the adverse event was colchicine. Since the vaccination the patient has not tested for COVID-19. The patient underwent lab tests and procedures which included sars-cov-2 test: positive on an unspecified date. Outcome of the events not recovered. Follow-up attempts are completed. No further information is expected.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Myocarditis
Hospital-Tage: -
Labordaten: Test Name: SARS-CoV-2 RT-PCR; Test Result: Positive
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: METOPROLOL TARTRATE
Allergien: -
Vorherige Impfungen: -

VAERS 1481648

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EW0183

schwer

Staat: NJ
Alter: 15,0
Geschlecht: M
Eingang: 17.07.2021
Impfdatum: 19.05.2021
Beginn: 19.05.2021
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: SYR / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: ja

Hypotension Syncope

Symptomtext

After the shot was given the nurse told my son to go in the next room and wait for the 15 min within 4 min my son faint on the floor everyone rush in the room and got him to wake up he had breakfast and lunch so we was sure why he fainted and we decided it's best to take him to the ER

Weitere VAERSDATA-Felder

Praegender Schweregrund: Syncope
Hospital-Tage: -
Labordaten: his blood pressure was low but the ER everything was ok
Aktuelle Erkrankungen: N/A
Vorgeschichte: N/A
Andere Medikamente: N/A
Allergien: N/A
Vorherige Impfungen: -

VAERS 1474516

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EW0183

schwer

Staat: WA
Alter: 25,0
Geschlecht: M
Eingang: 15.07.2021
Impfdatum: 10.07.2021
Beginn: 10.07.2021
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Loss of consciousness

Symptomtext

Guest was here for first dose of Pfizer COVID vaccine, reporting a hx of fainting after injection with a quick recovery. Vaccine was injected at 5:15pm by RN. The RN observed the guest losing consciousness briefly; she called for aid at 5:18pm. EMT arrived at 5:19pm. Guest was medically cleared after approximately 5 minutes of observation, stating that he felt recovered. Guest waited 15 minutes in observation area, stated that he felt well enough to walk home, and left on foot.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Loss of consciousness
Hospital-Tage: -
Labordaten: None
Aktuelle Erkrankungen: Unknown
Vorgeschichte: Unknown
Andere Medikamente: Unknown
Allergien: None
Vorherige Impfungen: -

VAERS 1464693

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EW0183

schwer

Staat: TX
Alter: 14,0
Geschlecht: F
Eingang: 12.07.2021
Impfdatum: 12.07.2021
Beginn: 12.07.2021
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Dizziness Pallor Syncope

Symptomtext

Patient received vaccine about 1415 and felt "dizzy" at about 1440pm. Pt was able to follow basic commands, appeared pale, and mother stated she "fainted." Pulse and o2 level were 70 and 97% on RA. Pt observed for 20 more minutes and was able to walk, A&O X4. Mother stated she usually feels dizzy when she gets lab work done; per mother, pt had not had anything to eat since last night.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Syncope
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: None
Vorgeschichte: None
Andere Medikamente: Omega 3
Allergien: None
Vorherige Impfungen: -

VAERS 1460379

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EW0183

schwer

Staat: CA
Alter: 16,0
Geschlecht: M
Eingang: 09.07.2021
Impfdatum: 29.06.2021
Beginn: 07.07.2021
Tage bis Beginn: 8,0
Dosis: 2
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: ja Hospital: ja Disable: unbekannt ER: ja Erholt: nein

Computerised tomogram head normal Drug screen negative Electroencephalogram abnormal Intensive care Laboratory test normal Loss of consciousness Magnetic resonance imaging head normal Postictal state Seizure

Symptomtext

Late in the evening on July 7 patient began having multiple seizures. EMTs were called and patient was transferred to local hospital while seizing. Patient stabilized in ER with injections. But since patient was unconscious (postIcatal) he was transferred to ICU until stabilized on oral medication. Patient in hospital for 36 hours.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Intensive care
Hospital-Tage: 1,0
Labordaten: MRI, CT and EEG. Also labs such as drug screens. Everything negative except EEg which showed increase activity in right midtemporal lobe
Aktuelle Erkrankungen: Fractured right wrist on May 18, 2016
Vorgeschichte: none
Andere Medikamente: none
Allergien: none
Vorherige Impfungen: -

VAERS 1457701

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EW0183

schwer

Staat: ID
Alter: 27,0
Geschlecht: M
Eingang: 08.07.2021
Impfdatum: 13.05.2021
Beginn: 29.06.2021
Tage bis Beginn: 47,0
Dosis: 2
Route/Site: SYR / UN

Tod: unbekannt Lebensbedrohlich: ja Hospital: ja Disable: unbekannt ER: unbekannt Erholt: nein

Abdominal pain Biopsy heart Cardiac tamponade Constipation Echocardiogram Electrocardiogram abnormal Eosinophilic myocarditis

Symptomtext

~6 weeks after receiving the second dose of his COVID vaccine, Patient developed abdominal pain and constipation that worsened over several days and prompted him to seek treatment in the ED. In the ED he was found to have cardiac tamponade and was hospitalized. A biopsy of his heart tissue revealed that he had eosinophilic myocarditis. He is currently receiving treatment and further studies are being performed to evaluate for possible causes. At this time, it is unclear what role the COVID vaccine played in the development of his condition. While he is outside the window of time in which patients usually develop myocarditis due to the COVID vaccine, our team wanted to report this potential adverse event for the sake of thoroughness.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Eosinophilic myocarditis
Hospital-Tage: 4,0
Labordaten: - Multiple EKGs 7/4-7/8 - Transthoracic Echocardiography 7/4, 7/6 - Endomyocardial biopsy 7/6
Aktuelle Erkrankungen: - palmar eczema
Vorgeschichte: - none
Andere Medikamente: - topical bethamethasone - oral finasteride
Allergien: - none
Vorherige Impfungen: -

VAERS 1446685

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EW0183

schwer

Staat: WA
Alter: 14,0
Geschlecht: M
Eingang: 04.07.2021
Impfdatum: 04.06.2021
Beginn: 11.06.2021
Tage bis Beginn: 7,0
Dosis: 2
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Blood creatine phosphokinase normal Brain natriuretic peptide normal Chest X-ray normal Chest pain Dizziness Dyspnoea Electrocardiogram normal Fatigue Syncope Troponin normal

Symptomtext

1 week after receiving vaccine #2, PT complained of fatigue and. Started getting lightheaded with standing and walking. Day 11 after the vaccine he complained of chest pain, so I took in to the ED at Hospital. His EKG, CXR, tropinin, CK,BNP were normal but he was orthostatic by heart rate. He followed up with Dr. and he recommended push fluids, more salt/Gatorade. He has continued to have orthostatic tachycardia and when he walks household distances his HR goes up to 120-140. He is lightheaded with minimal exertion. Climbing one flight of stairs makes him short of breath. He has an appointment with Dr. tomorrow, 7-5 and I will request more labs and cardiology referral. PT was in good shape and played basketball before the vaccine.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Syncope
Hospital-Tage: -
Labordaten: EKG, BNP, CK, CXR, tropinin all normal 6//15/21
Aktuelle Erkrankungen: None
Vorgeschichte: None
Andere Medikamente: Ibuprofen prior to dose.
Allergien: None
Vorherige Impfungen: -

VAERS 1446524

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EW0183

schwer

Staat: NH
Alter: 44,0
Geschlecht: F
Eingang: 04.07.2021
Impfdatum: 20.05.2021
Beginn: 20.05.2021
Tage bis Beginn: 0,0
Dosis: 2
Route/Site: SYR / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: ja ER: unbekannt Erholt: nein

Abnormal dreams Asthenia Autoimmune disorder Blood test Chest pain Chills Dizziness Electric shock sensation Electrocardiogram Head discomfort Headache Immediate post-injection reaction Loss of personal independence in daily activities Paraesthesia Peripheral swelling Pyrexia Tinnitus

Symptomtext

Normal immune reaction: fever, chills, headache Abnormal immune reactions developed immediately including tinnitus in left ear, brain zaps or head rushes constantly throughout the day and night with and without dizziness and tingling and swelling in extremities. This has not resolved six weeks post-vaccine. Developed chest pain, vivid dreams, and head pressure/pain. I've seen an ENT specialist and the Neurologist who are calling these long-haul autoimmune reactions. It feels as if my nervous system is in overdrive and inflamed. It is debilitating and is inhibiting my daily life. I am a healthy 44-year-old woman who was in great health prior to this vaccine.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Electric shock sensation
Hospital-Tage: -
Labordaten: EKG Full panel blood work MRI to be conducted 7/12/21
Aktuelle Erkrankungen: None
Vorgeschichte: Vestibular issues in the left ear but have been resolved for years.
Andere Medikamente: Vybrid 10 milligrams
Allergien: Sulfa
Vorherige Impfungen: tetannis shot at age 10 and had adverse reaction, sick for over a week with flu like symptoms.

VAERS 1442649

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EW0183

schwer

Staat: MI
Alter: 48,0
Geschlecht: F
Eingang: 02.07.2021
Impfdatum: 01.06.2021
Beginn: 01.06.2021
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: - / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Aphonia Chest discomfort Chills Coagulation test Cough Feeling cold Feeling hot Hyperhidrosis Oropharyngeal pain Rhinorrhoea SARS-CoV-2 test Thrombosis White blood cell count

Symptomtext

Her body produces mucous/blowing her nose; She had a horrible cough she couldn't get out; her blood clot was already high; lose her voice; She had chills; rattle in her chest; She was cold ,and it was hot (88 degrees); She was sweating, and was warm all over her body.; She was sweating, and was warm all over her body.; Her throat seemed sore after.; She had dry cough. It felt dry; This is a spontaneous report from a contactable consumer (Patient) via Medical Information Team. A 48-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation: solution for injection, Batch/Lot Number: EW0183, NDC number and Expiry date: Unknown), via an unspecified route of administration, administered in left arm on 01Jun2021 (at the age of 48-years-old) as dose 1, single for COVID-19 immunisation. Medical history included ongoing high WBC/white blood cell count increased and anaemic. Patient was overweight. Patient said that before the shot, she as been exposed to COVID-19 and never caught the virus. She has taken a COVID-19 test and it was negative two days ago and does not have COVID. Concomitant medication(s) included fenofibrate taken for blood cholesterol, colecalciferol (VITAMIN D 2000), iron, losartan and hydrochlorothiazide taken for blood pressure, from an unspecified start date and ongoing. It was reported that, two days after getting vaccinated, the patient got sick, and she feels like she has pneumonia. She was overweight. On an unspecified date in Jun2021, her body produces mucous/blowing her nose, and she had chills on 03Jun2021. Patient said that it all started a little after the shot. She felt like she had sand in her throat and she woke up feeling bad. She had a horrible cough on an unspecified date she could not get out. She still has a rattling in her chest. She wants to know if it is possible for this to stay in her chest and form a blood clot. Patient said that after vaccination, she had her nephew graduation, and she screamed at it. Then her throat seemed sore after and she would lose her voice, but it would come back. Her throat started hurting. As the days went on, she felt like there was dust in her throat. She had dry cough and it felt dry. It was like more dust had collected in her throat. Patient felt real sick, but she never had a fever. She was cold and it was hot (88 degrees) in and was sweating and was warm all over her body. Patient has a higher than normal WBC/ and that was one of her main concerns about getting the vaccine. Since her blood clot was already high and she was scared it would put her WBC in maximum overdrive. There was no investigation assessment. The patient underwent lab tests and procedures which included coagulation test: high on unspecified date in 2021 her blood clot was already high, SARS-CoV-2 test: Negative on 30May2021 and white blood cell count: high on unspecified date in 2021 (high white blood cell count). Patient wanted to know if there is any chance of getting pneumonia with the vaccine for which patient received response as "a review of the Prescribing Information for Pfizer COVID-19 vaccine failed to find any information regarding pneumonia being an adverse event with the vaccine". Patient was wondering if Pfizer is getting reports of side effects being full on pneumonia like symptoms that last. Patient asked if there was any chance that of blood clots after vaccination, and would like to know if anemic people who had the vaccine had adverse events and if there had been reports of cytokine storm and received response which says, failed to find any information regarding cytokine storm being an adverse event with the vaccine and was asked patient to consult with her doctor or health care provider for further guidance. The outcome of the events rattle in her chest, her throat seemed sore after, she had dry cough and her blood clot was already high was not recovered, and the outcome of chills, she got sick, her body produces mucous/blowing her nose, she had a horrible cough she couldn't get out, she was cold, and it was hot (88 degrees), she was sweating, and was warm all over her body and lose her voice was unknown. Information on Lot/Batch number was available. Additional information has been requested.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Thrombosis
Hospital-Tage: -
Labordaten: Test Date: 2021; Test Name: Blood clot; Result Unstructured Data: Test Result:High; Comments: her blood clot was already high.; Test Date: 20210530; Test Name: COVID-19; Test Result: Negative ; Test Date: 2021; Test Name: WBC; Result Unstructured Data: Test Result:High; Comments: high white blood cell count
Aktuelle Erkrankungen: WBC increased (she has a high white blood cell count and is anemic.)
Vorgeschichte: Medical History/Concurrent Conditions: Anemic (she has a high white blood cell count and is anemic.); Overweight (She is overweight)
Andere Medikamente: FENOFIBRATE; VITAMIN D 2000; IRON; LOSARTAN; HYDROCHLOROTHIAZIDE
Allergien: -
Vorherige Impfungen: -

VAERS 1440503

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EW0183

schwer

Staat: VA
Alter: 18,0
Geschlecht: M
Eingang: 01.07.2021
Impfdatum: 26.06.2021
Beginn: 27.06.2021
Tage bis Beginn: 1,0
Dosis: 2
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: ja

Chest pain Echocardiogram Electrocardiogram ST segment elevation Hyperdynamic left ventricle Myocarditis Troponin I increased

Symptomtext

Chest pain found to have perimyocarditis

Weitere VAERSDATA-Felder

Praegender Schweregrund: Myocarditis
Hospital-Tage: -
Labordaten: Troponin I 7.99 EKG with ST elevation in mid precordial leads TTE: hyperdynamic systolic function
Aktuelle Erkrankungen: None
Vorgeschichte: psoriasis alopecia
Andere Medikamente: Ixekizumab every 4 weeks
Allergien: none
Vorherige Impfungen: -

VAERS 1437894

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EW0183

schwer

Staat: NY
Alter: 12,0
Geschlecht: F
Eingang: 30.06.2021
Impfdatum: 30.06.2021
Beginn: 30.06.2021
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Syncope

Symptomtext

Patient fainted after she received Pfizer 1st dose.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Syncope
Hospital-Tage: -
Labordaten: None
Aktuelle Erkrankungen: None according to vaccination record
Vorgeschichte: None according to vaccination record
Andere Medikamente: None known
Allergien: None known
Vorherige Impfungen: -

VAERS 1437022

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EW0183

schwer

Staat: MA
Alter: 16,0
Geschlecht: M
Eingang: 30.06.2021
Impfdatum: 08.05.2021
Beginn: 01.05.2021
Tage bis Beginn: -
Dosis: 1
Route/Site: OT / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Seizure

Symptomtext

Breakthrough seizure; This is a spontaneous report from a contactable consumer. This consumer reported for a 16-year-old male patient (reporter's son) who received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, lot number was EW0183 and expiration date was not reported), dose 1 via intramuscular route, administered in arm right on 08May2021 at 09:00 as dose 1, single and dose 2 via intramuscular route, administered in arm right on 29May2021 at 09:00 (lot number was EW0191 and expiration date was not reported) as dose 2, single for COVID-19 immunisation. Medical history included epilepsy. The additional information reported as: he had not a seizure in over an year until he got the vaccine. He was on medication and he has just got his level checked, a month before and they were fine, they were in range. The patient did not receive any other vaccination within 4 weeks prior to the first administration of the suspect vaccine. Concomitant medications included levetiracetam (KEPPRA) taken for an unspecified indication, start and stop date were not reported. On an unspecified date in May2021, the patient experienced breakthrough seizure. The clinical course of the event was reported as: The reporter was calling just to let know that, a week after each of the vaccine shot the reporter's son got, a week after each of those shots he had a bad seizure, a breakthrough seizure which was he was on his medication. His end level range and had seizure that whether it was the side effect from Pfizer or not the reporter just wanted to make aware it happened both times the first time was coincidence but happened twice, just wanted to make aware. 09 days after the first shot he got a seizure and then after his second shot, 12 days later he had a seizure. The reporter inquired if someone aware of it, in case someone else had the same thing. The outcome of the event was unknown. Information on lot/batch number was available. Additional information has been requested.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Seizure
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: Medical History/Concurrent Conditions: Epilepsy (He hasn't a seizure in over an year until he got the vaccine.)
Andere Medikamente: KEPPRA
Allergien: -
Vorherige Impfungen: -

VAERS 1403790

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EW0183

schwer

Staat: CA
Alter: 23,0
Geschlecht: M
Eingang: 30.06.2021
Impfdatum: 11.06.2021
Beginn: 14.06.2021
Tage bis Beginn: 3,0
Dosis: 2
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: ja

C-reactive protein increased Chest pain Myocarditis Troponin increased Dyspnoea Electrocardiogram abnormal

Symptomtext

Chest pain two days after receiving second dose of vaccine that lasted for about an hour. Located in center of chest, associated with some shortness of breath.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Myocarditis
Hospital-Tage: -
Labordaten: EKG showed changes in inferior leads, troponin level elevated. (6/24/21)
Aktuelle Erkrankungen: -
Vorgeschichte: None
Andere Medikamente: None
Allergien: None
Vorherige Impfungen: -

VAERS 1410144

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge ew0183

schwer

Staat: MI
Alter: 15,0
Geschlecht: M
Eingang: 29.06.2021
Impfdatum: 14.06.2021
Beginn: 16.06.2021
Tage bis Beginn: 2,0
Dosis: 1
Route/Site: IM / AR

Tod: unbekannt Lebensbedrohlich: ja Hospital: ja Disable: unbekannt ER: unbekannt Erholt: ja

Chest pain Electrocardiogram abnormal Malaise Troponin increased Echocardiogram normal Electrocardiogram normal Myocarditis

Symptomtext

chest pain and malaise

Weitere VAERSDATA-Felder

Praegender Schweregrund: Myocarditis
Hospital-Tage: 3,0
Labordaten: elevated troponins, ekg changes
Aktuelle Erkrankungen: none
Vorgeschichte: none
Andere Medikamente: none
Allergien: none
Vorherige Impfungen: -

VAERS 1431091

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge ew0183

schwer

Staat: MI
Alter: 56,0
Geschlecht: M
Eingang: 28.06.2021
Impfdatum: 20.05.2021
Beginn: 24.05.2021
Tage bis Beginn: 4,0
Dosis: 2
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein

Seizure

Symptomtext

The patient stated they had a seizure 3 days after the second COVID vaccine. He was taken by ambulance to the hospital for treatment.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Seizure
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1382634

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EW0183

schwer

Staat: MA
Alter: 13,0
Geschlecht: F
Eingang: 28.06.2021
Impfdatum: 04.06.2021
Beginn: 07.06.2021
Tage bis Beginn: 3,0
Dosis: 1
Route/Site: IM / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: ja

Blood thyroid stimulating hormone Brain natriuretic peptide normal Chest X-ray normal Chest pain Dyspnoea C-reactive protein increased Magnetic resonance imaging abnormal Magnetic resonance imaging heart Myocarditis Electrocardiogram abnormal Full blood count normal Metabolic function test Red blood cell sedimentation rate Red blood cell sedimentation rate increased Troponin T increased SARS-CoV-2 test negative Troponin increased

Symptomtext

Chest pain

Weitere VAERSDATA-Felder

Praegender Schweregrund: Myocarditis
Hospital-Tage: 3,0
Labordaten: Elevated Troponin T high sensitivity. Mildly elevated ESR and CRP. Cardiac MRI - mild myocarditis features.
Aktuelle Erkrankungen: none
Vorgeschichte: none
Andere Medikamente: none
Allergien: none
Vorherige Impfungen: -

VAERS 1424872

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EW0183

schwer

Staat: -
Alter: 17,0
Geschlecht: F
Eingang: 24.06.2021
Impfdatum: 24.06.2021
Beginn: 24.06.2021
Tage bis Beginn: 0,0
Dosis: UNK
Route/Site: - / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: unbekannt

Blood glucose normal Dizziness Fall Head injury Memory impairment Nausea Pallor Syncope

Symptomtext

Upon walking to recovery area patient went pale and fainted. Witnessed fall, fell and hit head on the floor. Vital signs taken: BP:110/60 HR:70 SpO2: 98% in RA. Pt initially did not recall receiving vaccine but when asked orientation questions, she answered all appropriately (A&Ox4). Within five minutes EMS on scene to assess pt. Pt could not recall last meal, BG checked and was 91. Upon sitting up pt was nauseated and dizzy. Pt transferred to ED for follow up care.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Syncope
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: n/a
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1417915

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EW0183

schwer

Staat: -
Alter: 28,0
Geschlecht: M
Eingang: 22.06.2021
Impfdatum: 17.04.2021
Beginn: 20.05.2021
Tage bis Beginn: 33,0
Dosis: UNK
Route/Site: - / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: unbekannt

Condition aggravated Electrocardiogram change Pericarditis Troponin

Symptomtext

28 year old male with history of pericarditis in 2018 with recurrence that occurred approximately 3 weeks after 2nd dose of Pfizer vaccine. No elevated troponins, but did have EKG changes; no comparison from previous studies.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Pericarditis
Hospital-Tage: 2,0
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: Hx of pericarditis in 2018
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1413494

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EW0183

schwer

Staat: IN
Alter: 12,0
Geschlecht: F
Eingang: 20.06.2021
Impfdatum: 18.06.2021
Beginn: 18.06.2021
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: SYR / LA

Tod: unbekannt Lebensbedrohlich: ja Hospital: ja Disable: unbekannt ER: ja Erholt: ja

Blood test Computerised tomogram Electroencephalogram Seizure Urine analysis

Symptomtext

Multiple seizures lasting longer than 30 minutes. This happened after the second dose on 6/18/2021. Happened approximately 7 hours post vaccination. Required ambulance transport to emergency room and overnight hospitalization at a hospital.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Seizure
Hospital-Tage: 1,0
Labordaten: Blood tests CT scan EEG urinalysis
Aktuelle Erkrankungen: N/A
Vorgeschichte: Autism
Andere Medikamente: Seroquil Adderall Zoloft
Allergien: None
Vorherige Impfungen: -

VAERS 1413331

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EW0183

schwer

Staat: VA
Alter: 12,0
Geschlecht: M
Eingang: 20.06.2021
Impfdatum: 15.06.2021
Beginn: 17.06.2021
Tage bis Beginn: 2,0
Dosis: 1
Route/Site: IM / AR

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: ja

Cardiac imaging procedure abnormal Chest pain Chills Headache Myocarditis Pyrexia Troponin I increased

Symptomtext

The day after receiving the second dose of the Pfizer mRNA SARS-CoV-2 vaccine the patient had a transient tactile fever and headache. He felt well on 6/17 and went swimming which brought on transient chills and then proceeded to develop midline chest pain. The chest pain worsened, leading to hospitalization on 6/18 with confirmation of myocarditis on cardiac MRI and with elevated troponin.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Myocarditis
Hospital-Tage: 2,0
Labordaten: 6/18/21: Troponin I 15 ng/mL 6/19/21: MRI chest with myocarditis with normal heart function
Aktuelle Erkrankungen: Developed a tactile fever and headache, which were transient, the day prior to onset of chest pain. Also had transient chills prior to onset of chest pain, but the chills occurred with the patient using a swimming pool. The patient also has baseline migraine headaches.
Vorgeschichte: ADHD, migraine headaches
Andere Medikamente: Takes Adderall at baseline for ADHD but had been off of this for 2 weeks prior to onset of chest pain with cessation of school.
Allergien: None
Vorherige Impfungen: -

VAERS 1374198

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EW0183

schwer

Staat: WA
Alter: 15,0
Geschlecht: M
Eingang: 19.06.2021
Impfdatum: 25.05.2021
Beginn: 02.06.2021
Tage bis Beginn: 8,0
Dosis: 1
Route/Site: - / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein

Blood magnesium Chest X-ray Electrocardiogram Electrocardiogram abnormal Full blood count Pericarditis Syncope Metabolic function test Troponin

Symptomtext

Syncope event resulting in abnormal ekg and possible pericarditis; Syncope event resulting in abnormal ekg and possible pericarditis; Syncope event resulting in abnormal ekg and possible pericarditis; This is a spontaneous report from a contactable consumer (patient). A 15-years-old male patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration, administered in arm right on 25May2021 12:00 (Lot Number: EW0183) as first single dose for covid-19 immunization. Age at vaccination: 15-years-old. Medical history included attention deficit hyperactivity disorder (ADHD). No known allergies. Prior to vaccination, the patient was not diagnosed with COVID-19. Concomitant medications included amfetamine aspartate, amfetamine sulfate, dexamfetamine saccharate, dexamfetamine sulfate (ADDERALL) taken for an unspecified indication, start and stop date were not reported; guanfacine (GUANFACINE) taken for an unspecified indication, start and stop date were not reported. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient experienced syncope event resulting in abnormal EKG and possible pericarditis (medically significant) on 02Jun2021 15:15 with outcome of unknown. The patient underwent lab tests and procedures which included electrocardiogram: abnormal on 02Jun2021. The adverse event result in doctor or other healthcare professional office/clinic visit and emergency room/department or urgent care. Unknown if treatment was received for the event. Since the vaccination, the patient has not been tested for COVID-19. Information on lot/batch number was available. Additional information has been requested.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Syncope
Hospital-Tage: -
Labordaten: Test Date: 20210602; Test Name: ekg; Result Unstructured Data: Test Result:Abnormal
Aktuelle Erkrankungen: -
Vorgeschichte: Medical History/Concurrent Conditions: ADHD
Andere Medikamente: ADDERALL; GUANFACINE
Allergien: -
Vorherige Impfungen: -

VAERS 1374198

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EW0183

schwer

Staat: WA
Alter: 15,0
Geschlecht: M
Eingang: 19.06.2021
Impfdatum: 25.05.2021
Beginn: 02.06.2021
Tage bis Beginn: 8,0
Dosis: 1
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein

Blood magnesium Chest X-ray Electrocardiogram Electrocardiogram abnormal Full blood count Pericarditis Syncope Metabolic function test Troponin

Symptomtext

Syncope event resulting in abnormal ekg and possible pericarditis; Syncope event resulting in abnormal ekg and possible pericarditis; Syncope event resulting in abnormal ekg and possible pericarditis; This is a spontaneous report from a contactable consumer (patient). A 15-years-old male patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration, administered in arm right on 25May2021 12:00 (Lot Number: EW0183) as first single dose for covid-19 immunization. Age at vaccination: 15-years-old. Medical history included attention deficit hyperactivity disorder (ADHD). No known allergies. Prior to vaccination, the patient was not diagnosed with COVID-19. Concomitant medications included amfetamine aspartate, amfetamine sulfate, dexamfetamine saccharate, dexamfetamine sulfate (ADDERALL) taken for an unspecified indication, start and stop date were not reported; guanfacine (GUANFACINE) taken for an unspecified indication, start and stop date were not reported. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient experienced syncope event resulting in abnormal EKG and possible pericarditis (medically significant) on 02Jun2021 15:15 with outcome of unknown. The patient underwent lab tests and procedures which included electrocardiogram: abnormal on 02Jun2021. The adverse event result in doctor or other healthcare professional office/clinic visit and emergency room/department or urgent care. Unknown if treatment was received for the event. Since the vaccination, the patient has not been tested for COVID-19. Information on lot/batch number was available. Additional information has been requested.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Syncope
Hospital-Tage: -
Labordaten: Test Date: 20210602; Test Name: ekg; Result Unstructured Data: Test Result:Abnormal
Aktuelle Erkrankungen: -
Vorgeschichte: Medical History/Concurrent Conditions: ADHD
Andere Medikamente: ADDERALL; GUANFACINE
Allergien: -
Vorherige Impfungen: -

VAERS 1403346

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EW0183

schwer

Staat: MA
Alter: 15,0
Geschlecht: M
Eingang: 16.06.2021
Impfdatum: 10.06.2021
Beginn: 11.06.2021
Tage bis Beginn: 1,0
Dosis: 2
Route/Site: IM / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: ja

Blood test Brain natriuretic peptide normal C-reactive protein increased Chest X-ray normal Chest pain Chills Dyspnoea Echocardiogram abnormal Electrocardiogram ST segment elevation Epstein-Barr virus antibody Epstein-Barr virus test positive Fatigue Fibrin D dimer increased Full blood count normal Haematocrit decreased Headache Human herpes virus 6 serology Immunoglobulin therapy

Symptomtext

Patient is a healthy 15 year old male presenting with chest pain in the setting of recent SARS-CoV2 vaccination. He was in his usual state of health until he received the second dose of the Pfizer/BNT SARS-CoV2 vaccination on Thursday 6/10. Shortly after and into the following day, he developed fatigue, chills, and a headache, which resolved within 24 hours. However, early this morning at around 2am, he awoke with sharp central chest pain associated with some shortness of breath, radiating to his left, prompting him to present to the ED. Initially presented to Hospital ED. Vitals stable. Labs notable for troponin 0.07 and d-dimer 1.48. EKG with sinus rhythm, ST elevation in inferior leads. Given ibuprofen 600mg and contacted Cardiology, who recommended transfer to another ED for echocardiogram and further evaluation. Here in the ED, vital stable, exam non-focal. Labs notable for troponin 0.13 and CRP 3.0; CBC, chem 10, LFTs, BNP, all within normal limits. CXR normal. Echo done which showed normal function (prelim read). Seen by ID who recommended standard workup for vaccine-induced myocarditis. He was admitted to the floor in stable condition. Hospital Course: Due to rising troponin during hospital day 1 (peak 0.23), patient was treated with IVIG 2 g/kg (6/14) and methylprednisone 30 mg BID (6/14 - 6/15). On 6/15 a cardiac MRI was obtained that showed a small area of late gadolinium enhancement of the LV with normal function. Troponin was trended every 12 hours and had decreased to 0.11 on 6/15 AM. He was transitioned to oral prednisone 30 mg BID to complete a total steroid course of 5 days (6/14 - 6/18). During admission he was found to be EBV PCR positive with all other viral testing including EBV serologies pending. It is still thought this is likely due to post-vaccine inflammation and not viral myocarditis but serologies should be followed up as outpatient. By time of discharge, patient was well-appearing, vitals stable, demonstrating good PO intake. Prescriptions sent to preferred pharmacy. Follow up with cardiology. Discharge instructions and return precautions reviewed with patient and parent, who expressed good understanding and agreement with plan. Reasons for new, changed, and discontinued medications: Prednisone for myocarditis Famotidine for stomach protection while on prednisone Discharged home with follow up tests scheduled for 6/17/21.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Myocarditis
Hospital-Tage: 3,0
Labordaten: Relevant Diagnostic Images/Studies: Cardiac MRI (6/15): ? Normal biventricular size and systolic function. No regional wall motion abnormalities. ? Small focal area of left ventricular late gadolinium enhancement consistent with myocarditis. ? No significant valvular dysfunction. ? No pericardial effusion. Echo (6/13): ? Mild tricuspid regurgitation. ? No other significant valvar dysfunction. ? No significant right ventricular hypertension. ? Normal left ventricular size and systolic function. ? Qualitatively normal right ventricular systolic function. ? No pericardial effusion. ? Incomplete anatomic survey. CXR (6/13): Lungs: Clear. Heart/mediastinum: The cardiomediastinal silhouette is normal in size with normal contours. Pleural effusion: None. Pneumothorax: None. Osseous/soft tissue structures: Normal. Included upper abdomen: Normal. Laboratory Results Returned 48 Hours Prior to Discharge Event Name Event Result Date/Time Hematocrit 31.8 % Low 06/15/21 D-Dimer 1.48 mcg/mL FEU High 06/14/21 Troponin T 0.11 ng/mL Critical 06/15/21 Troponin T 0.13 ng/mL Critical 06/14/21 Troponin T 0.23 ng/mL Critical 06/14/21 Tests Pending EBV Antibody IgG EBV Antibody IgM EBV Antibody to NA, IgG HHV6 Antibody IgG Mycoplasma pneumoniae Antibody, IgG Mycoplasma pneumoniae Antibody, IgM Parvovirus B-19 IgG Parvovirus B-19 IgM Parvovirus DNA PCR QuaNT, Blood
Aktuelle Erkrankungen: None noted
Vorgeschichte: None noted
Andere Medikamente: None
Allergien: Penicillin
Vorherige Impfungen: -

VAERS 1402387

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EW0183

schwer

Staat: MI
Alter: 15,0
Geschlecht: M
Eingang: 16.06.2021
Impfdatum: 11.06.2021
Beginn: 11.06.2021
Tage bis Beginn: 0,0
Dosis: 2
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: ja

Malaise Seizure

Symptomtext

Per incident report: Pt stated not feeling well and Dad asked for water. At 5:41pm pt began to seize in chair, 2 staff members assisted pt to ground. Seizure lasted approximately 1 minute, pt was oriented x3 after seizure. EMS was called, transported to hospital for evaluation. Staff member called next day to check on pt, pt's mom stated he saw physician and was doing well.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Seizure
Hospital-Tage: -
Labordaten: N/A
Aktuelle Erkrankungen: N/A
Vorgeschichte: N/A
Andere Medikamente: N/A
Allergien: N/A
Vorherige Impfungen: -

VAERS 1402248

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EW0183

schwer

Staat: NJ
Alter: 14,0
Geschlecht: F
Eingang: 16.06.2021
Impfdatum: 15.06.2021
Beginn: 15.06.2021
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Cold sweat Dizziness Pallor Syncope

Symptomtext

Immediately after recieving the vaccination the patient stood up and collapsed. She was attened to be our nurses. The patient was pail and clammy and a litte dizzy. We called for paramedics who came and examined her. They offered to transport her to the hospital, but they mother declined.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Syncope
Hospital-Tage: -
Labordaten: None
Aktuelle Erkrankungen: None
Vorgeschichte: None
Andere Medikamente: None
Allergien: None
Vorherige Impfungen: -

VAERS 1400188

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EW0183

schwer

Staat: IL
Alter: 15,0
Geschlecht: M
Eingang: 15.06.2021
Impfdatum: 11.06.2021
Beginn: 13.06.2021
Tage bis Beginn: 2,0
Dosis: 1
Route/Site: IM / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: unbekannt

Myocarditis

Symptomtext

Myocarditis

Weitere VAERSDATA-Felder

Praegender Schweregrund: Myocarditis
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1396795

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EW0183

schwer

Staat: CA
Alter: 15,0
Geschlecht: M
Eingang: 14.06.2021
Impfdatum: 28.05.2021
Beginn: 28.05.2021
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: ja

Blood test normal Fatigue Heart rate increased Syncope

Symptomtext

We sat at the Care facility for approximately 10-15 min. We left facility and my son was saying in the car that he felt very tired and wanted to go home and go to bed. As soon as we got home, he was walking toward his bedroom and he say "whoa" and then fell to his knees as I caught him and fainted. He was passed out for a few seconds. I called 911 immediately and then he came to and said "what happened". Fire Dept. took blood pressure, which was 152/74 and heart rate at 136. They said his heart rate was fast. I drove him to ER at and he had a very fast heart rate, around 150 -170. He was able to go home around 10pm after the negative tests and heart rate coming down to 80-90s for a short time, but still would get high. My son kept saying he felt fine even after passing out and at the ER. He did not feel like he had a fast heart rate. ER recommended purchase a pulse oxi meter to test heart rate at home, which I purchased the next day and he's been in the normal range. He is scheduled to take the 2nd dose June 18th, but I will not let him get it since he had a severe reaction to the 1st dose.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Syncope
Hospital-Tage: -
Labordaten: did blood tests for myocarditis, blood clots, diabetes, thyroid etc. and came out negative
Aktuelle Erkrankungen: None
Vorgeschichte: None
Andere Medikamente: None
Allergien: Septra (antibiotic
Vorherige Impfungen: -

VAERS 1396778

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EW0183

schwer

Staat: TX
Alter: 15,0
Geschlecht: F
Eingang: 14.06.2021
Impfdatum: 11.06.2021
Beginn: 12.06.2021
Tage bis Beginn: 1,0
Dosis: 2
Route/Site: SYR / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Dizziness Electrocardiogram Fall Loss of consciousness Orthostatic heart rate test Presyncope Syncope

Symptomtext

18 hours after receiving the vaccine, she fainted for one minute. During this time, she first felt presyncope and then fell to the ground and lost consciousness. She revived within one minute, but has felt dizziness for 2 days after.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Loss of consciousness
Hospital-Tage: -
Labordaten: EKG Orthostatic Test
Aktuelle Erkrankungen: none
Vorgeschichte: none
Andere Medikamente: None
Allergien: none
Vorherige Impfungen: -

VAERS 1395991

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EW0183

schwer

Staat: CA
Alter: 14,0
Geschlecht: F
Eingang: 14.06.2021
Impfdatum: 07.06.2021
Beginn: 08.06.2021
Tage bis Beginn: 1,0
Dosis: 2
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Seizure

Symptomtext

Single seizure the next morning. No further events.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Seizure
Hospital-Tage: -
Labordaten: Patient will have EEG and see Pediatric Neurology.
Aktuelle Erkrankungen: None
Vorgeschichte: Incontinentia Pigmenti Syndrome. Seizure history.
Andere Medikamente: None
Allergien: None known
Vorherige Impfungen: -

VAERS 1394206

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge ew0183

schwer

Staat: MI
Alter: 57,0
Geschlecht: M
Eingang: 12.06.2021
Impfdatum: 22.05.2021
Beginn: 05.06.2021
Tage bis Beginn: 14,0
Dosis: 1
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Bell's palsy

Symptomtext

pt reported symptoms of bell's palsy 2 weeks following initial pfizer vaccine. pt was diagnosed and treated by physician with 60mg prednisone per day.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Bell's palsy
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1394086

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EW0183

schwer

Staat: NY
Alter: 53,0
Geschlecht: M
Eingang: 12.06.2021
Impfdatum: 13.05.2021
Beginn: 01.05.2021
Tage bis Beginn: -
Dosis: 1
Route/Site: - / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Condition aggravated Erythema Hypoaesthesia Investigation Paraesthesia Thrombosis

Symptomtext

Seriousness: Does not really know what it is, it could be thrombosis; Caller has experienced redness/redness in thumb and finger tips; tingling/tingling in left hand; decrease sensation in his finger tips/numbness and decreased sensation in left hand; He is still experiencing all of these and has gotten worse; This is a spontaneous report from a contactable physician (patient). A 53-year-old male patient received bnt162b2 (BNT162B2), dose 1 via an unspecified route of administration, administered in Arm Left on 13May2021 (Batch/Lot Number: EW0183) in the morning between 10:00 and 11:00 am as single dose for covid-19 immunisation at the age of 53-year-old. Medical history included an open reduction internal fixation, surgery on his right clavicle 5 years ago, which is what made him want to get the vaccine. Concomitant drugs included Multivitamin, Vitamin A and Vitamin D. The patient had an exam in December and all of the test results were normal. On 16May or 17May2021, the patient has experienced redness in thumb and fingertips, numbness, and decreased sensation in left hand, tingling in left hand. Symptoms have been ongoing for 10 days; it has progressively gotten worse. It was reported that the symptoms started 2 days after getting the vaccine on 13May2021, was 16May2021 or 17May2021. He takes multi vitamins and minerals and thought it may be related to that. He takes high doses of Vitamin A and Vitamin D. He actually thought it was due to the Vitamin A and Vitamin D. He stopped the vitamins for a few days. Treatment included: Thought maybe, apart from the vitamins, it may be because he was washing his hands so much that it may be from that. He used Aveno lotion to try and lubricate them. The outcome of event Thrombosis was unknown, outcome of other events was not recovered. The reported considered the events were related to the vaccine as it was the left finger tips, especially the thumb, compared to the right. That's why he thinks it is related to the vaccine. The clinical course was reported as: The redness was first, then the tingling. He doesn't remember the exact day. The numbness and decreased sensation were afterward. He is still experiencing all of these and has gotten worse. The thumb on the left hand looks pink and wrinkled. When comparing the right see the difference tell they are different. Seriousness: Does not really know what it is, it could be thrombosis. The redness in the thumb and finger tips is in the right as well but is not as bad as in the left. Follow attempts needed. Further information is expected.; Sender's Comments: Based on plausible dose -event relationship post vaccination and no other alternate explanation the causal role of BNT162B2 cannot be excluded for the reported event of thrombosis. The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to regulatory authorities, Ethics Committees, and Investigators, as appropriate

Weitere VAERSDATA-Felder

Praegender Schweregrund: Thrombosis
Hospital-Tage: -
Labordaten: Test Date: 202012; Test Name: exam; Result Unstructured Data: Test Result:all of the test results were normal
Aktuelle Erkrankungen: -
Vorgeschichte: Medical History/Concurrent Conditions: Open reduction of fracture with internal fixation (Had surgery on his right clavicle 5 years ago, which is what made him want to get the vaccine.)
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1374166

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EW0183

schwer

Staat: MA
Alter: 30,0
Geschlecht: M
Eingang: 04.06.2021
Impfdatum: 20.05.2021
Beginn: 26.05.2021
Tage bis Beginn: 6,0
Dosis: 2
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Electrocardiogram abnormal Pericarditis

Symptomtext

Onset of pericarditis 6 days after 2nd Pfizer vaccine - with CRP elevation and EKG changes. Symptomatically resolving after 1 week of treatment with ibuprofen.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Pericarditis
Hospital-Tage: -
Labordaten: 5/27/2021 - EKG with diffuse ST seg elevations; CRP 32.2 6/2/2021 - EKG with normalization of ST segs; CRP 3.6
Aktuelle Erkrankungen: None
Vorgeschichte: None
Andere Medikamente: None
Allergien: Sulfa - unknown reaction in childhood
Vorherige Impfungen: -

VAERS 1371766

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EW0183

schwer

Staat: TX
Alter: 12,0
Geschlecht: M
Eingang: 03.06.2021
Impfdatum: 03.06.2021
Beginn: 03.06.2021
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt

Loss of consciousness Nausea

Symptomtext

Pt stated feeling nausea, mother stated pt passed out for 15 seconds then gained consciousness. P:80 BP: 126/79 O2: 99% T: 77.5 F RR:14

Weitere VAERSDATA-Felder

Praegender Schweregrund: Loss of consciousness
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: N/A
Vorgeschichte: N/A
Andere Medikamente: N/A
Allergien: N/A
Vorherige Impfungen: -

VAERS 1371298

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge ew0183

schwer

Staat: OH
Alter: 16,0
Geschlecht: F
Eingang: 03.06.2021
Impfdatum: 02.06.2021
Beginn: 02.06.2021
Tage bis Beginn: 0,0
Dosis: 2
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Dizziness Fall Nervousness Syncope

Symptomtext

This young lady was at the school to receive her second dose of the Pfizer vaccine, she answered all the questions with a No answer, she stated she was feeling well and had minimal reaction to first vaccine. She appeared to be nervous as reported by the nurse. after recieving her second shot, as the nurse was finishing up paperwork and filling out card, the student felt like passing out, one of the other nurses that were at her side, caught her as she fainted out of chair, she was placed on the ground and EMS was called at 10:10 and Nursing Supervisor was notified at 10:15. EMS determined she had a Vasovagal Syncope. EMS attended to patient and it was unknown if she was released after observation or taken to ED for further evaluation. a field emergency record was recorded and return to the nursing supervisor at the health department.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Syncope
Hospital-Tage: -
Labordaten: Unknown
Aktuelle Erkrankungen: none reported
Vorgeschichte: none reported
Andere Medikamente: unknown
Allergien: none reported
Vorherige Impfungen: -

VAERS 1365135

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EW0183

schwer

Staat: MI
Alter: 13,0
Geschlecht: F
Eingang: 01.06.2021
Impfdatum: 28.05.2021
Beginn: 28.05.2021
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Immediate post-injection reaction Loss of consciousness Mydriasis Pallor Unresponsive to stimuli

Symptomtext

Very pale, pupils dilated, non responsive, passed out immediately after vaccination

Weitere VAERSDATA-Felder

Praegender Schweregrund: Loss of consciousness
Hospital-Tage: -
Labordaten: Epi-Pen was given
Aktuelle Erkrankungen: unknown
Vorgeschichte: unknown
Andere Medikamente: unknown
Allergien: unknown
Vorherige Impfungen: -

VAERS 1361782

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EW0183

schwer

Staat: IN
Alter: 24,0
Geschlecht: M
Eingang: 30.05.2021
Impfdatum: 28.05.2021
Beginn: 28.05.2021
Tage bis Beginn: 0,0
Dosis: 2
Route/Site: SYR / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Body temperature increased Chills Decreased appetite Fatigue Headache Injection site pain Lymphadenopathy Pain Seizure Somnolence

Symptomtext

05/28/21 around 22:30 waves of convulsions including uncontrolled shacking of the hands and upper body followed by chills and high body temperature. This lasted for until about 03:00 05/29/21. 05/29/21 consisted of mainly being in a bedridden state of fatigue, sleeping, loss of appetite, swollen and inflamed lymph glands particularly under the armpit of the injection site arm, soreness and pain in the injection site arm, headache, aches and pains throughout the entire body, and the inability to walk or stand for long periods of time. 05/30/21 lymph glands are still inflamed and swollen (particularly as stated above under the armpit of the arm that got the injection), head stills persists, along with some fatigue, and loss of appetite.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Seizure
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: No.
Vorgeschichte: No.
Andere Medikamente: Vitamin D supplement and multi vitamin.
Allergien: No.
Vorherige Impfungen: -

VAERS 1361183

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EW0183

schwer

Staat: NY
Alter: 42,0
Geschlecht: F
Eingang: 29.05.2021
Impfdatum: 29.05.2021
Beginn: 29.05.2021
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Abdominal pain Chest pain Chills Dizziness Feeling cold Hyperventilation Loss of consciousness Panic attack Vital signs measurement

Symptomtext

Pt felt dizzy, took slow deep breaths, then fell asleep onto husband's shoulder in chair for 30 seconds. Pt awoke and said she was cold and shivering, pt admits to some "chest pain", pt's vital signs were: 126/80 mmHg, 91 bpm pulse, 99% O2 sat on room air. Pt stated she has had a panic attack 4 years ago, she stated this episode "felt similar to last time". Pt given candy by staff, warm water, and emotional support by staff and spouse. Pt reported some abdominal pain after the panic attack, but improvement in other symptoms following being given warm water. No medications were administered.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Loss of consciousness
Hospital-Tage: -
Labordaten: None.
Aktuelle Erkrankungen: Denies.
Vorgeschichte: Anxiety and panic attack (4 years ago).
Andere Medikamente: Denies.
Allergien: NKDA, NKEA, NKFA.
Vorherige Impfungen: -

VAERS 1360486

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EW0183

schwer

Staat: MD
Alter: -
Geschlecht: M
Eingang: 29.05.2021
Impfdatum: 01.05.2021
Beginn: 01.05.2021
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: - / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Syncope

Symptomtext

Fainting episode upon rising from a chair; This is a spontaneous report from a contactable consumer (patient). A 12-year-old male patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE), dose 1 via an unspecified route of administration, administered in arm left on May2021 (Batch/Lot Number: EW0183) as 1st dose, single dose for covid-19 immunisation. The patient received the vaccine in a Public Health Clinic. Medical history included juvenile idiopathic arthritis from an unknown date and unknown if ongoing (Previously diagnosed with JIA, but resolved with diet change), mold, gluten and lactose intolerance from an unknown date and unknown if ongoing. The patient's concomitant medications were not reported. The patient previously took gluten for food allergy and experienced food allergy. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient experienced fainting episode upon rising from a chair on May2021. No treatment was received in response to the event. The patient was recovering from the event. Follow-up attempts are needed. Additional information has been requested.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Syncope
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: Medical History/Concurrent Conditions: Allergy to molds (Mold, gluten and lactose intolerance); Juvenile idiopathic arthritis (Previously diagnosed with JIA, but resolved with diet change); Lactose intolerance (Mold, gluten and lactose intolerance)
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1358515

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EW0183

schwer

Staat: CA
Alter: 44,0
Geschlecht: F
Eingang: 28.05.2021
Impfdatum: 14.05.2021
Beginn: 16.05.2021
Tage bis Beginn: 2,0
Dosis: 1
Route/Site: IM / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Asthenia Condition aggravated Guillain-Barre syndrome Hypoaesthesia Paraesthesia

Symptomtext

flare of GB symptoms including lower extremity weakness, numbness, and tingling.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Guillain-Barre syndrome
Hospital-Tage: -
Labordaten: Neurology referral pending
Aktuelle Erkrankungen: COVID-19 07/2020, Guillain-Barre diagnosed 2001
Vorgeschichte: Guillain-Barre
Andere Medikamente: meclizine, Zyrtec, Ventolin, Flonase
Allergien: NKDA
Vorherige Impfungen: -

VAERS 1356311

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EW0183

schwer

Staat: MI
Alter: 21,0
Geschlecht: F
Eingang: 27.05.2021
Impfdatum: 22.05.2021
Beginn: 22.05.2021
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: SYR / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Abdominal discomfort Dizziness Syncope

Symptomtext

Was extremely lightheaded right afterwards. Passed out during the 15-minute observation. Was lightheaded the next couple of days, passed out twice more that day. Was really sick to my stomach for 3 days after, with on and off dizzy spells and lightheadedness.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Syncope
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: None
Vorgeschichte: Marfan's Syndrome
Andere Medikamente: None
Allergien: None
Vorherige Impfungen: -

VAERS 1354094

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EW0183

schwer

Staat: UT
Alter: 14,0
Geschlecht: M
Eingang: 27.05.2021
Impfdatum: 17.05.2021
Beginn: 25.05.2021
Tage bis Beginn: 8,0
Dosis: 1
Route/Site: IM / -

Tod: unbekannt Lebensbedrohlich: ja Hospital: ja Disable: unbekannt ER: ja Erholt: nein

Angiogram abnormal Angiogram cerebral abnormal Aphasia Arteriogram carotid abnormal Basal ganglia infarction Basal ganglia stroke Cerebral artery occlusion Computerised tomogram head abnormal Hemiparesis Intensive care Ischaemic stroke Magnetic resonance imaging head abnormal Syncope Thrombectomy

Symptomtext

Received COVID vaccine on 5/17/21 5/25/21 around 0100 patient collapsed with acute onset right sided weakness and expressive aphasia. Brought to an ED where CTA found an occlusion of the L MCA which was confirmed as a ischemic stroke. He received TPA and underwent a IR guided thrombectomy. Patient continues to be admitted to the PICU with intermittent expressive aphasia and mild right sided weakness.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Basal ganglia stroke
Hospital-Tage: -
Labordaten: CT brain and CTA head/neck 5/25: large vessel occlusion involving the M1 branch of L MCA MRI and MRA brain 5/26: acute infarct of L basal ganglia CT brain and CTA head/neck 5/27: evolving L basal ganglia stroke Pending coagulation testing including antiphospholipid panel, common thrombosis panel, uncommon thrombosis panel, heparin-induced thrombocytopenia PF4 antibody If additional labs/reports are desired, PCH Information Release Department
Aktuelle Erkrankungen: n/a
Vorgeschichte: Hypoplastic left heart syndrome s/p fenestrated Fontan in December 2008 Fontan-induced liver fibrosis
Andere Medikamente: Aspirin 81mg PO daily Sildenafil 20mg PO BID Vitamin B complex capsule daily Vitamin C 25mg oral tablet daily Vitamin D with minerals oral tablet daily
Allergien: NKA
Vorherige Impfungen: -

VAERS 1353535

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EW0183

schwer

Staat: MD
Alter: 56,0
Geschlecht: F
Eingang: 27.05.2021
Impfdatum: 06.05.2021
Beginn: 06.05.2021
Tage bis Beginn: 0,0
Dosis: 2
Route/Site: - / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Biopsy Headache Hypersomnia Nausea Thrombosis Ultrasound scan Vaginal haemorrhage

Symptomtext

Vaginal bleeding in a menopausal woman with blood clots.; Vaginal bleeding in a menopausal woman with blood clots.; Also slept for 13 hours the day following the shot and had a continual headache with nausea; Also slept for 13 hours the day following the shot and had a continual headache with nausea; Also slept for 13 hours the day following the shot and had a continual headache with nausea; This is a spontaneous report from a contactable consumer (patient). A 56-year-old female patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) on 06May2021 at 09:45 at single dose in left arm for COVID-19 immunisation at the age of 56-year-old. Lot number EW0183. Medical history included menopausal woman. Concomitant medications were none. Historical vaccine included BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) on 15Apr2021 at 10:30, Lot number EW0164, dose number: 1, in left arm. On 06May2021, the patient also slept for 13 hours the day following the shot and had a continual headache with nausea. On 10May2021, the patient experienced vaginal bleeding in a menopausal woman with blood clots. It was very concerning; the patient was going to Ob/Gyn soon. The patient underwent ultrasound and biopsy. Prior to vaccination, the patient was not diagnosed with COVID-19; since the vaccination, the patient has not been tested for COVID-19. The outcome of the events was unknown. Follow up needed, further information has been requested

Weitere VAERSDATA-Felder

Praegender Schweregrund: Thrombosis
Hospital-Tage: -
Labordaten: Test Name: biopsy; Result Unstructured Data: Test Result:unknown results; Test Name: ultrasound; Result Unstructured Data: Test Result:unknown results
Aktuelle Erkrankungen: -
Vorgeschichte: Medical History/Concurrent Conditions: Menopause
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1351598

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EW0183

schwer

Staat: CA
Alter: 12,0
Geschlecht: F
Eingang: 26.05.2021
Impfdatum: 26.05.2021
Beginn: 26.05.2021
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Cold sweat Confusional state Hypotension Pallor Syncope

Symptomtext

Approximately 15 seconds after patient received covid-19 vaccine pt had syncopal episode which lasted a few seconds, she was able to regain some consciousness for a few seconds but had syncopal episode again. Pt was unconscious for less than a minute. When pt awoke, she was pale, confused, and clammy. An ice pack was placed in the back on her back, ice water was given for patient to drink, legs were elevated, vital signs taken at 1203. Initially vital signs were 66/38, HR62, 99% O2 on room air. At 1210 second set of vitals were taken and recorded as the following, 87/40, HR88, 100% O2 on room air. Pt was placed on the gurney when patient was feeling better, pt was able to walk to gurney with no issues. Pt taken to treatment room for further observation at 1215. Report was given to RN who took patient down on gurney with Covid-19 RN, alongside pt's father. Both pt and father state pt has never had a syncopal episode in the past with vaccines or blood drawn.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Syncope
Hospital-Tage: -
Labordaten: n/a
Aktuelle Erkrankungen: n/a
Vorgeschichte: n/a
Andere Medikamente: n/a
Allergien: n/a
Vorherige Impfungen: -

VAERS 1351271

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EW0183

schwer

Staat: PA
Alter: 66,0
Geschlecht: M
Eingang: 26.05.2021
Impfdatum: 12.05.2021
Beginn: 19.05.2021
Tage bis Beginn: 7,0
Dosis: 1
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: unbekannt

COVID-19 Computerised tomogram head normal Computerised tomogram thorax normal Dizziness Dyspnoea Hyperhidrosis Loss of consciousness Nausea Scan with contrast Syncope Ultrasound Doppler normal

Symptomtext

ED to Hosp-Admission Current 5/20/2021 - present (6 days) Last attending ? Treatment team Syncope and collapse Principal problem History of Present Illness a 66 y.o. yo male presenting to the ED with syncope. Patient is diagnosed with COVID-19. He has passed out twice today. He feels lightheaded and nauseous prior to passing out. He wakes up feeling diaphoretic. Denies chest pain. Admits to shortness of breath and the feeling of difficulty getting a deep breath in. Patient denies history of blood clots, recent unilateral leg swelling or edema, hemoptysis.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Loss of consciousness
Hospital-Tage: 6,0
Labordaten: 05/19/21 1525 COVID-19 (SARS CoV-2,RNA Molecular Amplification) Collected: 05/19/21 0938 | Final result | Specimen: Swab from Nasopharynx COVID-19 SARS-CoV-2 Overall Result DetectedCritical CT angiogram chest pulmonary embolism with and without contrast [3284247929] Resulted: 05/20/21 2125 Order Status: Completed Updated: 05/20/21 2125 Narrative: CTA CHEST PULMONARY EMBOLISM W WO CONTRAST IMPRESSION: 1. Normal CT chest. 2. No evidence pulmonary embolism. 3. No acute airspace disease in the chest. END OF IMPRESSION: INDICATION: Covid positive, high concern for pulmonary embolism TECHNIQUE: 2 mm axial images from the lung apices to the adrenal glands were obtained. Images also viewed in sagittal and coronal reconstruction. 3-D shaded surface display, Maximum Curved Intensity Projection (MIP) and multiplanar reconstructions were performed on an independent workstation and permanently recorded. Images of the chest were also obtained. CONTRAST: 80mL of IOHEXOL 350 MG IODINE/ML INTRAVENOUS SOLUTION administered INTRAVENOUS. COMPARISON: 3/8/2015 FINDINGS: Heart and mediastinum: No mediastinal or hilar adenopathy. Heart size normal. Good enhancement pulmonary arteries. No filling defects. Lungs: Clear. No nodules or masses. Pleural space: Clear. Bones: No focal lesions. Soft tissues: Images including the upper abdomen are normal. No axillary lymphadenopathy. This report was created using Voice Recognition software. Thank you for allowing us to participate in the care of your patient. CT head without contrast [3284247930] Resulted: 05/20/21 2118 Order Status: Completed Updated: 05/20/21 2118 Narrative: CT HEAD WO CONTRAST IMPRESSION: 1. No evidence of acute intracranial hemorrhage or acute cortical-based infarct at this time. 2. No gross intracranial mass. 3. Incidental tiny metal foreign body in right forehead scalp soft tissues END OF IMPRESSION: INDICATION: Multiple syncopal episodes TECHNIQUE: Axial images from skull base to vertex of head were obtained. COMPARISON: None available. CONTRAST: No IV contrast was administered. FINDINGS: Ventricles: Normal. Brain parenchyma: Normal. No areas of abnormal high or low attenuation. Midline shift: None. Mass effect: None. Extra-axial collection: None. Calvarium and skull base: Intact. Soft tissues: Tiny metal foreign body in right frontal scalp soft tissues This report was created using Voice Recognition software. Thank you for allowing us to participate in the care of your patient. Ultrasound lower extremity venous left [3284247981] Resulted: 05/20/21 2058 Order Status: Completed Updated: 05/20/21 2058 Narrative: US LOWER EXTREMITY VENOUS LEFT IMPRESSION: No ultrasound evidence of left thigh or proximal calf vein DVT. END OF IMPRESSION: INDICATION: Left leg pain. TECHNIQUE: Grayscale, color-flow, and duplex Doppler sonography of the deep venous system of the left lower extremity was performed. Permanently recorded images were obtained and stored. COMPARISON: None available. FINDINGS: All veins are normally compressible from the common femoral vein to the popliteal vein. Normal color flow and Doppler waveforms. Visualized segments of proximal calf and saphenous vein are also unremarkable. Normal color flow and Doppler signal in the contralateral right common femoral VEIN
Aktuelle Erkrankungen: -
Vorgeschichte: Neoplasm of uncertain behavior of connective and other soft tissue Benign essential hypertension Coagulation defect (CMS/HCC) Hyperlipidemia
Andere Medikamente: aspirin 81 mg tablet lisinopriL (ZESTRIL) 40 mg tablet predniSONE (DELTASONE) 20 mg tablet tamsulosin (FLOMAX) 0.4 mg capsule traZODone (DESYREL) 100 mg tablet
Allergien: Dilaudid [Hydromorphone]Anaphylaxis
Vorherige Impfungen: -

VAERS 1347767

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EW0183

schwer

Staat: MI
Alter: 29,0
Geschlecht: M
Eingang: 25.05.2021
Impfdatum: 21.05.2021
Beginn: 21.05.2021
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Dizziness Loss of consciousness Syncope

Symptomtext

Approximately 5 minutes after receiving his first dose of the pfizer covid vaccine, the patient began feeling faint and ended up fainting while sitting down. He laid his head on his girlfriend's shoulder and fainted. He was alert and conscious within 2 minutes. At that time, the patient said he does suffer from vasovagal syncope and frequently passes out when his anxiety is high. He denied our attempts to call for 911. After 30 minutes, the patient left under his own strength. His girlfriend drove them both home.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Loss of consciousness
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1346628

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EW0183

schwer

Staat: IL
Alter: 17,0
Geschlecht: F
Eingang: 25.05.2021
Impfdatum: 19.05.2021
Beginn: 22.05.2021
Tage bis Beginn: 3,0
Dosis: 2
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Cough Electrocardiogram Electroencephalogram Loss of consciousness Syncope

Symptomtext

Pt was swimming and started to cough (felt swallowed water) and upon getting out of water - collapsed and lost consciousness for a few seconds

Weitere VAERSDATA-Felder

Praegender Schweregrund: Loss of consciousness
Hospital-Tage: -
Labordaten: ekg and eeg (pending results)
Aktuelle Erkrankungen: None
Vorgeschichte: Concussion / post - concussion syndrome - just released from f/u care. Convergence insufficiency Asthenopia Atopic Dermatitis
Andere Medikamente: Blisovi-Fe 24, Claritin
Allergien: Zofran (Ondansetron) - Rash
Vorherige Impfungen: -

VAERS 1331138

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EW0183

schwer

Staat: WA
Alter: 25,0
Geschlecht: M
Eingang: 25.05.2021
Impfdatum: 16.05.2021
Beginn: 18.05.2021
Tage bis Beginn: 2,0
Dosis: 2
Route/Site: SYR / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: ja

Chest discomfort Chest pain Hypoaesthesia Myocardial necrosis marker Myocarditis Electrocardiogram abnormal Pericarditis Pleuritic pain Painful respiration Troponin increased

Symptomtext

5/18 chest pain when taking a deep breath, went to primary care and urgent care. The symptom relieved later. 5/19 hollowness and tightness on the left chest, numbness on the left arm, went to urgent care and transferred to ER because of abnormal cardiac enzymes. Hospitalized overnight. 5/20 Diagnosed with myocarditis. Discharged at 7pm.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Pericarditis
Hospital-Tage: 2,0
Labordaten: -
Aktuelle Erkrankungen: None
Vorgeschichte: None
Andere Medikamente: Vitamin C
Allergien: None
Vorherige Impfungen: -

VAERS 1343845

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EW0183

schwer

Staat: NH
Alter: 19,0
Geschlecht: M
Eingang: 24.05.2021
Impfdatum: 12.05.2021
Beginn: 14.05.2021
Tage bis Beginn: 2,0
Dosis: 2
Route/Site: SYR / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: nein

Chest pain Chills Electrocardiogram abnormal Enzyme level increased Enzyme level test Hyperhidrosis Myocarditis Palpitations Pericarditis Pyrexia Respiration abnormal

Symptomtext

Typical side effect symptoms experienced and cleared within 24 hours. Same symptoms returned (chills, low fever, heavy sweating, tense breathing) approx. 60 hours later along with severe aching chest pain. All symptoms resolved by next morning besides chest pain, which was severe enough to warrant emergency room admission about 72 hours after vaccination. Admitted to hospital overnight with an episode of palpitations around 6pm on the first night, being given motrin and colchicine throughout stay. Pain somewhat resolved and was discharged aprox. 100 hours after vaccination. Continued use of ibuprofen and colchicine in weeks following as pain slowly resolves.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Myocarditis
Hospital-Tage: 1,0
Labordaten: Unsure exact procedures and numbers. Multiple EKGs and blood enzyme laboratory tests throughout 5/15 and 5/16 indicating pericarditis and mild myocarditis throughout stay. Enzymes spiked at around 3AM 5/16.
Aktuelle Erkrankungen: None
Vorgeschichte: None
Andere Medikamente: 200mg Lamotrigine
Allergien: None
Vorherige Impfungen: -

VAERS 1323770

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EW0183

schwer

Staat: CA
Alter: 16,0
Geschlecht: M
Eingang: 24.05.2021
Impfdatum: 16.05.2021
Beginn: 16.05.2021
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: ja

Blood test Electrocardiogram Loss of consciousness Immediate post-injection reaction Syncope Unresponsive to stimuli

Symptomtext

ONE MINUTE AFTER ADMINISTERING PAITENT HIS FIRST DOSE OF PFIZER COVID-19 VACCINE, THE PATIENT FELL TO THE FLOOR. PATIENT REPORTS , " HE FELL ASLEEP", BUT CLAIMED HE WAS OKAY. THE PATIENT WAS ESCORTED TO THE WAITING AREA AND INSTRUCTED TO WAIT FOR 15-30 MINUTES FOR OBSERVATION. SOON AFTER SITTING IN THE WAITING AREA,THE PHARMACIST WHO ADMINISTERED THE VACCINE REPORTS THE PATIENT PASSED OUT FOR THE SECOND TIME. PER PHARMACIST REPORT, THE PATIENT WAS UNRESPONSIVE AND SEEMED NOT TO BE BREATHING. EPINEPHRINE 0.3MG DOSE WAS GIVEN INTRAMUSCULARLY AND EMERGENCY WAS CALLED AT 11:56AM. THE PATIENT REVIVED AND REPORTED HE "FELT FINE". EMERGENCY HEALTHCARE AND AMBULANCE ARRIVED AT 12:06PM AND TOOK OVER CARE OF THE PATIENT.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Loss of consciousness
Hospital-Tage: -
Labordaten: N/A
Aktuelle Erkrankungen: UKNOWN
Vorgeschichte: UNKNOWN
Andere Medikamente: UNKNOWN
Allergien: NO KNOWN ALLERGIES
Vorherige Impfungen: -

VAERS 1341744

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EW0183

schwer

Staat: -
Alter: 22,0
Geschlecht: M
Eingang: 23.05.2021
Impfdatum: 22.05.2021
Beginn: 22.05.2021
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt

Syncope

Symptomtext

Pt fainted. Vitals taken and recovered. Evaluated by EMS-Cleared

Weitere VAERSDATA-Felder

Praegender Schweregrund: Syncope
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1341380

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge ew0183

schwer

Staat: IN
Alter: 85,0
Geschlecht: M
Eingang: 22.05.2021
Impfdatum: 20.05.2021
Beginn: 21.05.2021
Tage bis Beginn: 1,0
Dosis: 2
Route/Site: SYR / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Muscle spasms Pain Pyrexia Seizure

Symptomtext

Fever, Body Aches, Muscle Cramps, Seisures

Weitere VAERSDATA-Felder

Praegender Schweregrund: Seizure
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: Heart, Low Back Pain, Arthrites, High Blood Pressure,
Andere Medikamente: Carvedilol, Entresto, Gabapentin, Oxycodone/acetaminophen, Bumetanide, Plavix, Fluoxetine, Tamsulosin, Aspirin
Allergien: -
Vorherige Impfungen: -

VAERS 1341096

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EW0183

schwer

Staat: WA
Alter: 37,0
Geschlecht: M
Eingang: 22.05.2021
Impfdatum: 22.05.2021
Beginn: 22.05.2021
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Dizziness Hyperhidrosis Syncope

Symptomtext

This reporter received documentation for pt. here for first dose of Pfizer vaccine, found by clinical staff 'slumped over in chair'. Pt. reported to partner feeling lightheaded and dizzy before event. Aid called and pt. laid down on cot. A&Ox4, VSS, diaphoretic. States this has happened before during blood draws. {t/ cleared by EMS to exit facility with partner.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Syncope
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1338608

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EW0183

schwer

Staat: AZ
Alter: 30,0
Geschlecht: M
Eingang: 21.05.2021
Impfdatum: 21.05.2021
Beginn: 21.05.2021
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: IM / UN

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein

Fall Head injury Hypotension Nausea Pallor Skin abrasion Syncope

Symptomtext

Had syncopal episode after vaccine while walking to chair. Fell and hit head, has abrasion above left eye. No head neck or back pain. Is very pale with a heart rate in the 40's and hypotensive. IV established and brought blood pressure up and heart rate up. Was nauseated prior to IV but that resolved. Transported to hospital by ambulance.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Syncope
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: None
Vorgeschichte: None
Andere Medikamente: None
Allergien: None
Vorherige Impfungen: -

VAERS 1337885

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EW0183

schwer

Staat: -
Alter: 21,0
Geschlecht: F
Eingang: 21.05.2021
Impfdatum: 21.05.2021
Beginn: 21.05.2021
Tage bis Beginn: 0,0
Dosis: 2
Route/Site: IM / AR

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt

Loss of consciousness

Symptomtext

Patient passed out after receiving the vaccine. She had no problems with the first vaccine but has had a history of passing out with other vaccinations. Patient had just gotten to the waiting area after receiving her vaccine and sat down and her mom caught her from falling from the chair. Mom held her for a few minutes as she went in and out of consciousness. When she came back to we laid her on the ground. Patients BP was taken as she started to feel better and was 120/74. Patient and mom stayed with us as she gradually started to feel better. Mom drove her home.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Loss of consciousness
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1337430

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EW0183

schwer

Staat: MI
Alter: 14,0
Geschlecht: M
Eingang: 21.05.2021
Impfdatum: 21.05.2021
Beginn: 21.05.2021
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein

Bradycardia Hypotension Pallor Respiratory rate increased Seizure

Symptomtext

Within 30 secs to 1 minute following vaccination patient started to seize. He came out of the seizure quickly (approx 20-30 sec). EMS was called and on site in minutes. Patient was breathing on his own but breathing was rapid. He lost color in his face/lips. When EMS arrived they noted that he was hypotensive and bradycardic. He began to regain color while EMS was on site. They opted to take him in for further evaluation. No history of seizures.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Seizure
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: NA
Vorgeschichte: None reported to pharmacy
Andere Medikamente: NA
Allergien: NKDA
Vorherige Impfungen: -

VAERS 1336770

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EW0183

schwer

Staat: NY
Alter: 41,0
Geschlecht: F
Eingang: 21.05.2021
Impfdatum: 21.05.2021
Beginn: 21.05.2021
Tage bis Beginn: 0,0
Dosis: UNK
Route/Site: IM / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Bradycardia Dizziness Presyncope

Symptomtext

41 yo female with PMHx morbid obesity (s/p gastric bypass) and HTN, p/w LH, after COVID vaccine. No h/o LH, palp, arrthythmia. Has h/o HTN, on losartan and metoprolol. Took meds today, no recent dose changes, though has had doses decreased in past year after gastric bypass. Has not had BP checked recently due to doctor visits being mostly virtual now. Has had h/o dumping syndrome, but none recently. Felt better after sitting down, HR initially high 40s, BP 108/80, shortly after HR up to 55 with resolution of sxs. After 20 min, orthostatics checked, which were negative. Pt ambulated without symptoms. Pt released after 30 min observation period.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Presyncope
Hospital-Tage: -
Labordaten: none
Aktuelle Erkrankungen: none
Vorgeschichte: HTN, obesity
Andere Medikamente: metoprolol, losartan
Allergien: none
Vorherige Impfungen: -

VAERS 1336714

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EW0183

schwer

Staat: MA
Alter: 16,0
Geschlecht: F
Eingang: 21.05.2021
Impfdatum: 14.05.2021
Beginn: 18.05.2021
Tage bis Beginn: 4,0
Dosis: 1
Route/Site: IM / UN

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Bell's palsy Facial paralysis Lyme disease

Symptomtext

4 days after vaccination (on 5/18/21) she presented with right facial droopiness (unable to close right eye, unable to smile on right side etc) consistent with Bell's Palsy. Symptoms are (unsurprisingly) persistent now 3 days later

Weitere VAERSDATA-Felder

Praegender Schweregrund: Bell's palsy
Hospital-Tage: -
Labordaten: Lyme test done on day of presentation (5/18/21) and was negative.
Aktuelle Erkrankungen: none
Vorgeschichte: anxiety and depression
Andere Medikamente: Lexapro 20mg once daily Latuda 20mg once daily
Allergien: none
Vorherige Impfungen: -

VAERS 1336648

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EW0183

schwer

Staat: VT
Alter: 24,0
Geschlecht: M
Eingang: 21.05.2021
Impfdatum: 17.05.2021
Beginn: 17.05.2021
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Presyncope Vomiting

Symptomtext

Vaso Vagal response, vomiting

Weitere VAERSDATA-Felder

Praegender Schweregrund: Presyncope
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1336631

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EW0183

schwer

Staat: VT
Alter: 22,0
Geschlecht: M
Eingang: 21.05.2021
Impfdatum: 17.05.2021
Beginn: 17.05.2021
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Presyncope Vomiting

Symptomtext

Vasovagal response with vomiting

Weitere VAERSDATA-Felder

Praegender Schweregrund: Presyncope
Hospital-Tage: -
Labordaten: none, supportive care only
Aktuelle Erkrankungen: unknown
Vorgeschichte: unknown
Andere Medikamente: unknown
Allergien: denies allergies
Vorherige Impfungen: -

VAERS 1334640

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EW0183

schwer

Staat: WI
Alter: 53,0
Geschlecht: M
Eingang: 20.05.2021
Impfdatum: 20.05.2021
Beginn: 20.05.2021
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein

Dizziness Hypotension Loss of consciousness

Symptomtext

Patient was seated in waiting area post vaccination. communicated to technician he felt dizzy. Pharmacist came to patient's side. Patient slowly went unconscious, folding forward in chair for about 30 seconds. Pharmacist kept patient in chair and called for technician to call 911. patient regained consciousness and pharmacist talked patient down to the ground for safety and rested against wall with head by knees. patient stayed conscious until paramedics arrived. they tested vitals and patient's blood pressure was very low. patient loaded onto a gurney and taken to unknown hospital.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Loss of consciousness
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1333904

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EW0183

schwer

Staat: -
Alter: 17,0
Geschlecht: F
Eingang: 20.05.2021
Impfdatum: 20.05.2021
Beginn: 20.05.2021
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Presyncope Vision blurred

Symptomtext

Blurry vision, near syncope after receiving vaccine. Onset of symptoms was 3-4mins after vaccine administration. Did not eat breakfast this morning Given juice and crackers Exam was normal Discharged to home

Weitere VAERSDATA-Felder

Praegender Schweregrund: Presyncope
Hospital-Tage: -
Labordaten: Pulse 55 Respirations 18 SPO2 95% BP 100/50 Vital signs were normal prior to discharge
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1333802

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EW0183

schwer

Staat: MN
Alter: 12,0
Geschlecht: M
Eingang: 20.05.2021
Impfdatum: 19.05.2021
Beginn: 19.05.2021
Tage bis Beginn: 0,0
Dosis: 2
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Fall Head injury Syncope

Symptomtext

Syncopal episode - fell and hit his head on door No loss of consciousness Patient was possibly dehydrated or had low blood sugar, states that he had not eaten since 11:00am and had been playing golf all day until he arrived at clinic at 5:30 pm. Patient's father was present and took him home after evaluation by medical staff and sign off by medical director.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Syncope
Hospital-Tage: -
Labordaten: N/A
Aktuelle Erkrankungen: N/A
Vorgeschichte: No
Andere Medikamente: N/A
Allergien: N/A
Vorherige Impfungen: -

VAERS 1333397

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EW0183

schwer

Staat: -
Alter: 27,0
Geschlecht: M
Eingang: 20.05.2021
Impfdatum: 20.05.2021
Beginn: 20.05.2021
Tage bis Beginn: 0,0
Dosis: 2
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt

Arthralgia Dizziness Loss of consciousness Seizure

Symptomtext

Almost immediately after patient received the second dose of vaccine he stood up and passed out to the floor. He slightly seized for a few seconds until it stopped. When patient came to he stated that his knee hurt but he didnt believe he hit his head and he felt a bit light headed. Patient laid down for a while with us until he started to feel better. His BP was 102/58, but normally runs low. He said that he has passed out before and has been under a lot of stress, also had not eaten that morning before getting vaccinated. His significant other was with him and was planning to drive home. Patient was offered a call to EMS but refused.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Loss of consciousness
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1330954

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge EW0183

schwer

Staat: NY
Alter: 14,0
Geschlecht: M
Eingang: 19.05.2021
Impfdatum: 19.05.2021
Beginn: 19.05.2021
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Fall Product administered to patient of inappropriate age Skin abrasion Skin laceration Syncope

Symptomtext

Brief syncopal episode, fell from chair, struck head on floor, suffered small laceration and abrasion to left eyebrow.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Syncope
Hospital-Tage: -
Labordaten: Vital signs: BP 100/80, Pulse 92, Resp 18, SaO2 98%. Staff recommends ambulance transport to Hospital, parents state will take patient to Urgent Care via personal vehicle.
Aktuelle Erkrankungen: None
Vorgeschichte: None
Andere Medikamente: None
Allergien: None
Vorherige Impfungen: -

VAERS 1330941

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EW0183

schwer

Staat: NY
Alter: 12,0
Geschlecht: M
Eingang: 19.05.2021
Impfdatum: 19.05.2021
Beginn: 19.05.2021
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Nausea Presyncope Vomiting

Symptomtext

Nausea, vomiting, near syncopal episode

Weitere VAERSDATA-Felder

Praegender Schweregrund: Presyncope
Hospital-Tage: -
Labordaten: Vital signs: BP 90/60, Pulse 88, Resp 16, SaO2 96%
Aktuelle Erkrankungen: None
Vorgeschichte: None
Andere Medikamente: None
Allergien: None
Vorherige Impfungen: -

VAERS 1330936

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EW0183

schwer

Staat: -
Alter: 13,0
Geschlecht: M
Eingang: 19.05.2021
Impfdatum: 19.05.2021
Beginn: 19.05.2021
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: ja

Cyanosis Disorientation Fatigue Nausea Pulse abnormal Seizure Unresponsive to stimuli

Symptomtext

Patient had convulsive seizure, became unresponsive and was cyanotic, sternal rub, patient opened eyes. Heart rate was thready. Patient felt nauseous. Patient was disoriented for 1min and quickly regained orientation. Patient was given water, patient laid on the floor. Discharged to ER Past Medical Hx Hx of seizure at age 4

Weitere VAERSDATA-Felder

Praegender Schweregrund: Seizure
Hospital-Tage: -
Labordaten: Pulse 83 Respirations 18 SPO2 100% BP 90/60 Exam was abnormal, patient felt fatigue and nauseous VSS Heart and lung sounds normal
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1330673

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EW0183

schwer

Staat: NY
Alter: 14,0
Geschlecht: F
Eingang: 19.05.2021
Impfdatum: 19.05.2021
Beginn: 19.05.2021
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Syncope

Symptomtext

Brief near syncopal episode, approximately 2-3 minutes after administration

Weitere VAERSDATA-Felder

Praegender Schweregrund: Syncope
Hospital-Tage: -
Labordaten: Vital Signs: BP 90/60, Pulse 68, Resp 16, SaO2 98%
Aktuelle Erkrankungen: None
Vorgeschichte: Anxiety
Andere Medikamente: None
Allergien: None
Vorherige Impfungen: -

VAERS 1330442

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EW0183

schwer

Staat: NY
Alter: 19,0
Geschlecht: M
Eingang: 19.05.2021
Impfdatum: 19.05.2021
Beginn: 19.05.2021
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Presyncope

Symptomtext

Near syncopal episode 3-5 minutes after vaccination.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Presyncope
Hospital-Tage: -
Labordaten: BP - 135/80, Pulse 100, SaO2 96% room air
Aktuelle Erkrankungen: None
Vorgeschichte: Anxiety and depression
Andere Medikamente: Hydroxyzine, Prozac
Allergien: None
Vorherige Impfungen: -

VAERS 1330418

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EW0183

schwer

Staat: -
Alter: 12,0
Geschlecht: F
Eingang: 19.05.2021
Impfdatum: 19.05.2021
Beginn: 19.05.2021
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Seizure Vomiting

Symptomtext

Patient reported history of syncope episode with another vaccine in the past. Patient has history of seizure disorder. At 10:10am, patient was sitting with her mother when she started to convulse sitting up right in a chair. She also vomited while convulsing for about 15seconds. Full consciousness regained.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Seizure
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: Syncope episode

VAERS 1330387

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EW0183

schwer

Staat: MD
Alter: 13,0
Geschlecht: M
Eingang: 19.05.2021
Impfdatum: 19.05.2021
Beginn: 19.05.2021
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Cooling therapy Hepatic enzyme increased Loss of consciousness Syncope

Symptomtext

Vasovagal syncope a few minutes after receiving shot. Waiting to check in to observation area and fainted. LOC but immediately awake, A&O. LEs elevated, cool compress to neck. HR, BP checked, stable. Rested and resolved. Home with dad.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Loss of consciousness
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: None
Vorgeschichte: None
Andere Medikamente: None
Allergien: None
Vorherige Impfungen: -

VAERS 1330312

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EW0183

schwer

Staat: MA
Alter: 19,0
Geschlecht: M
Eingang: 19.05.2021
Impfdatum: 19.05.2021
Beginn: 19.05.2021
Tage bis Beginn: 0,0
Dosis: UNK
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Syncope

Symptomtext

SYNCOPE POST-VACCINATION

Weitere VAERSDATA-Felder

Praegender Schweregrund: Syncope
Hospital-Tage: -
Labordaten: VITAL SIGNS MONITORING, LAID SUPINE
Aktuelle Erkrankungen: NONE
Vorgeschichte: NONE
Andere Medikamente: NONE
Allergien: NKDA NKA
Vorherige Impfungen: -

VAERS 1330078

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge ew0183

schwer

Staat: RI
Alter: 21,0
Geschlecht: F
Eingang: 19.05.2021
Impfdatum: 19.05.2021
Beginn: 19.05.2021
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Pallor Syncope Vomiting

Symptomtext

post vaccine administration, pt experienced a syncopal episode. Pt did not fall from chair. Pt vomited and appeared pale. Pt A+O x4, refused vitals. After a few minutes color came back to Pts face and pt stated she felt much better. Pt sat in observation area for 30 minutes and felt okay to leave. This was all done WOI.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Syncope
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: none
Vorgeschichte: none
Andere Medikamente: none
Allergien: penicillin
Vorherige Impfungen: -

VAERS 1327986

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EW0183

schwer

Staat: NY
Alter: 13,0
Geschlecht: M
Eingang: 18.05.2021
Impfdatum: 18.05.2021
Beginn: 18.05.2021
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Cold sweat Hyperhidrosis Immediate post-injection reaction Pallor Presyncope

Symptomtext

Received Vaccine, immediately became pale, clammy, diaphoretic, had near syncope episode, brought to mat to lie down, elevated feet on chair, AAO, no loc, no sob, ice pack to neck, front, back, and stomach, MD assessed surmised vaso vagal reaction occurred, patient came from a baseball game, Patients mom at the side, Vitals: 110/80, HR-60, regular and strong, respirations 12, regular nonlabored, 02 Sat 98%, After 10 minutes sat up and had water for hydration and snack for nourishment. Monitored for 30 minutes, provided reassurance, okay to exit with Mom after 30 minutes, provided education to mother regarding reaction

Weitere VAERSDATA-Felder

Praegender Schweregrund: Presyncope
Hospital-Tage: -
Labordaten: Vital signs taken, listed above, monitored 30 minutes
Aktuelle Erkrankungen: None
Vorgeschichte: None
Andere Medikamente: None
Allergien: None
Vorherige Impfungen: -

VAERS 1324109

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EW0183

schwer

Staat: GA
Alter: 14,0
Geschlecht: F
Eingang: 17.05.2021
Impfdatum: 13.05.2021
Beginn: 13.05.2021
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: IM / OT

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Eye movement disorder Seizure Syncope

Symptomtext

Vasovagal Syncope @ 10:05 14 year old female. No breakfast or fluids in am before vaccination. EMT called BP 104/68 oxygen 99% HR 78 . BS 85. 10:14 seizure like behavior eyes roll back in head both arms constrict. BP 100/60 IV fluids started 100ml saline. 10:30 BP 104/70. ( Per mother history of syncope four years ago after receiving an allergy shot.) alert and oriented x4 at 10:40. released to mother .

Weitere VAERSDATA-Felder

Praegender Schweregrund: Seizure
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: none
Vorgeschichte: unkown
Andere Medikamente: none
Allergien: none
Vorherige Impfungen: Allergy shot 4 yrs ago

VAERS 1323410

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EW0183

schwer

Staat: MA
Alter: 12,0
Geschlecht: M
Eingang: 17.05.2021
Impfdatum: 13.05.2021
Beginn: 13.05.2021
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: ja

Electrocardiogram Electrocardiogram QT prolonged Loss of consciousness Pallor Presyncope Respiratory rate increased Tremor

Symptomtext

From ED Note: 12 year old male with PMH of asthma on flovent, food allergies with epi-pen (has not required this) and pre-syncope/syncope who presents with concern for loss of consciousness and possible seizure-like activity following a COVID vaccine. Mom notes that he was in his usual state of health when he presented to COVID clinic to get his first vaccine. He got the Pfizer vaccine, seconds after getting in his left arm, mom noted that he looked very "wide eyed" and distraught. She notes that he slumped forward and had lost consciousness for approximately 5 seconds. She noticed shaking movements in his right arm and bilateral lower legs. She notes that his left arm was against her and therefore cannot comment on it. She notes that his eyes were closed. No tongue biting and no incontinence. No secondary trauma. She notes that when these 5 seconds were over he then had a period for about 30 minutes where he looked pale and was breathing heavy but was alert and answering questions. She notes that he has had presyncopal episodes and episodes of feeling faint when getting flu shots in the past. However, this time she noted that he had shaking which made her nervous for possible seizure activity. Patient denies any chest pain or headache prior to the symptoms. She came via ambulance for further evaluation. On arrival, he reports that he feels 90% back to his baseline. He notes that he does not feel quite ready to run around yet however denies any pains or discomforts, headache, weakness, numbness, or tingling. He had eaten a full breakfast prior to getting the shot. He had a normal night sleep and a normal day yesterday per mom. Medical History: as above Surgical history: none Family History: Reviewed and no pertinent related family hx pertaining to this visit Social History: Lives with family Allergies: food allergies Medications: flovent, epi-pen Immunizations: Up to date Medical Decision Making 12 year old male with PMH of asthma on flovent, food allergies with epi-pen (has not required this) and pre-syncope/syncope who presents with concern for loss of consciousness and possible seizure-like activity following a COVID vaccine. On arrival, he was alert, well-appearing, in no acute distress. His vital signs were normal for age on room air. His physical exam was very reassuring as above with a normal neurologic and cardiac evaluation. Differential includes vasovagal/syncope in the setting of a known stressful trigger vs seizure given report of shaking in his extremities. We feel the latter is significantly less likely given the timeline of the events. Has no known seizure activity nor any triggers per history (fever, trauma, etc.). He also has a normal neurologic assessment. At this time we will defer neurology consults given low concern for seizure. It is possible that this represents a side effect of the vaccine however we also feel that this is less likely given the fact that his symptoms have been seconds after receiving the vaccine. Nonetheless we reported the symptoms to the pharmacist who recorded it in the database. We attained an EKG showing a known incomplete right bundle branch block (unchanged from 2013) and a slightly prolonged QTC of 477 (previously 451). I encourage patient to stay well-hydrated, well rested in the setting of his suspected syncopal episode this morning. I also suggested that for further vaccinations, that he lay down on the table and drink/eat well prior. We provided strict return to ED criteria in the setting of worsening symptoms. All questions were answered at the time of discharge. Mom verbalized her understanding and agreement of the plan. He was discharged in a stable condition with mom at side. **After patient was discharged, cardiology called the follow-up team due to the prolonged QTC to ensure that we were aware. I contacted the patient's PCP to do a follow-up EKG in 1 month's time.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Loss of consciousness
Hospital-Tage: -
Labordaten: EKG borderline prolonged QTc 477
Aktuelle Erkrankungen: None reported
Vorgeschichte: asthma, food allergies, presyncope/syncope
Andere Medikamente: Albuterol MDI, Fluticasone 110 mcg, cetirizine 10 mg, EpiPen 0.3 mg PRN
Allergien: Peanuts, tree nuts
Vorherige Impfungen: influenza vaccine, presyncopal events

VAERS 1322213

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EW 0183

schwer

Staat: VA
Alter: 14,0
Geschlecht: M
Eingang: 16.05.2021
Impfdatum: 16.05.2021
Beginn: 16.05.2021
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: IM / AR

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Loss of consciousness Presyncope Syncope

Symptomtext

Client received Pfizer # 1 @ 09:26 Hx of fainting w/ blood draws and injections in past but did not inform staff Mother present at all times Client had vasovagal episode with syncope within seconds of receiving vaccine Was unresponsive for < 15 seconds. Did not fall or slide off chair at vaccinator's table Taken to EMS area for observation via W/C BP/P 100/60, 60 lying, sitting and standing Client felt back to normal within minutes of episode EMS advised transport to hospital. Mother declined. Observed for 30 minutes in EMS area Client and mother left EMS area independently @ 10:00

Weitere VAERSDATA-Felder

Praegender Schweregrund: Loss of consciousness
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: N/A
Vorgeschichte: N/A
Andere Medikamente: MVI
Allergien: N/A
Vorherige Impfungen: -

VAERS 1321009

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EW0183

schwer

Staat: RI
Alter: 15,0
Geschlecht: M
Eingang: 15.05.2021
Impfdatum: 15.05.2021
Beginn: 15.05.2021
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein

Head injury Headache Hyperhidrosis Nausea Pallor Peripheral coldness Syncope

Symptomtext

Pt had just received vaccine, was walking to waiting area and experienced a syncopal episode, head stuck floor. Pt appeared to posture, skin was cool, pale, and diaphoretic. C collar applied by ems, PT TF to stretcher from floor and TF to EMS room. Vitals obtained, BP 150/90, HR 76, RR 20, SpO2 98% RA, pupils PEARL. Pt complaint of head pain and nausea. Pt's father advised that Pt needs to be TP to hospital by Rescue and father agreed. PT care TF to Rescue crew.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Syncope
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: none
Vorgeschichte: none
Andere Medikamente: none
Allergien: none
Vorherige Impfungen: -

VAERS 1320935

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EW0183

schwer

Staat: MD
Alter: 16,0
Geschlecht: F
Eingang: 15.05.2021
Impfdatum: 15.05.2021
Beginn: 15.05.2021
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Syncope

Symptomtext

Patient fainted after vaccination. Patient was put into the wheel chair by the nurse and taken to observation area. Patient wake up and was alert and oriented. Patient was asked to sit for 30mins observation. Patient feels better.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Syncope
Hospital-Tage: -
Labordaten: VS: BP. 102/64, P 60, R 22
Aktuelle Erkrankungen: NA
Vorgeschichte: NA
Andere Medikamente: NA
Allergien: NA
Vorherige Impfungen: -

VAERS 1318562

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EW0183

schwer

Staat: WA
Alter: 36,0
Geschlecht: M
Eingang: 14.05.2021
Impfdatum: 14.05.2021
Beginn: 14.05.2021
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Loss of consciousness Syncope

Symptomtext

Syncope. pt lost consciousness briefly (under 1 mintue) pt was alert and oriented by the time I saw him. pt has hx of same for every vaccination.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Loss of consciousness
Hospital-Tage: -
Labordaten: None
Aktuelle Erkrankungen: Nione
Vorgeschichte: None
Andere Medikamente: None
Allergien: Unk
Vorherige Impfungen: similar event with all vaccines

VAERS 1317449

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge ew0183

schwer

Staat: OH
Alter: 12,0
Geschlecht: F
Eingang: 14.05.2021
Impfdatum: 13.05.2021
Beginn: 13.05.2021
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Syncope

Symptomtext

The patient was given the pfizer vaccine and then was standing watch her brother gets his. She all the sudden fainted and dropped to the floor. We rushed over and put her feet in the air on a chair and checked her BP and pulse ( 115/70, 71). She didn't look pale or sweaty or any other symptoms per patients response. We gave her an ice pack for head and had her lay down for 15mins. I repeated the BP/pulse and still WNL.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Syncope
Hospital-Tage: -
Labordaten: none
Aktuelle Erkrankungen: unknown
Vorgeschichte: unknown
Andere Medikamente: unknown
Allergien: unknown
Vorherige Impfungen: -

VAERS 1315247

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EW0183

schwer

Staat: OH
Alter: 31,0
Geschlecht: F
Eingang: 13.05.2021
Impfdatum: 11.05.2021
Beginn: 12.05.2021
Tage bis Beginn: 1,0
Dosis: 2
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Blindness Chills Cold sweat Dizziness Fatigue Feeling hot Hyperhidrosis Hyperventilation Loss of consciousness Seizure Tinnitus

Symptomtext

The evening after her second COVID shot, the patient experienced a 10-minute seizure where she was unable to move or uncurl her fists. Afterwards, she began to loosen-up, hyperventilate and then passed out twice. After this, she lost vision for 5 minutes. Then she became very hot with profuse sweating, ringing ears and dizziness. She then got cold sweats and chills for about 30 minutes. After this, she still had some tension in her calves. It took another 30 minutes before she was able to walk again. She took some Tylenol for the pain. Later, when she took her temperature, it was normal. She has been tired and resting since the incident but has not had any more seizures.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Loss of consciousness
Hospital-Tage: -
Labordaten: None
Aktuelle Erkrankungen: none
Vorgeschichte: none
Andere Medikamente: unknown
Allergien: Bactrim, amoxicillin, clindamycin, azithromycin, doxycyline, benzoyl peroxide
Vorherige Impfungen: -

VAERS 1314658

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EW0183

schwer

Staat: -
Alter: 42,0
Geschlecht: F
Eingang: 13.05.2021
Impfdatum: 13.05.2021
Beginn: 13.05.2021
Tage bis Beginn: 0,0
Dosis: 2
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: unbekannt

Arthralgia Headache Hyperhidrosis Loss of consciousness Skin abrasion

Symptomtext

Client had vaccine fainted fell out of chair. Abrasion to right cheek , eye and left elbow reported right head pain from the fall. Stated she felt like she hit on her right shoulder. Diaphoretic b/p 104/72 99%PSO2 pulse 68. Did not want to go to ER. 2:10 diaphorectic fainted again. b/p 110/68 pso2 98% pulse 62. woke quickly taken to ER via wheelchair @2:13

Weitere VAERSDATA-Felder

Praegender Schweregrund: Loss of consciousness
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1314507

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge ew0183

schwer

Staat: MD
Alter: 13,0
Geschlecht: M
Eingang: 13.05.2021
Impfdatum: 13.05.2021
Beginn: 13.05.2021
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Loss of consciousness Pallor Tremor Vision blurred

Symptomtext

he had his vaccination at 2:18, sat down in observation and after one minute, he lost consciousness, caught by father, and began having tremors. Woke up after 30 seconds - 1 minute. Helped to wheelchair. Skin was pale, but pt. was alert and oriented x 3, he reported blurry vision prior to incident. Observed on cot for 30 minutes. Given water, vital signs checked, wnl. Pt. left with father, escorted in wheelchair.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Loss of consciousness
Hospital-Tage: -
Labordaten: none
Aktuelle Erkrankungen: none
Vorgeschichte: none
Andere Medikamente: none
Allergien: none
Vorherige Impfungen: -

VAERS 1314023

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EW0183

schwer

Staat: WI
Alter: 16,0
Geschlecht: F
Eingang: 13.05.2021
Impfdatum: 08.05.2021
Beginn: 08.05.2021
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: ja

Dizziness Electrocardiogram normal Hypotension Loss of consciousness

Symptomtext

PATIENT LOST CONSCIOUSNESS, FELL FORWARD OUT OF CHAIR (WAS CAUGHT AND ASSISTED TO THE FLOOR), PATIENT REGAINED CONSCIOUSNESS, EMERGENCY SERVICES WERE CALLED, PULSE, BLOOD SUGAR, OXYGEN, AND VISION WERE FINE, PATIENT VERY LIGHT HEADED, BLOOD PRESSURE EXTREMELY LOW, WASN'T RETURNING TO NORMAL

Weitere VAERSDATA-Felder

Praegender Schweregrund: Loss of consciousness
Hospital-Tage: -
Labordaten: EKG PERFORMED BY PARAMEDIC'S IN AMBULANCE, AND A SECOND PERFORMED BY URGENT CARE
Aktuelle Erkrankungen: N/A
Vorgeschichte: N/A
Andere Medikamente: N/A
Allergien: N/A
Vorherige Impfungen: -

VAERS 1311431

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EW0183

schwer

Staat: CA
Alter: 18,0
Geschlecht: M
Eingang: 13.05.2021
Impfdatum: 12.05.2021
Beginn: 12.05.2021
Tage bis Beginn: 0,0
Dosis: 2
Route/Site: SYR / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Loss of consciousness Pallor Pruritus Rash

Symptomtext

Pt. received the first COVID vaccine (Pfizer, lot # EW0182 and use by date is 05/13/21 at 0930am) around 1123am. LVN, administered the Pfizer vaccine and approximately 10 seconds after the vaccine was administered, the patient became pale and the patient loss consciousness for approximately 4 seconds. LVN ensured that the patient did not fall off the chair while RN (and Co-Lead), RN (Lead Vaccinator), and EMT observer, immediately ran to assist LVN with assisting the patient to the ground. The patient was alert and oriented when the nurses assisted him to the floor and had him lie in a supine position with his legs elevated. The patient was alert and oriented to person, place, time, and situation. Vital signs were immediately taken at 1124 when the patient was supine on the ground with his legs elevated: blood pressure of 112/58 (right arm, supine) , heart rate of 48 beats per minute, respiratory rate of 16 breaths per minute, and 100% oxygen saturation at room air. The patient denied any headache, nausea, or dizziness. The patient was moved to the gravity chair and was placed in Fowler's position. The patient was given Gatorade, as the patient did not eat or drink anything prior to being vaccinated. Vitals were taken at 1131: BP 114/78 (Right arm, sitting) , 66 beats per minute, 16 breaths per minute, and 100% oxygen saturation at room air. Alert and oriented to person, place, time, and situation. Denied any history of fainting . Denied taking any medications or having any chronic medical conditions. The patient continued drinking Gatorade and was offered a granola bar, the patient did not have any known allergies to medications, foods, or dust. At 1141, vitals were retaken, BP 122/87 (Right arm, sitting), HR 63, RR 16, and 100% oxygen saturation at room air. The patient denied any chest pain, shortness of breath, lightheadedness, dizziness, or headache. The patient ate a breakfast biscuit at 1148. At 1153 the patient was positioned from a Fowler's position to sitting upright in the gravity chair. Instructed the patient to have a friend or family member drive him home, the patient then called a friend to transport him home. RN, went over the V-Safe app with the patient and instructed him to eat breakfast and drink fluids the next time he arrived for his 2nd Pfizer vaccine. RN also instructed him to inform the vaccinator the next time he is vaccinated (for his second dose), to inform him/her about his history of fainting with his first dose. The patient's vitals were taken at 1158 when he was sitting upright, BP: 138/80 (right arm), HR 67, RR 15, and oxygen saturation at 99%. RN instructed the patient about ER precautions and to follow up with his primary care provider. The patient's vital signs were taken a final time at 1210, BP 122/78, RR 16, HR 67, and 100% oxygen saturation at room air. The patient's ride arrived on site around 1215, and the patient had a steady and even gait when ambulating to the vehicle, where he was driven home by a friend.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Loss of consciousness
Hospital-Tage: -
Labordaten: None
Aktuelle Erkrankungen: No
Vorgeschichte: None
Andere Medikamente: None
Allergien: None
Vorherige Impfungen: -

VAERS 1311415

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EW0183

schwer

Staat: CT
Alter: 30,0
Geschlecht: F
Eingang: 12.05.2021
Impfdatum: 08.05.2021
Beginn: 09.05.2021
Tage bis Beginn: 1,0
Dosis: 2
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Seizure Tremor

Symptomtext

Uncontrollable shaking and convulsions that lasted approximately an hour and a half.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Seizure
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1310935

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EW0183

schwer

Staat: -
Alter: 37,0
Geschlecht: M
Eingang: 12.05.2021
Impfdatum: 12.05.2021
Beginn: 12.05.2021
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt

Dizziness Hyperhidrosis Pallor Swelling face Syncope

Symptomtext

syncope episode/ lightheaded after 10 minutes of vaccination, slightly diaphonic, pale, swelling to head. water and crackers for the patient BP 100/55, 55, 100% Feeling better then d/c to home

Weitere VAERSDATA-Felder

Praegender Schweregrund: Syncope
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1310337

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EW0183

schwer

Staat: ME
Alter: 42,0
Geschlecht: F
Eingang: 12.05.2021
Impfdatum: 12.05.2021
Beginn: 12.05.2021
Tage bis Beginn: 0,0
Dosis: 2
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein

Blood glucose normal Eye pain Facial paralysis

Symptomtext

Patient reported significant unilateral eye pain behind her left eye ~15 minutes following injection of second dose. ~20 minutes after vaccine injection, patient developed some facial droop on her left side. Initial patient was given juice and was given powder acetominophen by her mother. After facial droop was noted, EMS was contacted for transport to local ED

Weitere VAERSDATA-Felder

Praegender Schweregrund: Facial paralysis
Hospital-Tage: -
Labordaten: blood glucose - 120
Aktuelle Erkrankungen: see chronic conditions History of TBI, CVA and seizure disorder antiphospholipid antibody syndrome
Vorgeschichte: History of TBI, CVA and seizure disorder antiphospholipid antibody syndrome
Andere Medikamente: risperidone; lamotrigine; perampenel; clonidine; lorazepam; xarelto
Allergien: toradol; Keppra; mobic; topamax
Vorherige Impfungen: -

VAERS 1302682

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EW0183

schwer

Staat: CA
Alter: 34,0
Geschlecht: F
Eingang: 10.05.2021
Impfdatum: 06.05.2021
Beginn: 06.05.2021
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Dizziness Syncope Tremor

Symptomtext

Dizziness and shaking fainted - Physician called to evaluate the patient. Patient transferred to gurney from chair. Vitals checked BP:95/60 Pulse: 70 o2:99% After few minutes patient responds and stoked she fells better now. Patient stated she usually fainted whenever any blood was done on her. Patient had sips of water and said she is normal now. Suggest her to stay for more 30 minutes for evaluation. BP: 98/65 Pulse: 74 Advice her to consult her primary physician about adverse reaction. Patient left for home with husband. #21 Went home

Weitere VAERSDATA-Felder

Praegender Schweregrund: Syncope
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: N/A
Vorherige Impfungen: -

VAERS 1301281

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge ew0183

schwer

Staat: NY
Alter: 33,0
Geschlecht: M
Eingang: 09.05.2021
Impfdatum: 09.05.2021
Beginn: 09.05.2021
Tage bis Beginn: 0,0
Dosis: 2
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Presyncope

Symptomtext

vasovagal episode that begin immediately following the injection with vaccine. Patient was alert, oriented. He was evaluated, blood pressure and vital signs checks were performed. Mental status was maintained. following a period of rest he recovered and was discharged

Weitere VAERSDATA-Felder

Praegender Schweregrund: Presyncope
Hospital-Tage: -
Labordaten: none
Aktuelle Erkrankungen: none
Vorgeschichte: none
Andere Medikamente: none
Allergien: none
Vorherige Impfungen: -

VAERS 1301194

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EW0183

schwer

Staat: -
Alter: 31,0
Geschlecht: M
Eingang: 09.05.2021
Impfdatum: 09.05.2021
Beginn: 09.05.2021
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Dizziness Hyperhidrosis Nausea Presyncope

Symptomtext

PMH: Vasovagal with injection. Ambulate to healthcare with assistance. Onset diaphoresis, nausea, lightheadedness. CV: RRR No vomiting, no meds,. Ate prior to vaccination (water and crackers). At 12:43PM patient feels better, no symptoms. Discharge at 12:45PM BP: 119/78

Weitere VAERSDATA-Felder

Praegender Schweregrund: Presyncope
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: Vasovagal

VAERS 1300865

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EW0183

schwer

Staat: -
Alter: 16,0
Geschlecht: M
Eingang: 09.05.2021
Impfdatum: 09.05.2021
Beginn: 09.05.2021
Tage bis Beginn: 0,0
Dosis: 2
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt

Gait disturbance Presyncope

Symptomtext

Vasovagal reaction, awaked quickly, tolerated , ambulates with difficulty, no further symptoms, no medication taken then released at 08: 30 AM

Weitere VAERSDATA-Felder

Praegender Schweregrund: Presyncope
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1300219

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge ew0183

schwer

Staat: MO
Alter: 47,0
Geschlecht: M
Eingang: 08.05.2021
Impfdatum: 08.05.2021
Beginn: 08.05.2021
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Loss of consciousness

Symptomtext

patient lost consciousness at about 1038 am, I laid him down on the floor called ems, he came to I had him rest for a few minutes and sat him up, gave him some water he stated he had not had anything to eat that morning EBS cam took vitals and released him. he said he felt fine waled around the store for a few minutes and drove himself home. I told him if he had any other problems to call 911

Weitere VAERSDATA-Felder

Praegender Schweregrund: Loss of consciousness
Hospital-Tage: -
Labordaten: blood pressure 112/68 pulse and blood glucose 96
Aktuelle Erkrankungen: none
Vorgeschichte: -
Andere Medikamente: none
Allergien: none
Vorherige Impfungen: -

VAERS 1297330

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge ew0183

schwer

Staat: MO
Alter: 16,0
Geschlecht: M
Eingang: 07.05.2021
Impfdatum: 07.05.2021
Beginn: 07.05.2021
Tage bis Beginn: 0,0
Dosis: 2
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: ja

Altered state of consciousness Hyperhidrosis Mydriasis Pallor Syncope

Symptomtext

Patient had no issues with 1st shot. After 5 minutes of injection pt fainted. He revived right away but pupils were dilated and he had trouble staying conscious. After a few more minutes pupils were normal but he was pale and sweaty. He drank some water and felt better. EMS were called and said he was ok. All happened within 30 minutes.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Syncope
Hospital-Tage: -
Labordaten: na
Aktuelle Erkrankungen: none
Vorgeschichte: none
Andere Medikamente: none
Allergien: none
Vorherige Impfungen: -

VAERS 1296689

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EW0183

schwer

Staat: CT
Alter: 16,0
Geschlecht: F
Eingang: 07.05.2021
Impfdatum: 07.05.2021
Beginn: 07.05.2021
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein

Dizziness Fatigue Loss of consciousness Tremor

Symptomtext

Approximately after 1 minute from receiving her first pfizer vaccine the patient reported to her mother that she feels like she is going to pass out. This RN was alerted about the situation by the patients mother and when approaching the patient this RN noticed the patient losing consciousness and drawing her arms to chest and curling her hands with tremors throughout her body. This RN placed the patient on the floor for safety out of the chair and had other staff member contact 911. Tremors lasted approximately 30 seconds and patient regained consciousness however appeared tired and stated she is unware of what just happened. Vitals were taken which were within normal limits and continued to be taken frequently until EMS arrive to transport patient to Hospital

Weitere VAERSDATA-Felder

Praegender Schweregrund: Loss of consciousness
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: amoxicillin
Vorherige Impfungen: -

VAERS 1293512

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EW0183

schwer

Staat: WA
Alter: 29,0
Geschlecht: M
Eingang: 06.05.2021
Impfdatum: 06.05.2021
Beginn: 06.05.2021
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: ja

Abdominal discomfort Chest discomfort Dizziness Fall Feeling hot Hyperhidrosis Hypotension Loss of consciousness Memory impairment Seizure Vision blurred

Symptomtext

Patient got the 1st dose of Pfizer vaccine at 1:58 pm on 5/6/21. Patient felt slightly dizzy about 3 minutes after getting the vaccine. Then he passed out and fell on the floor with seizure for about 5 seconds. He regain conscious and said he didn't remember anything. He also said his stomach felt upset. Later he felt chest tightness and blurry vision. We called 911 at 2:02 pm. They came in at 2:07 pm. They checked the patient's blood pressure. Patient had low blood pressure. He was sweating and felt hot. He didn't eat or drink anything before getting the vaccine. They transferred him to the emergency room for further check-up.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Loss of consciousness
Hospital-Tage: -
Labordaten: Blood pressure checked. Low blood pressure per medical team.
Aktuelle Erkrankungen: No
Vorgeschichte: No
Andere Medikamente: N/A
Allergien: No known allergy
Vorherige Impfungen: -

VAERS 2617517

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EW0183

moderat

Staat: -
Alter: 73,0
Geschlecht: M
Eingang: 19.04.2023
Impfdatum: 22.12.2021
Beginn: 27.07.2022
Tage bis Beginn: 217,0
Dosis: 3
Route/Site: - / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt

Hypotension

Symptomtext

PATIENT RECEIVED FROM OUTSIDE SOURCE HYPOTENSION

Weitere VAERSDATA-Felder

Praegender Schweregrund: Hypotension
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2607567

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EW0183

moderat

Staat: -
Alter: 80,0
Geschlecht: F
Eingang: 31.03.2023
Impfdatum: 23.06.2021
Beginn: 04.10.2021
Tage bis Beginn: 103,0
Dosis: 2
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: nein

Hypotension

Symptomtext

HYPOTENSION 10/4/2021

Weitere VAERSDATA-Felder

Praegender Schweregrund: Hypotension
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2591049

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EW0183

moderat

Staat: MI
Alter: 86,0
Geschlecht: F
Eingang: 03.03.2023
Impfdatum: 05.10.2021
Beginn: 21.02.2023
Tage bis Beginn: 504,0
Dosis: 3
Route/Site: - / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: ja

Asthenia Blood culture negative COVID-19 Chest X-ray Cough Culture urine negative Dysstasia Fatigue Influenza virus test negative Laboratory test abnormal Lactic acidosis Leukocytosis Pyrexia Pyuria Respiratory syncytial virus test negative SARS-CoV-2 test positive Sepsis Tachycardia

Symptomtext

Discharge Provider: MD Primary Care Provider: DO Admission Date: 2/21/2023 Discharge Date: Feb 25, 2023 PRESENTING PROBLEM: Generalized weakness [R53.1] COVID-19 virus infection [U07.1] HOSPITAL COURSE: Patient is a 88 y.o. female with medical history significant for coronary artery disease, hypertension, dyslipidemia, CKD stage IIIA, prior stroke, dementia. Presents ER for weakness over the past day. History gathered from chart review, patient has dementia (A&Ox2-3 at baseline) . Recent admission 1/4-1/6/2023 (notes reviewed) after presenting to ER for weakness and fatigue as well as cough, admitted for sepsis syndrome and lactic acidosis. COVID-19, influenza, RSV negative. Urinalysis showing significant pyuria and labs showing leukocytosis so patient started on IV Rocephin for possible urinary tract infection. Also started on IV fluids. Blood and urine cultures negative however patient's symptoms improved with fluids and antibiotics. PT/OT evaluated patient who recommended discharge home with assistance. Working with PT following discharge with improvement in strength, discharged from PT on 02/15 due to patient meeting goals and being independent with home exercise programs with daughter's supervision. Back to ER evening of 2/21 reportedly due to increasing weakness over the previous 12 hours. She had been ambulating independently with a walker, but this evening, was unable to even stand due to weakness. Patient herself says she feels well, does report a cough for 2 weeks as well as weakness, otherwise denies concerns. No headache, chest pain or pressure, shortness of breath, abdominal pain, vomiting, diarrhea or bowel changes. Denies known sick contacts. Received last COVID-19 booster in 10/2021. In ER, noted to be febrile with T-max 102.7? F, mildly tachycardic and tachypneic, vitals otherwise stable. No hypoxia. Labs unremarkable. UA negative. CXR. Found to be COVID-19 positive. Due to significant weakness and inability to safely return home, will place in observation for further management and safe dispo. Pt was observed for 24 hrs. Labs and VS wnl. PT/OT consulted for placement. Recs SAR.This was discussed with pts daughter. On day of discharge pt feels well. Denies any complaints. Stable for discharge.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Tachycardia
Hospital-Tage: 4,0
Labordaten: -
Aktuelle Erkrankungen: 9/26/2021 - 9/29/2021 (3 days) Hospital PRESENTING PROBLEM: TIA (transient ischemic attack) [G45.9] Slurred speech [R47.81] Acute CVA (cerebrovascular accident) (HCC) [I63.9]
Vorgeschichte: Coronary artery disease Interstitial cystitis Hyperlipidemia Chronic rhinitis Colon polyps Spinal stenosis Depression Tremor, essential Impaired fasting glucose GERD (gastroesophageal reflux disease) Glaucoma Microalbuminuria Stage 3 chronic kidney disease (HCC) Uses hearing aid First degree AV block Abnormal SPEP Alzheimer's dementia without behavioral disturbance (HCC) Anxiety disorder, unspecified Cardiac murmur, unspecified Prediabetes Generalized weakness Ischemic cardiomyopathy Major depressive disorder, single episode, unspecified Mild aortic insufficiency Old myocardial infarction PFO (patent foramen ovale) Unspecified osteoarthritis, unspecified site Personal history of transient ischemic attack (TIA), and cerebral infarction without residual deficits Acute right-sided weakness Acute arterial ischemic stroke, multifocal, multiple vascular territories (HCC) Essential hypertension COVID-19
Andere Medikamente: acetaminophen (TYLENOL) 500 MG tablet albuterol HFA (PROVENTIL HFA, VENTOLIN HFA, PROAIR HFA) 108 (90 Base) MCG/ACT inhaler atorvastatin (LIPITOR) 40 MG tablet benzonatate (TESSALON) 100 MG capsule cholecalciferol (VITAMIN D3) 50 MCG (2000
Allergien: CarvedilolDiarrhea Crestor [Hmg-coa-r Inhibitors] Demerol LisinoprilCough MetforminDiarrhea Metoprolol Morphine Sulfa Drugs
Vorherige Impfungen: -

VAERS 2576561

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EW0183

moderat

Staat: MI
Alter: 41,0
Geschlecht: F
Eingang: 06.02.2023
Impfdatum: 26.08.2021
Beginn: 27.01.2023
Tage bis Beginn: 519,0
Dosis: 3
Route/Site: - / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: ja

Angiogram pulmonary normal COVID-19 Chest pain Cortisol decreased Dizziness Dyspnoea Echocardiogram normal Hypotension Hypoxia SARS-CoV-2 test positive

Symptomtext

Discharge Provider: MD Primary Care Provider: MD Admission Date: 1/27/2023 Discharge Date: Feb 2, 2023 PRESENTING PROBLEM: Shortness of breath [R06.02] Lightheadedness [R42] Chest pain, unspecified type [R07.9] COVID-19 [U07.1] HOSPITAL COURSE: Patient is a 42-year-old woman who presented to emergency department due to shortness of breath. She was positive for COVID in the emergency department and also found to be hypotensive. She has a history of long haul COVID. On further evaluation she was hypoxic in 80s with ambulation. She was immediately started on Decadron. Her blood pressures did respond to IV fluids however it continued to be soft in 90s. Cortisol level was checked which was low. Endocrine was consulted who thought the patient's cortisol level is low because of Decadron use and most likely this is contributing to her low blood pressures. Decadron was stopped as patient remained on room air. Patient was started on hydrocortisone which improved her blood pressures. Echocardiogram was obtained during this admission which was within normal limits. CT angiogram thorax was negative for pulmonary embolism as well. Patient was doing well however suddenly again became hypoxic with ambulation r hence was restarted on Decadron after discussing with Endocrine. Hydrocortisone was stopped. Patient blood pressure remained stable in spite of stopping hydrocortisone. She was discharged home with prescription for Decadron to finish total of 10 days. At the time of discharge he was evaluated by Pulmonary in have and did not require home oxygen . She was feeling significantly better with improvement in all her symptoms related to COVID and hypotension at the time of discharge. Orthostatics were also checked which were negative during this admission.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Chest pain
Hospital-Tage: 6,0
Labordaten: -
Aktuelle Erkrankungen: None
Vorgeschichte: Migraine without aura Insomnia Diminished ovarian reserve Ventricular tachycardia Noninflammatory pericardial effusion Corneal scar Ventricular premature depolarization Other primary thrombophilia Generalized anxiety disorder Ankylosing spondylitis Post-COVID-19 condition Exercise hypoxemia Irritable bowel syndrome with diarrhea Snoring Dyspnea on exertion History of COVID-19 COVID-19
Andere Medikamente: celecoxib (CELEBREX) 200 MG capsule dexamethasone (DECADRON) 6 MG tablet FLUoxetine (PROZAC) 20 MG capsule Golimumab (SIMPONI ARIA IV) L-ARGININE-500 PO ondansetron (ZOFRAN-ODT) 4 MG disintegrating tablet topiramate (TOPAMAX) 100 MG tablet
Allergien: Phenergan Plain SyrupOther Enbrel [Etanercept] Humira Pen Starter [Adalimumab] Promethazine Secukinumab
Vorherige Impfungen: -

VAERS 2576554

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EW0183

moderat

Staat: MI
Alter: 56,0
Geschlecht: F
Eingang: 06.02.2023
Impfdatum: 17.09.2021
Beginn: 05.01.2023
Tage bis Beginn: 475,0
Dosis: 2
Route/Site: - / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: unbekannt

COVID-19 Dyspnoea Fatigue SARS-CoV-2 test positive

Symptomtext

01/05/23 presents to ED for "fatigue, SOB". PMHx of "heavy uterine bleeding requiring pRBC transfusions, recent diagnosis of DVT/PE and leukocytosis"

Weitere VAERSDATA-Felder

Praegender Schweregrund: Dyspnoea
Hospital-Tage: -
Labordaten: 01/05/23 SARS-CoV-2 (COVID-19) by NAA detected
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2570644

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EW0183

moderat

Staat: MI
Alter: 62,0
Geschlecht: F
Eingang: 30.01.2023
Impfdatum: 17.06.2021
Beginn: 30.12.2022
Tage bis Beginn: 561,0
Dosis: 1
Route/Site: - / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: unbekannt

COVID-19 Chest pain Cough SARS-CoV-2 test positive

Symptomtext

12/30/22 presents to ED for "cough" "chest pain". PMHx of "COPD, hypertension, GERD, DM type II, hepatitis C, hypercholesterolemia, CAD"

Weitere VAERSDATA-Felder

Praegender Schweregrund: Chest pain
Hospital-Tage: -
Labordaten: 12/30/22 SARS-CoV-2 (COVID-19) by NAA detected
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2559698

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EW0183

moderat

Staat: -
Alter: 66,0
Geschlecht: M
Eingang: 13.01.2023
Impfdatum: 21.08.2021
Beginn: 20.12.2022
Tage bis Beginn: 486,0
Dosis: 2
Route/Site: - / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: unbekannt

Acute kidney injury Anticoagulant therapy Bladder catheterisation Blood creatinine increased Chest X-ray normal Chronic kidney disease Computerised tomogram abdomen normal Condition aggravated Culture urine Echocardiogram normal Fatigue Laboratory test abnormal Leukocytosis Renal tubular necrosis SARS-CoV-2 test positive Urine output decreased

Symptomtext

Patient is a 68 y.o. male patient of MD with past medical history of hypertension, hyperlipidemia, coronary artery disease, diastolic congestive heart failure, type 2 diabetes mellitus insulin-dependent, CKD stage IV, moderate obesity body mass index 39, presented with decreased urine output and abnormal labs Acute kidney injury, ATN, creatinine on admission 4 CKD stage IV, baseline creatinine 2 IV fluid hydration Foley catheter placement Closely monitor urine output and kidney function test Daily BMP and magnesium Follow with nephrology CT abdomen pelvis showed no hydronephrosis. Serum Cr improved close to baseline Covid-19 Virus Infection Date of onset of symptoms: 12/18/2022 Symptoms present on admission: Generalized tiredness and fatigue and decreased urine output Date of covid positive test: 12/20/2022 Vaccination status: vaccinated Imaging: Chest x-ray no acute finding Oxygen requirements on admission: Room air Current oxygen requirements: Room air Medical therapy: steroids, will discontinue patient is on room air Consultants following: ID Anticipated special isolation end date: 12/28/2022 Insulin-dependent diabetes mellitus with hyperglycemia Hemoglobin A1c Resume Lantus Insulin sliding scale. Hypertension Norvasc 5 mg daily Carvedilol 6.25 mg twice daily, increase to 12.5 twice daily, increase to home dose of 25 twice daily Isordil 20 mg 3 times daily, add hydralazine 50 3 times daily IV hydralazine and labetalol as needed Coronary artery disease Hyperlipidemia Guideline directed medical therapy Currently on Eliquis and Plavix Echocardiogram 3/22/2022 showed EF 73% with normal LV systolic and diastolic function. Leukocytosis Concern of acute lower urinary tract infection Broad-spectrum IV antibiotics Urine culture Follow with infectious disease team Morbid obesity Body mass index 39.3 Encouraged weight loss and lifestyle modification

Weitere VAERSDATA-Felder

Praegender Schweregrund: Condition aggravated
Hospital-Tage: 5,0
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2512829

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge ew0183

moderat

Staat: MI
Alter: 34,0
Geschlecht: F
Eingang: 21.11.2022
Impfdatum: 10.05.2021
Beginn: 01.05.2021
Tage bis Beginn: -
Dosis: 1
Route/Site: - / UN

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Delivery Dyspnoea Echocardiogram Electrocardiogram Exposure during pregnancy Heart rate increased Hypertension Influenza like illness Palpitations

Symptomtext

I received covid vaccine around 20 weeks pregnant 1st dose April 2021 no adverse reaction. 2nd dose in May, flu like symptoms. Shortly after second dose was received i began having heart palpitations, shortness of breath and increased heart rate. Delivery 10/13/2021. Palpitations subsided post partum; however shortness of breath and newly diagnosed HBP remain.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Dyspnoea
Hospital-Tage: -
Labordaten: ekg, echo
Aktuelle Erkrankungen: none
Vorgeschichte: none
Andere Medikamente: prenatal vitamin
Allergien: shellfish
Vorherige Impfungen: -

VAERS 2480819

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge ew0183

moderat

Staat: CA
Alter: 57,0
Geschlecht: F
Eingang: 17.10.2022
Impfdatum: 06.05.2021
Beginn: 06.05.2021
Tage bis Beginn: 0,0
Dosis: 2
Route/Site: - / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Ageusia Chest pain Chills Decreased appetite Dysmenorrhoea Hypoaesthesia oral Lethargy Migraine Pyrexia Tinnitus

Symptomtext

1. Numbness at tip of tongue 2. loss of taste and appetite 3. fever 4. Chills 5. lethargic 6. ringing in my ears 7. increase in migraine headaches that lasted 6 months 8. one time chest pain 5 days after shot while climbing flights of stairs 9. menstrual cramps on and off for 5 months even though I was post-menopausal.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Chest pain
Hospital-Tage: -
Labordaten: None
Aktuelle Erkrankungen: None
Vorgeschichte: Migraines
Andere Medikamente: Ibuprofen, Pepcid AC
Allergien: Amoxicillin
Vorherige Impfungen: -

VAERS 2468555

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EW0183

moderat

Staat: TX
Alter: 77,0
Geschlecht: M
Eingang: 04.10.2022
Impfdatum: 18.06.2021
Beginn: 16.01.2022
Tage bis Beginn: 212,0
Dosis: 2
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: ja

Acute kidney injury Chest pain Cough Dehydration Diarrhoea Dyspnoea Nausea Suspected COVID-19 Vomiting

Symptomtext

Admit for suspected COVID infection, presenting with SOB, CP, cough, N, V, D; exposed to ill daughter. Fully vaccinated. Did not require targeted treatmetn for COVID, minimal need for O2 therapy. Treated for dehydration and AKI. Improved and discharged home.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Chest pain
Hospital-Tage: 6,0
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2440988

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EW0183

moderat

Staat: MI
Alter: 101,0
Geschlecht: F
Eingang: 12.09.2022
Impfdatum: 14.10.2021
Beginn: 06.09.2022
Tage bis Beginn: 327,0
Dosis: 3
Route/Site: - / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: ja

Asthenia COVID-19 Condition aggravated Hypoxia Laboratory test normal Respiratory symptom SARS-CoV-2 test positive X-ray normal

Symptomtext

Discharge Provider: MD Primary Care Provider: DO Admission Date: 9/6/2022 Discharge Date: 09/08/2022 PRESENTING PROBLEM: Hypoxia Acute COVID-19 COVID-19 virus infection Generalized weakness HOSPITAL COURSE: Patient is a 102 y.o. female with past medical history significant for HTN, HLD, and osteoporosis presented to the emergency department for generalized weakness and mild upper respiratory infection symptoms. She is found to be COVID positive. She had mild ambulatory hypoxia but SPO2 stable at rest on RA. X-ray with no acute cardiopulmonary process in labs essentially unremarkable. Was given dose of Decadron and admitted to internal medicine service. She had no further hypoxia at rest or with ambulation so steroids were not continued. She received 2 doses of Remdesivir. PT recommended home with assist and HHC which was arranged. Patient discharged home in stable condition

Weitere VAERSDATA-Felder

Praegender Schweregrund: Condition aggravated
Hospital-Tage: 2,0
Labordaten: -
Aktuelle Erkrankungen: None
Vorgeschichte: Hypertension Hypercholesteremia Osteoporosis Auditory hallucinations Acute bronchitis due to human metapneumovirus At risk for falls Vitamin D deficiency Thrombocytopenia, unspecified Atherosclerosis of artery of left lower extremity Acute COVID-19 Anxiety disorder Generalized weakness
Andere Medikamente: albuterol HFA (PROVENTIL HFA, VENTOLIN HFA, PROAIR HFA) 108 (90 Base) MCG/ACT inhaler ALPRAZolam (XANAX) 0.25 MG tablet ARIPiprazole (ABILIFY) 2 MG tablet cholecalciferol (VITAMIN D3) 50 MCG (2000 UT) TABS lisinopril (PRINIVIL,ZESTRIL) 10 M
Allergien: Iodine Sulfa DrugsOther
Vorherige Impfungen: -

VAERS 2433601

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EW0183

moderat

Staat: MI
Alter: 71,0
Geschlecht: F
Eingang: 08.09.2022
Impfdatum: 17.05.2021
Beginn: 24.08.2022
Tage bis Beginn: 464,0
Dosis: 1
Route/Site: - / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: unbekannt

Abdominal pain COVID-19 Dyspnoea SARS-CoV-2 test positive

Symptomtext

08/24/22 presents to EC ED for "abdominal pain, shortness of breath". PMHx of "MS, CVA, recent fall and left rib fracture"

Weitere VAERSDATA-Felder

Praegender Schweregrund: Dyspnoea
Hospital-Tage: -
Labordaten: 08/24/22 SARS-CoV-2 (COVID-19) by NAA detected
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2431190

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EW0183

moderat

Staat: MI
Alter: 58,0
Geschlecht: F
Eingang: 07.09.2022
Impfdatum: 06.10.2021
Beginn: 24.08.2022
Tage bis Beginn: 322,0
Dosis: 3
Route/Site: - / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: ja

Abdominal pain Biliary catheter insertion COVID-19 Carbohydrate antigen 19-9 increased Chest X-ray normal Cholangitis Cholangitis sclerosing Computerised tomogram abdomen normal Condition aggravated Liver function test increased Pyrexia SARS-CoV-2 test positive

Symptomtext

Admission Date: 8/24/2022 Discharge Date: 8/28/2022 PRESENTING PROBLEM: Primary sclerosing cholangitis [K83.01] Abdominal pain [R10.9] Elevated LFTs [R79.89] Intractable abdominal pain [R10.9] COVID-19 virus infection [U07.1] Cholangitis [K83.09] HOSPITAL COURSE: The patient is a 59-year-old female with a history of PSC, chronic back pain, essential hypertension, remote history of Roux-en-Y gastric bypass, herpes simplex, and chronic pruritus due to PSC who presented with increasing abdominal pain, febrile illness and elevated LFTs.. Patient does have a history of PTC with biliary drain placed on 03/16/2022 at which was removed on 04/05/2022. At the time of admission she was found to have elevated LFTs. CT scan of the abdomen pelvis showed no acute changes. Patient was also found to have COVID infection, but chest x-ray was negative, and the patient's O2 saturations were stable on room air. Patient was admitted to the hospital service and started on Zosyn. GI was consulted. Was also consulted, as it was initially felt the patient likely would need repeat PTC drainage. MRCP was consistent with PSC with active cholangitis, with several areas of narrowing. The case was discussed with attending, who felt that there was no need for intervention. Hepatology initially felt that the patient would require PTC with brushings of the bile ducts, as CA 19 9 is elevated. With antibiotics the patient's abdominal pain significantly improved and LFTs also returned to near normal levels. With clinical improvement and improved LFTs, it was felt the patient did not require PTC drainage at this time. Patient's case is to be discussed by GI with the soft tissue tumor board on 09/13. Patient also has an appoint with on 09/13 and was encouraged to keep this appointment. The patient did have positive COVID test, with fever on admission however was otherwise asymptomatic with regards to her COVID infection, and was not treated with Paxlovid, remdesivir or dexamethasone. As patient was clinically stable, she was transition from Zosyn to Augmentin, to be continued to complete a 14 day course of treatment, and discharged to home on 08/28.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Condition aggravated
Hospital-Tage: 4,0
Labordaten: -
Aktuelle Erkrankungen: None
Vorgeschichte: Prediabetes Stricture or kinking of ureter History of pulmonary embolism s/p IVC filter hx of gastric bypass, 2004 (Roux-en-Y) Positive TB test Fecal incontinence Genital herpes simplex Essential hypertension, benign Fibromyalgia Elevated CA 19-9 level Hyperlipidemia Primary sclerosing cholangitis Obstructive sleep apnea hypopnea, mild H. pylori infection Pain in joint, ankle and foot, unspecified laterality Excessive skin and subcutaneous tissue Muscle spasms of lower extremity, unspecified laterality Venous stasis Urge incontinence Encounter for monitoring opioid maintenance therapy Protrusion of lumbar intervertebral disc Spinal stenosis of lumbar region, unspecified whether neurogenic claudication present Spondylolisthesis, lumbar region Back pain Primary insomnia Osteoarthritis of left hip GAD (generalized anxiety disorder) Osteopenia of multiple sites Primary osteoarthritis of right knee Lipoma of back Biliary drain displacement AKI (acute kidney injury) (HCC) Hyponatremia Biliary drain displacement, initial encounter S/P insertion of IVC (inferior vena caval) filter Obesity (BMI 30-39.9) Biliary stricture
Andere Medikamente: amLODIPine (NORVASC) 5 MG tablet amoxicillin-clavulanate (AUGMENTIN) 875-125 MG per tablet aspirin 81 MG enteric coated tablet ergocalciferol (VITAMIN D, ERGOCALCIFEROL,) 1.25 MG (50000 UT) capsule hydroCHLOROthiazide (HYDRODIURIL) 25 MG ta
Allergien: DuloxetineNausea Only, Rash, Hallucinations LisinoprilSwelling, Hallucinations TizanidineNausea Only, Hallucinations, Confusion FurosemideSwelling LatexHives, Itching MethadoneItching MorphineItching
Vorherige Impfungen: -

VAERS 2425346

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EW0183

moderat

Staat: SC
Alter: 58,0
Geschlecht: F
Eingang: 31.08.2022
Impfdatum: 24.08.2021
Beginn: 01.11.2021
Tage bis Beginn: 69,0
Dosis: 3
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein

Arrhythmia Asthenia Atrial fibrillation Blood test normal Dyspnoea exertional Echocardiogram Ejection fraction normal Electrocardiogram abnormal Electrocardiogram ambulatory abnormal Fatigue Impaired work ability Mobility decreased Supraventricular extrasystoles Thyroid disorder Thyroid function test normal

Symptomtext

Starting in November it was a incidental finding. I was having issues with my pulsometer so I tested it on my self and the wave form was very abnormal. After checking on one of my peers and she came back with normal with a normal wave form. I placed EKG stickers on ,myself and discovered a sinus rhythm with frequent premature atrial contractions. My heart rate was 95 but I was only profusing at a rate of 60. I spoke to a fellow provider and he had me to put on his Apple watch and check my EKG which read Atrial Fibrillation. My doctor advised me that it could flip into A-Fib at any time. I went to the ER and had EKG and full workout. No heart attack was detected but I was still in this arrhythmia. By January, I made an appointment with a cardiologist and had an EKG. He indicated that he thought it was my thyroid and put me on a strong beta blocker. I was prescribed Metoprolol 50mg and asked me to double the dose to 100 mg. I was able to tolerate the 50 with just feeling tired. When I switched to 100 mg, I was at work and could hardly get out of my chair. I checked my heart rate which was at about 40. My blood pressure was 90/40. I immediately stopped the medication. I was sent a halter monitor in the mail. I wore it for 3 days. I noticed that when attempting to climb stairs I was short of breath. The completed an echocardiogram. My ejection fraction went from 73 to 61%. The cardiologist referred me to an Electrophysiology Cardiologist. I was able to see him in middle June. He showed me the results of the halter and told me I was on the verge of going into A-Fib. He placed me on a different medication and stopped the Metoprolol all together. I had Thyroid lab completed and the results were normal. I was placed on Plaquenide and Cardizem. I am still having the same symptoms of shortness of breath and lack of energy. I do want to add that I was survivor of Cancer an received Taxol which the doctor thought could be related.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Arrhythmia
Hospital-Tage: -
Labordaten: EKG-Multiple-Dates Unknown-Normal Sinus Rhythm with abnormal EKG Echocardiogram-Structural Heart is Fine-Arrhythmia still present affecting ejection fracture Thyroid Lab-Normal Blood Panel-Normal
Aktuelle Erkrankungen: N/A
Vorgeschichte: Graves Disease; Asthma; GERD; Cancer Survivor
Andere Medikamente: Prilosec; Singulair; Atenolol; Claritin; Prozac; Hydrochlorothiazide; Advair Inhaler; Glucosamine Joint Supplements; Tapazole
Allergien: Penicillin; Cephalosporin
Vorherige Impfungen: -

VAERS 2423103

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EW0183

moderat

Staat: MI
Alter: 66,0
Geschlecht: F
Eingang: 29.08.2022
Impfdatum: 02.11.2021
Beginn: 02.11.2021
Tage bis Beginn: 0,0
Dosis: 3
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Blindness unilateral Chest pain Eye disorder Intraocular pressure test Nausea Optic neuritis Optical coherence tomography abnormal Pyrexia Retinal degeneration Visual field tests abnormal Vomiting

Symptomtext

Four hours after my 3rd dose I had a fever; vomiting; nausea and I stay in bed all day. I couple weeks after I had chest pain. In February of 2022 I had eye problems. I went to the doctor and they said I might have optic neuritis. Now I take medications to treat it.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Chest pain
Hospital-Tage: -
Labordaten: OCT retinal loss in both eyes; Tonometry-Pressures were normal; Humphrey visual test-Loss of field in the right eye.
Aktuelle Erkrankungen: N/A
Vorgeschichte: Cataract; Heart disease; Asthma; Seizures
Andere Medikamente: Albuterol inhaler
Allergien: Latex; sulfa; TEGRETOL; DILANTIN
Vorherige Impfungen: -

VAERS 2415641

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EW0183

moderat

Staat: NY
Alter: 33,0
Geschlecht: F
Eingang: 19.08.2022
Impfdatum: 20.01.2022
Beginn: 03.02.2022
Tage bis Beginn: 14,0
Dosis: 3
Route/Site: - / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein

Autonomic nervous system imbalance Blood pressure measurement Body temperature Collagen disorder Connective tissue disorder Diplopia Dry eye Dry mouth Dyspnoea Exercise tolerance decreased Fatigue Feeling abnormal Food allergy Gait disturbance Gastrooesophageal reflux disease Head discomfort Heart rate Heart rate irregular

Symptomtext

Joints clicking; Hypermobile/lax joints - similar to EDS; Hypermobile/lax joints - similar to EDS; stretchy skin; Insomnia; Gait change; Numbness in foot; Progressive muscle atrophy; connective tissue/collagen issue; connective tissue/collagen issue; Head pressure; Floaters in eyes; Double vision; Light sensitivity (couldn't look at screen); Shortness of breath; Automatic nervous system disfunction; Bobble head sensation/weak neck; Brain fog; Fatigue PEM; Fatigue PEM; Low blood pressure; Exercise intolerance; New allergies to high histamine foods; Hand/foot pain; Irregular heartbeat; Inflammation; Low grade fever for weeks; GI issues / acid reflux; Dry mouth / eyes; Dry mouth / eyes; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient. A 33-year-old female patient (not pregnant) received BNT162b2 (BNT162B2), on 20Jan2022 as dose 3 (booster), single (Lot number: EW0183) at the age of 33 years, in left arm for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: BNT162b2 (Dose Number: 1, Batch/Lot No: FJ5683, Location of injection: Arm Left), administration date: 06Jun2021, when the patient was 33-year-old, for Covid-19 immunization; BNT162b2 (Dose Number: 2, Batch/Lot No: EW0177, Location of injection: Arm Left), administration date: 16May2021, when the patient was 33-year-old, for Covid-19 immunization. The following information was reported: DRY MOUTH (non-serious), DRY EYE (non-serious) all with onset 03Feb2022, outcome "not recovered" and all described as "Dry mouth / eyes"; GASTROOESOPHAGEAL REFLUX DISEASE (non-serious) with onset 03Feb2022, outcome "not recovered", described as "GI issues / acid reflux"; PAIN IN EXTREMITY (non-serious) with onset 03Feb2022, outcome "not recovered", described as "Hand/foot pain"; INFLAMMATION (non-serious) with onset 03Feb2022, outcome "not recovered"; HEART RATE IRREGULAR (non-serious) with onset 03Feb2022, outcome "not recovered", described as "Irregular heartbeat"; PYREXIA (non-serious) with onset 03Feb2022, outcome "not recovered", described as "Low grade fever for weeks"; AUTONOMIC NERVOUS SYSTEM IMBALANCE (non-serious) with onset Apr2022, outcome "not recovered", described as "Automatic nervous system disfunction"; MUSCULOSKELETAL DISCOMFORT (non-serious) with onset Apr2022, outcome "not recovered", described as "Bobble head sensation/weak neck"; FEELING ABNORMAL (non-serious) with onset Apr2022, outcome "not recovered", described as "Brain fog"; DIPLOPIA (non-serious) with onset Apr2022, outcome "not recovered", described as "Double vision"; EXERCISE TOLERANCE DECREASED (non-serious) with onset Apr2022, outcome "not recovered", described as "Exercise intolerance"; FATIGUE (non-serious), MALAISE (non-serious) all with onset Apr2022, outcome "not recovered" and all described as "Fatigue PEM"; VITREOUS FLOATERS (non-serious) with onset Apr2022, outcome "not recovered", described as "Floaters in eyes"; HEAD DISCOMFORT (non-serious) with onset Apr2022, outcome "not recovered", described as "Head pressure"; PHOTOPHOBIA (non-serious) with onset Apr2022, outcome "not recovered", described as "Light sensitivity (couldn't look at screen)"; HYPOTENSION (non-serious) with onset Apr2022, outcome "not recovered", described as "Low blood pressure"; FOOD ALLERGY (non-serious) with onset Apr2022, outcome "not recovered", described as "New allergies to high histamine foods"; DYSPNOEA (non-serious) with onset Apr2022, outcome "not recovered", described as "Shortness of breath"; GAIT DISTURBANCE (non-serious) with onset Jun2022, outcome "not recovered", described as "Gait change"; JOINT LAXITY (non-serious), HYPERMOBILITY SYNDROME (non-serious) all with onset Jun2022, outcome "not recovered" and all described as "Hypermobile/lax joints - similar to EDS"; INSOMNIA (non-serious) with onset Jun2022, outcome "not recovered"; JOINT NOISE (non-serious) with onset Jun2022, outcome "not recovered", described as "Joints clicking"; HYPOAESTHESIA (non-serious) with onset Jun2022, outcome "not recovered", described as "Numbness in foot"; MUSCLE ATROPHY (non-serious) with onset Jun2022, outcome "not recovered", described as "Progressive muscle atrophy"; CONNECTIVE TISSUE DISORDER (non-serious), COLLAGEN DISORDER (non-serious) all with onset Jun2022, outcome "not recovered" and all described as "connective tissue/collagen issue"; SKIN DISORDER (non-serious) with onset Jun2022, outcome "not recovered", described as "stretchy skin". The events "hand/foot pain", "irregular heartbeat", "inflammation", "low grade fever for weeks", "gi issues / acid reflux", "dry mouth / eyes", "head pressure", "floaters in eyes", "double vision", "light sensitivity (couldn't look at screen)", "shortness of breath", "automatic nervous system disfunction", "bobble head sensation/weak neck", "brain fog", "fatigue pem", "low blood pressure", "exercise intolerance", "new allergies to high histamine foods", "joints clicking", "hypermobile/lax joints - similar to eds", "stretchy skin", "insomnia", "gait change", "numbness in foot", "progressive muscle atrophy" and "connective tissue/collagen issue" required physician office visit and emergency room visit. Relevant laboratory tests and procedures are available in the appropriate section. Therapeutic measures were not taken as a result of pain in extremity, heart rate irregular, inflammation, pyrexia, gastrooesophageal reflux disease, dry mouth, dry eye, head discomfort, vitreous floaters, diplopia, photophobia, dyspnoea, autonomic nervous system imbalance, musculoskeletal discomfort, feeling abnormal, fatigue, malaise, hypotension, exercise tolerance decreased, food allergy, joint noise, joint laxity, hypermobility syndrome, skin disorder, insomnia, gait disturbance, hypoaesthesia, muscle atrophy, connective tissue disorder, collagen disorder. Additional information: The patient had no other medical history; previously very healthy and active. The patient did not have COVID prior to vaccination. There were no other vaccines within four weeks. First wave of effects happened proportional to 2 weeks after booster shot and lasted from Feb2022 to Apr2022 which included: Hand/foot pain, irregular heartbeat, inflammation, low grade fever for weeks, GI issues / acid reflux, dry mouth / eyes. Second wave of symptoms occurring from Apr2022 to Jun2022 included: head pressure, floaters in eyes, double vision, light sensitivity (couldn't look at screen), shortness of breath, automatic nervous system disfunction, bobble head sensation/weak neck, brain fog, fatigue PEM, low blood pressure, exercise intolerance, new allergies to high histamine food. Then the last wave of symptoms started in Jun2022 and were currently still affecting the patient included: joints clicking, hypermobile/lax joint-similar to EDS, stretchy skin, insomnia, gait change, numbness in foot, progressive muscle atrophy, felt like connective tissue/collagen issue. Follow-up (18Aug2022): Follow-up attempts are completed. No further information is expected.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Dyspnoea
Hospital-Tage: -
Labordaten: Test Date: 20220203; Test Name: Blood pressure; Result Unstructured Data: Test Result:Low blood pressure; Test Date: 20220203; Test Name: Fever; Result Unstructured Data: Test Result:Low grade fever; Test Date: 20220203; Test Name: Heart rate; Result Unstructured Data: Test Result:Irregular heartbeat; Test Date: 20220630; Test Name: Covid test; Test Result: Negative ; Comments: Nasal Swab
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2404272

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EW0183

moderat

Staat: MI
Alter: 75,0
Geschlecht: F
Eingang: 08.08.2022
Impfdatum: 26.10.2021
Beginn: 23.01.2022
Tage bis Beginn: 89,0
Dosis: 3
Route/Site: IM / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: unbekannt

Abdominal pain Alanine aminotransferase normal Aspartate aminotransferase normal Asymptomatic COVID-19 Blood albumin decreased Blood lactate dehydrogenase normal Blood lactic acid Blood potassium decreased C-reactive protein increased Chest X-ray normal Clostridium test positive Computerised tomogram abdomen abnormal Culture urine Electrocardiogram T wave abnormal Electrocardiogram abnormal Fibrin D dimer increased Influenza A virus test negative Influenza B virus test

Symptomtext

Pt presented to the ED on 1/23 with CC of abdominal pain and N/V. IN ED pt with VS of temperature 99?, heart rate 118, respiration rate 16, blood pressure 116/67, and sats 97% on room air. Labs with white blood cell count elevated at 15.32, absolute neutrophil count elevated at 13.39, potassium low at 3.4, albumin low at 2.8, AST ALT within normal limits, LDH of 174, lactate of 0.9, CRP elevated at 15.10, D-dimer elevated at 2214, ferritin elevated at 337.8, procalcitonin within normal limits at 0.10, influenza a and B PCR negative, RSV PCR negative, COVID-19 PCR positive. UA appears contaminated and urine cultures currently pending. C diff PCR positive. Troponin x4 within normal limits. EKG with sinus tachycardia, heart rate 111, T-wave abnormalities noted in inferior and lateral leads. Chest x-ray within normal limits. CT abdomen pelvis with contrast showed diffuse rocking pharyngeal mucosal thickening of the distal half with descending colon and sigmoid colon possibly due to colitis or diverticulitis extent of mucosal thickening in the colon slightly increased since previous exam. She continued to be asymptomatic for COVID during her hospital stay.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Sinus tachycardia
Hospital-Tage: 7,0
Labordaten: See above
Aktuelle Erkrankungen: -
Vorgeschichte: 12/11/2013 Breast cancer, left (HCC) Date Unknown Arthritis Date Unknown CPAP (continuous positive airway pressure) dependence Date Unknown GERD (gastroesophageal reflux disease) Date Unknown High cholesterol Date Unknown PICC (peripherally inserted central catheter) in place Date Unknown Post-menopausal Date Unknown Sleep apnea
Andere Medikamente: acidophillus/lactobacillus (FLORANEX) chew tablet anastrozole (ARIMIDEX) 1 MG tablet Calcium Carb-Cholecalciferol 600-1000 MG-UNIT CAPS Cholecalciferol (VITAMIN D3) 10000 UNIT CAPS ezetimibe (ZETIA) 10 MG tablet Multiple Vitamin (MULTI
Allergien: No known allergies
Vorherige Impfungen: -

VAERS 2403123

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EW0183

moderat

Staat: IL
Alter: 54,0
Geschlecht: M
Eingang: 05.08.2022
Impfdatum: 24.04.2021
Beginn: 16.08.2021
Tage bis Beginn: 114,0
Dosis: 2
Route/Site: IM / AR

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: ja ER: ja Erholt: nein

Acute kidney injury Anti-neutrophil cytoplasmic antibody positive vasculitis Antineutrophil cytoplasmic antibody positive COVID-19 Computerised tomogram thorax abnormal Cough Differential white blood cell count Dyspnoea Fatigue Full blood count Haemoptysis Laboratory test Metabolic function test Pneumonia Renal function test abnormal Renal impairment Ultrasound kidney abnormal

Symptomtext

after the vaccination, I was coughin sporadically, chronic Fatigue, then got Diagnosed with Pneumonia on 08/2021 the doctors noticed the kidney function was at its lowest in record but considered it normal due to the pneumonia, I was prescribed 2 types of antibiotic. recovered from the pneumonia but the fatigue and coughin continued In november I started noticing dots of blood in my cough by December 23, 2021 the fatigue was extreme, I was short of breath and the blood every time I coughed was evident and constant, so I called my primary physician who instructed me to go to the ER where I was diagnosed with Covid Acute Kidney injury and ANCA Vasculitis

Weitere VAERSDATA-Felder

Praegender Schweregrund: Dyspnoea
Hospital-Tage: 6,0
Labordaten: Ultrasound examination of the kidneys,CT chest without contrast, ANCA screen/refle titers, Renal pathology, basic metabolic panel, CD20 BCell monitoring, CBC with differential
Aktuelle Erkrankungen: -
Vorgeschichte: High blood pressure
Andere Medikamente: multivitamins, CoQ10, pantoprazole 40 mg, losartan 10 mg, vita, Vitamin D, Vitamin C, Longs Fish oil.
Allergien: Milk intolerance, Egg white intolerance
Vorherige Impfungen: -

VAERS 2399280

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EW0183

moderat

Staat: MI
Alter: 70,0
Geschlecht: M
Eingang: 02.08.2022
Impfdatum: 24.09.2021
Beginn: 21.07.2022
Tage bis Beginn: 300,0
Dosis: 3
Route/Site: - / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: ja

Asthenia Atelectasis Blood lactic acid normal COVID-19 Chest X-ray abnormal Computerised tomogram head abnormal Condition aggravated Cough Eating disorder Hallucination Imaging procedure Intracranial mass Laboratory test Limb injury Magnetic resonance imaging head abnormal Metastasis Mucosal inflammation Nodule

Symptomtext

DATE OF ADMISSION: 07/21/2022 DATE OF DISCHARGE: 07/27/2022 HOSPITAL COURSE The patient is a very pleasant 71-year-old male with past medical history as listed above including esophageal adenocarcinoma on trial drug who presented to Hospital with vague complaints of feeling progressively weak with excessive cough, difficulty eating secondary to mouth sores. Initial laboratory studies and imaging can be found per review. The patient was pancytopenic. The patient was placed in severe respiratory isolation given recent diagnosis of COVID and COVID positive test on presentation. Chest x-ray showed right basilar atelectasis versus pneumonitis. He was empirically treated with cefepime. Procalcitonin and lactic acid were within normal limits. He was stable on room air. He did complete remdesivir while hospitalized. The patient had complaints of hallucinations prior to admission, and a CT head on 07/21 showed deep white matter left occipital mass or metastasis. He underwent MRI of the brain on July 22 showing rim enhancing nodule with vasogenic edema concerning for metastatic disease. He was placed on IV Decadron. Neurosurgery was consulted. No surgical intervention recommended. Radiation Oncology was recommended, who evaluated the patient and is planning simulation and RT as an outpatient. For his mucositis, he was treated with Collin solution, BMX, lidocaine, and nystatin. Palliative Care was consulted to assist with pain control. For his right hand wound, Wound was consulted who recommended moisturizing the area. In terms of his esophageal adenocarcinoma, given new brain metastasis, he is now off trial, but does have other therapy options that will be considered in the future when the patient's nutrition and functional status improve. Physical, Occupational, and Nutritional Therapy were consulted, who recommended home at discharge with outpatient PT, OT. Care Management was consulted to facilitate discharge planning. He was felt medically stable for discharge on 07/27/2022.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Condition aggravated
Hospital-Tage: 6,0
Labordaten: -
Aktuelle Erkrankungen: None
Vorgeschichte: HLD (hyperlipidemia) Hypogonadism male HTN (hypertension) OSA (obstructive sleep apnea) Ocular migraine Senile nuclear cataract, right Myopia of both eyes Type 2 diabetes mellitus with both eyes affected by mild nonproliferative retinopathy without macular edema, with long-term current use of insulin Cancer of distal third of esophagus Dry eyes, bilateral Pneumonia Failure to thrive in adult Callous ulcer, limited to breakdown of skin Mucositis Brain lesion Dysphagia Goals of care, counseling/discussion Nausea Constipation Brain metastasis Brain metastases
Andere Medikamente: Accu-Chek FastClix Lancets acetaminophen (TYLENOL) 500 MG tablet atorvastatin (LIPITOR) 20 MG tablet blood glucose test strips compounded medication (MAGIC MOUTHWASH) suspension dexamethasone (DECADRON) 4 MG tablet dulaglutide (TRULIC
Allergien: Flonase [Fluticasone]Other ShrimpHives
Vorherige Impfungen: -

VAERS 2396520

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EW0183

moderat

Staat: MI
Alter: 49,0
Geschlecht: F
Eingang: 29.07.2022
Impfdatum: 22.10.2021
Beginn: 26.07.2022
Tage bis Beginn: 277,0
Dosis: 3
Route/Site: - / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: ja

COVID-19 Chest pain Condition aggravated Dyspnoea Immunodeficiency Malaise Pyrexia Respiratory failure Sinus bradycardia

Symptomtext

Discharge Provider: Primary Care Provider: Admission Date: 7/26/2022 Discharge Date: Jul 28, 2022 PRESENTING PROBLEM: COVID-19 [U07.1] HOSPITAL COURSE: Pt. is 50 y.o. with Crohn's disease on infliximab, hypothyroidism, OSA on CPAP, non-insulin-dependent type 2 diabetes mellitus, for evaluation of dyspnea, chest pain, fever, malaise which started on 07/25 and was found to have COVID-19 and hypoxic respiratory failure. She completed 3 days of remdesivir as an inpatient due to her immunocompromised state. She also was given a 10 day course of decadron. After 3 days in the hospital, she improved and was able to be weaned off oxygen. She was noted to have asymptomatic sinus bradycardia but was otherwise well and eager to discharge home.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Chest pain
Hospital-Tage: 2,0
Labordaten: -
Aktuelle Erkrankungen: None
Vorgeschichte: Abdominal pain Irritable bowel syndrome with constipation Tobacco abuse Obesity due to excess calories Ileitis Small bowel obstruction Altered bowel habits Arthritis Depression Dyspnea on exertion Hidradenitis suppurativa History of small bowel obstruction Incisional hernia, without obstruction or gangrene Internal hemorrhoids Lesion of female perineum Medical non-compliance MRSA (methicillin resistant staph aureus) culture positive OSA (obstructive sleep apnea) Prediabetes Ventral hernia, recurrent Morbid obesity Arthritis of right knee Crohn's disease of small intestine without complication COVID-19 Sinus bradycardia
Andere Medikamente: acetaminophen (TYLENOL) 500 MG tablet albuterol HFA (PROVENTIL HFA, VENTOLIN HFA, PROAIR HFA) 108 (90 Base) MCG/ACT inhaler benzonatate (TESSALON) 100 MG capsule cyclobenzaprine (FLEXERIL) 10 MG tablet dexamethasone (DECADRON) 6 MG tabl
Allergien: CodeineHives, Nausea and Vomiting
Vorherige Impfungen: -

VAERS 2364444

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EW0183

moderat

Staat: IL
Alter: 66,0
Geschlecht: F
Eingang: 11.07.2022
Impfdatum: 25.06.2021
Beginn: 27.12.2021
Tage bis Beginn: 185,0
Dosis: 2
Route/Site: IM / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: ja

Asthenia COVID-19 Communication disorder Contusion Culture urine positive Escherichia test positive Faecaloma Fall Fatigue Gait inability Inappropriate schedule of product administration Nausea Pneumonia Pneumonia viral Retching SARS-CoV-2 test positive Urinary tract infection Vomiting

Symptomtext

Pfizer Dose 1 5/28/21 (EW0183) Pfizer Dose 2 6/25/21 (EW0183) COVID Positive 1/1/22 1/1/22: Patient is very tired, retching, not able to communicate the time of my examination. Most of the history is obtained by personal review of records. Patient is 66-year-old lady with intellectual disability. She is a resident at a group home. She also has diabetes mellitus. Had cerebral hemorrhage in past. History of weakness and multiple falls for last few days. Was evaluated in emergency department on 12/27/2021 following a fall and was diagnosed with UTI. She has facial bruising from previous fall. She is on ciprofloxacin. Urine culture has grown pansensitive E coli. Had multiple falls again on 1/1/2022. Is not able to ambulate because of generalized weakness. She has severe nausea and had multiple bouts of emesis. Denied chest pain or abdominal pain. See tested positive for SARS-CoV-2. 1/4/22: Bilateral viral pneumonia : Oxygen will be supplemented as needed. Noninvasive positive-pressure ventilation as needed. Positive for SARS- CoV-2 : Remdesivir, and antibiotic will be administered. Liver functions will be monitored. Inflammatory markers will be monitored Generalized weakness: Will get physical therapy, occupation therapy consults. Social services consult for discharge planning needs Intractable nausea and vomiting:Resolved SLP evaluated and will diabetic diet. Large stool burden with probable fecal impaction: Abdominal series confirms. Pt tolerated bowel regimen and having regular bowel movements Non-insulin-dependent diabetes mellitus with neuropathy : Started on sliding scale insulin. Resumed home meds Recent pansensitive E. coli urinary tract infection : As noted above patient is now on IV Levaquin

Weitere VAERSDATA-Felder

Praegender Schweregrund: Pneumonia
Hospital-Tage: 4,0
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: intellectual disability cerebral hemorrhage DM mental retardation
Andere Medikamente: APAP 650 mg PO Q4h PRN Mylanta 15 mL PO PRN ammonium lactate 12% lotion HS apixaban 2.5 mg PO BID atorvastatin 10 mg PO QD benztropine 1 mg PO QD bisacodyl 10 mg supp PR PRN diphenhydramine 25 mg PO Q6h PRN ferrous sulfate 324 mg PO QD furo
Allergien: cephalexin - unknown
Vorherige Impfungen: -

VAERS 2362645

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EW0183

moderat

Staat: -
Alter: 32,0
Geschlecht: M
Eingang: 08.07.2022
Impfdatum: 12.05.2021
Beginn: 16.05.2021
Tage bis Beginn: 4,0
Dosis: 2
Route/Site: - / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Back pain Chest pain Electrocardiogram ST-T segment abnormal Heart rate increased Left atrial enlargement

Symptomtext

Back and chest pain for months. An EKG done showed probably LAE, non-specific ST-T abnormality. Chest and back pain would reliably come up with activity such as swimming and be relieved with rest. Around this. His heart rate started to rise precipitously with some heart rate levels well above 160 beats per minute.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Chest pain
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: none
Vorgeschichte: none
Andere Medikamente: none
Allergien: none
Vorherige Impfungen: -

VAERS 2341773

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EW0183

moderat

Staat: VA
Alter: 13,0
Geschlecht: M
Eingang: 29.06.2022
Impfdatum: 26.06.2021
Beginn: 04.07.2021
Tage bis Beginn: 8,0
Dosis: 2
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: nein

Abdominal pain Allergy test positive Colonoscopy normal Dehydration Dysphagia Endoscopy normal Feeding disorder Hunger Laboratory test Malaise Retching Vomiting

Symptomtext

My son received the vaccine on 06/26/2021. Gagging started on July 4 with vomiting. The vomiting would last a couple of days. He would be hungry and he couldn't eat. He experiences abdominal pain with eating or drinking water. He has a high pain tolerance from other surgeries he has had in the past. The routine is he will be sick for 5 days, he will be okay for a couple of weeks and he will be sick for 5 days. When he gets so dehydrated, we take him to the ER for IVs. He has been to numerous doctors/specialists for a diagnoses but they can't find anything wrong. We feed him purified food which he has difficulty swallowing. Water, PEDIALYTE, juice is all difficult for him to swallow. He was tested for allergies and he is very allergic to certain medicine and unable to process.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Dehydration
Hospital-Tage: 1,0
Labordaten: Endoscopy and colonoscopy within normal range. He has been seen by numerous doctors and has had numerous test.
Aktuelle Erkrankungen: N/A
Vorgeschichte: Cardiac patient; tumors in his ears
Andere Medikamente: TYLENOL; MOTRIN; omega 3; multivitamin
Allergien: Amoxicillin; oxycodone; latex
Vorherige Impfungen: -

VAERS 2327238

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EW0183

moderat

Staat: MI
Alter: 60,0
Geschlecht: M
Eingang: 22.06.2022
Impfdatum: 25.04.2022
Beginn: 07.06.2022
Tage bis Beginn: 43,0
Dosis: 2
Route/Site: UN / UN

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: ja

Asthenia COVID-19 Cough Diabetic ketoacidosis Dyspnoea Faeces discoloured Fall Hyperglycaemia Hypoaesthesia Loss of personal independence in daily activities Magnetic resonance imaging spinal abnormal Nausea SARS-CoV-2 test positive Vomiting

Symptomtext

Provider summary: "Patient is a 61 YO male with a PMHx of T2 DM on insulin, diabetic neuropathy, HTN, HLD, microcytic anemia, GERD, PUD, CAD s/p CABG, depression, anxiety, and OSA who presented with hyperglycemia. Pt reports that for the past 2-3 weeks, he has been having progressively worsening weakness. It started around his groin areas and moved to his entire body. He now struggles to get his daily activities done due to weakness and reports multiple falls during this time period. He has numbness on his lower extremities at baseline. He denies recent illness. Pt states that he has been feeling nauseated for the past 2-3 weeks and did vomit about a week ago. He does admit that he does not use insulin regularly because he feels like it is not helping much (though he states that he knows that it is not true). He believes he has been using insulin every other day for the last 3 weeks. He denies sick contacts and is unsure where he may have gotten COVID-19. He does report getting dry coughs and SOB for the past 1 week. He also endorses having black stools, which started about 2 weeks ago. DKA resolved following IVF resuscitation and K+/Mg+ replacement in the ED. Diet restarted and blood glucose controlled with 50 units of glargine and lispo sliding scale insuline. Held over night due to concerns for recent falls. Neurological status remained at baseline throughout stay. It is recommended that he follow-up with neurology for lumbar spine findings on MRI dated 5/9/2022. Patient seen by gastroenterology who recommend outpatient elective endoscopy once COVID-19 has resolved. PT recommends outpatient physical therapy in the home while OT thinks that inpatient post-acute occupational therapy would be beneficial."

Weitere VAERSDATA-Felder

Praegender Schweregrund: Dyspnoea
Hospital-Tage: 3,0
Labordaten: Positive COVID PCR 6/7/22
Aktuelle Erkrankungen: -
Vorgeschichte: Oliguria 4/20/2021 Diabetic ketoacidosis with coma associated with type 2 diabetes mellitus 4/20/2021 Normocytic anemia 4/20/2021 Metabolic encephalopathy 4/20/2021 Gastroesophageal reflux disease without esophagitis 4/20/2021 Bilateral pleural effusion 4/20/2021 Closed fracture of transverse process of lumbar vertebra 4/20/2021 Displaced fracture of lesser trochanter of left femur, initial encounter for closed fracture 4/20/2021 Fracture of greater trochanter of left femur 4/20/2021 Critical illness myopathy 4/29/2021 Closed fracture of head of right humerus 6/8/2021 Failure to thrive in adult 6/8/2021 Closed fracture of proximal end of right humerus with routine healing 7/7/2021 Diabetic ketoacidosis without coma associated with type 2 diabetes mellitus
Andere Medikamente: dulozetine gluagon lansoprazole loperamide metformin ondastron trazodone
Allergien: -
Vorherige Impfungen: -

VAERS 2319029

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EW0183

moderat

Staat: MI
Alter: 36,0
Geschlecht: F
Eingang: 14.06.2022
Impfdatum: 22.05.2021
Beginn: 24.05.2022
Tage bis Beginn: 367,0
Dosis: 2
Route/Site: - / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: unbekannt

Back pain COVID-19 Chest pain SARS-CoV-2 test positive

Symptomtext

5/24 37 year old female w/ hx of sickle cell disease, cholelithiasis, who presented to BHS-RO ED w/ c/o chest and back pain. Symptoms started 2 days prior to admission.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Chest pain
Hospital-Tage: -
Labordaten: 5/24 SARS-CoV-2 by NAA, Detected
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2311633

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EW0183

moderat

Staat: NC
Alter: 20,0
Geschlecht: M
Eingang: 07.06.2022
Impfdatum: 27.08.2021
Beginn: 27.08.2021
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: SYR / AR

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: ja ER: ja Erholt: nein

Chest pain Dyspnoea Heart rate increased

Symptomtext

Constant chest pain daily which gets worst when heart rate increases and shortness of breath.Treatment was tylenol, ibuprofen, lidocaine patches. None of the medications that was given to me ever helped the pain stayed persistent.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Chest pain
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: None
Vorgeschichte: None
Andere Medikamente: None
Allergien: -
Vorherige Impfungen: -

VAERS 2310357

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EW0183

moderat

Staat: CA
Alter: 55,0
Geschlecht: M
Eingang: 06.06.2022
Impfdatum: 28.05.2021
Beginn: 22.06.2021
Tage bis Beginn: 25,0
Dosis: 2
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

COVID-19 Cardiac stress test Chest pain Echocardiogram normal Electrocardiogram normal Exercise electrocardiogram

Symptomtext

1. Covid. Recovered after 5 weeks. 2. Intermittent sharp fleeting chest pain left of sternum, multiple times per day

Weitere VAERSDATA-Felder

Praegender Schweregrund: Chest pain
Hospital-Tage: -
Labordaten: EKG normal. ECHO Adult Stress Test with Treadmill normal.
Aktuelle Erkrankungen: none
Vorgeschichte: Asthma
Andere Medikamente: Trelegy 100 cg
Allergien: none
Vorherige Impfungen: Pfizer Covid vaccine 5/5/21

VAERS 2303512

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EW0183

moderat

Staat: WI
Alter: 71,0
Geschlecht: M
Eingang: 31.05.2022
Impfdatum: 17.06.2021
Beginn: 24.05.2022
Tage bis Beginn: 341,0
Dosis: 1
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: unbekannt

COVID-19 pneumonia

Symptomtext

Patient admitted as observation on 5/24 due to pneumonia due to COVID-19 virus

Weitere VAERSDATA-Felder

Praegender Schweregrund: COVID-19 pneumonia
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2294350

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EW0183

moderat

Staat: -
Alter: 32,0
Geschlecht: F
Eingang: 25.05.2022
Impfdatum: 24.04.2021
Beginn: 20.05.2022
Tage bis Beginn: 391,0
Dosis: 2
Route/Site: - / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: unbekannt

Abdominal pain Condition aggravated Gastrointestinal disorder Internal hernia Laparoscopy abnormal Small intestinal obstruction Surgery

Symptomtext

5/20 33y.o. w/ a PMHx significant for roux-en-y gastric bypass and laparscopic reduction of internal hernia who presented with abdominal pain and was found to have a SBO for which she had diagnostic laparoscopy, reduction of internal hernia and repair of mesenteric defect x2 on 5/20.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Condition aggravated
Hospital-Tage: 3,0
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2290342

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge ew0183

moderat

Staat: VA
Alter: 41,0
Geschlecht: F
Eingang: 23.05.2022
Impfdatum: 21.05.2021
Beginn: 17.12.2021
Tage bis Beginn: 210,0
Dosis: 2
Route/Site: SYR / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

COVID-19 COVID-19 pneumonia Heavy menstrual bleeding

Symptomtext

Had covid 12/17/2021. Received antibody therapy 12/21/2021. Was treated in the ER 12/23/2022 and diagnosed with covid pneumonia. Treated with steroids and continued with breathing treatments. Took 30 days for symptoms to improve. From January 4-31, 2022 I had a menstrual period. Have been having menstrual periods monthly since June 2021 lasting 14-21 days each month. Was not previously having periods due to IUD.

Weitere VAERSDATA-Felder

Praegender Schweregrund: COVID-19 pneumonia
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: none
Vorgeschichte: asthma; lymphoma (remission 03/08/2021)
Andere Medikamente: prenatal vitamin
Allergien: penicillin
Vorherige Impfungen: -

VAERS 2287091

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EW0183

moderat

Staat: MN
Alter: 68,0
Geschlecht: M
Eingang: 20.05.2022
Impfdatum: 16.04.2021
Beginn: 01.01.2022
Tage bis Beginn: 260,0
Dosis: 2
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: ja

COVID-19 Chills Cough Dyspnoea Pyrexia SARS-CoV-2 test positive Wheezing

Symptomtext

SOB, COUGH, WHEEZING, FEVER, CHILLS

Weitere VAERSDATA-Felder

Praegender Schweregrund: Dyspnoea
Hospital-Tage: 2,0
Labordaten: POSITIVE COVID TEST 5/17/2022
Aktuelle Erkrankungen: -
Vorgeschichte: Anxiety Diverticulitis Enlarged prostate Esophageal thickening Heartburn Prostate disease Hypothyroidism
Andere Medikamente: atorvastatin (LIPITOR) 20 mg Oral Tab citalopram (CELEXA) 20 mg Oral Tab famotidine (PEPCID) 20 mg oral tablet levothyroxine (SYNTHROID) 112 mcg Oral Tab traZODone (DESYREL) 50 mg Oral Tab
Allergien: Percocet [Oxycodone-Acetaminophen]
Vorherige Impfungen: -

VAERS 2267480

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EW0183

moderat

Staat: MI
Alter: 56,0
Geschlecht: M
Eingang: 09.05.2022
Impfdatum: 03.01.2022
Beginn: 03.05.2022
Tage bis Beginn: 120,0
Dosis: 2
Route/Site: IM / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: ja

Cough Dyspnoea Hypoxia Polyuria Pyrexia COVID-19 Chest X-ray abnormal Chills Chronic obstructive pulmonary disease Condition aggravated Respiratory disorder SARS-CoV-2 test positive

Symptomtext

Discharge Provider: DO Primary Care Provider at Discharge: DO Admission Date: 5/3/2022 Discharge Date: 5/7/2022 PRESENTING PROBLEM: Acute exacerbation of chronic obstructive pulmonary disease (COPD) (HCC) [J44.1] COVID-19 virus infection [U07.1] Acute respiratory disease due to COVID-19 virus [U07.1, J06.9] HOSPITAL COURSE: Patient is a 57 y.o. male who presents today with dyspnea hypoxia cough and subjective fever and chills. He has had the symptoms for 2 days becoming progressively worse. He has a history of chronic obstructive pulmonary disease and came to the emergency department for evaluation. He was hypoxic and started on 2 L of supplemental oxygen. COVID-19 testing was positive. He is fully vaccinated with 3 doses. Chest x-ray showed possible airspace disease but pattern was not consistent with COVID. I was contacted by the emergency department staff agreed to admit him for acute respiratory disease secondary to COVID-19 and exacerbation chronic obstructive pulmonary disease. Continue aggressive pulmonary toilet monitor serial labs keep him diuresed well and monitor daily weights. Supplemental oxygen to maintain sats above 88%. Steroids and inhalers for chronic obstructive pulmonary disease. patient was admitted and treated with aggressive pulmonary toilet Remdesivir and dexamethasone. He responded well to therapy where the weaning of supplemental oxygen over the next couple of days. His chronic obstructive pulmonary disease stabilized as well he was seen on the day of discharge on room air anxious to go home. He was subsequently discharged home to return to his regular medication regimen as previously ordered. Diet and activity as tolerated. He was recommended follow-up with primary care provider in 7-10 days. He has recommended isolate until May 11th. He understood all these instructions and was discharged home in stable condition

Weitere VAERSDATA-Felder

Praegender Schweregrund: Condition aggravated
Hospital-Tage: 4,0
Labordaten: -
Aktuelle Erkrankungen: None
Vorgeschichte: Primary hypertension Type 2 diabetes mellitus without complication, without long-term current use of insulin (HCC) Dyslipidemia Fracture of proximal end of right humerus with routine healing Chest pain, unspecified type ASHD (arteriosclerotic heart disease) Fatigue Cough Sepsis due to pneumonia (HCC) Left subclavian artery occlusion Seizure disorder (HCC) Chronic obstructive pulmonary disease with acute lower respiratory infection (HCC) Chronic pain Stroke (HCC) Anxiety Acute respiratory failure with hypoxemia (HCC) Neurogenic orthostatic hypotension (HCC) Acute occlusion of aortoiliac artery due to thrombosis (HCC) Critical lower limb ischemia (HCC) Aortoiliac occlusive disease (HCC) Hypercholesterolemia Tobacco abuse Postoperative hypoxia Peripheral vascular disease (HCC) Unstable angina (HCC) Hypokalemia STEMI (ST elevation myocardial infarction) (HCC) Ischemic cardiomyopathy Long term current use of antiarrhythmic drug Gastro-esophageal reflux disease without esophagitis Paroxysmal atrial fibrillation (HCC) S/P drug eluting coronary stent placement Blood-tinged sputum Pulmonary nodule Congestive heart failure (HCC)
Andere Medikamente: ALPRAZolam (XANAX) 1 MG tablet amiodarone (PACERONE) 200 MG tablet apixaban (ELIQUIS) 5 MG tablet atorvastatin (LIPITOR) 80 MG tablet clopidogrel (PLAVIX) 75 MG tablet empagliflozin (JARDIANCE) 10 MG tablet Fluticasone Furoate 100 MCG
Allergien: None
Vorherige Impfungen: -

VAERS 2227953

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EW0183

moderat

Staat: WI
Alter: 58,0
Geschlecht: M
Eingang: 12.04.2022
Impfdatum: 21.04.2021
Beginn: 01.09.2021
Tage bis Beginn: 133,0
Dosis: UNK
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Body temperature decreased Cardiac stress test Chest pain Coronavirus test Echocardiogram Electrocardiogram General physical health deterioration Heart rate irregular Hyperhidrosis Malaise X-ray

Symptomtext

My temperature was low very low but sweating my hand where ice that was from second shot and continued until my chest started to hurt. My health got worse after the shots, I got really sick in November. I thought nothing of it but to go back work I had to the coronavirus test, well the doctor heard my heart was irregular heart beat. She called my normal doctor left her a message. I saw my normal three days later she heard it.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Chest pain
Hospital-Tage: -
Labordaten: She ordered a X Rays and EKG and echocardiogram stress test. Sent my information to a cardiologist he ordered a CT Scan I still have another test to schedule at the hospital
Aktuelle Erkrankungen: None
Vorgeschichte: High blood pressure Mental health issues
Andere Medikamente: venlafaxine XR 75 MG 24 hr capsule losartan 100 MG tablet Hydrochlorothiazide 12.5
Allergien: None
Vorherige Impfungen: -

VAERS 2214237

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EW0183

moderat

Staat: -
Alter: 50,0
Geschlecht: F
Eingang: 04.04.2022
Impfdatum: 27.04.2021
Beginn: 23.01.2022
Tage bis Beginn: 271,0
Dosis: UNK
Route/Site: - / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: unbekannt

COVID-19 Dyspnoea SARS-CoV-2 test positive

Symptomtext

01/23/22 presents to ED for "Shortness of breath". PMHx of "metastatic colon cancer with liver mets" "HTN, GERD, and anemia"

Weitere VAERSDATA-Felder

Praegender Schweregrund: Dyspnoea
Hospital-Tage: -
Labordaten: 01/23/22 SARS-CoV-2 (COVID-19) by NAA detected
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2206701

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EW0183

moderat

Staat: IA
Alter: 50,0
Geschlecht: F
Eingang: 30.03.2022
Impfdatum: 16.05.2021
Beginn: 16.05.2021
Tage bis Beginn: 0,0
Dosis: 2
Route/Site: SYR / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Fatigue Pain in extremity Periarthritis Mobility decreased Pain

Symptomtext

Patient reports burning pain for several months and she was not able to use her arm in the workplace. Patient states that she is still not able to lift her arm over her head.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Mobility decreased
Hospital-Tage: -
Labordaten: Patient reports a physical therapist told her she had "frozen shoulder."
Aktuelle Erkrankungen: unknown
Vorgeschichte: unknown
Andere Medikamente: unknown
Allergien: unknown
Vorherige Impfungen: -

VAERS 2179832

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EW0183

moderat

Staat: VA
Alter: 78,0
Geschlecht: F
Eingang: 15.03.2022
Impfdatum: 03.09.2021
Beginn: 01.01.2022
Tage bis Beginn: 120,0
Dosis: 3
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

COVID-19 Cough Fatigue Haemoglobin increased Illness Pneumonia Sinusitis Transfusion X-ray

Symptomtext

In January 2022 is when I got sick. I had a sinus infection, hard cough, very tired. I saw my doctor. I was told I had COVID-19 because I was suppose to have surgery on the 23rd of January and I had to cancel. Later, I had pneumonia. My doctor was doing x-rays to make sure I still didn't have pneumonia. The did not put me in the hospital. The doctor followed up with me. I was taking cough syrup and antibiotics. My symptoms lasted for 4 weeks. As a result of Hydrea, on 02/16/2022- My blood count dropped, hemoglobin was 5. I had 3 pints of blood and a pint of iron.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Pneumonia
Hospital-Tage: -
Labordaten: X-rays to check my pneumonia
Aktuelle Erkrankungen: No
Vorgeschichte: Myelofibrosis - Blood cancer, Anemia
Andere Medikamente: Allergy medication, Alopurinol, Triamterene, Vitamin D -3, Iron, Regular vitamin, Chemo drug- Jakafi bd, Hydrea - chemo drug, Pravastatin, Vitamin C, Baby aspirin
Allergien: Sulfa, Clindamycin, Keflex
Vorherige Impfungen: -

VAERS 1785776

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EW0183

moderat

Staat: TX
Alter: 46,0
Geschlecht: M
Eingang: 12.03.2022
Impfdatum: 30.07.2021
Beginn: 02.08.2021
Tage bis Beginn: 3,0
Dosis: 1
Route/Site: - / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Electromyogram normal Heart rate increased Hypoaesthesia Magnetic resonance imaging head normal Magnetic resonance imaging neck Electromyogram Heart rate Magnetic resonance imaging head Magnetic resonance imaging spinal Nerve conduction studies Paraesthesia SARS-CoV-2 test Nerve conduction studies normal

Symptomtext

Post vaccine I have paresthesia and numbness in the face, arms and legs. For the first several weeks I also had a rapid heart rate. I have seen my primary care physician and a neurologist.; Post vaccine I have paresthesia and numbness in the face, arms and legs. For the first several weeks I also had a rapid heart rate. I have seen my primary care physician and a neurologist. EMG and; Post vaccine I have paresthesia and numbness in the face, arms and legs. For the first several weeks I also had a rapid heart rate. I have seen my primary care physician and a neurologist. EMG and; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient. A 46 year-old male patient received bnt162b2 (BNT162B2), administered in arm left, administration date 30Jul2021 08:00 (Lot number: EW0183) at the age of 46 years as dose 1, single for covid-19 immunisation. The patient had no relevant medical history. There were no concomitant medications. The following information was reported: PARAESTHESIA (non-serious) with onset 02Aug2021 08:00, outcome "not recovered", described as "Post vaccine I have paresthesia and numbness in the face, arms and legs. For the first several weeks I also had a rapid heart rate. I have seen my primary care physician and a neurologist."; HEART RATE INCREASED (non-serious), HYPOAESTHESIA (non-serious) all with onset 02Aug2021 08:00, outcome "not recovered" and all described as "Post vaccine I have paresthesia and numbness in the face, arms and legs. For the first several weeks I also had a rapid heart rate. I have seen my primary care physician and a neurologist. EMG and". The events "post vaccine i have paresthesia and numbness in the face, arms and legs. for the first several weeks I also had a rapid heart rate. i have seen my primary care physician and a neurologist.", "post vaccine I have paresthesia and numbness in the face, arms and legs. for the first several weeks i also had a rapid heart rate. i have seen my primary care physician and a neurologist. emg and" and "post vaccine i have paresthesia and numbness in the face, arms and legs. for the first several weeks i also had a rapid heart rate. i have seen my primary care physician and a neurologist. emg and" were evaluated at the physician office visit. Relevant laboratory tests and procedures are available in the appropriate section. Therapeutic measures were not taken as a result of paraesthesia, heart rate increased, hypoaesthesia. Additional Information: The facility type vaccine was hospital. The patient had no allergies. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had been tested for COVID-19. No follow-up attempts are possible. No further information is expected.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Paraesthesia
Hospital-Tage: -
Labordaten: Test Date: 20210802; Test Name: EMG; Result Unstructured Data: Test Result: Normal; Comments: EMG and NCS tests were normal; Test Date: 20210802; Test Name: heart rate; Result Unstructured Data: Test Result: rapid; Comments: I also had a rapid heart rate; Test Date: 20210802; Test Name: MRI's; Result Unstructured Data: Test Result: Normal; Comments: MRI's for brain and cervical spine showed normal.; Test Date: 20210802; Test Name: MRI's; Result Unstructured Data: Test Result: Normal; Comments: MRI's for brain and cervical spine showed normal.; Test Date: 20210802; Test Name: NCS; Result Unstructured Data: Test Result:Normal; Comments: EMG and NCS tests were normal; Test Date: 20210806; Test Name: Nasal Swab; Test Result: Negative
Aktuelle Erkrankungen: -
Vorgeschichte: Comments: List of non-encoded Patient Relevant History: Patient Other Relevant History 1: None
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1785776

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EW0183

moderat

Staat: TX
Alter: 46,0
Geschlecht: M
Eingang: 12.03.2022
Impfdatum: 30.07.2021
Beginn: 02.08.2021
Tage bis Beginn: 3,0
Dosis: 1
Route/Site: SYR / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Electromyogram normal Heart rate increased Hypoaesthesia Magnetic resonance imaging head normal Magnetic resonance imaging neck Electromyogram Heart rate Magnetic resonance imaging head Magnetic resonance imaging spinal Nerve conduction studies Paraesthesia SARS-CoV-2 test Nerve conduction studies normal

Symptomtext

Post vaccine I have paresthesia and numbness in the face, arms and legs. For the first several weeks I also had a rapid heart rate. I have seen my primary care physician and a neurologist.; Post vaccine I have paresthesia and numbness in the face, arms and legs. For the first several weeks I also had a rapid heart rate. I have seen my primary care physician and a neurologist. EMG and; Post vaccine I have paresthesia and numbness in the face, arms and legs. For the first several weeks I also had a rapid heart rate. I have seen my primary care physician and a neurologist. EMG and; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient. A 46 year-old male patient received bnt162b2 (BNT162B2), administered in arm left, administration date 30Jul2021 08:00 (Lot number: EW0183) at the age of 46 years as dose 1, single for covid-19 immunisation. The patient had no relevant medical history. There were no concomitant medications. The following information was reported: PARAESTHESIA (non-serious) with onset 02Aug2021 08:00, outcome "not recovered", described as "Post vaccine I have paresthesia and numbness in the face, arms and legs. For the first several weeks I also had a rapid heart rate. I have seen my primary care physician and a neurologist."; HEART RATE INCREASED (non-serious), HYPOAESTHESIA (non-serious) all with onset 02Aug2021 08:00, outcome "not recovered" and all described as "Post vaccine I have paresthesia and numbness in the face, arms and legs. For the first several weeks I also had a rapid heart rate. I have seen my primary care physician and a neurologist. EMG and". The events "post vaccine i have paresthesia and numbness in the face, arms and legs. for the first several weeks I also had a rapid heart rate. i have seen my primary care physician and a neurologist.", "post vaccine I have paresthesia and numbness in the face, arms and legs. for the first several weeks i also had a rapid heart rate. i have seen my primary care physician and a neurologist. emg and" and "post vaccine i have paresthesia and numbness in the face, arms and legs. for the first several weeks i also had a rapid heart rate. i have seen my primary care physician and a neurologist. emg and" were evaluated at the physician office visit. Relevant laboratory tests and procedures are available in the appropriate section. Therapeutic measures were not taken as a result of paraesthesia, heart rate increased, hypoaesthesia. Additional Information: The facility type vaccine was hospital. The patient had no allergies. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had been tested for COVID-19. No follow-up attempts are possible. No further information is expected.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Paraesthesia
Hospital-Tage: -
Labordaten: Test Date: 20210802; Test Name: EMG; Result Unstructured Data: Test Result: Normal; Comments: EMG and NCS tests were normal; Test Date: 20210802; Test Name: heart rate; Result Unstructured Data: Test Result: rapid; Comments: I also had a rapid heart rate; Test Date: 20210802; Test Name: MRI's; Result Unstructured Data: Test Result: Normal; Comments: MRI's for brain and cervical spine showed normal.; Test Date: 20210802; Test Name: MRI's; Result Unstructured Data: Test Result: Normal; Comments: MRI's for brain and cervical spine showed normal.; Test Date: 20210802; Test Name: NCS; Result Unstructured Data: Test Result:Normal; Comments: EMG and NCS tests were normal; Test Date: 20210806; Test Name: Nasal Swab; Test Result: Negative
Aktuelle Erkrankungen: -
Vorgeschichte: Comments: List of non-encoded Patient Relevant History: Patient Other Relevant History 1: None
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2173511

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EW0183

moderat

Staat: MA
Alter: 44,0
Geschlecht: F
Eingang: 11.03.2022
Impfdatum: 06.05.2021
Beginn: 06.05.2021
Tage bis Beginn: 0,0
Dosis: 2
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

COVID-19 Cardiac imaging procedure abnormal Chest pain Ejection fraction Left atrial enlargement Left ventricular dilatation Loss of personal independence in daily activities Right atrial enlargement Tricuspid valve incompetence Troponin T

Symptomtext

Pt continues to be very symptomatic in the setting of a complex chest pain syndrome that is atypical in its description but has been persistent since she developed Covid or receive the Covid vaccine and is limiting her daily activities. She is in extensive cardiac work-up and this has effectively ruled out obstructive epicardial coronary artery disease, cardiomyopathy, infiltrative disease, conduction system disease, or pulmonary hypertension. The only significant finding we have is that she has a mild increase in her index of microvascular resistance in the setting of a normal coronary flow reserve suggesting that she does have an element of microvascular disease but it is also plausible that this does not explain all of her symptoms, especially since she found almost no relief with nitrates and several days on a calcium channel blocker. It is also possible that many of the symptoms are due to endothelial inflammation that occurred secondary to either Covid or the vaccine and that these are slowly resolving over time as there does appear to be improvement in her biventricular function and return to normal size.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Chest pain
Hospital-Tage: -
Labordaten: Managed at outpatient. CRP - not checked during this time period Troponin T HS Gen % (ref range 0-9). 7/20/21 = < assay (<6) cMRI 7/16/21 IMPRESSIONS: 1. The left ventricular size is mildly dilated. The LV end-diastolic volume index measured 99 mL/m2 (normal < 92 mL/m2). The left ventricular ejection fraction is 60 % by Simpson's method. Global left ventricular function is normal. There are no regional wall motion abnormalities of the left ventricular wall. The left ventricular mass is normal. 2. There is no resting first pass myocardial perfusion defect. There is no late gadolinium enhancement to suggest prior infarct, inflammation, or infiltration. The global native T1-time is normal, ranging from 1030 to 1060 ms (normal 1000 +- 50 ms at 1.5T). There is no evidence of focal myocardial edema by T2 weighted imaging. 3. The right ventricular size is in the upper limit of normal. The RV end-diastolic volume index measured 101 mL/m2 (normal < 103 mL/m2 for matched age and sex). Global right ventricular function is normal. There are no regional wall motion abnormalities of the right ventricular wall. 4. Left atrial size is mildly enlarged. Right atrial size is mildly enlarged. 5. There is mild tricuspid regurgitation.
Aktuelle Erkrankungen: unk
Vorgeschichte: hypothyroid Varicose veins schatzki ring of esophagus CV dural arteriovenous fistual Cerebral venous thrombosis of sigmoid sinus subarachnoid hemorrhage GERD CVA neuroma osteopenia Dural arteriovenous fistula
Andere Medikamente: aspirin atorvastatin diltiazem keppra levothyroxine lisinopril magnesium metoprolol Riboflavin MVI
Allergien: nkda
Vorherige Impfungen: -

VAERS 2155376

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EW0183

moderat

Staat: -
Alter: 42,0
Geschlecht: M
Eingang: 03.03.2022
Impfdatum: 31.08.2021
Beginn: 23.02.2022
Tage bis Beginn: 176,0
Dosis: 2
Route/Site: OT / OT

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: unbekannt

Chills Dyspnoea Pyrexia Respiratory tract congestion

Symptomtext

chills, fever, congestion, shortness of breath

Weitere VAERSDATA-Felder

Praegender Schweregrund: Dyspnoea
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2146840

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EW0183

moderat

Staat: MI
Alter: 25,0
Geschlecht: M
Eingang: 26.02.2022
Impfdatum: 27.05.2021
Beginn: 27.05.2021
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: - / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Dizziness Pain in extremity Paraesthesia Somnolence

Symptomtext

Severe drowsiness after 2 hours; Light headedness immediately as well as tingling pain in the opposite arm from the injection; Light headedness immediately as well as tingling pain in the opposite arm from the injection; Light headedness immediately as well as tingling pain in the opposite arm from the injection; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient. A 25 year-old male patient received bnt162b2 (BNT162B2), administered in arm left, administration date 27May2021 12:30 (Lot number: EW0183) at the age of 25 years as dose 1, single for covid-19 immunisation. The patient had no relevant medical history. The patient's concomitant medications were not reported. The following information was reported: DIZZINESS (non-serious), PARAESTHESIA (non-serious), PAIN IN EXTREMITY (non-serious) all with onset 27May2021 12:30, outcome "recovering" and all described as "Light headedness immediately as well as tingling pain in the opposite arm from the injection"; SOMNOLENCE (non-serious) with onset 27May2021 14:30, outcome "recovering", described as "Severe drowsiness after 2 hours". Therapeutic measures were not taken as a result of dizziness, paraesthesia, pain in extremity, somnolence. Additional information: The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Patient had not been diagnosed with COVID-19 prior to vaccination. Patient had not been tested for COVID-19 Since the vaccination. Device Date: 27May2021. No follow-up attempts are possible. No further information is expected.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Paraesthesia
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: Comments: List of non-encoded Patient Relevant History: Patient Other Relevant History 1: None, Comment: Other Medical History: No
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2146638

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge ew0183

moderat

Staat: NM
Alter: 16,0
Geschlecht: F
Eingang: 26.02.2022
Impfdatum: 16.05.2021
Beginn: 16.05.2021
Tage bis Beginn: 0,0
Dosis: 2
Route/Site: OT / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Anxiety Confusional state Fatigue Lacrimation increased Tremor

Symptomtext

anxiety; exhaustion; teary; hands shaking; discombobulated; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the parent. A 16 year-old female patient (not pregnant) received bnt162b2 (BNT162B2), intramuscular, administered in arm left, administration date 16May2021 10:00 (Lot number: ew0183) at the age of 16 years as dose 2, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Bnt162b2 (Dose: 01, lot number: ew0176,, administration route: intramuscular, vaccine location: left arm, time: 09:30), administration date: 26Apr2021, when the patient was 16 years old, for COVID-19 immunization. The following information was reported: ANXIETY (non-serious) with onset 16May2021 22:00, outcome "recovered" (May2021), described as "anxiety"; FATIGUE (non-serious) with onset 16May2021 22:00, outcome "recovered" (May2021), described as "exhaustion"; LACRIMATION INCREASED (non-serious) with onset 16May2021 22:00, outcome "recovered" (May2021), described as "teary"; TREMOR (non-serious) with onset 16May2021 22:00, outcome "recovered" (May2021), described as "hands shaking"; CONFUSIONAL STATE (non-serious) with onset 16May2021 22:00, outcome "recovered" (May2021), described as "discombobulated". Therapeutic measures were not taken as a result of anxiety, fatigue, lacrimation increased, tremor, confusional state. No follow-up attempts are possible. No further information is expected.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Tremor
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2139846

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EW0183

moderat

Staat: -
Alter: 88,0
Geschlecht: F
Eingang: 25.02.2022
Impfdatum: 30.04.2021
Beginn: 11.01.2022
Tage bis Beginn: 256,0
Dosis: UNK
Route/Site: - / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: unbekannt

COVID-19 Dyspnoea Nucleic acid test SARS-CoV-2 test positive

Symptomtext

01/11/22 presents to ED for "SOB and positive COVID". PMHx of "recurrent pneumonia, bronchiectasis, paroxysmal atrial fibrillation on Eliquis, HFpEF, aortic regurgitation, SSS, CKD stage II, HLD, dementia, anemia, malnutrition, hypothyroidism"

Weitere VAERSDATA-Felder

Praegender Schweregrund: Dyspnoea
Hospital-Tage: -
Labordaten: 01/11/22 SARS-CoV-2 (COVID-19) by NAA detected
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1876033

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EW0183

moderat

Staat: TX
Alter: 25,0
Geschlecht: F
Eingang: 25.02.2022
Impfdatum: 05.05.2021
Beginn: 06.05.2021
Tage bis Beginn: 1,0
Dosis: 2
Route/Site: - / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Axillary pain Burning sensation Chest pain Dyspnoea Headache Nasopharyngitis Pain Pyrexia

Symptomtext

Chest pain, difficulty breathing, slight burning sensation when deeply exhaling. Pain sensation extended to the left lateral area of the chest onto the armpit. These symptoms lasted about 3 to 4 days. The pain around the armpit area lasted about a week and a half. Now, in February of 2022, my heart does experience a very mild burning sensation every so often (although I assume it may be related to academic stress).

Weitere VAERSDATA-Felder

Praegender Schweregrund: Chest pain
Hospital-Tage: -
Labordaten: None
Aktuelle Erkrankungen: None
Vorgeschichte: None
Andere Medikamente: None
Allergien: None
Vorherige Impfungen: -

VAERS 1876033

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EW0183

moderat

Staat: TX
Alter: 25,0
Geschlecht: F
Eingang: 25.02.2022
Impfdatum: 05.05.2021
Beginn: 06.05.2021
Tage bis Beginn: 1,0
Dosis: 2
Route/Site: UN / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Axillary pain Burning sensation Chest pain Dyspnoea Headache Nasopharyngitis Pain Pyrexia

Symptomtext

Chest pain, difficulty breathing, slight burning sensation when deeply exhaling. Pain sensation extended to the left lateral area of the chest onto the armpit. These symptoms lasted about 3 to 4 days. The pain around the armpit area lasted about a week and a half. Now, in February of 2022, my heart does experience a very mild burning sensation every so often (although I assume it may be related to academic stress).

Weitere VAERSDATA-Felder

Praegender Schweregrund: Chest pain
Hospital-Tage: -
Labordaten: None
Aktuelle Erkrankungen: None
Vorgeschichte: None
Andere Medikamente: None
Allergien: None
Vorherige Impfungen: -

VAERS 2137614

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EW0183

moderat

Staat: -
Alter: 51,0
Geschlecht: F
Eingang: 24.02.2022
Impfdatum: 29.04.2021
Beginn: 22.12.2021
Tage bis Beginn: 237,0
Dosis: UNK
Route/Site: - / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: unbekannt

COVID-19 Cough Dyspnoea Pain Pyrexia SARS-CoV-2 test positive

Symptomtext

12/22/21 presents to ED for "cough, fever, shortness of breath, generalized body aches". PMHx of "metabolic disorder, obesity"

Weitere VAERSDATA-Felder

Praegender Schweregrund: Dyspnoea
Hospital-Tage: -
Labordaten: 12/23/21 SARS-CoV-2 (COVID-19) by NAA detected
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2137069

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EW0183

moderat

Staat: MI
Alter: 65,0
Geschlecht: F
Eingang: 24.02.2022
Impfdatum: 01.11.2021
Beginn: 01.11.2021
Tage bis Beginn: 0,0
Dosis: 3
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Condition aggravated Electrocardiogram ambulatory Ventricular extrasystoles

Symptomtext

Ongoing PVCs continuous ongoing all day every day 10 days after booster since 11/11/2021 . Have been trying beta blockers which have helped cut down by half. Very disturbing.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Condition aggravated
Hospital-Tage: -
Labordaten: Wore 2 monitors halter for 48 hrs each
Aktuelle Erkrankungen: This was the booster
Vorgeschichte: Blood clots PVCs with one to three episodes a month very minor Stomach gerd
Andere Medikamente: Lovenox injections Klonopin
Allergien: Seafood Antibiotics very sensitive to
Vorherige Impfungen: -

VAERS 2134639

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EW0183

moderat

Staat: MI
Alter: 59,0
Geschlecht: M
Eingang: 23.02.2022
Impfdatum: 24.08.2021
Beginn: 22.02.2022
Tage bis Beginn: 182,0
Dosis: 3
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: nein

Blood bicarbonate decreased Blood creatinine increased Blood glucose increased Blood phosphorus decreased Blood potassium increased Blood sodium decreased Blood urea increased COVID-19 Full blood count Glomerular filtration rate decreased Glucose urine present Haematocrit decreased Haemoglobin decreased Lymphocyte count increased Mean cell haemoglobin decreased Metabolic function test Monocyte count increased Neutrophil count increased

Symptomtext

Admitted to hospital on 2/22 with RLL pneumonia on day 20 of COVID infection after receiving three doses of the vaccine.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Pneumonia
Hospital-Tage: 1,0
Labordaten: CMP 2/22 - Na 132, K+ 5.8, HCO3 20, glucose 277, BUN 49, creatinine 2.18, MDRD eGFR 31 Phosphorus 2/22 - 2.1 CBC 2/22 - WBC 13.34, RBC 4.49, Hgb 12.0, hematocrit 38.6, MCH 26.7, lymphocyte 12.0, neutrophil 10.25, monocyte 1.35 Troponin 2/22 - 57 COVID test 2/22 - detected Urinalysis 2/22 - urine glucose 300
Aktuelle Erkrankungen: -
Vorgeschichte: Tremor, transposition of great arteries (corrected), pulmonary nodule, obstructive sleep apnea, heart transplant, migraines, memory disorder, lumbar degenerative disc disease, kidney stones, hypertension, hyperlipidemia, esophageal reflux, dyslipidemia, diverticulosis, diabetes mellitus type 2, depression, coronary artery disease, congenital heart disease, colon polyps, chronic renal insufficiency, coronary artery disease, benign prostatic hypertrophy, atrial fibrillation, asthma, anxiety, anemia
Andere Medikamente: Vitamin D3, cyclosporine, desvenlafaxine, depakote, robitussin, hydralazine, insulin degludec, insulin lispro, magnesium oxide, melatonin, mycophenolate, protonix, prednisone, crestor, sodium chloride nasal spray, bactrim ss, flomax, trazod
Allergien: Lisinopril, NSAIDs, everolimus, morphine, norco, norvasc
Vorherige Impfungen: -

VAERS 2127493

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EW0183

moderat

Staat: CA
Alter: 60,0
Geschlecht: F
Eingang: 19.02.2022
Impfdatum: 06.05.2021
Beginn: 06.05.2021
Tage bis Beginn: 0,0
Dosis: 2
Route/Site: - / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Irritability Tremor

Symptomtext

My hand is just shaking; It's like my fingers, especially my thumb is just shaking; it's kind of annoying; My hand is just shaking; It's like my fingers, especially my thumb is just shaking; it's kind of annoying; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient. A 60 year-old female patient received bnt162b2 (BNT162B2), administration date 06May2021 10:00 (Lot number: EW0183) at the age of 60 years as dose 2, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Bnt162b2 (DOSE 1, SINGLE, lot number: EW0164), administration date: 15Apr2021, when the patient was 60 years old, for Covid-19 immunization. The following information was reported: TREMOR (non-serious), IRRITABILITY (non-serious) all with onset 06May2021, outcome "unknown" and all described as "My hand is just shaking; It's like my fingers, especially my thumb is just shaking; it's kind of annoying". Additional information: The patient got the second Pfizer vaccine today and noticed that hand was just shaking. It was 4 O clock there and patient got the shot around 10 am. So that was something that never happened. It was like patient fingers, especially thumb was just shaking. When paraphrased the above concern, consumer wanted to report it because patient did not hear of it and saw many people reporting it. Patient wanted to keep Pfizer know. It was not like patient need to go the emergency or anything, but it was definitely because of the vaccine, and it was on the same arm too, where patient got the vaccine. The patient was going to try stretching and moving around to see if it gets better but was kind of annoying. Other than that patient just want to report it. No follow-up attempts are possible. No further information is expected.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Tremor
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2121108

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EW0183

moderat

Staat: NH
Alter: 54,0
Geschlecht: F
Eingang: 17.02.2022
Impfdatum: 06.05.2021
Beginn: 06.06.2021
Tage bis Beginn: 31,0
Dosis: 2
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Basedow's disease Hyperthyroidism Insomnia Irritability Myositis Pain in extremity Tachycardia Thyroid stimulating immunoglobulin

Symptomtext

One month later developed bilateral muscle inflammation and pain in legs, this resolved several weeks later. No labs done. Developed insomnia and irritability in following month, three months later (november) diagnosed with hyperthyroidism with tachycardia. Now this month confirmed diagnosis of new onset Graves Disease Thyroid stimulating IG level 3.38. Had prior history of thyrotoxicosis 10 years prior after a viral illness. Spontaneously resolved after 9 months.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Tachycardia
Hospital-Tage: -
Labordaten: Elevated TSH (November 2021, December 2021 and February 2022) . Positive elevated thyroid stimulating immunoglobulin.
Aktuelle Erkrankungen: None
Vorgeschichte: Elevated cholesterol
Andere Medikamente: fluoxetine, atorvastatin, Multivitamin, fish oil
Allergien: Ceclor
Vorherige Impfungen: -

VAERS 2118573

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EW0183

moderat

Staat: TX
Alter: 36,0
Geschlecht: M
Eingang: 17.02.2022
Impfdatum: -
Beginn: 09.10.2021
Tage bis Beginn: -
Dosis: 3
Route/Site: - / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Blister Chills Condition aggravated Cough Eye pain Fatigue Headache Lacrimation increased Oropharyngeal pain Pyrexia SARS-CoV-2 test Taste disorder

Symptomtext

Headache; Chills; Throat Pain; Bubbles on face and whole body in worse condition; Bubbles on face and whole body in worse condition; Tiredness; Fever; Cough; Eye Watery; Bad food taste; Eyes pain; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient. A 36 year-old male patient received bnt162b2 (BNT162B2), administered in arm left (Lot number: EW0183) at the age of 36 years as dose 3 (booster), single for covid-19 immunisation. The patient's relevant medical history was not reported. There were no concomitant medications. Vaccination history included: Bnt162b2 ([{product=COVID 19, brand=Pfizer,, brand unknown=False,, lot number=EW0183,, lot unknown=False, dose number=1,, vaccine location=Left arm}]), for Covid-19 immunization; Bnt162b2 (DOSE 2, SINGLE), for Covid-19 immunization. The following information was reported: HEADACHE (non-serious) with onset 09Oct2021, outcome "not recovered", described as "Headache"; CHILLS (non-serious) with onset 09Oct2021, outcome "not recovered", described as "Chills"; OROPHARYNGEAL PAIN (non-serious) with onset 09Oct2021, outcome "not recovered", described as "Throat Pain"; BLISTER (non-serious), CONDITION AGGRAVATED (non-serious) all with onset 09Oct2021, outcome "not recovered" and all described as "Bubbles on face and whole body in worse condition"; FATIGUE (non-serious) with onset 09Oct2021, outcome "not recovered", described as "Tiredness"; PYREXIA (non-serious) with onset 09Oct2021, outcome "not recovered", described as "Fever"; COUGH (non-serious) with onset 09Oct2021, outcome "not recovered", described as "Cough"; LACRIMATION INCREASED (non-serious) with onset 09Oct2021, outcome "not recovered", described as "Eye Watery"; TASTE DISORDER (non-serious) with onset 09Oct2021, outcome "not recovered", described as "Bad food taste"; EYE PAIN (non-serious) with onset 09Oct2021, outcome "not recovered", described as "Eyes pain". Relevant laboratory tests and procedures are available in the appropriate section. Therapeutic measures were not taken as a result of headache, chills, oropharyngeal pain, blister, condition aggravated, fatigue, pyrexia, cough, lacrimation increased, taste disorder, eye pain. Additional information: Patient did not receive any other vaccines within 4 weeks and did not receive other medications within 2 weeks of vaccination. Patient was not diagnosed with COVID-19 prior to vaccination and was tested for COVID post vaccination. No follow-up attempts are possible. No further information is expected.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Condition aggravated
Hospital-Tage: -
Labordaten: Test Date: 20211012; Test Name: Nasal Swab; Test Result: Negative
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2112952

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EW0183

moderat

Staat: GA
Alter: 58,0
Geschlecht: F
Eingang: 15.02.2022
Impfdatum: 13.05.2021
Beginn: 13.05.2021
Tage bis Beginn: 0,0
Dosis: 2
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein

Blood pressure increased Cardiac disorder Chest pain Electrocardiogram Lung disorder Renal disorder

Symptomtext

Once she received the injection her blood pressure shot up and she had to be rushed to the ER. She was having chest pains and was told she was at stroke level. Having problems with kidneys, heart and lungs. Also she took a whooping cough shot a week before taking the second vaccine.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Chest pain
Hospital-Tage: -
Labordaten: yes ekg
Aktuelle Erkrankungen: no
Vorgeschichte: no
Andere Medikamente: no
Allergien: penicillin
Vorherige Impfungen: after taking the first vaccine she had COVID symptoms for 2 days

VAERS 2110434

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EW0183

moderat

Staat: MI
Alter: 66,0
Geschlecht: F
Eingang: 14.02.2022
Impfdatum: 12.08.2021
Beginn: 12.08.2021
Tage bis Beginn: 0,0
Dosis: 2
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Chest discomfort Cough Dizziness Dyspnoea Fatigue Myalgia Palpitations Pyrexia Visual impairment

Symptomtext

2 hours after receiving my second dose of the vaccine I started running a high fever of 102.4 F. I am a recovering covid patient from November of 2020. I also was experiencing muscle aches, heart palpitations started to occur as well. Also experienced tightness in the chest. Felt very winded and out of breathe, and I had a very persistent cough, lightheadedness, fatigued for about 2 days following the vaccine. The symptoms were like getting covid all over again, the symptoms that I experienced felt like everything I experienced with covid just worst. Also my vision has gradually gotten worse to where I can know something is in front of me but I just do not see it, my eye doctor says I have a delayed response with my vision.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Dyspnoea
Hospital-Tage: -
Labordaten: None
Aktuelle Erkrankungen: N/A
Vorgeschichte: Still experiencing Covid symptoms from November 2020, Mild cardiaties,
Andere Medikamente: Miralax, Vitamin D-3, Aspirin, Metoprolol, Pravastatin, Nitrol prm
Allergien: Mycin, Flu vaccines, betadine
Vorherige Impfungen: influenza shots- they caused a rash around the injection site, diarrhea occurred, flu like symptoms but a little more heightened

VAERS 2110379

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EW0183

moderat

Staat: MI
Alter: 48,0
Geschlecht: F
Eingang: 14.02.2022
Impfdatum: 18.05.2021
Beginn: 18.05.2021
Tage bis Beginn: 0,0
Dosis: 2
Route/Site: UN / UN

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: nein

COVID-19 Chills Diarrhoea Dizziness Dyspnoea Fatigue Malaise Nausea Pyrexia SARS-CoV-2 test positive

Symptomtext

Patient is a 49 y/o female that presents to the ED to covid symptoms. She reports that she tested positive two days prior at her PCP office for COVID. She states that over the last several days she has had worsening symptoms and severe SOB. She reports that she she has also had extreme fatigue, nausea, diarrhea, fevers, chills, and dizziness. She reports that she is vaccinated but has not received the booster. She has a history of hypertension. She denies any other complaints including CP, Syncope, numbness, tingling, or recent trauma

Weitere VAERSDATA-Felder

Praegender Schweregrund: Dyspnoea
Hospital-Tage: 4,0
Labordaten: Patient is a 49 y/o female that presents to the ED to covid symptoms. She reports that she tested positive two days prior at her PCP office for COVID
Aktuelle Erkrankungen: Hypertension
Vorgeschichte: Hypertension
Andere Medikamente: Medication Administration Record reviewed. aspirin, 81 mg, Oral, DAILY atorvastatin, 20 mg, Oral, Q HS dexamethasone, 6 mg, Intravenous, Q 24 H enoxaparin, 40 mg, Subcutaneous, Q 24 H insulin regular human, 2-12 Units, Subcutaneous, AC & HS
Allergien: No Known Drug Allergy
Vorherige Impfungen: -

VAERS 2095833

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EW0183

moderat

Staat: MI
Alter: 64,0
Geschlecht: M
Eingang: 08.02.2022
Impfdatum: 03.09.2021
Beginn: 27.01.2022
Tage bis Beginn: 146,0
Dosis: 3
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: nein

Abdominal distension Acute kidney injury Alanine aminotransferase normal Anion gap Aspartate aminotransferase normal Asthenia Back pain Blood albumin decreased Blood alkaline phosphatase increased Blood bicarbonate normal Blood bilirubin normal Blood calcium normal Blood chloride increased Blood creatinine increased Blood culture negative Blood glucose normal Blood potassium normal Blood sodium increased

Symptomtext

Hospitalized (1.27.22 - still admitted currently); COVID-19 positive (1.26.22); fully vaccinated PLUS Booster - pfizer x3 1/27/22 H&P: CHIEF COMPLAINT: AMS (altered mental status) ASSESSMENT / PLAN: Patient is a 64 yo M with h/o alcoholic/Hep C cirrhosis s/p liver transplant in 2013, complete heart block s/p pacemaker, Afib/aflutter (Eliquis), CKD3, COPD, Bipolar disorder, and CHF who presents on 1/27 with cough x2 weeks and weakness/falls/confusion x 1week. #AMS Patient reportedly more confused than baseline over the past couple days and was A&O x1 on admission. Quickly improved and was A&O times 2-3 on evaluation. Concern for polypharmacy versus infection versus COVID symptom. - blood, sputum cultures, UA pending - Hold home Arpiprazole, Lamotrigine, Tizanidine, Gabapentin, and Baclofen until AMS resolves - daily cmp, cbc - Folate, B12, CRP/Sed rate pending #Acute on Chronic Generalized weakness #Multiple falls #Acute headache Patient uses walker intermittently at baseline and has multiple falls per year. Weakness has acutely worsened over past week. Suspect deconditioning versus COVID symptom. CT head was negative for acute pathologies - PT/OT - Acetaminophen PRN for pain #Concern for diskitis # Chronic back pain # h/o L4/L5 fusion Pt received an MRI 10/2021 due to worsening of chronic back pain, and findings were concerning for L3 - L4 diskitis/osteomyelitis. F/u with ID with plans for an outpatient biopsy. Patient has chronic back pain and muscle spasms for which he receives treatment through his PCP. Also follows with pain clinic. He is on home Percocet 7.5 q.6, tizanidine, and gabapentin 600 TID. - ID, IR consult for biopsy - Continue Oxy 7.5 q6hrs PRN for pain - Hold tizanidine, gabapentin for AMS on admission #COVID #COPD Diagnosed 1/26. Vaccinated. Had productive cough over the past 2 weeks. Became hypoxic shortly after admission requiring 2 L nasal cannula. Out of Remdesivir window. - Started Decadron 6 - Continue Guaifenesin, tesslan perles PRN - Continue Tiotropium, albuterol, symbicort PRN - continuous pulse ox #AKI on CKD3 Cr 3.28 on admission; baseline 2 - 2.3. Suspect pre-renal secondary to dehydration. - hold home Torsemide #Aflutter/Afib #Complete heart block s/p pacemaker - Hold Eliquis for potential biopsy #Alcoholic/hep C Cirrhosis s/p transplant Transplant through HCF in 2013. Had prior concerns for recurrent HCV, acute Hep E; now resolved/stable. Chronic, mild transaminitis and elevated ALP since hep E infection. - Continue home mycophenolate and cyclosporine # Bipolar disorder Pt is on home Arpiprazole, Lamotrigine, and Venlafaxine. - Hold Arpiprazole and Lamotrigine for AMS - Continue home Venlafaxine # HFpEF # HTN LVEF 60%. No current signs of volume overload. - Continue home carvedilol 25, hydralazine, and imdur. - hold home Torsemide for AKI #Hypothyroidism: Continue home levothyroxine #GERD: Continue pantoprazole #BPH: Continue Tamsulosin #h/o T2DM HbA1c 6.2. No current medications. Diet: NPO DVT prophylaxis: home Eliquis Full Code Dispo: Pending evaluation of weakness and recent diskitis HISTORY OF PRESENT ILLNESS: Patient is a 64 y.o. male who presents today with worsening weakness and to mechanical falls over the past week. He notes that he developed a cough productive of yellow sputum around 2 weeks ago. No dyspnea, chest pain, congestion. About 1 week ago, he notes increased fatigue, diffuse weakness, and mild confusion. He uses a walker intermittent at baseline and has a history of falls; approximately once every month or so. He reports walking up a parking lot brand when he fell backwards and hit his head on the ground. He does not believe he lost consciousness, but he is unsure. He thinks he was on the ground for a couple minutes before standing and driving home. No prodrome or postictal state. No focal deficits. He has had a stable headache since hitting his head. In his 2nd fall, his leg became tangled and he fell to the ground. Currently, he still feels weaker than baseline and he has a severe headache centered on the spot where he hit his head. He has a history of alcoholic and hepatitis cirrhosis status post transplant in 2013. He regularly follows up with the transplant doctor and has no current concerns regarding his liver. He also has a history of third-degree heart block with a pacemaker. He was previously diagnosed with type 2 diabetes, but his glucose has been controlled without medications. He is a half pack per day active smoker. Denies any alcohol or drug usage. Review of Systems Constitutional: Positive for fatigue and fever. Negative for chills. HENT: Negative for hearing loss and ear pain. Eyes: Negative for pain and visual disturbance. Respiratory: Positive for cough. Negative for shortness of breath and sputum production. Cardiovascular: Negative for chest pain and palpitations. Gastrointestinal: Negative for nausea, vomiting, abdominal pain, constipation and diarrhea. Genitourinary: Negative for difficulty urinating, dysuria and frequency. Musculoskeletal: Positive for falls. Negative for neck pain, back pain and joint pain. Neurological: Positive for headaches. Negative for light-headedness, numbness/tingling and weakness. Endo/Heme/Allergy: Negative for easy bleeding or bruising. Skin: Negative for rash and wound. OBJECTIVE: BP 134/58 | Pulse 85 | Temp 36.6 ?C (Axillary) | Resp 18 | Ht 1.854 m | Wt 101.9 kg | SpO2 92% | BMI 29.64 kg/m? Physical Exam Vitals and nursing note reviewed. Constitutional: General: He is not in acute distress. Appearance: Normal appearance. HENT: Head: Normocephalic. Comments: 1.5 inch area of ecchymosis with mild excoriations on R posterior scalp. No laceration or active bleeding. Mouth/Throat: Mouth: Mucous membranes are dry. Pharynx: Oropharynx is clear. Eyes: General: No scleral icterus. Pupils: Pupils are equal, round, and reactive to light. Cardiovascular: Rate and Rhythm: Normal rate and regular rhythm. Pulses: Normal pulses. Heart sounds: Normal heart sounds. No murmur heard. Pulmonary: Effort: Pulmonary effort is normal. No respiratory distress. Breath sounds: Normal breath sounds. No wheezing. Abdominal: General: Abdomen is flat. Bowel sounds are normal. Palpations: Abdomen is soft. Tenderness: There is no abdominal tenderness. Musculoskeletal: Cervical back: Normal range of motion and neck supple. No rigidity. Right lower leg: No edema. Left lower leg: No edema. Skin: General: Skin is warm and dry. Capillary Refill: Capillary refill takes less than 2 seconds. Neurological: General: No focal deficit present. Mental Status: He is alert. Motor: No weakness. Comments: AxO x2 (person, place, month but not day). Good historian. Answers all questions appropriately. 1/28/22 ID consult: Reason for Consult: Concern for diskitis and liver transplant patient Inpatient Consult to Infectious Diseases Performed by: MD Authorized by: 2nd MD Assessment: 1. Status post liver transplant - transplant in 2013 due to cirrhosis. Follows with a HCF. 2. Concern for diskitis. Patient has hardware in place at L4/L5. MRI in October due to worsening back pain with concern for L3-L4 diskitis/osteo. Outpatient biopsy had been planned 3. Altered mental status - reportedly A&O x1 on admission now appears to be baseline. 4. COVID-19 - vaccinated and boosted. Diagnosed 1/26. Hypoxic requiring supplemental oxygen. Reportedly has had cough for 2 weeks 5. Leukopenia -unclear if this is due to comorbid rhesus side effect of immunosuppression. 6. Immunosuppressed - On cyclosporine and mycophenolate 7. AKI on CKD 3. Baseline creatinine 2-2.3 elevated at 3.28 on admission 8. Generalized weakness/falls 9. Chronic obstructive pulmonary disease Plan: 1. Agree with IR consult for biopsy for diskitis/osteomyelitis - Please send for tissue pathology and cultures 2. Would not start antibiotics at this time 3. Agree with Decadron given hypoxia 4. Not a candidate for remdesivir given creatinine clearance 5. Recommend primary service contact HCF regarding the patient's immunosuppression HPI: Patient is a 64 y.o. male with a past medical history significant for liver transplantation secondary to cirrhosis. He is currently hospitalized at a local Hospital under the care of the hospital Service. He presented with concerns of weakness, mechanical falls, and cough productive of some yellow sputum. Patient reports he developed a cough for about 2 weeks ago, for the past week he has noticed increasing fatigue some weakness and mild confusion. He does intermittently use a walker at baseline and has a history of mechanical falls typically occurring once every month or so. He has fallen twice within the past 2 weeks. He states that he does feel weaker than he typically does. The patient was seen in Infectious Disease Clinic on 01/25/2022 due to concerns of an abnormal MRI concerning for diskitis/osteomyelitis of the spine. Patient does have a history of an L4/L5 fusion and has had spinal injections in the past but no recent spinal instrumentation. He underwent MRI imaging due to ongoing back pain which is what revealed changes compatible with osteo/diskitis. Plan had been for him to undergo IR biopsy as an outpatient, however, he was hospitalized shortly after his clinic visit. Patient's initial lab work did not display a leukocytosis, creatinine was elevated from baseline at 3.28, proBNP elevated at 13,662, CRP elevated at 90.5. Peripheral blood cultures obtained with no growth to date. Reportedly the patient was confused upon admission was only alert and oriented x1, this appears to have resolved. Today he states that he continues to have cough and does still feel weak compared to his usual baseline. With regards to his transplant he follows with HCF he states there has been no concerns with his transplant currently but he has had episodes of rejection requiring steroids in the past. Objective: Vitals: BP 134/78 | Pulse 69 | Temp 36.5 ?C (Oral) | Resp 16 | Ht 1.854 m | Wt 101.9 kg | SpO2 93% | BMI 29.64 kg/m? Wt Readings from Last 4 Encounters: 01/27/22 101.9 kg 01/25/22 106.3 kg 01/11/22 97.5 kg 12/15/21 97.5 kg Physical Exam Vitals reviewed. Constitutional: General: He is not in acute distress. Appearance: He is ill-appearing. He is not toxic-appearing. HENT: Head: Normocephalic and atraumatic. Right Ear: External ear normal. Left Ear: External ear normal. Nose: Nose normal. No congestion. Comments: Nasal cannula in place Mouth/Throat: Mouth: Mucous membranes are moist. Pharynx: No oropharyngeal exudate or posterior oropharyngeal erythema. Eyes: General: Right eye: No discharge. Left eye: No discharge. Cardiovascular: Rate and Rhythm: Normal rate. Pulses: Normal pulses. Pulmonary: Effort: Pulmonary effort is normal. Comments: Recurring supplemental oxygen. Air entry equal bilaterally. Scattered crackles present. Abdominal: General: There is distension. Palpations: Abdomen is soft. There is no mass. Tenderness: There is no abdominal tenderness. There is no guarding. Musculoskeletal: General: No deformity or signs of injury. Skin: General: Skin is warm. Capillary Refill: Capillary refill takes less than 2 seconds. Coloration: Skin is not jaundiced. Findings: No bruising. Neurological: General: No focal deficit present. Mental Status: He is alert and oriented to person, place, and time. Mental status is at baseline. Comments: Strength is 4/5 in the lower extremities bilaterally. Some complaint of hyper sensitization compatible with neuropathy.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Condition aggravated
Hospital-Tage: 12,0
Labordaten: D-Dimer (Abnormal) Collected: 02/08/22 1144 Order Status: Completed Specimen: Blood, Venous Updated: 02/08/22 1217 D-Dimer Quant 27,700 High 0 - 500 ng/mL FEU Reactive Protein (CRP), Blood Level (Abnormal) Collected: 02/08/22 0836 Order Status: Completed Specimen: Blood, Venous Updated: 02/08/22 0929 C-Reactive Protein 38.8 High <=5.0 mg/L Comprehensive Metabolic Panel (CMP) (Abnormal) Collected: 02/08/22 0836 Order Status: Completed Specimen: Blood, Venous Updated: 02/08/22 0929 Sodium Level 146 134 - 146 mmol/L Potassium Level 4.3 3.4 - 5.0 mmol/L Chloride 113 High 98 - 112 mmol/L HCO3 21 21 - 29 mmol/L Anion Gap 12 9 - 18 mmol/L Glucose Level 149 High 70 - 99 mg/dL Blood Urea Nitrogen 76 High 8 - 20 mg/dL Creatinine 1.97 High 0.60 - 1.30 mg/dL MDRD eGFR 34 Low >=60 mL/min/1.73 m2 CG eCrCl 43 mL/min/1.73 m2 Calcium Level Total 9.0 8.6 - 10.4 mg/dL Protein Total 5.8 Low 6.0 - 8.0 g/dL Albumin Level 2.4 Low 3.5 - 5.0 g/dL Bilirubin Total 1.0 0.2 - 1.0 mg/dL Alkaline Phosphatase 273 High 40 - 129 IU/L Alanine Aminotransferase 19 10 - 40 IU/L Aspartate Aminotransferase 35 10 - 40 IU/L Complete Blood Count w/Differential (Abnormal) Collected: 02/08/22 0836 Order Status: Completed Specimen: Blood, Venous Updated: 02/08/22 0928 White Blood Cell 9.95 4.00 - 10.80 x10*3/uL Red Blood Cell 3.05 Low 4.60 - 6.00 x10*6/uL Hemoglobin 8.5 Low 14.0 - 18.0 g/dL Hematocrit 26.6 Low 42.0 - 52.0 % Mean Cell Volume 87.2 80.0 - 100.0 fL Mean Cell Hemoglobin 27.9 27.0 - 33.0 pg Mean Cell Hemoglobin Concentration 32.0 32.0 - 37.0 g/dL Red Cell Diameter Width 13.7 11.0 - 16.0 % NRBC Absolute Count 0.00 0.00 - 0.01 x10*3/uL NRBC Automated 0.0 0.0 - 0.1 %WBC Platelet 68 Low 140 - 400 x10*3/uL Mean Platelet Volume -- Comment: NOT MEASURED. Neutrophil Absolute Count 8.96 High 1.80 - 7.80 x10*3/uL
Aktuelle Erkrankungen: HCF ED on 1/25 & 1/26 d/t falls
Vorgeschichte: Past Medical History: Diagnosis Date ? Anxiety state 12/23/2020 ? Arthritis ? Attention deficit hyperactivity disorder (ADHD) 12/23/2020 ? Chronic diastolic congestive heart failure 3/11/2021 ? Cirrhosis of liver ? Elevated liver enzymes ? Encounter for pulmonary function testing 2/22/2008 ? Gall bladder disease ? Hepatitis ? Hepatitis C ? Hypertension ? Liver dysfunction ? PPD negative ? Retention of urine
Andere Medikamente: Acetaminophen 500 mg Oral Albuterol Sulfate 108 (90 Base) MCG/ACT 2 puffs Inhalation Allopurinol 100 MG 1 tablet Alpha-Lipoic Acid 600 MG 1-3 capsules Oral Daily, Once daily between meals on empty stomach amLODIPine Besylate 5 MG No dose, r
Allergien: Allergies Allergen Reactions ? Ace Inhibitors Other and Unknown ? Pregabalin Confusion and Other ? Tacrolimus Confusion, Hallucinations and Other Mental status changes, hallucinations ? Fentanyl ? Ibuprofen
Vorherige Impfungen: -

VAERS 2079389

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EW0183

moderat

Staat: MI
Alter: 79,0
Geschlecht: M
Eingang: 01.02.2022
Impfdatum: 05.05.2021
Beginn: 05.01.2022
Tage bis Beginn: 245,0
Dosis: 2
Route/Site: - / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: unbekannt

Anticoagulant therapy Atrial fibrillation COVID-19 Condition aggravated Cough Diarrhoea Heart rate abnormal Pulmonary imaging procedure normal Respiratory tract congestion SARS-CoV-2 test positive Troponin increased

Symptomtext

Patient is fully vaccinated. COVID + at hospitalization 1/5/2022. 80y.o. year old male with PMHx of atrial fibrillation, CAD, DM, HTN, MI, and stroke presents with COVID. Per ER note, Pt was brought in after having 5 episodes of diarrhea at home.Pt presented in Afib with RVR on presentation. Started on Cardizem gtt with improvement in HR. Troponins noted to be elevated, started on Heparin gtt. Pt reported that he also had some congestion and cough. Imaging was negative for PE. Started on IV antibiotics. Was given 2L bolus. He states that he does not have any chest pain, shortness of breath, abdominal pain or fever. Treatment with decadron and remdesivir. Discharged home.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Condition aggravated
Hospital-Tage: 11,0
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2063040

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EW0183

moderat

Staat: MI
Alter: 25,0
Geschlecht: F
Eingang: 25.01.2022
Impfdatum: 26.10.2021
Beginn: 12.01.2022
Tage bis Beginn: 78,0
Dosis: 1
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: ja

Ageusia Angiogram pulmonary abnormal Anosmia Anticoagulant therapy Base excess Blood bicarbonate Blood gases COVID-19 Chest pain Cough Dyspnoea Electrocardiogram T wave abnormal Electrocardiogram abnormal Exposure during pregnancy Fatigue Granulomatous liver disease Hepatic calcification Nausea

Symptomtext

Patient is 26 years old female at 31w4d. Hospitalized (1.13.22); COVID-19 positive (1.12.22); fully vaccinated (no booster) Admission Date: 1/13/2022 Discharge Date: 1/15/2022 RECOMMENDED FOLLOW-UP: - will plan to follow up for regularly scheduled OB Visits ASSESSMENT / PLAN: Patient is a 26 y.o. female at 31w2d who presents with coughing, fever, congestion, loss of smell, SOB, chest pain with coughing, and nausea. 1. COVID-19 in pregnancy - Patient endorses symptoms since 1/11/22 (day 3 of symptoms), +COVID-19 PCR 1/12/22 - Symptoms of: shortness of breath, cough, rever, loss of taste or smell, nausea and congestion/runny nose - Vaccinated x 2 Pfizer - Vitals: SpO2: 97 % BP 117/72 | Pulse 111 | Temp 36.9 ?C (Oral) | Resp 16 | Ht 1.651 m | Wt 75.3 kg | SpO2 97% | BMI 27.62 kg/m? HOSPITAL COURSE: The patient is a 26 y.o. female at 31w4d who presented with symptomatic Covid in pregnancy. She was admitted and treated with remdesivir and dexamethasone for two days. Following treatment she voiced significant improvement in shortness of breath and was deemed stable for discharge. Will plan to discharge on Lovenox for 10 days.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Chest pain
Hospital-Tage: 2,0
Labordaten: ABG No results found for: PHART, PCO2ART, PO2ART, HCO3ART, BASEEXCESS - EKG: Sinus tachycardia with nonspecific T wave abnormality - CTA: no evidence of acute PE or focal airspace disease, no pleural effusion. Left lower lobe 2 mm nodules, calcified hepatic and splenic granulomas - LE US: negative for DVT
Aktuelle Erkrankungen: 1.12.22: Urgent Care: HPI: 26-year-old female who is 31 weeks of gestation presents with complaints of sore throat, cough, sinus congestion, rhinorrhea, fatigue starting 2 days ago. Denies any shortness of breath, wheezing, fever/chills, vomiting, diarrhea. Denies any known exposures to COVID-19. No smoking history. No history of asthma. Patient has had 2 doses of the COVID-19 vaccine. She is worried about possible strep or COVID-19. Has tried Tylenol for symptoms. 31 weeks gestation of pregnancy - Your rapid strep screen was negative at the Urgent Care today. - Will send out a throat culture and notify if positive/antibiotics are needed. - Robitussin for cough as needed - Rest and push fluids - Cough/sore throat lozenges/warm salt water gargles as needed. - Tylenol as needed for pain/discomfort. - Seek follow up care if symptoms worsen or do not improve. - Follow up with PCP Patient is breathing and conversing comfortably in office and is nontoxic appearing. Lungs are CTAB bilaterally without rales, rhonchi, or signs of consolidation on exam. No respiratory distress or tachypnea. Patient is afebrile and pulse ox is 100%. Patient advised on signs and symptoms to monitor for indicating prompt return to clinic or emergency department. Questions and concerns addressed at this time. Patient advised to follow up with PCP/OBGYN. Patient verbally understands and agrees with plan of care. Patient is stable at time of discharge. Work/school note not provided.
Vorgeschichte: Generalized anxiety disorder Abnormal Pap smear of cervix Cervical intraepithelial neoplasia grade 1 on colposcopy 1/2019 Vitamin D deficiency Fall due to slipping on ice or snow, initial encounter
Andere Medikamente: acetaminophen (TYLENOL) 500 MG tablet aspirin EC 81 MG enteric coated tablet enoxaparin Sodium (LOVENOX) 40 MG/0.4ML injection (Expired) famotidine (PEPCID) 20 MG tablet Prenatal Vit-Fe Fumarate-FA (PRENATAL PO)
Allergien: NKDA
Vorherige Impfungen: -

VAERS 2054056

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EW0183

moderat

Staat: MI
Alter: 90,0
Geschlecht: F
Eingang: 21.01.2022
Impfdatum: 21.10.2021
Beginn: 13.01.2022
Tage bis Beginn: 84,0
Dosis: 3
Route/Site: UN / UN

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: nein

Adenovirus test Asthenia Blood bicarbonate normal Blood chloride normal Blood creatinine normal Blood glucose normal Blood potassium normal Blood sodium decreased Blood urea increased Bordetella test negative C-reactive protein abnormal COVID-19 Chest X-ray normal Chlamydia test negative Coronavirus test negative Decreased appetite Dehydration Enterovirus test negative

Symptomtext

Patient discharged. 90yo admitted with covid 19 infection, no breathing issues but generalized weakness. Her husband is ill with the same symptoms. She was placed in observation and PT/OT worked with her and recommended SAR. She was placed on keflex for questionable cellulitis of LLE and chronic wound that "got better then came back in the same spot." CRP trended and improved. Her potassium was replaced and given fluids for dehydration. Her appetite improved. CM gave her places for SAR but then pt changed her mind and did not want to go to SAR. She wanted to go home with husband also admitted. She was discharged with her husband in the same Non-Emergency Medical Transit to home with home health care. Referral for wound clinic placed at discharge. She will continue keflex to finish her course and follow up with PCP.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Dehydration
Hospital-Tage: 4,0
Labordaten: Recent Labs 01/15/22 1653 WBC 6.21 HGB 10.9* HCT 34.9* PLATELET 229 SODIUM 135 POTASSIUM 3.5 CHLORIDE 103 HCO3 23 CREATININE 0.64 BUN 23* GLUCOSE 194* USV Venous Lower Extremity Duplex Left Resulted: 01/14/22 0124 Order Status: Completed Updated: 01/14/22 0126 Narrative: EXAMINATION: Complete Left Lower Extremity Venous Duplex Doppler Ultrasound EXAM DATE: 1/14/2022 12:00 AM TECHNIQUE: Real-time B-mode imaging with and without compression was used to evaluate the left lower extremity for deep venous thrombosis (DVT). Duplex Doppler with color and spectral Doppler was used. INDICATION: LLE erythema, swelling, covid + COMPARISON: None _____________________ FINDINGS: Left Common Femoral Vein: No DVT. Left Femoral Vein: No DVT. Left Popliteal Vein: No DVT. Left Posterior Tibial Veins: No DVT. Left Peroneal Veins: No DVT. Left proximal Greater Saphenous Vein: No thrombus. Duplex Doppler: Spectral Doppler demonstrates a normal respirophasic waveform in the common femoral vein. Additional Findings: None. _____________________ Impression: There is no deep venous thrombosis in the visualized deep veins of the left lower extremity. * DR CHEST 2 VIEWS FRONTAL AND LATERAL Resulted: 01/13/22 1801 Order Status: Completed Updated: 01/13/22 1804 Narrative: EXAMINATION: Frontal and Lateral View Chest EXAM DATE: 1/13/2022 5:51 PM TECHNIQUE: Frontal and lateral views INDICATION: covid +, weakness. COMPARISON CHEST RADIOGRAPH: None ENCOUNTER: Not applicable _________________________ FINDINGS: The cardiomediastinal silhouette is not enlarged. There is no focal lung consolidation. Possible small calcified granulomas are present in the lower lobes. No pleural effusion or pneumothorax is visualized. ______________________________________ Impression: No acute cardiopulmonary findings. Respiratory Pathogens by Film Array (Abnormal) Collected: 01/14/22 1019 Order Status: Completed Specimen: Swabbed Collection from Nasopharynx Updated: 01/14/22 1222 Adenovirus PCR Film Array Not Detected Not Detected Coronavirus 229E PCR Film Array Not Detected Not Detected Coronavirus HKU1 PCR Film Array Not Detected Not Detected Coronavirus NL63 PCR Film Array Not Detected Not Detected Coronavirus OC43 PCR Film Array Not Detected Not Detected COVID-19 PCR Detected Abnormal Metapneumovirus PCR Film Array Not Detected Not Detected Rhinovirus-Enterovirus PCR Film Array Not Detected Not Detected Influenza A PCR Film Array Not Detected Not Detected Influenza A H3 PCR Film Array Not Detected Not Detected Influenza A H1 PCR Film Array Not Detected Not Detected Influenza A 2009 H1 PCR Film Array Not Detected Not Detected Influenza B PCR Film Array Not Detected Not Detected Parainfluenza 1 PCR Film Array Not Detected Not Detected Parainfluenza 2 PCR Film Array Not Detected Not Detected Parainfluenza 3 PCR Film Array Not Detected Not Detected Parainfluenza 4 PCR Film Array Not Detected Not Detected Respiratory Syncytial Virus PCR Film Array Not Detected Not Detected Bordetella pertussis PCR Not Detected Not Detected Bordetella parapertussis PCR Not Detected Not Detected Chlamydia pneumoniae PCR Not Detected Not Detected Mycoplasma pneumoniae PCR Not Detected Not Detected
Aktuelle Erkrankungen: Hospitalized for multiple falls and rehabilitation.
Vorgeschichte: Circulatory Hypertension Hematologic Chronic anemia Other Falls frequently Gait instability Mass of left side of neck Fall with significant injury, initial encounter Closed displaced fracture of first cervical vertebra with routine healing Restless leg syndrome Primary insomnia Weight loss Depression Closed fracture of multiple pubic rami, left, initial encounter (HCC)
Andere Medikamente: acetaminophen (TYLENOL) 500 MG tablet aspirin 81 MG chewable tablet Calcium Carb-Cholecalciferol 600-200 MG-UNIT TABS calcium carbonate 1250 mg, 500 mg calcium, (OS-CAL) 1250 (500 Ca) MG tablet cephalexin (KEFLEX) 500 MG capsule cholecalcif
Allergien: No Known Allergies
Vorherige Impfungen: -

VAERS 2051155

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EW0183

moderat

Staat: MN
Alter: 52,0
Geschlecht: M
Eingang: 20.01.2022
Impfdatum: 26.04.2021
Beginn: 18.01.2022
Tage bis Beginn: 267,0
Dosis: 2
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: ja

Atrial fibrillation COVID-19 Cough Dizziness Dyspnoea Palpitations SARS-CoV-2 test positive Wheezing

Symptomtext

SHORTNESS OF BREATH, COUGH, WEEZE, DIZZINESS

Weitere VAERSDATA-Felder

Praegender Schweregrund: Dyspnoea
Hospital-Tage: 2,0
Labordaten: POSITIVE COVID TEST 1/18/22
Aktuelle Erkrankungen: 4/27/2021 - ATRIAL FLUTTER, SCHF, NONCOMPLIANCE WHO WAS ADMITTED WITH PALPATIONS AND DYSPNEA, FOUND TO HAVE A FIB WITH RVR
Vorgeschichte: Acute pancreatitis Acute renal failure Altered mental status Blood in stool Heartburn Hypoglycemia Pneumothorax Systolic congestive heart failure TB Hemorrhoids Diverticulosis Atrial flutter Macrocytic anemia Alcohol induced fatty liver Insomnia Alcohol use disorder Depression
Andere Medikamente: amiodarone (CORDARONE) 200 mg oral tablet furosemide (LASIX) 20 mg oral tablet isosorbide mononitrate (IMDUR) 30 mg oral extended release tablet 24 HR Melatonin 5 mg oral tablet metoprolol succinate, XL, (TOPROL XL) 50 mg oral extended rele
Allergien: -
Vorherige Impfungen: -

VAERS 2047646

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EW0183

moderat

Staat: KY
Alter: 63,0
Geschlecht: F
Eingang: 19.01.2022
Impfdatum: 26.06.2021
Beginn: 12.01.2022
Tage bis Beginn: 200,0
Dosis: 1
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: nein

COVID-19 COVID-19 pneumonia SARS-CoV-2 test positive

Symptomtext

Pt admitted w/ covid PNA 15L high flow, recieving dexamethasone

Weitere VAERSDATA-Felder

Praegender Schweregrund: COVID-19 pneumonia
Hospital-Tage: -
Labordaten: 1/18 COVID positive
Aktuelle Erkrankungen: has a past medical history of Anxiety, COPD (chronic obstructive pulmonary disease), Coronary artery disease, ESRD (end stage renal disease), Falls, Hyperlipemia, Hypertension, Kidney tumor, Seizures, Sleep apnea, and Stroke.
Vorgeschichte: has a past medical history of Anxiety, COPD (chronic obstructive pulmonary disease), Coronary artery disease, ESRD (end stage renal disease), Falls, Hyperlipemia, Hypertension, Kidney tumor, Seizures, Sleep apnea, and Stroke.
Andere Medikamente: ALPRAZolam, Dialyvite 800, Eslicarbazepine Acetate, Glycopyrrolate, O2, Vitamin D, acetaminophen, amitriptyline, cinacalcet, formoterol, levETIRAcetam, metoprolol tartrate, pantoprazole, polyethylene glycol, rosuvastatin, sevelamer, sucralf
Allergien: tuberculin ppd, pcn, simvastatin, Bactrim
Vorherige Impfungen: -

VAERS 2047646

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EW0183

moderat

Staat: KY
Alter: 63,0
Geschlecht: F
Eingang: 19.01.2022
Impfdatum: 26.06.2021
Beginn: 12.01.2022
Tage bis Beginn: 200,0
Dosis: 2
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: nein

COVID-19 COVID-19 pneumonia SARS-CoV-2 test positive

Symptomtext

Pt admitted w/ covid PNA 15L high flow, recieving dexamethasone

Weitere VAERSDATA-Felder

Praegender Schweregrund: COVID-19 pneumonia
Hospital-Tage: -
Labordaten: 1/18 COVID positive
Aktuelle Erkrankungen: has a past medical history of Anxiety, COPD (chronic obstructive pulmonary disease), Coronary artery disease, ESRD (end stage renal disease), Falls, Hyperlipemia, Hypertension, Kidney tumor, Seizures, Sleep apnea, and Stroke.
Vorgeschichte: has a past medical history of Anxiety, COPD (chronic obstructive pulmonary disease), Coronary artery disease, ESRD (end stage renal disease), Falls, Hyperlipemia, Hypertension, Kidney tumor, Seizures, Sleep apnea, and Stroke.
Andere Medikamente: ALPRAZolam, Dialyvite 800, Eslicarbazepine Acetate, Glycopyrrolate, O2, Vitamin D, acetaminophen, amitriptyline, cinacalcet, formoterol, levETIRAcetam, metoprolol tartrate, pantoprazole, polyethylene glycol, rosuvastatin, sevelamer, sucralf
Allergien: tuberculin ppd, pcn, simvastatin, Bactrim
Vorherige Impfungen: -

VAERS 2039447

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EW0183

moderat

Staat: KY
Alter: 80,0
Geschlecht: M
Eingang: 17.01.2022
Impfdatum: 06.08.2021
Beginn: 15.01.2022
Tage bis Beginn: 162,0
Dosis: 1
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: nein

COVID-19 pneumonia Chills Cough Dyspnoea Malaise Pain Pyrexia Respiratory tract congestion SARS-CoV-2 test positive

Symptomtext

Admitted on 10L o2 w/ COVID PNA. sx include shortness of breath, fever, chills, cough and congestion over a week ago; he has had aches and malaise. Recieving dexamethasone and remdesivir

Weitere VAERSDATA-Felder

Praegender Schweregrund: COVID-19 pneumonia
Hospital-Tage: -
Labordaten: 1/15/21 COVID positive
Aktuelle Erkrankungen: Arthritis, Cervical neck pain with evidence of disc disease, Chronic kidney disease, Claudication (HCC), Diabetes mellitus (HCC), H/O urinary frequency, Headache, colonoscopy, Hyperlipidemia, Hypertension, Neuropathy, Nocturnal leg cramps, Obesity, and Pancreatitis.
Vorgeschichte: Arthritis, Cervical neck pain with evidence of disc disease, Chronic kidney disease, Claudication (HCC), Diabetes mellitus (HCC), H/O urinary frequency, Headache, colonoscopy, Hyperlipidemia, Hypertension, Neuropathy, Nocturnal leg cramps, Obesity, and Pancreatitis.
Andere Medikamente: amLODIPine, atorvastatin, cetirizine, dextromethorphan-guaifenesin, doxazosin, insulin NPH-insulin regular, lisinopril, ondansetron, senna, and vitamin D
Allergien: NSAID
Vorherige Impfungen: -

VAERS 2032864

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge Ew0183

moderat

Staat: MN
Alter: 58,0
Geschlecht: M
Eingang: 13.01.2022
Impfdatum: 14.04.2021
Beginn: 04.01.2022
Tage bis Beginn: 265,0
Dosis: 2
Route/Site: - / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Cough Dyspnoea Nasal congestion Sinus congestion

Symptomtext

cough- shortness of breath- sinus congestion- nasal congestion. starting on 1/4/22

Weitere VAERSDATA-Felder

Praegender Schweregrund: Dyspnoea
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: none
Vorgeschichte: Tob abuse. Anxiety/depression. HTN.
Andere Medikamente: ?hydroCHLOROthiazide 25 MG Tablet 1 tablet in the morning Orally Once a day ?Metoprolol Succinate ER 100 MG Tablet Extended Release 24 Hour 1 tablet Orally Once a day Not-Taking ?Ibuprofen 200 MG Tablet 1 tablet with food or milk as n
Allergien: Augmentin: Allergy
Vorherige Impfungen: -

VAERS 2032084

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EW0183

moderat

Staat: MI
Alter: 66,0
Geschlecht: F
Eingang: 13.01.2022
Impfdatum: 05.08.2021
Beginn: 07.01.2022
Tage bis Beginn: 155,0
Dosis: 1
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: ja

Blood culture COVID-19 Chest X-ray abnormal Condition aggravated Cough Dyspnoea Exposure to SARS-CoV-2 Leukocytosis Lung infiltration Nausea Pneumonia Pulmonary congestion Pyrexia SARS-CoV-2 test positive Vomiting White blood cell count increased

Symptomtext

Hospitalized 01/07/2022; COVID-19 positive 01/07/2022; fully vaccinated Admit Date: 1/7/2022 12:29 PM Discharge Date: 1/10/2022 Hospital Course: Patient is a 66 y.o. female with past medical history significant for chronic obstructive pulmonary disease, diastolic congestive heart failure, chronic respiratory failure on 2 L of oxygen in the outpatient setting, morbid obesity, presented to the emergency department with chief complaint of fever, nausea with vomiting and cough. Patient was residing at a skilled nursing home since a motor vehicle accident last year. Patient's roommate was recently diagnosed with COVID. Patient reported increased shortness of breath, cough, and fever. Patient's oxygenation was at 70% prior to arrival but was not wearing her home oxygen. In the emergency department patient had a low-grade temperature of 99?, blood pressure and heart rate were reassuring. Patient was oxygenating 96% on 3 L nasal cannula (baseline). Patient had leukocytosis with elevated white count of 21.4. COVID-19 PCR was positive. Chest x-ray with evidence of bilateral patchy infiltrates and mild pulmonary vascular congestion. Patient was started on IV azithromycin and cefepime with concern for healthcare acquired pneumonia given patient's status as a nursing home resident. Blood cultures were obtained. Patient was admitted to Hospital for further management. As patient was requiring supplemental oxygen patient was started on remdesivir and dexamethasone. As patient's oxygen requirements but at baseline days were discontinued on day 2. Patient continued to improve clinically. Patient was transitioned to oral Augmentin to treat pneumonia. Patient was placed on sodium and fluid restriction for chronic congestive heart failure. Patient was discharged to long-term care facility in stable condition.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Condition aggravated
Hospital-Tage: 3,0
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: COPD (chronic obstructive pulmonary disease) (HCC) Sleep apnea Pulmonary nodule Chronic respiratory failure with hypoxia and hypercapnia (HCC) Community acquired pneumonia Pleural effusion, bilateral Chronic maxillary sinusitis Acute on chronic respiratory failure with hypoxia and hypercapnia (HCC) Pneumonia due to COVID-19 virus Hypertension Chronic diastolic congestive heart failure (HCC) Murmur, cardiac Acute embolism and thrombosis of superficial vein of right upper extremity Acute on chronic diastolic heart failure (HCC) Morbid obesity (HCC) Diverticulosis of colon Cirrhosis of liver (HCC) Gastroesophageal reflux disease without esophagitis Nausea and vomiting Vitamin D deficiency Neoplasm of uncertain behavior of colon Other chest pain Delirium Paresthesia of left arm Cerebral atrophy (HCC) Migraine Chest pain Hyperlipidemia Hypothyroid Thyroid nodule Depression At risk for falls History of malignant neoplasm of cervix MVC (motor vehicle collision), sequela Anxiety disorder Right medial tibial plateau fracture, open type I or II, with routine healing, subsequent encounter Closed fracture of proximal end of right fibula with routine healing Closed fracture of tenth thoracic vertebra with routine healing Closed fracture of metacarpal bone Chronic ulcer of left calf with fat layer exposed (HCC) Mild cognitive impairment Herniated lumbar intervertebral disc
Andere Medikamente: acetaminophen (TYLENOL) 500 MG tablet albuterol HFA (PROVENTIL HFA, VENTOLIN HFA, PROAIR HFA) 108 (90 Base) MCG/ACT inhaler amoxicillin-clavulanate (AUGMENTIN) 875-125 MG per tablet ARIPiprazole (ABILIFY) 15 MG tablet ARIPiprazole (ABILIFY)
Allergien: NKA
Vorherige Impfungen: -

VAERS 2032084

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EW0183

moderat

Staat: MI
Alter: 66,0
Geschlecht: F
Eingang: 13.01.2022
Impfdatum: 05.08.2021
Beginn: 07.01.2022
Tage bis Beginn: 155,0
Dosis: 2
Route/Site: IM / AR

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: ja

Blood culture COVID-19 Chest X-ray abnormal Condition aggravated Cough Dyspnoea Exposure to SARS-CoV-2 Leukocytosis Lung infiltration Nausea Pneumonia Pulmonary congestion Pyrexia SARS-CoV-2 test positive Vomiting White blood cell count increased

Symptomtext

Hospitalized 01/07/2022; COVID-19 positive 01/07/2022; fully vaccinated Admit Date: 1/7/2022 12:29 PM Discharge Date: 1/10/2022 Hospital Course: Patient is a 66 y.o. female with past medical history significant for chronic obstructive pulmonary disease, diastolic congestive heart failure, chronic respiratory failure on 2 L of oxygen in the outpatient setting, morbid obesity, presented to the emergency department with chief complaint of fever, nausea with vomiting and cough. Patient was residing at a skilled nursing home since a motor vehicle accident last year. Patient's roommate was recently diagnosed with COVID. Patient reported increased shortness of breath, cough, and fever. Patient's oxygenation was at 70% prior to arrival but was not wearing her home oxygen. In the emergency department patient had a low-grade temperature of 99?, blood pressure and heart rate were reassuring. Patient was oxygenating 96% on 3 L nasal cannula (baseline). Patient had leukocytosis with elevated white count of 21.4. COVID-19 PCR was positive. Chest x-ray with evidence of bilateral patchy infiltrates and mild pulmonary vascular congestion. Patient was started on IV azithromycin and cefepime with concern for healthcare acquired pneumonia given patient's status as a nursing home resident. Blood cultures were obtained. Patient was admitted to Hospital for further management. As patient was requiring supplemental oxygen patient was started on remdesivir and dexamethasone. As patient's oxygen requirements but at baseline days were discontinued on day 2. Patient continued to improve clinically. Patient was transitioned to oral Augmentin to treat pneumonia. Patient was placed on sodium and fluid restriction for chronic congestive heart failure. Patient was discharged to long-term care facility in stable condition.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Condition aggravated
Hospital-Tage: 3,0
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: COPD (chronic obstructive pulmonary disease) (HCC) Sleep apnea Pulmonary nodule Chronic respiratory failure with hypoxia and hypercapnia (HCC) Community acquired pneumonia Pleural effusion, bilateral Chronic maxillary sinusitis Acute on chronic respiratory failure with hypoxia and hypercapnia (HCC) Pneumonia due to COVID-19 virus Hypertension Chronic diastolic congestive heart failure (HCC) Murmur, cardiac Acute embolism and thrombosis of superficial vein of right upper extremity Acute on chronic diastolic heart failure (HCC) Morbid obesity (HCC) Diverticulosis of colon Cirrhosis of liver (HCC) Gastroesophageal reflux disease without esophagitis Nausea and vomiting Vitamin D deficiency Neoplasm of uncertain behavior of colon Other chest pain Delirium Paresthesia of left arm Cerebral atrophy (HCC) Migraine Chest pain Hyperlipidemia Hypothyroid Thyroid nodule Depression At risk for falls History of malignant neoplasm of cervix MVC (motor vehicle collision), sequela Anxiety disorder Right medial tibial plateau fracture, open type I or II, with routine healing, subsequent encounter Closed fracture of proximal end of right fibula with routine healing Closed fracture of tenth thoracic vertebra with routine healing Closed fracture of metacarpal bone Chronic ulcer of left calf with fat layer exposed (HCC) Mild cognitive impairment Herniated lumbar intervertebral disc
Andere Medikamente: acetaminophen (TYLENOL) 500 MG tablet albuterol HFA (PROVENTIL HFA, VENTOLIN HFA, PROAIR HFA) 108 (90 Base) MCG/ACT inhaler amoxicillin-clavulanate (AUGMENTIN) 875-125 MG per tablet ARIPiprazole (ABILIFY) 15 MG tablet ARIPiprazole (ABILIFY)
Allergien: NKA
Vorherige Impfungen: -

VAERS 2029036

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EW0183

moderat

Staat: WA
Alter: 64,0
Geschlecht: F
Eingang: 12.01.2022
Impfdatum: 10.06.2021
Beginn: 03.01.2022
Tage bis Beginn: 207,0
Dosis: 2
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: unbekannt

Appendicectomy Appendicitis Biopsy liver COVID-19 COVID-19 pneumonia Chronic obstructive pulmonary disease Condition aggravated Hepatic mass Inappropriate schedule of product administration Laparoscopic surgery SARS-CoV-2 test positive

Symptomtext

Patient received Pfizer COVID vaccine on 5/13/21 and 6/10/21. On 1/3/22 and 1/9/22, patient tested positive for COVID. On 1/9/22, patient admitted to our inpatient facility for acute appendicitis with COVID-19 pneumonia and acute COPD exacerbation. On 1/12/22, patient underwent laparoscopic appendectomy and biopsy of liver nodule. As of today (1/12/22), patient is still admitted in our med/surg unit.

Weitere VAERSDATA-Felder

Praegender Schweregrund: COVID-19 pneumonia
Hospital-Tage: 3,0
Labordaten: COVID status positive 1/3/22 and 1/9/22.
Aktuelle Erkrankungen: -
Vorgeschichte: COPD, GERD, HLD, HTN, DM2, OSA, chronic diastolic CHF, cirrhosis with portal hypertension, IBS
Andere Medikamente: albuterol inh, bupropion sr, hydroxyzine, Humalog 75/25 pen, lisinopril, metolazone, omeprazole, ondansetron, oxycodone, potassium chloride, ropinirole, simvastatin, torsemide,
Allergien: NKDA
Vorherige Impfungen: -

VAERS 2028497

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EW0183

moderat

Staat: WI
Alter: 66,0
Geschlecht: M
Eingang: 12.01.2022
Impfdatum: 02.06.2021
Beginn: 05.01.2022
Tage bis Beginn: 217,0
Dosis: 2
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: unbekannt

COVID-19 COVID-19 pneumonia SARS-CoV-2 test positive

Symptomtext

Patient admitted as inpatient on 1/5/22 due to pneumonia due to COVID-19 virus. Patient was tested for COVID-19 and was positive on 1/5/22.

Weitere VAERSDATA-Felder

Praegender Schweregrund: COVID-19 pneumonia
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2027992

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EW0183

moderat

Staat: MI
Alter: 50,0
Geschlecht: M
Eingang: 12.01.2022
Impfdatum: 14.05.2021
Beginn: 10.01.2022
Tage bis Beginn: 241,0
Dosis: 2
Route/Site: UN / UN

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: nein

Abdominal discomfort Asthenia COVID-19 Chest X-ray normal Dyspnoea Nausea Respiratory tract congestion Rhinorrhoea SARS-CoV-2 test positive

Symptomtext

01/10/2022: Event occurred after 2nd vaccine. Patient presents to the emergency department secondary to weakness times approximately 1 week. History of renal transplant on antirejection medications has not missed any doses. Patient admits to intermittent nausea and some mild abdominal discomfort but no overt abdominal pain. Denies vomiting. Patient denies chest pain but admits to intermittent shortness of breath, rhinorrhea and congestion has been present for approximately 3 or 4 days. Denies any productive cough, or hemoptysis. Patient denies: vomiting, diarrhea, fever, blurred vision, sore throat, back pain, palpitations, dizziness, and rash. He suspects he is in DKA as he presented very similarly approximately 2 months ago. Remains in hospital.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Dyspnoea
Hospital-Tage: 2,0
Labordaten: 01/10/2022: chest x-ray- IMPRESSION: Negative acute. Radiographically Stable chest. SARScov2- positive.
Aktuelle Erkrankungen: unknown
Vorgeschichte: renal transplant, Diabetes
Andere Medikamente: unknown
Allergien: penicillin, IV dye contrast
Vorherige Impfungen: -

VAERS 2014779

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EW0183

moderat

Staat: MI
Alter: 59,0
Geschlecht: M
Eingang: 07.01.2022
Impfdatum: 25.05.2021
Beginn: 26.12.2021
Tage bis Beginn: 215,0
Dosis: 2
Route/Site: UN / UN

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: unbekannt

COVID-19 Chills Cough Dyspnoea Myalgia Pyrexia SARS-CoV-2 test positive

Symptomtext

chills, fever, cough, short of breath, myalgia + COVID test

Weitere VAERSDATA-Felder

Praegender Schweregrund: Dyspnoea
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2014434

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EW0183

moderat

Staat: CA
Alter: 28,0
Geschlecht: M
Eingang: 07.01.2022
Impfdatum: 30.09.2021
Beginn: 07.10.2021
Tage bis Beginn: 7,0
Dosis: 3
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: ja

Anxiety Blood test Cardiac stress test normal Chest pain Echocardiogram normal Palpitations

Symptomtext

I started feeling moderate chest pain right in the center of my chest and it turned into heavy heart palpitations and a lot of anxiety. I was given an Echo and stress test that were normal, but I am still having the issue. I have an upcoming appointment with a cardiologist.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Chest pain
Hospital-Tage: -
Labordaten: Echo. Stress Test. Blood Work.
Aktuelle Erkrankungen: None
Vorgeschichte: Thyroid condition
Andere Medikamente: Ibuprofen
Allergien: None
Vorherige Impfungen: -

VAERS 2006538

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EW0183

moderat

Staat: RI
Alter: 60,0
Geschlecht: M
Eingang: 05.01.2022
Impfdatum: 19.05.2021
Beginn: 09.12.2021
Tage bis Beginn: 204,0
Dosis: 1
Route/Site: SYR / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Electrocardiogram Tachycardia

Symptomtext

None at the time of injection... tachycardia was detected on 12/09/2021

Weitere VAERSDATA-Felder

Praegender Schweregrund: Tachycardia
Hospital-Tage: -
Labordaten: ECG - 12/09/2021
Aktuelle Erkrankungen: -
Vorgeschichte: Cardiac A-Fib
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2002047

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EW0183

moderat

Staat: WI
Alter: 42,0
Geschlecht: F
Eingang: 04.01.2022
Impfdatum: 08.05.2021
Beginn: 16.06.2021
Tage bis Beginn: 39,0
Dosis: 2
Route/Site: SYR / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: ja

Breast cyst Chest pain Echocardiogram Electrocardiogram Electrocardiogram ambulatory Heart rate increased Magnetic resonance imaging Musculoskeletal stiffness Pain in extremity SARS-CoV-2 test negative Thyroid mass X-ray

Symptomtext

Increased heart rate during both rest and sleep. Chest pain. Arm pain on my right side. It was discovered I had nodules in my Thyroid. And a cyst in my left breast. Stiffness in my neck and back.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Chest pain
Hospital-Tage: -
Labordaten: EKG- shortened PR; 24hour heart monitor; Zio patch; Ultrasound of the heart; MRI; X-ray; COVID test- negative
Aktuelle Erkrankungen: None
Vorgeschichte: Kidney Stones, Chronic UTI
Andere Medikamente: Microbid; Vitamin C; Vitamin D
Allergien: None
Vorherige Impfungen: -

VAERS 2001461

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EW0183

moderat

Staat: MA
Alter: 49,0
Geschlecht: F
Eingang: 04.01.2022
Impfdatum: 10.05.2021
Beginn: 10.05.2021
Tage bis Beginn: 0,0
Dosis: 2
Route/Site: SYR / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: ja

Arrhythmia Bed rest Chest discomfort Chills Decreased appetite Fatigue Headache Pain Respiratory tract congestion

Symptomtext

I had body chills, headache, congestion, chest pressure and felt fatigue. I thought I had heart arrhythmia. I had no appetite. I went to the urgent care by my house, but they sent me home because I wasn't exhibiting all the symptoms of someone with COVID-19. They told me to go to the emergency room if I felt I couldn't handle it on my own. So I called my doctor and she prescribed me antibiotics Albuterol and Tylenol to take to help reduce my symptoms and body aches. After a couple of weeks of bed rest and antibiotics, I started feeling better.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Arrhythmia
Hospital-Tage: -
Labordaten: N/A
Aktuelle Erkrankungen: N/A
Vorgeschichte: asthma
Andere Medikamente: acetaminophen 650mg
Allergien: aspirin
Vorherige Impfungen: -

VAERS 1999835

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EW0183

moderat

Staat: OH
Alter: 75,0
Geschlecht: F
Eingang: 03.01.2022
Impfdatum: 29.09.2021
Beginn: 17.12.2021
Tage bis Beginn: 79,0
Dosis: 3
Route/Site: SYR / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: nein

Bladder cancer Bladder mass Bladder neoplasm surgery Blood test Blood urine present Bronchitis Chemotherapy Chest X-ray Cough Cystitis Cystoscopy abnormal Echocardiogram abnormal Electrocardiogram abnormal Pain in extremity Supraventricular tachycardia Ultrasound abdomen Urinary retention

Symptomtext

After the vaccine was given I had a sore arm for a day or two. That was all I had directly from the vaccine. On November 4th I had blood in my urine. I was unable to urinate. I had went to an urgent care. They said it was a bladder infection. I was given antibiotics. On November 7th went back to the urgent care and I was diagnosed with Supraventricular Tachycardia. They sent me to Hospital for 3 days. That cleared up on its own. Because I had blood in my urine I had a cystoscopy so the doctors could look in my bladder. I went to another doctor and had surgery done to remove the tumor on December 15th. After that surgery I started having bronchitis. December 19th I went to urgent care and was diagnosed with bronchitis. I have been taking cough medicine benzonatate up to 200mg and liquid cough syrup Hydrocodone-Homatropine 5mg/1.5mg of 5 mL syrup at bedtime. I was also prescribed albuterol sulfate HFA inhaler and depressants. I have recovered from the SVT but I am still having chemo treatments for bladder cancer. I still have a little cough but I'm feeling better.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Supraventricular tachycardia
Hospital-Tage: 3,0
Labordaten: Bloodwork Heart Pap EKG Chest X-ray Sonogram of abdomen Echocardiogram
Aktuelle Erkrankungen: none
Vorgeschichte: Diabetic Bladder Cancer Bad Spine
Andere Medikamente: Lantus Insulin 36 units Metformin ER 500mg 2xday Enalapril 2.5mg 1xday Atenolol 50mg 1xday Vitamin B 1000 1xday Vitamin D 1000 1xday Aspirin 81mg
Allergien: Erythromycin Eggplant Dairy Products
Vorherige Impfungen: Any Vaccines- I would have a sore arm.

VAERS 1998910

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EW0183

moderat

Staat: MI
Alter: 25,0
Geschlecht: F
Eingang: 03.01.2022
Impfdatum: 02.09.2021
Beginn: 25.12.2021
Tage bis Beginn: 114,0
Dosis: 3
Route/Site: UN / UN

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: nein

Angiogram abnormal Atypical pneumonia Blood culture negative COVID-19 Cardiomegaly Chest pain Chills Cough Diarrhoea Dyspnoea Fatigue Haemoptysis Hypophagia Inflammatory marker increased Influenza A virus test negative Influenza B virus test Lung opacity Nausea

Symptomtext

PATIENT WAS HOSPITALIZED AND DISCHARGED AFTER 3 DAYS. 12/25-12/28/21. The patient is a 25 y.o. female with past medical history of OHT 10/28/20, HTN, HLD, CKD II, migraines, anxiety and depression; she presents with 10 day history of multiple infectious symptoms including cough, congestion, N/V/D, chills, fatigue and fever as noted in ROS with significantly decreased oral intake the last 2 days. She was noted to be tachycardic and febrile on examination. Patient tested positive for COVID-19 on PCR. She was admitted and given monoclonal antibody therapy (while in observation) and then decadron. She remained inpatient until she was able to stay off o2 for 24 hours. Symptoms improved and inflammatory markers down-trending. Discharged in stable condition.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Atypical pneumonia
Hospital-Tage: -
Labordaten: CT ANGIO THORAX WITH IV CONTRAST Resulted: 12/25/21 2344 Order Status: Completed Updated: 12/25/21 2346 Narrative: EXAMINATION: CT Angiography of the Thorax EXAM DATE: 12/25/2021 11:24 PM TECHNIQUE: Standard protocol CT angiogram images were obtained through the chest following the administration of intravenous contrast. Coronal and sagittal MIP 3-D reformations were performed. CONTRAST: 80 mL of Isovue-370. QPP DOCUMENTATION: At least one of the following dose reduction techniques was utilized: Iterative reconstruction, and/or Automatic Exposure Control, and/or mA/kV adjustment based on body size. INDICATION: PE suspected, high prob, hx of heart transplant, hemoptysis, sharp chest pain, short of breath, fever, chills, diarrhea/vomiting x last 4 days. Evaluate for pulmonary embolism and for pneumonia. The patient is COVID 19 positive. COMPARISON: CT thorax, abdomen and pelvis performed October 13, 2020, CTA thorax performed October 11, 2020. ENCOUNTER: Not applicable. ____________________ FINDINGS: Base of Neck & Axillae: There is no lymph node enlargement. Mediastinum & Hila: There are no enlarged mediastinal lymph nodes. Mild bilateral hilar nodal prominence is nonspecific but is likely reactive. Cardiovascular: The heart is mildly enlarged. There is no pericardial effusion. There is no evidence of right heart strain. The thoracic aorta enhances normally with no aneurysm, dissection or intramural hematoma. There has been a sternotomy, per history for heart transplant. Pulmonary Arteries: The pulmonary arteries are well-opacified. There is no evidence of pulmonary embolism. The main pulmonary artery has normal caliber. Lungs & Airways: The trachea and the central bronchi are widely patent. There is no bronchial wall thickening. There are scattered small airspace opacities throughout both lungs, the changes worse on the left, particularly involving the left lower lobe. The appearance suggests an atypical infection. While nonspecific, evolving COVID 19 pneumonia could have this appearance. Pleural Space: There is no pleural effusion. There is no pneumothorax. Upper Abdomen: Included portions of the upper abdomen are unremarkable. Chest Wall & Musculoskeletal: No significant abnormality. ____________________ Impression: 1. No evidence of pulmonary embolism. 2. There are scattered airspace opacities throughout both lungs, the changes worse on the left. The appearance suggests an atypical pneumonia. The appearance is nonspecific. Evolving COVID 19 pneumonia could have this appearance. 3. No pleural effusion. No pneumothorax. Peripheral Blood Culture Collected: 12/25/21 2037 Order Status: Completed Specimen: Blood, Venous Updated: 12/30/21 2202 Cult Blood Peripheral No bacteria or yeast isolated Peripheral Blood Culture Collected: 12/25/21 2045 Order Status: Completed Specimen: Blood, Venous Updated: 12/30/21 2202 Cult Blood Peripheral No bacteria or yeast isolated Collected: 12/25/21 2045 Order Status: Completed Specimen: Swabbed Collection from Nasopharynx Updated: 12/25/21 2147 COVID-19 PCR Detected Abnormal Influenza A PCR Not Detected Not Detected Influenza B PCR Not Detected Not Detected RSV PCR Not Detected Not Detected
Aktuelle Erkrankungen: Ovarian cyst and abnormal uterine bleeding 8/12/21
Vorgeschichte: Circulatory Antibody mediated rejection of transplanted heart (HCC) Essential hypertension Digestive Vitamin D deficiency, unspecified Hematologic Other iron deficiency anemia Genitourinary CKD (chronic kidney disease) stage 2, GFR 60-89 ml/min Complex cyst of right ovary Endocrine/Metabolic Steroid-induced hyperglycemia Hypokalemia Immune Immunosuppressed status (HCC) Other History of CVA (cerebrovascular accident) Heart transplant recipient (HCC) Aftercare following organ transplant History of migraine headaches Muscle cramps Major depressive disorder, single episode, moderate (HCC) Generalized anxiety disorder with panic attacks
Andere Medikamente: acetaminophen (TYLENOL) 500 MG tablet amLODIPine (NORVASC) 10 MG tablet aspirin 81 MG chewable tablet dexamethasone (DECADRON) 6 MG tablet dilTIAZem (CARDIZEM CD) 240 MG 24 hr capsule ergocalciferol (VITAMIN D2) 1.25 MG (50000 UT) capsule e
Allergien: Lisinopril-Swelling Nickel
Vorherige Impfungen: -

VAERS 1992451

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EW0183

moderat

Staat: MN
Alter: 88,0
Geschlecht: M
Eingang: 30.12.2021
Impfdatum: 27.04.2021
Beginn: 20.12.2021
Tage bis Beginn: 237,0
Dosis: 2
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: nein

COVID-19 Dyspnoea SARS-CoV-2 test positive

Symptomtext

SOB

Weitere VAERSDATA-Felder

Praegender Schweregrund: Dyspnoea
Hospital-Tage: -
Labordaten: POSITIVE COVID TEST 12/25
Aktuelle Erkrankungen: -
Vorgeschichte: Glaucoma Hypertension Hyperlipidemia Lumbar stenosis Multiple thyroid nodules Obstructive sleep apnea Restless leg syndrome Ulnar neuropathy Displacement of lumbar intervertebral disc
Andere Medikamente: Aspirin 81 mg Oral Tab fenofibrate (TRICOR) 145 mg Oral Tab lisinopril (PRINIVIL) 20 mg Oral Tab Lisinopril-Hydrochlorothiazide 20-12.5 mg Oral Tab timolol (TIMOPTIC) 0.25 % Opht Drop travoprost (TRAVATAN)
Allergien: -
Vorherige Impfungen: -

VAERS 1986136

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EW0183

moderat

Staat: KY
Alter: 47,0
Geschlecht: M
Eingang: 28.12.2021
Impfdatum: 01.09.2021
Beginn: 01.09.2021
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Chest pain Dizziness Dyspnoea

Symptomtext

O2 sats down from 99% to 90%; Shortness of breath; Chest pain; Dizzy; symptoms lasted around 3 weeks

Weitere VAERSDATA-Felder

Praegender Schweregrund: Chest pain
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: none
Vorgeschichte: none
Andere Medikamente: none
Allergien: none
Vorherige Impfungen: -

VAERS 1981753

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EW0183

moderat

Staat: MI
Alter: 66,0
Geschlecht: F
Eingang: 27.12.2021
Impfdatum: 27.08.2021
Beginn: 20.12.2021
Tage bis Beginn: 115,0
Dosis: 1
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: ja

Abdominal pain Acute kidney injury Alanine aminotransferase normal Anion gap Aspartate aminotransferase increased Blood alkaline phosphatase increased Blood bicarbonate decreased Blood bilirubin increased Blood calcium decreased Blood chloride increased Blood creatinine increased Blood glucose increased Blood potassium normal Blood sodium normal Blood urea increased C-reactive protein increased COVID-19 COVID-19 pneumonia

Symptomtext

Hospitalized (12.20.21 - 12.23.21); COVID-19 positive (12.20.21); Fully vaccinated -pfizer x2 D/C Summary: Discharge Summary Physician ? ? General Medicine BRIEF OVERVIEW: Discharge Provider: Primary Care Provider: Admission Date: 12/20/2021 Discharge Date: Dec 23, 2021 Active Hospital Problems Diagnosis Date Noted POA ? Pneumonia due to COVID-19 virus 12/20/2021 Yes ? Hypoxia 12/20/2021 Yes ? Acute renal failure (ARF) 11/15/2018 Yes Resolved Hospital Problems No resolved problems to display. Pre-Existing Active Problems Diagnosis Date Noted POA ? Peripheral vascular disease, unspecified 08/06/2021 Unknown ? Hyperparathyroidism, unspecified 08/06/2021 Unknown ? Platelets decreased 08/06/2021 Unknown ? Cirrhosis of transplanted liver 08/03/2020 Unknown ? Status post kidney transplant 08/03/2020 Unknown ? Immunosuppression 08/03/2020 Unknown ? Insomnia disorder related to known organic factor 11/30/2018 Unknown ? Anemia of chronic renal failure 11/14/2018 Unknown ? CRF (chronic renal failure), stage 3 (moderate) 02/05/2016 Unknown ? CRF (chronic renal failure), stage 4 (severe) 08/01/2015 Unknown ? Nuclear senile cataract of both eyes 03/06/2012 Unknown ? Hypermetropia of both eyes 03/06/2012 Unknown ? Recurrent skin cancer 11/28/2011 Unknown ? Status post liver transplant 06/24/2010 Unknown ? Non-ischemic cardiomyopathy 06/24/2010 Unknown ? Hemosiderosis on liver biopsy 06/24/2010 Unknown ? Osteoporosis 06/24/2010 Unknown ? liver anastomosis 06/24/2010 Unknown ? Aortic stenosis 06/24/2010 Unknown ? stenosis portal vein 06/24/2010 Unknown ? Pancytopenia 01/10/2010 Unknown Discharge Disposition: home health care svc Active Issues Requiring Follow-up: Patient will follow-up with her transplant service on Monday after getting her tacrolimus levels. She has been advised to increase her fluid intake in the short term. DETAILS OF HOSPITAL STAY: PRESENTING PROBLEM: Pneumonia due to COVID-19 virus [U07.1, J12.82] COVID-19 [U07.1] HOSPITAL COURSE: 66-year-old female with a past medical history significant for immunosuppression due to history of liver and renal transplant who presented to the emergency department with complaints of nausea, diarrhea, and shortness of breath on exertion. She was found to have COVID-19. Patient did require oxygen on admission to the hospital. Based on her duration of symptoms and need for hospitalization with oxygen use, she was precluded from monoclonal antibiotic therapy. Her mycophenolate was held in the setting of her acute illness. Her prednisone dose was thought to be in need of increased and she was placed on initially methylprednisolone and subsequently after that 40 mg of prednisone daily. Her tacrolimus was held on admission and tacrolimus level was checked in the setting of AKI. With her AKI, it was suspected that she was suffering from volume depletion therefore IV fluids were started and Nephrology was consulted. Patient was seen in consultation by Nephrology who agreed with holding tacrolimus and mycophenolate initially and providing IV fluids. Patient was also seen in consultation briefly by Gastroenterology by Gastroenterology had nothing to offer in regards to use of the patient's immunosuppressive agents. Patient's transplant service was contacted and they agreed withholding mycophenolate and once tacrolimus level came back greatly elevated at 28, they also agreed with holding of tacrolimus. Patient was found to maintain adequate oxygen saturation on room air shortly after admission but did desaturate significantly with ambulation was thought to qualify for home oxygen. She overall felt better shortly after admission with the use of IV fluids and supplemental oxygen. After repeat tacrolimus level came back at 16, after discussion with the University transplant service, patient was thought to be okay to resume her tacrolimus morning of 12/24 at decreased dose of 2 mg. Patient was also advised to consume more liquids as her renal function overall improved from a creatinine of 1.85 on admission down to a creatinine of 1.32. As she was anxious to go home for the holidays, she was allowed to be discharged home on 12/23/2021 with repeat labs to be done on 12/27 to further evaluate her tacrolimus level. She has also been prescribed a short course of tapering prednisone. CONSULTS / RECOMMENDATION: Consult Orders (From admission, onward) IP CONSULT TO GI Provider: IP CONSULT TO NEPHROLOGY Provider: INPATIENT PROCEDURES: Surgery and Procedures None Non-surgical Procedures (From admission, onward) None BP 137/83 | Pulse 100 | Temp 36.6 ?C (Oral) | Resp 16 | Ht 1.626 m | Wt 66.9 kg | SpO2 94% | BMI 25.32 kg/m? Physical Exam General: No acute distress Respiratory: Clear to auscultation bilaterally with no wheezes and no use of accessory respiratory muscles H&P: CHIEF COMPLAINT: Pneumonia due to COVID-19 virus Assessment/Plan ASSESSMENT / PLAN: COVID-19 PNEUMONIA BILATERAL ACUTE KIDNEY INJURY, DEHYDRATION, DIARRHEA, REDUCED ORALLY INTAKE KIDNEY TRANSPLANT, LIVER TRANSPLANT ON IMMUNOSUPPRESSION HYPOXIA Oxygen supplementation as needed Steroids will use Solu-Medrol given the fact that she is already on chronic steroids IV hydration Monitor creatinine Check procalcitonin Antibiotics Rocephin, Zithromax given history of transplant and immunosuppression KIDNEY TRANSPLANT Consult Nephrology Continue immunosuppressants, steroids LIVER TRANSPLANT WITH CIRRHOSIS OF TRANSPLANTED LIVER Consult GI Lipase slightly elevated LEFT LEG SWELLING Check leg Dopplers HYPERTENSION Norvasc, Lopressor depending on blood pressure readings GERD BARRETT'S ESOPHAGUS PPI HYPERLIPIDEMIA Lipitor DVT PROPHYLAXIS Subcu heparin FULL CODE Subjective HISTORY OF PRESENT ILLNESS: Pt. is a 66 y.o. female with a past medical history of liver transplant, kidney transplant, cirrhosis, hypertension, hyperlipidemia, GERD who presents today with diarrhea and shortness of breath Patient has not been feeling well for the 7 days. She has been noting nausea, 2-3 episodes of diarrhea a day, reduced orally intake, generalized body aches, fatigue, sore throat, shortness of breath with exertion. She has not had much cough or chest pain or abdominal pain. She has been exposed to her son who has COVID-19. She had 2 shots of COVID-19 vaccine in August 2021 and was due for her booster in February 2022. She is on prednisone for immunosuppression. Saturating 87% on room air with ambulation, 90% on room air at rest, blood pressure 109/49 mm, COVID-19 positive, creatinine 1.84 with a baseline of 0.8, lipase 168, AST 40, ALT 26, alkaline phosphatase 168 and bilirubin 1.7, WBC 6, chest x-ray with bilateral interstitial opacities. Patient has been given Decadron Patient Active Problem List Diagnosis ? Status post liver transplant ? Non-ischemic cardiomyopathy ? Hemosiderosis on liver biopsy ? Osteoporosis ? liver anastomosis ? Aortic stenosis ? stenosis portal vein ? Recurrent skin cancer ? Nuclear senile cataract of both eyes ? Hypermetropia of both eyes ? CRF (chronic renal failure), stage 4 (severe) ? CRF (chronic renal failure), stage 3 (moderate) ? Anemia of chronic renal failure ? Acute renal failure (ARF) ? Pancytopenia ? Insomnia disorder related to known organic factor ? Cirrhosis of transplanted liver ? Status post kidney transplant ? Immunosuppression ? Severe malnutrition ? Peripheral vascular disease, unspecified ? Hyperparathyroidism, unspecified ? Platelets decreased ? Pneumonia due to COVID-19 virus ? Hypoxia Review of Systems Constitutional: Positive for chills and fatigue. Negative for appetite change. HENT: Positive for sore throat. Negative for ear pain, tinnitus and nosebleeds. Eyes: Negative for eye discharge and itching. Respiratory: Positive for shortness of breath. Negative for cough, wheezing and chest tightness. Cardiovascular: Positive for leg swelling (Left lower extremity). Negative for chest pain and palpitations. Gastrointestinal: Positive for diarrhea. Negative for heartburn, nausea, vomiting and abdominal pain. Genitourinary: Negative for difficulty urinating, dysuria and hematuria. Musculoskeletal: Negative for back pain and joint swelling. Neurological: Negative for headaches, dizziness, light-headedness, seizures and tremors. Endo/Heme/Allergy: Negative for easy bleeding or bruising. Psychiatric/Behavioral: Negative for depression and anxiety. Skin: Negative for itching and rash. Objective OBJECTIVE: BP 110/54 | Pulse 91 | Temp 36.4 ?C (Oral) | Resp 17 | SpO2 93% Physical Exam Vitals reviewed. Constitutional: Appearance: She is well-developed. HENT: Head: Normocephalic and atraumatic. Nose: Nose normal. Mouth/Throat: Mouth: Mucous membranes are moist. Eyes: General: Right eye: No discharge. Left eye: No discharge. Pupils: Pupils are equal, round, and reactive to light. Neck: Vascular: No JVD. Trachea: No tracheal deviation. Cardiovascular: Rate and Rhythm: Normal rate and regular rhythm. Heart sounds: No murmur heard. No gallop. Pulmonary: Effort: Pulmonary effort is normal. Breath sounds: No wheezing or rales. Abdominal: General: Bowel sounds are normal. Palpations: Abdomen is soft. Tenderness: There is no abdominal tenderness. There is no rebound. Musculoskeletal: General: No tenderness or deformity. Cervical back: Normal range of motion and neck supple. Right lower leg: No edema. Left lower leg: Edema (Trace) present. Skin: General: Skin is warm. Findings: No rash. Neurological: General: No focal deficit present. Mental Status: She is alert and oriented to person, place, and time. Cranial Nerves: No cranial nerve deficit. Coordination: Coordination normal. Psychiatric: Mood and Affect: Mood normal.

Weitere VAERSDATA-Felder

Praegender Schweregrund: COVID-19 pneumonia
Hospital-Tage: 3,0
Labordaten: Tacrolimus Blood Level [359755401] (Abnormal) Collected: 12/23/21 0559 Order Status: Completed Specimen: Blood, Venous Updated: 12/23/21 0927 Tacrolimus Level 16.3 High 5.0 - 15.0 ng/mL C Reactive Protein (CRP), Blood Level [359755399] (Normal) Collected: 12/23/21 0559 Order Status: Completed Specimen: Blood, Venous Updated: 12/23/21 0828 C-Reactive Protein 3.1 <=5.0 mg/L Basic Metabolic Panel (BMP) [359755400] (Abnormal) Collected: 12/23/21 0559 Order Status: Completed Specimen: Blood, Venous Updated: 12/23/21 0828 Sodium Level 141 134 - 146 mmol/L Potassium Level 4.2 3.4 - 5.0 mmol/L Chloride 110 98 - 112 mmol/L HCO3 16 Low 21 - 29 mmol/L Anion Gap 15 9 - 18 mmol/L Glucose Level 312 High 70 - 99 mg/dL Blood Urea Nitrogen 36 High 8 - 20 mg/dL Creatinine 1.32 High 0.50 - 1.10 mg/dL MDRD eGFR 40 Low >=60 mL/min/1.73 m2 CG eCrCl 36 mL/min/1.73 m2 Comment: Creatinine clearance calculated by the Cockroft-Gault equation using age, calculated ideal body weight, gender, and serum creatinine. This equation is typically used for drug dosing determinations, but can also be used to assess for renal impairment. Calcium Level Total 8.5 Low 8.6 - 10.4 mg/dL D-Dimer [359755386] (Abnormal) Collected: 12/22/21 0618 Order Status: Completed Specimen: Blood, Venous Updated: 12/22/21 0804 D-Dimer Quant 810 High 0 - 500 ng/mL FEU
Aktuelle Erkrankungen: -
Vorgeschichte: Past Medical History: Diagnosis Date ? Barrett's esophagus ? Cancer ? Cirrhosis ? CRF (chronic renal failure), stage 3 (moderate) 2/5/2016 ? Fracture ? GERD (gastroesophageal reflux disease) ? Hepatitis C ? HTN (hypertension) ? Kidney disease ? Kidney failure ? Kidney transplanted ? Liver cancer ? Liver transplant 12/2002 ? Menopause ? Osteopenia ? Pneumonia ? Skin cancer basal cell
Andere Medikamente: amLODIPine Besylate 10 mg Oral Aspirin 81 mg Oral Daily Atenolol 50 mg Oral Every morning Atorvastatin Calcium 10 mg Oral Daily, for cholesterol B Complex Vitamins 1 tablet Oral Daily Calcitriol 1 tablet Oral Every Mo, We and Fr Calcium Ace
Allergien: albuterol - insensitivity celebrex - hives peanut-derived products - hives prograf tacrolimu - hives/seizures cipro - rash
Vorherige Impfungen: -

VAERS 1981369

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EW0183

moderat

Staat: HI
Alter: 42,0
Geschlecht: F
Eingang: 27.12.2021
Impfdatum: 04.06.2021
Beginn: 17.06.2021
Tage bis Beginn: 13,0
Dosis: 1
Route/Site: SYR / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Chest X-ray Chest pain Costochondritis Rales

Symptomtext

Chest Pain in the center of the chest. Crackling feeling in the chest.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Chest pain
Hospital-Tage: -
Labordaten: 10/23 Chiropractor for Chest Pain see if adjustment could help. 10/27 Visit to Doctor for Chest Pain diagnosed with Costochondritis was given medication 10/28 Visit to Doctor for Chest Pain. 12/13 Chest X-Ray
Aktuelle Erkrankungen: -
Vorgeschichte: Kidney Stones
Andere Medikamente: Ortho-Tri-Cyclin LO
Allergien: Sulfa
Vorherige Impfungen: Chest pain, 42, 6/4/21 and 6/25/21, COVID-19, pfizer

VAERS 1976758

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EW0183

moderat

Staat: RI
Alter: 41,0
Geschlecht: F
Eingang: 23.12.2021
Impfdatum: 28.04.2021
Beginn: 29.04.2021
Tage bis Beginn: 1,0
Dosis: 2
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Loss of personal independence in daily activities Lymphadenopathy Muscular weakness Paraesthesia Urticaria

Symptomtext

Paresthesia in left arm/hand lasting 7 months after first dose. Weakness in left hand causing difficulty with normal tasks (grasping, writing) lasting 7 months after first dose. Lymphadenopathy on left side has not yet resolved (8 months after 1st dose.) Uticaria lasting 4 months after 2nd dose.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Paraesthesia
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: None
Vorgeschichte: None
Andere Medikamente: None
Allergien: None
Vorherige Impfungen: -

VAERS 1955362

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EW0183

moderat

Staat: MN
Alter: 34,0
Geschlecht: M
Eingang: 16.12.2021
Impfdatum: 16.04.2021
Beginn: 14.12.2021
Tage bis Beginn: 242,0
Dosis: 2
Route/Site: - / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Cough Dyspnoea Headache Nasal congestion Pain Sinus congestion Upper-airway cough syndrome

Symptomtext

headache, cough, shortness of breath, body aches, sinus congestion, nasal congestion, post nasal drainage. starting 12/14/21.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Dyspnoea
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: none.
Vorgeschichte: hypertension.
Andere Medikamente: Lisinopril.
Allergien: none.
Vorherige Impfungen: -

VAERS 1944273

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EW0183

moderat

Staat: -
Alter: 70,0
Geschlecht: F
Eingang: 13.12.2021
Impfdatum: 30.04.2021
Beginn: 01.12.2021
Tage bis Beginn: 215,0
Dosis: UNK
Route/Site: - / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: unbekannt

COVID-19 Cough Dyspnoea Fatigue Pyrexia SARS-CoV-2 test positive

Symptomtext

12/01/21 patient presents to ED for "cough, fatigue, fever, & shortness of breath". PMHx of "COPD, CAD, hypertension"

Weitere VAERSDATA-Felder

Praegender Schweregrund: Dyspnoea
Hospital-Tage: -
Labordaten: 12/1/21 SARS-CoV-2 (COVID-19) by NAA detected
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1943452

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EW0183

moderat

Staat: MI
Alter: 36,0
Geschlecht: F
Eingang: 13.12.2021
Impfdatum: 12.05.2021
Beginn: 22.11.2021
Tage bis Beginn: 194,0
Dosis: 2
Route/Site: - / UN

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: nein

COVID-19 Cough Dyspnoea Pneumonia SARS-CoV-2 test positive

Symptomtext

Patient is a 37y.o. y.o. female who presents to the ED on 11/23/21 for evaluation of possible LUE DVT. Patient was dx with pneumonia on Friday, confirmed COVID positive yesterday, and was sent in by her PCP today for concern of DVT. Pt has PICC line present to RUE and states that she has a hx of DVT around it, and is concerned she has another one. Reports hx of clotting disorders for which she is taking blood thinners. Pt has been taking doxycycline and prednisone for her pneumonia. There are no other complaints or modifying factors at this time. Review of Systems Constitutional: Negative for chills and fever. Respiratory: Positive for cough and shortness of breath. Negative for wheezing. Cardiovascular: Negative for chest pain and palpitations. Gastrointestinal: Negative for abdominal pain, diarrhea, nausea and vomiting. Genitourinary: Negative for dysuria, frequency and urgency. Musculoskeletal: Negative for back pain and neck pain. Skin: Negative for rash. Neurological: Negative for headaches. Psychiatric/Behavioral: Negative for suicidal ideas.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Dyspnoea
Hospital-Tage: 7,0
Labordaten: Patient is a 37y.o. y.o. female who presents to the ED on 11/23/21 for evaluation of possible LUE DVT. Patient was dx with pneumonia on Friday, confirmed COVID positive yesterday, and was sent in by her PCP today for concern of DVT. Pt has PICC line present to RUE and states that she has a hx of DVT around it, and is concerned she has another one. Reports hx of clotting disorders for which she is taking blood thinners. Pt has been taking doxycycline and prednisone for her pneumonia. There are no other complaints or modifying factors at this time. Review of Systems Constitutional: Negative for chills and fever. Respiratory: Positive for cough and shortness of breath. Negative for wheezing. Cardiovascular: Negative for chest pain and palpitations. Gastrointestinal: Negative for abdominal pain, diarrhea, nausea and vomiting. Genitourinary: Negative for dysuria, frequency and urgency. Musculoskeletal: Negative for back pain and neck pain. Skin: Negative for rash. Neurological: Negative for headaches. Psychiatric/Behavioral: Negative for suicidal ideas.
Aktuelle Erkrankungen: CHF (congestive heart failure) 01/22/2020 ? Collagen vascular disease 01/22/2020 ? Diabetes mellitus 01/22/2020 ? Hypertension 01/22/2020 ? Multiple myeloma 01/22/2020 ? Renal insufficiency 01/22/2020 ? Sickle cell disease 01/22/2020
Vorgeschichte: CHF (congestive heart failure) 01/22/2020 ? Collagen vascular disease 01/22/2020 ? Diabetes mellitus 01/22/2020 ? Hypertension 01/22/2020 ? Multiple myeloma 01/22/2020 ? Renal insufficiency 01/22/2020 ? Sickle cell disease 01/22/2020
Andere Medikamente: ACETAMINOPHEN (TYLENOL) 325 MG PO TAB take 2 Tablets by mouth every 6 hours as needed for FOR FEVER (For temperature > 100.4 F). ATORVASTATIN (LIPITOR) 10 MG PO TAB take 1 Tablet by mouth once every night at bedtime. BACLOFEN 5 M
Allergien: Latex Rash/Itching ? Contrast [Gadolinium] Rash/Itching No steroids for CT prep just benadryl ? Environmental [Sutures] Rash/Itching "dermabond" ? Iv Dye [Iodinated Diagnostic Agents] Rash/Itching ? Sulfa Antibiotics Hives, Rash/Itching and Rash ? Sulfasalazine Hives and Rash/Itching ? Cashew Nut Oil Other Swelling eyes, itching throat ? Macadamia Nut Oil Other Swelling eyes, itching throat ? Succinylcholine Other Muscle Pain for 5 days after use
Vorherige Impfungen: -

VAERS 1940065

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EW0183

moderat

Staat: MA
Alter: 52,0
Geschlecht: F
Eingang: 10.12.2021
Impfdatum: 25.04.2021
Beginn: 06.12.2021
Tage bis Beginn: 225,0
Dosis: 3
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: ja

COVID-19 Chest X-ray normal Cough Dyspnoea Headache Myalgia Oropharyngeal pain Pyrexia SARS-CoV-2 test positive

Symptomtext

Patient presented on 12/6/21 with fever, HA, nonproductive cough, sore throat, myalgias and SOB for 3 days. Patient is fully vaccinated. Chest x ray showed no acute abnormality. Patient was given x1 IV vanco/cefepime in the ED. Patient was discharged on 12/7/21 with an outpatient monoclonal antibody therapy on 12/8.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Dyspnoea
Hospital-Tage: 1,0
Labordaten: covid positive test on 12/6/21. chest x ray impression on 12/7/21: no acute abnormality
Aktuelle Erkrankungen: N/A
Vorgeschichte: R sided TNBC
Andere Medikamente: acetaminophen, adapalene, vitamin d3, zofran, prochlorperazine, zarxio injection
Allergien: NO known allergies
Vorherige Impfungen: -

VAERS 1935616

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EW0183

moderat

Staat: -
Alter: 42,0
Geschlecht: F
Eingang: 09.12.2021
Impfdatum: 14.05.2021
Beginn: 27.11.2021
Tage bis Beginn: 197,0
Dosis: UNK
Route/Site: - / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: unbekannt

Chills Cough Dyspnoea Hypoaesthesia Myalgia Nausea Paraesthesia Pyrexia Vomiting

Symptomtext

11/27/21 presents to EC ED for "cough, shortness of breath, mylagias, chills, fever, nausea, vomiting, numbness and tingling in her hands". PMHx of "asthma, MS"

Weitere VAERSDATA-Felder

Praegender Schweregrund: Dyspnoea
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1935595

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EW0183

moderat

Staat: -
Alter: 51,0
Geschlecht: F
Eingang: 09.12.2021
Impfdatum: 29.04.2021
Beginn: 26.11.2021
Tage bis Beginn: 211,0
Dosis: UNK
Route/Site: - / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: unbekannt

Cough Dyspnoea Pyrexia

Symptomtext

11/26/21 presents to EC ED for "fever, SOB, cough". PMHx of "psoriatic arthritis on immunosuppressant therapy, HTN"

Weitere VAERSDATA-Felder

Praegender Schweregrund: Dyspnoea
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1916999

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EW0183

moderat

Staat: MN
Alter: 27,0
Geschlecht: F
Eingang: 02.12.2021
Impfdatum: 22.04.2021
Beginn: 29.11.2021
Tage bis Beginn: 221,0
Dosis: 2
Route/Site: - / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Anosmia Chest discomfort Chills Cough Dyspnoea Hyperhidrosis Nasal congestion Nausea Oropharyngeal pain Pain

Symptomtext

sore throat and mild cough on 11/30. She then developed nausea, body aches, chills and sweats. She has had SOB starting yesterday with some chest tightness-she does have asthma, and her albuterol is helping. She has mild nasal congestion, sore throat is now mild. Loss of smell today Her boyfriend got a positive COVId-19 result last night .

Weitere VAERSDATA-Felder

Praegender Schweregrund: Dyspnoea
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: none
Vorgeschichte: Allergic rhinitis, Asthma, Depression/anxiety, Insomnia, Previous hx of anorexia, Gastritis/gastroesophageal reflux disease, hemorrhagic cyst of the right ovary March 2010, Attention deficit hyperactivity disorder (saw psyc previously), Hypoglycemia reactions, Immune to varicella (see 3/31/11 titre), Mononucleosis 11/2015, Acne, hyperthyroidism/Graves disease (abnormal thyroid uptake scan) 7/2019; Dr., celiac disease (dx at Clinic 2/2021) - now on gluten free diet, vitamin B12 deficiency, vitamin D deficiency, folate deficiency, zinc deficiency, iron deficiency.
Andere Medikamente: Taking methIMAzole 10 MG Tablet 2 and a half tablets Orally Once a day, Notes: 25mg days she works and 20 on days she does not work, Taking Vitamin D (Ergocalciferol) 1.25 MG (50000 UT) Capsule 1 capsule Orally Once a week, Taking Folic Aci
Allergien: Chocolate: hives - Allergy, Amoxicillin-Pot Clavulanate.
Vorherige Impfungen: -

VAERS 1913419

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EW0183

moderat

Staat: -
Alter: 83,0
Geschlecht: M
Eingang: 01.12.2021
Impfdatum: 11.06.2021
Beginn: 30.11.2021
Tage bis Beginn: 172,0
Dosis: UNK
Route/Site: - / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: unbekannt

Body temperature decreased Chills Cough Hyperhidrosis Tremor Upper-airway cough syndrome

Symptomtext

he was in his usual state of health until about 230 this afternoon he started to have chills. These progressed to shaking chills and rigors by 330. He was at his Oncology office in the took his temperature which was 96 F. However with concerns of infection he was referred to the emergency department. Upon arrival here he still complains of chills and sweats. He reports a small cough which feels like postnasal drip but denies shortness of breath, chest pain, abdominal pain, nausea vomiting, diarrhea or constipation, difficulty urinating or burning urination. He denies skin lesions

Weitere VAERSDATA-Felder

Praegender Schweregrund: Tremor
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1913110

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EW0183

moderat

Staat: AZ
Alter: 58,0
Geschlecht: F
Eingang: 01.12.2021
Impfdatum: 04.11.2021
Beginn: 05.11.2021
Tage bis Beginn: 1,0
Dosis: 3
Route/Site: SYR / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Asthma Biopsy lymph gland Condition aggravated Cough Lymphadenopathy Mobility decreased Pain

Symptomtext

1. Woke up with Asthma and coughing out of nowhere at 2 a.m. Usually only get asthma if I have a bronchial cold 2. Giant swollen and extremely sore lymph nodes under right arm. Hard to put arm down.(could it be related to my breast cancer being on that side and testing lymph nodes and then having chemo 9 years ago? 3. General achiness all over Resolved within 48 hours.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Condition aggravated
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: none
Vorgeschichte: Asthma (childhood and only flares up now when sick) Immune-compromised - chemotherapy and breast cancer 9 years ago
Andere Medikamente: sudafed, benedryl, clarinex, effexor, tiazadine, melatonin 3 mg.
Allergien: lanolin
Vorherige Impfungen: Felt achy after 2nd dose of Pfizer for about 4 hours, and then was fine.

VAERS 1910228

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EW0183

moderat

Staat: CA
Alter: 60,0
Geschlecht: F
Eingang: 30.11.2021
Impfdatum: 30.11.2021
Beginn: 30.11.2021
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Angioedema Diarrhoea Dyspnoea Nausea Urticaria Vomiting

Symptomtext

0.3ml dose was withdrawn from the un-reconstituted vial (120 mcg - 4x recommended dose of 30 mcg) and administered onto the right deltoid. No sign/symptoms of immediate reactions such as shortness of breath, urticaria, angioedema, nausea/vomiting, or diarrhea were reported. Vital signs were stable. Patient was admitted into the ED for 24 hour observation.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Dyspnoea
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: lupus myocarditis, hypertension, alcohol/nicotine use, heart failure
Vorgeschichte: lupus myocarditis, hypertension, alcohol/nicotine use, heart failure
Andere Medikamente: acetaminophen, albuterol, calcium carbonate-vitamin D, carvedilol, desonide cream, diclofenac gel, econazole nitrate cream, folic acid, gabapentin, lidocaine 5% patch, losartan, methyl salicylate menthol cream, naloxone nasal spray, nicotin
Allergien: sulfa antibiotic - rash
Vorherige Impfungen: -

VAERS 1906029

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EW0183

moderat

Staat: VT
Alter: 59,0
Geschlecht: F
Eingang: 29.11.2021
Impfdatum: 13.05.2021
Beginn: 13.05.2021
Tage bis Beginn: 0,0
Dosis: 2
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Arthralgia Hypoaesthesia Injection site pain Joint range of motion decreased Limb discomfort Loss of personal independence in daily activities Pain Pain in extremity Paraesthesia Peripheral coldness Sleep disorder

Symptomtext

Possible adhesive capsulitis s/p COVID vaccination. Had her second COVID vaccine on 5/13. She had more pain with the second dose than the first injection. C/o persistent pain in her left arm since. Started as pain at the area of injection--no redness or swelling. Immediately after her vaccine, she had a lot of body aches in her knees. That improved after about 1 week, but arm continued to feel sore. She felt like the shot went very deep on the second vaccine. For a while, her tricep was painful. ROM is impaired. She has been able to go about her normal activity. Over the last 1 month, the pain has migrated into her deltoid muscle -- worse with sudden movements or reaching for something or catching herself. Hard to even run due to pain with running motions so it is now interfering with her daily life. Mostly bothered by aching pain. She has a sensation of numbness into her left wrist. No neck pain, back pain. She does have some left shoulder pain if she sleeps on her left side. She started using heat and ice over the last week. Using arnica and performing exercise. Is moving arm differently. Dorsal wrist is numb and tingly, sleeping differently. Fingers feel cooler. Is right handed, but also using left arm less due to discomfort.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Paraesthesia
Hospital-Tage: -
Labordaten: Referral to sports medicine provider in 9/2021
Aktuelle Erkrankungen: none known
Vorgeschichte: none known
Andere Medikamente: DMG dietary supplement
Allergien: Sulfa drug allergy
Vorherige Impfungen: -

VAERS 1903650

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EW0183

moderat

Staat: NY
Alter: 23,0
Geschlecht: U
Eingang: 27.11.2021
Impfdatum: 06.07.2021
Beginn: 15.07.2021
Tage bis Beginn: 9,0
Dosis: 1
Route/Site: - / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Migraine Tremor

Symptomtext

Shaking in my hand; Very severe migraine; This is a spontaneous report from a contactable consumer or other non healthcare professional. A 23-years-old patient of an unspecified gender received bnt162b2 (Pfizer-BioNTech COVID-19 Vaccine, solution for injection, Lot number: EW0183), via an unspecified route, administered in Arm Left on 06Jul2021 (at the age of 23 years), as DOSE 1, SINGLE for covid-19 immunisation. The patient medical history and concomitant medications were not reported. On 15Jul2021, the patient experienced shaking in my hand and very severe migraine. The patient took Advil for migraine. The outcome of the events was unknown. Follow-up attempts are completed. No further information is expected.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Migraine
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1896790

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EW0183

moderat

Staat: MI
Alter: 37,0
Geschlecht: M
Eingang: 24.11.2021
Impfdatum: 22.09.2021
Beginn: 01.10.2021
Tage bis Beginn: 9,0
Dosis: 1
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Atrial fibrillation Condition aggravated Immediate post-injection reaction

Symptomtext

Worsening (increasing / more frequent) atrial fibrillation episodes (not responsive to medication) Immediately after getting Pfizer vaccinated (late September), in early October, I have been dealing with Afib episodes every 7-10 days. These episodes are not responding to my Pill in the Pocket meds, and have been lasting 2-4 days each. (historically, Afib episodes occurred every 4-6 weeks). from primary care visit 11.12.21: Paroxysmal afib Follows with Cardiology Symptomatic when he is in AFib Currently takes metoprolol and flecainide if he feels himself go into afib (pill in pocket, per cardiology). Since his COVID vaccinations he has noticed that he seems to be in AFib more frequently, and that the medications are not always effective at getting him out of AFib. Get symptoms every couple of weeks now -due to his increased symptom frequency as well as fact that it it does not consistently respond the flecainide I do think that ablation is worth considering. He will call Cardiology to set up an appointment to discuss

Weitere VAERSDATA-Felder

Praegender Schweregrund: Condition aggravated
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: NA
Vorgeschichte: Atrial fibrillation (HCC) OSA (obstructive sleep apnea) Hypertrophic cardiomyopathy (HCC)
Andere Medikamente: flecainide (TAMBOCOR) 150 MG tablet ketoconazole (NIZORAL) 2 % cream metoprolol succinate-XL (TOPROL-XL) 25 MG 24 hr tablet
Allergien: NKDA
Vorherige Impfungen: -

VAERS 1896790

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EW0183

moderat

Staat: MI
Alter: 37,0
Geschlecht: M
Eingang: 24.11.2021
Impfdatum: 22.09.2021
Beginn: 01.10.2021
Tage bis Beginn: 9,0
Dosis: 2
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Atrial fibrillation Condition aggravated Immediate post-injection reaction

Symptomtext

Worsening (increasing / more frequent) atrial fibrillation episodes (not responsive to medication) Immediately after getting Pfizer vaccinated (late September), in early October, I have been dealing with Afib episodes every 7-10 days. These episodes are not responding to my Pill in the Pocket meds, and have been lasting 2-4 days each. (historically, Afib episodes occurred every 4-6 weeks). from primary care visit 11.12.21: Paroxysmal afib Follows with Cardiology Symptomatic when he is in AFib Currently takes metoprolol and flecainide if he feels himself go into afib (pill in pocket, per cardiology). Since his COVID vaccinations he has noticed that he seems to be in AFib more frequently, and that the medications are not always effective at getting him out of AFib. Get symptoms every couple of weeks now -due to his increased symptom frequency as well as fact that it it does not consistently respond the flecainide I do think that ablation is worth considering. He will call Cardiology to set up an appointment to discuss

Weitere VAERSDATA-Felder

Praegender Schweregrund: Condition aggravated
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: NA
Vorgeschichte: Atrial fibrillation (HCC) OSA (obstructive sleep apnea) Hypertrophic cardiomyopathy (HCC)
Andere Medikamente: flecainide (TAMBOCOR) 150 MG tablet ketoconazole (NIZORAL) 2 % cream metoprolol succinate-XL (TOPROL-XL) 25 MG 24 hr tablet
Allergien: NKDA
Vorherige Impfungen: -

VAERS 1889892

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EW0183

moderat

Staat: MI
Alter: 64,0
Geschlecht: M
Eingang: 22.11.2021
Impfdatum: 21.07.2021
Beginn: 07.11.2021
Tage bis Beginn: 109,0
Dosis: 2
Route/Site: - / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: nein

COVID-19 Dyspnoea SARS-CoV-2 test positive

Symptomtext

SOB

Weitere VAERSDATA-Felder

Praegender Schweregrund: Dyspnoea
Hospital-Tage: 7,0
Labordaten: 11.7.21 positive on admission.
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1880791

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EW0183

moderat

Staat: MI
Alter: 58,0
Geschlecht: M
Eingang: 18.11.2021
Impfdatum: 18.08.2021
Beginn: 14.11.2021
Tage bis Beginn: 88,0
Dosis: 3
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: ja

Alanine aminotransferase normal Anion gap Anticoagulant therapy Arthralgia Aspartate aminotransferase normal Asthenia Basophil count normal Basophil percentage decreased Blood albumin decreased Blood alkaline phosphatase normal Blood bicarbonate decreased Blood bilirubin normal Blood calcium normal Blood chloride increased Blood creatinine increased Blood glucose normal Blood potassium increased Blood sodium normal

Symptomtext

Hospitalized (11.14.21-11.17.21; COVID-19 positive (11.10.21); fully vaccinated PLUS Booster HISTORY OF PRESENT ILLNESS: Patient is a 58 y.o. male who presented to the ED today with generalized weakness that has been progressive since November 6th. He was evaluated in the ED on November 10th and was found to be positive for COVID 19. He continued to feel poorly with generalized weakness, poor orally intake, nonproductive cough and shortness of breath. He reports oral intake has been poor. He was taking Tylenol for symptom management. He was having difficulty ambulating due to generalized weakness and left hip pain with negative x-rays so PT and OT evaluated patient with recommendations for Sar placement. His remained on room air without significant respiratory symptoms. Because of need for placement he required admission and no beds available at Hospital so he was transferred to Campus HOSPITAL COURSE: 58 yo x3 vaccinated man with: Left lateral buttock pain w/ radiation to posterior mid-thigh Challenging to localize such a dermatome but S1 possible given posterior location Generalized weakness Inability to ambulate Began 1-2 weeks PTA His chiropractor suggested he was suffering from sciatica No recalled injury and no falls No numb/tingling at leg/foot Could consider MRI L-spine and sacrum PT/OT SAR advised Covid positive, no PNA Sore throat 11/9/21 HS Covid + 11/10/21 No SOB, hypoxia, and not on O2 CRP: 49.5 D-dimer: 990 Monoclonal antibodies provided CKD stage IV Nephrotic syndrome with membranous glomerular nephritis Cr 3.64 -> 2.88 Undergoing workup in Ann Arbor for renal transplant Avoid nephrotoxic agents and renal dose meds Hyperkalemia, mild Likely related to decreased renal function Provide information on potassium restricting diet Hypertension No med in use for this condition Hyperlipidemia No med in use for this condition Hypothyroidism, TSH 1.14 11/14/21 L-thyroxine 112 daily continued VTE ppx: Lovenox 30 SQ d given decreased renal function Diet: General Full code Dispo: Home w/ OP PT

Weitere VAERSDATA-Felder

Praegender Schweregrund: Dyspnoea
Hospital-Tage: 4,0
Labordaten: x-rays negative Comprehensive Metabolic Panel (CMP) (Abnormal) Collected: 11/17/21 1654 Order Status: Completed Specimen: Blood, Venous Updated: 11/17/21 1731 Sodium Level 138 134 - 146 mmol/L Potassium Level 5.2 High 3.4 - 5.0 mmol/L Chloride 108 98 - 112 mmol/L HCO3 19 Low 21 - 29 mmol/L Anion Gap 11 9 - 18 mmol/L Glucose Level 79 70 - 99 mg/dL Blood Urea Nitrogen 39 High 8 - 20 mg/dL Creatinine 2.56 High 0.60 - 1.30 mg/dL MDRD eGFR 26 Low >=60 mL/min/1.73 m2 CG eCrCl 37 mL/min/1.73 m2 Calcium Level Total 9.0 8.6 - 10.4 mg/dL Protein Total 6.4 6.0 - 8.0 g/dL Albumin Level 2.5 Low 3.5 - 5.0 g/dL Bilirubin Total 0.3 0.2 - 1.0 mg/dL Alkaline Phosphatase 73 40 - 129 IU/L Alanine Aminotransferase 9 Low 10 - 40 IU/L Aspartate Aminotransferase 22 10 - 40 IU/L C Reactive Protein (CRP), Blood Level (Abnormal) Collected: 11/17/21 1654 Order Status: Completed Specimen: Blood, Venous Updated: 11/17/21 1731 C-Reactive Protein 40.1 High <=5.0 mg/L D-Dimer (Abnormal) Collected: 11/17/21 1654 Order Status: Completed Specimen: Blood, Venous Updated: 11/17/21 1721 D-Dimer Quant 1,020 High 0 - 500 ng/mL FEU Complete Blood Count w/Differential (Abnormal) Collected: 11/17/21 1653 Order Status: Completed Specimen: Blood, Venous Updated: 11/17/21 1702 White Blood Cell 8.17 4.00 - 10.80 x10*3/uL Red Blood Cell 3.85 Low 4.60 - 6.00 x10*6/uL Hemoglobin 11.4 Low 14.0 - 18.0 g/dL Hematocrit 35.3 Low 42.0 - 52.0 % Mean Cell Volume 91.7 80.0 - 100.0 fL Mean Cell Hemoglobin 29.6 27.0 - 33.0 pg Mean Cell Hemoglobin Concentration 32.3 32.0 - 37.0 g/dL Red Cell Diameter Width 14.6 11.0 - 16.0 % NRBC Absolute Count 0.00 0.00 - 0.01 x10*3/uL NRBC Automated 0.0 0.0 - 0.1 %WBC Platelet 365 140 - 400 x10*3/uL Mean Platelet Volume 10.1 7.4 - 11 fL Neutrophil Automated 72.1 35.0 - 80.0 % Immature Granulocyte Automated 1.0 High 0.0 - 0.6 % Lymphocyte Automated 13.7 Low 20.0 - 50.0 % Monocytes Automated 9.9 2.0 - 12.0 % Eosinophil Automated 3.2 0.0 - 6.0 % Basophil Automated 0.1 0.0 - 2.0 % Neutrophil Absolute Count 5.89 1.80 - 7.80 x10*3/uL Immature Granulocyte Absolute Count 0.08 High 0.00 - 0.05 x10*3/uL Lymphocyte Absolute Count 1.12 1.00 - 4.00 x10*3/uL Monocyte Absolute Count 0.81 0.00 - 0.90 x10*3/uL Eosinophil Absolute Count 0.26 0.00 - 0.50 x10*3/uL Basophil Absolute Count 0.01 0.00 - 0.20 x10*3/uL
Aktuelle Erkrankungen: -
Vorgeschichte: Past Medical History: Diagnosis Date ? Arthritis ? CKD (chronic kidney disease) stage 4, GFR 15-29 ml/min ? Colon polyp 06/2016 ? COVID-19 ? DVT (deep venous thrombosis) ? Essential hypertension, benign ? GERD (gastroesophageal reflux disease) ? Heart murmur ? Hodgkin's lymphoma 1990 Stage IIA mixed cellularity ? Hyperlipidemia ? Hypothyroidism ? Membranoproliferative nephropathy ? Mitral regurgitation with mild prolapse ? Mitral valve prolapse ? Nephrolithiasis ? Nephrotic syndrome with lesion of membranous glomerulonephritis ? Personal history of colonic polyps 1/5/2021
Andere Medikamente: levothyroxine 112 mcg daily, famotidine 20 mg daily prn, vit D-3 50 mcg 2,000 units daily, lidoderm 4% patch - 1 daily on 12 hrs/off 12 hrs, flexeril 10 mg 1 tab TID as needed, alprostadil 500 mcg prn
Allergien: demerol, IVP dye-iodine containing, shellfish
Vorherige Impfungen: -

VAERS 1869405

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EW0183

moderat

Staat: VA
Alter: 43,0
Geschlecht: M
Eingang: 15.11.2021
Impfdatum: 19.05.2021
Beginn: 23.05.2021
Tage bis Beginn: 4,0
Dosis: 2
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Angina pectoris Dizziness Dyspnoea Heart rate irregular

Symptomtext

episodic acute heart pain, erratic pulse, lightheadedness, shortness of breath - symptoms would subside with rest - no treatment.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Dyspnoea
Hospital-Tage: -
Labordaten: none
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: Vitamins C, D, E, zinc
Allergien: -
Vorherige Impfungen: -

VAERS 1868403

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EW0183

moderat

Staat: OK
Alter: 33,0
Geschlecht: F
Eingang: 14.11.2021
Impfdatum: 30.06.2021
Beginn: 01.07.2021
Tage bis Beginn: 1,0
Dosis: 1
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: ja Hospital: ja Disable: ja ER: ja Erholt: nein

Agitation Blood test Chest pain Disorientation Electrocardiogram Fatigue Hypoaesthesia Nervousness Palpitations Panic attack

Symptomtext

PFIZER COVID VAC 0.3ML - Chest pain, left arm went numb, unexplainable nervousness, distraught, fatigued, disorientated and panic attack(s) with heart palpitations that resulted in an ER visit.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Chest pain
Hospital-Tage: 15,0
Labordaten: Measures taken - EKG test, blood was drawn and tested. Left without any further recommendations except to follow-up with PCP and hydrate. Re-hydratration via intravenous was not given nor offered.
Aktuelle Erkrankungen: Onset anxiety that causes cognitive decline alongside nerve pain and depression.
Vorgeschichte: Eczema, ADHD symptoms, anxiety, MDD, PTSD, migraines & obesity - now 150 lbs lighter.
Andere Medikamente: Duloxetine & Amphetamine; I also was had just stopped taking the smoking cessation medication Chantix for a relapse if nicotine starting the month of April of 2021. Chantix was recalled before the Pfizer vaccination. Shortly after the vacci
Allergien: No known or severe allergies; have been tested by allergy and ENT locally.
Vorherige Impfungen: -

VAERS 1857595

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EW0183

moderat

Staat: WI
Alter: 46,0
Geschlecht: F
Eingang: 10.11.2021
Impfdatum: 11.05.2021
Beginn: 20.07.2021
Tage bis Beginn: 70,0
Dosis: 2
Route/Site: SYR / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: nein

Ankle fracture Asthenia Blood test abnormal Computerised tomogram abnormal Culture stool negative Electroencephalogram normal Fall Foot fracture Hypotension Nausea Neurological examination normal SARS-CoV-2 test negative X-ray limb abnormal

Symptomtext

Mild symptoms after the vaccine with nausea for 2 days. In Jul 2021, my blood pressure was low 70s over 60 and falling down and broke bones in both my feet. I was hospitalized, too weak to do the test to check on low blood pressure. I have high blood pressure.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Hypotension
Hospital-Tage: 16,0
Labordaten: X-rays Broken bones on both feet and bone chipped out of ankle CT scans Broken bones on both feet and bone chipped out of ankle COVID-19 Negative Bloodwork some meds were affecting my kidney and now rectified EEG Negative Stool sample Negative Neurologist Negative
Aktuelle Erkrankungen: No
Vorgeschichte: Type 2 Diabetes Hashimoto's Chronic Pain Depression And Anxiety High Blood Pressure
Andere Medikamente: Morphine 15mg to 7.5mg four times daily Zanaflex 4mg to 12mg 3 times daily Levothyroxine 175mcg Bupropion extended release 150mg 2 tablets daily Sertiline 100mg 1.5 tablets daily Metformin 500mg Trazadone 500mg daily Losartan 50mg daily Am
Allergien: Codeine Effector Sulfa Aryltriazene Lisinopril
Vorherige Impfungen: -

VAERS 1855341

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EW0183

moderat

Staat: TX
Alter: 46,0
Geschlecht: M
Eingang: 09.11.2021
Impfdatum: 10.05.2021
Beginn: 07.10.2021
Tage bis Beginn: 150,0
Dosis: 2
Route/Site: SYR / AR

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein

Abdominal pain Abdominal pain upper Blood test Dizziness Dyspnoea Erythema Hyperhidrosis Hypersensitivity Nausea Pruritus Pruritus genital Sleep disorder Urticaria Vertigo

Symptomtext

I had abdominal pain. The pain was right underneath my sternum. It was about the size of a baseball. I was sweating profusely from one minute to another. I was dripping off of my nose - really bad sweating. I got light-headed and the room started spinning a little bit. It felt like I had to defecate but when I sat down, I couldn't do anything. It also gave me nausea, but I couldn't throw up. It went away after about an hour and a half. I didn't call the ambulance because I was in the hotel with my daughter - 13 and 17 and I didn't want to scare them. I waited it out and walked around the room and then I went to bed when it went away. Four days later, Monday night, I was at a conference, and we had just had a few beers and I went to a restaurant and before I ate, I got that same pain in my stomach. I went to restroom. From the time I got up from the table to get to the restroom - I was sweating profusely and got a little dizzy. That pain was in that same spot under the sternum and the pain was probably twice as bad. A waitress saw me and called 9-1-1. I was with my boss, and they called him to come into the restroom and he thought I was having a heart attack. In both instances, I was short of breath - gasping for breath. But I could only get air in in short little bursts. They did take me to a hospital. The pain was intense. They gave me Fentanyl in the ambulance, and it did not take the pain away (Fentanyl) They triaged me in the hospital, and they took my blood but I was never seen because I had been in there for 6 hours and so I asked them to take the thing out of my arm because they hadn't seen me. The put Fentanyl in my arm and something for an allergy in case I was having an allergic reaction. Within three hours of onset, I didn't feel sick at all anymore. The pain was gone, and the sweating was gone. Everything was gone. About 10 days ago, I woke up and was short of breath. I had no pain - or very little pain in my stomach but it felt like something was there in that same place as before in my stomach. I wasn't sweating at all. I did have a little bit of labored breathing. I broke out in the worst case of hives - all over my body. It started in my pubic area where I could feel the itching. Right above me tailbone - right on top of my butt, I was itching bad. My body turned beet red all over and even on my skull and that was itchy, too. After about 45 minutes, that subsided. I waited that episode out without calling an ambulance. Four or about five days - Hives all over my body and labored breathing - the same symptoms as 10 days ago and that again lasted about 45 minutes. I went to see my Internal Medicine doctor. He prescribed me something for allergy - Prednisone - to take in case it happens again. He took blood to see if it could be an allergy. He sent me to Gastroenterologist. Tomorrow, I will have a colonoscopy and endoscopy. Note: I had the flu shot about a month and a half ago. I got it at my doctor's office. In my right shoulder.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Dyspnoea
Hospital-Tage: -
Labordaten: Blood Tests Doctor
Aktuelle Erkrankungen: None
Vorgeschichte: None
Andere Medikamente: COQ10 Omega 3 Fish Oil
Allergien: Penicillin prior to college; but not anymore
Vorherige Impfungen: -

VAERS 1854278

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EW0183

moderat

Staat: MI
Alter: 62,0
Geschlecht: F
Eingang: 09.11.2021
Impfdatum: 26.04.2021
Beginn: 06.11.2021
Tage bis Beginn: 194,0
Dosis: 2
Route/Site: IM / UN

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: nein

Blood glucose increased COVID-19 pneumonia Chest X-ray abnormal Condition aggravated Diabetes mellitus Eating disorder Lung opacity

Symptomtext

11/6 Pt to ED via EMS with c/o high blood sugar. Hx of diabetes and hasnt eaten in 2 weeks. Pt chest x-ray showed bilateral basilar interstitial airspace opacity, left more than right. 11/8 Dx COVID Pneumonia, Steroids and anticoagulation to be started.

Weitere VAERSDATA-Felder

Praegender Schweregrund: COVID-19 pneumonia
Hospital-Tage: -
Labordaten: See 18
Aktuelle Erkrankungen: N/A
Vorgeschichte: Hypoxia, hypoglycemia, diabetes type 2, cancer, dementia, hyperlipidemia, Acute renal failure.
Andere Medikamente: Advair Diskus, albuterol, amlodiPINe, betamethasone valerate clotrimazole clotrimazole-betamethasone cyproheptadine donepezil esomeprazole famotidine glipiZIDE Glucagon Gvoke HypoPen hydroCHLOROthiazide insulin glargine JANUVIA lo
Allergien: N/A
Vorherige Impfungen: -

VAERS 1853764

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge EW0183

moderat

Staat: CA
Alter: 45,0
Geschlecht: F
Eingang: 09.11.2021
Impfdatum: 07.05.2021
Beginn: 07.05.2021
Tage bis Beginn: 0,0
Dosis: 2
Route/Site: SYR / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Burning sensation Condition aggravated Fatigue Hypoaesthesia Swelling face Urticaria

Symptomtext

Following the vaccination, I got a swollen left cheek, and heat on my face. And Numbing of my whole left arm. It resolved the next day. -went back to normal. September 7th, my hives returned after 8years of remission. My doctor Believes, the carrier of the hives was triggered by an immune response. Fatigue.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Condition aggravated
Hospital-Tage: -
Labordaten: Blood Normal
Aktuelle Erkrankungen: N/A
Vorgeschichte: Chronic Herpes Chronic Hives
Andere Medikamente: Valacyclovir For Herpes Zyrtec For Allergies
Allergien: Nsaid Ibuprofen Family
Vorherige Impfungen: -

VAERS 1832201

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EW0183

moderat

Staat: NY
Alter: 53,0
Geschlecht: F
Eingang: 09.11.2021
Impfdatum: 29.10.2021
Beginn: 29.10.2021
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: - / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Abdominal pain upper Diarrhoea Dizziness Fatigue Palpitations Pyrexia Swollen tongue Urticaria Vomiting Unevaluable event

Symptomtext

Hives; Palpitations; Swelling of tongue; Fever; Dizziness; Stomach pain; Fatigue; Diarrhea; Vomiting; This is a spontaneous report from a contactable consumer, the patient. A 53-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0183) via an unspecified route of administration in the left arm (also reported as left shoulder) on 29Oct2021 at 13:00 (at the age of 53-years-old) as a single dose for COVID-19 immunisation. Medical history included hives, positional vertigo, solar urticaria and allergy to nickel. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications were not reported. The patient previously received ibuprofen (MOTRIN) and experienced drug allergy. On 29Oct2021, the patient experienced hives, palpitations, swelling of tongue, fever, dizziness, stomach pain, fatigue, diarrhea and vomiting. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events hives, palpitations, swelling of tongue, fever, dizziness, stomach pain, fatigue, diarrhea and vomiting were resolved with lasting effects on an unknown date in 2021.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Palpitations
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: Medical History/Concurrent Conditions: Hives; Nickel sensitivity (Known Allergies: Nickel); Solar urticaria (Known allergies: Solar urticaria); Vertigo positional (Positional vertigo)
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1832201

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EW0183

moderat

Staat: NY
Alter: 53,0
Geschlecht: F
Eingang: 09.11.2021
Impfdatum: 29.10.2021
Beginn: 29.10.2021
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: SYR / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Abdominal pain upper Diarrhoea Dizziness Fatigue Palpitations Pyrexia Swollen tongue Urticaria Vomiting Unevaluable event

Symptomtext

Hives; Palpitations; Swelling of tongue; Fever; Dizziness; Stomach pain; Fatigue; Diarrhea; Vomiting; This is a spontaneous report from a contactable consumer, the patient. A 53-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0183) via an unspecified route of administration in the left arm (also reported as left shoulder) on 29Oct2021 at 13:00 (at the age of 53-years-old) as a single dose for COVID-19 immunisation. Medical history included hives, positional vertigo, solar urticaria and allergy to nickel. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications were not reported. The patient previously received ibuprofen (MOTRIN) and experienced drug allergy. On 29Oct2021, the patient experienced hives, palpitations, swelling of tongue, fever, dizziness, stomach pain, fatigue, diarrhea and vomiting. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events hives, palpitations, swelling of tongue, fever, dizziness, stomach pain, fatigue, diarrhea and vomiting were resolved with lasting effects on an unknown date in 2021.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Palpitations
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: Medical History/Concurrent Conditions: Hives; Nickel sensitivity (Known Allergies: Nickel); Solar urticaria (Known allergies: Solar urticaria); Vertigo positional (Positional vertigo)
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1851331

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EW0183

moderat

Staat: MN
Alter: 56,0
Geschlecht: F
Eingang: 08.11.2021
Impfdatum: 16.04.2021
Beginn: 05.11.2021
Tage bis Beginn: 203,0
Dosis: 2
Route/Site: - / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Ageusia Anosmia Chills Cough Dyspnoea Ear discomfort Eye pruritus Nasal congestion Rhinorrhoea Sneezing Upper-airway cough syndrome

Symptomtext

nonproductive cough, chills, shortness of breath, loss of taste, loss of smell, nasal congestion, post nasal drainage, sneezing, itchy eyes runny nose, ear fullness. starting on 11/5/2021

Weitere VAERSDATA-Felder

Praegender Schweregrund: Dyspnoea
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: none
Vorgeschichte: History of Depression. Menopause at age 44.
Andere Medikamente: ?Vitamin D 2000 UNIT Tablet 3 capsules Orally Once a day ?Multi For Her - Tablet as directed Orally
Allergien: none
Vorherige Impfungen: -

VAERS 1849717

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EW0183

moderat

Staat: MI
Alter: 55,0
Geschlecht: F
Eingang: 07.11.2021
Impfdatum: 14.05.2021
Beginn: 01.11.2021
Tage bis Beginn: 171,0
Dosis: 2
Route/Site: IM / AR

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: ja

Breath sounds abnormal COVID-19 COVID-19 pneumonia Chest X-ray abnormal Chronic obstructive pulmonary disease Condition aggravated Cough Dyspnoea Dyspnoea exertional Electrocardiogram ST-T segment abnormal Fatigue Hypoxia Incisional hernia Laboratory test normal Lung hyperinflation Productive cough Pyrexia SARS-CoV-2 test positive

Symptomtext

Hospitalized (11.1.21); COVID-19 vaccine (11.1.21); fully vaccinated Discharge Provider: Doctor Primary Care Provider at Discharge: Physician Assistant Admission Date: 11/1/2021 Discharge Date: 11/3/2021 PRESENTING PROBLEM: COVID-19 HOSPITAL COURSE: Patient is a 55 y.o. female with a history of inflammatory arthritis and chronic obstructive pulmonary disease, who is not oxygen dependent, presents today with increasing shortness of breath and cough. She had received 2 doses of Pfizer vaccine for COVID-19. Patient reported onset of fever, fatigue productive cough and shortness of breath 3 days ago. She noted coughing up green sputum. She denied any chest pain, abdominal pain, nausea or vomiting, diarrhea or urinary symptoms. She used her home inhalers without any improvement. She tried to get into her PCP office but they had no openings so she scheduled a tele medicine visit today. She noted the provider instructed her to be seen in the emergency department due to her coarse lung sounds and wheezing. She proceeded to Emergency Department for evaluation. Patient was hypoxic at 85% on room air and placed on 1 L of oxygen to maintain sats above 90%. Laboratory studies unremarkable. EKG showed normal sinus rhythm with nonspecific ST and T wave abnormality. No change from previous EKG. COVID-19 positive. Chest xray demonstrated hyperinflated lungs without acute cardiopulmonary process. She was given IV Decadron and albuterol treatments but continued to require 1 L of oxygen. Given her continued hypoxia she was transferred via EMS to Big Rapids Hospital for further care and treatment of chronic obstructive pulmonary disease exacerbation secondary to COVID-19 Pneumonia. Patient was weaned to room air on 11/2 though her work of breathing warranted further monitoring. On 11/3 she had some dyspnea with exertion but was feeling well at rest; she felt confident to go home. She will be discharged in stable condition on room air with a medrol dose pack and guaifenesin. She understands she is recommended to follow up with her PCP to ensure resolution of Covid-19 with concomitant COPD exacerbation.

Weitere VAERSDATA-Felder

Praegender Schweregrund: COVID-19 pneumonia
Hospital-Tage: 3,0
Labordaten: -
Aktuelle Erkrankungen: 10/5/21: OP note - Admission; procedure; incisional hernia, without obstruction or gangrene 10/14/21: PCP office - COPD 11/1/21: ED - SOB, COVID-19, cough
Vorgeschichte: Solitary cyst of breast History of elevated antinuclear antibody (ANA) Seasonal allergic rhinitis, unspecified allergic rhinitis trigger Colonoscopy refused DDD (degenerative disc disease), lumbar Chronic left-sided low back pain with left-sided sciatica Chronic kidney disease (CKD), stage III (moderate) Tobacco abuse disorder Other emphysema Palpitations Paroxysmal SVT (supraventricular tachycardia) Inflammatory arthritis Moderate persistent asthma, uncomplicated History of hernia repair COVID-19 Rheumatoid arthritis Smoker
Andere Medikamente: acetaminophen (TYLENOL) 500 MG tablet albuterol (PROVENTIL) (2.5 MG/3ML) 0.083% nebulization albuterol HFA (PROVENTIL HFA, VENTOLIN HFA, PROAIR HFA) 108 (90 Base) MCG/ACT inhaler atenolol (TENORMIN) 25 MG tablet azelastine (ASTELIN) 0.1 % n
Allergien: TapeHives ErythromycinRash PenicillinsRash Zyban [Bupropion]
Vorherige Impfungen: -

VAERS 1848852

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EW0183

moderat

Staat: MI
Alter: 34,0
Geschlecht: F
Eingang: 06.11.2021
Impfdatum: 06.11.2021
Beginn: 06.11.2021
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: IM / UN

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Paraesthesia oral Throat tightness

Symptomtext

Within the first few minutes after receiving the vaccine, the patient indicated that her tongue felt tingly. She denied any additional symptoms, but within the next few minutes she began to experience mild throat tightness, although the tingly tongue resolved. She denied DIB, SOB, wheezing, chest tightness, swollen tongue, racing pulse, or anxiety. She was given a dose of diphenhydramine 25 mg at 1119 and was reassessed frequently. Approximately 10-15 minutes after the diphenhydramine, she verbalized that she was feeling some improvement of the throat tightness. She stated she had diphenhydramine at home and would take an additional 25 mg if her symptoms worsened again. She was also instructed to go to the ED if her symptoms rebounded.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Paraesthesia oral
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: NSAIDS
Vorherige Impfungen: -

VAERS 1846649

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EW0183

moderat

Staat: MI
Alter: 83,0
Geschlecht: M
Eingang: 05.11.2021
Impfdatum: 22.10.2021
Beginn: 01.11.2021
Tage bis Beginn: 10,0
Dosis: 3
Route/Site: - / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: nein

COVID-19 Chest pain Malaise SARS-CoV-2 test positive

Symptomtext

Patient presented to emergency department on 11/3/2021 with complaints of chest pain. He reported feeling unwell for the past week and tested positive for COVID-19 on 11/1/2021. Patient did not require any symptomatic treatment for his COVID-19 infection during admission. He was discharged home on 11/5/2021. Patient completed his primary COVID-19 vaccine series with Pfizer on 1/26/2021 and 2/16/2021.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Chest pain
Hospital-Tage: 2,0
Labordaten: COVID-19 test positive on 11/1/2021.
Aktuelle Erkrankungen: None known
Vorgeschichte: Coronary artery disease involving native coronary artery of native heart with angina pectoris; DM (diabetes mellitus); hyperlipidemia; post coronary artery bypass graft status; essential hypertension; intermittent claudication; PAF (paroxysmal atrial fibrillation); carotid stenosis; degenerative arthritis of left knee; acute flank pain; atrial fibrillation; encounter for long-term (current) use of other medications; spasm of thoracolumbar muscle; DM (diabetes mellitus); obesity; Stage 3A chronic kidney disease; DJD (degenerative joint disease) of knee; history of coronary artery bypass graft; CAD (multiple vessel); insulin-requiring or dependent type II diabetes mellitus; type 2 diabetes mellitus without complication; unspecified long term insulin use status; coronary artery disease with angina pectoris; unspecified vessel or lesion type; unspecified whether native or transplanted heart; diabetic nephropathy associated with type 2 diabetes mellitus; weight loss subtherapeutic anticoagulation; congestive heart failure, unspecified HF chronicity, unspecified heart failure type; anemia, unspecified type; SIRS (systemic inflammatory response syndrome); former smoker; unstable angina; acute on chronic combined systolic and diastolic CHF (congestive heart failure); recurrent pleural effusion on left; dyspnea on exertion; left atrial thrombus; OSA (obstructive sleep apnea); dyslipidemia; cervical DDD (degenerative disc disease); skin lesion of cheek; CAD in native artery; recurrent left pleural effusion; symptomatic sinus bradycardia; depression, recurrent
Andere Medikamente: Cordarone (amiodarone) 200mg tablet; Norvasc (amlodipine) 5mg tablet; Eliquis (apixaban) 5mg tablet; Halfprin (aspirin) 81mg tablet; Lipitor (atorvastatin) 20mg tablet; Lipitor (atorvastatin) 40mg tablet; Feosol (ferrous sulfate) 325/65mg F
Allergien: CT dye (hives); sulfa drugs
Vorherige Impfungen: -

VAERS 1833211

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EW0183

moderat

Staat: MI
Alter: 41,0
Geschlecht: F
Eingang: 01.11.2021
Impfdatum: 30.09.2021
Beginn: 30.09.2021
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Asthenia Chills Diarrhoea Dizziness Heart rate increased Hypoaesthesia Nausea Paraesthesia Vision blurred

Symptomtext

Patient reported (following her 2nd dose of her vaccine): a fast heartbeat, dizziness / weakness, numbness and tingling. She also reported chills, nausea and diarrhea - along with "cloudy vision". These were reported to have started within 4 hours of receiving the vaccine. She reported at a PCP visit on 10.26.21: "She reports her eyes are "gloomy/foggy" since receiving both COVID shots in September. She believes that this has worsened with her recent illness."

Weitere VAERSDATA-Felder

Praegender Schweregrund: Paraesthesia
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: fatigue
Vorgeschichte: Acne vulgaris Other allergic rhinitis Herpes stomatitis Food allergy -- aspartame Class 1 obesity due to excess calories without serious comorbidity with body mass index (BMI) of 33.0 to 33.9 in adult Situational anxiety
Andere Medikamente: albuterol HFA (PROVENTIL HFA, VENTOLIN HFA, PROAIR HFA) 108 (90 Base) MCG/ACT inhaler Bacillus Coagulans-Inulin (PROBIOTIC FORMULA PO) benzonatate (TESSALON PERLES) 100 MG capsule doxycycline (ADOXA) 100 MG tablet EPINEPHrine 0.3 MG/0.3ML a
Allergien: Bactrim [Sulfamethoxazole W-trimethoprim]Throat swelling PenicillinsHives, Anaphylaxis Metronidazole [Kdc:edetic Acid+methylparaben+metronidazole+propylene Glycol+...]Hives TramadolOther Adhesive Bandages Misc CephalexinRash CiprofloxacinAsthma/Shortness of Breath ClindamycinOther Metronidazole Minocycline Naproxen Sulfa DrugsShortness of Breath, Rash, Swelling Zantac [Ranitidine]Rash
Vorherige Impfungen: -

VAERS 1833211

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EW0183

moderat

Staat: MI
Alter: 41,0
Geschlecht: F
Eingang: 01.11.2021
Impfdatum: 30.09.2021
Beginn: 30.09.2021
Tage bis Beginn: 0,0
Dosis: 2
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Asthenia Chills Diarrhoea Dizziness Heart rate increased Hypoaesthesia Nausea Paraesthesia Vision blurred

Symptomtext

Patient reported (following her 2nd dose of her vaccine): a fast heartbeat, dizziness / weakness, numbness and tingling. She also reported chills, nausea and diarrhea - along with "cloudy vision". These were reported to have started within 4 hours of receiving the vaccine. She reported at a PCP visit on 10.26.21: "She reports her eyes are "gloomy/foggy" since receiving both COVID shots in September. She believes that this has worsened with her recent illness."

Weitere VAERSDATA-Felder

Praegender Schweregrund: Paraesthesia
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: fatigue
Vorgeschichte: Acne vulgaris Other allergic rhinitis Herpes stomatitis Food allergy -- aspartame Class 1 obesity due to excess calories without serious comorbidity with body mass index (BMI) of 33.0 to 33.9 in adult Situational anxiety
Andere Medikamente: albuterol HFA (PROVENTIL HFA, VENTOLIN HFA, PROAIR HFA) 108 (90 Base) MCG/ACT inhaler Bacillus Coagulans-Inulin (PROBIOTIC FORMULA PO) benzonatate (TESSALON PERLES) 100 MG capsule doxycycline (ADOXA) 100 MG tablet EPINEPHrine 0.3 MG/0.3ML a
Allergien: Bactrim [Sulfamethoxazole W-trimethoprim]Throat swelling PenicillinsHives, Anaphylaxis Metronidazole [Kdc:edetic Acid+methylparaben+metronidazole+propylene Glycol+...]Hives TramadolOther Adhesive Bandages Misc CephalexinRash CiprofloxacinAsthma/Shortness of Breath ClindamycinOther Metronidazole Minocycline Naproxen Sulfa DrugsShortness of Breath, Rash, Swelling Zantac [Ranitidine]Rash
Vorherige Impfungen: -

VAERS 1825754

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EW0183

moderat

Staat: MD
Alter: 53,0
Geschlecht: F
Eingang: 28.10.2021
Impfdatum: 04.04.2021
Beginn: 10.05.2021
Tage bis Beginn: 36,0
Dosis: 3
Route/Site: SYR / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Arthralgia Magnetic resonance imaging abnormal Mobility decreased Tendonitis

Symptomtext

Right Elbow pain- can't lift anything. MRI shows tendonitis. I'm left handed.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Mobility decreased
Hospital-Tage: -
Labordaten: MRI 10/23/21
Aktuelle Erkrankungen: none
Vorgeschichte: hypothyroidism, lupus, sjogren's syndrome, hashimoto's disease, Vitamin D deficiency
Andere Medikamente: Levothyroxine 125 MCG, Hydroxychloroquine 200 MG Bupropion HCL XL 150 MG, Vitamin D2 25MG.
Allergien: none
Vorherige Impfungen: -

VAERS 1825427

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EW0183

moderat

Staat: NY
Alter: 57,0
Geschlecht: F
Eingang: 28.10.2021
Impfdatum: 27.10.2021
Beginn: 27.10.2021
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: SYR / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein

Blood test normal Chest X-ray normal Electrocardiogram normal Heart rate increased Palpitations

Symptomtext

Heart Palpitations, rapid heart beat.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Palpitations
Hospital-Tage: -
Labordaten: EKG, chest X-ray, blood testing- Negative
Aktuelle Erkrankungen: UTI
Vorgeschichte: Reflux & IBS
Andere Medikamente: Famotidine, Vit D, Vit C, Zinc, Elderberry.
Allergien: Macrobid & Dexilant
Vorherige Impfungen: -

VAERS 1824675

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EW0183

moderat

Staat: NY
Alter: 28,0
Geschlecht: F
Eingang: 28.10.2021
Impfdatum: 20.05.2021
Beginn: 04.06.2021
Tage bis Beginn: 15,0
Dosis: 2
Route/Site: - / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Condition aggravated Heavy menstrual bleeding Vaginal haemorrhage

Symptomtext

Spotting around Ovulation was reported as worsened; Caller states it seems more pronounced and heavier this second month; experiencing spotting around the ovation time; This is a spontaneous report from a contactable consumer. This female consumer (reported for herself): A 28-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; solution for injection, Lot Number: EW0183), via unspecified route of administration, in left arm on 20May2021 (at the age of 28-year-old) as a dose 2, single for COVID-19 immunization. The patient medical history included anxiety. The concomitant medication of the patient included escitalopram oxalate (LEXAPRO) for anxiety. The patient previously received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Lot Number:EW0158), via unspecified route of administration on 29Apr2021, as a dose 1, single for COVID-19 immunization. On 04Jun2021 the patient experienced spotting around the ovation time. On an unspecified date of Jul2021 patient reported that it was worsened and also reported that it seems more pronounced and heavier this second month. The patient reported that she had a change in her menstrual cycle. Patient had both doses of the vaccine and for the past 2 months, she has had a similar thing that had never happened before. Patient stated that she had spotting around ovulation and it seems odd and she was not sure how much data was being reported about it.The patient was more pronounced and heavier in second month. Patient also stated that the second time she was noticing it and this time it was more obvious. Patient stated that last month she didn't write down exactly how long, but it was a short one day thing in June and then she got her period 2 weeks later so that would check out and on Monday it was day 17 of her cycle and she had spotting. The patient queried if there was a way to access any mass collection of information on her side effect. The patient not received any treatment for spotting around the ovation time. The outcome for spotting around the ovation time and it seems more pronounced and heavier this second month was not recovered. The outcome for spotting around ovulation was reported as worsened was unknown. Follow-up attempts are completed. No further information is expected.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Condition aggravated
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: Medical History/Concurrent Conditions: Anxiety
Andere Medikamente: LEXAPRO
Allergien: -
Vorherige Impfungen: -

VAERS 1824377

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EW0183

moderat

Staat: VT
Alter: 43,0
Geschlecht: F
Eingang: 28.10.2021
Impfdatum: 08.05.2021
Beginn: 09.05.2021
Tage bis Beginn: 1,0
Dosis: 2
Route/Site: - / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Fatigue Migraine Nausea

Symptomtext

Extreme Migraine; Nausea; Fatigue; This is a spontaneous report from a contactable consumer, the patient. A 43-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0183) via an unspecified route of administration on 08May2021 (at the age of 43-years-old) as a single dose for COVID-19 immunisation. Medical history was not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications included triamcinolone acetonide (NASACORT) and oxymetazoline (AFRIN); for an unknown indication, on an unknown date and unknown if ongoing. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0169) via an unspecified route of administration on 17Apr2021 (at the age of 43-years-old) as a single dose for COVID-19 immunisation. On 09May2021 at 10:00, the patient experienced extreme migraine, nausea and fatigue. The events did not result in doctor or other healthcare professional office/clinic visit/ emergency visit. Since the vaccination, the patient had not been tested for COVID-19. Therapeutic measures were not taken as a result of adverse events. The clinical outcome of the events extreme migraine, nausea and fatigue was recovered on an unknown date in May2021. No follow-up attempts are needed. No further information is expected.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Migraine
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: NASACORT; AFRIN [OXYMETAZOLINE]
Allergien: -
Vorherige Impfungen: -

VAERS 1821279

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EW0183

moderat

Staat: MA
Alter: 42,0
Geschlecht: M
Eingang: 27.10.2021
Impfdatum: 18.05.2021
Beginn: 10.10.2021
Tage bis Beginn: 145,0
Dosis: 2
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: ja

COVID-19 COVID-19 pneumonia Chest X-ray abnormal Cough Infection Lung opacity Pyrexia SARS-CoV-2 test positive

Symptomtext

Patient presented to ED on 10/10/21 with one week of recurrent fevers and persistent dry cough after recent admission for covid PNA on 9/5. Patient's PCP instructed the patient to come to the ED after fever didn't resolve with antibiotics. Patient was appropriately treated and was discharged on 10/16/21.

Weitere VAERSDATA-Felder

Praegender Schweregrund: COVID-19 pneumonia
Hospital-Tage: 6,0
Labordaten: 10/11/21 covid positive chest x ray impression on 10/10/21: right upper lobe area of airspace opacity along with scattered right middle and lower lobes small patchy areas of groundglasss opacity, may represent an infectious process/multifocal pneumonia
Aktuelle Erkrankungen: N/A
Vorgeschichte: multiple sclerosis
Andere Medikamente: vitamin d3, vitamin b12, melatonin, ocrelizumab
Allergien: no known allergies
Vorherige Impfungen: -

VAERS 1817342

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EW0183

moderat

Staat: NC
Alter: 31,0
Geschlecht: F
Eingang: 26.10.2021
Impfdatum: 27.08.2021
Beginn: 27.08.2021
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: - / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Fatigue Headache Hypoaesthesia Insomnia Nausea Tremor Vomiting

Symptomtext

Severe Headache; LT arm numbness and shaking; LT arm numbness and shaking/Involuntary muscle jerks in LT arm and shoulder; Nausea; Vomitting; Fatigue; Insomnia; This is a spontaneous report from a contactable other health care professional (patient). A 31-year-old non-pregnant female patient received first dose of bnt162b2 (BNT162B2, Solution for injection, Batch/Lot Number: EW0183) via an unspecified route of administration, administered in left arm on 27Aug2021 at 01:45 (at the age of 31-year-old) as single dose for COVID-19 immunization. Patient had known allergies to penicillins, Ibuprofen. The patient's concomitant medications were not reported. The patient did not received any other vaccines within 4 weeks prior to the COVID vaccine. It was unknown if the patient diagnosed with COVID-19 prior to the vaccination. The patient had been not tested for COVID-19 since the vaccination. The patient received within 2 weeks of vaccination naproxen sodium (ALEVE, batch/lot number not reported), route of administration, start and stop date, dose not reported. The patient previously took ibuprofen and experienced drug hypersensitivity. On 27Aug2021 at 14:00 the patient experienced severe headache, arm numbness and shaking, involuntary muscle jerks in lt arm and shoulder, nausea, vomiting, fatigue, insomnia. Treatment received with OTC medications for the event headache. No treatment received for other events. Device Date: 29Aug2021. Outcome of the events were not resolved. Follow-up attempts are completed. No further information is expected.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Tremor
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: Medical History/Concurrent Conditions: Drug allergy; Penicillin allergy.
Andere Medikamente: ALEVE
Allergien: -
Vorherige Impfungen: -

VAERS 1812639

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EW0183

moderat

Staat: WI
Alter: 49,0
Geschlecht: M
Eingang: 23.10.2021
Impfdatum: 18.05.2021
Beginn: 18.05.2021
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: - / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Arthralgia Musculoskeletal chest pain Pain

Symptomtext

but now he hurts whenever he walks or just sitting down it hurts; pain right above his hip that's shooting up to his rib cage, he's in constant pain and it hurts when he walks; pain right above his hip that's shooting up to his rib cage, he's in constant pain and it hurts when he walks; This is a spontaneous report from a sponsored program. This is a report of a contactable male consumer (patient). A 49-year-old male patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation: Solution for injection, Lot Number: EW0183; Expiration Date: 31Aug2021), dose 1 via an unspecified route of administration, administered in Arm Left (because his right side is hurting) on 18May2021 12:17 (Age at Vaccination was 49 years) as dose 1, single for COVID-19 immunisation. The patient medical history included COVID-19 (he had COVID before for about 12 hours and he just loss taste and that was it). The patient's concomitant medications were not reported. The patient family medical history was cancer. It was reported that, He was taking the Pfizer Covid vaccine well because science says he has to get it or keep a mask on. He states that, he got it and they had him sit in the room for 15 minutes and he could leave at 12:32. He does have to say props to the needles because they did not hurt whatsoever when it went in his arm, so props for that. He had no previous immunization with the vaccine considered as suspect and no additional vaccines administered on same date of the suspect. He did not receive any other vaccinations within 4 weeks prior to COVID vaccination. The information about other Products received in 2 weeks was not reported. On 18May2021 15:30, the patient experienced pain right above his hip that was shooting up to his rib cage, he was in constant pain, and it hurts when he walks as worsened. When he tries to walk on it, he has to limp. but now he hurts whenever he walks or just sitting down it hurts. He states that he was working until 11:00 and he was sitting down most of the time, but he was still hurting. The patient did not visit an emergency room or physician office as a result of events. But he also stated that, he will go to the emergency room if he still is hurting later. The patient had his next appointment due on 08Jun2021 for his second dose. The outcome of the events was not recovered. Follow-up attempts completed. No further information expected.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Musculoskeletal chest pain
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: Medical History/Concurrent Conditions: Cancer (None, unless you count cancer); COVID-19 (he had COVID before for about 12 hours and he just loss taste and that was it.)
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1812605

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EW0183

moderat

Staat: WI
Alter: 41,0
Geschlecht: M
Eingang: 23.10.2021
Impfdatum: 14.05.2021
Beginn: 14.05.2021
Tage bis Beginn: 0,0
Dosis: 2
Route/Site: - / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Anxiety Chills Confusional state Dyspnoea Fatigue Pain Skin burning sensation Somnolence

Symptomtext

drowsiness; chills; body aches; burning sensation of the skin; shortness of breath; extreme fatigue; anxiety; confusion; This is a spontaneous report from a contactable consumer. A 41-years-old male patient received bnt162b2 (Formulation: Solution for injection; Batch/Lot Number: EW0183), dose 2 via an unspecified route of administration, administered in Arm Left on 14May2021 09:30 as dose 2, single for covid-19 immunisation (at the age of 41 years). Medical history included covid-19 from an unknown date and unknown if ongoing. Prior to vaccination, the patient was diagnosed with COVID-19. The patient's concomitant medications were not reported. Not known allergies. The patient previously received first dose of bnt162b2 on an unspecified date for covid-19 immunisation. On 14May2021 20:00 patient experienced drowsiness, chills, body aches, burning sensation of the skin. Days 2 through 4 - shortness of breath, extreme fatigue, anxiety and confusion. The treatment was not received. Since the vaccination, the patient has not been tested for COVID-19. The outcome of the events was not recovered. Follow-up attempts completed. No further information expected.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Dyspnoea
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: Medical History/Concurrent Conditions: COVID-19 (Prior to vaccination, was the patient diagnosed with COVID-19?:Yes)
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1812472

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EW0183

moderat

Staat: OR
Alter: 67,0
Geschlecht: F
Eingang: 23.10.2021
Impfdatum: 11.05.2021
Beginn: 11.05.2021
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: - / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Diarrhoea Discomfort Dyspnoea Erythema Pruritus Urticaria Vaccination site pain Visual impairment

Symptomtext

she started itching everywhere; had hives; she also had massive diarrhea.; Her injection site was also extremely painful/Injection site really sore and hurtful; She also had vision blurriness/Vision affected a little; shortness of breath; redness and spots; quite uncomfortable; This is a spontaneous report received from a contactable consumer (patient, self-reported) via medical information team. A 67-year-old female patient BNT162B2 (PFIZER-BIONTEC COVID-19 mRNA VACCINE, Solution for injection, lot/batch number: EW0183 and expiry date was not reported), via an unspecified route of administration in arm right, on 11May2021 at 12:45 PM (age at vaccination: 67 years), as a single dose for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. On 11May2021, the patient experienced she started itching everywhere, had hives, she also had massive diarrhoea, her injection site was also extremely painful/injection site really sore and hurtful, she also had vision blurriness/vision affected a little, shortness of breath, redness and spots, quite uncomfortable. Clinical course was reported as female patient who received her 1st dose of the vaccine yesterday. within 2 hours after the injection the patient had itching everywhere and had hives. This proceeded to continue to the night, where she also had massive diarrhoea. Reportedly the patient injection site was also extremely painful, which made her quite uncomfortable. She also had vision blurriness and shortness of breath. The patient also stated that the itchiness was still there, but it was nothing like it was be-fore. The redness and spots have diminished but she was still itching to death. The patient also stated that they are better than last night but still ongoing. Reportedly the patient did not want to get the injection, but her family suggested it. The patient also stated that she has some health problems. No further information provided by the patient. Reportedly the patient just wanted to report her information that she was concerned about getting the second shot. States that she has multiple allergies, does not specify. Reported that that she spoke with her allergist before the first shot, and they told her to get the injection. Reportedly the patient was wondering if she should get the second injection. The clinical outcome of the event she started itching everywhere was not recovered, and other event redness and spots was recovered, and other events was recovering. No follow-up attempts are needed. No further information is expected.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Dyspnoea
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1791068

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EW0183

moderat

Staat: NC
Alter: 34,0
Geschlecht: F
Eingang: 16.10.2021
Impfdatum: 07.09.2021
Beginn: 10.09.2021
Tage bis Beginn: 3,0
Dosis: 1
Route/Site: - / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: nein

Bowel movement irregularity Dysphagia Dyspnoea Feeling abnormal Gait disturbance Head discomfort Headache Hypoxia Impaired work ability Muscle fatigue Muscle twitching Otorrhoea Pain Paraesthesia Pelvic pain SARS-CoV-2 test Sensory loss Vaginal discharge

Symptomtext

fatigued breathing; fatigued muscles as if not getting enough oxygen to head; fatigued muscles as if not getting enough oxygen to head; trouble walking; trouble swallowing; Severe head pressure that turns into severe head pain; Severe head pressure that turns into severe head pain; Cool mint tingling in arms; coming and going of loss of touch, loss feeling in face; Pelvic pain comes and goes; coming and going of loss of touch, loss feeling in face,calves; Leg and eye twitches; Bowel movements and vaginal discharge have a distinct chemical like odor; Bowel movements and vaginal discharge have a distinct chemical like odor; Striking random pains; not been able to return to work; Pushes down into ear pressure eventually draining ears; This is a spontaneous report from a contactable other healthcare professional (patient). A 34-year-old female non-pregnant patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE lot number: EW0183) via an unspecified route of administration, administered on the left arm on 07Sep2021 13:00 (at the age of 34-year-old) as dose 1, single for COVID-19 immunization. Medical history included PCOS and COVID-19 (prior vaccination). Concomitant medications included cetirizine hydrochloride (ZYRTEC [CETIRIZINE HYDROCHLORIDE]); and ascorbic acid, betacarotene, calcium sulfate, colecalciferol, cyanocobalamin, ferrous fumarate, folic acid, nicotinamide, pyridoxine hydrochloride, retinol acetate, riboflavin, thiamine mononitrate, tocopheryl acetate, zinc oxide (PRENATAL VITAMINS). The patient previously took claritin allergic and experienced known allergies. On 10Sep2021 12:00 the patient experienced 24 days of continuous cyclic symptoms that include: fatigued breathing, fatigued muscles as if not getting enough oxygen to head, trouble walking, trouble swallowing. Severe head pressure that turns into severe head pain. Pushes down into ear pressure eventually draining ears. Cool mint tingling in arms, coming and going of loss of touch, loss feeling in face, calves. Leg and eye twitches. Pelvic pain comes and goes. Bowel movements and vaginal discharge have a distinct chemical like odor. Striking random pains. No improvements, every day she have a slew of symptoms that won't go away. Room tilts to the left at times. Patient have not been able to return to work. The events resulted in Doctor or other healthcare professional office/clinic visit Emergency room/department or urgent care, Hospitalization for 1 day. No treatment received for the events. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient underwent lab tests and procedures which included Nasal Swab: negative on 12Sep2021. Outcome of the events was not recovered.; Sender's Comments: Based on the information in the case report and a plausible temporal relationship, a possible causal relationship between the reported events and suspect drug BNT162B2 cannot be excluded. The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to regulatory authorities, Ethics Committees, and Investigators, as appropriate.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Dyspnoea
Hospital-Tage: 1,0
Labordaten: Test Date: 20210912; Test Name: Nasal Swab; Test Result: Negative
Aktuelle Erkrankungen: -
Vorgeschichte: Medical History/Concurrent Conditions: COVID-19 (prior vaccination); Polycystic ovarian syndrome
Andere Medikamente: ZYRTEC [CETIRIZINE HYDROCHLORIDE]; PRENATAL VITAMINS [ASCORBIC ACID;BETACAROTENE;CALCIUM SULFATE;COLECALCIFEROL;CYANOCOBALAMIN;FERROUS
Allergien: -
Vorherige Impfungen: -

VAERS 1785685

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EW0183

moderat

Staat: AZ
Alter: 20,0
Geschlecht: M
Eingang: 14.10.2021
Impfdatum: 11.10.2021
Beginn: 12.10.2021
Tage bis Beginn: 1,0
Dosis: 3
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Hypoaesthesia Injection site hypoaesthesia Injection site paraesthesia Paraesthesia

Symptomtext

Pt c/o numbness and tingling at injection site with motion beginning next day. Symptoms last 1-2 seconds and at times travels down arm to wrist. Pt advised to take OTC nsaid as directed and apply cold compress 10 min several times a day if possible. Pt to follow with provider at clinic if no improvement or symptoms worsen.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Injection site paraesthesia
Hospital-Tage: -
Labordaten: None
Aktuelle Erkrankungen: None
Vorgeschichte: Anxiety/Depression
Andere Medikamente: Escitalopram 20 mg tab po daily
Allergien: PCN / Hives
Vorherige Impfungen: -

VAERS 1778873

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EW0183

moderat

Staat: -
Alter: 36,0
Geschlecht: F
Eingang: 12.10.2021
Impfdatum: 08.10.2021
Beginn: 08.10.2021
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Chest X-ray normal Chest pain Chills Dyspnoea Electrocardiogram normal Headache Oropharyngeal pain Pain

Symptomtext

Patient received her first Pfizer Covid vaccine on 10/8/21. Around 11 pm that evening she woke up with chills, body aches, a headache and a sore throat. The following day her body aches became more severe. She took Tylenol which helped with the pain. She did not check her temperature. On 10/9 she developed a substernal CP described as a burning in her chest which was constant at first and now comes and goes. She also has SOB at rest. She contacted the employee exposure line o 10/11 and was instructed to go to urgent care. At urgent care she had CXR and EKG was unremarkable. She was instructed to schedule a follow up with her cardiologist and follow up at urgent care on 10/15.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Chest pain
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1772099

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EW0183

moderat

Staat: AZ
Alter: 26,0
Geschlecht: F
Eingang: 08.10.2021
Impfdatum: 02.10.2021
Beginn: 03.10.2021
Tage bis Beginn: 1,0
Dosis: 3
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein

C-reactive protein Chest X-ray Chest pain Computerised tomogram thorax Echocardiogram Fatigue Fibrin D dimer Headache Pain Red blood cell sedimentation rate normal Troponin

Symptomtext

Chest pain, Body aches, headache, fatigue

Weitere VAERSDATA-Felder

Praegender Schweregrund: Chest pain
Hospital-Tage: -
Labordaten: CXR, Chest CT W/ and W/O, Echocardiogram, D-dimer, ESR, CRP, troponin panel
Aktuelle Erkrankungen: None
Vorgeschichte: None
Andere Medikamente: None
Allergien: None
Vorherige Impfungen: -

VAERS 1765495

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EW0183

moderat

Staat: CA
Alter: 69,0
Geschlecht: M
Eingang: 06.10.2021
Impfdatum: 22.08.2021
Beginn: 26.08.2021
Tage bis Beginn: 4,0
Dosis: 3
Route/Site: SYR / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein

Blood test Cognitive disorder Extra dose administered Fine motor skill dysfunction Full blood count Hypertension Hypoaesthesia Hyporesponsive to stimuli Nausea Neuropathy peripheral Pain Pain in extremity Paraesthesia Retching

Symptomtext

There were no immediate adverse events such as flu like symptoms, arrhythmia, breathing issues etc. We did notice that following his 3rd dose, his blood pressure was running high for the next number of weeks until as recent as 10/5. He has been taking medication and PRN benazepril for any reading with diastolic of 85 or systolic is 150 or higher. He has had to take these multiple times. Over this time starting on 9/30, because the pain in his legs were so severe, he was put on 25mg tramadol. It did not help so it went up to 50mg. It went up again to 75mg which caused nausea. He was taken off of tramadol. He is now on Zanaflex. His gabapentin has also been increased from 1500 to 1800mg. He is also experiencing progressively bad nausea. It started lightly and then gradually got to dry heaving and retching. We work with a mental cognition program for about 33 days straight. I have noticed over the last week that Norman's cognition has dropped a little. Also his response rate has decreased. His dexterity has also been affected in both hands. His finger in his right hand has tingling and numbness. His oncologist has stated this is some kind of neuropathy and can be unrelated to his cancer. She has even put this in writing. It leads to question if the vaccine could be linked to the pain he is experiencing.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Hypertension
Hospital-Tage: -
Labordaten: CBC; Blood Panel
Aktuelle Erkrankungen: No
Vorgeschichte: 8 years ago prostatectomy; Prostate cancer metastasized to all bones except forearm and arms
Andere Medikamente: Yes
Allergien: Sulfa; levofloxacin
Vorherige Impfungen: -

VAERS 1765237

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EW0183

moderat

Staat: NH
Alter: 44,0
Geschlecht: F
Eingang: 06.10.2021
Impfdatum: 06.05.2021
Beginn: 01.06.2021
Tage bis Beginn: 26,0
Dosis: 2
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein

Burning sensation Chest X-ray Dizziness Electrocardiogram Electroencephalogram Headache Heart rate increased Immune reconstitution inflammatory syndrome Magnetic resonance imaging head Magnetic resonance imaging neck Magnetic resonance imaging thoracic Muscle twitching Neuropathy peripheral Paraesthesia

Symptomtext

Diagnosed with post vaccine inflammatory syndrome Five months of chronic head pain/zaps, dizziness, peripheral neuropathy with tingling and burning, and twitching. rapid heart rate

Weitere VAERSDATA-Felder

Praegender Schweregrund: Paraesthesia
Hospital-Tage: -
Labordaten: MRI of brain, cervical (neck) and thoracic spine. EEG, EKG, chest x-ray
Aktuelle Erkrankungen: None
Vorgeschichte: None
Andere Medikamente: Vybrid 10 mlg
Allergien: Sulfa - slight allergy
Vorherige Impfungen: -

VAERS 1765039

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EW0183

moderat

Staat: TX
Alter: 30,0
Geschlecht: F
Eingang: 06.10.2021
Impfdatum: 06.10.2021
Beginn: 06.10.2021
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein

Dyspnoea Rales

Symptomtext

Patient was given the Pfizer Covid vaccine at 0938 and was placed to be observed. She started showing signs of SOB at 0950 and was placed in an Exam room. O2 was applied at 0953 at 2 L 911 was called at 0953 Patient was communicating and never lose conscious. HR 147, O2 stat was 97 Epi 0.3 ml given at 0955 RN and NP were in the room with me assisting. EMS arrived at 1002. O2 was increased and Nebulizer applied due to reported Rails in lungs Additional Epi was given by EMS 1010 patient said her brother was outside in the car. She produced her phone and found his number and Her Brother was called who was waiting outside the building and instructed that she was going to be taken to Medical Center and directions were given.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Dyspnoea
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: none noted
Vorgeschichte: history of seizures
Andere Medikamente: Keppra - weaning off
Allergien: flu vaccine, eggs, peanut, almond, Propofol, fentanyl
Vorherige Impfungen: flu

VAERS 1761844

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge ew0183

moderat

Staat: WA
Alter: 44,0
Geschlecht: F
Eingang: 05.10.2021
Impfdatum: 01.09.2021
Beginn: 07.09.2021
Tage bis Beginn: 6,0
Dosis: UNK
Route/Site: - / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt

Condition aggravated Local reaction Migraine Migraine without aura Peripheral swelling

Symptomtext

. Local reaction to COVID-19 vaccine 2. Migraine without aura and without status migrainosus, not intractable PLAN Imitrex/Benadryl/Phenergan in the emergency department. Supportive care regarding the vaccine reaction. Discharge Instructions There is no blood clot in the arm. This is a local reaction of the vaccine. It should get better with time. You can use Tylenol safely to the extent that you tolerate it. COURSE & MEDICAL DECISION MAKING 10: 53. Imitrex 6 subcu. Benadryl 50 mg IM. Phenergan 25 mg IM. CHIEF COMPLAINT Chief Complaint Patient presents with ? Arm Swelling is a 44 y.o. female who presents to the ED with swelling and pain in the right arm since receiving a Pfizer Covid vaccine in the right deltoid 1 week ago. The pain has been severe. No fevers or chills. The patient also has a recurrent migraine consistent with previous migraines and requests her usual cocktail for this.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Condition aggravated
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1761560

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EW0183

moderat

Staat: MN
Alter: 42,0
Geschlecht: M
Eingang: 05.10.2021
Impfdatum: 22.04.2021
Beginn: 04.10.2021
Tage bis Beginn: 165,0
Dosis: 2
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: unbekannt

Asymptomatic COVID-19 Condition aggravated Hallucination SARS-CoV-2 test positive

Symptomtext

ASYMPTOMATIC . ADMITTED FOR RECURRING HALLUCINATIONS

Weitere VAERSDATA-Felder

Praegender Schweregrund: Condition aggravated
Hospital-Tage: -
Labordaten: POSITIVE COVID TEST 10/4/21
Aktuelle Erkrankungen: ALCOHOL INTOXICATION, AUDITORY/VISUAL HALLUCINATIONS, HIGH BLOOD SUGAR 4/17/21
Vorgeschichte: Alcohol withdrawal delirium Paranoia Alcohol dependence with alcohol-induced anxiety disorder
Andere Medikamente: citalopram (CELEXA) 20 mg oral tablet insulin aspart, pen, (NOVOLOG) 100 units/mL SubQ pen insulin glargine, pen, (LANTUS) 100 unit/mL SubQ pen metFORMIN ER (GLUCOPHAGE XR) 500 mg oral extended release tablet 24 HR
Allergien: Cranberry Pcn [Penicillins]
Vorherige Impfungen: -

VAERS 1760002

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EW0183

moderat

Staat: PA
Alter: 54,0
Geschlecht: F
Eingang: 04.10.2021
Impfdatum: 01.10.2021
Beginn: 03.10.2021
Tage bis Beginn: 2,0
Dosis: 3
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Headache Injection site induration Injection site pain Injection site swelling Injection site warmth Lymphadenopathy Mobility decreased Pain Skin warm Tenderness

Symptomtext

I received the booster 10/1/2021 minor headache and aches 10/2/2021 but woke up 10/3/2021 massive lymphadenopathy under left arm size of baseball ready to explode and golf ball size in left supraclavicular so painful to touch could not move. used heat and advil to manage . Very red hot to touch as well as injection site hard swollen and hot. better little 10/4/2021 but still very tender and swollen. also filed incidence with work and seeing PCP tomorrow. I am an oncology nurse 35 years and never saw LN this large even with lymphoma.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Mobility decreased
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: none
Vorgeschichte: HTN, hashimotos
Andere Medikamente: Synthroid, zetia, norvasc, biotin, co-Q10
Allergien: sulfa and tetanus
Vorherige Impfungen: -

VAERS 1758907

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EW0183

moderat

Staat: VA
Alter: 60,0
Geschlecht: F
Eingang: 04.10.2021
Impfdatum: 01.10.2021
Beginn: 02.10.2021
Tage bis Beginn: 1,0
Dosis: 1
Route/Site: SYR / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein

Asthenopia Blood test normal Chest pain Dehydration Diarrhoea Head discomfort Headache Palpitations Pyrexia Vomiting

Symptomtext

The day of the shot I was fine, Friday 10/1. The very next day, 10/2 at 7am I began throwing up and diarrhea that didn't stop for 3 hours. I also had a fever of 100.4 along with extreme headache. My head felt like a watermelon and my eyes felt incredibly heavy/full. I had to go to the emergency room due to dehydration - that was aroun 10:15 am. I got an IV with anti-nausea. My fever of 100.4-100.5 persisted all night into the early morning hours of 10/3. I also experienced extreme heart pounding late on 10/2 and acute chest pain the evening of 10/3. I am still experiencing on/off fever and headache

Weitere VAERSDATA-Felder

Praegender Schweregrund: Chest pain
Hospital-Tage: -
Labordaten: they took a blood test to determine electrolyte level and kidney assessment due to the dehydration as a precaution. 10/3 all seemed fine
Aktuelle Erkrankungen: none
Vorgeschichte: None
Andere Medikamente: Synthroid, .50mg Lisinopril/Hctz 20-12.5mg
Allergien: Flexerill - muscle relaxer
Vorherige Impfungen: tetanus 2010 , age 50, extreme flu symptoms, high temperature, 2 days,

VAERS 1752079

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EW0183

moderat

Staat: CA
Alter: 26,0
Geschlecht: F
Eingang: 01.10.2021
Impfdatum: 12.08.2021
Beginn: 13.08.2021
Tage bis Beginn: 1,0
Dosis: 1
Route/Site: - / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Angina pectoris Axillary pain Breast pain Chest discomfort Chills Disorientation Dizziness Dysmenorrhoea Dyspnoea Fatigue Headache Heavy menstrual bleeding Intermenstrual bleeding Irritability Loss of personal independence in daily activities Lymphadenopathy Menstruation irregular Mental fatigue

Symptomtext

muscle tightness, especially in my chest, with a stabbing pain near my heart; fatigue/physical exhaustion; muscle aches; headache/long and random head pain; low-grade fever; minor chills; enhanced irritability; menstrual cycle became irregular, spotty, and abnormally painful, with two full periods in a month span of time and spotting in between; menstrual cycle became irregular, spotty, and abnormally painful, with two full periods in a month span of time and spotting in between; muscle tightness, especially in my chest, with a stabbing pain near my heart; muscle tightness, especially in my chest, with a stabbing pain near my heart; making it difficult to breath; I feel dizzy; disoriented like I forget where I am; I have swollen lymph nodes; my throat is constantly swollen; menstrual cycle became irregular, spotty, and abnormally painful, with two full periods in a month span of time and spotting in between; two full periods in a month span of time; mental and physical exhaustion; unable to perform job duties; stabbing pain near her heart, under arms and breasts; stabbing pain near her heart, under arms and breasts; This is a spontaneous report from a contactable consumer or other non HCP (Patient). A 26-year-old non pregnant female patient received bnt162b2 (BNT162B2 Formulation: Solution for injection), dose 1 via an unspecified route of administration, administered in Arm Left on 12Aug2021 at 13:00 (Batch/Lot Number: EW0183) as DOSE 1, SINGLE (at the age of 26-year-old) for covid-19 immunisation. The patient was not pregnant at the time of vaccination. The patient medical history and concomitant medications were not reported. It was unknown if prior to vaccination, the patient diagnosed with COVID-19 or not. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient received the vaccine 12Aug2021 and by the next morning (13Aug2021), the patient had began to experience typical side effects of fatigue/ physical exhaustion, muscle aches, headache/ long and random head pain, low-grade fever, minor chills, enhanced irritability, her menstrual cycle became irregular, spotty, and abnormally painful, with two full periods in a month span of time and spotting in between. The patient stated she worked out every day, but directly after receiving the vaccine, she consistently felt muscle tightness, especially in my chest, with a stabbing pain near her heart, under arms and breasts with no relief after working out or stretching. This tightness in chest worsens when she lay down, making it difficult to breath. On same day (13Aug2021), the patient experience daily fatigue, long and random head pain, and feel dizzy often and disoriented like she forget where she, swollen lymph nodes, throat was constantly swollen. It was reported she unable to perform job duties for extended periods of time from mental and physical exhaustion. Since the vaccination, the patient was not tested for COVID-19. No treatment received for the events. The outcome of events reported as not resolved. Follow-up attempts are completed. No further information is expected.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Dyspnoea
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1749607

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EW0183

moderat

Staat: MI
Alter: 46,0
Geschlecht: F
Eingang: 30.09.2021
Impfdatum: 13.08.2021
Beginn: 13.08.2021
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: SYR / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Hypoaesthesia Paraesthesia Paraesthesia oral Pharyngeal hypoaesthesia Pharyngeal swelling

Symptomtext

The first shot I immediately received tingling in my hands then within an hour the left side of my lips, tongue and throat became numb, and felt swollen as if I had lidocaine injection at the dentist. But only the left side. The numbness lasted about 36 hours with the first injection. It did not however effect my ability to swallow. With the second shot, my hands did not tingle but within 30m the left side of my lips, throat and tongue went numb and felt swollen as before but this time it also included my left cheek, my left nostril, a small portion of my left lower jaw, all the way over to my left ear, and my left ear. There was a spot on my cheek closest to my nose that went completely dead to the touch. Had a different, more intense numb feeling. The reaction lasted about 6 hours this time. It never effected my ability to swallow.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Paraesthesia
Hospital-Tage: -
Labordaten: none
Aktuelle Erkrankungen: none
Vorgeschichte: None
Andere Medikamente: Vit C, Vit D, Women's Multi Vitamin
Allergien: Sulfa, Strawberries
Vorherige Impfungen: -

VAERS 1742178

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EW0183

moderat

Staat: MI
Alter: 51,0
Geschlecht: F
Eingang: 28.09.2021
Impfdatum: 09.09.2021
Beginn: 10.09.2021
Tage bis Beginn: 1,0
Dosis: 1
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Arthralgia Axillary pain Back pain Blood test Bone pain Breast pain Ear pain Fatigue Groin pain Lymphadenopathy Muscle spasms Musculoskeletal chest pain Musculoskeletal pain Neck pain Oropharyngeal pain Pain in extremity Tinnitus

Symptomtext

Bilateral lymph node swelling and pain starting in armpit on 9/10/21 on vaccine side that continued to spread over the course of the week to breast; ribs; collar bone; neck; back/shoulder blades; ears; hips; groin; and extremities with calf pain/cramps; tinnitus in right ear; sore throat; and extreme fatigue. Above symptoms remained steady throughout the next week. At time of report- day 19- pain and/or swelling concentrated to opposite side groin; ears; throat; neck; and vaccine side arm, breast, armpit region. Fatigue continues. Palliative care at home: tylenol, ibuprofen, Epsom salt baths, topical pain relief ointments, and compresses. Communication with PCP. Appointment scheduled at 2 weeks without relief.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Musculoskeletal chest pain
Hospital-Tage: -
Labordaten: Contacted PCP at week 1 and 2 of symptoms. Appointment on 9/28/21. Blood work collected. Appointment scheduled for 10/7/21 to follow up after 2nd dose.
Aktuelle Erkrankungen: none
Vorgeschichte: none
Andere Medikamente: Vitamins
Allergien: Flu vaccine, sulfa, various beauty products, other meds.
Vorherige Impfungen: Flu vaccine- event reported to VAERS (approximately 2009). Neurological reaction to old Tetanus vaccine.

VAERS 1741437

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EW0183

moderat

Staat: MN
Alter: 56,0
Geschlecht: M
Eingang: 28.09.2021
Impfdatum: 06.05.2021
Beginn: 20.09.2021
Tage bis Beginn: 137,0
Dosis: 2
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein

Alcohol test Blood pressure increased C-reactive protein abnormal Chest pain Differential white blood cell count Full blood count Hypoaesthesia Inflammation Lipase Metabolic function test Paraesthesia Troponin I

Symptomtext

elevated blood pressure, numbness and tingling in left arm, chest pain, started on rivaroxaban

Weitere VAERSDATA-Felder

Praegender Schweregrund: Chest pain
Hospital-Tage: -
Labordaten: BLOOD ALCOHOL C-REACTIVE PROTEIN (INFLAMMATION) COMPREHENSIVE METABOLIC PANEL LAB ONLY-COMPLETE BLOOD COUNT WITH DIFFERENTIAL LIPASE TROPONIN I performed 2 times
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1740903

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EW0183

moderat

Staat: CO
Alter: 22,0
Geschlecht: M
Eingang: 28.09.2021
Impfdatum: 27.09.2021
Beginn: 27.09.2021
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Condition aggravated Hyperhidrosis Hypotonia Tremor

Symptomtext

Approximately 10 minutes after vaccination during post vaccination observation in lobby, patient's mother called for help and stated, "I think he's having a seizure." Patient appeared alert and oriented, seizure not observed by medical staff. Per mother, patient had a seizure at 4 months old where "he started shaking and went limp, and that's what happened today." Pt diaphoretic but otherwise well-appearing. Alert and oriented X3. Pt provided with juice and crackers; states he did not eat or drink very much on the day of vaccination. VS at 1451: O2 97%; HR 57bpm; RR 16; BP 127/83. VS at 1455: O2 95%; HR 68bpm; RR 18; BP 120/88. VS at 1500: O2 95%; HR 66bpm; RR 16; BP 110/77. After eating and drinking, pt reported feeling better. Patient offered option for EMS to be called; declined EMS. Advised to follow-up with primary care provider; verbalized understanding. Patient remained in observation for about 20 more minutes and left with parents.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Condition aggravated
Hospital-Tage: -
Labordaten: n/a
Aktuelle Erkrankungen: none reported
Vorgeschichte: Per mother who was present with patient, the patient has a history of seizures with first seizure occurring at 4 months old and last known seizure at 5 years old though patient may have had a seizure in 2018 where patient lost consciousness at work which resulted in a concussion though patient's mother unsure if seizure preceded loss of consciousness. No seizure disorder diagnosed, patient and mother unsure of what types of seizures patient has had.
Andere Medikamente: no medications reported
Allergien: no known allergies
Vorherige Impfungen: -

VAERS 1734488

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge ew0183

moderat

Staat: PA
Alter: 27,0
Geschlecht: F
Eingang: 25.09.2021
Impfdatum: 12.08.2021
Beginn: 16.08.2021
Tage bis Beginn: 4,0
Dosis: 1
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein

Blepharospasm Blood pressure increased Dizziness Electrocardiogram Hypertension Neurological examination Palpitations Vertigo

Symptomtext

palpitations, dizziness, vertigo, eye twitching, high blood pressure (150/100)

Weitere VAERSDATA-Felder

Praegender Schweregrund: Hypertension
Hospital-Tage: -
Labordaten: ekg, neurological exam, blood pressure reading
Aktuelle Erkrankungen: n/a
Vorgeschichte: n/a
Andere Medikamente: n/a
Allergien: sulfa drugs
Vorherige Impfungen: -

VAERS 1732840

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EW0183

moderat

Staat: NY
Alter: 54,0
Geschlecht: F
Eingang: 24.09.2021
Impfdatum: 11.05.2021
Beginn: 11.05.2021
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: SYR / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Arthralgia Arthritis Condition aggravated Joint stiffness Mobility decreased Myalgia Pyrexia Walking aid user

Symptomtext

I had fever, myalgia and arthralgia. Stiffness, inflammation on my right knee. I could not move from my bed for one week. I was using cane for two months. Right now, I am using a knee pad, and more ambulatory.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Condition aggravated
Hospital-Tage: -
Labordaten: Unfortunately, I visited my orthopedic doctor only on 06/10/2021, but he disregarded my symptoms and chief complaint as been related to covid vaccine and only treated me with medication and physical therapy.
Aktuelle Erkrankungen: I had a history of Knee pain derived from polio sequelae.
Vorgeschichte: I suffered polio at age 4, and it affected my mobility. I have lower extremity length discrepancy of 0.9 cm, left lower extremity being longer than the right according to an X-ray bone length study done on August 31, 2019.
Andere Medikamente: none
Allergien: no
Vorherige Impfungen: -

VAERS 1731744

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EW0183

moderat

Staat: NY
Alter: 73,0
Geschlecht: F
Eingang: 24.09.2021
Impfdatum: 21.05.2021
Beginn: 04.06.2021
Tage bis Beginn: 14,0
Dosis: 1
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Blood creatine phosphokinase Chest X-ray Computerised tomogram Differential white blood cell count Electrocardiogram Flat affect Full blood count Gait disturbance Imaging procedure Metabolic function test Speech disorder Tremor Troponin Urine analysis

Symptomtext

HANDS/ARMS/LEGS TREMORS, UNSTEADY GAIT, SPEECH IMPEDIMENT, FLATTENED AFFECT

Weitere VAERSDATA-Felder

Praegender Schweregrund: Tremor
Hospital-Tage: -
Labordaten: 9/11/21 AT HOSPITAL EMERGENCY DEPARTMENT ; BASIC METABOLIC PANEL, CBC AUTO DIFFERENTIAL, CK, HEPATIC FUNCTION PANEL, TROPONIN, URINALYSIS, IMAGING TESTS, CT BTAIN WO CONTRAST, ED EKG, 12LEAD, XR CHEST AP PORTABLE
Aktuelle Erkrankungen: NONE
Vorgeschichte: SEASONAL ALLERGY, STIFF NECK, STIFF SHOULDERS, LOWER BACK PAIN
Andere Medikamente: NONE
Allergien: SEASONAL ALLERGY ( POLLEN)
Vorherige Impfungen: -

VAERS 1731167

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge ew0183

moderat

Staat: PA
Alter: 55,0
Geschlecht: F
Eingang: 24.09.2021
Impfdatum: 22.09.2021
Beginn: 22.09.2021
Tage bis Beginn: 0,0
Dosis: 2
Route/Site: SYR / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Anxiety Chest discomfort Chest pain Chills Dysgeusia Fatigue Impaired work ability Jaw disorder Pain Pyrexia Tongue discomfort

Symptomtext

After vaccine exhaustion set in and fell asleep propped up. when woke up around 4-5 pm was not expecting to feel pressure/soreness in one spot under right breast at rib line. this made me feel anxious. i had let my primary care know i was getting vax today and asked for any input if i had any issues so i checked email and she said to ice area when i got home and take 2 excedrin extra strength and a .025 xanax. i did so and let her know the symptom. she said it can be normal to feel something on the same side of vaccine. i drank lots of fluids to point of having to relieve every 30 mins. i also noticed a fullness feeling in my right jaw but around the jowls area. after another nap i feel like there was a metallic taste in the base of tongue and it also felt full but was not swollen during early AM of 9/24 i awoke 4am? 5am? and felt hot assumed a fever but did not have thermometer so treated again with one extra strength tylenol and 1 excedrin. also felt chills. now 9am 9/24 i have aches and pains more broadly. i took my normal does of famotadine at 8:30 am and will monitor symptoms i am still fatigued and had to call out of work. i

Weitere VAERSDATA-Felder

Praegender Schweregrund: Chest pain
Hospital-Tage: -
Labordaten: none
Aktuelle Erkrankungen: on and off headaches
Vorgeschichte: migraine acid reflux anxiety with medical procedures and dentist
Andere Medikamente: famotadine as needed but only after the vax excedrin migraine viramin d vitamin c zince
Allergien: seasonal allergies augmenting most antibodies i get a reaction
Vorherige Impfungen: -

VAERS 1731140

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge Ew0183

moderat

Staat: MI
Alter: 56,0
Geschlecht: F
Eingang: 24.09.2021
Impfdatum: 23.08.2021
Beginn: 01.09.2021
Tage bis Beginn: 9,0
Dosis: UNK
Route/Site: SYR / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Dyspnoea Palpitations

Symptomtext

Pounding and rushing of heart has been ongoing in the weeks after I got the shot. Feels like my heart is too big for my chest cavity. A little shortness of breath.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Dyspnoea
Hospital-Tage: -
Labordaten: Haven't gone to the doc for it. Hoping it would go away. Will call to make appointment.
Aktuelle Erkrankungen: None
Vorgeschichte: Heel spurs, plantar fascists [autocorrect won't let me fix that spelling], general tendency for tendinitis [elbow, Achilles, shoulder, etc.]
Andere Medikamente: I had used birth control as a hormone/menopause management med until June 2021. Use ibuprofen once a day for foot pain.
Allergien: Penicillin Raw onions and heavy garlic in any form really bother my mouth and stomach.
Vorherige Impfungen: -

VAERS 1727420

UNKNOWN MANUFACTURER · VACCINE NOT SPECIFIED (NO BRAND NAME) · Charge EW0183

moderat

Staat: NC
Alter: 27,0
Geschlecht: M
Eingang: 23.09.2021
Impfdatum: 25.08.2021
Beginn: 01.09.2021
Tage bis Beginn: 7,0
Dosis: 1
Route/Site: SYR / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein

Axillary pain Back pain Chest pain Dyspnoea Feeling cold Pain Painful respiration Pyrexia

Symptomtext

Pt. is 27 yo presenting with substernal, pressing chest pain radiating to L axilla and back, worse with running and associated with shortness of breath. Also worse with deep breathing, post eating, and worse at night (laying on the bed). Some subjective F/C but non-febrile in clinic. EKG abnormalities noted in clinic. Pt. sent to the ER for further lab/work-up and referred to Cardiology with concern for pericarditis. Symptoms began 1wk s/p 1st vaccination, peaked at 2wk post, and then improved. After 2nd vaccination Pt. noted worse symptoms and SOB with CP during morning run with unit. Pt. presented to the clinic the following day.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Chest pain
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: None
Vorgeschichte: None
Andere Medikamente: Ibuprofen, Triamcinolone topical, Valacyclovir
Allergien: None
Vorherige Impfungen: -

VAERS 1722505

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EW0183

moderat

Staat: ME
Alter: 60,0
Geschlecht: F
Eingang: 22.09.2021
Impfdatum: 23.08.2021
Beginn: 23.08.2021
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Migraine Vision blurred

Symptomtext

Migraine headache and blurry vision.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Migraine
Hospital-Tage: -
Labordaten: None
Aktuelle Erkrankungen: None
Vorgeschichte: None
Andere Medikamente: Vericare 5mg PO daily
Allergien: NKDA
Vorherige Impfungen: -

VAERS 1721948

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EW0183

moderat

Staat: IL
Alter: 83,0
Geschlecht: F
Eingang: 22.09.2021
Impfdatum: 26.05.2021
Beginn: 26.05.2021
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: - / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: nein

Blister Burning sensation Chest pain Erythema Herpes zoster Neuralgia Pruritus Rash

Symptomtext

She had red blisters and pain; She had red blisters and pain/it was nerve pain; Chest pain; Shingles; Rash scalp, neck and shoulders; It still itches and burns/itching and burning; Her neck was red and rashy; It still itches and burns/neck was itching/itching and burning/her scalph was itching; it is also right across the top of her shoulders and she is pretty sure it is on her scalp because it is itching; This is a spontaneous report from a contactable consumer (patient). A 83-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Lot Number: EW0183), via an unspecified route of administration on 26May2021 (at the age of 83-year-old), as dose 1, single in left arm for COVID-19 immunization at hospital. The patient's medical history included blood pressure high from 2 years, takes blood pressure by her own and was never normal, 185 over sometimes; had colon cancer two years ago and had surgery but did not take chemo; 20 years ago, she got an autoimmune disorder and lost weight after surgery for colon cancer and has not been able to get over 100 pounds. The patient's past drugs included prednisone; Methotrexate but took them only for a couple of years and had reaction to a codeine product. Concomitant medications included Lisinopril twice daily for two years taken for high blood pressure for two years and Amlodipine added three weeks ago for high blood pressure; start and stop dates were not reported. Patient did not take any other vaccines within 4 weeks after COVID vaccine. On 26May2021, after first dose of vaccine, at night, the patient experienced rash on scalp, neck and shoulders. After vaccination, patient came home and that night after she went to bed, she noticed her neck was itching, she got up and her neck was red and rashy, itching and burning, like a bad sunburn. Patient still had rash four months later. Patient had seen three different doctors; two put her on prednisone; she took two courses of prednisone; and they gave her a prescription for a cream for itching and burning every day. Doctor told her not to get the second dose because she has had a bad reaction and he didn't know what would happen; he doesn't know if it was an allergic reaction. Patient had itches and burns. On an unspecified date in Jun2021, about three weeks or a month after the first dose of the vaccination, she got shingles. Patient never had them before and had to go to the ER to find out why she was in such pain. Doctor explained it was nerve pain. She was in the hospital for about four days from unspecified date in Jun2021 to an unspecified date in Jun2021, for shingles. When she went to the emergency room, she had chest pain and had to admit her to find out exactly what was happening. She was in the hospital about four days but doesn't remember the exact dates. Doctor prescribed prednisone; seven days' supply. She got it and took it exactly as he said and nothing happened, so she called a different doctor who prescribed prednisone again and she took it again. She was also prescribed a cream that did nothing. Now she was doing nothing about it. The doctor at the hospital gave her an antiviral medication for the shingles; she got it twice and it didn't help. Provided the second bottle acyclovir 800mg; one five times daily; prior to that they gave her the same thing, but it was two, three times a day. The shingles are down below the rash a couple of inches, on the right side of her chest and right side of her back and under her right arm and down to the elbow on the right arm. The only cream that kind of helped a little is aspercreme. She can't remember the names of the numbing creams she tried and can't find them. Patient doesn't have any test results from the hospital. The clinical outcome of events shingles; rash scalp, neck and shoulders; it still itches and burns/itching and burning/ her scalp was itching; it is also right across the top of her shoulders and she is pretty sure it is on her scalp because it is itching was not resolved. The clinical outcome of all other events was unknown. Follow-up attempts are completed. No further information is expected.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Chest pain
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: Medical History/Concurrent Conditions: Autoimmune disorder (Verbatim: 20 years ago she got an autoimmune disorder); Blood pressure high (from two years; she takes her own blood pressure and it is never normal; sometime 185 over something); Colon cancer (from two years ago and had surgery but did not take chemo); Lost weight; Surgery
Andere Medikamente: LISINOPRIL; AMLODIPINE
Allergien: -
Vorherige Impfungen: -

VAERS 1719416

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EW0183

moderat

Staat: CA
Alter: 57,0
Geschlecht: F
Eingang: 21.09.2021
Impfdatum: 31.08.2021
Beginn: 31.08.2021
Tage bis Beginn: 0,0
Dosis: UNK
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Computerised tomogram head Dizziness Headache Hypertension Immediate post-injection reaction Impaired work ability Laboratory test Nausea Vision blurred

Symptomtext

Dizziness, hypertensive immediately after vaccine. By. 9/20/21 pt has been having ongoing headaches, dizziness, blurred vision, nausea, difficulty performing well at work

Weitere VAERSDATA-Felder

Praegender Schweregrund: Hypertension
Hospital-Tage: -
Labordaten: labs /head CT done 9/15/21
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1718970

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EW0183

moderat

Staat: IL
Alter: 37,0
Geschlecht: M
Eingang: 21.09.2021
Impfdatum: 31.08.2021
Beginn: 31.08.2021
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: SYR / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Dyspnoea Headache Nausea Paraesthesia

Symptomtext

1.) Headaches 2.) Nausea 3.) Tingling sensation equivalent to when your hand/arm etc falls asleep in both my legs and the left side of my face. 4.) Occasional feeling of being short of breath - noticeable when I speak for an extended period. The tingling sensation lasted less than 24 hours. Nausea and headaches persisted for the better part of a week (5 days roughly). The feeling of being short of breath still happens now and again, but I only really notice it if I am speaking for a prolonged period.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Dyspnoea
Hospital-Tage: -
Labordaten: I had a thorough physical conducted prior to receiving the first dose the same day - 31 August. I was informed by my primary care that I was perfectly healthy, and had no cause for concern of suffering severe side effects.
Aktuelle Erkrankungen: None
Vorgeschichte: Recently diagnosed with elevated cholesterol and Hypothyroidism
Andere Medikamente: Thyroid medication, Ibuprofen, Vitamin D supplements
Allergien: Prone to medicinal side effects
Vorherige Impfungen: -

VAERS 1718930

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EW0183

moderat

Staat: NC
Alter: 15,0
Geschlecht: M
Eingang: 21.09.2021
Impfdatum: 17.09.2021
Beginn: 17.09.2021
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: ja

Back pain Chest pain Musculoskeletal chest pain Pain in extremity Urticaria

Symptomtext

Patient was given the first dose of Pfizer vaccine in left deltoid. Approximately 10 minutes into his observation period he started complaining of pain in his ribs, head, chest and back. Vitals were checked by on site nurse and EMS was called. EMS arrived and upon their examination they found he had hives on his back. EMS transported to Hospital

Weitere VAERSDATA-Felder

Praegender Schweregrund: Chest pain
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: None reported
Vorgeschichte: None reported
Andere Medikamente: None reported
Allergien: None reported
Vorherige Impfungen: -

VAERS 1718849

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EW0183

moderat

Staat: KY
Alter: 37,0
Geschlecht: F
Eingang: 21.09.2021
Impfdatum: 16.09.2021
Beginn: 01.09.2021
Tage bis Beginn: -
Dosis: 2
Route/Site: SYR / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Arthralgia Condition aggravated Hypoacusis Mobility decreased Tinnitus

Symptomtext

Next morning, 09/17/2021, woke up with all over joint pain that caused difficulty in moving, tinnitus worsening, and additional difficulty in hearing. I had to turn up my hearing aid volume in order to hear clearly and understand conversation. The joint pain started easing by the 2nd day, 09/18/2021, and was completely gone by the 3rd day, 09/20/2021. Tinnitus and increase hearing trouble has not changed.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Condition aggravated
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: Vitamin D deficiency
Vorgeschichte: Allergies (year-round seasonal), allergy-induced asthma, Hashimoto's thyroiditis (thyroid is functioning; synthroid not need at this time), osteo- and rheumatoid arthritis, bilateral sensorineural hearing loss and tinnitus, calcification of tendon in left shoulder with minute tear in said tendon
Andere Medikamente: Advair diskus (generic) - as needed for asthma flare-ups, taken 1/ daily during these periods; OTC allergy medicine (generic Claritin or Zyrtec) - 1/ daily; albuterol inhaler - emergency use; Spring Valley Immunity Plus - 2 gummies 1/ daily
Allergien: bleu cheese, penicillins, erthtomycin base, latex, azithromycin, trichophyton
Vorherige Impfungen: -

VAERS 1716772

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EW0183

moderat

Staat: GA
Alter: 29,0
Geschlecht: F
Eingang: 20.09.2021
Impfdatum: 03.09.2021
Beginn: 03.09.2021
Tage bis Beginn: 0,0
Dosis: UNK
Route/Site: SYR / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Anxiety Asthenia Dizziness Dyspnoea Fatigue Headache Hypoaesthesia Nightmare Palpitations Paraesthesia

Symptomtext

Within a few hours, I had a sudden onset of dizziness, weakness throughout body, with the feeling I could tip over and pass out with each step. Throughout the night and two two days following I experienced the same symptoms noted above along with additional headache, heart racing, Arm/hand numbness and tingling and nightmares at bedtime. Since my vaccine date to date, I still am having off and on numbness in my hands, severe anxiety, dizziness, breathlessneth, nightmares at night, and extreme fatigue and weakness that comes and goes suddenly. Sometimes the symptoms improve with rest, but within hours my body feels very weak. I?m still having nightmares every night since the day of vaccine.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Dyspnoea
Hospital-Tage: -
Labordaten: None
Aktuelle Erkrankungen: None.
Vorgeschichte: Tourette?s Syndrome, High Blood Pressure, Hypothyroidism, Degenerative Disc disease, Anxiety.
Andere Medikamente: Risperdal, Ativan, Levothyroxine, Lisinopril, Hydrochlorathyaxide, LarinnFe, Vitamin D Supplements, Ibprofen.
Allergien: Amlodipine
Vorherige Impfungen: -

VAERS 1715906

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EW0183

moderat

Staat: CA
Alter: 43,0
Geschlecht: F
Eingang: 20.09.2021
Impfdatum: 10.06.2021
Beginn: 27.08.2021
Tage bis Beginn: 78,0
Dosis: 2
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Asthma COVID-19 Condition aggravated Cough Dysphagia Dyspnoea Pharyngeal swelling SARS-CoV-2 test positive

Symptomtext

08/29/2021 went in for treatment. Got sick though it was her Asthma condition. Through was swollen in size was not able to swallow, was very painful cough and hard time catching her breath and asthma inhaler was not working, so she went in for testing. 08/31/2021 received the COVID positive results. They gave her a stripe test. They gave prescription to pick up and was given dexamethasone a steroid. Patient fog. 8 Benzonatate 100mg for coughing, monoclonal antibodies infusion from the ER, 8 pills of hydrocodone for pain, Zofran for nausea, and inhaler three times a day.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Condition aggravated
Hospital-Tage: -
Labordaten: Testing PCR test was taken.
Aktuelle Erkrankungen: -
Vorgeschichte: Asthma; NAF Liver Disease; Diverticulosis; GI issues
Andere Medikamente: No medication
Allergien: Aspirin; Penicillin
Vorherige Impfungen: -

VAERS 1715813

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EW0183

moderat

Staat: CA
Alter: 36,0
Geschlecht: F
Eingang: 20.09.2021
Impfdatum: 20.08.2021
Beginn: 26.08.2021
Tage bis Beginn: 6,0
Dosis: 2
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein

Decreased appetite Dizziness Feeling hot Loss of personal independence in daily activities Migraine

Symptomtext

face was hot, dizziness, loss of appetite, light headed and having horrible migraines has been affecting everyday routine

Weitere VAERSDATA-Felder

Praegender Schweregrund: Migraine
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: no
Vorgeschichte: no
Andere Medikamente: descovy
Allergien: penicillin
Vorherige Impfungen: -

VAERS 1715801

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge Ew0183

moderat

Staat: NY
Alter: 46,0
Geschlecht: M
Eingang: 20.09.2021
Impfdatum: 01.05.2021
Beginn: 01.06.2021
Tage bis Beginn: 31,0
Dosis: 2
Route/Site: SYR / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Cardiac flutter Chest discomfort Headache Palpitations

Symptomtext

Heart flutter/palpitations Chest tightness Headaches

Weitere VAERSDATA-Felder

Praegender Schweregrund: Palpitations
Hospital-Tage: -
Labordaten: None
Aktuelle Erkrankungen: None
Vorgeschichte: None
Andere Medikamente: None
Allergien: None
Vorherige Impfungen: -

VAERS 1715673

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge ew0183

moderat

Staat: WA
Alter: 51,0
Geschlecht: M
Eingang: 20.09.2021
Impfdatum: 10.08.2021
Beginn: 10.08.2021
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: SYR / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Confusional state Fatigue Heart rate irregular Hypoaesthesia Impaired driving ability Impaired work ability Paraesthesia

Symptomtext

I had a variety of symptoms after receiving the first dose of the Pfizer vaccine. In total, these lasted for three weeks, and I was unable to work for one week. Most seriously, I felt a very irregular heartbeat the evening after the vaccine injection. This started about four hours after the injection, and lasted two hours. Although I fortunately did not need to go to the hospital, I was considering it and I would have had to do so urgently if it had become any worse. The other symptoms included: Numb and tingling feet, which started almost immediately after the injection and lasted for three days. Mental confusion, which made driving difficult and somewhat dangerous. This started about 30 minutes after the injection, and it lasted on and off for two weeks. It became somewhat difficult to get food, because I was avoiding driving. Fatigue. This lasted about three weeks, and it was especially bad for the first 10 days. On two days, I was so tired that I had to stay in bed most of the day and slept. In conclusion, before having the Pfizer vaccine, I felt fine and I had no illnesses. I am in otherwise good health and I do not take any prescriptions. After the vaccine, I was really quite sick for two weeks.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Paraesthesia
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: None
Vorgeschichte: None
Andere Medikamente: None
Allergien: Possibly penicillin
Vorherige Impfungen: -

VAERS 1709680

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge ew0183

moderat

Staat: TX
Alter: 24,0
Geschlecht: F
Eingang: 17.09.2021
Impfdatum: 02.09.2021
Beginn: 06.09.2021
Tage bis Beginn: 4,0
Dosis: 1
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Arthralgia Back pain Chest pain Chills Cough Fatigue Headache Hyperacusis Hypersomnia Oropharyngeal pain Rhinorrhoea SARS-CoV-2 test negative Sinusitis Streptococcus test negative

Symptomtext

Woke up on 9/6/2021 with sore throat, headache, sound sensitivity, chills, runny nose. Contacted AF nurse health line, advised to get tested for Covid. Tested negative. Advised to go to where tested negative for strep and given Augmentin EQ 875 mg and BromPhen/PSE/DM. Developed lower back and chest pain, which migrated up into upper back and then into sternum over next 2 days. Main symptoms continued for 4 days, accompanied by joint pain. Coughing and headache finally fading today, 11 days later. Fatigued; sleeping 10+ hours a night since shot.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Chest pain
Hospital-Tage: -
Labordaten: COVID test (negative) 9/7/2021 Strep test (negative) 9/7/2021 Dx: Sinusitis, even though patient declared vaccination
Aktuelle Erkrankungen: None
Vorgeschichte: None
Andere Medikamente: Glutathione, Quercetin, Resveratrol/Curcumin
Allergien: None known
Vorherige Impfungen: -

VAERS 1708489

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EW0183

moderat

Staat: CT
Alter: 26,0
Geschlecht: F
Eingang: 17.09.2021
Impfdatum: 14.06.2021
Beginn: 14.06.2021
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: SYR / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein

Aphasia Chest X-ray normal Chest discomfort Chest pain Costochondritis Decreased appetite Diarrhoea Dizziness Electrocardiogram Fatigue Fibrin D dimer normal Gait disturbance Immediate post-injection reaction Muscular weakness Nausea Painful respiration Photophobia Platelet count increased

Symptomtext

Patient immediately felt dizzy and shaky upon receiving the first injection. About 30-40 minutes after injection the patient started experiencing chest tightness, severe chest pain, a thunder clap headache and extreme fatigue. Patient also experienced whole body muscle weakness, it was extremely difficult to move or talk. After sleeping for several hours the patient was still experiencing severe chest pain and chest tightness, experiencing pain while breathing and was taken to the Emergency Room for evaluation. At the ER an EKG was done, it was abnormal due to sinus tachycardia. A chest x-ray was clean and blood work was normal. Further testing was done by the patient's Rheumatologist/Allergist/Internist, blood work taken on July 1 included: C-reactive protein, SED levels, CBC, folate, tryptase, SARS COV 2 AN (IGG) Spike, carnitine, and EBV antibody panel. Covid antibody level was 11.78 U (Quest). C-reactive protein and SED rate were normal, EBV panel showed a continued EBV reactivation EBV (VCA) IGG was 398H and EBV (EBNA) IGG was 461H (original EBV reactivation occurred with covid infection in March 2020). Platelet count was 406H, spike in white blood cell count (still in normal range but high end of the scale).

Weitere VAERSDATA-Felder

Praegender Schweregrund: Chest pain
Hospital-Tage: -
Labordaten: At the ER an EKG was done, it was abnormal due to sinus tachycardia. A chest x-ray was clean and blood work was normal. Further testing was done by the patient's Rheumatologist/Allergist/Internist blood work taken on July 1 included: C-reactive protein, SED levels, CBC, folate, tryptase, SARS COV 2 AN (IGG) Spike, carnitine, and EBV antibody panel. Covid antibody level was 11.78 U (Quest). C-reactive protein and SED rate were normal, EBV panel showed a continued EBV reactivation EBV (VCA) IGG was 398H and EBV (EBNA) IGG was 461H (original EBV reactivation occurred with covid infection in March 2020). Platelet count was 406H, spike in white blood cell count (still in normal range but high end of the scale). D-Dimer was normal. Patient continued to experience regular tachycardia and was prescribed Propranolol to manage symptoms and still needs to take the beta blocker twice daily. Dr diagnosed costochondritis, and said the patient did not have an allergic reaction to the vaccine. 10 days of low dose steroids did not improve symptoms. After 3 months patient is still experiencing fatigue, tachycardia, severe chest pain, severe daily migraines and weekly thunder clap headaches, severe GI upset (daily diarrhea, nausea and loss of appetite), phantom peripheral movement and light sensitivity.
Aktuelle Erkrankungen: n/a
Vorgeschichte: Asthma (diagnosed age 5) Vasovagal syncope (diagnosed age 9) Anorexia (since age 12) Hashimoto's Thyroiditis (started Synthroid in June 2020) Long Haul Covid (PCAS) (since infection March 2020) Fibromyalgia (diagnosed March 2021) POTS (diagnosed March 2021)
Andere Medikamente: Zyrtec, pepcid, benadryl, quercetin, Vitamin A, Vitamin D, Folic acid, naturopathic allergy spray
Allergien: Gabapentin, wheat, gluten
Vorherige Impfungen: -

VAERS 1704367

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EW0183

moderat

Staat: TX
Alter: 65,0
Geschlecht: F
Eingang: 16.09.2021
Impfdatum: 11.06.2021
Beginn: 11.06.2021
Tage bis Beginn: 0,0
Dosis: 3
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Chest discomfort Paraesthesia Vision blurred

Symptomtext

CHEST TIGHTNESS, GAVE HISTORY OF ANXIETY ATTACKS. AFTER A FEW MINUTES COMPLAINED OF BLURRED VISIONAND GENERALIZE TINGLING. EMS CALLED AT HER REQUEST, EVALUATION WNL AND SHE WAS ALLOWED TO GO HOME ON HER OWN.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Paraesthesia
Hospital-Tage: -
Labordaten: NA
Aktuelle Erkrankungen: NOT REPORTED
Vorgeschichte: NOT REPORTED
Andere Medikamente: NOT REPORTED
Allergien: NKA
Vorherige Impfungen: -

VAERS 1659490

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EW0183

moderat

Staat: MI
Alter: 41,0
Geschlecht: F
Eingang: 15.09.2021
Impfdatum: 14.08.2021
Beginn: 30.08.2021
Tage bis Beginn: 16,0
Dosis: 1
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Back pain Coordination abnormal Headache Hypoaesthesia Muscular weakness Fatigue Neuropathy peripheral Neck pain Paraesthesia

Symptomtext

Only information available is that reported by patient on a survey following vaccination. Survey response submitted on 9.8.21. (no other information in electronic health record) ADVERSE REACTION WHICH REACTION Numbness and tingling;Other ADVERSE REACTION OTHER neuropathy of the brachial plexus - severe head/neck/back pain with left arm weakness, incoordination of hand and numbness and tingling of forearm. PCP agreed neuropathy - was treated with steroids and improved with steroids, but is still present.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Paraesthesia
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: NA
Vorgeschichte: NA
Andere Medikamente: MONO-LINYAH 0.25-35 MG-MCG per tablet predniSONE (DELTASONE) 10 MG tablet
Allergien: NA
Vorherige Impfungen: -

VAERS 1693738

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EW0183

moderat

Staat: -
Alter: -
Geschlecht: U
Eingang: 12.09.2021
Impfdatum: -
Beginn: -
Tage bis Beginn: -
Dosis: 1
Route/Site: SYR / LA

Tod: unbekannt Lebensbedrohlich: ja Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Asthenia Dizziness Dyspnoea Heart rate increased Hypertension Pharyngeal swelling

Symptomtext

Throat swelling shut, difficulty breathing , rapid heart rate, hypertension, dizziness, weakness

Weitere VAERSDATA-Felder

Praegender Schweregrund: Dyspnoea
Hospital-Tage: -
Labordaten: None
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: MMR

VAERS 1693016

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EW0183

moderat

Staat: NJ
Alter: 57,0
Geschlecht: M
Eingang: 11.09.2021
Impfdatum: 09.06.2021
Beginn: 16.06.2021
Tage bis Beginn: 7,0
Dosis: 2
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Cardiac flutter Chest discomfort Chest pain Fatigue Hyperhidrosis Stress echocardiogram Swelling

Symptomtext

On about 6/16/2021, when I got up at about 6:00 AM, I noticed that I felt a pressure and rapid fluttering in my chest. Ever since then, I have continued to feel the pressure and fluttering. It feels rather achy, sort of like I have a bruise in that area. The feeling is uncomfortable and causes me to toss and turn in bed and awaken early in the morning. I have also experienced extreme fatigue and sweating. My head seems to have also swollen, because caps now feel tighter and I sweat whenever I wear them. Caps are so uncomfortable now that I either have to loosen them or else take them off. I went to see my cardiologist, in July 2021. I told him about the chest pressure and fluttering, and he scheduled me to undergo a stress echocardiogram with treadmill in August 2021. I underwent the test, and Dr. said afterwards that he would have liked to see my heartrate achieved to a higher level on the treadmill. Dr. has scheduled me to undergo a carotid ultrasound on 9/30/2021

Weitere VAERSDATA-Felder

Praegender Schweregrund: Chest pain
Hospital-Tage: -
Labordaten: In August 2021 (day unknown), I underwent a stress echocardiogram with treadmill.
Aktuelle Erkrankungen: None.
Vorgeschichte: Hypertension, a history of non-Hodgkin's lymphoma.
Andere Medikamente: Atenolol, amlodipine, pantoprazole, clonazepam.
Allergien: Pollen, grass, dust, trees.
Vorherige Impfungen: -

VAERS 1692226

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge ew0183

moderat

Staat: -
Alter: -
Geschlecht: F
Eingang: 11.09.2021
Impfdatum: -
Beginn: -
Tage bis Beginn: -
Dosis: UNK
Route/Site: - / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Angina pectoris Arthralgia Arthritis Body temperature Diarrhoea Fatigue Lymphadenopathy Myalgia Neck pain Pain in extremity Palpitations Pyrexia

Symptomtext

heart pain; Fever 100.9; (L) arm pain down to fingers and back up to shoulder and neck; (L) arm pain down to fingers and back up to shoulder and neck; (L) arm pain down to fingers and back up to shoulder and neck; Increased (L) lymph node, grape size; Muscle aches; fatigue; diarrhea; Chest palpitations; Arthritis flare; This is a spontaneous report from a non-contactable consumer (patient). A 53-year-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE), via an unspecified route of administration on an unspecified date (Lot Number: ew0183) as dose number unknown, single for COVID-19 immunisation. The patient's medical history and concomitant medications were not reported. The patient experienced fever 100.9, left (L) arm pain down to fingers and back up to shoulder and neck. Increased (L) lymph node, grape size. Called PCP and was told to see a surgeon for removal. Muscle aches, fatigue, diarrhea, heart pain, chest palpitations, arthritis flare. The patient had not COVID and she was non COVID tested post vaccination. The outcome of events was unknown. No follow-up attempts are possible. No further information is expected.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Palpitations
Hospital-Tage: -
Labordaten: Test Name: Fever; Result Unstructured Data: Test Result:100.9
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1689680

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EW0183

moderat

Staat: -
Alter: 44,0
Geschlecht: F
Eingang: 10.09.2021
Impfdatum: 10.09.2021
Beginn: 10.09.2021
Tage bis Beginn: 0,0
Dosis: UNK
Route/Site: IM / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein

Arthralgia Feeling abnormal Injection site hypoaesthesia Injection site paraesthesia Pain in extremity

Symptomtext

L Arm is numb and tingly from injection site (L deltoid) down into finger tips. Pain in elbow/hand/fingers. "Just feels weird"

Weitere VAERSDATA-Felder

Praegender Schweregrund: Injection site paraesthesia
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1689651

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EW0183

moderat

Staat: NC
Alter: 66,0
Geschlecht: M
Eingang: 10.09.2021
Impfdatum: 23.08.2021
Beginn: 28.08.2021
Tage bis Beginn: 5,0
Dosis: 1
Route/Site: SYR / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Body temperature decreased Chills Condition aggravated Gout

Symptomtext

For the first 4-5 days was okay and one of days I felt my temperature go down. I felt chilled and then I got a small case gout I got it in my right toes and a few fingers on my right and when I have gotten it in the past it was always on my left side and at first it was mild then it was got worse and the worse case of gout I have ever had. I used to get gout when I drank beer, I haven't have gout in over a decade. I would say I have 95% recovered

Weitere VAERSDATA-Felder

Praegender Schweregrund: Condition aggravated
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: high blood pressure, low grade diabetes , gout
Andere Medikamente: hydrochlorothiazide 25 mg, Tamsulosin 4mg, amlodipine 10 mg, over counter folic acid, multi vitamin High blood Pressure
Allergien: -
Vorherige Impfungen: -

VAERS 1689010

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EW0183

moderat

Staat: IL
Alter: 36,0
Geschlecht: F
Eingang: 10.09.2021
Impfdatum: 23.08.2021
Beginn: 27.08.2021
Tage bis Beginn: 4,0
Dosis: 1
Route/Site: SYR / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Chest X-ray Chest pain Dizziness Dyspnoea Electrocardiogram Full blood count Headache Paraesthesia Rash

Symptomtext

rash on left arm, shortness of breath, tingling in chest, pain in chest, dizziness, headache

Weitere VAERSDATA-Felder

Praegender Schweregrund: Chest pain
Hospital-Tage: -
Labordaten: sought medical treatment on 9/9/21 because symptoms were still present. Had CBC, EKG, and chest xray performed. Awaiting results.
Aktuelle Erkrankungen: none
Vorgeschichte: none
Andere Medikamente: none
Allergien: none
Vorherige Impfungen: -

VAERS 1685370

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge ew0183

moderat

Staat: PA
Alter: 32,0
Geschlecht: F
Eingang: 09.09.2021
Impfdatum: 07.08.2021
Beginn: 07.08.2021
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Injection site swelling Pain in extremity Paraesthesia Peripheral swelling

Symptomtext

patient experienced tingling and swelling on the injection arm after she got home. Pain in arm and swelling from the injection site to the index finger. she came for her 2nd dose on 09/07/2021, was given benadryl before receiving 2nd dose.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Paraesthesia
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: n/a
Vorgeschichte: n/a
Andere Medikamente: n/a
Allergien: n/a
Vorherige Impfungen: -

VAERS 1682873

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EW0183

moderat

Staat: MI
Alter: 17,0
Geschlecht: M
Eingang: 08.09.2021
Impfdatum: 31.08.2021
Beginn: 03.09.2021
Tage bis Beginn: 3,0
Dosis: 2
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: nein

Arthralgia Back pain C-reactive protein increased Cardiac telemetry Chest X-ray normal Chest pain Chills Echocardiogram normal Electrocardiogram normal Fibrin D dimer normal Full blood count normal Headache Hyperhidrosis Metabolic function test normal Monocyte count increased Muscle tightness Myocardial necrosis marker Pain

Symptomtext

Pt received the second COVID shot on 8/31/21. On 9/1/21 he developed a headache, body aches, chills, and a low grade fever. On 9/3/21 he developed dull sternal chest pain that radiated to the center of his back, neck tightness, and bilateral shoulder pain around noon. He was also pale and diaphoretic. Mom called the PCP after these symptoms started. PCP directed mom to take pt to the ED. He was taken to Hospital Emergency Room on 9/3/21. Chest pain resoled on its own before pt arrived in the ED, according to the ED report. In the ED labs were drawn, EKG, and Chest Xray were completed. Pt was admitted to cardiology in stable condition for an echocardiogram in observation as well as to trend his cardiac enzymes. Pt was monitored overnight via telemetry. Echocardiogram was completed on 9/4/21. Two repeat Troponin levels were drawn the morning of 9/4/21, 6 hrs apart from one another. Pt was discharged home due to a normal echocardiogram and asymptomatic status. Pt has a follow up appointment with Cardiology on 9/9/21. Cardiology will do another echo and draw another Troponin level. Cardiology recommended no athletic activity until cleared by Cardiologist.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Chest pain
Hospital-Tage: 1,0
Labordaten: EKG and CXR were normal on 9/3/21. CMP, D Dimer, Sedimentation Rate were normal. CBC on 9/3/21 was normal outside of monocyte level of 13.1. Troponin on 9/3/21 was elevated at 251 ng/L. CRP on 9/3/21 was also elevated at 13 mg/L. Troponin on 9/4/21 at 0400 was elevated at 378. Troponin level 6 hrs later at 1000 was still 378. Echocardiogram on 9/4/21 showed a normal cardiac structure with normal ventricular function. No signs of acute mycoarditis.
Aktuelle Erkrankungen: Pt received his first COVID vaccine on 08/10/2021. Developed body aches, weakness, headache, stomachache, "burping", and chills on 8/11/2021.
Vorgeschichte: Allergic Rhinitis- Allergic to Pollen
Andere Medikamente: None
Allergien: None
Vorherige Impfungen: -

VAERS 1682823

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge ew0183

moderat

Staat: WA
Alter: 60,0
Geschlecht: F
Eingang: 08.09.2021
Impfdatum: 09.08.2021
Beginn: 20.08.2021
Tage bis Beginn: 11,0
Dosis: UNK
Route/Site: - / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Abdominal discomfort Arthralgia Breast tenderness Dizziness Headache Injection site pain Loss of personal independence in daily activities Malaise Mobility decreased Myalgia Nausea Respiratory tract congestion

Symptomtext

1st Covid Vaccine: Pfizer 8/9/21 Symptoms: dizziness, headache, extreme nausea + digestive upset, congestion, muscle + joint aches, tender breasts and painful injection site -Day after vaccine: unable to function, feeling extremely ill, in bed -Headache, dizziness, nausea + digestive upset, muscle aches, tender breasts continue until 8/18 -Nausea + digestive upset and tender breasts continue until today Question: Great concern in regard to receiving 2nd vaccine. If yes, when? If no, letter of exemption? If yes: optimal wait time until 2nd shot, supporting body with second shot, teaching until receiving second shot? If no: Exemption from vaccine, recommendation for medical leave? Teaching without second vaccine? Safety measures?

Weitere VAERSDATA-Felder

Praegender Schweregrund: Mobility decreased
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1663796

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EW0183

moderat

Staat: OR
Alter: 30,0
Geschlecht: M
Eingang: 01.09.2021
Impfdatum: 20.07.2021
Beginn: 23.07.2021
Tage bis Beginn: 3,0
Dosis: 1
Route/Site: SYR / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein

Chest X-ray Chest discomfort Chest pain Coagulation test Electrocardiogram Enzyme level test Pain in extremity

Symptomtext

CHEST PAIN, CHEST TIGHTNESS, PAIN DOWN LEFT ARM?

Weitere VAERSDATA-Felder

Praegender Schweregrund: Chest pain
Hospital-Tage: -
Labordaten: ER VISIT CHEST X-RAY, ENZYME TESTS, BLOOD CLOT TEST, EKG
Aktuelle Erkrankungen: None
Vorgeschichte: None
Andere Medikamente: None
Allergien: None
Vorherige Impfungen: -

VAERS 1663792

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EW0183

moderat

Staat: MI
Alter: 50,0
Geschlecht: F
Eingang: 01.09.2021
Impfdatum: 15.06.2021
Beginn: 26.08.2021
Tage bis Beginn: 72,0
Dosis: 2
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: ja

COVID-19 Condition aggravated Hypotension Knee arthroplasty Lethargy Osteoarthritis SARS-CoV-2 test negative SARS-CoV-2 test positive

Symptomtext

Found to be COVID-19 positive during hospital admission (patient fully vaccinated) Admission Date: 8/23/2021 Discharge Date: 08/27/2021 Hospitalization - 8.23.21 - Active Hospital Problems Diagnosis Date Noted POA ? Primary osteoarthritis of right knee 08/23/2021 No DETAILS OF HOSPITAL STAY: PRESENTING PROBLEM: Primary osteoarthritis of right knee [M17.11] HOSPITAL COURSE: Was admitted to the Hospital 08/23/2021. She underwent a right total knee arthroplasty. After short stay in PACU and she was transferred to the floor. She is placed on appropriate antibiotics was DVT prophylaxis. PT and OT rest evaluate see patient postop day 1. To begin weight-bearing as tolerated. Patient postoperatively was very lethargic and had low blood pressure possibly secondary to her psychotropic drugs. She did continue to improve and was finally discharged home on 08/27/2021. She will continue weight-bearing as tolerated lower extremity. She will follow up in the office in 2 weeks for re-x-ray and re-evaluation lower extremity. She was called in or prescription for pain medication. She will change her aspirin to 2 times a day of an 81 mg. She will re-initiate her home medication as prior to surgery. Visiting therapy and nurse have been set up to follow up outpatient. It is of note that patient did have a positive COVID test with a subsequent negative follow-up test performed. Prognosis for patient is guarded.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Condition aggravated
Hospital-Tage: 5,0
Labordaten: -
Aktuelle Erkrankungen: 08/23/2021 she underwent a right total knee arthroplasty.
Vorgeschichte: Hypercholesteremia Dissection, vertebral artery (HCC) Suicidal behavior Severe major depression, single episode (HCC) Chronic migraine without aura, with intractable migraine, so stated, with status migrainosus Possible Nummular headache Osteoarthritis of left knee Essential hypertension, benign Chronic schizophrenic (HCC) GERD (gastroesophageal reflux disease) Renal insufficiency Anxiety Osteoarthritis of right knee CKD (chronic kidney disease) stage 3, GFR 30-59 ml/min Obesity Tachycardia Primary osteoarthritis of right knee
Andere Medikamente: amLODIPine (NORVASC) 5 MG tablet aripiprazole (ABILIFY) 30 MG tablet aspirin EC 81 MG enteric coated tablet atenolol (TENORMIN) 50 MG tablet atorvastatin (LIPITOR) 40 MG tablet Blood Pressure Monitoring (BLOOD PRESSURE CUFF) MISC diazePAM (
Allergien: Oxycodone - hallucinations Amoxicillin - other
Vorherige Impfungen: -

VAERS 1628096

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EW0183

moderat

Staat: NC
Alter: 61,0
Geschlecht: F
Eingang: 31.08.2021
Impfdatum: 28.05.2021
Beginn: 28.05.2021
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: ja Hospital: ja Disable: unbekannt ER: ja Erholt: nein

Asthenia Chest pain Fatigue Hypoaesthesia Paraesthesia Listless Peripheral swelling

Symptomtext

left arm became tingly; left arm numb; listless; began to swell 13 minutes after the vaccine.; This is a spontaneous report from a contactable consumer (patient). A 61-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), dose 2 via an unspecified route of administration, administered in Arm Left on 28May2021 08:30 (Lot Number: EW0183) (at age of 61-year-old) as DOSE 2, SINGLE for covid-19 immunisation. Patient took the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) on an unknown date at age of 61-year-old at left arm for covid-19 immunization. Patient was not pregnant. There was known allergies. No covid prior vaccination, no covid tested post vaccination. Medical history included IBS-D, Fibromyalgia, Sciatic Nerve Nerve, degenerative Joint Disease, TMJ Syndrome. There were no concomitant medications. No other vaccine in four weeks. The patient experienced left arm became tingly, numb, listless and began to swell 13 minutes after the vaccine. Events onset date was reported as 28May2021 08:30 AM. AEs resulted in: Doctor or other healthcare professional office/clinic visit, Emergency room/department or urgent care, Hospitalization, Life threatening illness (immediate risk of death from the event), hospitalization for 3 days. Patient received treatment for the adverse events. The outcome of events was not recovered.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Chest pain
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: Medical History/Concurrent Conditions: Degenerative joint disease; Diarrhea (IBS-D); Fibromyalgia; Irritable bowel syndrome; Multiple allergies; Sciatic nerve injury; TMJ syndrome
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1628096

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EW0183

moderat

Staat: NC
Alter: 61,0
Geschlecht: F
Eingang: 31.08.2021
Impfdatum: 28.05.2021
Beginn: 28.05.2021
Tage bis Beginn: 0,0
Dosis: 2
Route/Site: - / LA

Tod: unbekannt Lebensbedrohlich: ja Hospital: ja Disable: unbekannt ER: ja Erholt: nein

Asthenia Chest pain Fatigue Hypoaesthesia Paraesthesia Listless Peripheral swelling

Symptomtext

left arm became tingly; left arm numb; listless; began to swell 13 minutes after the vaccine.; This is a spontaneous report from a contactable consumer (patient). A 61-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), dose 2 via an unspecified route of administration, administered in Arm Left on 28May2021 08:30 (Lot Number: EW0183) (at age of 61-year-old) as DOSE 2, SINGLE for covid-19 immunisation. Patient took the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) on an unknown date at age of 61-year-old at left arm for covid-19 immunization. Patient was not pregnant. There was known allergies. No covid prior vaccination, no covid tested post vaccination. Medical history included IBS-D, Fibromyalgia, Sciatic Nerve Nerve, degenerative Joint Disease, TMJ Syndrome. There were no concomitant medications. No other vaccine in four weeks. The patient experienced left arm became tingly, numb, listless and began to swell 13 minutes after the vaccine. Events onset date was reported as 28May2021 08:30 AM. AEs resulted in: Doctor or other healthcare professional office/clinic visit, Emergency room/department or urgent care, Hospitalization, Life threatening illness (immediate risk of death from the event), hospitalization for 3 days. Patient received treatment for the adverse events. The outcome of events was not recovered.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Chest pain
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: Medical History/Concurrent Conditions: Degenerative joint disease; Diarrhea (IBS-D); Fibromyalgia; Irritable bowel syndrome; Multiple allergies; Sciatic nerve injury; TMJ syndrome
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1651546

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EW 0183

moderat

Staat: CA
Alter: 67,0
Geschlecht: F
Eingang: 28.08.2021
Impfdatum: 06.08.2021
Beginn: 07.08.2021
Tage bis Beginn: 1,0
Dosis: 1
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Decreased appetite Fatigue Headache Musculoskeletal stiffness Pain Pelvic pain Peripheral coldness Pyrexia Skin discolouration Tachycardia Vomiting

Symptomtext

Day after: headaches, high fever (100.5 ), vomiting, anorexia, lac, of appetite, pelvic pain, severe body aches, neck stiffness, fatigue Long term: tachycardia, pelvic pain, headaches, feet turn blue and feel cold, fatigue.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Tachycardia
Hospital-Tage: -
Labordaten: Clinical assessment
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1646020

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EW0183

moderat

Staat: -
Alter: 50,0
Geschlecht: F
Eingang: 28.08.2021
Impfdatum: 02.07.2021
Beginn: 02.07.2021
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: - / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: ja

Asthenia Back pain Bedridden Blood test Dizziness Feeling abnormal Gait disturbance Hot flush Hyperhidrosis Incontinence Nasal discomfort Oropharyngeal discomfort Pallor Renal pain Sleep disorder Speech disorder Tremor Urine analysis

Symptomtext

kidney pain/kidneys got sore; and the whole back around that area started getting really sore; dizzy; got hot, started to feel a hot flush; throat felt more restricted; nose felt more restricted; involuntary tremors going through in a rhythmic cycle; fell asleep for a really long time; discovered she was incontinent; had a loss of color; felt like she couldn't speak very well; just felt really bad; couldn't make herself get up; sweating profusely from her feet and palms; weak; , didn't feel like she could walk there; she just felt really bad.; This is a spontaneous report from a contactable consumer (Patient) via Medical Information Team. A 50-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; formulation: Solution for injection, Lot Number: EW0183), via an unspecified route of administration, administered in left arm on 02Jul2021 (at the age of 50-years-old) as dose 1, single for COVID-19 immunisation. Medical history included haemochromatosis, COVID-19 from Mar2020 to an unknown date (she reports she believes she had Covid in Mar2020). Concomitant medications were none. It was reported that the patient got her first vaccine on 02Jul2021. Patient within almost immediately, felt like she was dizzy, had a wave of dizziness and she laid down and just started drinking water, she got hot and started to feel warm, a hot flush, she felt like after a while. Her throat felt like she had to sit up because it felt more restricted and same with her nose after about an hour. She was sweating profusely from her feet and palms but mainly her feet and she had an involuntary tremor or shutter going through in a rhythmic cycle and she fell asleep for a really long time and didn't realize she was asleep for a while and put ice on. When she got up, she went to the restroom, was very dizzy, weak and didn't feel like she could walk there and went and they wheeled her over, she was in a gymnasium, they took her to the restroom. The patient stayed at facility for 2 hours and when she got home, she rested and drank liquids like they told, and then she discovered she was incontinent, she didn't notice at the time, she definitely noticed that. She had a loss of color and felt like she couldn't speak very well or have a conversation, she just didn't want to not speak and wanted to lay down, she just felt really bad. That was on Friday (02Jul2021) and she went to the emergency room (05Jul2021) on Monday because on Sunday (04Jul2021), she couldn't make herself get up and she thought she would go to the emergency room due to pain and to check her kidneys because they got sore and the whole back around that area started getting really sore and she started getting pain in that area of her kidneys even though she was drinking a lot of water. In ER, they did urine test and blood work and determined that my kidneys were fine. I felt really bad for 5 days, and by tenth day she felt normal. The patient reported that for a week probably she had a hard time, definitely the first 5 days. Ten days from when she didn't feel anything, and 5 days were super difficult. The event kidney pain/kidneys got sore was serious (medically significant). She's waiting to get her second dose and she's reading over the information and it looks like she's had all but one of the following allergic reactions from the first shot, so just wanted to report previous symptoms, and get medical advice to ask about that before she got the second dose. She confirms all symptoms began in Jul2021 and ended in Jul2021. The outcome of all the events was recovered on an unspecified date in Jul2021.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Tremor
Hospital-Tage: -
Labordaten: Test Date: 20210705; Test Name: Blood work; Result Unstructured Data: Test Result:Unknown results; Test Date: 20210705; Test Name: Urine test/got kidneys checked; Result Unstructured Data: Test Result:kidneys were fine
Aktuelle Erkrankungen: -
Vorgeschichte: Medical History/Concurrent Conditions: COVID-19 (She reports she believes she had Covid in Mar2020.); Hemochromatosis
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1321670

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EW0183

moderat

Staat: CA
Alter: 60,0
Geschlecht: F
Eingang: 28.08.2021
Impfdatum: 15.05.2021
Beginn: 15.05.2021
Tage bis Beginn: 0,0
Dosis: 2
Route/Site: - / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein

Ageusia Allergy test Fatigue Hypersensitivity Vaccination site erythema Wheezing Cough Dysphagia Dyspnoea Hypoaesthesia oral

Symptomtext

wheezing; This is a spontaneous report from a contactable consumer (patient). A 60-year-old female patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration, administered in arm left on 15May2021 at 11:30 (Lot Number: EW0183) (at the age of 60-year-old) as single dose for COVID-19 immunisation. Medical history was not reported. The patient's concomitant medications were not reported. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 VACCINE) via an unspecified route of administration, administered in arm left on 02Apr2021 at 11:00 (Lot Number: EW0151) for COVID-19 immunisation and experienced allergic reaction, could not swallow, hard to swallow/breathe, tongue become numb, red bump where injection was given, funny metal taste, and fatigue. The patient experienced wheezing (medically significant) on 15May2021 at 11:30. The event required visit to emergency room and physician office. The patient underwent lab tests and procedures which included allergy test: result unknown (reaction to her testing that received 3 breathing treatment, 5 shot for testing). On an unspecified date. Unspecified therapeutic measures were taken as a result of wheezing. The patient outcome of the event was not recovered. Follow-up attempts are completed. No further information is expected.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Dyspnoea
Hospital-Tage: -
Labordaten: Test Name: allergy test; Result Unstructured Data: Test Result: Result unknown; Comments: reaction to her testing that received 3 breathing treatment, 5 shot for testing.
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1321670

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EW0183

moderat

Staat: CA
Alter: 60,0
Geschlecht: F
Eingang: 28.08.2021
Impfdatum: 15.05.2021
Beginn: 15.05.2021
Tage bis Beginn: 0,0
Dosis: 2
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein

Ageusia Allergy test Fatigue Hypersensitivity Vaccination site erythema Wheezing Cough Dysphagia Dyspnoea Hypoaesthesia oral

Symptomtext

wheezing; This is a spontaneous report from a contactable consumer (patient). A 60-year-old female patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration, administered in arm left on 15May2021 at 11:30 (Lot Number: EW0183) (at the age of 60-year-old) as single dose for COVID-19 immunisation. Medical history was not reported. The patient's concomitant medications were not reported. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 VACCINE) via an unspecified route of administration, administered in arm left on 02Apr2021 at 11:00 (Lot Number: EW0151) for COVID-19 immunisation and experienced allergic reaction, could not swallow, hard to swallow/breathe, tongue become numb, red bump where injection was given, funny metal taste, and fatigue. The patient experienced wheezing (medically significant) on 15May2021 at 11:30. The event required visit to emergency room and physician office. The patient underwent lab tests and procedures which included allergy test: result unknown (reaction to her testing that received 3 breathing treatment, 5 shot for testing). On an unspecified date. Unspecified therapeutic measures were taken as a result of wheezing. The patient outcome of the event was not recovered. Follow-up attempts are completed. No further information is expected.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Dyspnoea
Hospital-Tage: -
Labordaten: Test Name: allergy test; Result Unstructured Data: Test Result: Result unknown; Comments: reaction to her testing that received 3 breathing treatment, 5 shot for testing.
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1637609

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge Ew0183

moderat

Staat: NC
Alter: 45,0
Geschlecht: F
Eingang: 26.08.2021
Impfdatum: 04.08.2021
Beginn: 07.08.2021
Tage bis Beginn: 3,0
Dosis: 1
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein

Arthralgia Back pain Blepharospasm Blood test Electrocardiogram normal Heart rate increased Hypoaesthesia Lymph node pain Muscle twitching Nervousness Pain Pain in extremity Paraesthesia Pyrexia

Symptomtext

Starting late Friday night/ early Saturday morning (8/7/21) I started feeling numbness in my mouth, cheek and eyelid on my left side. I also experienced numbness and tingling on the tops of my feet on both sides, hands, forearms, and other places around my limbs. I also have eye twitching on my left side and twitching at the corner of my mouth on the same side. Additionally, I have had a low grade fever off and on through today, 8/26/21. Random seeming and short lived bursts of pain throughout the body, including the right hand, right knee, shoulders, thighs and back. The pain only lasts 15-30 seconds. I still have all of these symptoms today. I also feel shaky and have had a higher than normal heart rate on and off. In addition I have had sore lymph nodes in the underarms, groin area and clavicle. I have treated with supplements including turmeric, glutathione, quercetin as well as ibuprofen. I received an ekg and bloodwork at my provider. Prior to seeing her I went to urgent care on 8/8/21 but they did not do or say anything and I received no treatment.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Paraesthesia
Hospital-Tage: -
Labordaten: Ekg was normal. Bloodwork has not been reported yet.
Aktuelle Erkrankungen: Asthma
Vorgeschichte: Asthma, trigeminal neuralgia
Andere Medikamente: Norethindrone 2.5mg daily and omeprazole 20mg daily
Allergien: Allergic to iodine, shellfish
Vorherige Impfungen: -

VAERS 1637375

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EW0183

moderat

Staat: OR
Alter: 49,0
Geschlecht: F
Eingang: 26.08.2021
Impfdatum: 05.08.2021
Beginn: 06.08.2021
Tage bis Beginn: 1,0
Dosis: 2
Route/Site: SYR / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Arthralgia Chest X-ray Condition aggravated Dysphagia Fatigue Increased upper airway secretion Oral candidiasis Rash Respiratory disorder SARS-CoV-2 test negative Tongue coated Urine analysis

Symptomtext

08/06/2021- I experienced an intense joint pain episode. The second vaccine I was fatigued, horrible joint pain, respiratory issues, 1 urgent care visit. I had difficulty swallowing. I had a lot of mucus. I have a strange coating on my tongue that the doctor said is probably thrush. Last night 08/25/2021 I noticed a rash on my torso and back more on my left side than my right side.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Condition aggravated
Hospital-Tage: -
Labordaten: Covid test- Negative (08/17/2021) Chest Xray- 08/17/2021, Urinalysis- 08/17/2021
Aktuelle Erkrankungen: Long Covid- Joint pain, low grade fever, fatigue, brain fog, cold like symptoms
Vorgeschichte: None
Andere Medikamente: Gabapentin, Oxycodone, Tylenol
Allergien: None
Vorherige Impfungen: -

VAERS 1632680

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EW0183

moderat

Staat: MI
Alter: 19,0
Geschlecht: F
Eingang: 25.08.2021
Impfdatum: 05.08.2021
Beginn: 05.08.2021
Tage bis Beginn: 0,0
Dosis: 2
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: ja

Chest pain Dyspnoea Heart rate increased Throat tightness

Symptomtext

throat tightness DIB, CP rapid heart rate.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Chest pain
Hospital-Tage: -
Labordaten: none
Aktuelle Erkrankungen: none
Vorgeschichte: none
Andere Medikamente: claritin
Allergien: none
Vorherige Impfungen: -

VAERS 1628772

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EW0183

moderat

Staat: WA
Alter: 36,0
Geschlecht: F
Eingang: 24.08.2021
Impfdatum: 03.08.2021
Beginn: 03.08.2021
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Fatigue Nausea Palpitations Vomiting

Symptomtext

A interpreter is used for this intake. Client reports she is scheduled for second Pfizer vaccine tomorrow. She reports nausea and vomiting for several days after her first vaccine. She reports fatigue and has experienced heart palpitations since her first vaccine twenty days ago. A MD call was made by the house supervisor and client was advised to have her fatigue and heart evaluated by a provider before moving forward with a second vaccine. Two providers were provided to the patient. Patient plans to travel back to her home by the end of the month and wishes to move forward with the second vaccine. She was advised to see a provider first, but she wishes to have the second vaccine tomorrow and take the risk of having worsening symptoms. Patient will return tomorrow with her uncle who is her driver and is staying at his home. Patient advised to eat a full meal and drink plenty of fluids before her appointment. She was also advised that she will need to stay in observation for 30 minutes.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Palpitations
Hospital-Tage: -
Labordaten: None completed - patient advised to see a provider.
Aktuelle Erkrankungen: unknown- patient reported she had a physical prior to travel and was told she did not have a heart condition.
Vorgeschichte: unknown
Andere Medikamente: unknown
Allergien: unknown
Vorherige Impfungen: -

VAERS 1628060

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EW0183

moderat

Staat: SC
Alter: 38,0
Geschlecht: F
Eingang: 24.08.2021
Impfdatum: 18.08.2021
Beginn: 20.08.2021
Tage bis Beginn: 2,0
Dosis: 2
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein

Amnesia Back pain Blood test normal Chest X-ray abnormal Chest discomfort Chills Confusional state Constipation Cough Diarrhoea Headache Hyperhidrosis Injection site pain Myalgia Nasal dryness Nausea Pneumonia Pyrexia

Symptomtext

I got a sinus infection and was prescribed two antibiotics and two doses of steroids as well. They have been trying to figure out what is going on and yesterday, 8/23/2021, they finally figured out that I am on the verge of pneumonia. I had gone to on call three times and the DR two times and it has just been ongoing. The DR checked me for various viruses and they could not figure it out. My symptoms started with a headache and then of course the pain from the shot and the swelling, muscle aches and it varied through the month, what my symptoms were. There was chest tightness, cough, runny nose, congestion. My nose went from dry to runny, as I said it just varied from day to day. I also had vomiting and nausea. I also went from being constipated to having diarrhea. I had a fever and chills and was just like pouring sweat too. I want to say, confusion was there too, loss of memory a but if that makes sense. Also my lower back hurt really, really bad.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Pneumonia
Hospital-Tage: -
Labordaten: Chest x-ray pneumonia 8/23/2021. 15 panel viral panel negative 08/2021. Blood work normal 08/2021.
Aktuelle Erkrankungen: Sinus infection after first dose
Vorgeschichte: High blood pressure; anxiety; depression
Andere Medikamente: Zoloft; Abilify; Norvasc
Allergien: Amoxicillin; Phenergan
Vorherige Impfungen: -

VAERS 1623597

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EW0183

moderat

Staat: MI
Alter: 25,0
Geschlecht: F
Eingang: 23.08.2021
Impfdatum: 17.08.2021
Beginn: 01.08.2021
Tage bis Beginn: -
Dosis: 1
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Menstrual disorder Migraine Nausea

Symptomtext

Patient reported: Extreme nausea, migraine, and menstrual cycle activated (even though patient typically does not have a period).

Weitere VAERSDATA-Felder

Praegender Schweregrund: Migraine
Hospital-Tage: -
Labordaten: NA
Aktuelle Erkrankungen: NA
Vorgeschichte: Dysmenorrhea Anxiety Dyspareunia in female Vaginismus
Andere Medikamente: Norethin-Eth Estrad-Fe Biphas (LO LOESTRIN FE) 1 MG-10 MCG / 10 MCG TABS Omeprazole Magnesium (PRILOSEC OTC PO)
Allergien: Azithromycin Ciprofloxacin Nausea Only Penicillins Hives
Vorherige Impfungen: -

VAERS 1623597

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EW0183

moderat

Staat: MI
Alter: 25,0
Geschlecht: F
Eingang: 23.08.2021
Impfdatum: 17.08.2021
Beginn: 01.08.2021
Tage bis Beginn: -
Dosis: 2
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Menstrual disorder Migraine Nausea

Symptomtext

Patient reported: Extreme nausea, migraine, and menstrual cycle activated (even though patient typically does not have a period).

Weitere VAERSDATA-Felder

Praegender Schweregrund: Migraine
Hospital-Tage: -
Labordaten: NA
Aktuelle Erkrankungen: NA
Vorgeschichte: Dysmenorrhea Anxiety Dyspareunia in female Vaginismus
Andere Medikamente: Norethin-Eth Estrad-Fe Biphas (LO LOESTRIN FE) 1 MG-10 MCG / 10 MCG TABS Omeprazole Magnesium (PRILOSEC OTC PO)
Allergien: Azithromycin Ciprofloxacin Nausea Only Penicillins Hives
Vorherige Impfungen: -

VAERS 1603807

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EW0183

moderat

Staat: CO
Alter: 53,0
Geschlecht: F
Eingang: 21.08.2021
Impfdatum: 16.08.2021
Beginn: 16.08.2021
Tage bis Beginn: 0,0
Dosis: 2
Route/Site: SYR / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein

Blood test Chest X-ray normal Condition aggravated Dyspnoea Electrocardiogram normal Herpes zoster Injection site erythema Injection site swelling Injection site warmth Insomnia Pain Pruritus Rash

Symptomtext

Shots were performed at Clinic, Had the 1st shot on 7/26/2021 had alot of fatigue, sore arm and felt very feverish for 2 days started having some itching on my back however the following week andwhen I looked at back in the mirror I had two spots that looked like misquito bites so just let it go Had 2nd shot on 8/16/2021 within a couple hours my arm had a baseball size, red, raised, warm circle below the shot about 1/2 inch. Within about 4 hours, itching on back worsened and a rash developed on the left side of my back and under my left breast and around my chest cavity. That night I had trouble sleeping and my breathing became short. The next day 8/17 the rash seemed to be spreading and the breathing especially while laying down worsened. I finally could not stand the pain that was developing and the breathing had me concerned I went into the ER on 8/18 about 9am. Chest xrays were done, pulmonary embolism test was performed as well as an EKG. They couldn't find anything wrong. (the Dr listed on my paper work must have been physician on call because a woman didn't get her name was the one ordering tests etc...) they briefly looked at my rashes and sent me on my way and said use benadryl cream. The following day I ended up at Doctors office and was diagnosed with Shingles.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Condition aggravated
Hospital-Tage: -
Labordaten: Chest xray, EKG, Pulmonary embolism, blood tests all done on 8/18/2021
Aktuelle Erkrankungen: Haven't been ill since Jan 2020
Vorgeschichte: Possible TIA's in 2016 and 1989
Andere Medikamente: Nothing
Allergien: Penecillian., Erythrimiacin, Codeine
Vorherige Impfungen: -

VAERS 1592541

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EW0183

moderat

Staat: IN
Alter: 38,0
Geschlecht: M
Eingang: 20.08.2021
Impfdatum: 07.08.2021
Beginn: 09.08.2021
Tage bis Beginn: 2,0
Dosis: 1
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein

Blood test normal Chest X-ray normal Chest pain Electrocardiogram normal Heart rate increased Pain in extremity

Symptomtext

Started having constant chest pain on left side from middle of chest into armpit. Pains then started shooting down left arm. Elevated heart rate and elevated blood pressure and headache Went to ER, and EKG was performed and found it wasn't a heart attack and was told to follow up with my Primary Care Physician Still have elevated blood pressure (higher than normal), still have chest pains occasionally (about 10-12 times a day but don't last longer than 10 minutes

Weitere VAERSDATA-Felder

Praegender Schweregrund: Chest pain
Hospital-Tage: -
Labordaten: EKG - Normal Chest X-Ray - Normal Blood Work - Normal
Aktuelle Erkrankungen: N/A
Vorgeschichte: High Blood Pressure Hypothyroidism
Andere Medikamente: Levothyroxine Losartin Lisinopril Daily Vitamin Probiotic Vitamin C Vitamin D
Allergien: N/A
Vorherige Impfungen: -

VAERS 1587384

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EW0183

moderat

Staat: TX
Alter: 60,0
Geschlecht: F
Eingang: 19.08.2021
Impfdatum: 19.08.2021
Beginn: 19.08.2021
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Tremor

Symptomtext

Patient started to shake after Covid vaccination. Her vital sign was checked. She was referred to EMS. EMS checked BP/BS.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Tremor
Hospital-Tage: -
Labordaten: O2 = 97% PR = 88 BP - 120/75
Aktuelle Erkrankungen: N/A
Vorgeschichte: N/A
Andere Medikamente: N/A
Allergien: N/A
Vorherige Impfungen: -

VAERS 1587192

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EW0183

moderat

Staat: MI
Alter: 43,0
Geschlecht: F
Eingang: 19.08.2021
Impfdatum: 19.08.2021
Beginn: 19.08.2021
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: ja

Chest discomfort Dizziness Dyspnoea

Symptomtext

SOB , feeling like she was going to pass out. chest pressure

Weitere VAERSDATA-Felder

Praegender Schweregrund: Dyspnoea
Hospital-Tage: -
Labordaten: none
Aktuelle Erkrankungen: none
Vorgeschichte: none
Andere Medikamente: none
Allergien: meperdine, phenylephedrine pseudowphedrine sulfa
Vorherige Impfungen: -

VAERS 1586931

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EW0183

moderat

Staat: KY
Alter: 58,0
Geschlecht: M
Eingang: 19.08.2021
Impfdatum: 06.08.2021
Beginn: 10.08.2021
Tage bis Beginn: 4,0
Dosis: 1
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: nein

COVID-19 pneumonia Dyspnoea Fatigue Pyrexia SARS-CoV-2 test positive

Symptomtext

Patient presented to the ED on 8/16 complaining of shortness of breath, fatigue, fever. Tested positive for COVID 6 days prior. Admitted for COVID pneumonia.

Weitere VAERSDATA-Felder

Praegender Schweregrund: COVID-19 pneumonia
Hospital-Tage: -
Labordaten: COVID +
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1582783

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EW0183

moderat

Staat: MI
Alter: 47,0
Geschlecht: F
Eingang: 18.08.2021
Impfdatum: 06.08.2021
Beginn: 06.08.2021
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein

Dyspnoea Hypertension Tachycardia

Symptomtext

hypertensive, tachycardia and SOB with in min of vaccine.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Dyspnoea
Hospital-Tage: -
Labordaten: On going with cardiologist
Aktuelle Erkrankungen: none
Vorgeschichte: none
Andere Medikamente: cardizem, stelara, temovate
Allergien: pcn, efalizumab, shin test, tb
Vorherige Impfungen: -

VAERS 1577968

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EW0183

moderat

Staat: NJ
Alter: 40,0
Geschlecht: M
Eingang: 17.08.2021
Impfdatum: 21.06.2021
Beginn: 22.06.2021
Tage bis Beginn: 1,0
Dosis: 2
Route/Site: SYR / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Cardiac stress test Chest pain Dyspnoea Electrocardiogram normal Heart rate increased Pain Palpitations

Symptomtext

Increased heart rate, prolonged chest pain, radiating pain on left side of upper body, shortness of breath, heart palpitations

Weitere VAERSDATA-Felder

Praegender Schweregrund: Chest pain
Hospital-Tage: -
Labordaten: EKG (normal) ECG (normal) stress test (normal)
Aktuelle Erkrankungen: N/A
Vorgeschichte: N/A
Andere Medikamente: N/A
Allergien: Strawberries
Vorherige Impfungen: -

VAERS 1577949

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge Ew0183

moderat

Staat: OK
Alter: 25,0
Geschlecht: F
Eingang: 17.08.2021
Impfdatum: 04.08.2021
Beginn: 05.08.2021
Tage bis Beginn: 1,0
Dosis: 1
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Arthralgia Dyspnoea Musculoskeletal stiffness Skin discolouration

Symptomtext

Stiff neck/shoulder pain, trouble breathing ( few hours after) and clusters of discoloration on my arm the next day after vaccination. The discoloration still persists.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Dyspnoea
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: None
Vorgeschichte: Asthma
Andere Medikamente: None
Allergien: Nickel
Vorherige Impfungen: -

VAERS 1569922

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EW0183

moderat

Staat: CA
Alter: 30,0
Geschlecht: F
Eingang: 15.08.2021
Impfdatum: 24.07.2021
Beginn: 24.07.2021
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: ja

Paraesthesia Paraesthesia oral

Symptomtext

Patient presented to Vaccination sit at her scheduled appointment time to receive her 2nd dose of the COVID Pfizer vaccine. While being processed for 2nd dose vaccination, the client reported that approximately 25-30 minutes after receiving her first Pfizer dose, she experienced tingling in her lips, bilateral cheeks, and left arm from her elbow to her hand. Client she drove home and called DR, and was told to go to urgent care. The client states she decided to wait approximately 4 hours from onset of symptoms before going to urgent care. Client states during that time the tingling in her arm resolved within an hour and the tingling in her lips and cheeks resolved approximately 2 hours after onset. Client states at urgent care they advised her to go home and take claritin. Client reports she drove home and took claritin of unknown strength. She reports she has been feeling well since then and denies following up with her PCP.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Paraesthesia
Hospital-Tage: -
Labordaten: None provided at Public health clinic
Aktuelle Erkrankungen: None reported by client.
Vorgeschichte: None reported by client.
Andere Medikamente: Birth Control, unknown name per client.
Allergien: None reported by client.
Vorherige Impfungen: -

VAERS 1540689

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EW0183

moderat

Staat: TX
Alter: 38,0
Geschlecht: F
Eingang: 10.08.2021
Impfdatum: 10.08.2021
Beginn: 10.08.2021
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Blood pressure increased Condition aggravated Hypertension Hypoaesthesia Limb discomfort

Symptomtext

c/o Right arm numbness and heaviness. BP 190/96, P 80, R Patient states that is she prescribed blood pressure medicine (amlodipine) but cannot afford it so she does not take it in weeks. Patient denies HA, SOB or chest pain. Nurse advised patient to report to medical facility immediately because BP is not declining. Vaccine site(left deltoid) not affected

Weitere VAERSDATA-Felder

Praegender Schweregrund: Condition aggravated
Hospital-Tage: -
Labordaten: none
Aktuelle Erkrankungen: none
Vorgeschichte: High BP
Andere Medikamente: c/o Right arm numbness and heaviness. BP 190/96, P 80, R Patient states that is she prescribed blood pressure medicine (amlodipine) but cannot afford it so she does not take it in weeks. Patient denies HA, SOB or chest pain. Nurse advise
Allergien: Possible allergic reaction in the past to Motrin
Vorherige Impfungen: -

VAERS 1512755

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge ew0183

moderat

Staat: IA
Alter: 14,0
Geschlecht: F
Eingang: 09.08.2021
Impfdatum: 28.07.2021
Beginn: 28.07.2021
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: - / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein

Asthenia Bone pain Chest pain Chills Dermatitis Dizziness Fatigue Dyspnoea Erythema Hypoaesthesia Movement disorder Mobility decreased Myalgia Nausea Paraesthesia Myositis Tourette's disorder Pyrexia

Symptomtext

numbess and tingling in arms and legs, inability to move them, nausea, difficulty breathing, chest pains, bones and muscle pain, skin red all over, skin and muscles inflammed, weakness chills, dizziness, worsened tourette syndrome

Weitere VAERSDATA-Felder

Praegender Schweregrund: Mobility decreased
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: autism adhd
Andere Medikamente: prazosin, singalair
Allergien: amoxicilin cefzil penicilin
Vorherige Impfungen: -

VAERS 1535060

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EW0183

moderat

Staat: TX
Alter: 19,0
Geschlecht: F
Eingang: 07.08.2021
Impfdatum: 05.08.2021
Beginn: 06.08.2021
Tage bis Beginn: 1,0
Dosis: 3
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: unbekannt

Chest pain

Symptomtext

CHEST PAIN

Weitere VAERSDATA-Felder

Praegender Schweregrund: Chest pain
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: postural orthostatic tachycardia syndrome
Andere Medikamente: -
Allergien: cinnamon, sulfa
Vorherige Impfungen: -

VAERS 1534092

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EW0183

moderat

Staat: MA
Alter: 22,0
Geschlecht: M
Eingang: 07.08.2021
Impfdatum: 24.05.2021
Beginn: 28.05.2021
Tage bis Beginn: 4,0
Dosis: 2
Route/Site: - / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein

Angina pectoris Chest pain

Symptomtext

The pain varies in location over my heart and chest.; chest pain; This is a spontaneous report from a contactable consumer (patient). A 22-year-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration, administered in Arm Left on 24May2021 15:00 (Batch/Lot Number: EW0183) as dose 2, single for covid-19 immunisation at a hospital. Medical history included known allergies. Prior to vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient received other medications within 2 weeks of vaccination. The patient had the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; lot number: EW1075) on 28Apr2021 15:30 in the left arm for Covid-19 immunization. The patient began having chest pain 3-4 days after his 2nd covid vaccine and this has continued since then. The pain occurs sometimes when resting but at all times when getting up and moving around. For example, he has chest pain when he walks down the stairs and even when he was standing up and washing the dishes. The pain sometimes lasts for 5 minutes but at other times it lasts for hours. The pain varies in location over his heart and chest. No SOB. He had to take an LOA from his job because of the continued chest pain which would last for hours while he was at work. The events started on 28May2021 and resulted in doctor or other healthcare professional office/clinic visit and emergency room/department or urgent care. The events were not treated. Since the vaccination, the patient has not been tested for COVID-19. The outcome of the events was not recovered.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Chest pain
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: Medical History/Concurrent Conditions: Allergy NOS
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1531988

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EW0183

moderat

Staat: MI
Alter: 27,0
Geschlecht: F
Eingang: 06.08.2021
Impfdatum: 23.07.2021
Beginn: 23.07.2021
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Chills Cough Dyspnoea Fatigue Headache Impaired work ability Influenza virus test Injection site pain Malaise Oropharyngeal pain Respiratory tract congestion SARS-CoV-2 test negative Streptococcus test negative

Symptomtext

Around 11:30 PM on 07/23/2021 my arm where the injection was given was sore and tender to the touch. I ended up getting a cough, congestion, headache, body chills, fatigue, sore throat and shortness of breath and just felt like I had been hit by a bus. My symptoms are still ongoing. My sore arm lasted until 07/26/2021 and all other symptoms continued until 07/30/2021. I do currently still had cough, congestion, and shortness of breath. I was taking off work on 07/26/2021 and sent for a Covid test that came back negative. I then seen the doctor on 07/27/2021 and was tested for strep and flu and that came back negative as well. My employer sent me for another Covid test on 07/29/2021 which came back negative again. On 07/30/2021 the doctor prescribed Prednisone and a Z-pak and I was on that for 5 days but it only helped at the bare minimum. I still had a cough and congestion after finishing it and then when I went to see the doctor again on 08/05/2021 they put me on Singulair and a 12 day prescription on Prednisone. I am also on Pro-air Inhaler for my exercise induced asthma. From what my doctor told me after he spoke with infection disease, is that he does think that is a reaction to vaccine that has possibly affected my asthma and made my asthma worse.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Dyspnoea
Hospital-Tage: -
Labordaten: Covid test (x2); Strep; Flu
Aktuelle Erkrankungen: None
Vorgeschichte: Exercise induced asthma; anxiety; depression; PCOS
Andere Medikamente: LEXAPRO; prenatal vitamin, Pro-Air inhaler
Allergien: Lactose Intolerant
Vorherige Impfungen: -

VAERS 1525697

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EW0183

moderat

Staat: CA
Alter: 40,0
Geschlecht: F
Eingang: 04.08.2021
Impfdatum: 04.08.2021
Beginn: 04.08.2021
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Chest pain Dizziness Nervousness

Symptomtext

CHEST PAIN, DIZZY, NERVOUS, IMBALANCED

Weitere VAERSDATA-Felder

Praegender Schweregrund: Chest pain
Hospital-Tage: -
Labordaten: BP AND OXYGEN TESTED ON SITE, WITHIN NORMAL LIMITS, PTX DRANK 12 OUNCES WATER WITH NO RELIEF, PTX OBSERVED 30-40 MINUTE AND RELEASED BY LOCAL FIRE DEPT.
Aktuelle Erkrankungen: NONE STATED
Vorgeschichte: NONE STATED
Andere Medikamente: NONE KNOWN
Allergien: NONE KNOWN
Vorherige Impfungen: -

VAERS 1525085

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EW0183

moderat

Staat: MN
Alter: 35,0
Geschlecht: U
Eingang: 04.08.2021
Impfdatum: 07.05.2021
Beginn: 07.05.2021
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: - / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Dysphagia Furuncle Paraesthesia oral

Symptomtext

Tingling lips and fingers; Red, zit like bumps on arms; Difficulty swallowing; This is a spontaneous report from a contactable consumer, the patient. A 35-year-old patient with unspecified gender received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0183) via an unspecified route of administration in the left arm on 07May2021 at 13:00 (at the age of 35-years-old) as a single dose for COVID-19 immunisation. Medical history included gout. The patient had no known allergies. Concomitant medications included allopurinol (MANUFACTURER UNKNOWN), vitamin d (MANUFACTURER UNKNOWN), multivitamins (MANUFACTURER UNKNOWN) and omega 3 (MANUFACTURER UNKNOWN) all from unknown dates and unknown indications and unknown if ongoing. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 07May2021 at 13:15, the patient experienced tingling lips and fingers, red zit like bumps on arms and difficulty swallowing. Therapeutic measures were taken as a result of these events which included treatment with benadryl syrup (MANUFACTURER UNKNOWN). The adverse events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. The clinical outcome of the events tingling lips and fingers, red zit like bumps on arms and difficulty swallowing was recovered at the time of this report. No follow-up attempts are needed. No further information is expected.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Paraesthesia oral
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: Medical History/Concurrent Conditions: Gout
Andere Medikamente: ALLOPURINOL; Vitamin d
Allergien: -
Vorherige Impfungen: -

VAERS 1412452

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EW0183

moderat

Staat: WA
Alter: 51,0
Geschlecht: F
Eingang: 03.08.2021
Impfdatum: 25.05.2021
Beginn: 26.05.2021
Tage bis Beginn: 1,0
Dosis: 1
Route/Site: - / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein

Anxiety Blood test Electromyogram Neurological examination Paraesthesia Immune reconstitution inflammatory syndrome Small fibre neuropathy Vasculitis

Symptomtext

Tingling in scalp began the day after vaccine, and on the 27th I began having tingling in lower arms, lower legs, hands, feet. This got worse with exertion - prickling in trunk, glutes. Today I still have paresthesia with more prickling with exertion, however it is mostly less intense and less often at this point in time. I was sent to ER Friday, 28th May where I was told it may be from vaccine but probably anxiety and sent home with xanax. I knew it was not anxiety so researched on internet and found hundreds of people with paresthesia/neuropathy after either dose 1 or 2 of Pfizer vaccine - including doctors. The location has it listed as sided effect on the government health website. Doctors in ER are recognizing it as a symptom of the Pfizer vaccine and seeing it more and more (my cousing got severe pins and needles in hands and feet after dose 2).

Weitere VAERSDATA-Felder

Praegender Schweregrund: Paraesthesia
Hospital-Tage: -
Labordaten: Neurological test (06/04/21) EMG test (07/28/21) Follow up visit (06/01/21), blood work (06/07/21) ER - blood work (05/28/21) Blood work (07/30/21)
Aktuelle Erkrankungen: none
Vorgeschichte: allergies
Andere Medikamente: multi - vitamin (evening) fexofenadine (not taken yet on the day of vaccination) cal-mag-citrate (evening)
Allergien: penicillin codeine percocet darvacet tree nuts peanuts sesame apples kiwi banana stone fruits red wine pollen
Vorherige Impfungen: anaphylaxis, November 2012 - vaccines given were tdap, Hep A & B, typhoid

VAERS 1412452

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EW0183

moderat

Staat: WA
Alter: 51,0
Geschlecht: F
Eingang: 03.08.2021
Impfdatum: 25.05.2021
Beginn: 26.05.2021
Tage bis Beginn: 1,0
Dosis: 1
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein

Anxiety Blood test Electromyogram Neurological examination Paraesthesia Immune reconstitution inflammatory syndrome Small fibre neuropathy Vasculitis

Symptomtext

Tingling in scalp began the day after vaccine, and on the 27th I began having tingling in lower arms, lower legs, hands, feet. This got worse with exertion - prickling in trunk, glutes. Today I still have paresthesia with more prickling with exertion, however it is mostly less intense and less often at this point in time. I was sent to ER Friday, 28th May where I was told it may be from vaccine but probably anxiety and sent home with xanax. I knew it was not anxiety so researched on internet and found hundreds of people with paresthesia/neuropathy after either dose 1 or 2 of Pfizer vaccine - including doctors. The location has it listed as sided effect on the government health website. Doctors in ER are recognizing it as a symptom of the Pfizer vaccine and seeing it more and more (my cousing got severe pins and needles in hands and feet after dose 2).

Weitere VAERSDATA-Felder

Praegender Schweregrund: Paraesthesia
Hospital-Tage: -
Labordaten: Neurological test (06/04/21) EMG test (07/28/21) Follow up visit (06/01/21), blood work (06/07/21) ER - blood work (05/28/21) Blood work (07/30/21)
Aktuelle Erkrankungen: none
Vorgeschichte: allergies
Andere Medikamente: multi - vitamin (evening) fexofenadine (not taken yet on the day of vaccination) cal-mag-citrate (evening)
Allergien: penicillin codeine percocet darvacet tree nuts peanuts sesame apples kiwi banana stone fruits red wine pollen
Vorherige Impfungen: anaphylaxis, November 2012 - vaccines given were tdap, Hep A & B, typhoid

VAERS 1514782

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EW0183

moderat

Staat: NY
Alter: 30,0
Geschlecht: M
Eingang: 30.07.2021
Impfdatum: 25.06.2021
Beginn: 01.07.2021
Tage bis Beginn: 6,0
Dosis: 1
Route/Site: - / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: nein

Arrhythmia Blood test Electrocardiogram Headache Heart rate Heart rate increased Spinal pain

Symptomtext

heart arrhythmia; headache; It was from the back of his head down to his spine; heart started hurting; This is a spontaneous report from a contactable consumer (patient) received from a Pfizer-sponsored program. A 30-year-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection, Lot number: EW0183), via an unspecified route of administration in arm right on 25Jun2021 at 11:30 (at the age of 30-year-old) as a dose 1, single for COVID-19 immunisation. The family medical history included his family has cardiovascular issues on his dad's side. The patient's medical history (including any illness at time of vaccination) included allergic to pollen. The patient's concomitant medications were not reported. History of all previous immunization with the Pfizer vaccine considered as suspect (or patient age at first and subsequent immunizations if dates of birth or immunizations are not available) was reported as this was his first dose. Additional vaccines administered on same date of the Pfizer suspect was reported as none. Prior vaccinations (within 4 weeks) prior to the first administration date of the suspect vaccine(s) were reported as none. The AE(s) following prior vaccinations were reported as none. Enquired, inbound call received, warm transfer from (name withheld) with DSU, NTID - #, Reportum - #. The caller was transferred from one place to another, CEP 159558. The caller was a consumer who received his first vaccine dose on 25Jun2021 in his right arm, lot: EW0183 or EO183. There is a date on the back of the card that says 03Sep2020. Stated that, the reporter was going to be a healthcare professional (dental hygienist) in a couple of months. It was required for the dental field so he had to get the vaccine. Afterwards the patient experienced a headache and he went to the emergency room. It was from the back of his head down to his spine and he lost control of his knees for some reason. The headache started 2 days prior to when he went to the emergency room on 08Jul2021 in the afternoon. He still has the headache a little bit. It was a little better. After his first dose of the Covid vaccine, his heart started hurting about 10 days later. When he went to the hospital, he started getting heart arrhythmia and was in the emergency room on 10Jul2021 at 22:00. When he went to the hospital on the first day, he was not admitted, he was in the emergency room. It lasted from 10Jul2021, 11Jul2021, 12Jul2021, and part of 13Jul2021. Stated that, he was 80% recovered. The caller reported that, he was supposed to get his second dose of the vaccine tomorrow and asked, was it ok or safe to postpone that dose to a later time or would that cause side effects. He wanted to go to the doctor and find out whether the heart problems were from the vaccine. Stated that, the caller comes on the line. He verified information provided by transfer agent. Stated that, he has a question regarding the timeless between the first and second dose. Stated that, he knows it was supposed to be 2 weeks max. He had an arrhythmia, it was very high up and he ended up in the hospital. The patient was hospitalized for the event arrythmia. The EKG was normal, but to be on the safe side he was hoping to postpone the second dose. He asked whether he can get the second dose after 4 weeks if possible. The AEs require a visit to emergency room was reported as yes and physician office was reported as no. On 10Jul2021, the patient underwent lab tests and procedures which included blood test, resulted as unknown results and EKG, resulted as normal, heart started hurting, resulted as increased. The outcome of the events for heart arrythmia was recovered on 13Jul2021 and for headache was recovering while for the other events was unknown.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Arrhythmia
Hospital-Tage: -
Labordaten: Test Date: 20210710; Test Name: blood test; Result Unstructured Data: Test Result:Unknown results; Test Date: 20210710; Test Name: EKG; Result Unstructured Data: Test Result:normal; Test Date: 20210710; Test Name: heart started hurting; Result Unstructured Data: Test Result:increased
Aktuelle Erkrankungen: -
Vorgeschichte: Medical History/Concurrent Conditions: Cardiovascular disorder; Pollen allergy (Allergic to pollen)
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1509696

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EW0183

moderat

Staat: CO
Alter: 32,0
Geschlecht: F
Eingang: 28.07.2021
Impfdatum: 10.05.2021
Beginn: 13.05.2021
Tage bis Beginn: 3,0
Dosis: 2
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: ja

Blood chloride increased Blood creatinine decreased Blood electrolytes Carbon dioxide decreased Condition aggravated Full blood count Haematocrit decreased Haemoglobin decreased Pain SARS-CoV-2 test negative Sickle cell anaemia with crisis

Symptomtext

Pfizer-BioNTech COVID-19 Vaccine EUA: Patient presented to emergency department (ED) in painful sickle cell crisis. Patient receives monthly exchange transfusions, utilizes oxygen at home at night, and has been hospitalized frequently for painful sickle cell crises. Symptoms were managed with home pain medication regimen but pain intensified after vaccination and could no longer be managed at home. Patient admitted, received analgesics and oxygen, infectious workup negative, and discharged to home medically stable.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Condition aggravated
Hospital-Tage: 19,0
Labordaten: In ED: Hemoglobin: 7.7 mg/dL, hematocrit: 24.0, rest of CBC within normal ranges Chloride 109 mmol/L, CO2 20 mmol/L, creatinine 0.48 mg/dL, rest of electrolytes within normal ranges SARS-CoV-2 RNA; negative
Aktuelle Erkrankungen: sickle cell crisis
Vorgeschichte: cholelithiasis, phlebitis, thrombophlebitis, sickle cell anemia, CVA in childhood, thromboembolic disorder
Andere Medikamente: diphenhydramine, duloxetine, Flonase nasal, lamotrigine, methadone, morphine, rivaroxaban, trazodone, drospirenone
Allergien: None reported
Vorherige Impfungen: -

VAERS 1509657

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EW0183

moderat

Staat: TX
Alter: 54,0
Geschlecht: F
Eingang: 28.07.2021
Impfdatum: 21.07.2021
Beginn: 22.07.2021
Tage bis Beginn: 1,0
Dosis: 1
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Chest discomfort Dyspnoea Exercise tolerance decreased Sensation of blood flow Sensory disturbance

Symptomtext

Tightness in chest, vascular sensations in head that come and go, muscle sensation that comes and goes in right leg above the knee to the outer side of the knee. Have not sought treatment as these are indicated side effects. Will decide to seek treatment if continues or worsens. Have refrained from exercise. Still can perform daily activities, but seem winded at times.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Dyspnoea
Hospital-Tage: -
Labordaten: None
Aktuelle Erkrankungen: None
Vorgeschichte: None
Andere Medikamente: None
Allergien: NKA
Vorherige Impfungen: -

VAERS 1508786

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EW0183

moderat

Staat: CA
Alter: 18,0
Geschlecht: F
Eingang: 28.07.2021
Impfdatum: 24.05.2021
Beginn: -
Tage bis Beginn: -
Dosis: 1
Route/Site: - / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Burning sensation Chest pain Dyspnoea

Symptomtext

Chest pain; Breathing difficulty; Part of my body is like burning now; side of my body, my back is burning; This is a spontaneous report from a contactable consumer. A 18-year-old female patient received bnt162b2 (BNT162B2, Solution for injection), dose 1 via an unspecified route of administration, administered in Arm Right on 24May2021 (Batch/Lot Number: EW0183) as DOSE:1, SINGLE for covid-19 immunisation. The patient's medical history and concomitant medications were not reported. On an unknown date patient experienced chest pain , breathing difficulty, part of my body is like burning now; side of my body, my back is burning. Consumer stated, I am having some side effects from my vaccine, chest pain and difficulty breathing and then a part of my body is like burning now. Do you know if it's an allergy? I don't know what it is? Consumer stated, Yeah, really bad chest pain like the first day I took it which goes away but today I am experiencing the back of my body really some it should I don't know, something wrong in my body. Consumer stated, the breathing that has gotten better but reactions today, side of my body, my back is burning. Consumer stated, I have just received the first shot. The date that was I believe that was 24MAY at, I believe that 2:05. Expiration Date of first dose of COVID Vaccine: Consumer stated, No, I don't see it expiration date, I only see the date I took the Vaccine. Consumer stated, I would say the first day I experience like chest pain and little difficulty to breathe and then that went away. That was the first day yes and the second day no symptoms and then the third day I have been just happen initially today just like the back of my body is like burning. Consumer stated, I believe on the right side, I got the shot on my right arm I believe. Consumer stated, all medical condition I have just allergies that is it. (Further not clarified. Hence, not captured in tab). Consumer stated, I have not taken any treatment. Consumer was informed about the for the concern and was provided with the number as ## and requested to dial the option 3 and informed about timings as 8AM to 8PM Monday to Friday and 9AM to 3PM Saturday and Sunday as per time. The outcome for the events was unknown. Follow-up attempts completed. No further information expected.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Chest pain
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1505706

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EW0183

moderat

Staat: NY
Alter: 33,0
Geschlecht: F
Eingang: 27.07.2021
Impfdatum: 23.07.2021
Beginn: 23.07.2021
Tage bis Beginn: 0,0
Dosis: UNK
Route/Site: - / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt

Anxiety Dizziness Dyspnoea Nausea

Symptomtext

15 minutes after administration of Pfizer vaccine her Initial complaint was light headedness and nausea, shortly followed by shortness of breath and anxiety. Taken to ED

Weitere VAERSDATA-Felder

Praegender Schweregrund: Dyspnoea
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1505417

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EW0183

moderat

Staat: CA
Alter: 34,0
Geschlecht: F
Eingang: 27.07.2021
Impfdatum: 14.06.2021
Beginn: 19.06.2021
Tage bis Beginn: 5,0
Dosis: 2
Route/Site: UN / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein

Chest pain Computerised tomogram thorax Dyspnoea Laboratory test Nausea

Symptomtext

chest pain, shortness of breath, nausea

Weitere VAERSDATA-Felder

Praegender Schweregrund: Chest pain
Hospital-Tage: -
Labordaten: CT chest, labs
Aktuelle Erkrankungen: migraines
Vorgeschichte: migraines
Andere Medikamente: none
Allergien: none
Vorherige Impfungen: -

VAERS 1503132

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge ew0183

moderat

Staat: CA
Alter: 30,0
Geschlecht: M
Eingang: 26.07.2021
Impfdatum: 26.07.2021
Beginn: 26.07.2021
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: - / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Condition aggravated Dizziness Nausea Pallor

Symptomtext

client's fiance alerted EMTs client was lightheaded and with nausea. EMT brought client anti-gravity chair and emesis bag. EMT began vitals. PHN arrived at 1825, client sitting upright in chair, pale, alert and oriented 4. Per client has history of syncope with needles but did not tell vaccinator. Client stated on his way to observation began feeling lightheaded and "felt his heart racing". Vitals at 1925: blood pressure 132/76, pulse 57, oxygen sat 99%. Client stated no additional medical history, no current medication, no known allergies. Client denied headache, blurry vision, nausea, chest pain, palpitations, or shortness of breath. PHN gave client water and asked client to take small sips. Client asked to stay longer in observation. EMTs stayed with client. Vitals at 1835: blood pressure 135/70, pulse 67, oxygen sat 98%. Client stated nausea resolved and lightheadedness improving. EMT gave client Capri-Sun juice at client's request. Client brought to a sitting position in anti-gravity chair. Client's skin color normal for ethnicity. PHN advised client to not drive, per client fiance would drive. Vitals at 1845: blood pressure 130/68, pulse 60, oxygen 99%. Client stated "there is no more nausea and no dizziness". Client informed EMTs he wanted to stand up and walk. At 1847 client stated he wanted to leave. EMTs advised client to follow up with provider and gave ER precautions. Client left before completing observation time and left facility with steady gait at 1848.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Condition aggravated
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: hx of syncope with needles
Andere Medikamente: none
Allergien: none
Vorherige Impfungen: -

VAERS 1502338

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EW0183

moderat

Staat: -
Alter: 52,0
Geschlecht: F
Eingang: 26.07.2021
Impfdatum: 23.07.2021
Beginn: 23.07.2021
Tage bis Beginn: 0,0
Dosis: 2
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Paraesthesia oral Vaccine positive rechallenge

Symptomtext

At approximately 1625, patient reported a tingling sensation in the lips. Patient denied itchiness, rashes, hives, swelling of lips/tongue, difficulty breathing, and difficulty swallowing. Patient given water. Patient able to drink water. Patient reported similar reaction to first dose. Patient reported following up with primary care provider regarding first dose reaction. Patient stated "my doctor said it was okay to get the second shot". Patient reported no known allergies. Patient reported history of hypertension and current medications include metoprolol and amlodipine for hypertension. Patient offered intramuscular diphenhydramine. Patient agreed to intramuscular diphenhydramine. At 1627, RN assessed patient vital signs: 179/103 mmHg, pulse 70 beats/minute, and SpO2 97%. At 1634, RN administered 50 mg/1 ml intramuscular diphenhydramine in patient's right deltoid. Patient advised to wait for 30 minutes for further observation. At 1639, RN assessed patient vital signs: blood pressure 160/105 mmHg, pulse 69 beats/minute and SpO2 98%. At 1645, EMT assessed patient vitals signs: blood pressure 162/92 mmHg, pulse 64 beats/minute, and SpO2 96%. Patient reported feeling less tingling in the lips. At 1648, patient reported the tingling in the lips felt "very faint". At 1651, EMT assessed patient vital signs: blood pressure 150/92 mmHg, pulse 65 beats/minute, and SpO2 96%. At 1700, lead nurse assessed patient. Patient stated "the tingling is completely gone". Patient denied swelling of lips/tongue, difficulty swallowing, and difficulty breathing. Patient denied drowsiness and reported she can drive herself home. Lead nurse educated patient on signs/symptoms of when to seek emergency care, to follow up with primary care provider, and to sign up on v-safe. At approximately 1703, patient left facility with unlabored respirations and steady gait.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Paraesthesia oral
Hospital-Tage: -
Labordaten: none
Aktuelle Erkrankungen: none reported
Vorgeschichte: hypertension
Andere Medikamente: metropolol and amlodipine for hypertension
Allergien: no known allergies
Vorherige Impfungen: Patient reported tingling lips after her first dose of her Pfizer vaccine.

VAERS 1501450

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EW0183

moderat

Staat: TX
Alter: 15,0
Geschlecht: F
Eingang: 26.07.2021
Impfdatum: 14.05.2021
Beginn: 18.05.2021
Tage bis Beginn: 4,0
Dosis: UNK
Route/Site: SYR / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: nein

Asthenia Blood test normal Cough Dizziness Dyspnoea Furuncle Heart rate increased Hypotension Laboratory test normal Monoplegia Oropharyngeal pain Pain SARS-CoV-2 test negative

Symptomtext

continues cough, heavy body pain ,shortness of breath, dizziness, low blood pressure, high heart rate, pain full boils on body, sore throat,

Weitere VAERSDATA-Felder

Praegender Schweregrund: Dyspnoea
Hospital-Tage: 2,0
Labordaten: 3 covid test done all came out negative 5/26/2021 at 11 PM i was taken by ambulance to Hospital with all above mentioned trouble. Covid tests were done and all came out negative. kept all night in the waiting area with no treatment given. Dad brought me back home on 5/27/2021 at 7:30 AM and took me to my pediatrician. 5/27/2021 blood test was done by Dr., (my pediatrician) all reports came out negative. medication given by doctor had no effects 5/28/2021 my parents took me to Hospital. I was taken in immediately. all tests came out negative. They gave me medication and sent me home. But the medication didn't help We called my other pediatrician and told my situation and he recommended to go to the ER because my situation was getting worse 6/2/2021 was taken again to Hospital ER and treatment was started and did more test and more medication and i was sent home 6/3/2021 I was taken to Dr. and he gave me medication and i was still having pain but it took me weeks to feel little better and to this day I still have weakness, shortness of breath, arm pain and the boils on my body
Aktuelle Erkrankungen: N/A
Vorgeschichte: N/A
Andere Medikamente: N/A
Allergien: any type of nuts
Vorherige Impfungen: -

VAERS 1498412

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EW0183

moderat

Staat: CA
Alter: 36,0
Geschlecht: F
Eingang: 23.07.2021
Impfdatum: 22.07.2021
Beginn: 22.07.2021
Tage bis Beginn: 0,0
Dosis: 2
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Chest discomfort Condition aggravated Dizziness Headache Injection site pain Paraesthesia Vision blurred

Symptomtext

Client received second dose of Covid vaccine @3:39pm, complained of tingling feeling in chest and blurred vision. Client was vaccinated in zero-gravity chair, given water to drink. Vital signs stable. At 4:14pm client complained of internal itching, dizziness, blurred vision. Vital signs stable, denied shortness of breath and difficulty breathing. At 4:24 pm client offered Benadryl, she declines, reports less tingling , no itchiness, complains of headache, sore arm, less tingling. At 4:30pm, client attempts to stand up, would like to go home. Client reports dizziness. Back in chair and observed. Vital signs are stable. Client able to go home @4:35 pm with steady gait and support person, client reports only headache and sore arm at injection site.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Condition aggravated
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: Unknown
Vorgeschichte: Unknown
Andere Medikamente: Prenatal vitamins
Allergien: Nuts, drinking alcohol
Vorherige Impfungen: Client reports migraine headache, red specks, tingling, itchiness, blurred vision, dizziness within 15 minutes of receiving firs

VAERS 1493623

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EW0183

moderat

Staat: -
Alter: 47,0
Geschlecht: M
Eingang: 22.07.2021
Impfdatum: 12.05.2021
Beginn: 08.07.2021
Tage bis Beginn: 57,0
Dosis: UNK
Route/Site: - / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Hypertension

Symptomtext

Experiencing unusually high/extremely high blood pressure.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Hypertension
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: Zyrtec
Allergien: -
Vorherige Impfungen: -

VAERS 1488008

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EW0183

moderat

Staat: CA
Alter: 55,0
Geschlecht: F
Eingang: 20.07.2021
Impfdatum: 20.07.2021
Beginn: 20.07.2021
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Blood pressure increased Condition aggravated Dizziness Intentional dose omission Limb discomfort Nausea

Symptomtext

Client reported dizziness to EMT's upon arrival to the observation area at 2:06PM. The client began drinking water. The client ambulated unassisted from a chair to the anti-gravity chair and sat down in the anti-gravity chair. The anti-gravity chair was then placed in the reclined position. The client reported that she did eat breakfast. Client denied any shortness of breathe. Vitals obtained at 2:10PM were as follows: manual BP 176/80, HR 89, O2 94%. Provided education regarding elevated blood pressure and recommended the client follow up with PCP within one month. The client reported she does not currently have a PCP. The client has a history of hypertension. She stated that she was prescribed Lisinopril and Hydralazine daily by her PCP. The client stated her gynecologist recommended she take her blood pressure medications as needed. The client states she takes the medications as needed when she has a headache or feels her pulse is fast. The client denied taking her medications today. The client was unsure of her regular blood pressure. At 2:14PM the client responded, "No, I'm feeling better." RN provided education regarding s/s of anaphylaxis, when to seek EMS, and V-safe. The client voiced understanding of this education. Vitals obtained by at 2:18PM were as follows: BP 176/86, HR 75, and O2 95%. The client denied feeling dizziness at that time. At 2:21 PM the client took her personal Lisinorpil and Hydralazine PO. At 2:23PM the client reported feeling dizzy and nausea. Moved the anti-gravity chair into an upright position. The client was provided an emesis bag and held it up to her face. EMT offered to activate EMS. The client was unsure if she wanted EMS activated. Vitals obtained at 2:28PM were as follows: HR 86 and O2 98%. The client stated, "my legs feel heavy." Activated 911 at 2:29PM. Manual BP taken at 2:35 by EMT was 178/75. At 2:36PM the client stated she was feeling a little better, and that the heaviness in her legs comes in waves. At 2:41PM the client reported that her legs did not feel heavy and denied any nausea. At 2:45PM the client denied any dizziness, and said her legs did not feel heavy. The client stated "I feel good now." Vitals obtained at 2:45PM were as follows: manual BP 178/89, HR 77, O2 98%. At 2:54PM EMS arrived and assumed care. The client denied EMS transportation. The client signed paperwork with EMS at 3:12PM. Client left the facility unassisted with a steady gait at 3:15PM. .

Weitere VAERSDATA-Felder

Praegender Schweregrund: Condition aggravated
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: Hypertension
Andere Medikamente: Lisinopril & Hydrochlorothiazide
Allergien: -
Vorherige Impfungen: -

VAERS 1482840

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EW0183

moderat

Staat: WI
Alter: 57,0
Geschlecht: F
Eingang: 18.07.2021
Impfdatum: 20.05.2021
Beginn: 20.05.2021
Tage bis Beginn: 0,0
Dosis: 2
Route/Site: OT / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: ja ER: unbekannt Erholt: nein

Alopecia Decreased appetite Fatigue Insomnia Migraine Myalgia Nausea Weight increased

Symptomtext

hair loss; migraine; Nausea; Fatigue; increase weight gain; no appetite; shooting pain in the muscles; Insomnia for 9 days; This is a spontaneous report from a contactable nurse. A 57-year-old female nurse (patient) reported for herself. A 57-years-old non pregnant female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, Batch/Lot Number: EW0183, Expiration date: Unknown), via intramuscular route, administered in left arm (deltoid) on 20May2021 16:00 (at the age of 57-years-old) as dose 2, single for covid-19 immunisation in public health clinic/veterans administration facility. Medical history included known allergies. The concomitant medications were none. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. The patient previously received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, Batch/Lot Number: EW0179, Expiration date: Unknown), via intramuscular route, administered in deltoid on 29Apr2021 (at the age of 57-years-old) as dose 1, single for covid-19 immunisation and no problem with first injection. On 20May2021 at 02:00 Am, the patient experienced insomnia for 9 days. On 21May2021 at 02:00, the patient experienced, hair loss, migraine, nausea For 4 weeks, fatigue, increase weight gain, no appetite, shooting pain in the muscles. Since the vaccination, the patient has not been tested for COVID-19. Therapeutic measures were taken as a result of insomnia for 9 days, migraine with smudging with SAGE disease and Tylenol 500 mg respectively. The event Insomnia and nausea were reported as Persistent/ Significant disability/ Incapacity, Important medical event, migraine was reported as Persistent/ Significant disability/ Incapacity, and hair loss was reported as Important medical event. The outcome of the event migraine was resolved on an unspecified date in 2021 and nausea was resolved on 15Jun2021, hair loss was not resolved and other events were resolving. Follow-up attempts are needed. Further information is requested. Follow-up: This is a follow up-spontaneous report from a contactable other HCP (nurse). This other HCP (nurse) reported in response to HCP letter via follow-up letter:; Sender's Comments: Considering a plausible temporal relationship, a possible contributory role of suspect product BNT162B2 to the reported Insomnia, hair loss and Migraine cannot be excluded. The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to Regulatory Authorities, Ethics Committees, and Investigators, as appropriate.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Migraine
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: Medical History/Concurrent Conditions: Allergy
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1474745

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EW0183

moderat

Staat: -
Alter: 27,0
Geschlecht: F
Eingang: 15.07.2021
Impfdatum: 05.05.2021
Beginn: 25.05.2021
Tage bis Beginn: 20,0
Dosis: UNK
Route/Site: - / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: unbekannt

Back pain Chest pain Complication of pregnancy Dyspnoea Exposure during pregnancy Premature rupture of membranes

Symptomtext

pregnant at time of vaccination On 5/25/21, patient presented to ED and was admitted O24.420 - Gestational diabetes mellitus in childbirth, diet controlled O42.02 - Full-term prem ROM, onset labor within 24 hours of rupture On 6/10/21, patient presented to ED: O99.893 - Other specified diseases and conditions complicating puerperium CHEST PAIN SHORTNESS OF BREATH BACK PAIN

Weitere VAERSDATA-Felder

Praegender Schweregrund: Chest pain
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1470739

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EW0183

moderat

Staat: UT
Alter: 50,0
Geschlecht: F
Eingang: 14.07.2021
Impfdatum: 11.06.2021
Beginn: 11.06.2021
Tage bis Beginn: 0,0
Dosis: 2
Route/Site: SYR / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Anosmia Chills Fatigue Feeling abnormal Headache Injection site erythema Mobility decreased Nausea Oral disorder Pain Peripheral swelling Vaccination site pain Vaccination site swelling

Symptomtext

I had pained at the vaccination site with swelling and redness. I was fatigue, nausea, headache, chills, and body aches. I also loss my sense of smell as well. I was in bed for a few days after my shot. I also had brain fogs. I had swelling my lower extremities. I got tress in my mouth for 3 times now.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Mobility decreased
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: Hashimoto Thyroiditis high blood pressure anxiety depression
Andere Medikamente: Synthroid, Leica, Alpine, Thorndale, Zolfo , Melatonin, Cali sum (Vitamin D), inhaler as needed.
Allergien: Penicillin, Amoxicillin
Vorherige Impfungen: -

VAERS 1466968

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge Ew0183

moderat

Staat: TX
Alter: 16,0
Geschlecht: F
Eingang: 13.07.2021
Impfdatum: 13.07.2021
Beginn: 13.07.2021
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Palpitations

Symptomtext

Complains of heart palpitations , pulse 120 when checked. Please went down to 105.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Palpitations
Hospital-Tage: -
Labordaten: Pulse ox, hydrate
Aktuelle Erkrankungen: None
Vorgeschichte: None
Andere Medikamente: None
Allergien: None
Vorherige Impfungen: -

VAERS 1466796

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EW0183

moderat

Staat: CA
Alter: 51,0
Geschlecht: M
Eingang: 13.07.2021
Impfdatum: 22.05.2021
Beginn: -
Tage bis Beginn: -
Dosis: 2
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Arthralgia Musculoskeletal stiffness Paraesthesia Sleep disorder

Symptomtext

Body stiffness to the point where other people have noticed it. Knee pain. Sleep disturbance problems. Tingling sensation on my back. I will be seeing a doctor soon regarding these issues.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Paraesthesia
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1417581

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EW0183

moderat

Staat: -
Alter: 58,0
Geschlecht: F
Eingang: 13.07.2021
Impfdatum: 04.05.2021
Beginn: 01.05.2021
Tage bis Beginn: -
Dosis: 2
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Biopsy kidney Blood culture Chills Computerised tomogram Dehydration Fatigue Feeling abnormal Headache Night sweats Full blood count Metabolic function test Pallor Pyrexia Nightmare Pain in extremity Taste disorder Urine odour abnormal Renal failure

Symptomtext

urinated and had an odor that came out of her that was so pungent like sulfur and ammonia; sore arm; chills; night sweats; Taste was definitely altered; headache; doesn't feel like herself; nightmare; fatigue; This is a spontaneous report received from a contactable consumer (patient). A 58-years-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation solution for injection, lot number: EW0170 and expiration date unknown) via an unspecified route of administration, administered in Arm Left on 04May2021 as dose 1, single dose for covid-19 immunization (at the age of 58-years-old). The patient medical history and concomitant medications were reported as no. It was reported by the patient that on 04May2021 she received first dose of vaccine and stated that she was in the hospital and was fine in perfect health, and after very first dose, on 05May2021 she had sore arm, and three days later on 07May2021 she woke up in the middle of the night and urinated and had an odour that came out of her that was so pungent like sulfur and ammonia. She thought "this was not a UTI" because the urine wasn't cloudy or anything, then she went back to bed. After that in the morning she woke up later and she smelled the same smell again to check if it was in the urine and so she smelled the toilet, but she could not smell it. After that the next time she urinated, she urinated in a container and the urine smelled normal and it appeared that this odour was coming out when the caller was urinating from the kidney or vagina and mentioned that it happened 4 times and then vanished. Then may be 3 days, on an unknown date in May2021, she experienced chills and night sweats where the bed was completely wet to the mattress cover and her taste buds-she can not say she lost her taste, but her taste was definitely altered, even the toothpaste tasted differently, everything tasted differently. After that she was starting to connect the dots like she had covid but knew she did not. She was experiencing the chills and fatigue which was all part of it, and the headache, then that gradually dissolved. Then she kept saying she did not feel herself. She also stated that the chills and sweating were nonstop and later on, it was not as much but the sweats were still there. Then she had a nightmare and every hour on the hour she would have to get up and change from the night sweats. The patient was on the road to recovery. The patient was recovered from the event of urine odour abnormal on 07May2021 and from event night sweats on 13Jun2021 and was recovering from rest of the other events. Follow-up attempts are needed. Further information is expected

Weitere VAERSDATA-Felder

Praegender Schweregrund: Dehydration
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1464806

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EW0183

moderat

Staat: PA
Alter: 61,0
Geschlecht: F
Eingang: 12.07.2021
Impfdatum: 01.06.2021
Beginn: 01.06.2021
Tage bis Beginn: 0,0
Dosis: UNK
Route/Site: SYR / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Burning sensation Erythema Paraesthesia

Symptomtext

notice a tingling burning sensation throughout my body. Also redness on chest and pins and needles throughout body.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Paraesthesia
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: none
Vorgeschichte: high cholesterol, high blood pressure
Andere Medikamente: pravastatin, levothyroxine, losartan, Vit. D & Vit B12
Allergien: sulfa
Vorherige Impfungen: -

VAERS 1462016

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EW0183

moderat

Staat: WA
Alter: 42,0
Geschlecht: F
Eingang: 10.07.2021
Impfdatum: 11.06.2021
Beginn: 11.06.2021
Tage bis Beginn: 0,0
Dosis: 2
Route/Site: SYR / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Abdominal discomfort Arthralgia Back pain Blood test Bone pain Chills Diarrhoea Fluid retention Gait disturbance Headache Influenza like illness Insomnia Joint swelling Mobility decreased Musculoskeletal stiffness Nausea Pain in extremity Pyrexia

Symptomtext

The first night I had a mild fever and Severe headache. Then my neck was stiff the next day and my back was sore in addition to the headache. I had nausea and chills. I also had stomach upset with diarrhea. Then over the next few days the pain stayed in my back and I felt like I had the flu. By the 5th day, I felt like I had pain in my bones in my legs. The pain was bad enough that I couldn't sleep at night. I was taking ibuprofen several times a day and waking up in the middle of the night to take more ibuprofen. After a full two weeks of leg pain my doctor sent me to have an ultrasound of my veins in my legs because of the pain. I also had a little swelling in my left ankle. The ultrasound came back ok. The pain has subsided for the most part, but I still have pain in my left ankle. Yesterday I sat with my foot up most of the afternoon because of the pain. And it kept me up last night. I took Tylenol before bed and again at 5:00 AM because I couldn't sleep from my ankle aching. This morning when I got up, my left ankle is swollen and still aching. I have occasional pain in my legs, and left arm. But the ankle pain in my left ankle and swelling for no reason are starting to concern me. It's now been a month since my second dose of the vaccine and I'm walking with a limp because my ankle is so sore. There appears to be a bit of fluid on my ankle, or swelling. And I haven't done anything that would cause this. The pain is exactly the same as it started, its an ache in the bones and joints.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Mobility decreased
Hospital-Tage: -
Labordaten: Ultrasound of the veins in my legs was done on 06/16/2021 and blood work was also done on 06/16/2021
Aktuelle Erkrankungen: Hypothyroid
Vorgeschichte: Hypothyroid
Andere Medikamente: Euthyrox 137 MCG 1x per day ( Hypothyroid ) Liothyronine 50 MCG 1x per day ( Hypothyroid ) Progest 200 MG 1 x per day Magnesium Citrate 150mg 1x per day
Allergien: Sesame oil, sulfa, vicodin
Vorherige Impfungen: -

VAERS 1461914

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EW0183

moderat

Staat: IL
Alter: 46,0
Geschlecht: M
Eingang: 10.07.2021
Impfdatum: 20.05.2021
Beginn: 20.05.2021
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Arthralgia Chest discomfort Disturbance in attention Dyspnoea Fatigue Gait disturbance Headache Joint swelling Magnetic resonance imaging head normal Malaise Pain in extremity Rash Rash pruritic Tachycardia Tinnitus Ultrasound scan normal X-ray limb normal

Symptomtext

Rash eczema/psoriasis behind left knee and by right knee. Knee pain including significant swelling behind left knee which has resolved. Rash behind left knee resolved but right knee rash (burning/itching) has persisted but improved and using topical steroid. Severe diffuse headache, difficulty concentrating, slow performance, tachycardia to 120's mainly and some shortness of breath and left sided chest pressure for 48 hours along with fatigue. June 01, had tinnitus for a day. June 07, general intense feeling of not feeling well and headache. June 15, developed severe left leg pain and malaise. June 23, 8-9/10 pain behind left thigh and difficulty walking. Later developed exacerbation of prior mild right knee pain of recent onset to point could not walk.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Dyspnoea
Hospital-Tage: -
Labordaten: 06-10: ultrasound of left leg negative for DVT; normal knee x-rays; MRI of brain negative except non-specific white matter changes MRI's of knees at a later date showing meniscal tears
Aktuelle Erkrankungen: none
Vorgeschichte: Had Covid-19 in early Feb 2021
Andere Medikamente: None
Allergien: generic levaquin
Vorherige Impfungen: -

VAERS 1458621

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EW0183

moderat

Staat: CO
Alter: 36,0
Geschlecht: F
Eingang: 09.07.2021
Impfdatum: 03.07.2021
Beginn: 05.07.2021
Tage bis Beginn: 2,0
Dosis: 1
Route/Site: SYR / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: ja

Abdominal distension Abdominal pain upper Anxiety Blood test Chest pain Electrocardiogram X-ray

Symptomtext

Stubbing chest pain for a couple times for 1 day, bloating and pain stomach and anxiety (in the morning of July 4th and a few hours in afternoon) Following day mild chest pain and anxiety ( July 5th late afternoon and night) July 6th in morning I went to Emergency room to get checked.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Chest pain
Hospital-Tage: -
Labordaten: Heart ECG Heart X-ray Blood work All tests were made on July 6th
Aktuelle Erkrankungen: -
Vorgeschichte: Hypothyroidism
Andere Medikamente: Iboprufen
Allergien: Betamethasone
Vorherige Impfungen: Steroids' injection- allergy to Betamethasone

VAERS 1457173

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EW0183

moderat

Staat: DE
Alter: 51,0
Geschlecht: F
Eingang: 08.07.2021
Impfdatum: 30.06.2021
Beginn: 01.07.2021
Tage bis Beginn: 1,0
Dosis: 1
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Arthralgia Burning sensation Dizziness Dyspnoea Fatigue Headache Mobility decreased Pain in extremity Palpitations Pyrexia Tinnitus

Symptomtext

The first day: I had symptoms of fatigue, mild headache, dizziness and buzzing in my ears, could not get out of bed, in the afternoon I had fever (99F), my arm was burning and it hurt. I called the Dr. and she told me the symptoms the vaccine causes (headache, burning). She told me to wait a week and if it continued to go see a doctor. I took anti-allergy medicine and it helped me. I am taking azelastine (nasal allergy) and it has helped me. 2nd day: Rapid heart palpitations (heart pounding). 3rd day: Palpitations and shortness of breath when changing positions. I also have a pain above my hip on the right side.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Dyspnoea
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: Fever, Throat pain, sinus infection
Vorgeschichte: Sjogren's Syndrome and joint inflammation
Andere Medikamente: CONCOR; hydroxyzine -HCl - (did not take it 3days before and 3 days after)
Allergien: Severe Urticaria. NSAIDS. Sulfa, Latex, Penicillin
Vorherige Impfungen: -

VAERS 1379731

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EW0183

moderat

Staat: WA
Alter: 17,0
Geschlecht: F
Eingang: 08.07.2021
Impfdatum: 25.05.2021
Beginn: 25.05.2021
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: - / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein

Cardiac monitoring Dizziness Electrocardiogram Sinus tachycardia

Symptomtext

Postural orthostatic sinus tachycardia; This is a spontaneous report from a contactable consumer (patient). A 17-years-old non-pregnant female patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, Lot Number: EW0183), via an unspecified route on 25May2021 at 14:30 (at the age of 17-years) as dose 1, single in the right arm for covid-19 immunisation. The patient medical history included migraines and known allergies to cetirizine hydrochloride (ZYRTEC). The patient concomitant medications were not reported. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient did not receive any other medications within two weeks prior to the vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. On 25May2021 at 14:45, the patient experienced postural orthostatic sinus tachycardia. The patient visited to emergency room and physician office. The patient did not received treatment for events. Since the vaccination, the patient had not been tested for COVID-19. The outcome of the events was not resolved. Information on Lot/Batch number was available. Additional information has been requested Follow-up (28Jun2021): Follow-up attempts are completed. No further information is expected.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Sinus tachycardia
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: Medical History/Concurrent Conditions: Migraine
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1379731

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EW0183

moderat

Staat: WA
Alter: 17,0
Geschlecht: F
Eingang: 08.07.2021
Impfdatum: 25.05.2021
Beginn: 25.05.2021
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein

Cardiac monitoring Dizziness Electrocardiogram Sinus tachycardia

Symptomtext

Postural orthostatic sinus tachycardia; This is a spontaneous report from a contactable consumer (patient). A 17-years-old non-pregnant female patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, Lot Number: EW0183), via an unspecified route on 25May2021 at 14:30 (at the age of 17-years) as dose 1, single in the right arm for covid-19 immunisation. The patient medical history included migraines and known allergies to cetirizine hydrochloride (ZYRTEC). The patient concomitant medications were not reported. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient did not receive any other medications within two weeks prior to the vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. On 25May2021 at 14:45, the patient experienced postural orthostatic sinus tachycardia. The patient visited to emergency room and physician office. The patient did not received treatment for events. Since the vaccination, the patient had not been tested for COVID-19. The outcome of the events was not resolved. Information on Lot/Batch number was available. Additional information has been requested Follow-up (28Jun2021): Follow-up attempts are completed. No further information is expected.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Sinus tachycardia
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: Medical History/Concurrent Conditions: Migraine
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1454456

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EW0183

moderat

Staat: MN
Alter: 46,0
Geschlecht: M
Eingang: 07.07.2021
Impfdatum: 06.05.2021
Beginn: 24.06.2021
Tage bis Beginn: 49,0
Dosis: 2
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein

Cardiovascular evaluation Chest X-ray Chest pain Electrocardiogram Full blood count Metabolic function test Muscle strain Palpitations

Symptomtext

chest pain, palpitations, muscle strain

Weitere VAERSDATA-Felder

Praegender Schweregrund: Chest pain
Hospital-Tage: -
Labordaten: CBC, BMP, cardiac labs, chest xray, EKG
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1453756

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EW0183

moderat

Staat: NJ
Alter: 23,0
Geschlecht: F
Eingang: 07.07.2021
Impfdatum: 16.06.2021
Beginn: 16.06.2021
Tage bis Beginn: 0,0
Dosis: 2
Route/Site: - / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Disease recurrence Migraine

Symptomtext

I have had a migraine for the past week since I received the vaccine.; I have had a migraine for the past week since I received the vaccine.; This is a spontaneous report from a contactable consumer (Pharmacist). This Pharmacist reported for herself. A 23-years-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection. Lot Number: EW0183), dose 2 via an unspecified route of administration, administered in right arm on 16Jun2021 at 13:30 (at the age of 23-years-old) as dose 2, single for COVID-19 immunization. Medical history included migraine. Historical vaccine included 1st of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Lot Number: EW0187) as 1st single dose, administered in right arm, on 25May2021 at 02.30AM. Facility where the most recent COVID-19 vaccine was administered at hospital. Patient did not receive any other vaccines within 4 weeks prior to the COVID-19 vaccine. The patient had not been tested for COVID-19 nor before neither since the vaccination. Concomitant medications received within 2 weeks of vaccination include ibuprofen (ADVIL MIGRAINE), sumatriptan (SUMATRIPTAN) and omeprazole (OMEPRAZOLE). The patient experienced migraine for the past week since patient received the vaccine on 16Jun2021 at 08:00. On the second day, patient took 800mg of ibuprofen and 1000 mg of Tylenol ES and it did nothing to my migraine. Patient have had to take several sumatriptans since then and it only "dulls" patient migraines but it does not go away. Patient had been trying higher doses of ibuprofen (not exceeding total daily dose) and sumatriptan together, which had managed to allow patient to get through the day, but migraines had not went away. The outcome of the event was not recovered. Additional Information has been requested.; Sender's Comments: As there is temporal relationship in the case provided, the causal association between the event and the suspect drug cannot be excluded. The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to RAs, Ethics Committees, and Investigators, as appropriate.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Migraine
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: Medical History/Concurrent Conditions: Migraine
Andere Medikamente: ADVIL MIGRAINE; SUMATRIPTAN; OMEPRAZOLE
Allergien: -
Vorherige Impfungen: -

VAERS 1437782

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EW0183

moderat

Staat: CA
Alter: 60,0
Geschlecht: F
Eingang: 07.07.2021
Impfdatum: 30.06.2021
Beginn: 30.06.2021
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein

Asthenia Blood pressure increased Dizziness Dry mouth Dysstasia Feeling jittery Palpitations Fatigue Feeling cold Heart rate increased Malaise Muscle spasms Nausea Paraesthesia Tremor

Symptomtext

AFTER RECEIVING MY FIRST DOSE I WENT TO WAIT IN THE WAITING ROOM AND BEGAN HAVING A RACING HEARTBEAT ABOUT 10 MINUTES AFTER THE SHOT. I BEGAN TO FEEL DIZZY, MY HEART WAS RACING, MY PULSE SHOT UP FROM 64 TO 154 PER MY WATCH AND MY MOUTH GOT DRY. I ASKED FOR A NURSE AND THEY ESCORTED ME BACK TO A ROOM. I WAS FEELING LIKE I WAS GOING TO PASS OUT SO THEY LOWERED ME ON THE THE TABLE. THEY CHECKED MY PULSE AND 02. MY MOUTH WAS DRY AND MY LEGS AND HANDS WERE TINGLING. MY HEART WAS POUNDING AND I FELT SICK TO MY STOMACH. THEY CHECKED MY BP WHICH IS USUALLY LOW AND IT WAS REALLY HIGH. I WAS FEELING WEAK AND UNABLE TO STAND SO THEY TOLD ME THEY WERE TRANSPORTING ME TO THE ER. I WAS SHAKING, FREEZING, MY MUSCLES WERE CRAMPING IN MY ARMS AND LEGS. MY HEART CONTINUED TO RACE, I WAS DIZZY AND REALLY WEAK. I HAVE CONTINUED TO HAVE A RACING HEART BEAT AT RANDOM TIMES DURING THE DAY, STILL FEEL DIZZY AND FATIGUED. MY HEART ALSO POUNDS AT RANDOM TIMES DURING THE DAY. I AM NOT FEELING WELL.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Palpitations
Hospital-Tage: -
Labordaten: NONE
Aktuelle Erkrankungen: NONE
Vorgeschichte: NONE
Andere Medikamente: AMOUR THYROID, BUSPAR, VALCYCLOVIR,
Allergien: SULFA, NEOSPORINE
Vorherige Impfungen: -

VAERS 1450417

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EW0183

moderat

Staat: MA
Alter: 46,0
Geschlecht: F
Eingang: 06.07.2021
Impfdatum: 03.07.2021
Beginn: 04.07.2021
Tage bis Beginn: 1,0
Dosis: 2
Route/Site: IM / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Chest pain Dyspnoea Electrocardiogram normal Neck pain Pain Pain in extremity

Symptomtext

Dull chest/arm/neck pain with some shortness of breath, ekg was performed & normal, discussed possible affected lymph nodes, directed to ice area & take Tylenol for pain

Weitere VAERSDATA-Felder

Praegender Schweregrund: Chest pain
Hospital-Tage: -
Labordaten: EKG on 7/6/2021 normal
Aktuelle Erkrankungen: N/A
Vorgeschichte: None
Andere Medikamente: Fexofenadine otc
Allergien: Intolerance to Biaxin, adverse reaction to Methergine
Vorherige Impfungen: -

VAERS 1450393

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EW0183

moderat

Staat: CA
Alter: 18,0
Geschlecht: M
Eingang: 06.07.2021
Impfdatum: 06.07.2021
Beginn: 06.07.2021
Tage bis Beginn: 0,0
Dosis: UNK
Route/Site: - / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Asthma Condition aggravated

Symptomtext

First, sever Asthma, following immunization person had Asthma. Epinephrine injection, USP 0.3mg X2. Oxygen, Ems care has Transport

Weitere VAERSDATA-Felder

Praegender Schweregrund: Condition aggravated
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: Asthma
Vorgeschichte: Asthma
Andere Medikamente: did not take Albuterol and Advair today
Allergien: None known
Vorherige Impfungen: -

VAERS 1449491

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EW0183

moderat

Staat: CO
Alter: 42,0
Geschlecht: M
Eingang: 06.07.2021
Impfdatum: 18.06.2021
Beginn: 18.06.2021
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: - / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: ja

Angina pectoris Palpitations Renal pain

Symptomtext

Heart Palpitations; severe Angina was completely out of the norms; Heart Palpitations; severe Angina was completely out of the norms; Kidney Problem; This is a spontaneous report from a contactable consumer. A 42-year- old male patient received BNT162B2 (sPFIZER-BIONTECH COVID-19 VACCINE, solution for injection, lot no: EW0183), via unspecified route as dose 1, single, on on 18Jun2021 for COVID-19 immunisation.The patient had had Covid in Feb2020 and he sustained at the time that he had really severe kidney pain. The patient concomitant medication was not reported. On 18June2021, the patient stated that Within 3 hours of vaccination, he experienced heart palpitations raised, severe Angina because that completely out of the norms for him and he never had a heart problem that kind of result and he was in the Emergency Room of the Hospital The patient was out of the Emergency Room by 10 o clock (18Jun2021) but now he has same kidney problem that he had half and Year ago, severe kidney pain. He had been experiencing that kidney issue all over again. When probed for any treatment for the problems (events), reporter stated, The local Hospital said to take Ibuprofen, lots of water and bed rest but he has not taken anything yet and also on Pedialyte Electrolyte. He was released from the Hospital at 10 o clock on 18Jun2021 because the heart palpitations and severe Angina resolved itself over about the period of about 4 hours. The outcome of events kidney pain was reported as unknown. No follow-up attempts are possible. No further information is expected.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Palpitations
Hospital-Tage: 1,0
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: Medical History/Concurrent Conditions: COVID-19; Kidney disorder
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1408223

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EW0183

moderat

Staat: TX
Alter: 37,0
Geschlecht: F
Eingang: 06.07.2021
Impfdatum: 17.06.2021
Beginn: 19.06.2021
Tage bis Beginn: 2,0
Dosis: 1
Route/Site: IM / OT

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein

Anxiety Panic attack Chest pain Electrocardiogram

Symptomtext

Chest pain started 2 days after shot and continues at different levels of pain, intensifying to the point of my going to an urgent care facility because I thought I was having a heart attack.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Chest pain
Hospital-Tage: -
Labordaten: EKGs - 3 performed during an urgent care visit on Saturday, June 26th after feeling like I was having a heart attack.
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: Wheat, sulfa, gluten
Vorherige Impfungen: -

VAERS 1408223

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EW0183

moderat

Staat: TX
Alter: 37,0
Geschlecht: F
Eingang: 06.07.2021
Impfdatum: 17.06.2021
Beginn: 19.06.2021
Tage bis Beginn: 2,0
Dosis: 1
Route/Site: SYR / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein

Anxiety Panic attack Chest pain Electrocardiogram

Symptomtext

Chest pain started 2 days after shot and continues at different levels of pain, intensifying to the point of my going to an urgent care facility because I thought I was having a heart attack.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Chest pain
Hospital-Tage: -
Labordaten: EKGs - 3 performed during an urgent care visit on Saturday, June 26th after feeling like I was having a heart attack.
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: Wheat, sulfa, gluten
Vorherige Impfungen: -

VAERS 1446379

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EW0183

moderat

Staat: OR
Alter: 16,0
Geschlecht: M
Eingang: 03.07.2021
Impfdatum: 01.07.2021
Beginn: 02.07.2021
Tage bis Beginn: 1,0
Dosis: 2
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein

Condition aggravated Differential white blood cell count normal Full blood count normal Haematuria International normalised ratio normal Metabolic function test Urine analysis

Symptomtext

Urinating blood multiple times. This has occurred over the course of 2 days now and is ongoing, but getting a bit better. Symptoms came 1 day after receiving 2nd dose of Pfizer COVID 19 vaccination. At the advice of the doctor, we went to the Emergency Room as it was Friday night at 9 p.m. A urine test confirmed blood in the urine and the diagnosis was "gross hematuria" and "adverse effect of vaccine, initial encounter"

Weitere VAERSDATA-Felder

Praegender Schweregrund: Condition aggravated
Hospital-Tage: -
Labordaten: All tests done at Emergency Room on July 2, 2021: CBC with Auto Differential CK Comprehensive Metabolic Panel PT INR UA W Microscopic C/S if indicated _POCT U Dipstick instrument Only result was confirmation of blood in the urine. All other results were normal.
Aktuelle Erkrankungen: No.
Vorgeschichte: None.
Andere Medikamente: Multi-vitamin.
Allergien: No.
Vorherige Impfungen: 1st dose of COVID 19 on 5/27/21. Suspected blood in urine but much less prevalent than the recent experience.

VAERS 1446328

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EW0183

moderat

Staat: WA
Alter: 14,0
Geschlecht: M
Eingang: 03.07.2021
Impfdatum: 14.05.2021
Beginn: 15.05.2021
Tage bis Beginn: 1,0
Dosis: 2
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein

Blood test Chest X-ray Chest pain Dyspnoea Electrocardiogram Postural orthostatic tachycardia syndrome Troponin

Symptomtext

symptomatic with POTS (Postural Orthostatic Tachycardia Syndrome), chest pain, short of breath.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Chest pain
Hospital-Tage: -
Labordaten: CXR, EKG, troponin + other blood tests at Hospital ER on 6/15/2021
Aktuelle Erkrankungen: None
Vorgeschichte: None
Andere Medikamente: None
Allergien: None
Vorherige Impfungen: -

VAERS 1441328

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge Ew0183

moderat

Staat: CA
Alter: 43,0
Geschlecht: F
Eingang: 01.07.2021
Impfdatum: 23.06.2021
Beginn: 24.06.2021
Tage bis Beginn: 1,0
Dosis: 1
Route/Site: SYR / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Chest X-ray normal Chest discomfort Chills Dyspnoea Electrocardiogram normal Sleep disorder Throat tightness

Symptomtext

14 hours after the shot, woke up in the middle of the night with some chills, followed by difficulty breathing. Throat felt narrowed. Lasted for about 2 hours. The next 8 days chest feels heavy and have to catch a breath here and there. Today is day 8

Weitere VAERSDATA-Felder

Praegender Schweregrund: Dyspnoea
Hospital-Tage: -
Labordaten: Ekg Chest xray Both normal
Aktuelle Erkrankungen: No
Vorgeschichte: Blocked tear ducts
Andere Medikamente: Steroid drops for eyes
Allergien: Antacid meds
Vorherige Impfungen: -

VAERS 1438022

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EW0183

moderat

Staat: NY
Alter: 23,0
Geschlecht: M
Eingang: 30.06.2021
Impfdatum: 30.06.2021
Beginn: 30.06.2021
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Electrocardiogram Palpitations

Symptomtext

23 y/o complained of heart palpitations, heart pounding after 1st dose of Pfizer vaccine. Service was rendered to patient by EMT and Nurse Practitioner on site. According to notes on report, after examination, pt was breathing adequately, 3 lead EKG was normal sinus rythim, Pt. feels better and is observed for another 30 minutes. He refused transport to hospital. He was advised to follow up w/PCP.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Palpitations
Hospital-Tage: -
Labordaten: None
Aktuelle Erkrankungen: History of Brugada Syndrome per NP's account. Information from the patient and his mother.
Vorgeschichte: History of Brugada Syndrome. Heart condition per patient.
Andere Medikamente: Unknown
Allergien: Unknown
Vorherige Impfungen: -

VAERS 1437499

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EW0183

moderat

Staat: -
Alter: -
Geschlecht: U
Eingang: 30.06.2021
Impfdatum: -
Beginn: -
Tage bis Beginn: -
Dosis: 1
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: ja Hospital: unbekannt Disable: ja ER: unbekannt Erholt: nein

Angina pectoris Audiogram Blood test Cardiac rehabilitation therapy Deafness Dyspnoea Echocardiogram Electroencephalogram Heart rate increased Hypotension Pain in extremity Swelling

Symptomtext

Severe Heart ache, Left arm severe pain. Swelling, shortness of breath, hearing loss, low blood pressure, rapid heart rate.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Dyspnoea
Hospital-Tage: -
Labordaten: EEG, echocardiogram, cardiac rehab, soma upper/lower, audiovisual, bible test, blood test
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1437493

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EW0183

moderat

Staat: VA
Alter: 26,0
Geschlecht: F
Eingang: 30.06.2021
Impfdatum: 01.05.2021
Beginn: 25.05.2021
Tage bis Beginn: 24,0
Dosis: 1
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: ja Hospital: unbekannt Disable: ja ER: unbekannt Erholt: nein

Angina pectoris Blood test Deafness Dyspnoea Echocardiogram Electroencephalogram Heart rate increased Hypotension Laboratory test Pain in extremity Swelling

Symptomtext

Severe Heart ache, Left arm severe pain. Swelling, shortness of breath, hearing loss, low blood pressure, rapid heart rate.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Dyspnoea
Hospital-Tage: -
Labordaten: EEG, echocardiogram, cardiac rehab, soma upper/lower, audiovisual, bible test, blood test
Aktuelle Erkrankungen: POTS
Vorgeschichte: NA
Andere Medikamente: Mistonin Betaxelol Fish oil Co q10
Allergien: Gluten Dextromethorphan
Vorherige Impfungen: -

VAERS 1437343

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EW0183

moderat

Staat: NY
Alter: 15,0
Geschlecht: M
Eingang: 30.06.2021
Impfdatum: 18.06.2021
Beginn: 19.06.2021
Tage bis Beginn: 1,0
Dosis: 2
Route/Site: SYR / LA

Tod: unbekannt Lebensbedrohlich: ja Hospital: ja Disable: ja ER: ja Erholt: nein

Blood test Cardiac imaging procedure Carditis Chest pain Fatigue Troponin increased

Symptomtext

My son experienced chest pain and was very tired - Sat 6/19 - I thought normal Sunday 6/20 - seemed normal Monday 6/21 at 11 am severe chest pain. Taken to hospital - was hospitalized with heart inflammation and very high troponin numbers until Thursday 6/24 - numbers were still elevated but he was allowed to go home since the numbers where on the downward trajectory Has a follow up apt 7/2 @ 3 pm.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Chest pain
Hospital-Tage: 4,0
Labordaten: heart scan blood work 2 times a day
Aktuelle Erkrankungen: n/a
Vorgeschichte: n/a
Andere Medikamente: n/a
Allergien: n/a
Vorherige Impfungen: -

VAERS 1433340

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EW0183

moderat

Staat: NC
Alter: 58,0
Geschlecht: F
Eingang: 29.06.2021
Impfdatum: 18.06.2021
Beginn: 19.06.2021
Tage bis Beginn: 1,0
Dosis: 1
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Cough Headache Hypoaesthesia Hypoaesthesia oral Influenza like illness Musculoskeletal stiffness Nausea Pain Paraesthesia Paraesthesia oral Pyrexia

Symptomtext

One day 1, after vaccine, patient had flu-like symptoms with low grade fever, nausea, headache, body aches x 4 days. Around day 3, symptoms of severe headache with stiff neck and dry cough started along with tingling and numbness of shoulders, arms, hands, lips, legs bilaterally. These symptoms continue today.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Paraesthesia
Hospital-Tage: -
Labordaten: None
Aktuelle Erkrankungen: None
Vorgeschichte: Hypertension (does not take medication)
Andere Medikamente: None
Allergien: Affexor, Albuterol-hives
Vorherige Impfungen: -

VAERS 1415353

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EW0183

moderat

Staat: NV
Alter: 14,0
Geschlecht: M
Eingang: 28.06.2021
Impfdatum: 11.06.2021
Beginn: 14.06.2021
Tage bis Beginn: 3,0
Dosis: 2
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: nein

Brain natriuretic peptide increased Chest X-ray normal Chest pain Echocardiogram Troponin increased Echocardiogram normal

Symptomtext

C/O chest pain,presented to Medical Center on 6/14 for evaluation and was transferred to hospital for further evaluation due to elevated troponin.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Chest pain
Hospital-Tage: -
Labordaten: 6/14/21 CXR 2 views - No acute cardiopulmonary disease TROP- 311 BNP 28 ECHO
Aktuelle Erkrankungen: none
Vorgeschichte: none
Andere Medikamente: Escitalpram 10mg daily
Allergien: none
Vorherige Impfungen: -

VAERS 1429834

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EW 0183

moderat

Staat: NY
Alter: 21,0
Geschlecht: M
Eingang: 26.06.2021
Impfdatum: 21.06.2021
Beginn: 22.06.2021
Tage bis Beginn: 1,0
Dosis: 2
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Angina pectoris Arthralgia Chest discomfort Dyspnoea Gait disturbance Muscular weakness

Symptomtext

Stabbing heart pain. Shortness of breath. Weakness in right hand (opposite the arm vaccinated). Extreme joint pain to the extend of difficulty walking. Symptoms abated strongly after 48 hours with the exception of tightness in chest.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Dyspnoea
Hospital-Tage: -
Labordaten: None
Aktuelle Erkrankungen: None
Vorgeschichte: None
Andere Medikamente: None
Allergien: None
Vorherige Impfungen: -

VAERS 1427742

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EW0183

moderat

Staat: OR
Alter: 63,0
Geschlecht: M
Eingang: 25.06.2021
Impfdatum: 20.05.2021
Beginn: 21.05.2021
Tage bis Beginn: 1,0
Dosis: 2
Route/Site: SYR / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein

Blood test Cardiac disorder Condition aggravated Echocardiogram Electrocardiogram Heart rate abnormal Heart rate decreased Hypertension Inflammation Left ventricular hypertrophy Supraventricular extrasystoles

Symptomtext

When I got the shot, nothing happened. My blood pressure was normal. The next day when I woke up, my heart problems had worsened and my blood pressure was high. Through out the day my blood pressure stayed high. Days later I spoke with a doctor and decided to go to urgent care. They triaged me there. They did vital signs and got me into a clinic examination room. They noticed my heart rate was fluctuating from 93 to 49 BPM. My heart rate had been dipping into the 40s. I didn't take the medicine I was given because of my already low heart rate. I was concerned that the medicine was going to make my heart rate drop even more. When I spoke to my cardiologist he said it may of been the vaccine that caused inflammation and problems with my heart rate. June 14th I went to the ER because my heart beats were severe. At the ER they agreed that it could've been the vaccine that caused the problems. The doctor said it may be inflammation that would resolve in time. It was an unusual heart beat pattern. The ER doctor told me to request an echocardiogram. The echocardiogram said I had atrial premature complex and left ventricular hypertrophy. After the 1st dose my high blood pressure went up but intensified after the 2nd dose.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Condition aggravated
Hospital-Tage: -
Labordaten: EKG, Echocardiogram, Blood test
Aktuelle Erkrankungen: -
Vorgeschichte: Heart Complications
Andere Medikamente: Multivitamins
Allergien: -
Vorherige Impfungen: -

VAERS 1426968

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EW0183

moderat

Staat: MD
Alter: 73,0
Geschlecht: F
Eingang: 25.06.2021
Impfdatum: 11.06.2021
Beginn: 11.06.2021
Tage bis Beginn: 0,0
Dosis: 2
Route/Site: - / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Paraesthesia

Symptomtext

Having trouble with pins and needles and tingling in the hand; I started feeling the tingling in my hand and pins and needles and they are all really very sore; This is a spontaneous report from a contactable consumer (patient). A 73-year-old female patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, Batch/Lot Number: EW0183) via an unspecified route of administration in Arm Left on 11Jun2021 as dose 2, single for COVID-19 immunization. Medical history included blood pressure measurement and Irregular heartbeat. Concomitant medications included atenolol (ATENOLOL) and flecainide (FLECAINIDE), 50mg once a day. The patient previously received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection) via an unspecified route of administration on an unspecified date as dose 1, single for COVID-19 immunization. The patient reported that it was only 24 hours and on the sheet here was lists some of the side effects. The patient was little bit concerned about her hand the arm they used was the left arm and had trouble with pins and needles and tingling in the hand and they are all really very sore on 11Jun2021. she was wondering if she should be concerned about that or wait another day and to see if it still, if it doesn't go away and then to be concerned about it. It was reported that events were persisting. They haven't got any worse and they haven't gotten any better. It's just about the same. The patient had not yet recovered from the event. Follow up attempts are needed. Further information has been requested.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Paraesthesia
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: Medical History/Concurrent Conditions: Blood pressure; Heartbeats irregular
Andere Medikamente: ATENOLOL; FLECAINIDE
Allergien: -
Vorherige Impfungen: -

VAERS 1424823

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EW0183

moderat

Staat: VA
Alter: 15,0
Geschlecht: F
Eingang: 24.06.2021
Impfdatum: 13.05.2021
Beginn: 20.05.2021
Tage bis Beginn: 7,0
Dosis: UNK
Route/Site: IM / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein

Blood test Chest pain Electrocardiogram Fatigue Headache Heart rate increased Malaise

Symptomtext

Daughter began having chest pain, severe fatigue, overall malaise, rapid heart beat, headaches

Weitere VAERSDATA-Felder

Praegender Schweregrund: Chest pain
Hospital-Tage: -
Labordaten: Blood work (5/31), EKG, (5/31) , ECG (6/11
Aktuelle Erkrankungen: None
Vorgeschichte: None
Andere Medikamente: None
Allergien: None
Vorherige Impfungen: -

VAERS 1423639

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EW0183

moderat

Staat: TX
Alter: 16,0
Geschlecht: M
Eingang: 24.06.2021
Impfdatum: 24.06.2021
Beginn: 24.06.2021
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: ja

Anxiety Chest pain Heart rate increased

Symptomtext

Patient described increased heart rate and eventually chest pain after 20 minutes of receiving vaccine. Ambulance was called to assist - relayed heart rate and blood pressure was normal and deemed it "situational anxiety". Mom decided to have patient transported to ER.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Chest pain
Hospital-Tage: -
Labordaten: Vitals tested and were normal
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1423522

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EW0183

moderat

Staat: IN
Alter: 55,0
Geschlecht: M
Eingang: 24.06.2021
Impfdatum: 28.05.2021
Beginn: 01.06.2021
Tage bis Beginn: 4,0
Dosis: 1
Route/Site: IM / AR

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Condition aggravated Neuropathy peripheral

Symptomtext

Patient reports an exacerbation of peripheral neuropathy after receiving first covid vaccination. Patient has had in but reports this is worse that before There has been no further medication intervention for this event

Weitere VAERSDATA-Felder

Praegender Schweregrund: Condition aggravated
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: None
Vorgeschichte: h/o colon CA Neuropathy
Andere Medikamente: Aspirin 81 mg
Allergien: None
Vorherige Impfungen: -

VAERS 1421568

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EW0183

moderat

Staat: MD
Alter: 55,0
Geschlecht: F
Eingang: 23.06.2021
Impfdatum: 23.06.2021
Beginn: 23.06.2021
Tage bis Beginn: 0,0
Dosis: 2
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: ja Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein

Chest discomfort Cough Dyspnoea Tachycardia Tachypnoea

Symptomtext

Was triaged to 30 minute observation due to prior hx anaphylaxis during allergy shots. Had done well with dose #1. During observation period after 2nd dose, reported inhaling large amput of alcohol spray being used to clean the chairs. Began coughing and developed chest tightness, dyspnea, tachypnea, tachycardia. Stated felt like prior asthma attacks. Was evaluated: p ox 100%, pulse 120's, RR 20's, BP 155/88, questionable tightness at lung bases, increased WOB with difficulty completing sentances, OP clear without visible edema/ erythema, cap refill intact, no hoarseness, no facial swelling, no noted rashes). Advised calling EMS for transport, declined. Continued coughing despite drinking a few sips of water. Took 2 puffs of her home dose albuterol and had slight calming of RR, pulse, WOB, but still noted chest tightness. Agreed to EMS transport. Walked to cot to be more comfortable, without incident. Vitals monitored pending transfer of care to EMS. While waiting, used 2 more puffs of home albuterol and had additional improvements in symptoms but had not returned to baseline by the time EMS arrived and was transferred to their care, with recommendation for albuterol neb and likely ED further evaluation and care.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Dyspnoea
Hospital-Tage: -
Labordaten: Unknown
Aktuelle Erkrankungen: -
Vorgeschichte: Allergies (undergoing immunotherapy desensitization, had shot last week), asthma, HTN, hyperlipidemia, anemia, obesity
Andere Medikamente: Lisinipril, simvastatin, cetirizine, iron, Qvar, albuterol HFA prn
Allergien: Multiple environmental and seasonal allergies (animals including cats and dogs, ragweed, pollen). Bronchospasm with certain strong fumes
Vorherige Impfungen: -

VAERS 1420690

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EW0183

moderat

Staat: MI
Alter: 15,0
Geschlecht: M
Eingang: 23.06.2021
Impfdatum: 04.06.2021
Beginn: 21.06.2021
Tage bis Beginn: 17,0
Dosis: 2
Route/Site: SYR / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein

Blood test normal Chest discomfort Crying Dyspnoea Echocardiogram Electrocardiogram normal Pain in extremity Urine analysis

Symptomtext

Patient felt like he was having an asthma attack on the night of the 21st when playing outside with friends (running and climbing). He has never had asthma, but said his chest was tight and it was hard to breathe. He said when he stopped and sat for a while it seemed to get better. He went to sleep at about 2am and woke me up at 5:20am crying. His chest hurt really bad and the pain was traveling down his arm. When we took his blood pressure at home it was 205/125 and his heart rate was 112. We went to the emergency room at hospital immediately. Once there they did an EKG. The doctor said there was not reason to be alarmed, but the EKG showed signs of possible pericarditis. They then took blood work, a urine sample, an xray and did an echocardiogram. The doctor told us that the blood work did not show any signs of an actual heart attack or any damage done to the heart. She said the echocardiogram showed some fluid build up in the pericardia sac surrounding his heart. She said this is considered pericardia. She mentioned that some young men are having this happen after being vaccinated. She said we seem to have caught it early. They gave him Tordal through his IV when we were there and that took his pain away. We were told to follow up with a cardiologist within 24-48 hours. We have an appointment at Hospital tomorrow at 10:45am.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Dyspnoea
Hospital-Tage: -
Labordaten: 6/22 EKG - abnormal urine - normal blood - normal echocardiogram - showed fluid build up in pericardia sac
Aktuelle Erkrankungen: None
Vorgeschichte: None
Andere Medikamente: None
Allergien: None
Vorherige Impfungen: -

VAERS 1397244

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EW0183

moderat

Staat: HI
Alter: 51,0
Geschlecht: F
Eingang: 23.06.2021
Impfdatum: 17.05.2021
Beginn: 17.05.2021
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: - / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein

Blood pressure increased Blood test Chest discomfort Chills Cough Blood pressure measurement Burning sensation Electrocardiogram Dizziness Dyspnoea Feeling hot Gait disturbance Headache Heart rate increased Immediate post-injection reaction Pain Paraesthesia Heart rate

Symptomtext

Intermittent increased heart rate and blood pressure.; intermittent increased heart rate and blood pressure.; tingling in her hands and from knees to feet.; sometimes cold and tingling in hands and from knees down to her feet; heaviness in chest; she has heat and burning; This is spontaneous report from a contactable consumer (patient). A 51-years-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE), dose 1 via an unspecified route of administration, administered in Arm Right on 17May2021 (Batch/Lot Number: EW0183) age at vaccination of 51-years-old, as single dose, for covid-19 immunisation. Medical history included ongoing corneal erosion (diagnosed about 20 years ago), ongoing sleep apnoea syndrome (diagnosed about a year ago). Concomitant medications included naproxen sodium (ALEVE) taken for an unspecified indication, start and stop date were not reported; naphazoline hydrochloride (EYE DROPS [NAPHAZOLINE HYDROCHLORIDE]) taken for an unspecified indication, start and stop date were not reported. The patient got the first dose of the Pfizer Covid vaccine on 17May2021 and within 5 minutes her hear rate (HR) and blood pressure were really high, stated her blood pressure was like 169/114 at the time or something like that. The patient also felt some weight on her chest, sometimes cold tingling in her hands and from knees to feet and heat and burning, all on 17May2021. The patient had no issues prior to the vaccine. The patient stated that over the last three weeks she has been to urgent care, her doctor's office, and even had an ambulance take her to the ER for high blood pressure and heart rate, stated she just keeps having episodes. The patient is now waiting on her cardiologist, stated they did tests at hospital yesterday, has had some EKGs and blood tests, no exact information known, states sent her home and had another episode not as bad. Doctor has not seen this type of reaction, wondering what is going on with this kind of reaction. They treated her high blood pressure with two different medications: carvedilol and tried a different one as well, metoprolol. The patient underwent lab tests and procedures which included blood pressure measurement 169/114 on 17May2021 within 5 minutes her HR and BP were really high, blood test unknown results on 17May2021, electrocardiogram unknown results on 17May2021, heart rate really high on 17May2021. The patient was not recovered from the events blood pressure high, tingling feet/hands, cold hands & feet, chest heaviness while outcome of the other events was unknown.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Dyspnoea
Hospital-Tage: -
Labordaten: Test Date: 20210517; Test Name: Blood pressure; Result Unstructured Data: Test Result:169/114; Comments: within 5 minutes her HR and BP were really high; Test Date: 20210517; Test Name: Blood tests; Result Unstructured Data: Test Result:Unknown results; Test Date: 20210517; Test Name: EKGs; Result Unstructured Data: Test Result:Unknown results; Test Date: 20210517; Test Name: HR; Result Unstructured Data: Test Result:really high
Aktuelle Erkrankungen: Corneal erosion (diagnosed about 20 years ago); Sleep apnea (diagnosed about a year ago)
Vorgeschichte: -
Andere Medikamente: ALEVE; EYE DROPS [NAPHAZOLINE HYDROCHLORIDE]
Allergien: -
Vorherige Impfungen: -

VAERS 1397244

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EW0183

moderat

Staat: HI
Alter: 51,0
Geschlecht: F
Eingang: 23.06.2021
Impfdatum: 17.05.2021
Beginn: 17.05.2021
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: SYR / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein

Blood pressure increased Blood test Chest discomfort Chills Cough Blood pressure measurement Burning sensation Electrocardiogram Dizziness Dyspnoea Feeling hot Gait disturbance Headache Heart rate increased Immediate post-injection reaction Pain Paraesthesia Heart rate

Symptomtext

Intermittent increased heart rate and blood pressure.; intermittent increased heart rate and blood pressure.; tingling in her hands and from knees to feet.; sometimes cold and tingling in hands and from knees down to her feet; heaviness in chest; she has heat and burning; This is spontaneous report from a contactable consumer (patient). A 51-years-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE), dose 1 via an unspecified route of administration, administered in Arm Right on 17May2021 (Batch/Lot Number: EW0183) age at vaccination of 51-years-old, as single dose, for covid-19 immunisation. Medical history included ongoing corneal erosion (diagnosed about 20 years ago), ongoing sleep apnoea syndrome (diagnosed about a year ago). Concomitant medications included naproxen sodium (ALEVE) taken for an unspecified indication, start and stop date were not reported; naphazoline hydrochloride (EYE DROPS [NAPHAZOLINE HYDROCHLORIDE]) taken for an unspecified indication, start and stop date were not reported. The patient got the first dose of the Pfizer Covid vaccine on 17May2021 and within 5 minutes her hear rate (HR) and blood pressure were really high, stated her blood pressure was like 169/114 at the time or something like that. The patient also felt some weight on her chest, sometimes cold tingling in her hands and from knees to feet and heat and burning, all on 17May2021. The patient had no issues prior to the vaccine. The patient stated that over the last three weeks she has been to urgent care, her doctor's office, and even had an ambulance take her to the ER for high blood pressure and heart rate, stated she just keeps having episodes. The patient is now waiting on her cardiologist, stated they did tests at hospital yesterday, has had some EKGs and blood tests, no exact information known, states sent her home and had another episode not as bad. Doctor has not seen this type of reaction, wondering what is going on with this kind of reaction. They treated her high blood pressure with two different medications: carvedilol and tried a different one as well, metoprolol. The patient underwent lab tests and procedures which included blood pressure measurement 169/114 on 17May2021 within 5 minutes her HR and BP were really high, blood test unknown results on 17May2021, electrocardiogram unknown results on 17May2021, heart rate really high on 17May2021. The patient was not recovered from the events blood pressure high, tingling feet/hands, cold hands & feet, chest heaviness while outcome of the other events was unknown.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Dyspnoea
Hospital-Tage: -
Labordaten: Test Date: 20210517; Test Name: Blood pressure; Result Unstructured Data: Test Result:169/114; Comments: within 5 minutes her HR and BP were really high; Test Date: 20210517; Test Name: Blood tests; Result Unstructured Data: Test Result:Unknown results; Test Date: 20210517; Test Name: EKGs; Result Unstructured Data: Test Result:Unknown results; Test Date: 20210517; Test Name: HR; Result Unstructured Data: Test Result:really high
Aktuelle Erkrankungen: Corneal erosion (diagnosed about 20 years ago); Sleep apnea (diagnosed about a year ago)
Vorgeschichte: -
Andere Medikamente: ALEVE; EYE DROPS [NAPHAZOLINE HYDROCHLORIDE]
Allergien: -
Vorherige Impfungen: -

VAERS 1416469

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EW0183

moderat

Staat: MD
Alter: 16,0
Geschlecht: M
Eingang: 22.06.2021
Impfdatum: 15.06.2021
Beginn: 19.06.2021
Tage bis Beginn: 4,0
Dosis: 2
Route/Site: IM / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: ja

Chest pain Electrocardiogram normal Troponin increased

Symptomtext

Chest pain

Weitere VAERSDATA-Felder

Praegender Schweregrund: Chest pain
Hospital-Tage: 1,0
Labordaten: Elevated troponin levels with normal EKG
Aktuelle Erkrankungen: None
Vorgeschichte: None
Andere Medikamente: None
Allergien: None
Vorherige Impfungen: -

VAERS 1415501

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EW0183

moderat

Staat: MA
Alter: 17,0
Geschlecht: F
Eingang: 21.06.2021
Impfdatum: 17.05.2021
Beginn: 28.05.2021
Tage bis Beginn: 11,0
Dosis: 2
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: nein

Arthralgia Bacterial test Blood lactate dehydrogenase increased Borrelia test negative C-reactive protein increased Chlamydia test Culture throat negative Cytomegalovirus test negative Ehrlichia test Epstein-Barr virus test Erythema nodosum Gait inability Joint swelling Mobility decreased Mycobacterium tuberculosis complex test Mycoplasma test Neutrophil count decreased Neutrophil percentage

Symptomtext

Bilateral knee swelling and pain (severely limiting mobility to the point of being unable to walk due to pain/swelling), rash (c/f erythema nodosum) for 2-3 weeks (presented on 6/18/21). Concerning for flare of JIA vs other autoimmune etiology (infectious studies mostly negative, though some studies pending). Diagnostics ongoing.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Mobility decreased
Hospital-Tage: -
Labordaten: 6/21/21: LDH 265, mycoplasma pending, COVID neg, 6/20/21: ESR 36, CRP 146.5, throat culture - no growth to date, Chlamydia/Gonorrheae pending, T spot pending, streptococcal ab pending, urinalysis negative 6/18/21: WBC 2.71, Plt 140, Neutrophils 1.74 (64.2%), Ehrlichia/anaplasma PCR neg, EBV pending, respiratory viral panel neg, CMV neg, Lyme neg,
Aktuelle Erkrankungen: -
Vorgeschichte: Juvenile idiopathic arthritis, uveitis
Andere Medikamente: naproxen, famotidine
Allergien: No known allergies.
Vorherige Impfungen: -

VAERS 1414296

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EW0183

moderat

Staat: NC
Alter: 39,0
Geschlecht: F
Eingang: 21.06.2021
Impfdatum: 11.06.2021
Beginn: 11.06.2021
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Cough Dizziness Erythema Eye irritation Headache Mobility decreased Nausea Pain Peripheral swelling Pyrexia Sinus operation

Symptomtext

Patient reports dizziness immediately after vaccine. Upon getting home from vaccine, reports HA, redness/swelling of left arm. HA worsened to radiate down back. Nausea, body ache, fever over night. Next day, patient could not raise arm for swelling/pain. All of these symptoms continue but are lessening in severity. Fever continues(around 100.3). Cough, sinus drainage, burning of eyes started 5 days later and continue.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Mobility decreased
Hospital-Tage: -
Labordaten: None
Aktuelle Erkrankungen: Covid April 11th 2021
Vorgeschichte: irregular heart beat, DM 1, COPD, asthma, high BP, heart defect, heart murmur, CHF, acid reflux kidney failure, nuropathy, scholosis, gastrophuresis, restless leg syndrome, urine retention, anemia, migraines, high cholestrerol, arthritis, seizures, sleep apnea.
Andere Medikamente: Phenergren Amatiza Nurtec Mirapax Lipitor Lomectol Quareg Velduca Miralax Ubrelvy Aimovig Noratriptoline Flexifil Keppra Prilosec Imotrex Luvox Mucamist Straterra Vraylar Seriquil SR Guavisin Levamir Humalog Xopenex Carafate Protonix Valari
Allergien: Zofran, Percicet, Dilaudid, Dermerol, Morphine, latex, hepirin
Vorherige Impfungen: Various vaccines. Flu(upset stomach, diarrhea, body ache, headache. Pneumonia- fatigue, fever

VAERS 1413369

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EW0183

moderat

Staat: WA
Alter: 60,0
Geschlecht: F
Eingang: 20.06.2021
Impfdatum: 12.05.2021
Beginn: 14.05.2021
Tage bis Beginn: 2,0
Dosis: 2
Route/Site: SYR / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Angiogram Anion gap decreased Blood albumin normal Blood chloride normal Blood creatinine normal Blood glucose normal Blood potassium normal Blood sodium normal Blood urea normal Carbon dioxide normal Chest X-ray Dyspnoea Fatigue Fibrin D dimer normal Glomerular filtration rate decreased Pleurisy Protein total normal Pulmonary pain

Symptomtext

2 days after my second Pfizer vaccine I experienced lung pain when breathing, pleurisy, fever, dypsnea, shortness of breath, extreme fatigue.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Dyspnoea
Hospital-Tage: -
Labordaten: Troponin 05/30/2021 <0.03 D Dimer 05/30/2021 <0.27 Sodium 05/30/2021 139 meq/L Potassium 05/30/2021 4.0 meq/L Chloride 05/30/2021 105 meq/L CO 05/30/2021 25 meq/L Anion Gap 05/30/2021 9 Glucose 05/30/2021 87 mg/dL Urea Nitrogen 05/30/2021 20 mg/dL Creatinine 05/30/2021 0.83 mg/dL Protein 05/30/2021 7.0 g/dL Albumin 05/30/2021 4.4 g/dL GFR >60 xR chest 2 views 05/30/2021 cTA chest PE with contrast 05/30/2022
Aktuelle Erkrankungen: None
Vorgeschichte: I have trigeminal neuropathy of my left V3 branch of the trigeminal nerve.
Andere Medikamente: Mexillitine, sertraline, lacosamide, naltrexone, prazasin, memantine, Align,
Allergien: Sulfa drugs
Vorherige Impfungen: Anaphylactic shock

VAERS 1410844

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EW0183

moderat

Staat: NC
Alter: 17,0
Geschlecht: M
Eingang: 18.06.2021
Impfdatum: 16.06.2021
Beginn: 17.06.2021
Tage bis Beginn: 1,0
Dosis: 1
Route/Site: SYR / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein

Arthralgia Blood creatine phosphokinase Chest X-ray Chest pain Differential white blood cell count Electrocardiogram Fibrin D dimer Full blood count Metabolic function test Muscle spasms Nausea Pain in extremity Troponin I Vomiting

Symptomtext

He had sharp chest pains that would come and go in left side near ribs beginning around noon on 6/17/2021. They seemed to worsen throughout day & with laying down. Then, increasing pain along left side of body into hip and leg around 5:30pm. He experienced very "bad, cramp-like" pain in left calf area around 6:30pm. Sharp Chest pains intermittent at "10 pain level" & lower left leg at "8 pain level". Some nausea and vomited once at this point. We called the urgent care line for our doctor's office and spoke with nurse who instructed us to go to the ER. They performed ECG and Chest XR. Labs were BMP, CBC, CK, D-dimer (quantitative), & Triponon-I. They gave 800mg Motrin, IV fluids and keterolac in IV. They said they "did not identify a specific problem" but to rest, take ibuprofen, and follow-up with doctor and cardiologist. They said it was most likely related to the Covid-19 vaccination but could not give causation. Patient seems fine so far today, but still has medication in system.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Chest pain
Hospital-Tage: -
Labordaten: ECG, XR Chest 2 views, BMP, CBC with platelet and differential CK, D-dimer, troponin-I
Aktuelle Erkrankungen: None
Vorgeschichte: None
Andere Medikamente: Amoxicillin
Allergien: None
Vorherige Impfungen: -

VAERS 1404014

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge Ew0183

moderat

Staat: RI
Alter: 25,0
Geschlecht: M
Eingang: 16.06.2021
Impfdatum: 15.06.2021
Beginn: 16.06.2021
Tage bis Beginn: 1,0
Dosis: 1
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Chest pain Chills Feeling abnormal Headache Insomnia Pyrexia

Symptomtext

Fever, (temperature not taken mother was asleep at 2 am) Chills, Headache, Chest Pain, Insomnia, Feeling of weightlessness, onset at 2 am bedridden Tylenol given at 6 pm 6/16/21

Weitere VAERSDATA-Felder

Praegender Schweregrund: Chest pain
Hospital-Tage: -
Labordaten: None
Aktuelle Erkrankungen: None
Vorgeschichte: Asthma; Chronic Lyme Disease, Chronic Bartonella, HBP, Obesity
Andere Medikamente: Chlorthalidone, Vitamin C, NAC, Zinc, Alpha Lipoic Acid, Glutathione, Vitamin D
Allergien: Severe Allergy w/ anaphylaxis to sunflower & sesame
Vorherige Impfungen: -

VAERS 1403517

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EW0183

moderat

Staat: MD
Alter: 35,0
Geschlecht: F
Eingang: 16.06.2021
Impfdatum: 13.05.2021
Beginn: 16.06.2021
Tage bis Beginn: 34,0
Dosis: 1
Route/Site: SYR / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Abortion spontaneous Exposure during pregnancy Fatigue Headache Migraine Pain Pyrexia SARS-CoV-2 antibody test negative

Symptomtext

3 days after I received a first doze of Pfizer vaccine on May 13, I found out that I was pregnant, about 5 weeks. I consulted with my OBGYN and also called CDC phone number to consult regarding getting the 2nd doze, and both encouraged me to get the 2nd doze. My bloodwork showed low levels of progestrerone, so I was prescribed it to support the pregnancy. My 2nd doze was on June 3, and on the next day after the vaccination I've experienced strong vatigue, headache, and overall low-grade fever achy sensations. On the 4th day after getting vaccinated with my 2nd doze, I got a terrible migrain that lasted for 48 hours; I was unable to keep any food or fluids in, and actually lost 7.5 lbs over the period of 2 days. A couple of days after that, I had a similar migraine that lasted by 24 hours, and I lost another 3 lbs. Today, June 16, I came in for my 1st 10-week sonogram, only to find out that I had a Blighted Ovum Miscarriage. This is make it my 3rd pregnancy and my 3rd miscarrige. My OBGYN has ordered some blood tests, and we're trying to get as much information about the possible cause on our end. In the meantime, I felt obligated to share my story in case the vaccine had any hand in this... I get the flu shot every year, and I am pro vaccination. I've been tested negative for COVID-19; prior to getting teh vcaccine I also checked for anti-bodies, and the result was negative as well.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Migraine
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: none
Vorgeschichte: none
Andere Medikamente: 3 days after I received a first doze of Pfizer vaccine on May 13, I found out that I was pregnant, about 5 weeks. I consulted with my OBGYN and also called CDC phone number to consult regarding getting the 2nd doze, and both encouraged me t
Allergien: none
Vorherige Impfungen: -

VAERS 1400165

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EW0183

moderat

Staat: NY
Alter: 14,0
Geschlecht: M
Eingang: 15.06.2021
Impfdatum: 12.06.2021
Beginn: 12.06.2021
Tage bis Beginn: 0,0
Dosis: 2
Route/Site: IM / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: nein

Chest pain Chills Echocardiogram normal Headache Nausea Oropharyngeal pain Pyrexia Troponin Viral test Viral test negative

Symptomtext

6/12 vaccine at 3pm, 10pm started shivering 6/13: headache, sore throat, nausea and fever by the evening 6/14 symptoms continued with the addition of chest pain, brought to the ER. Troponin 10, transferred to hospital.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Chest pain
Hospital-Tage: -
Labordaten: Troponin 6/14 10 Troponin 6/15 5 Viral multiplex negative Viral serum testing pending Echo normal
Aktuelle Erkrankungen: None
Vorgeschichte: None
Andere Medikamente: None
Allergien: None
Vorherige Impfungen: -

VAERS 1400046

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EW0183

moderat

Staat: WA
Alter: 13,0
Geschlecht: F
Eingang: 15.06.2021
Impfdatum: 09.06.2021
Beginn: 12.06.2021
Tage bis Beginn: 3,0
Dosis: 2
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: ja

Chest X-ray normal Chest pain Dyspnoea Electrocardiogram normal Injection site pain Laboratory test normal

Symptomtext

Pt had second dose of Pfizer COVID vaccine, initial sx of just arm pain/soreness at injection site. Three days later, went to ER due to shortness of breath, chest pain for evaluation. She had chest xray, labs, EKG that were all normal. Given albuterol and ibuprofen with improvement in the ER and sent home. She took a few doses of albuterol and ibuprofen the same night and by next day symptoms had all resolved. She previously did not have any reactive airway, allergy or respiratory history. She did not have any of these reactions with the first dose.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Chest pain
Hospital-Tage: -
Labordaten: See above- all done at the ER on 6/12 the day symptoms started
Aktuelle Erkrankungen: None
Vorgeschichte: None
Andere Medikamente: None
Allergien: None
Vorherige Impfungen: -

VAERS 1399256

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EW0183

moderat

Staat: MN
Alter: 21,0
Geschlecht: F
Eingang: 15.06.2021
Impfdatum: 06.05.2021
Beginn: 14.06.2021
Tage bis Beginn: 39,0
Dosis: 2
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein

Abdominal pain upper Blood magnesium Chest X-ray Chest pain Full blood count Metabolic function test Nausea Prothrombin time Troponin Vomiting

Symptomtext

Chest pain, vomiting, epigastric abdominal pain, nausea

Weitere VAERSDATA-Felder

Praegender Schweregrund: Chest pain
Hospital-Tage: -
Labordaten: troponin, CBC with Differential, CMP, magnesium, PT/INR, chest xray
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1397492

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EW0183

moderat

Staat: NY
Alter: 15,0
Geschlecht: M
Eingang: 14.06.2021
Impfdatum: 11.06.2021
Beginn: 13.06.2021
Tage bis Beginn: 2,0
Dosis: 2
Route/Site: SYR / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Chest discomfort Chest pain Disturbance in attention Dyspnoea Heart rate increased Hypertension

Symptomtext

healthy kid with no health issues or ever illnesses. woke up in middle of night day after 2nd vaccination with sever chest pain. he had shortness of breathe. checked blood pressure and pulse, and both were very high. gasped for air often kept him upright all night. As of 6/14 he is still slightly gasping for deep breathes and it is hard for him to concentrate. has pressure in chest. seeking pediatric cardiologist.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Chest pain
Hospital-Tage: -
Labordaten: None done yet
Aktuelle Erkrankungen: None
Vorgeschichte: None
Andere Medikamente: None
Allergien: None
Vorherige Impfungen: -

VAERS 1391510

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EW0183

moderat

Staat: WI
Alter: 14,0
Geschlecht: F
Eingang: 11.06.2021
Impfdatum: 21.05.2021
Beginn: 22.05.2021
Tage bis Beginn: 1,0
Dosis: 1
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: ja

C-reactive protein increased COVID-19 Chest X-ray abnormal Cough Lung disorder Pneumonia Pyrexia SARS-CoV-2 test positive

Symptomtext

Patient reports cough and fever since 5/22. Was seen by pediatrician in clinic on 5/25, diagnosed with pneumonia and prescribed azithromycin. Parent reported compliance with medication but reported that patient started to have coughing fits and fever of 104 at home. This prompted ER evaluation and subsequently admitted to hospital for observation. During admission, patient was treated with IV Ceftriaxone x 3 days and PRN Mucinex for pneumonia. No oxygen requirements, so no further intervention was needed per MD.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Pneumonia
Hospital-Tage: 3,0
Labordaten: 5/28 chest xray shows worsening patchy airspeace disease in left lung base. Positive COVID test on 5/28, elevated CRP values on 5/28 and 5/29.
Aktuelle Erkrankungen: N/A
Vorgeschichte: Obesity (BMI 35), ADHD
Andere Medikamente: N/A
Allergien: NKDA
Vorherige Impfungen: -

VAERS 1391097

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EW0183

moderat

Staat: NJ
Alter: 52,0
Geschlecht: M
Eingang: 11.06.2021
Impfdatum: 01.06.2021
Beginn: 01.06.2021
Tage bis Beginn: 0,0
Dosis: 2
Route/Site: - / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Balance disorder Blood pressure measurement Dyspnoea Feeling abnormal Head discomfort Heart rate increased Hot flush Hypotension Palpitations Photosensitivity reaction Rash Respiratory rate Scab Sensitivity to weather change

Symptomtext

Caller stated he got the second shot two days ago and that next day he had a rash.; when he is in a hot room like 78 degrees with the window open he can not take the heat like he used to; Hot flashes; rash got bright pink, patient stated within that second day of getting the first dose it was pink, then it came back again after the second dose and now the rash was healing; Scrapes in hands little dots now and skin peeled away got worse. Still a little pink on pinky but have little scabs. Last time felt tight but not it is stinging; felt like he was drugged; pulse rate has been a little elevated; Palpitations: Caller stated this started the same day 10 to 12 hours after getting the first shot. Caller stated it was getting somewhat better but after the second shot it got worse.; getting out of breath was reported as worsened; felt like there was pressure in his skull; he felt like he was going sideways and had to grab onto rail for 30 seconds to a minute so would not fall ove; Blood pressure went down to 124/78 and so his blood pressure has been better since the vaccine; This is a spontaneous report from a contactable consumer (patient, self-reported). A 52-year-old patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Solution for injection; Lot number: EW0183; expiry date: 31Aug2021) via unspecified route of administration in left arm on 01Jun2021 as single dose of COVID-19 immunization. The patient's medical history and concomitant medications was not reported. The patient previously received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Solution for injection; Lot number: EW0173; expiry date: 31Aug2021) via unspecified route of administration in left arm on 11May2021 as single dose of COVID-19 immunization and experienced palpitations, felt like he was drugged, felt like there was pressure in his skull, getting out of breath, rash got bright pink, respiratory rate was somewhere around 16, blood pressure went down to 124/78 and so his blood pressure has been better since the vaccine, pulse rate has been a little elevated, on his first finger, the thumb, there was a rash that started bubbling up below the middle knuckle. On an unspecified date in Jun2021, after second dose of vaccination, the patient experienced palpitations, getting out of breath like when he was walking up and down the stairs especially when carrying laundry or a garbage can and he never had this problem doing that unless he had an upper respiratory infection and prior to the vaccine he was perfectly fine, palpitations was reported as worsened, getting out of breath was reported as worsened, rash on his left side where he got the shot on his hand, specifically the top of hand and on his first, second, third, fourth, and fifth finger was reported as worsened, on his first finger, the thumb, there was a rash that started bubbling up below the middle knuckle was reported as worsened, crack in the knuckle area on the second finger was reported as worsened, rash got bright pink was reported as worsened, felt like he was drugged, Blood pressure went down to 124/78 and so his blood pressure has been better since the vaccine, pulse rate has been a little elevated, felt like there was pressure in his skull, felt like he was going sideways, and on 01Jun2021 experienced hot flashes. On 02Jun2021, he was in a hot room like 78 degrees with the window open he cannot take the heat like he used to. On an unspecified date in Jun2021, patient stated that palpitations got worse after the second shot it was started on the same day of first shot of vaccination, 10 to 12 hours after getting the first shot. The patient stated it was getting somewhat better but after the second shot it got worse. On 03Jun2021, that next day of vaccination, patient had a rash and explained that on his first finger, the thumb, there was a rash that started bubbling up below the middle knuckle, this stopped a week to ten days after the first dose and then it came back after the second. Patient had a crack in the knuckle area on the second finger: patient stated he was scheduled for the dose around 12:20 and they had to get more vaccines and so he had to get it around 3:00pm. The patient stated this started to feel bad in the first two hours. For the event of rash got bright pink, patient stated within that second day of getting the first dose it was pink, then it came back again after the second dose and now the rash was healing. Scrapes in hands little dots now and skin peeled away got worse. Still a little pink on pinky but have little scabs. Last time felt tight but not it is stinging. For the event "felt like he was drugged" patient stated this started within 4 hours of first dose, he started to feel better in 5 days and then 10 days after he was completely better and stated he got this again from the second shot and it was getting better but the more he exerts himself the slower he feels but he does not feel like he is on anesthesia. The patient stated that his pulse rate has been a little elevated, stated on the following day after first dose his pulse rate was 114 and 120 was the highest. He stated after the first dose it was between 116 to 120 and after the second dose it was slightly elevated like 90 or something. The patient stated but his pulse rate has been 86, 87, 90 so the pulse rate has been a little elevated. The patient reported he also had hot flashes. He felt like there was pressure in his skull, 10 to 12 day after the first vaccine and this got better, then within 7 to 10 days after the second shot he got it again and he anticipates that for 7 to 10 days he will have to deal with the same crap. The patient felt like he was going sideways, this stopped within two days after the first dose and then it happened within one day or a day in half after the second shot. The patient stated that hot flashes lasted a day or day in a half. The other problem he had noticed is when he is in a hot room like 78 degrees with the window open, he cannot take the heat like he used to. Reportedly, after the second shot they had the patient sit for 15 minutes and so he went to the hospital main area after to get a pass to eat and he felt like he was going sideways and had to grab onto rail for 30 seconds to a minute so would not fall over. He stated the first hour or so after the vaccine he felt like he was drug and he even had caffeine and got his car cleaned, but he felt like his body was behind him like woozy to stomach like in slow motion with exertion and it felt like he was drugged. The patient stated he just wished the vaccine dosage had a high of like if it was 0.3 maybe should be 0.2. The patient stated there should be a different regimen based on height and weight. The outcome of the event "hot flush" was resolved on 01Jun2021, for the event "Palpitations: The patient stated this started the same day 10 to 12 hours after getting the first shot. The patient stated it was getting somewhat better but after the second shot it got worse", "getting out of breath was reported as worsened", "The patient stated he got the second shot two days ago and that next day he had a rash", "he felt like he was going sideways and had to grab onto rail for 30 seconds to a minute so would not fall over", "felt like there was pressure in his skull", "Blood pressure went down to 124/78 and so his blood pressure has been better since the vaccine", "felt like he was drugged", "pulse rate has been a little elevated", "when he is in a hot room like 78 degrees with the window open he cannot take the heat like he used to" was not resolved and for the event "Scrapes in hands little dots now and skin peeled away got worse. Still a little pink on pinky but have little scabs. Last time felt tight but not it is stinging" was unknown, for the event "rash got bright pink, the patient stated within that second day of getting the first dose it was pink, then it came back again after the second dose and now the rash was healing" was recovering.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Dyspnoea
Hospital-Tage: -
Labordaten: Test Date: 2021; Test Name: Blood pressure; Result Unstructured Data: Test Result:124/78; Comments: Blood pressure went down to 124/78 and so his blood pressure has been better since the vaccine: Caller stated this started either 12May2021 or 13May2021; Test Date: 2021; Test Name: Blood pressure; Result Unstructured Data: Test Result:119/26; Comments: the blood pressure has even been 119/26; Test Date: 2021; Test Name: Blood pressure; Result Unstructured Data: Test Result:126/74; Comments: The blood pressure has been 126/74; Test Date: 2021; Test Name: Pluse rate; Result Unstructured Data: Test Result:86,; Comments: 86,87,90 the pulse rate has been a little elevated.; Test Date: 2021; Test Name: Pluse rate; Result Unstructured Data: Test Result:87; Comments: 86,87,90 the pulse rate has been a little elevated.; Test Date: 2021; Test Name: Pluse rate; Result Unstructured Data: Test Result:90; Comments: 86,87,90 the pulse rate has been a little elevated.; Test Date: 2021; Test Name: Pluse rate; Result Unstructured Data: Test Result:114; Comments: his pulse rate was 114 and 120 was the highest.; Test Date: 2021; Test Name: Pluse rate; Result Unstructured Data: Test Result:120; Comments: his pulse rate was 114 and 120 was the highest.
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1389166

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EW0183

moderat

Staat: MI
Alter: 29,0
Geschlecht: M
Eingang: 10.06.2021
Impfdatum: 22.05.2021
Beginn: 26.05.2021
Tage bis Beginn: 4,0
Dosis: 2
Route/Site: SYR / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Angina pectoris Palpitations

Symptomtext

Less than a week after receiving my second dose of Phizer, I started having a sharp pain in the center of my chest (heart), felt like palpitations. It would happen a couple times a day. This continued for a little less than a week, maybe 5 days. Since then, no symptoms.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Palpitations
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: n/a
Vorgeschichte: n/a
Andere Medikamente: n/a
Allergien: Tree nuts
Vorherige Impfungen: -

VAERS 1386149

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EW0183

moderat

Staat: -
Alter: 43,0
Geschlecht: F
Eingang: 09.06.2021
Impfdatum: 09.06.2021
Beginn: 09.06.2021
Tage bis Beginn: 0,0
Dosis: UNK
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt

Dyspnoea Tongue disorder

Symptomtext

Patient received Pfizer vaccine, before sitting in waiting area. Almost immediately complained of SOB and tongue feeling thick. Epipen given. BP 180/68 HR163 POX 93% on RA. Stat Team called. BP down to 158/42, HR 137, Pulse ox 99% on 2L, tongue feeling better and less SOB. Move to ER with stat team.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Dyspnoea
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1383813

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EW0183

moderat

Staat: CA
Alter: 33,0
Geschlecht: F
Eingang: 09.06.2021
Impfdatum: 03.06.2021
Beginn: 08.06.2021
Tage bis Beginn: 5,0
Dosis: 2
Route/Site: SYR / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Arthralgia Dizziness Malaise Mobility decreased Pain Pyrexia

Symptomtext

After having my second dosage on Thursday (06/03/2021) at 4:30pm I was feeling ok until Friday (06/04/2021) morning I was really achy and could not get out of bed because my whole body was hurting. I was experiencing pain in my joints and could not bend my fingers from either hand. I was having slight fevers on and off. The pain in my joints and aches in my body continued through Sunday evening 06/06/2021. On Monday 06/07/2021 I was still achy but was able to be more mobile and was almost back to my normal state of being. On Tuesday 06/08/2021 At 9:30pm I went to take a shower and started feeling like I was beginning to feel unwell. I started to feel light headed and like I was going to faint so I sat down. I went to lay down for about 15min and started to feel better by 10:30pm.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Mobility decreased
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1382709

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EW0183

moderat

Staat: MI
Alter: 40,0
Geschlecht: F
Eingang: 08.06.2021
Impfdatum: 31.05.2021
Beginn: 03.06.2021
Tage bis Beginn: 3,0
Dosis: 1
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Abdominal distension Arthralgia Joint swelling Menstruation delayed Pain in extremity Paraesthesia

Symptomtext

3 days after getting 1 dose of Pfizer vaccine I started I had pain in my left arm and was losing feeling from the injection site into my fingers--tingly feeling. Joint pain in both hands--this subsided about 10 days afterwards. 13 days afterwards, my abdomen swelled--normal waist is 27--went up to 30/31 inches. 15 days afterwards (today) ankles swollen and tingly in both feet but the left worse than the right. Period is also 10 days late as of today--I was regular before the vaccine.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Paraesthesia
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: None.
Vorgeschichte: None.
Andere Medikamente: Multiple vitamin with Iron, B-complex, Vitamin C, Vitamin D, Zinc, probiotic, and Omega 3's.
Allergien: Cipro, Vicodin, and latex.
Vorherige Impfungen: -

VAERS 1382016

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EW0183

moderat

Staat: PA
Alter: 15,0
Geschlecht: F
Eingang: 08.06.2021
Impfdatum: 01.06.2021
Beginn: 03.06.2021
Tage bis Beginn: 2,0
Dosis: 2
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Chest pain

Symptomtext

Patient woke up with chest pain, worsened by position changes and with inspiration. Saw pediatrician who suggested Tylenol for symptom relief. Pain subsided somewhat with 500mg Tylenol. Later changed to 400mg ibuprofen 400mg three times daily. No associated shortness of breath, palpitations, syncope.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Chest pain
Hospital-Tage: -
Labordaten: None
Aktuelle Erkrankungen: None
Vorgeschichte: Scoliosis
Andere Medikamente: None
Allergien: None
Vorherige Impfungen: morbilliform rash following 2nd dose of MMR at age 4

VAERS 1381972

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EW0183

moderat

Staat: NY
Alter: 19,0
Geschlecht: F
Eingang: 08.06.2021
Impfdatum: 03.06.2021
Beginn: 03.06.2021
Tage bis Beginn: 0,0
Dosis: 2
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Chest pain Lymphadenopathy Musculoskeletal chest pain

Symptomtext

Swollen lymph nodes under left arm , Arm of injection is L arm. In addition Rib pain across chest with pain while taking a deep breath

Weitere VAERSDATA-Felder

Praegender Schweregrund: Chest pain
Hospital-Tage: -
Labordaten: None as of yet
Aktuelle Erkrankungen: None
Vorgeschichte: None
Andere Medikamente: Fluoxetine, Low-OgestrelTabs
Allergien: NKDA
Vorherige Impfungen: -

VAERS 1381820

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EW0183

moderat

Staat: IL
Alter: 46,0
Geschlecht: M
Eingang: 08.06.2021
Impfdatum: 17.05.2021
Beginn: 17.05.2021
Tage bis Beginn: 0,0
Dosis: 2
Route/Site: SYR / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Arthralgia Computerised tomogram abnormal Dyspnoea Electrocardiogram normal Fatigue Fibrin D dimer increased Injection site pain Palpitations

Symptomtext

Initially, fatigue, joint pain, injection location soreness, then 3 days later I started getting heart palpitations that lasted for 2+ days (Thurs, Fri and part of Sat.), continued fatigue and shortness of breath.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Dyspnoea
Hospital-Tage: -
Labordaten: On May 26, I went to get evaluated and had labs done. D-dimer test showed slightly elevated levels of 502 nanograms. CT scan showed a small clot in my right lung. EKG normal. Other labs and test within normal range.
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: #1 Pfizer shot resulted in extreme fatigue, brain fog, joint pain, arthritis, exacerbated existing inflammation.

VAERS 1381802

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EW0183

moderat

Staat: CA
Alter: 61,0
Geschlecht: M
Eingang: 08.06.2021
Impfdatum: 13.05.2021
Beginn: 13.05.2021
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Hypoaesthesia Paraesthesia

Symptomtext

reports numbness and tingling on L hand radiates to elbow continues with symptoms at this time. Motor skills intact

Weitere VAERSDATA-Felder

Praegender Schweregrund: Paraesthesia
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: Lung CA
Vorgeschichte: Lung CA
Andere Medikamente: developed numbness and tingling from hand to elbow
Allergien: Lisinopril , ASA
Vorherige Impfungen: -

VAERS 1381706

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EW0183

moderat

Staat: MD
Alter: 27,0
Geschlecht: F
Eingang: 08.06.2021
Impfdatum: 08.06.2021
Beginn: 08.06.2021
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: IM / UN

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Dyspnoea Feeling hot Urticaria

Symptomtext

Patient reported having hives in two places (left thigh and left flank), hot face (not noticeably red), shortness of breath, pulse 68, BP 118/76; occurred within 15 mins of immunization, Benadryl 50 mg PO capsule x1 dose was administered and all symptoms resolved (per patient report) within 10 minutes. She reported a history of similar reactions, resolved using Benadryl. She also carries an epi pen and has one at home if needed.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Dyspnoea
Hospital-Tage: -
Labordaten: None
Aktuelle Erkrankungen: Unknown, none listed
Vorgeschichte: Unknown, none listed
Andere Medikamente: cyclobenzaprine (FLEXERIL) 10 MG tablet Take 0.5 tablets (5 mg per dose) by mouth 3 (three) times daily as needed for Muscle spasms. CAUTION: May cause drowsiness diphenhydrAMINE (BENADRYL) 25 mg tablet Take 2 tablets (50 mg per dose) by mo
Allergien: Cherry Cherry Not Specified 6/8/2021 Fish Containing Products Fish Containing Products Not Specified Allergy 6/25/2013 Grape Grape Not Specified Allergy 6/25/2013 Pork Derived (Porcine) Tylenol
Vorherige Impfungen: -

VAERS 1379750

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EW0183

moderat

Staat: CA
Alter: 13,0
Geschlecht: M
Eingang: 08.06.2021
Impfdatum: 02.06.2021
Beginn: 04.06.2021
Tage bis Beginn: 2,0
Dosis: 2
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: nein

C-reactive protein increased Chest pain Electrocardiogram ST segment elevation Laboratory test Nasopharyngitis Nausea Red blood cell sedimentation rate increased Troponin increased Vomiting

Symptomtext

Pt started with mild cold sxs the day after the vaccine. Then 2 days after the vaccine in the evening developed chest pain - mid sternal - when going to bad. Vomited x1 and pain resolved and fell asleep. Next day also with an episode of chest pain in the pm but more severe and also with n/v; took to ER but left before evaluation done bc pain resolved. The following day 2 more episodes of chest pain less severe. 5 days later sought care for follow up- EKG and labs abnormal so sent to ER for further evaluation.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Chest pain
Hospital-Tage: -
Labordaten: 6/7/2021: Troponin- 30; ESR- 35; CRP- 3.5; EKG- ST elevation; other labs from ER in process
Aktuelle Erkrankungen: mild cold symptoms started the day after the vaccine given-lasted for 2 days
Vorgeschichte: none
Andere Medikamente: none
Allergien: none
Vorherige Impfungen: -

VAERS 1334857

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EW0183

moderat

Staat: IN
Alter: 68,0
Geschlecht: F
Eingang: 08.06.2021
Impfdatum: 17.05.2021
Beginn: 01.05.2021
Tage bis Beginn: -
Dosis: 1
Route/Site: - / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Arthralgia Bone pain Burning sensation Chest pain Diarrhoea Hypoaesthesia Injection site pain Feeling abnormal Insomnia Musculoskeletal stiffness Neck pain Pain Pain in extremity Pain in jaw Skin discolouration Tinnitus Sleep disorder

Symptomtext

ringing in ears; Left arm, left side of neck, shoulder, chest, jaw and back of skull had intense burning and pain/ Pain in arm; Left arm, left side of neck, shoulder, chest, jaw and back of skull had intense burning and pain; Left arm, left side of neck, shoulder, chest, jaw and back of skull had intense burning and pain; Left arm, left side of neck, shoulder, chest, jaw and back of skull had intense burning and pain; Left arm, left side of neck, shoulder, chest, jaw and back of skull had intense burning and pain.; Left arm, left side of neck, shoulder, chest, jaw and back of skull had intense burning and pain.; Left arm, left side of neck, shoulder, chest, jaw and back of skull had intense burning and pain; could not sleep for 2 nights.; diarreha; numbness in left hand; brain fog; neck is stiff; This is a spontaneous report from a contactable consumer (Patient). A 68-year-old non-pregnant female patient received first dose of BNT162B2 (BNT162B2, Lot Number: EW0183), via an unspecified route of administration, administered in left arm on 17May2021 at 11:45 at age of 68-year-old as single dose for covid-19 immunisation. Medical history included allergies with poly glycol in cosmetics and penicillin, no other medical history. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient hadn't been tested for COVID-19. Facility where the most recent COVID-19 vaccine was administered was hospital. The patient didn't receive any other vaccines within 4 weeks prior to the COVID vaccine. Concomitant medications included xantofyl (LUTEIN), ascorbic acid/ zinc citrate (ZINC + VITAMIN C), vitamin D. On 17May2021, at 11:45 AM, immediate reaction after shot was done, patient had left arm, left side of neck, shoulder, chest, jaw and back of skull had intense burning and pain, patient stayed 30 min, and took a acetaminophen (TYLENOL) during this time. Patient came home drank lots of water, pain and burning increased all day took ibuprofin and kept icing. No relief. 4 hours after injection, numbness in left hand lasted 10 min. During night, patient was tried to get out of bed left foot number for 5 min. Patient had diarreha for 5 days. Pain in arm was extreme immediately, stayed sore for 5 days, could not sleep for 2 nights. Patient also had brain fog and ringing in ears starting 22May2021. Patient still had burning in left side of neck, shoulder and jaw and neck is stiff. Patient took benedryl, tylenol, ibuprofen, iced, and exercised stretched, no relief. The outcome of events was not recovered. The events were assessed as non-serious.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Chest pain
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: Medical History/Concurrent Conditions: Cosmetic allergy (allergies with poly glycol in cosmetics); Penicillin allergy
Andere Medikamente: LUTEIN; ZINC + VITAMIN C; VITAMIN D [VITAMIN D NOS]
Allergien: -
Vorherige Impfungen: -

VAERS 1330494

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EW0183

moderat

Staat: IN
Alter: 42,0
Geschlecht: F
Eingang: 08.06.2021
Impfdatum: 17.05.2021
Beginn: 17.05.2021
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: nein

Chest X-ray Dyspnoea Erythema Laboratory test Palpitations Cough Pharyngeal swelling

Symptomtext

my heart started racing; my chest and face turned red; coughing; difficulty breathing; This is a spontaneous report from a contactable Nurse (patient). A 42-year-old male patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Lot number: EN6205, Expiration date: Unknown), via an unspecified route of administration, in left arm on 17May2021 at 04:00 pm (at the age of 42-years old) as 1 ST DOSE, SINGLE for COVID-19 immunisation. The patient medical history included gastroparesis, seasonal allergy, allergy to soy, pencillin and sulfa allergy. The patient concomitant medications were not reported. Patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Patient received medications within two weeks prior vaccination included prilosec, synthroid, allegra, hydroxizine, Pepcid. The patient was not diagnosed with COVID-19, prior the vaccination. Since the vaccination, patient had not been tested for COVID-19. It was reported that on 17May2021 (30 minutes after receiving the vaccine), her heart started racing, chest and face turned red and also she experienced coughing and difficulty breathing. The case was considered as serious (hospitalization). The patient was taken to the ER and received IV Epinephrine, Solumedrol, Benadryl and Pepcid as treatment for the events. Patient was an inpatient for 2.5 days in the emergency room. The outcome of the events palpitations, redness was unknown and outcome for other events was not resolved.; Sender's Comments: Based on a positive temporal association, a possible contributory role of the suspect BNT162B2 cannot be excluded for the reported Cough, Erythema, Dyspnoea and palpitations. The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to regulatory authorities, Ethics Committees, and Investigators, as appropriate.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Dyspnoea
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: Medical History/Concurrent Conditions: Allergy (seasonal allergies); Gastroparesis; Penicillin allergy; Soy allergy; Sulfonamide allergy (Allergies to Sulfa's)
Andere Medikamente: PRILOSEC [OMEPRAZOLE]; SYNTHROID; ALLEGRA; HYDROXIZINE; PEPCID AC
Allergien: -
Vorherige Impfungen: -